<SEC-DOCUMENT>0000886163-21-000119.txt : 20210803
<SEC-HEADER>0000886163-21-000119.hdr.sgml : 20210803
<ACCEPTANCE-DATETIME>20210802195613
ACCESSION NUMBER:		0000886163-21-000119
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		59
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210803
DATE AS OF CHANGE:		20210802

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		211137452

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>lgnd-20210630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:28a37576-9b75-439f-9e08-1e286b83ffe6,g:5715a2c1-e324-41f6-868f-ac2db6a81a2a,d:934841341d8f4620843d0f6fb5e931d1--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:lgnd="http://www.ligand.com/20210630" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lgnd-20210630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80L2ZyYWc6Mzk4M2E5ZjQ3M2ZjNDUxYWFmOTE0NjhhZjEyOWU5OWEvdGFibGU6ZjdiNWZlOWRiYTFmNDUzMWI0YjdiN2EzNTY5Y2E3ZTAvdGFibGVyYW5nZTpmN2I1ZmU5ZGJhMWY0NTMxYjRiN2I3YTM1NjljYTdlMF8yLTEtMS0xLTA_5dbc0f37-110f-4320-b181-00d2db5eb965">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80L2ZyYWc6Mzk4M2E5ZjQ3M2ZjNDUxYWFmOTE0NjhhZjEyOWU5OWEvdGFibGU6ZjdiNWZlOWRiYTFmNDUzMWI0YjdiN2EzNTY5Y2E3ZTAvdGFibGVyYW5nZTpmN2I1ZmU5ZGJhMWY0NTMxYjRiN2I3YTM1NjljYTdlMF8zLTEtMS0xLTA_4fa1c300-1b3c-41e5-9aa8-842098e262b1">2021</ix:nonNumeric><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80L2ZyYWc6Mzk4M2E5ZjQ3M2ZjNDUxYWFmOTE0NjhhZjEyOWU5OWEvdGFibGU6ZjdiNWZlOWRiYTFmNDUzMWI0YjdiN2EzNTY5Y2E3ZTAvdGFibGVyYW5nZTpmN2I1ZmU5ZGJhMWY0NTMxYjRiN2I3YTM1NjljYTdlMF80LTEtMS0xLTA_1861bb00-3216-4081-afac-839d8e4f9a21">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80L2ZyYWc6Mzk4M2E5ZjQ3M2ZjNDUxYWFmOTE0NjhhZjEyOWU5OWEvdGFibGU6ZjdiNWZlOWRiYTFmNDUzMWI0YjdiN2EzNTY5Y2E3ZTAvdGFibGVyYW5nZTpmN2I1ZmU5ZGJhMWY0NTMxYjRiN2I3YTM1NjljYTdlMF81LTEtMS0xLTA_b47a421f-6a19-4968-abbd-15d22cbf9485">0000886163</ix:nonNumeric><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80L2ZyYWc6Mzk4M2E5ZjQ3M2ZjNDUxYWFmOTE0NjhhZjEyOWU5OWEvdGFibGU6ZjdiNWZlOWRiYTFmNDUzMWI0YjdiN2EzNTY5Y2E3ZTAvdGFibGVyYW5nZTpmN2I1ZmU5ZGJhMWY0NTMxYjRiN2I3YTM1NjljYTdlMF82LTEtMS0xLTA_cb72af3d-185b-47e8-a35f-29520b328394">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i4b8c7b189adb4ef7941efd43c9855c73_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfOS0wLTEtMS0w_4b78ef34-ac03-4169-9ec7-b34f5697db27">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="iaf96b8be4ae34fa8b6593ff5e5722455_D20180501-20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80Ni9mcmFnOjE2N2Q3MmIyOTk5NTRiZWRiNGRlYjA1NTgyNDJjODZjL3RhYmxlOmFiOGQzNDI0YmE4NjRmODliMTU1Yzg5NGNhMzkyMmI3L3RhYmxlcmFuZ2U6YWI4ZDM0MjRiYTg2NGY4OWIxNTVjODk0Y2EzOTIyYjdfMi0xLTEtMS0w_6fd202c2-e8c1-47d6-bebb-09172195eb2b">0.0040244</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lgnd-20210630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie37d0cd029f04b4cba79dd56d4faa880_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="iafdc6efe6f0a42d7882e9db52eca6047_I20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ieb2751225b4e422c8601c5b45f74edf0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="idc03d6d6660e4832837b896fd4ac920c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i007aacf643a441dfb068465b043a79cf_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd7a926ec01f44e1afa9cce80d7a71fe_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i451635563e0745a3903ab950f8d8acd1_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia82ef50770684157a9c74a354fbf2b24_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83e26ee83c2f49b7b63a20e39c84e036_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84dcdf4aa51446079e98d1cae23cc101_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia00ad653a232412cbc7060be9d5a8bf2_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e8ad17c667349d89a149e25562db6da_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ee54dca82994576be877ebf09f7324d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6a3f4144744455c937cf2f5a461ee71_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99224b8f7551423ab53c0612ea730573_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45213dff8ed44da68f68cf21fe41c95c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30bc2fe5fa8a4a7399a14d8b760b85c8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i958b44c6e798443596d92cd43ad05dbd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia118fd0c458241d9b6713e222eab7ee8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65849e650e524fdcb63b754a5d8436e0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe754546a5d24b98b707f86af828e94b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a1337c402e94895b3a0d72c858347c2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i345d86b3213949e0b68a46369dcbf41b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i076737849b6f47a39af33bac3b981eec_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f4979e27b50488cb8e40ce52db2db15_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie64508fea3fa42acaa53e660fd2c7de1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if65dba4c92e94e468d530e1cd6f9b9ff_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60594d6045784168a055ecf56059a566_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2464fae38d7345f798229c15c286e868_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba8102507d454bf4a847fd7b3e3a852e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ba2f1bd35304af6883bb88ec59143e5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9237b34bcc649f7a15194fe8593ae0c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fb3f6ec9b3240fe9fb304709b4784d0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0956ece74456424796eeb190e9b7d088_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i513fd4ed54aa4c60a395ce12b274185b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5faae008cb8d4fd182e505b46d24f42b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib66c936d8d3e4e1680b40926d0d9de06_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69b5b44a870842ceac65db79dc5b09f5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80771ca481e3433685a6e3d009b3f480_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29c88524b8d54c90ad5687ff71a4c6d1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5bc01a073dc4d9fba01b085fe94fb42_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f7fffe49713495aad4f0ffcb6a85aa9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb95b1f9e6304389b982e439c753ddd9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b4603280525438abad9ba8b3910e9d8_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b8c7b189adb4ef7941efd43c9855c73_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26498571827b412fb7bbe064394179d2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1527f605baa48ba80a450d04e29ba34_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86d6ecfa583141c4b8e165924fdbabb5_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14e87aa3f56d473daf037a89d1e3f4cb_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b401019625b4ffc9c1541fcb02abdca_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id89030d89d1e4b54bedf38e99c30adf4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic33d37a4611e4bf98bb41808ea525923_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie81d0a0753f34755ba559ce7e8f8a2c3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7eab6271f564f2dbb8e2c685ee1f69e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if602072ed0664abd9859c3de34709d83_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d0edf9b3b234e2eb42a295c13b96ee1_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i314cfb6dd50443a9b34351d3b514793e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e409ba4c7ff45558a246e22b72ee68b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i282a3b3636ac4fdbaf44b6dab63ac522_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11a40d625e53441aabf546066d2672ec_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaff82b7c098441c9ccc6088aa77f91a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i419faf2db8864f5abeee247d1e0449c9_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic303d3a8e76444c19a42764555e9621a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ff799492511435995a4fcce3087275c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e7b723bc7f4425da488009786365c0b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ecd868de4b74f8fb09905823604d5a3_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifab045615fd245ceaa2d3d8f22a26ea6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69fdb2d4d7f2476f80fef8c5512cf6f8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f1d98186147425ba46323876656de3c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i122a78b066844d89aea3dff0b2ed8fc0_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2793aa187d4547d9a9b81510f2035315_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45000082246d4ff88fd5232c1ee7a62a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i840f53fa92b64230898a1197eee37195_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia831e29650fd43b592b44596af1df346_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fdca9e3dfed4bb6afcc9aab7e6b5e28_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81a59b2059264ec5904d079ea451adab_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf215da56009467fb577f8853105c8ca_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cf7fd73de2649c6adb87d065a4be327_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30f51622e3664ef4a40338a9815f069d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic13ffc6f68cb4f39a642cd17209182cf_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia24e5130e49044f78de32bfba07a0e09_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if71a5d29e4fe413f9f12cd54d342dcf1_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic684af48acc3440ab9a6527375151fb9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1af11ab5c0343348fe9016b5ad09b44_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd9b8394e1cb440ab703e649cd6c4d17_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ebfbf5b5a194d5c80780257ca423e45_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b35216c25964eaabae221494b87f323_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50c8a90801e942c69a8f8861a2ca9c65_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4d14843835a4e1db7a4eae595d60048_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33f395a11457480697177a292c67ad43_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3488c7dfa3bd403998e2bc139e4b788c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d89a47caf084728b8ae0acda82c4344_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2df301919454ee598ea1eabd11d48dd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28f9aeb56b074a67bf4231acda630b3d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff698b58bad14579940ceafaf42bc7be_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06dea07a8e6c455f9a6b50cac32e6c7c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7420190e386d412d822b09d22bd8ee99_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i866af78581cc419ba80616eb6a2a7b51_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcd6f50d8ec2470fac2900fa32cb8766_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b92f0d8a3fa48a89bf3fb7d5efaab75_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icafafbdd0712443dbec74d4e5dc99655_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c2a17a99104485fbc33dea758b354d7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i801328559dbe4de794a22df113518552_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabea906284394a2e93e98586744d1714_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75e0f0f3c8b544fd9ffdf8a0ffcba669_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i243763dadfd64bd1beb7dc20bccd336c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd477c8a2f304ec2a970e27dae002cd7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1f3205f079b431c9d64b68d265849ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i996045b306724fc6bc06c217fc070834_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4caf3a29a8642828078a62b68f39097_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="position"><xbrli:measure>lgnd:position</xbrli:measure></xbrli:unit><xbrli:context id="i4cf5accb7aa14841b150df8d3aea6ae1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa1ef48af23941a2b697e7581d564363_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cb11b6f09ff4422b4d9ab2c7d7dd6ff_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaceb341416e648418eb641df20734f0f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3597ace5860a420cae4ec7819bea418b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i527caad11f5c499cb6f93ad3f37d9a05_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaadeca50c0b443ee929d80b58fa9d325_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i232ee16f6b6b445ea405613e39346280_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68df3e804e3343eb841aa45a3b23fc09_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0c0c0cca6254ee68e1a5f7df5bf4c6b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22bae2abb5014d60894b6b57f2d9642b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77623f06245d4063b189951809382a54_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2c3e0ab5c404e47a177e468672a1455_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i132e6a5556ef4b1d9a099d0161937187_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ia3d09f0c28ed43418f452c8a8c413e2c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1f82d2c30024c07a9201d0f6c666c56_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id539ee77085d45f4865a0e6a9a962ff2_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39531d4ab7cf4f0aace79c3dc0eb299a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78065ce772ec469298f8378f75ca1645_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa63d1e101a04ca3930b9a6c58bb223c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19e6852caf924e1e8b8bcb9b31317006_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e1e3edd32274cfa9dee37913732cc3f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedc8c2b179da4c57b0d69399b7319487_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i772dc85a5dae4c1d9ddf06f9992a3e6b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic946c1298336471283c1bde8dab683da_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91c0aa1e995c4988b6700da4987ed2a2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i163d925374744dc19e90ee21d40ac455_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i939615bc911747ff91466aa044f7d705_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf756f2501b74e0898048554c3c0783e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i796ab7b302fd449bb651ec4d41dac07e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f8cf2a139e64d1198f5d67aa364f965_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cf32622b6254648a6c2f68df210c48e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eaf883d9af8472c83fe21fa31227a28_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d3c3bdb624f4891bf85269d85f85683_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8e00bcc4ceb456280e021abea879ec0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e0a0c15e8e344eca24216baf962f264_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bec0cdf729b451dafb85f5a25d8f563_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61de52e98a8c4a8d83132e0c0db3dcd4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47ef30b73058418caaaaff016ffeff78_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i005e8c3fac4c461bbb49bcb0b925f653_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d2ea83589d04ffba237d02df0bd14ca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d8874a1883347ecba3086a56ff8551f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i387e213a06b04a448c4eb58b54ad09f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c7d0cf9f5d9461997395ecfa5774eee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia045228d9b614876a5e504039e235ae7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i641d7897463648d593b3ca40dbd5ede9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i220a77d258c24676985ff3e94a5777f2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d12e59c7f4c45f4a6acae8cdc855fd2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84e9a9944b144829ad78f048f85f8b72_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64737b59a93b4b3f8cbc8602eacded0f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id642d98b4ab5493492cd4d631e98f649_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16091b8d48fe4aa7aed58abf316cf655_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a0c0c9f6f014f8fb72f8cf92bde8fc0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i557878bd28b741ac8242fc9594c33f79_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f8e521dfd304b559210391763ef8967_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38789c05639047e786b0f44cd1f81a54_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic89b647aa620475b919305bbfb902e88_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib05226da6d8b49729bf12cbb13f48688_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dab2c8b54fd4ca4bd5583431d596fda_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib033d6a72993457c9d1212af5e26a84d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad453372414e43f4bbb5fa127bdfd4b6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b51bff8800c428797e64c37e8bf037b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if895305c42ba4796b58e31d56a083e2b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id649b26944164f4f97db61669a9fa440_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c5fd4abee7d4774b0069173b5ab7bd0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3981fc802cb453aa0560b2810a13ded_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97950dc03de449d4b199d76fa33d7646_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id37a246dde494a62b12b0bcc3808a45c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3247e24b5dd46618012805e016575c9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2739e8b8a37c4a40826744f663f3cd9b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71af70fa404948bfa683daccf446fe4e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdb36b5dd0ef4b7da44e14cd73f5fafb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76cad1a6417044928d62c1e4ab27cda9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedd025b870864e4d961da366b7b5528b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibda6b7d8020d42f3b17c4b1a9af44d12_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51c7fde616a242b9b7b30c2c7b19b923_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b8df10c2682432983902baa864b9142_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcd8f21f2f7c4238aa1325d72a7ebbdb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3fe525c20524b7eb5724b9edf213b37_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i061f31e310da49b8bdef63bdf885268c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b410efadd054a649b74fb4ab4b2541f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a8f0d4449da4cd59d8a03eb8dc3f11d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89c072c3ed814deabecf50119491b5cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffd18f96992e4b7ca3b22e6376f529fe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ab7b877600348b0a02624b9699a5469_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19a4f05983fd4dc5b7709df1b833f9c6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9ca0e4731fb4bb4993033661944bef4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ffa5a29a71643c88ede85aeb0f07ae0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75036d6e219044c292bf94448ff791de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9b46809a4a242e9b7e286c5f5853e33_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bc7b23b98c24bcb97086aedb8f6b9a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63e85efa2c7b4b8a8934c115e462671d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a6510d82770434b983d927bf24176d9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie905e4f33e8d4048b5cfaaf2621e7b22_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i253e61895f964faaa57258e78a2e242b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee7f60369ff44dc690747a7ded9f7378_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f492eb7b30f444ea91c469c951cac52_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3231b70ce9d74b739582396aea5f4596_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ac7ec1a94684eb4b17125ff94d45847_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i944386c5eaae4e9b9f6282141c8f6cd9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb2b256fccda44f789ccdb015560f400_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34aa94365beb4fda8e028ed4b2e49ffa_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie634e5d883a246c0b675b67cb23000bd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22bf6089dd044188988a26b040ff65c0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02324c19886a4c18b6067d16ace402b5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8ed0ac879e24c8088076f9f0f8287ed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9760653085dd4b7393829a3480ed5ec0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba7989e6f5e8482ab0daf120805cca55_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21134d594d0f44a3b592bd03f3304d4b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd625ffa45724705a1055f34d130688c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46d7fa3ab3de4bd0993ae0388c003976_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ab8e64374244574bfba15d1172a7cd3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i357340a5b0324e1e9aaa75a5ef7abab6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbfb293f7d7a4cc58fc7ee43b5c0eb61_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0358d88a74ec408bbf376519526abff1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41bb3ed9de1d46d79072d907dbbcda90_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="contingent_value_right"><xbrli:measure>lgnd:contingent_value_right</xbrli:measure></xbrli:unit><xbrli:context id="i4756268078d14fac936133a04e156f01_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="contingent_value_right_series"><xbrli:measure>lgnd:contingent_value_right_series</xbrli:measure></xbrli:unit><xbrli:context id="if487bbb8057a47a2bfafd87e853aa62f_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa9602c2fb6e4bc0a7dfeb7bb5e534d8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21a47f508af74c0c94d611302c008270_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa422606d00d4484ad76a52ce224d9f1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3819ef5e99824efb8df9aa305cf4213a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i382dac6fd2e349f5804856ab5f5e6561_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30b9d60f80524037808096d46cfdd9bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49489b4312d24480aa69abea662ae37a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4e0652f35f242c6a35f9468106a365d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie650f5facb7d4c908578773f98df20f6_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b069c2c100449aeadeb5889f43faee8_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="pure"><xbrli:measure>lgnd:pure</xbrli:measure></xbrli:unit><xbrli:context id="ic3e711d6bdc94af7b6ee030579f78de0_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b809d8e899c48f8b512ad46a079ce18_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icce7f0fe51bb4d6a83a6b3c726ccf985_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37ee9bbba7f147d591042cb6d0e8f335_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iede1f068bfc44082bd810dcfb2a02ad5_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ad6d1665fee4888888e6df28a252048_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4154c45af47f4f888c6561a6c50b57a6_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i373622f14721402a91753acb36279106_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3c7a4ec156b450fb7575fa2881109f7_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9de9ff92177493894947aa870f1fdb1_D20200909-20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-09</xbrli:startDate><xbrli:endDate>2020-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38e92ae2ce0a452cb6846f90bf759997_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightForInternalResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7615fe6e6d454f0fbf707d6edc90ebd9_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1190b533a86e41eca453e2df75138ff0_D20200909-20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-09</xbrli:startDate><xbrli:endDate>2020-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c18c4b370684d73aaaecae58235fa63_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23e8adba85424e069fb3b94c160243e2_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i877bb4cf5c014a2cb25d492e5c13e477_D20200909-20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-09</xbrli:startDate><xbrli:endDate>2020-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b82e3c101694a14a28cf38916f0faa7_D20200908-20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-08</xbrli:startDate><xbrli:endDate>2020-09-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e9a33faf4604184b79f97df731f1531_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia125689d8b6d45c8acc8d4e04a5c8dcb_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i104be1b5412749a98d1b83af0aa45462_D20200908-20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-08</xbrli:startDate><xbrli:endDate>2020-09-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54d5014ebd024ca98e929b3f83f093f0_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0c763244b8f494b9e10d8327366c0ac_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5723a94d9eda43fb8869b9e15a4fa617_D20200908-20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-08</xbrli:startDate><xbrli:endDate>2020-09-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8c72e7934ca467294335090971a29a5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf2d939c66e240b384df46c32a7696cc_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5cbd93c89514ab78b2dac40f63bcb20_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7603e0f422424be9889ff1051524dfb0_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6940e14a447b4533beb52b4a4a14f7dd_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aba352a45ca4f0e95b1673c0ce486b6_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0153378473074ebfa2f0f2c17278e656_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34d2746d79d3442aafdf1a56d6430b2c_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf96b8be4ae34fa8b6593ff5e5722455_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="i12aec736c95f4baa8c48022ee88902a7_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f99d4ba56e34f949157def3cb48d44b_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68aebd079e8d43ca8aaffead3aa479b9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63b28b3736b54b859065e5e8a9af5595_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9523ea7760f1491383b68be5f294a2a0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib669b81f00fd49af94c6193b9b28b3e4_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11b1244fd6124eb2b9e0ee4aa2f36ac9_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="option"><xbrli:measure>lgnd:option</xbrli:measure></xbrli:unit><xbrli:context id="ic5ad33f4bc734bcd93b25da90e7b9a20_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa6b8e5ef49e44a1a9aa9d047df544ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ce65c3cba6d4e1c8557dd4dafca661d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12c4ed3b655b4b9f9e07ed3bc8c69079_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia96af39bd7604591ab7fc340e359673e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2b7db7eef844718bf3f53433cde626e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e79a2e6b67647f882b54599c4f29c87_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89e8971a9fce47b4a1bcea09039305ed_I20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74efa80b6d414949ba31e1e709cc19df_D20190911-20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-11</xbrli:startDate><xbrli:endDate>2019-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="patent"><xbrli:measure>lgnd:patent</xbrli:measure></xbrli:unit><xbrli:context id="i3d23921891db45d19e297bbe9bbe585a_D20191029-20191029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:LupinPatentInfringementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-29</xbrli:startDate><xbrli:endDate>2019-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="civil_complaint"><xbrli:measure>lgnd:civil_complaint</xbrli:measure></xbrli:unit><xbrli:context id="i90fc81e184454d969b54196ebc6b39a6_D20191031-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-31</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="petition"><xbrli:measure>lgnd:petition</xbrli:measure></xbrli:unit><xbrli:context id="i89c035f5c0114d94bb9957d60b37cba3_D20190501-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:InterPartesReviewOfPatentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a9e8cc6b16b4c0e8960c2d7f31c2aaa_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:InterPartesReviewOfPatentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lgnd:GlaxoSmithKlineBiologicalsSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i934841341d8f4620843d0f6fb5e931d1_1"></div><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C.  20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18xNzI_467753f2-fbad-45c9-8111-dd599d30356c">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6Njc2NjNlNjk3Mzc5NDUwMTg0NjVkZTE3NjEwMmU1YTEvdGFibGVyYW5nZTo2NzY2M2U2OTczNzk0NTAxODQ2NWRlMTc2MTAyZTVhMV8wLTAtMS0xLTA_febb8fa7-d23d-4b4f-a1fc-6d962438f71a">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yOTc_e5eb65dc-c47a-448c-9472-2581bad48976">June&#160;30, 2021</ix:nonNumeric>  </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">or</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" format="ixt:booleanfalse" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6ZWJlZjEyZWM5NmQxNDFjOWE1MjViMjAwZTk1NTVhOTgvdGFibGVyYW5nZTplYmVmMTJlYzk2ZDE0MWM5YTUyNWIyMDBlOTU1NWE5OF8wLTAtMS0xLTA_c49ec62c-5045-4367-9746-b08a600ea684">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the Transition Period From ______ to ______ .     </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yMTky_e0c2fe58-f724-423a-a75b-9be8cf044f8d">001-33093</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><img src="lgnd-20210630_g1.jpg" alt="lgnd-20210630_g1.jpg" style="height:86px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"/></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY180MDA_cf67d3e1-e48b-4f94-84dd-2f57c61b3204">LIGAND PHARMACEUTICALS INCORPORATED</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:39.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NGIwM2ZiYTk3ZDc1NGUzYWJhYTc5YjE2NzFkYTI4YTMvdGFibGVyYW5nZTo0YjAzZmJhOTdkNzU0ZTNhYmFhNzliMTY3MWRhMjhhM18wLTAtMS0xLTA_80d6070d-773f-4b4a-8e79-317ebd5f13bb">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NGIwM2ZiYTk3ZDc1NGUzYWJhYTc5YjE2NzFkYTI4YTMvdGFibGVyYW5nZTo0YjAzZmJhOTdkNzU0ZTNhYmFhNzliMTY3MWRhMjhhM18wLTEtMS0xLTA_b612efaf-be21-4e20-854e-dd8db1d8ee62">77-0160744</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NGIwM2ZiYTk3ZDc1NGUzYWJhYTc5YjE2NzFkYTI4YTMvdGFibGVyYW5nZTo0YjAzZmJhOTdkNzU0ZTNhYmFhNzliMTY3MWRhMjhhM18zLTAtMS0xLTA_c2fa75c3-0f79-4b37-b6dd-965c675e9211">5980 Horton Street, Suite 405</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NGIwM2ZiYTk3ZDc1NGUzYWJhYTc5YjE2NzFkYTI4YTMvdGFibGVyYW5nZTo0YjAzZmJhOTdkNzU0ZTNhYmFhNzliMTY3MWRhMjhhM180LTAtMS0xLTA_e4ca5496-1834-4c9f-9303-dd0c1b6e7d53">Emeryville</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NGIwM2ZiYTk3ZDc1NGUzYWJhYTc5YjE2NzFkYTI4YTMvdGFibGVyYW5nZTo0YjAzZmJhOTdkNzU0ZTNhYmFhNzliMTY3MWRhMjhhM181LTAtMS0xLTA_735a3802-90b8-4a32-a1ef-799ad8e59363">CA</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NGIwM2ZiYTk3ZDc1NGUzYWJhYTc5YjE2NzFkYTI4YTMvdGFibGVyYW5nZTo0YjAzZmJhOTdkNzU0ZTNhYmFhNzliMTY3MWRhMjhhM181LTEtMS0xLTA_7be5c597-5ddf-471c-8f0f-516fa50fb4c5">94608</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yMTkz_e703c283-6491-4885-b98b-3d2c25348295">858</ix:nonNumeric>) <ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yMTk0_f49dcede-8281-45de-9275-580e6e1e8a26">550-7500</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's Telephone Number, Including Area Code) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="ie37d0cd029f04b4cba79dd56d4faa880_D20210101-20210630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18zMjk4NTM0ODg1ODgy_8eaa5ba5-c32c-4a32-ac23-65c920c17dc0">3911 Sorrento Valley Boulevard, Suite 110</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="ie37d0cd029f04b4cba79dd56d4faa880_D20210101-20210630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18zMjk4NTM0ODg1ODg0_2a0769b7-d1c1-44b3-95d1-a4d1d37ffc2b">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="ie37d0cd029f04b4cba79dd56d4faa880_D20210101-20210630" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18zMjk4NTM0ODg1ODg2_c903fe0d-9969-44e3-9cff-01ae93cb88c9">CA</ix:nonNumeric> <ix:nonNumeric contextRef="ie37d0cd029f04b4cba79dd56d4faa880_D20210101-20210630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18zMjk4NTM0ODg1ODg4_9e368346-e813-48f0-9969-825ae6c35d8d">92121</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading symbol:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6MjcxMjFmNGVjZjEyNGFmMGEwODQ2ZGIyNzMzMjNmMWUvdGFibGVyYW5nZToyNzEyMWY0ZWNmMTI0YWYwYTA4NDZkYjI3MzMyM2YxZV8xLTAtMS0xLTA_65ce4bf8-3ac0-47ad-8d73-72e6d90bd9e4">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6MjcxMjFmNGVjZjEyNGFmMGEwODQ2ZGIyNzMzMjNmMWUvdGFibGVyYW5nZToyNzEyMWY0ZWNmMTI0YWYwYTA4NDZkYjI3MzMyM2YxZV8xLTEtMS0xLTA_bf7f9b4e-bcb3-406b-ba38-5ede3d5b1536">LGND</ix:nonNumeric></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6MjcxMjFmNGVjZjEyNGFmMGEwODQ2ZGIyNzMzMjNmMWUvdGFibGVyYW5nZToyNzEyMWY0ZWNmMTI0YWYwYTA4NDZkYjI3MzMyM2YxZV8xLTItMS0xLTA_bc507074-116d-44b4-b06f-4decda117ef4">The Nasdaq Global Market</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    <ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yMTk1_c6a88c48-6b34-46c7-9e10-ffd4de436ad4">Yes</ix:nonNumeric>  &#9746;    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    <ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yMTk2_d520f547-f9f6-4ee7-bf70-e1149d82ef0e">Yes</ix:nonNumeric>  &#9746;    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See definitions of  &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;  &#8220;smaller reporting company,&#8221; </span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and "emerging growth company" in Rule 12b-2 of the Exchange Act.  (Check one)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"></td><td style="width:29.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NzYzNWRkMzBkMDI5NDY5Y2IwM2IxYjg5NmI5MGQ0OTIvdGFibGVyYW5nZTo3NjM1ZGQzMGQwMjk0NjljYjAzYjFiODk2YjkwZDQ5Ml8wLTAtMS0xLTA_95d741e9-79a0-4615-9053-3622f76a38b9">Large Accelerated Filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accelerated Filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Accelerated Filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller Reporting Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" format="ixt:booleanfalse" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NzYzNWRkMzBkMDI5NDY5Y2IwM2IxYjg5NmI5MGQ0OTIvdGFibGVyYW5nZTo3NjM1ZGQzMGQwMjk0NjljYjAzYjFiODk2YjkwZDQ5Ml8xLTQtMS0xLTA_57e5db07-d9bd-4e85-a2ff-78f5fce3e5ef">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NzYzNWRkMzBkMDI5NDY5Y2IwM2IxYjg5NmI5MGQ0OTIvdGFibGVyYW5nZTo3NjM1ZGQzMGQwMjk0NjljYjAzYjFiODk2YjkwZDQ5Ml8yLTEtMS0xLTA_8329a7e1-f988-41c6-b100-ebe40b44c814">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" format="ixt:booleanfalse" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yMTkx_3699606b-c867-4bed-be5c-1c563b2a596e">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    No  &#9746;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of July&#160;30, 2021, the registrant had <ix:nonFraction unitRef="shares" contextRef="iafdc6efe6f0a42d7882e9db52eca6047_I20210730" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yMTU0_acf96b22-75e1-47b0-829e-44210426e5a5">16,676,532</ix:nonFraction> shares of common stock outstanding.</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i934841341d8f4620843d0f6fb5e931d1_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I.  FINANCIAL INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_13">ITEM 1.  Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_16">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_19">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_22">Condensed Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_25">Condensed Consolidated Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_28">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_31">10</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_58">ITEM 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_58">25</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_70">ITEM 3.  Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_70">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_73">ITEM 4.  Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_73">32</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II.  OTHER INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_79">ITEM 1.  Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_79">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_82">ITEM 1A.  Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_82">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_85">ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_85">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_88">ITEM 3.  Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_88">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_91">ITEM 4.  Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_91">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_94">ITEM 5.  Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_94">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_97">ITEM 6.  Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_100">37</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_100">SIGNATURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i934841341d8f4620843d0f6fb5e931d1_100">37</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GLOSSARY OF TERMS AND ABBREVIATIONS</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Abbreviation</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definition</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020 Annual Report</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February 24, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$750.0 million aggregate principal amount of convertible senior unsecured notes due 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ab Initio</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ab Initio Biotherapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amgen</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amgen, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ANDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Abbreviated New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Codification</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASU</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Update</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo Med, LLC</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CE</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Captisol-enabled</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CorMatrix Cardiovascular, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVR</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent value right</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal Bioscience, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CStone Pharmaceuticals</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CStone Pharmaceuticals (Suzhou) Co., Ltd.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dianomi Therapeutics</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dianomi Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan, as amended and restated</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Food and Drug Administration</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Generally accepted accounting principles in the United States</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gilead</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gilead Sciences, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GRA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Glucagon receptor antagonist</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IND</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investigational New Drug</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex CVR</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Contingent value rights agreement, dated September 30, 2020, by and between Ligand and Pfenex</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfizer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfizer Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q2 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q2 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis, SA</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">sNDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Supplemental New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taurus</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Taurus Biosciences, LLC</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Teva</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd. and Actavis, LLC, collectively</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travere</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travere Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">xCella Biosciences, Inc.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">YTD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year-to-date</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i934841341d8f4620843d0f6fb5e931d1_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="i934841341d8f4620843d0f6fb5e931d1_13"></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">     Item 1. Condensed Consolidated Financial Statements</span></div><div id="i934841341d8f4620843d0f6fb5e931d1_16"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands, except par value)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMy0xLTEtMS0w_b6153bc4-ab34-497e-acce-9bc44e17ff25">21,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMy0zLTEtMS0w_73a2234a-fa18-47d5-ac83-7ad7612f7a72">47,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNC0xLTEtMS0w_5abca571-c7a4-4e1a-b34d-4c522edda02e">279,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNC0zLTEtMS0w_b5cb0aaf-7780-4bd9-ac64-ce87f0a80d45">363,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNS0xLTEtMS0w_22ca116d-f6e5-4579-9ed6-4cafdad83ae3">58,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNS0zLTEtMS0w_33dfc72b-7a29-47cb-a5eb-f5f6219f73a9">56,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNi0xLTEtMS0w_ce24bcb4-2738-47df-9929-312e8840e442">39,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNi0zLTEtMS0w_e9f2840d-0af0-4be3-9159-241d8e356c08">26,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNy0xLTEtMS0w_0e8d3fe0-b919-4bb4-a3f3-31809531e245">4,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNy0zLTEtMS0w_ee259a66-119e-4703-b399-0de4dcd69eef">2,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfOC0xLTEtMS0w_f4e0ea9d-8e84-4d60-8837-c67a38cb817f">6,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfOC0zLTEtMS0w_571573d4-1960-4c1d-bb31-b4d99f1d77b4">3,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfOS0xLTEtMS0w_fbe66311-17e5-4362-9e52-5e8829b77669">410,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfOS0zLTEtMS0w_d35065c0-9df8-4769-8303-f5daa8030a41">500,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTAtMS0xLTEtMA_5fc2c540-3bd5-454e-9a35-d0f0eff363f6">27,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTAtMy0xLTEtMA_f65799d2-e58b-4f80-ad42-5cda58abc01a">24,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTEtMS0xLTEtMA_58b727e1-f332-47ec-94cd-da383e53d5db">572,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTEtMy0xLTEtMA_93e87ff6-8507-470a-a755-b011d3b291d3">595,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTItMS0xLTEtMA_819ce23a-75ae-4562-ac9b-8fe636c1c175">190,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTItMy0xLTEtMA_1ff5fe29-6ca2-4e2c-8c57-999760976861">189,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial license and other economic rights, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:CommercialLicenseRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTMtMS0xLTEtMA_c62ccc58-5923-45cc-b567-15a171470955">10,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:CommercialLicenseRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTMtMy0xLTEtMA_49b96a0c-6e04-4227-a97e-dc85c9e09d0a">10,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTQtMS0xLTEtMA_f1c9353f-d422-4838-a3b1-43a3a95d1e4f">17,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTQtMy0xLTEtMA_f6d81b98-c14a-43c8-bf6f-5c6baee5efef">14,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTUtMS0xLTEtMA_bac26062-4eca-4c24-a548-5e79f2c029a2">6,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTUtMy0xLTEtMA_a6f7c97b-7bae-4340-bfcf-ec6fe54f7aca">6,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTYtMS0xLTEtMA_449494f3-2e82-4150-b820-137fc35c2625">17,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTYtMy0xLTEtMA_3989a8c2-a4bc-4d3f-92cc-539c3be6c529">15,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTctMS0xLTEtMA_a186bcd7-fede-4d45-8b20-92a3c79e3c27">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTctMy0xLTEtMA_3293f479-9e2c-4f6f-b8af-1e9af0465df2">4,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTgtMS0xLTEtMA_aed60434-1b8e-459b-aa1f-fa51495a9712">1,256,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTgtMy0xLTEtMA_cf3b1a9b-08ef-47b8-87ea-b1abc51a5746">1,362,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts payable </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjEtMS0xLTEtMA_c79a0148-42e2-444e-b0bf-7269351f5a41">17,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjEtMy0xLTEtMA_047d5fbc-e002-4e21-9777-627bff82fc03">3,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjItMS0xLTEtMA_90ba07e4-f2c5-4b24-b708-2d33b1585240">10,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjItMy0xLTEtMA_21d4c484-4301-4d06-b4f4-cf7de22a42ab">18,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjMtMS0xLTEtMA_83acf710-a5e7-4ca0-8d6e-f598628510b6">5,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjMtMy0xLTEtMA_d4465600-15b3-4eff-bdb7-9edc5d2ef49e">39,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjQtMS0xLTEtMA_b77cc548-2d5a-47cd-a340-cd0626ba646d">17,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjQtMy0xLTEtMA_9f2e5c2a-8a74-40d5-8a1a-34f03ad1609f">29,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjUtMS0xLTEtMA_2d0265e3-fa27-4f20-b3ff-2fe150ffca19">2,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjUtMy0xLTEtMA_9ddc1267-89d0-4c82-a139-374162c91653">1,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current financing lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjYtMS0xLTEtMA_64651f67-f0e7-4a25-9594-efdbeb1a3ae5">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjYtMy0xLTEtMA_114d6fad-86a9-41a9-818f-99f649df274d">6,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjctMS0xLTEtMA_4ac76338-55b3-4bf0-97e6-5efb5459d6b0">52,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjctMy0xLTEtMA_81b3ae54-2f93-4380-aa18-be43130e9086">100,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023 convertible senior notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjgtMS0xLTEtMA_37e8c8b2-ad22-4bbb-8b54-9988d8939522">315,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjgtMy0xLTEtMA_ab3fcff1-df97-48e3-92e4-1a376f787b4c">442,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:LiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjktMS0xLTEtMA_a560eba1-2196-4455-ac98-7360c3f36c9f">9,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:LiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjktMy0xLTEtMA_187d6410-6b11-41df-a976-ad2a18a973c3">9,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzAtMS0xLTEtMA_6ab22983-bd06-4067-9660-6df9a8cc78e4">60,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzAtMy0xLTEtMA_33a183b0-f4f5-4b30-b769-bdc5bcecac55">64,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzEtMS0xLTEtMA_16e32bca-b0dd-4ccd-944f-f0164449daab">4,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzEtMy0xLTEtMA_3acf8ce0-0fb9-4040-9c1a-de81e136885c">5,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzItMS0xLTEtMA_b16a78be-e0aa-43c8-ae5b-53d204de4850">28,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzItMy0xLTEtMA_a493dd12-057d-4a36-9366-a30bf527530d">30,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzMtMS0xLTEtMA_689cc08e-d2f6-44e5-89c4-4054b26e1fc1">469,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzMtMy0xLTEtMA_a024a10d-d464-49fa-b96d-5ecaaf8aac36">652,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzQtMS0xLTEtMA_e16befd5-3796-4caa-8221-a8623e347873"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzQtMy0xLTEtMA_189d7623-8de6-400d-b438-728f91423a5f"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzI0_615a499c-8198-48eb-b3d2-458164739e92"><ix:nonFraction unitRef="usdPerShare" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzI0_8e147206-862c-43a0-a2fb-7af1633e86d7">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzM4_114edf08-ca02-4f98-a27d-b1383cc7b0b9"><ix:nonFraction unitRef="shares" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzM4_f90b41f7-2731-48c7-893a-4738c5fcf2ef">5,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzYw_8463505b-6a1a-4a6d-bcd9-4d1959e1331c"><ix:nonFraction unitRef="shares" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzYw_8b1d3e7f-6c2e-4b38-9553-b258667adfd6"><ix:nonFraction unitRef="shares" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzYw_cb783802-d19b-4849-a06e-8b5d3bb14cbd"><ix:nonFraction unitRef="shares" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzYw_cd47bbed-fed9-4266-be6b-14e38f551b9f">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at June&#160;30, 2021 and December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMS0xLTEtMA_7924bfa0-9a79-4bdc-bce4-97ec01463218">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMy0xLTEtMA_7619d045-afa7-48fd-8a72-60e7d4586b46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzIx_098ce082-1f9d-4d1b-ab6c-bb5112a6a7f0"><ix:nonFraction unitRef="usdPerShare" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzIx_9a45b776-baea-4a43-a186-b8e717d8d4dd">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzM1_911c048e-20f6-4739-acf2-037626e8207e"><ix:nonFraction unitRef="shares" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzM1_daabf55f-0e95-459b-809c-25099265d9a4">60,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzU3_460c3913-06a7-4010-89fd-abb065fa6a6b"><ix:nonFraction unitRef="shares" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzU3_7e099ddd-780f-4549-ac4c-014977cde92f">16,676</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzY1_2b5f354a-c759-4ed7-860b-ef48768f6332"><ix:nonFraction unitRef="shares" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzY1_3d0df102-1eb7-47d8-b84f-864398e2933b">16,080</ix:nonFraction></ix:nonFraction>  shares issued and outstanding at June&#160;30, 2021 and December&#160;31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMS0xLTEtMA_856933d3-7993-45e9-9eb7-81677a329b70">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMy0xLTEtMA_66b8e482-4f90-44ac-a37e-dbdb59129f10">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzgtMS0xLTEtMA_b984c281-4c13-4400-93ae-24eabed1e06c">346,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzgtMy0xLTEtMA_23d0f330-c1ac-48e9-acef-bb450238f678">318,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzktMS0xLTEtMA_e63acbb3-d384-4044-a3b9-d158cb1e007e">861</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzktMy0xLTEtMA_978f7a7e-0d44-46aa-ac5d-97a3533e7454">801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Retained earnings </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNDAtMS0xLTEtMA_5deb00c8-6383-4fe1-ab98-d7a175c5f694">440,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNDAtMy0xLTEtMA_e65748bf-8acc-4057-a122-80e30b888faa">391,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNDEtMS0xLTEtMA_992fa464-72b5-4e2c-b7ca-0cf6c5192117">786,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNDEtMy0xLTEtMA_0dfcb5b9-54b7-4d38-911c-56fcf6e26775">709,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNDItMS0xLTEtMA_c5c923dc-9b76-44af-bfbd-0af2f36c3aa1">1,256,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNDItMy0xLTEtMA_f5289c00-0978-4e5c-a52d-ee1919e1fb6e">1,362,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div id="i934841341d8f4620843d0f6fb5e931d1_19"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc03d6d6660e4832837b896fd4ac920c_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNC0xLTEtMS0w_579b2159-fd92-439f-a28b-0adb106e646e">8,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007aacf643a441dfb068465b043a79cf_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNC0zLTEtMS0w_9818f62d-abd0-40c8-9912-5bf24e5d84e2">7,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd7a926ec01f44e1afa9cce80d7a71fe_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNC00LTEtMS0w_f3a2b8b2-0f95-4bc8-a626-b442a0685fd2">15,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i451635563e0745a3903ab950f8d8acd1_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNC02LTEtMS0w_c1b45031-1197-4c5a-a4a1-6ffaa0995d2f">13,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia82ef50770684157a9c74a354fbf2b24_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNS0xLTEtMS0w_41ef9340-8e54-4e96-a3bc-51410ba2bce8">62,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83e26ee83c2f49b7b63a20e39c84e036_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNS0zLTEtMS0w_22a856a9-2083-44e1-9a64-cddc89a42ca3">24,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84dcdf4aa51446079e98d1cae23cc101_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNS00LTEtMS0w_51a65ea4-acc9-4daa-8904-cbf500acd954">93,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00ad653a232412cbc7060be9d5a8bf2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNS02LTEtMS0w_5000b3ed-eda2-4d30-8d49-7ec0eede9eac">45,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Contract revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e8ad17c667349d89a149e25562db6da_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNi0xLTEtMS0w_67d57973-3117-4b1c-8b23-2bdc6fcdd50f">13,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee54dca82994576be877ebf09f7324d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNi0zLTEtMS0w_1c6110a9-679e-4ab6-aecf-0ae0db810e54">9,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6a3f4144744455c937cf2f5a461ee71_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNi00LTEtMS0w_ddb0ea14-d2d5-4b86-8d77-fbb543542f61">30,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99224b8f7551423ab53c0612ea730573_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNi02LTEtMS0w_60a75404-1cd7-4042-ac9b-119eda86869c">15,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNy0xLTEtMS0w_f12c62a0-95dd-4b40-af69-11feeaa2fa5e">84,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNy0zLTEtMS0w_4d7e9042-79cd-45d4-8d29-a629dd575645">41,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNy00LTEtMS0w_5c657c1c-b73c-4b21-82c2-49c3323f3430">139,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNy02LTEtMS0w_c6bef1b2-c1f3-40fc-96c6-132aa6099410">74,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cost of Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostDirectMaterial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfOS0xLTEtMS0w_de86684e-4873-42d5-b6c6-7785b9048b0c">30,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostDirectMaterial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfOS0zLTEtMS0w_6cccd826-cc35-45ca-89c6-9b53301ee310">7,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostDirectMaterial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfOS00LTEtMS0w_a5a3b15f-031c-4aba-a8c9-b927febc1677">38,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostDirectMaterial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfOS02LTEtMS0w_53807827-cef8-4653-a462-180927374e98">12,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTAtMS0xLTEtMA_851b39e7-36be-4884-a0ce-0801422ca7d5">11,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTAtMy0xLTEtMA_672c6a4a-35d8-478e-b7fc-16a3626b2f5e">3,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTAtNC0xLTEtMA_2d52c5ec-5e52-4f49-9d04-8ea32626ee10">23,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTAtNi0xLTEtMA_ed8f9fb0-f1ac-46b1-86a7-0304b69fd53a">7,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTEtMS0xLTEtMA_79cbafd8-14cf-4c4c-a1fe-dd5300d8684b">15,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTEtMy0xLTEtMA_fb9a8e0f-1de5-4044-ba57-de2f07801a4b">12,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTEtNC0xLTEtMA_60ddfbe0-975e-4532-941c-d5f8b1ee8ead">33,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTEtNi0xLTEtMA_5a12422f-7c8c-44ea-ba95-11f59a857c5e">24,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTItMS0xLTEtMA_46fee031-8291-4d6e-8acd-1e00d3dce154">14,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTItMy0xLTEtMA_4fb7149d-9c62-4923-8259-131cfa72fd16">10,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTItNC0xLTEtMA_292521bc-4c15-4a78-8f92-ec9fcd824b86">27,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTItNi0xLTEtMA_9c9d4526-f960-4b97-9562-52eb68d356f7">19,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other operating income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtMS0xLTEtMjczMQ_6d5432e8-ad85-43a5-8271-9bc21363d0b4">34,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtMy0xLTEtMjczNg_017c28d6-99f8-4422-a56b-8cc611bff50d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtNS0xLTEtMjcyNw_525dc2d0-10d8-43e9-aa0d-8c5dc3ee727e">33,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtNy0xLTEtMjc0MA_cad6a262-0668-43bc-8558-c35a98373315">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtMS0xLTEtMA_5df9bd15-198a-4816-b4d9-b1f84e53e9ab">38,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtMy0xLTEtMA_dcc0f8a7-d555-46f9-a465-03c48babe32b">34,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtNC0xLTEtMA_ac207514-65b1-40ee-a387-e0ac2256d226">89,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtNi0xLTEtMA_54165082-46fd-46d3-ac49-6f83c0a35972">63,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTQtMS0xLTEtMA_f381b1a7-3948-4ea2-8225-f0ee5fa6d0e9">45,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTQtMy0xLTEtMA_36572f7a-ee47-46a4-801a-5add815912cc">7,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTQtNC0xLTEtMA_8798f051-f812-40dd-8c67-976b547880e6">50,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTQtNi0xLTEtMA_8b4cb758-f94f-47c5-855d-5eefef5765d7">10,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Gain (loss) from short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTYtMS0xLTEtMA_c2be8118-b89b-43f6-82e9-ae3af624f288">6,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTYtMy0xLTEtMA_3cba9033-07bf-42c8-8cb4-c4a1c7e0eb86">23,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTYtNC0xLTEtMA_9e69285c-9213-44d7-94b5-89270cff0d06">6,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTYtNi0xLTEtMA_478545ad-858c-495e-985e-9150d7b1ea0f">7,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTctMS0xLTEtMA_c15b9ecc-a61b-4141-88c3-1d534e1b9a88">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTctMy0xLTEtMA_bc39855f-6751-485c-b1b7-72109d6c52bf">1,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTctNC0xLTEtMA_09bd8b1a-cd66-42ed-85ad-e30545408d82">529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTctNi0xLTEtMA_85af2df9-80fc-4918-811a-af2925ad53be">6,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTgtMS0xLTEtMA_c2e78880-70bd-4256-a53a-5c69d976b0e5">4,883</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTgtMy0xLTEtMA_a1792c58-ad42-479e-95c4-2c08c9544a5b">6,213</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTgtNC0xLTEtMA_cd51854b-e04c-4ef3-ac28-907f679a4d56">10,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTgtNi0xLTEtMA_b7ec0c71-34f6-4c02-8215-0db72643f699">14,761</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTktMS0xLTEtMA_a7133db0-08b6-40a2-95a6-3ea432825afe">924</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTktMy0xLTEtMA_b09924bf-7173-4762-a5dd-59a16cb54782">1,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTktNC0xLTEtMA_951caedc-ceac-473b-9db1-484c8d193bcb">7,401</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTktNi0xLTEtMA_fe4e61d5-11f2-4ff3-89f3-f748f422e18c">2,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income (loss), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjAtMS0xLTEtMA_e48baad2-939a-47dd-8be4-26922d602c82">12,438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjAtMy0xLTEtMA_0ea44324-67a2-4072-b3ab-030c6e4e990e">21,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjAtNC0xLTEtMA_f303ea40-b937-45d3-8137-9e7c6290e91a">11,389</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjAtNi0xLTEtMA_17894053-c2e0-40da-ba53-3ef4b7188ff1">13,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss)  before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjEtMS0xLTEtMA_40c5b873-39c8-48ef-b8d1-c44160ab491e">33,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjEtMy0xLTEtMA_7fa66aee-5449-445a-a896-9ec614fd3a2e">28,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjEtNC0xLTEtMA_3ac46eac-d0af-4d16-96d3-2d0d095e7482">39,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjEtNi0xLTEtMA_a4f0a9c7-d6f1-44e5-ad0d-b9ab6dc3bfd4">2,296</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjItMS0xLTEtMA_be6c0173-65e7-4687-bcd9-1d8e18f66f2f">2,576</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjItMy0xLTEtMA_dd3a1e7e-04b2-4d54-9e5c-94ae3bb839a5">6,033</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjItNC0xLTEtMA_c2916afb-aea4-46d7-953d-1179be6dad74">9,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjItNi0xLTEtMA_551986b0-7b5c-4782-a7b6-ca477c11f61a">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjMtMS0xLTEtMA_79f6b5ac-dc1a-43e7-86b9-481c96b1476c">30,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjMtMy0xLTEtMA_1a96e21b-b13a-4f04-9c6f-462621288dbc">22,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjMtNC0xLTEtMA_cbf22bc1-8940-42bc-bdcb-4cf1306c8f40">48,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjMtNi0xLTEtMA_7dd9f418-d462-46ac-ba24-3e3687183d1a">2,045</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic net income (loss) per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjUtMS0xLTEtMA_f509d717-44e9-46af-a5e1-e4c27f2f81b6">1.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjUtMy0xLTEtMA_f234141e-497e-458f-8b23-560fcdcc8488">1.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjUtNC0xLTEtMA_bce6fb35-16d3-4aad-979f-dc03b3f675a2">2.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjUtNi0xLTEtMA_232d18d5-17ab-4f8c-9d20-5673080d5f2f">0.13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in basic per share calculations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjYtMS0xLTEtMA_37181abe-9555-45a3-b129-5d4f8d3dc5dd">16,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjYtMy0xLTEtMA_2650f859-b5ca-4cc0-9f0b-d3203e201957">16,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjYtNC0xLTEtMA_2bf89553-5054-4754-b146-4d56096cfe57">16,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjYtNi0xLTEtMA_662d922f-c84e-4d0d-9e3e-757276090169">16,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted net income (loss) per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjgtMS0xLTEtMA_411629f7-25f8-4ff0-a245-e9a7bd034917">1.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjgtMy0xLTEtMA_8877161b-18cf-4ee0-9784-39fbae2174ff">1.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjgtNC0xLTEtMA_a90452c6-c8ab-4d4f-be5f-33579bd7f447">2.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjgtNi0xLTEtMA_3cbf59b8-2691-4d03-9bd5-c9df6d5d33d5">0.13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in diluted per share calculations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjktMS0xLTEtMA_30036ad2-f587-4e66-9bef-100bc57b1a9a">17,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjktMy0xLTEtMA_2d24b64b-86a7-43d8-9b07-920ca4dc34f4">16,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjktNC0xLTEtMA_fdffb41c-aff7-4292-ba5e-7413814f2294">17,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjktNi0xLTEtMA_9ba655de-cc49-4309-aa19-6ee3bd764fe2">16,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i934841341d8f4620843d0f6fb5e931d1_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss):</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfMy0xLTEtMS0w_e7711b78-5113-4aa0-90df-1c260a41094c">30,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfMy0zLTEtMS0w_0d2dabc2-5579-48a5-a20f-516968b3a982">22,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfMy00LTEtMS0w_bd4ee157-8958-43a8-b0d7-b58ccae9f4ab">48,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfMy02LTEtMS0w_1613a84b-32f8-4d81-bea6-224769b57d43">2,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized net gain (loss) on available-for-sale securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNC0xLTEtMS0w_72829c45-59ce-44b6-9895-40e1a615e50b">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNC0zLTEtMS0w_c34121ef-a360-45ef-bd37-2619901e695e">2,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNC00LTEtMS0w_25fdaa5d-226f-4f60-b38b-6d7e9767a0a4">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNC02LTEtMS0w_e68ce798-0b20-45fc-837f-abf93fa04970">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNS0xLTEtMS0w_47981a8f-4d28-4ef1-a780-eba4b76668d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNS0zLTEtMS0w_925d4340-1d2f-49f3-bf4c-0993b02b70cc">185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNS00LTEtMS0w_03cd53d0-55d0-40f6-8eee-420c3b59e867">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNS02LTEtMS0w_54b4326e-bbc9-4e30-9012-9853986de6a5">2,064</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNy0xLTEtMS0w_6c62abdc-5816-491c-bef2-4c5677ab1fb6">30,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNy0zLTEtMS0w_54a976f5-83b0-4071-807d-bb965ee7503e">24,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNy00LTEtMS0w_1a5b4fa5-2d7e-4a07-9600-f7224d88ae7b">48,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNy02LTEtMS0w_dc96b4b3-57b7-4cd3-b34e-83459e0ed2c1">4,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i934841341d8f4620843d0f6fb5e931d1_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i45213dff8ed44da68f68cf21fe41c95c_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMi0xLTEtMS0w_cdf3e569-f0d3-4a2a-8b08-9fa4db5ffff6">16,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45213dff8ed44da68f68cf21fe41c95c_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMi0yLTEtMS0w_a16d2359-faa5-4e7e-aad9-701e206ccba9">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30bc2fe5fa8a4a7399a14d8b760b85c8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMi0zLTEtMS0w_1db6ab09-988b-4f9a-9200-0a6f23f584b8">318,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958b44c6e798443596d92cd43ad05dbd_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMi00LTEtMS0w_87981fae-33ad-495e-8ea8-c8c199b611f5">801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia118fd0c458241d9b6713e222eab7ee8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMi01LTEtMS0w_b24e2b3d-f2f7-45a3-b9bb-f2272841d805">391,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMi02LTEtMS0w_0bc89441-8d66-41fe-a119-5349bd239d1e">709,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65849e650e524fdcb63b754a5d8436e0_D20210101-20210331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMy0xLTEtMS0w_db6ee282-5f44-4570-b496-ff6d3d59e326">572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65849e650e524fdcb63b754a5d8436e0_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMy0yLTEtMS0w_36fff678-1ecc-4871-b85a-66e6e88ed066">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe754546a5d24b98b707f86af828e94b_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMy0zLTEtMS0w_f73468dc-a85e-45ae-a559-51c5e6b9e840">20,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMy02LTEtMS0w_dff76159-8c0c-43b3-9f77-6a92f9e21377">20,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe754546a5d24b98b707f86af828e94b_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNC0zLTEtMS0w_28346e55-8afb-4868-a7a0-e344fac53984">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNC02LTEtMS0w_f774429d-bd39-468f-9a7b-85ee1ab89d21">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a1337c402e94895b3a0d72c858347c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNS00LTEtMS0w_bbea0197-07ab-4b88-9f20-890fb8d7aa01">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNS02LTEtMS0w_894f40c5-2819-4821-b72d-ba5b77ce9319">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe754546a5d24b98b707f86af828e94b_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNi0zLTEtMS0w_e374bacd-e78a-48c6-8105-da1c6a040ea8">9,086</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNi02LTEtMS0w_5e303efd-59f5-4fcc-a02d-927ac378a1dd">9,086</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrant and bond hedge unwind transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe754546a5d24b98b707f86af828e94b_D20210101-20210331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNy0zLTEtMS0w_99d06f8c-8854-40d7-8117-ffb67f79b6f6">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNy02LTEtMS0w_4d281c26-20a1-466c-b1bb-b885edbac7ff">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect for 2023 Notes transactions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe754546a5d24b98b707f86af828e94b_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfOC0zLTEtMS0w_83c893dd-8954-416a-a086-31bcf8eb01ae">2,032</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfOC02LTEtMS0w_39f3aa6e-e6ae-4b8c-9b9f-a71339c3c3ff">2,032</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i345d86b3213949e0b68a46369dcbf41b_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfOS01LTEtMS0w_b2188026-fd1d-47f1-a5fd-3691b5b18446">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfOS02LTEtMS0w_51a3470f-5f4a-4557-a074-9232626cd544">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i076737849b6f47a39af33bac3b981eec_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTAtMS0xLTEtMA_aadd59fb-53e8-445d-afae-68c3081c4ced">16,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i076737849b6f47a39af33bac3b981eec_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTAtMi0xLTEtMA_86b430aa-271b-4f7c-9a2d-ab939e59aa5e">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4979e27b50488cb8e40ce52db2db15_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTAtMy0xLTEtMA_c45944ed-f49a-4dd4-ace5-120dde249c36">336,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie64508fea3fa42acaa53e660fd2c7de1_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTAtNC0xLTEtMA_19036322-c8eb-4f41-acdf-4fb1801b4cce">856</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65dba4c92e94e468d530e1cd6f9b9ff_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTAtNS0xLTEtMA_4bf40473-f974-4d89-bf2f-6d537c7abca8">410,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60594d6045784168a055ecf56059a566_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTAtNi0xLTEtMA_360abb41-e5c9-4762-9dcd-b66fedeaf0a9">745,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2464fae38d7345f798229c15c286e868_D20210401-20210630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTEtMS0xLTEtMTky_5d6cd037-6eaf-4ced-adee-3464802bfabf">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba8102507d454bf4a847fd7b3e3a852e_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTEtMy0xLTEtMjAw_ec91f7ec-dde7-4161-8993-a78a8f2ac991">1,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTEtNi0xLTEtMTA3Mg_03ac122d-16ac-48a7-8ada-1563b484d6d1">1,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba8102507d454bf4a847fd7b3e3a852e_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTItMy0xLTEtMjAw_1a46a79c-0b0b-44cf-b681-8806734df174">10,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTItNi0xLTEtMTA3NA_85c6ab46-7a69-40d5-b13d-2b99fcb46d45">10,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ba2f1bd35304af6883bb88ec59143e5_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTQtNC0xLTEtMjA2_53062674-1ed3-4b1a-8f3d-c7ebbadf7abe">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTQtNi0xLTEtMTA3OA_687cb28b-25dd-44e9-a568-6d2682fd2706">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba8102507d454bf4a847fd7b3e3a852e_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTQtMy0xLTEtMjUxMA_9ca777dc-cc15-4074-abfd-f82a63cd0581">1,073</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTQtNi0xLTEtMjYzNw_fdc12f1c-88a8-40b3-8854-e0c576461a11">1,073</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect for 2023 Notes transactions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba8102507d454bf4a847fd7b3e3a852e_D20210401-20210630" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTUtMy0xLTEtMjUxMA_ae4f9eac-4f6c-4236-8f8f-079786fff2e3">289</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTUtNi0xLTEtMjYzOQ_48d87bb2-2815-4ae4-a572-b43b5b9c7e76">289</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9237b34bcc649f7a15194fe8593ae0c_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTUtNS0xLTEtMjE0_4b9b8574-daa2-42aa-9e85-5388264c204f">30,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTUtNi0xLTEtMTA2OA_841ac514-87a2-4101-b501-6155b9350d58">30,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0fb3f6ec9b3240fe9fb304709b4784d0_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTYtMS0xLTEtMTA4MA_05cba441-1eaa-4d39-9570-47247dc4bbea">16,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fb3f6ec9b3240fe9fb304709b4784d0_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTYtMi0xLTEtMTA4MA_fe3c9236-f190-41d6-8e82-e848b64d2d81">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0956ece74456424796eeb190e9b7d088_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTYtMy0xLTEtMTA4MA_c5af2afe-14ef-43d7-8c23-c57a00add1f4">346,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i513fd4ed54aa4c60a395ce12b274185b_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTYtNC0xLTEtMTA4MA_7d97d822-86b0-4a18-bb13-998091eae4cb">861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5faae008cb8d4fd182e505b46d24f42b_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTYtNS0xLTEtMTA4MA_d4de3d35-e334-4ec1-994a-4d8f5a7e31b5">440,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTYtNi0xLTEtMTA4MA_3e294117-608b-4672-9819-73ef71cc9d2c">786,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings (Accumulated deficit)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib66c936d8d3e4e1680b40926d0d9de06_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMi0xLTEtMS0w_236c7ede-a975-4f2c-b228-cbcdd160203d">16,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib66c936d8d3e4e1680b40926d0d9de06_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMi0yLTEtMS0w_9072a07d-fc34-427f-adfc-e13968531c14">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69b5b44a870842ceac65db79dc5b09f5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMi0zLTEtMS0w_5b882bc6-1a5f-4853-a4c0-d7dd90146eca">367,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80771ca481e3433685a6e3d009b3f480_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMi00LTEtMS0w_2ab55f1d-2714-4146-9899-0c3b2dc1f2ac">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29c88524b8d54c90ad5687ff71a4c6d1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMi01LTEtMS0w_68bbf169-842e-41f9-982a-b95c2dc6a67d">400,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5bc01a073dc4d9fba01b085fe94fb42_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMi02LTEtMS0w_95f78288-a67e-4d2f-b7d6-4dc02add675a">767,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8f7fffe49713495aad4f0ffcb6a85aa9_D20200101-20200331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMy0xLTEtMS0w_a03872d3-887a-4790-b401-491c6004f486">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb95b1f9e6304389b982e439c753ddd9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMy0zLTEtMS0w_89e28e17-9357-447f-8d0b-cf2851dc2808">1,008</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMy02LTEtMS0w_46209537-5e87-4bba-8907-a9664d6843b9">1,008</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb95b1f9e6304389b982e439c753ddd9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNC0zLTEtMS0w_404265d4-d4a0-4e2c-8322-8c188f24bd60">5,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNC02LTEtMS0w_c4cf8f45-4b19-481a-83aa-a3e73cac3d40">5,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8f7fffe49713495aad4f0ffcb6a85aa9_D20200101-20200331" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNS0xLTEtMS0w_d4d0d277-cf9e-4248-b380-09ac54aed17d">878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f7fffe49713495aad4f0ffcb6a85aa9_D20200101-20200331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNS0yLTEtMS0w_11137fad-25cb-4fdc-b673-2ebb50030a7b">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb95b1f9e6304389b982e439c753ddd9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNS0zLTEtMS0w_20c2b9ed-65ac-467f-ba27-2dc38aedce4a">73,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNS02LTEtMS0w_8329505c-3f4e-482c-9fac-7cc28f02ce44">73,287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b4603280525438abad9ba8b3910e9d8_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNi00LTEtMS0w_3efdc4df-b420-40c8-8956-fb53dcfe246d">2,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNi02LTEtMS0w_f530b96f-fc9a-4881-b408-71ea8504212b">2,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b4603280525438abad9ba8b3910e9d8_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNy00LTEtMS0w_4f7ebbcb-68ba-4350-a6f4-1807c4f2f86d">1,879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNy02LTEtMS0w_5e8b1cd9-fc0c-46dd-8059-0b1e7852ddb3">1,879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb95b1f9e6304389b982e439c753ddd9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfOC0zLTEtMS0w_f32f74fe-a8a8-4802-88b3-502b00449603">2,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfOC02LTEtMS0w_eb229fa2-8a16-4536-b750-3c684b5ec9c5">2,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfOS0wLTEtMS0w_4b78ef34-ac03-4169-9ec7-b34f5697db27">Cumulative-effect adjustment from adoption of ASU 2016-13, net of tax</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26498571827b412fb7bbe064394179d2_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfOS01LTEtMS0w_5b923453-c64b-4b49-b8e4-7ef7ca1d4af6">5,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1527f605baa48ba80a450d04e29ba34_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfOS02LTEtMS0w_e093361e-ea76-480c-bbd7-2dac53765204">5,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86d6ecfa583141c4b8e165924fdbabb5_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTAtNS0xLTEtMA_d2a52d0c-e482-4c53-8627-f6c9eb0fcbbc">24,131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTAtNi0xLTEtMA_d2f8d42c-61d9-4e7a-895a-5a487ee1f920">24,131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i14e87aa3f56d473daf037a89d1e3f4cb_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTEtMS0xLTEtMA_c48f6ff2-26b3-4050-9226-a450628a23b9">16,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14e87aa3f56d473daf037a89d1e3f4cb_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTEtMi0xLTEtMA_7fd85a21-74cb-4e0f-bbd3-5c817ebeaa03">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b401019625b4ffc9c1541fcb02abdca_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTEtMy0xLTEtMA_2a464dd6-e388-48db-8198-a440cf063546">295,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id89030d89d1e4b54bedf38e99c30adf4_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTEtNC0xLTEtMA_34800d65-154e-43eb-9372-2aca423ac670">4,867</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic33d37a4611e4bf98bb41808ea525923_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTEtNS0xLTEtMA_e858d64c-b7f4-4f74-8d2b-1b1ac0c03dfc">370,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie81d0a0753f34755ba559ce7e8f8a2c3_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTEtNi0xLTEtMA_79524453-df89-486a-a0ff-15b47bd9e23c">661,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7eab6271f564f2dbb8e2c685ee1f69e_D20200401-20200630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTItMS0xLTEtMTM3_9255cec8-a5c9-448f-8b7f-757f4a026df2">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if602072ed0664abd9859c3de34709d83_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTItMy0xLTEtMTQ1_4d149883-0545-45f1-8cad-bc91e6da1f1f">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTItNi0xLTEtMA_22c9d9bc-06b0-45e5-872e-86749faa3527">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if602072ed0664abd9859c3de34709d83_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTMtMy0xLTEtMTQ1_b1f4ef03-1ae0-4350-93ca-3227c4a6c64d">7,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTMtNi0xLTEtMTA4NA_919ab34a-aeca-4749-879d-f67f7dbfcfc2">7,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net gain on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d0edf9b3b234e2eb42a295c13b96ee1_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTQtNC0xLTEtMTQ5_26cbf5e1-f81f-47ff-98d3-273c157358aa">2,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTMtNi0xLTEtMA_2783a192-5204-4624-aadd-e01edf2b7d43">2,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d0edf9b3b234e2eb42a295c13b96ee1_D20200401-20200630" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTUtNC0xLTEtMTQ5_46be267e-d82a-4fd7-99cd-457922aae803">185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTQtNi0xLTEtMA_73530c85-3384-4054-84e3-b2685475dab0">185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustment on reacquisition of equity due to 2023 debt extinguishment, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if602072ed0664abd9859c3de34709d83_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTYtMy0xLTEtMTQ1_7ffa05c0-058a-43fe-8772-62c2420adfb6">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTUtNi0xLTEtMA_1f8b8921-a3e4-4824-806e-90e0606f378c">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i314cfb6dd50443a9b34351d3b514793e_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTctNS0xLTEtMTUy_1d07b46a-2c3f-4728-be18-1a09e0ec5643">22,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTYtNi0xLTEtMA_3a709b2f-7210-4869-8c4d-eb2c4f13f314">22,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7e409ba4c7ff45558a246e22b72ee68b_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTctMS0xLTEtMA_124cce07-9258-47a5-ab8d-9cb3545c3e5c">16,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e409ba4c7ff45558a246e22b72ee68b_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTctMi0xLTEtMA_b250cd84-724d-4c3a-9e5d-bd2fce4a3b2a">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i282a3b3636ac4fdbaf44b6dab63ac522_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTctMy0xLTEtMA_df8a871a-b31d-4ec9-8d06-d44556f59e68">304,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11a40d625e53441aabf546066d2672ec_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTctNC0xLTEtMA_99048352-5915-4b89-a599-1927e6d863fd">2,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaff82b7c098441c9ccc6088aa77f91a_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTctNS0xLTEtMA_4cb81830-912e-424a-89da-0b32b36f9045">392,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419faf2db8864f5abeee247d1e0449c9_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTctNi0xLTEtMA_a40c6d18-c0aa-4c1b-977e-7c61fc99eed9">695,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i934841341d8f4620843d0f6fb5e931d1_28"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMy0xLTEtMS0w_b7ae6e37-c849-4cff-b885-d3a4bc31dfda">48,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMy0zLTEtMS0w_8abb9d81-5d39-4a3b-bf80-b5dae62a4aac">2,045</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in estimated fair value of contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNS0xLTEtMS0w_54903fb6-6d37-447e-b212-b19345d326f6">33,502</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNS0zLTEtMS0w_c577d340-3674-4b80-b254-6472b823448e">371</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNi0xLTEtMS0w_68d6aee5-b51a-4549-b44a-5f69f88b8cfb">25,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNi0zLTEtMS0w_a566c246-5513-4cf2-8a23-e39b52682402">7,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of premium (discount) on investments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNy0xLTEtMS0w_b8a85f0d-888f-4e6e-b284-c232c7aeac41">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNy0zLTEtMS0w_5cd3dfdb-09d8-4f63-b50f-4f331b9328ac">1,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt discount and issuance fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfOC0xLTEtMS0w_6f848eed-1b72-477c-8611-a8c8abd10192">9,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfOC0zLTEtMS0w_2fb3b8e6-42b4-4a39-89b5-0043e9111322">12,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of commercial license and other economic rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" name="lgnd:AmortizationOfOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfOS0xLTEtMS0w_2a981c40-b111-4b11-b457-de215ab09e06">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AmortizationOfOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfOS0zLTEtMS0w_6744b566-8c8f-4ec4-b367-5f8991c80fcf">2,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss (gain) on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTAtMS0xLTEtMA_c9ee906b-05cf-4634-9df3-3be023b797f4">7,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTAtMy0xLTEtMA_793d65d3-c201-4dac-8c39-6f760fdb8997">659</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTEtMS0xLTEtMA_498d31a5-b572-464a-9e1b-3d7ad678e9f0">18,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTEtMy0xLTEtMA_af3215eb-b070-4c7b-a7ce-d7aea8375b1f">13,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTItMS0xLTEtMA_e43302b1-3213-471d-9d37-1f65402b734c">9,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTItMy0xLTEtMA_45ac31a5-b214-4b50-9174-7e23c0c75984">8,890</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss (gain) from short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:GainLossOnShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTMtMS0xLTEtMA_83d9e508-896b-41b3-846e-28f1b5eec403">6,197</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="lgnd:GainLossOnShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTMtMy0xLTEtMA_bc40b726-b999-4ed0-ac28-44f3cb27c12e">7,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTQtMS0xLTEtMA_a14fd2b7-72d0-4657-b24a-1d43bf39fa45">595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTQtMy0xLTEtMA_ca788208-1086-41cd-b8ad-5687b907ffaa">1,499</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTYtMS0xLTEtMA_b0f5a34e-960c-4ce6-b93d-055c3295a6dd">2,659</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTYtMy0xLTEtMA_55f3ca1b-aeaa-4bcb-8fa9-e8790edce7cf">11,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTctMS0xLTEtMA_c6ed8028-b7f7-4d66-aa66-a8331819a40f">2,326</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTctMy0xLTEtMA_3da57535-d0b6-42f6-8468-8d9abf3172ca">6,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts payable and accrued liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTgtMS0xLTEtMA_03f58b52-3c72-43ca-b70b-dfa4400de819">4,340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTgtMy0xLTEtMA_b9ba578a-06f2-4cd2-9a0f-5ca1a3c405ed">2,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income tax receivable and payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTktMS0xLTEtMA_392f2bd7-0606-4334-84e0-dc12195f753c">2,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTktMy0xLTEtMA_ce0ed31f-ea9b-4084-9436-6f7a95a03168">8,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjAtMS0xLTEtMA_1cd08679-dc23-466a-a31c-4b88b1c62b2b">14,605</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjAtMy0xLTEtMA_824ce34f-2868-4499-8cae-71f28cdbfe6f">7,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other assets and liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjEtMS0xLTEtMA_840bcfde-95f2-4cb1-8fa1-152732c72693">2,786</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjEtMy0xLTEtMA_883bce09-2c01-4648-ab2f-5eea00b33793">4,128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjItMS0xLTEtMA_8ebd8a5f-6b16-4ce0-9e44-514e08857510">31,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjItMy0xLTEtMA_023c2ec1-3bf0-478d-a114-b92f088a2367">41,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjUtMS0xLTEtMA_78db6edc-c513-4fd6-a3ef-dc2e0e3d9952">96,136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjUtMy0xLTEtMA_6729d976-92ee-42b9-aa94-96d9051ff056">336,726</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjYtMS0xLTEtMA_33712f05-c7b9-488c-9df5-14addf912623">150,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjYtMy0xLTEtMA_324a7b05-f143-469c-8650-28d3e1c9906e">179,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from maturity of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjctMS0xLTEtMA_5df0493c-0786-4649-8d76-21ba3d7d1806">34,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjctMy0xLTEtMA_2743b910-f9f8-4b99-919f-dc4c394b3425">452,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for acquisition, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjgtMS0xLTEtMA_fb020062-de34-4e1b-920e-e6cc610fb638">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjgtMy0xLTEtMA_733b9c16-542e-424c-8ec7-63855f2a0a91">15,140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzEtMS0xLTEtMzAyOA_6d153d13-a34e-4dae-a5a6-68a8c4153ff5">4,794</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzEtMy0xLTEtMzAzMQ_90627d80-c040-49c3-9e1d-2e554cc6170f">791</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzAtMS0xLTEtMA_d6952ae1-e915-475f-b538-ac52012e6120">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzAtMy0xLTEtMA_7ba33c62-e40f-4d76-9600-476498e50748">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzEtMS0xLTEtMA_77577308-f1ab-4cb5-884a-2323804ecdf2">84,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzEtMy0xLTEtMA_972abdf7-3edd-4cac-817c-b8a000127204">281,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of 2023 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzQtMS0xLTEtMA_f440b0a8-51ef-4e9d-9bae-8869b94a1cb5">153,381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzQtMy0xLTEtMA_6694cdf0-3939-4951-88d7-4dc20042d38f">203,210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments under financing lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzUtMS0xLTEtMA_6cc791d9-1e96-4902-ba38-965e8ee35b80">9,188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzUtMy0xLTEtMA_1e3590e1-294a-447c-ab71-6d11b2866cb3">1,134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from convertible bond hedge settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzYtMS0xLTEtMA_fa80d48d-713d-4c42-bf94-2d89c36113ef">16,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzYtMy0xLTEtMA_69005e63-2825-4118-a499-90128af809f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to convertible bond holders for warrant purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzctMS0xLTEtMA_fede5e0e-80f4-41dd-8b82-3afacccf50df">16,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzctMy0xLTEtMA_aa2ecd09-ea6b-446a-a40f-1eab0fe8bba6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from stock option exercises and ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzgtMS0xLTEtMA_09c512ec-5505-4e65-a265-f61bdf8729fe">27,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzgtMy0xLTEtMA_83e7c294-99d3-4f6c-9cfc-5298671c1682">1,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzktMS0xLTEtMA_3e699fa4-9902-4476-a8ea-b2e1b175e098">5,901</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzktMy0xLTEtMA_d6b2b139-6fef-4962-b61d-dd87fd40a89a">1,429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDAtMS0xLTEtMA_694bf311-0189-4e8f-a137-5fe460c8d325">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDAtMy0xLTEtMA_6434a4cd-670e-4408-adfd-bbe037c58b69">73,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDEtMS0xLTEtMA_3e1f6724-d9b6-44ae-9b4d-36ada1ebd213">1,050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDEtMy0xLTEtMA_da039f24-4f22-4f4f-b8c7-7693c8a35eba">1,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDMtMS0xLTEtMA_34def0c5-014f-4e55-9400-745510615251">141,540</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDMtMy0xLTEtMA_3a1e3e48-2420-4da1-8b14-f9d5116abb1b">279,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDQtMS0xLTEtMA_4a04033c-c72f-4b80-9596-a64b784e8b68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDQtMy0xLTEtMA_2f1be615-6039-4ed2-bf40-8cb379e382fd">160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDUtMS0xLTEtMA_b0ac0099-789d-4036-aba9-ee5722a28e0a">25,956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDUtMy0xLTEtMA_f06b029a-28e8-48ac-8b8c-2ff673880306">43,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDYtMS0xLTEtMA_a3a99aaa-a73c-4711-9d95-bb918552028e">47,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5bc01a073dc4d9fba01b085fe94fb42_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDYtMy0xLTEtMA_bb923afd-e98b-4e1a-a700-bc7b29714d98">72,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDctMS0xLTEtMA_ce73d9b5-87ce-4dc4-99e9-4185eba26073">22,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419faf2db8864f5abeee247d1e0449c9_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDctMy0xLTEtMA_8ccb8d96-f07a-4edc-a3fd-45c1722f67ae">115,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMS0xLTEtMS0w_a1a88a8b-5fa5-4a88-a6bd-9d8370dea245">1,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMS0zLTEtMS0w_afdc55d2-b884-415a-8ecb-24b97e081c69">2,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taxes paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMi0xLTEtMS0w_57c30978-c394-4acd-b6cd-3648a3e9e954">3,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMi0zLTEtMS0w_e698386e-35a7-41a9-b958-0561e94158a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash in other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMy0xLTEtMS0w_190bda26-5740-4c38-8346-4cbf1c02c099">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419faf2db8864f5abeee247d1e0449c9_I20200630" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMy0zLTEtMS0w_9c1209bb-84c6-4701-8d05-c52da013668a">730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental schedule of non-cash activity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued fixed asset purchases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfOS0xLTEtMS0w_5c466fad-e78b-4ebd-a34a-da823c6cba8b">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfOS0zLTEtMS0w_f43fe679-d9ad-496f-8795-cf0ac3994070">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued inventory purchases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AccruedInventoryPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMTEtMS0xLTEtMA_3df7be6f-1b02-427b-87c5-212924c7fe37">12,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AccruedInventoryPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMTEtMy0xLTEtMA_1ca7c5f5-c1fa-4af2-88f4-e51e31085414">3,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized loss on AFS investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMTMtMS0xLTEtMA_2b2e075a-c1fa-4c0d-9757-2c3e4bd1f2fa">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMTMtMy0xLTEtMA_b915fa53-bc46-4b7b-881b-3d69ad9fc0e9">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:90%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i934841341d8f4620843d0f6fb5e931d1_31"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div id="i934841341d8f4620843d0f6fb5e931d1_34"></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless the context requires otherwise, references in this report to &#8220;Ligand,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; the &#8220;Company,&#8221; and &#8220;our&#8221; refer to Ligand Pharmaceuticals Incorporated and its consolidated subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1.  <ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MTM_82416faa-edbe-4922-a725-e2c45e8c40d5" continuedAt="i35eed3b940ad4f5ebabbfed6135379c2" escape="true">Basis of Presentation and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i35eed3b940ad4f5ebabbfed6135379c2" continuedAt="i8140adedee5e4c768e2b40fdf282e909"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3NDQ_18df6055-0ee8-4319-9f65-7a9417e5d4e8" continuedAt="i3f50cb9aa5984465be96bc18c6ecc362" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3f50cb9aa5984465be96bc18c6ecc362">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2020 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</ix:continuation>  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MDc_be7f3860-fd97-409b-b8da-e0b8f016f3ac" continuedAt="iac5dfe0b04a64c309d18990ec5c80d64" escape="true">Reclassifications</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iac5dfe0b04a64c309d18990ec5c80d64">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#8220;contract revenue&#8221; and &#8220;service revenue&#8221; presented in the condensed consolidated statement of operations for the three and six months ended June&#160;30, 2021 have been combined into &#8220;contract revenue&#8221; in the condensed consolidated statement of operations to conform with the current period presentation.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2020 Annual Report. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3Mzc_ff920aab-a92a-4d79-beaa-6ce6fa1b00ef" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19 Pandemic</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current COVID-19 worldwide pandemic has presented substantial public health and economic challenges and is affecting our employees and partners, patients, communities and business operations, as well as the U.S. and global economy and financial markets. International and U.S. governmental authorities in impacted regions have taken actions in an effort to slow the spread of COVID-19, including issuing varying forms of &#8220;stay-at-home&#8221; orders, and restricting business functions outside of one&#8217;s home. In response, we have restricted in-person access to our executive offices, our administrative employees are mostly working remotely, and we have limited the number of staff in our research and development laboratories and other facilities. The continued spread of the COVID-19 pandemic and the measures taken by the governments of countries have affected, and could continue to affect, our business and the business of our partners, including future disruptions to our supply chain and the manufacture or shipment of drug substance and finished drug product for Captisol, delays by us or our partners in the initiation or enrollment of patients in clinical trials, discontinuations by patients enrolled in clinical trials, difficulties launching or commercializing products and other related activities, which could delay ongoing clinical trials, increase development costs, reduce royalty revenues and have a material adverse effect on our business, financial condition and results of operations. Several of our partners have reported that their operations have been impacted including delays in research and development programs and deprioritizing clinical trials in favor of treating patients who have contracted the virus or to prevent the spread of the virus. This may lead to clinical trial protocol deviations or to discontinuation of treatment for patients who are currently enrolled in the clinical trials being conducted by us or our partners. In addition, certain of our partners have reported negative impacts on product sales which will impact our royalty revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our partners are working to develop drugs to treat COVID-19. For example, we are supplying Captisol to partners, including Gilead and the Gilead consortium (a consortium of manufacturing partners that Gilead is working with to bring efforts together to help maximize global supply) for remdesivir, the first FDA-approved treatment for COVID-19 for the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i8140adedee5e4c768e2b40fdf282e909" continuedAt="i3b83b39d78214d00bac62c6e036a150c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">treatment of patients with COVID-19 requiring hospitalization. In addition, certain of our OmniAb partners have initiated antibody discovery programs for the potential treatment of COVID-19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, the businesses of our partners, our results of operations and our financial condition will depend on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning COVID-19, the actions taken to contain it or treat its impact, including the timing and extent of governments reopening or further restricting activities, the emergence and spread of COVID-19 variants, and the economic impact on local, regional, national and international markets.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MzE_c5fc34f6-5b50-4dcd-b555-c53d9fe2898c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#8217;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures. We intend to adopt this standard on January 1, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3Mjc_6bf4916d-5745-416d-b0aa-28ebfff5f9a0" continuedAt="i325699fedee74e029b8991ccdc98c68c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment.  These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Captisol Sales</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i3b83b39d78214d00bac62c6e036a150c" continuedAt="i2bdbaa151c7743f7836c97891902503f"><ix:continuation id="i325699fedee74e029b8991ccdc98c68c" continuedAt="id98ccd1be513413c8c2bb3a2f7c0f906"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. </span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id98ccd1be513413c8c2bb3a2f7c0f906">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.</ix:continuation> During the three and six months ended June&#160;30, 2021, the amount recognized as revenue that was previously deferred was $<ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTI2NTM_d4ef50c3-78e2-464d-a628-6efd45fc4de8">10.3</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY0OTI2NzQ2NDQ2NA_214db473-f4ab-42d4-b533-c58a78d96385">16.1</ix:nonFraction> million, respectively. During the three and six months ended June&#160;30, 2020, the amount recognized as revenue that was previously deferred was $<ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTI3NTE_5f89277f-ae14-4e76-88b6-ec14658311ed">2.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY0OTI2NzQ2NDQ3Mg_03c53186-4085-4cc4-9662-e36a92d11437">2.4</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3NDg_0ed9df5e-1b56-49dc-bfdb-6e4cb6c2f20b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic303d3a8e76444c19a42764555e9621a_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNC0yLTEtMS0w_922eaffb-00df-4ee2-97b2-bc52517c494c">5,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff799492511435995a4fcce3087275c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNC00LTEtMS0w_247e743d-a7c5-4c4b-8c42-9d48b4702430">5,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7b723bc7f4425da488009786365c0b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNC02LTEtMS0zMjc_6d43f0d3-d652-49a0-8723-97df2e66d3bf">9,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ecd868de4b74f8fb09905823604d5a3_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNC04LTEtMS0zMDA_45cbc4d9-7177-4d15-a1bc-ea81d84e2036">9,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifab045615fd245ceaa2d3d8f22a26ea6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNS0yLTEtMS0w_8e80e741-0dab-4a72-bb62-cd4cec77331d">2,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69fdb2d4d7f2476f80fef8c5512cf6f8_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNS00LTEtMS0w_3c9ac788-0f9e-49d6-abdb-b45787a4e189">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f1d98186147425ba46323876656de3c_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNS02LTEtMS0zMjc_1904ae0d-da7c-45a9-bcbe-de16dbe9e8f6">4,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i122a78b066844d89aea3dff0b2ed8fc0_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNS04LTEtMS0zMDA_3cda9219-b42a-427b-94dc-399397bff47c">2,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2793aa187d4547d9a9b81510f2035315_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNi0yLTEtMS0w_c63ef872-540e-41c2-9add-7b5d38e7870c">983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45000082246d4ff88fd5232c1ee7a62a_D20200401-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNi00LTEtMS0w_770a90af-26df-469a-8dcb-2228edf8aa32">501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i840f53fa92b64230898a1197eee37195_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNi02LTEtMS0zMjc_391853f6-ca07-4177-b2f7-b82f83eebcd0">1,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia831e29650fd43b592b44596af1df346_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNi04LTEtMS0zMDA_e483c965-b826-444c-82ed-72c9820d5b9b">1,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc03d6d6660e4832837b896fd4ac920c_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNy0yLTEtMS0w_fb396381-1ff8-48c8-b552-0c2b4ee7bf85">8,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007aacf643a441dfb068465b043a79cf_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNy00LTEtMS0w_11bd49cc-a25f-44fc-9d05-72c30b4bb57b">7,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd7a926ec01f44e1afa9cce80d7a71fe_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNy02LTEtMS0zMDg_a2630457-d54f-4646-ad73-6e3387c23479">15,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i451635563e0745a3903ab950f8d8acd1_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNy04LTEtMS0zMDY_23b5ef7d-c478-4c3e-bc44-34f0b4fd8fba">13,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia82ef50770684157a9c74a354fbf2b24_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfOS0yLTEtMS0w_41ef9340-8e54-4e96-a3bc-51410ba2bce8">62,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83e26ee83c2f49b7b63a20e39c84e036_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfOS00LTEtMS0w_940ff571-21f3-48ea-9f53-edf259fa0411">24,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84dcdf4aa51446079e98d1cae23cc101_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfOS02LTEtMS0zMjM_171396be-15b7-41ac-9f91-904439c22878">93,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00ad653a232412cbc7060be9d5a8bf2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfOS04LTEtMS0zMTk_479a171e-0d30-4c15-8c79-afa8f0afa372">45,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fdca9e3dfed4bb6afcc9aab7e6b5e28_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTItMi0xLTEtMA_48253d2c-55c4-427b-83b0-efdac76cdf3c">7,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a59b2059264ec5904d079ea451adab_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTItNC0xLTEtMA_26ab1d52-e122-4b23-9a9a-dfdc4efa3514">4,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf215da56009467fb577f8853105c8ca_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTItNi0xLTEtMzMz_f953260f-7ef4-40ec-ab0d-273b78f525b7">12,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf7fd73de2649c6adb87d065a4be327_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTItOC0xLTEtMzM4_e48a9010-3116-46ed-926c-6389cc60025d">7,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30f51622e3664ef4a40338a9815f069d_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTMtMi0xLTEtMA_abeb4146-e96a-4ecf-a416-aa1e9bd88cae">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic13ffc6f68cb4f39a642cd17209182cf_D20200401-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTMtNC0xLTEtMA_980b133f-c0f9-49a5-8a6c-29284dd1c2ca">660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia24e5130e49044f78de32bfba07a0e09_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTMtNi0xLTEtMzMz_43aaf2b4-dc25-4b49-b88c-55000a504850">2,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if71a5d29e4fe413f9f12cd54d342dcf1_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTMtOC0xLTEtMzM4_3d29f21d-490a-4685-88b7-3add159d1004">1,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic684af48acc3440ab9a6527375151fb9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTQtMi0xLTEtMA_a7e513c2-f192-4448-b0e2-06a42a7a70a7">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1af11ab5c0343348fe9016b5ad09b44_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTQtNC0xLTEtMA_dd496bd3-1b30-4935-a056-5bf3210812ef">3,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd9b8394e1cb440ab703e649cd6c4d17_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTQtNi0xLTEtMzMz_b3fcd5f0-88c5-45b9-9528-71a9d63ce1da">12,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ebfbf5b5a194d5c80780257ca423e45_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTQtOC0xLTEtMzM4_e7016e40-b4d2-44d2-99e6-6ea0ab16bdba">3,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b35216c25964eaabae221494b87f323_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTUtMi0xLTEtMA_6aeb9617-dd59-4a21-bb07-626b060bf25f">1,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c8a90801e942c69a8f8861a2ca9c65_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTUtNC0xLTEtMA_c6caeec1-0366-46fb-a211-b801b8415fc7">1,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4d14843835a4e1db7a4eae595d60048_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTUtNi0xLTEtMzMz_2cfbe0f2-fa79-4f2b-987d-53b79eba35c9">3,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33f395a11457480697177a292c67ad43_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTUtOC0xLTEtMzM4_1b92f478-7779-417b-afe1-52af1e23f0ab">1,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e8ad17c667349d89a149e25562db6da_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTYtMi0xLTEtMA_f306d348-05c0-4aee-9515-26a5b7065fb8">13,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee54dca82994576be877ebf09f7324d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTYtNC0xLTEtMA_0e4ba977-a4e6-4472-b854-5cf9f7f2af1b">9,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6a3f4144744455c937cf2f5a461ee71_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTYtNi0xLTEtMzQ0_0765d464-3677-4948-8949-03adf2938819">30,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99224b8f7551423ab53c0612ea730573_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTYtOC0xLTEtMzQ1_9a478b1b-c09f-4be2-a8a2-5a61655cd35c">15,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTgtMi0xLTEtMA_90e1b0ed-d063-4e96-8d86-f5ab9605bc8c">84,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTgtNC0xLTEtMA_a599ec45-f59b-4865-935b-3db9c845282e">41,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTgtNi0xLTEtMzQ5_6b2e732a-cac8-4107-bf09-e9f7b03d54f2">139,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTgtOC0xLTEtMzU0_dc396031-8c64-45cd-968d-138bd5e1e523">74,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i2bdbaa151c7743f7836c97891902503f" continuedAt="i469ba64147b84ed38252e487399cbe99"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="lgnd:ScheduleOfShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3Mzg_1f41a79f-52b0-4bdd-8824-ac85c6ebe9e6" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at June&#160;30, 2021 and December 31, 2020 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:21.722%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.410%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.359%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.909%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.359%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.659%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3488c7dfa3bd403998e2bc139e4b788c_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy0xLTEtMS0w_cce80387-9b22-4e24-9282-66eca3a29728">33,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3488c7dfa3bd403998e2bc139e4b788c_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy0zLTEtMS0w_53470d99-0756-4c64-8292-db6818cd1f10">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3488c7dfa3bd403998e2bc139e4b788c_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy01LTEtMS0w_0b7c4ffa-8875-4e39-9368-2dcaca624105">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3488c7dfa3bd403998e2bc139e4b788c_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy03LTEtMS0w_03fc0d14-9b92-40fd-8506-210f0e574296">33,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d89a47caf084728b8ae0acda82c4344_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy05LTEtMS0w_27d22a0b-7852-4fe2-8505-286dcb599d73">84,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d89a47caf084728b8ae0acda82c4344_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy0xMS0xLTEtMA_ddc36d76-a649-40df-a182-b8da538a690f">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d89a47caf084728b8ae0acda82c4344_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy0xMy0xLTEtMA_2d7f4c5b-ba51-49ff-badb-d6b18da4655e">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d89a47caf084728b8ae0acda82c4344_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy0xNS0xLTEtMA_b594284c-32c9-4fca-873b-58e43c1b11e1">84,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2df301919454ee598ea1eabd11d48dd_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC0xLTEtMS0w_de9fe05a-0602-4006-b44f-fa9abd873733">25,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2df301919454ee598ea1eabd11d48dd_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC0zLTEtMS0w_4e1ee1e0-e62b-4fd4-b922-900cb9eb3380">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2df301919454ee598ea1eabd11d48dd_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC01LTEtMS0w_b5c6c53b-8a85-407d-8d74-528bed84b486">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2df301919454ee598ea1eabd11d48dd_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC03LTEtMS0w_62f017ea-065b-4c43-b1bc-e3b81554ca95">26,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f9aeb56b074a67bf4231acda630b3d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC05LTEtMS0w_3b31d3a2-cfe8-45cf-97d6-960c25f18a7d">30,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f9aeb56b074a67bf4231acda630b3d_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC0xMS0xLTEtMA_809b0ab2-68c9-48d0-9cf9-a7a30ddbd564">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28f9aeb56b074a67bf4231acda630b3d_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC0xMy0xLTEtMA_9f1cff0f-0068-49ab-84c1-34d980bc5fec">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f9aeb56b074a67bf4231acda630b3d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC0xNS0xLTEtMA_7d8a4dfb-fa05-499c-956f-aa5a6379ab95">30,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff698b58bad14579940ceafaf42bc7be_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS0xLTEtMS0w_316b452f-7c08-455a-9361-6782028ed422">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff698b58bad14579940ceafaf42bc7be_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS0zLTEtMS0w_f00e1e3f-4262-4347-a7a5-9a692615a64b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff698b58bad14579940ceafaf42bc7be_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS01LTEtMS0w_d07ee6d2-f6d3-488d-b84b-ac9ccd912826">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff698b58bad14579940ceafaf42bc7be_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS03LTEtMS0w_5fc68863-52e0-4449-9292-9d0fbc32ccbe">2,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06dea07a8e6c455f9a6b50cac32e6c7c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS05LTEtMS0w_69be1a5f-96f8-4ccb-9a69-f85b76e81cf9">4,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06dea07a8e6c455f9a6b50cac32e6c7c_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS0xMS0xLTEtMA_451bf339-61f3-4e9c-b709-ba49c8d0a6ae">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06dea07a8e6c455f9a6b50cac32e6c7c_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS0xMy0xLTEtMA_3431759d-fc34-4722-8397-12d1d4c02879">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06dea07a8e6c455f9a6b50cac32e6c7c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS0xNS0xLTEtMA_bb548adb-de12-4281-be14-907718af8fd1">4,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7420190e386d412d822b09d22bd8ee99_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi0xLTEtMS0w_5608cef7-256c-4260-85fa-e0f96ac01c4f">19,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7420190e386d412d822b09d22bd8ee99_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi0zLTEtMS0w_0bebb1ef-0ffa-4b05-b81c-0433b287015b">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7420190e386d412d822b09d22bd8ee99_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi01LTEtMS0w_655ba3b7-8871-419d-bff2-9979ab60d6cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7420190e386d412d822b09d22bd8ee99_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi03LTEtMS0w_2bb22e32-926a-44b6-a847-9eb1ef5b244c">19,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866af78581cc419ba80616eb6a2a7b51_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi05LTEtMS0w_f86f2d42-d2e8-4e29-9f2f-725fbbbec309">45,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866af78581cc419ba80616eb6a2a7b51_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi0xMS0xLTEtMA_971f1285-949b-46b3-984e-7ff8e054b74a">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i866af78581cc419ba80616eb6a2a7b51_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi0xMy0xLTEtMA_8d4c34d9-9b6b-439a-ba4b-0b722da9b9dc">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866af78581cc419ba80616eb6a2a7b51_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi0xNS0xLTEtMA_8d0c649f-057f-4746-a13e-85c840f979f6">45,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd6f50d8ec2470fac2900fa32cb8766_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy0xLTEtMS0w_87af0dd3-a4dd-42f0-9d4f-3325679219bf">5,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd6f50d8ec2470fac2900fa32cb8766_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy0zLTEtMS0w_8cfc224d-28be-4f06-a02b-0713e2ba8cbe">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idcd6f50d8ec2470fac2900fa32cb8766_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy01LTEtMS0w_22dcf9a7-153a-4361-ba8f-4e440e726809">310</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd6f50d8ec2470fac2900fa32cb8766_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy03LTEtMS0w_fe2c4d66-5275-4559-95ed-7002d33f0671">5,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b92f0d8a3fa48a89bf3fb7d5efaab75_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy05LTEtMS0w_9af04e38-0688-4ca8-a23a-5759610d0c3b">4,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b92f0d8a3fa48a89bf3fb7d5efaab75_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy0xMS0xLTEtMA_0dcae70f-ccef-4f9f-ac75-ce7af9d17dc7">360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b92f0d8a3fa48a89bf3fb7d5efaab75_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy0xMy0xLTEtMA_6927b1bc-ed48-4eda-bd90-a0bbf581e9b2">1,388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b92f0d8a3fa48a89bf3fb7d5efaab75_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy0xNS0xLTEtMA_c146122a-8123-4038-ac47-e405a275fd26">3,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icafafbdd0712443dbec74d4e5dc99655_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC0xLTEtMS0w_2f49f42c-7a19-4ba7-970e-ed528b19056f">151,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icafafbdd0712443dbec74d4e5dc99655_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC0zLTEtMS0w_c0ae8288-00b8-43f3-9f24-aa5697c91ca6">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icafafbdd0712443dbec74d4e5dc99655_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC01LTEtMS0w_98bd1aef-67b9-423e-be2e-e8ea40c4d2f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icafafbdd0712443dbec74d4e5dc99655_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC03LTEtMS0w_ba872218-ba4c-4b6a-b82c-0806c8eec294">152,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2a17a99104485fbc33dea758b354d7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC05LTEtMS0w_8750ca5b-0db9-4d03-a8bb-27e758060dfe">151,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2a17a99104485fbc33dea758b354d7_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC0xMS0xLTEtMA_ac807f0e-4132-4f8f-853a-914845acd40a">386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2a17a99104485fbc33dea758b354d7_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC0xMy0xLTEtMA_87118661-6f45-4b47-a984-42c715e25b3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2a17a99104485fbc33dea758b354d7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC0xNS0xLTEtMA_17a783b9-504b-4e0e-a4ca-19daf304a05f">151,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Treasury bill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i801328559dbe4de794a22df113518552_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS0xLTEtMS0w_2aff873c-6072-47f3-8e32-014cd62f7b85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i801328559dbe4de794a22df113518552_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS0zLTEtMS0w_1dd8dbdf-5cff-4f5d-bc84-a5f19e48dd92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i801328559dbe4de794a22df113518552_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS01LTEtMS0w_777aa1eb-337a-42d8-8944-a20780e6b907">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i801328559dbe4de794a22df113518552_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS03LTEtMS0w_24658072-6254-4e4c-89a0-cef256e067b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabea906284394a2e93e98586744d1714_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS05LTEtMS0w_3dcf8abc-c58a-437e-82fe-a98fbd1e5f7e">3,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabea906284394a2e93e98586744d1714_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS0xMS0xLTEtMA_bfda019b-e9d0-422c-af56-76a1bd9f4441">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabea906284394a2e93e98586744d1714_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS0xMy0xLTEtMA_9a94d7d2-cee4-4bd9-b34e-5a88c4800013">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabea906284394a2e93e98586744d1714_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS0xNS0xLTEtMA_34ecfc4a-4219-40f9-a11f-69df51efa8b7">3,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75e0f0f3c8b544fd9ffdf8a0ffcba669_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtMS0xLTEtMA_871d02c8-9ae1-4dae-b48a-18e6346d7af9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75e0f0f3c8b544fd9ffdf8a0ffcba669_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtMy0xLTEtMA_111e4ee4-7cd9-4cdf-9bd3-5eaa0f86f726">713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75e0f0f3c8b544fd9ffdf8a0ffcba669_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtNS0xLTEtMA_79eac30f-8d8c-4a97-8642-b88edffc383e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75e0f0f3c8b544fd9ffdf8a0ffcba669_I20210630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtNy0xLTEtMA_522a9e3a-967f-4779-8450-de663b276127">713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243763dadfd64bd1beb7dc20bccd336c_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtOS0xLTEtMA_6202736d-66c3-463d-bdad-847701d8f314">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243763dadfd64bd1beb7dc20bccd336c_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtMTEtMS0xLTA_9daa0a10-b9a8-4f1a-bfc3-16e5eefb4d2e">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243763dadfd64bd1beb7dc20bccd336c_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtMTMtMS0xLTA_8337a497-7497-43ba-a75e-ac84d83a09e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243763dadfd64bd1beb7dc20bccd336c_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtMTUtMS0xLTA_d258955a-4a5a-4a71-ae05-c81ae40b775c">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtMS0xLTEtMA_5274dcc2-57b8-4311-abfa-27d69fde62d1">239,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtMy0xLTEtMA_34768f31-d123-4bc1-a568-0ddb5569f0fd">1,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtNS0xLTEtMA_c6617292-c365-4c29-a94c-d865666df57d">315</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtNy0xLTEtMA_c1a33018-9ad7-48c3-9c5f-564f39ed0391">239,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtOS0xLTEtMA_a74b0f29-cd13-43d8-85bf-472cdfa65ba2">324,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtMTEtMS0xLTA_cc7138dc-5b0f-430e-b14c-c20cf5c38c01">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtMTMtMS0xLTA_4cc2549f-e641-48df-899a-93f8bb530448">1,391</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtMTUtMS0xLTA_3fc6a8b2-3b8e-4c74-be65-293b5f609fd8">324,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd477c8a2f304ec2a970e27dae002cd7_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTItNy0xLTEtMA_1cd5cf43-e86e-4493-a321-7e9797fc7bbc">40,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1f3205f079b431c9d64b68d265849ce_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTItMTUtMS0xLTA_8871b439-f8b0-442a-acad-7877f27581d0">32,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75e0f0f3c8b544fd9ffdf8a0ffcba669_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTMtNy0xLTEtMA_dc48e03c-ab2c-4d98-a36d-6e59b9560057">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243763dadfd64bd1beb7dc20bccd336c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTMtMTUtMS0xLTA_d7ccb6a8-755e-4f9d-ab43-0bafad3c8306">6,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTQtNy0xLTEtMA_80481ee4-2ea6-4b73-8152-3dbe8df03ffb">279,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTQtMTUtMS0xLTA_2e61a54b-d44c-4d0a-aa78-aea8474ae8a6">363,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2021, we exercised all outstanding Viking warrants to purchase <ix:nonFraction unitRef="shares" contextRef="i996045b306724fc6bc06c217fc070834_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTMyMjA_68b5e47b-cb04-4307-aa52-11d9f99ded25">1.5</ix:nonFraction> million shares of Viking's common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic4caf3a29a8642828078a62b68f39097_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTMyNzk_9999c9e5-39d6-4095-b684-1c370fcabcf3">1.50</ix:nonFraction> per share. As of June&#160;30, 2021, we have <ix:nonFraction unitRef="shares" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTMzMTE_610952a2-a8ae-4714-becf-79cbc40dd1bc">zero</ix:nonFraction> Viking warrants outstanding.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three and six months ended June&#160;30, 2021.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MTE_cf5f48d5-24da-4251-acc8-b578ced1fa0a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmEyODliYzNkYTNiZDQ2NTFhZjFiOGMzNGI1N2Y4MDQ5L3RhYmxlcmFuZ2U6YTI4OWJjM2RhM2JkNDY1MWFmMWI4YzM0YjU3ZjgwNDlfMi0xLTEtMS0w_dfab9e98-8cef-4020-b553-32cb2761f809">57,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmEyODliYzNkYTNiZDQ2NTFhZjFiOGMzNGI1N2Y4MDQ5L3RhYmxlcmFuZ2U6YTI4OWJjM2RhM2JkNDY1MWFmMWI4YzM0YjU3ZjgwNDlfMi0zLTEtMS0w_42e44022-9e12-4e88-ae0b-58b977588c9f">58,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmEyODliYzNkYTNiZDQ2NTFhZjFiOGMzNGI1N2Y4MDQ5L3RhYmxlcmFuZ2U6YTI4OWJjM2RhM2JkNDY1MWFmMWI4YzM0YjU3ZjgwNDlfMy0xLTEtMS0w_2174994d-6b84-4eae-bfcd-fb288fb10696">23,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmEyODliYzNkYTNiZDQ2NTFhZjFiOGMzNGI1N2Y4MDQ5L3RhYmxlcmFuZ2U6YTI4OWJjM2RhM2JkNDY1MWFmMWI4YzM0YjU3ZjgwNDlfMy0zLTEtMS0w_c11c59ec-766a-49d5-be63-42fcb32dada9">23,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmEyODliYzNkYTNiZDQ2NTFhZjFiOGMzNGI1N2Y4MDQ5L3RhYmxlcmFuZ2U6YTI4OWJjM2RhM2JkNDY1MWFmMWI4YzM0YjU3ZjgwNDlfNC0xLTEtMS0w_b2b0b8d6-0d88-46f5-b1dc-fc3b0d4024d2">81,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmEyODliYzNkYTNiZDQ2NTFhZjFiOGMzNGI1N2Y4MDQ5L3RhYmxlcmFuZ2U6YTI4OWJjM2RhM2JkNDY1MWFmMWI4YzM0YjU3ZjgwNDlfNC0zLTEtMS0w_dd7d032b-b297-4ff2-9042-b4bc4a027ff0">81,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of <ix:nonFraction unitRef="position" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY0OTI2NzQ2NTI5Nw_6a212f66-d900-49b7-8868-c3808799a814">seven</ix:nonFraction> positions which were in an unrealized loss position as of June&#160;30, 2021. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, <ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTQ5MDE_2d78a107-98c6-4c6f-a55e-1dc72bf412c3">no</ix:nonFraction> credit losses were recognized for the three and six months ended June&#160;30, 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i469ba64147b84ed38252e487399cbe99" continuedAt="i01433493ef5440b994917b88eb59ec5f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMzI5ODUzNDkwNzUzOA_d6dbfe1a-b2a5-4168-8393-fdc65d4b494c" continuedAt="i1f4c8ae24c4b4f0b9a1e27a6e471ae7a" escape="true">Accounts Receivable and Allowance for Credit Losses</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1f4c8ae24c4b4f0b9a1e27a6e471ae7a">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.</ix:continuation> During the three and six months ended June&#160;30, 2021, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the COVID-19 pandemic on our business and recorded an adjustment of $<ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-4" format="ixt:numdotdecimal" name="lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY0OTI2NzQ2NTkzNw_9e2bb07a-e685-493a-8d6e-1d0fc90ebfd9">0.04</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY0OTI2NzQ2NTk2NA_46af2e14-e322-4831-a369-7a94e509fd9a">0.1</ix:nonFraction> million of allowance for credit losses, respectively, as of June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of prepaid inventory and finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2021, we have made advanced payments for inventory from our supplier of Captisol totaling $<ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdvancesOnInventoryPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfNDM5ODA0NjU0MTYyOQ_f4bcd614-5ad1-4a50-bb19-093538b23268">50.2</ix:nonFraction>&#160;million. We have applied credits for such inventory purchases of $<ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-5" format="ixt:numdotdecimal" name="lgnd:CreditsAppliedOnAdvancesOnInventoryPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfNDM5ODA0NjU0MTY0NA_7181c1b8-0c38-4522-8857-c655731db451">15.8</ix:nonFraction>&#160;million and will utilize the remaining advanced payments to offset a portion of the purchase price for future Captisol purchases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3NDA_93e2cfdb-86b2-4ace-86c4-6f0b84790ab3" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMy0xLTEtMS0w_819ce23a-75ae-4562-ac9b-8fe636c1c175">190,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMy0zLTEtMS0w_1021cf99-b220-491f-916f-a25f2ae7cccf">189,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf5accb7aa14841b150df8d3aea6ae1_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfNS0xLTEtMS0w_351c18a0-90c9-4ca9-8601-b2640c9453b8">277,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa1ef48af23941a2b697e7581d564363_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfNS0zLTEtMS0w_2951f8f0-21eb-4923-b20a-99326c4a33d9">277,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cf5accb7aa14841b150df8d3aea6ae1_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfNi0xLTEtMS0w_733c91b8-1813-44fc-b9d2-42c58d6fa061">71,276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa1ef48af23941a2b697e7581d564363_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfNi0zLTEtMS0w_9854c8d3-1f8c-4f40-8d8c-48d18d030dac">63,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb11b6f09ff4422b4d9ab2c7d7dd6ff_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfNy0xLTEtMS0w_5b3ae1ec-a03f-4628-b11f-4faf7a48830f">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaceb341416e648418eb641df20734f0f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfNy0zLTEtMS0w_46d93fc0-e164-4e6d-b900-63130668f538">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cb11b6f09ff4422b4d9ab2c7d7dd6ff_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfOC0xLTEtMS0w_fc4d8ccc-16ac-4bbb-8e85-47f7abf797df">1,378</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaceb341416e648418eb641df20734f0f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfOC0zLTEtMS0w_a45c6d63-5f47-4e89-afa9-c593ab2bd1df">1,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3597ace5860a420cae4ec7819bea418b_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfOS0xLTEtMS0w_7a3b7ea2-de8d-419a-ba56-7dbbd5440dc2">40,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i527caad11f5c499cb6f93ad3f37d9a05_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfOS0zLTEtMS0w_c49853f9-17a2-46c3-abdb-7802467e5775">40,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3597ace5860a420cae4ec7819bea418b_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTAtMS0xLTEtMA_1e9aeea6-8e6f-43ce-a74a-80f8dd9a1120">16,932</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i527caad11f5c499cb6f93ad3f37d9a05_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTAtMy0xLTEtMA_26313d96-c1ae-4d11-8f27-241ba43f994b">15,597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaadeca50c0b443ee929d80b58fa9d325_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTEtMS0xLTEtMA_16b16f2e-230f-4122-b8ec-a89d6c865f19">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i232ee16f6b6b445ea405613e39346280_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTEtMy0xLTEtMA_7f20dd34-c597-4133-8577-391a40faedab">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaadeca50c0b443ee929d80b58fa9d325_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTItMS0xLTEtMA_1076216d-bcf1-44e7-bc56-0a8d76efb8d1">21,730</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i232ee16f6b6b445ea405613e39346280_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTItMy0xLTEtMA_5c7d0867-c529-4069-8648-ffe00661095a">7,243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTMtMS0xLTEtMA_07d0fc25-6b0d-4453-aa91-a4bb111147e8">762,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTMtMy0xLTEtMA_867473ad-3439-43b9-bebb-3df41537b1d3">784,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial License and Other Economic Rights</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI2OTk_6dbf89ee-c988-4f76-abd3-a65e1ac309f9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license and other economic rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68df3e804e3343eb841aa45a3b23fc09_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMi0yLTEtMS0w_2deb96f8-653e-46b7-8dae-59103c391899">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68df3e804e3343eb841aa45a3b23fc09_I20210630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMi00LTEtMS0w_c6c5dad8-bd0f-4701-aad0-1a405599e19f">9,470</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68df3e804e3343eb841aa45a3b23fc09_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMi02LTEtMS0w_af2c64ef-aec9-4815-af8b-131a915aaeaf">8,226</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c0c0cca6254ee68e1a5f7df5bf4c6b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMi04LTEtMS0w_2c24ff5e-3a01-4aa3-abdb-eb236d45135d">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0c0c0cca6254ee68e1a5f7df5bf4c6b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMi0xMC0xLTEtMA_fcfe4493-0f5f-45dc-9b61-ff6ad82c051c">9,588</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c0c0cca6254ee68e1a5f7df5bf4c6b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMi0xMi0xLTEtMA_8e4748ac-752e-40df-bcf5-b2c1187154d1">8,108</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bae2abb5014d60894b6b57f2d9642b_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMy0yLTEtMS0w_092c8585-e59c-4f64-93c4-fb001d92e7d0">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22bae2abb5014d60894b6b57f2d9642b_I20210630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMy00LTEtMS0w_84aff11c-44e3-4d5e-a893-a8c9d41c7e06">8,190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bae2abb5014d60894b6b57f2d9642b_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMy02LTEtMS0w_483b7ed3-44f9-474a-937c-ac3737088a3b">2,412</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77623f06245d4063b189951809382a54_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMy04LTEtMS0w_36c3f9a2-917b-48df-aac3-f6c950b173ba">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77623f06245d4063b189951809382a54_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMy0xMC0xLTEtMA_d2294cf3-1804-498e-b99e-ad48c5aa382f">7,731</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77623f06245d4063b189951809382a54_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMy0xMi0xLTEtMA_ec1c3b3d-5408-4f20-8bdd-24f99f91ffba">2,871</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c3e0ab5c404e47a177e468672a1455_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfNC0yLTEtMS0w_41765a69-0f83-4c00-bf3e-630fc388c5b0">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c3e0ab5c404e47a177e468672a1455_I20210630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfNC00LTEtMS0w_c7980f15-5355-44d9-96dc-fc9e5b806849">17,660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c3e0ab5c404e47a177e468672a1455_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfNC02LTEtMS0w_05f72798-5d9e-41fe-b185-5b7910ce3766">10,638</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i132e6a5556ef4b1d9a099d0161937187_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfNC04LTEtMS0w_4befb27c-7736-4f58-bb5e-4485d73316e9">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i132e6a5556ef4b1d9a099d0161937187_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfNC0xMC0xLTEtMA_ccecd806-061f-4fac-8584-2e523d7bbcc5">17,319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i132e6a5556ef4b1d9a099d0161937187_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfNC0xMi0xLTEtMA_53ff1c11-cd8a-43f6-99de-1876f8cc2a9c">10,979</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="ie2c3e0ab5c404e47a177e468672a1455_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY1NjM_a7450921-245b-4291-ab52-2048032a186a">11.7</ix:nonFraction> million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="ie2c3e0ab5c404e47a177e468672a1455_I20210630" decimals="-5" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY1OTc_71615eca-2085-4566-9eb1-43a3c164535f">6.0</ix:nonFraction> million as of June&#160;30, 2021.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="i132e6a5556ef4b1d9a099d0161937187_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY2NzM_5624514b-2fa0-4d1d-9e18-a38e77ca8932">11.3</ix:nonFraction> million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="i132e6a5556ef4b1d9a099d0161937187_I20201231" decimals="-5" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY3MDc_e458f27f-a17f-49e3-8348-7a1bfc4cecae">6.0</ix:nonFraction> million as of December&#160;31, 2020.</span></div></ix:nonNumeric><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license and other economics rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis in April 2013 and April 2015, CorMatrix in May 2016, and Dianomi in January 2019. Commercial license rights acquired are accounted for as financial assets and other economic rights are accounted for as funded research and development as further discussed below and in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in our 2020 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2017, we entered into a Royalty Agreement with Aziyo pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. We account for the Aziyo commercial license right as a financial asset, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i01433493ef5440b994917b88eb59ec5f" continuedAt="i085dcf0eb504434ca6309cbcf7d51a90"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, we amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the Royalty Agreement with Aziyo as of June&#160;30, 2021 is <ix:nonFraction unitRef="number" contextRef="ia3d09f0c28ed43418f452c8a8c413e2c_D20210101-20210630" decimals="2" name="lgnd:ForecastedCashFlowsEffectiveInterestRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTc4OTA_59d2150c-f22e-4dd5-a7b7-30f7691c10b1">23</ix:nonFraction>%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received during the six months ended June&#160;30, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to 2020, we accounted for commercial license rights related to developmental pipeline products such as Selexis and Dianomi on a non-accrual basis. We continue to account for commercial license rights related to Dianomi on a non-accrual basis as of June&#160;30, 2021, but starting in 2020, given the expected cash flow from the Selexis program, we started to account for the Selexis commercial license right as a financial asset in accordance with ASC 310, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Selexis as of June&#160;30, 2021 is <ix:nonFraction unitRef="number" contextRef="id1f82d2c30024c07a9201d0f6c666c56_D20210101-20210630" decimals="2" name="lgnd:ForecastedCashFlowsEffectiveInterestRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTg4MDk_d3f8e4e1-31bc-4722-8970-f98c84d5a260">21</ix:nonFraction>%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received during the six months ended June&#160;30, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We recorded a $<ix:nonFraction unitRef="usd" contextRef="id539ee77085d45f4865a0e6a9a962ff2_I20200101" decimals="-5" format="ixt:numdotdecimal" name="lgnd:CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTkwODE_e874a843-8613-4c21-b9ac-9a47d238be0b">5.5</ix:nonFraction> million pre-tax reserve for credit losses upon adoption of the credit losses standard (ASU 2016-13) on January 1, 2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the six months ended June&#160;30, 2021, we further considered the current and expected future economic and market conditions surrounding novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accrued Liabilities</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MjI_77494ed8-da13-4071-ae61-5876b11e861d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMi0xLTEtMS0w_0b171fa4-d519-4940-a800-38c6e0b620f5">3,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMi0zLTEtMS0w_3e208064-b0fc-4fa1-897d-fa908a0f52ae">8,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMy0xLTEtMS0w_d60fa0ff-97bc-4dc6-9a23-c2239731ed29">977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMy0zLTEtMS0w_74011838-898f-41c4-a913-8fcd2de7a7e7">977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" name="lgnd:LicenseeAccrualCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNC0xLTEtMS0w_97e3c076-9461-4a42-a2b5-d1ae20b90152">446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" name="lgnd:LicenseeAccrualCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNC0zLTEtMS0w_6fa34f37-8efe-403e-a924-362d0953501e">421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNS0xLTEtMS0w_74eca5a5-c3fd-45c9-b2ea-db842c794b50">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNS0zLTEtMS0w_7e336ae0-ac2e-4ee9-9eec-a36cf1bf1cf4">693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" name="lgnd:ReturnsAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNi0xLTEtMS0w_073f68dc-2082-4b6b-932c-16b4bb15249e">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" name="lgnd:ReturnsAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNi0zLTEtMS0w_668f3e3d-7ab0-4f00-b7bf-b5883d17a971">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AccruedAssetAcquisitionsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNy0xLTEtMS0w_3388cb97-7b5d-4bfd-b004-16ae85a6fa74">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AccruedAssetAcquisitionsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNy0zLTEtMS0w_f02c2da5-e781-488e-a40a-6b42c40df2ea">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:zerodash" name="lgnd:AccruedSubcontractorExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfOC0xLTEtMS0w_46cdaaac-c2e0-498e-b789-194402287f7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" name="lgnd:AccruedSubcontractorExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfOC0zLTEtMS0w_aeceabf3-a60a-4bb8-b23d-850f386c14fa">733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" name="lgnd:AccruedSupplierExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfOS0xLTEtMS0w_ae8867cd-0e31-44de-b36d-386ec35bc0d6">681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" name="lgnd:AccruedSupplierExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfOS0zLTEtMS0w_5e0b1df5-70cd-4af5-b56b-3ffea96a35e0">604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMTAtMS0xLTEtMA_6ea4ef06-ea13-4a1b-b752-9e455a18cefe">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMTAtMy0xLTEtMA_282b54e5-fd3a-4155-9ead-6bc2c34b331c">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMTEtMS0xLTEtMA_57d1860e-baab-41db-abb4-4007d30425ef">2,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMTEtMy0xLTEtMA_40d2f9d8-e1fa-4d4e-aa7a-8f5935093c72">3,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMTItMS0xLTEtMA_2fa5d27e-b3c1-419a-8225-5f11198e6b93">10,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMTItMy0xLTEtMA_896ea038-cb4a-450a-b9b7-68fa1e94bb81">18,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3NTA_689d618c-72c8-493a-9a4f-0b626f395f8f" continuedAt="if60c6e81141d47da95f8a31e4ee53b5c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period until the last tranche vests. <ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3Mzk_ac14325b-7c45-48ba-9a87-08f8cbdfd1da" continuedAt="id22d4fc5e1a641b1a80ddc90b6323144" escape="true">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</ix:nonNumeric></span><ix:continuation id="id22d4fc5e1a641b1a80ddc90b6323144"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39531d4ab7cf4f0aace79c3dc0eb299a_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfMy0xLTEtMS0w_7c3bb7a0-8830-48d6-94ad-ec94e134b43a">4,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78065ce772ec469298f8378f75ca1645_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfMy0zLTEtMS0w_e4e4d6dd-88aa-4cd0-8bc1-962ade5297c1">3,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa63d1e101a04ca3930b9a6c58bb223c_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfMy05LTEtMS0w_58d01368-14d7-4513-8689-ff330e921c26">8,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e6852caf924e1e8b8bcb9b31317006_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfMy0xMS0xLTEtMA_7de21dd1-2405-4fa3-bf0c-694a7e2ce991">5,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e1e3edd32274cfa9dee37913732cc3f_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNC0xLTEtMS0w_a0fde784-3325-47f8-aa32-71c02f41236a">5,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedc8c2b179da4c57b0d69399b7319487_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNC0zLTEtMS0w_4e1830de-f5da-41b5-9098-2e5e894377c4">4,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i772dc85a5dae4c1d9ddf06f9992a3e6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNC05LTEtMS0w_80189a7b-2454-4e11-af39-0dd609471694">10,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic946c1298336471283c1bde8dab683da_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNC0xMS0xLTEtMA_8bc97d0a-dd29-4465-93de-7524957312c0">7,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNS0xLTEtMS0w_4e4ddac5-3de4-4f53-a4ea-fe4dd97d6801">10,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNS0zLTEtMS0w_55479b69-9987-4ad4-9fe6-10af7a4c9f84">7,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNS05LTEtMS0w_15f0e458-e16b-4907-a03f-7d3a5d12a2dd">18,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNS0xMS0xLTEtMA_43d02796-0bcc-4161-9849-626380eed8a6">13,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i085dcf0eb504434ca6309cbcf7d51a90"><ix:continuation id="if60c6e81141d47da95f8a31e4ee53b5c"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3NDM_1a60615c-5812-4f81-a35f-d603007fbacc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfMy0xLTEtMS0w_b0b0eb7b-b63f-4303-84a3-c8cbe4f36a10">0.9</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfMy0zLTEtMS0w_ad587af4-08b8-4419-b199-32d077871ed1">0.4</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfMy01LTEtMS00Nzk_55fe57c9-c356-4c73-8ffa-dd2e2f143359">0.5</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfMy03LTEtMS00NzU_676f5041-75da-46fd-999b-5908f37400f8">1.1</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNC0xLTEtMS0w_b7efee62-5e2b-43d7-87d3-d0cd76620b5b">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNC0zLTEtMS0w_33321d1a-a801-4a19-92d3-405c144e580e">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNC01LTEtMS00Nzk_81e4c885-dc06-4e14-a019-0dbf9d639597">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNC03LTEtMS00NzU_8c153cf6-f85e-4d32-8d7e-54898d43f07a">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNS0xLTEtMS0w_05b66096-5b86-4768-aebc-85ff9dca0e55">54</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNS0zLTEtMS0w_79aa6214-c73d-4f39-b32a-85f3989a622a">69</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNS01LTEtMS00Nzk_fb018770-0be6-44d3-a61f-a0e180701c7c">62</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNS03LTEtMS00NzU_3407db09-2e67-4fdf-b16f-8140e2200bc4">55</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNi0xLTEtMS0w_d931c39e-7890-4c9e-9cbe-9f2e1b326f8c">5.5</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNi0zLTEtMS0w_441ba9b5-c156-4d1d-9ec8-c1cb776bad71">5.1</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNi01LTEtMS00Nzk_aa3f101b-1c08-46a5-a283-d6ea27792191">5.0</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNi03LTEtMS00NzU_5b098ba1-ed3b-4d18-99e2-b1a69b93deb2">4.8</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a <ix:nonNumeric contextRef="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MzM_34ec15eb-4c02-47c0-9dbd-a0a6f211ed94">three-year</ix:nonNumeric> performance period, with a range of <ix:nonFraction unitRef="number" contextRef="i91c0aa1e995c4988b6700da4987ed2a2_D20210101-20210630" decimals="INF" name="lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjA5Njc_6328a771-15eb-4ebd-8f5a-7b624e5fcf45">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i163d925374744dc19e90ee21d40ac455_D20210101-20210630" decimals="INF" name="lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjA5NzM_ec63d4cc-654d-4bc2-93b1-0d4f7abdfffd">200</ix:nonFraction>% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MDE_6f77bf85-820a-4d4b-8de2-11b8ad3c4f21" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div></ix:nonNumeric><div><span><br/></span></div><div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MDQ_ec0e35d4-43bc-44c8-8d19-101f1f1077e4" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfMy0xLTEtMS0w_137e2acb-f0f3-4794-8f1b-923078ab9830">16,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfMy0zLTEtMS0w_ff4ad5b3-1120-481f-a156-425cb44d7e80">16,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfMy01LTEtMS01Mjc_1cdd49e4-3144-4477-bd43-3eae00d642c4">16,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfMy03LTEtMS01MTY_94067bb6-7ea4-4efc-87eb-3ba7d5a0af2e">16,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNS0xLTEtMS0w_bcc22b9c-0053-48f7-9a5f-0593fe81a70a">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNS0zLTEtMS0w_131094fb-e402-4d4e-8445-156222e11272">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNS01LTEtMS01MzE_7292d54f-0648-4392-ac22-6b850883374e">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNS03LTEtMS01MjA_f4ef5300-81e4-4159-b205-35f85620f34a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNi0xLTEtMS0w_3dca6f15-87d3-4d60-94d2-4fdeb17b0e7b">444</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNi0zLTEtMS0w_41048fcb-f4e9-4406-a677-dc46fae00785">599</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNi01LTEtMS01MzE_595ae22a-d82c-40be-9dd9-49712ddaae18">572</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNi03LTEtMS01MjA_d4ac708d-6da3-42dd-92c8-0d9aeecee3dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNy0xLTEtMS0w_2070d25f-f9a6-4067-a630-8e4de12c85a1">17,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNy0zLTEtMS0w_070b43d7-2730-47cc-a96b-0b25232d47f7">16,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNy01LTEtMS0xMDkx_66231318-236a-435f-bc55-b1117ad73505">17,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNy03LTEtMS0xMDkz_1a867bf6-c0ae-4b7f-8c12-217ce28ff099">16,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfOC0xLTEtMS0w_010f154d-c94f-43ec-bb31-ab5233c76f73">5,087</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfOC0zLTEtMS0w_023c944d-d751-4183-8a2b-24542841b100">7,832</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfOC01LTEtMS01MzY_6424a541-3408-4410-8d1e-862ec7a5cff1">4,684</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfOC03LTEtMS01MDc_28d2d4d8-fb2d-43dd-a182-9db23baf788a">8,988</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2020, all of the <ix:nonFraction unitRef="shares" contextRef="i939615bc911747ff91466aa044f7d705_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTA5OTUxMTY1NDUwNg_22579481-777d-4051-8f91-0d586919a7a2">0.6</ix:nonFraction>&#160;million weighted average shares of outstanding equity awards as of June&#160;30, 2020 were anti-dilutive due to the net loss for the period.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i934841341d8f4620843d0f6fb5e931d1_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.  <ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfNTk0Mg_9fddf693-8761-458f-946b-da767913928c" continuedAt="i067c6528b06c41aa9e7869cc03b20ef7" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i067c6528b06c41aa9e7869cc03b20ef7" continuedAt="ib91b0bfbc16945a6bb65a927a70a24ed"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfNTk0Mw_f6a7208d-e744-4496-9788-38682ee0fa11" continuedAt="id9fdc0a08ef8430bb9c00dc7f3d9efdc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.830%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf756f2501b74e0898048554c3c0783e_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy0yLTEtMS0w_fb439df9-b70d-4d47-a2e1-d53a72950c03">5,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i796ab7b302fd449bb651ec4d41dac07e_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy00LTEtMS0w_f5c78625-21f2-4920-a3a8-d215e86d53b1">233,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8cf2a139e64d1198f5d67aa364f965_I20210630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy02LTEtMS0w_de44af58-9560-49d9-81ea-d7aff5e6f7d3">712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf32622b6254648a6c2f68df210c48e_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy04LTEtMS0w_374e98a2-2f62-4fbf-aca4-3503b177ca97">239,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eaf883d9af8472c83fe21fa31227a28_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy0xMC0xLTEtMA_19b863a6-2fdd-4ae9-80e4-173734e343fc">3,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d3c3bdb624f4891bf85269d85f85683_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy0xMi0xLTEtMA_617b21f9-bf12-41de-82fb-331eef6bced4">320,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e00bcc4ceb456280e021abea879ec0_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy0xNC0xLTEtMA_ef073cbe-24f0-417d-a9c3-7c66d1952a5b">393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e0a0c15e8e344eca24216baf962f264_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy0xNi0xLTEtMA_bd9d0137-15b5-4c70-b182-d6d7ebf1e11e">324,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bec0cdf729b451dafb85f5a25d8f563_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC0yLTEtMS0w_5aec182a-9356-4252-a6f7-e885b91a4048">40,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61de52e98a8c4a8d83132e0c0db3dcd4_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC00LTEtMS0w_3ed570dc-9cba-454a-a185-4022b430fdff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47ef30b73058418caaaaff016ffeff78_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC02LTEtMS0w_1abab275-2aa9-4724-9d3b-f5e67bcb4ff4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i005e8c3fac4c461bbb49bcb0b925f653_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC04LTEtMS0w_dd939a59-1c5d-42e5-86cb-0b738c90e70c">40,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d2ea83589d04ffba237d02df0bd14ca_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC0xMC0xLTEtMA_925567cd-f553-4f1f-82a2-a30ceb3bb776">32,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d8874a1883347ecba3086a56ff8551f_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC0xMi0xLTEtMA_41f9ded4-1980-44c4-8201-5c0fad5b4acc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i387e213a06b04a448c4eb58b54ad09f9_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC0xNC0xLTEtMA_1c11f881-e8b1-4a24-aa1e-7e0b1a2014e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c7d0cf9f5d9461997395ecfa5774eee_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC0xNi0xLTEtMA_fde36c1e-521b-4bfc-8afe-24bd97878978">32,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia045228d9b614876a5e504039e235ae7_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS0yLTEtMS0w_015b25e0-e3de-4591-824f-e108b92cf299">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i641d7897463648d593b3ca40dbd5ede9_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS00LTEtMS0w_9bd289f9-ebcf-4ac6-abf7-a033c3121b97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220a77d258c24676985ff3e94a5777f2_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS02LTEtMS0w_e98af1f5-b4d4-48c1-8e0e-6358c9360e01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d12e59c7f4c45f4a6acae8cdc855fd2_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS04LTEtMS0w_6ef41e79-f932-477b-8403-896b4792fe1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84e9a9944b144829ad78f048f85f8b72_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS0xMC0xLTEtMA_dc3ae481-105d-4791-8e07-b19231a8840f">6,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64737b59a93b4b3f8cbc8602eacded0f_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS0xMi0xLTEtMA_1880f60a-027a-4c2c-a7f1-0577c510f144">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id642d98b4ab5493492cd4d631e98f649_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS0xNC0xLTEtMA_4fed0ee2-33e5-4e81-9f8c-323eac667f52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16091b8d48fe4aa7aed58abf316cf655_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS0xNi0xLTEtMA_a07cd89c-fb4f-43ba-abe5-bcaf963c795c">6,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a0c0c9f6f014f8fb72f8cf92bde8fc0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi0yLTEtMS0w_fcb7c2c6-8109-495d-a590-7bbe23595b9b">45,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i557878bd28b741ac8242fc9594c33f79_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi00LTEtMS0w_faa332a1-8cbf-469b-aeb8-a350792ddd6d">233,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f8e521dfd304b559210391763ef8967_I20210630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi02LTEtMS0w_bd0bd287-e910-43e0-bac8-f26f515201c7">712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38789c05639047e786b0f44cd1f81a54_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi04LTEtMS0w_62f721b7-6d14-4de8-a6b5-b0dc9fa30b9d">279,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic89b647aa620475b919305bbfb902e88_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi0xMC0xLTEtMA_0a12654b-da8e-480a-a097-98f327c587de">42,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib05226da6d8b49729bf12cbb13f48688_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi0xMi0xLTEtMA_073784a3-9062-4fc5-9083-dfb36456ef30">320,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dab2c8b54fd4ca4bd5583431d596fda_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi0xNC0xLTEtMA_0bdde3ad-142c-48c6-840a-431d0b4d5600">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib033d6a72993457c9d1212af5e26a84d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi0xNi0xLTEtMA_e68323fc-06d6-4638-b2f1-4a51aad5cfd4">363,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad453372414e43f4bbb5fa127bdfd4b6_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC0yLTEtMS0w_1f260522-0468-4a5a-b52b-ed303f1ddef8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b51bff8800c428797e64c37e8bf037b_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC00LTEtMS0w_4c4cc94a-434d-41fb-824d-4d35f636b4e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if895305c42ba4796b58e31d56a083e2b_I20210630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC02LTEtMS0w_57f1a730-49cf-42f3-a1a2-698c2cb738be">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id649b26944164f4f97db61669a9fa440_I20210630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC04LTEtMS0w_9633090d-8f8f-4df0-a300-9b77a8b0f38d">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c5fd4abee7d4774b0069173b5ab7bd0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC0xMC0xLTEtMA_130e03f1-17a4-4d3d-98c3-0d79b950aebf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3981fc802cb453aa0560b2810a13ded_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC0xMi0xLTEtMA_0aa99040-787d-45cd-b201-7709221a2842">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97950dc03de449d4b199d76fa33d7646_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC0xNC0xLTEtMA_9c4954a1-4c0b-4446-a4b8-04b3105850ae">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id37a246dde494a62b12b0bcc3808a45c_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC0xNi0xLTEtMA_7c35a5c3-0a52-4990-85a8-614ff679b72d">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3247e24b5dd46618012805e016575c9_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS0yLTEtMS0w_60ebcb2f-ad56-40b8-9853-df7a89c28054">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2739e8b8a37c4a40826744f663f3cd9b_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS00LTEtMS0w_888c5368-4a01-49b8-a1ad-b76fba523bed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71af70fa404948bfa683daccf446fe4e_I20210630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS02LTEtMS0w_286906f1-1444-4d0a-a9db-819c8074416f">376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdb36b5dd0ef4b7da44e14cd73f5fafb_I20210630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS04LTEtMS0w_12a1975d-5967-4887-914d-319d07c3815c">376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cad1a6417044928d62c1e4ab27cda9_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS0xMC0xLTEtMA_980c3f85-6c11-4e74-b411-2e1a7a949fa9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd025b870864e4d961da366b7b5528b_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS0xMi0xLTEtMA_46462a0d-271a-420c-9ec6-33f76fbd1898">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda6b7d8020d42f3b17c4b1a9af44d12_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS0xNC0xLTEtMA_8b6b0a16-eca4-4d3b-9693-99e16778b30c">508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51c7fde616a242b9b7b30c2c7b19b923_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS0xNi0xLTEtMA_ea539d4e-bf9b-4735-a4bb-ddc8dcfbb549">508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b8df10c2682432983902baa864b9142_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtMi0xLTEtMA_241b44a7-0f11-4d1e-9665-e5fa0bbb4a76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd8f21f2f7c4238aa1325d72a7ebbdb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtNC0xLTEtMA_b4fad447-cfce-46ea-980b-75cdbb7fee21">3,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3fe525c20524b7eb5724b9edf213b37_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtNi0xLTEtMA_bcadf28c-e616-4767-ad9b-e06a32d66a18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i061f31e310da49b8bdef63bdf885268c_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtOC0xLTEtMA_96f04578-b4a0-4946-b302-23f0146dd7b4">3,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b410efadd054a649b74fb4ab4b2541f_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtMTAtMS0xLTA_16c49bc5-1d55-4d5d-a4f5-dce2523ee3b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8f0d4449da4cd59d8a03eb8dc3f11d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtMTItMS0xLTA_36643ebc-c441-466b-ba62-a5b3d59ab63d">3,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89c072c3ed814deabecf50119491b5cb_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtMTQtMS0xLTA_9766a451-762c-4dc1-9933-220f41adfe8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffd18f96992e4b7ca3b22e6376f529fe_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtMTYtMS0xLTA_cfe81e27-f368-48a9-8bbb-24e7c013f7d9">3,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab7b877600348b0a02624b9699a5469_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtMi0xLTEtMA_ae662039-ca7c-4eb9-bf41-bb4d7e1d9755">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19a4f05983fd4dc5b7709df1b833f9c6_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtNC0xLTEtMA_e6557cef-8f8d-4cc9-b062-62a68d820a4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9ca0e4731fb4bb4993033661944bef4_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtNi0xLTEtMA_c7ae8c9c-a884-455b-9987-67beaaba08e9">5,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa5a29a71643c88ede85aeb0f07ae0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtOC0xLTEtMA_bba062d3-594a-4e8c-a519-f5ec6f35cb4d">5,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75036d6e219044c292bf94448ff791de_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtMTAtMS0xLTA_790e0431-a5d0-4b71-b1eb-5d389c5a0a73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b46809a4a242e9b7e286c5f5853e33_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtMTItMS0xLTA_35061103-1d20-4dff-b2ff-d28601ae5dde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc7b23b98c24bcb97086aedb8f6b9a9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtMTQtMS0xLTA_052da0e3-af44-4e5d-9553-4ed5f0655add">6,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e85efa2c7b4b8a8934c115e462671d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtMTYtMS0xLTA_ca129634-9fe4-4486-b19e-150a66d8aa05">6,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pfenex contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a6510d82770434b983d927bf24176d9_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItMi0xLTEtMA_78355400-5bce-432a-98c7-0fff4b4b6037">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie905e4f33e8d4048b5cfaaf2621e7b22_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItNC0xLTEtMA_be9fdb73-c89d-4df3-b76a-1dbfc61af16b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253e61895f964faaa57258e78a2e242b_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItNi0xLTEtMA_dca453da-31e9-47f7-b86e-e2f8723dacb1">3,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee7f60369ff44dc690747a7ded9f7378_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItOC0xLTEtMA_441d18a5-493b-45ba-88ce-c80304489aaf">3,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f492eb7b30f444ea91c469c951cac52_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItMTAtMS0xLTA_f4c94f1c-003c-4f3c-971b-8c6862cdcb64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3231b70ce9d74b739582396aea5f4596_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItMTItMS0xLTA_e48ce5bb-fe48-4a87-9942-89a60893ca6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac7ec1a94684eb4b17125ff94d45847_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItMTQtMS0xLTA_fba1fae4-fe90-4ce9-8723-2a1e5b27101c">37,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i944386c5eaae4e9b9f6282141c8f6cd9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItMTYtMS0xLTA_3e55a846-41d1-4667-b6ab-9219a095c709">37,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb2b256fccda44f789ccdb015560f400_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtMi0xLTEtMA_6e9b9d15-5c24-4c73-a893-3dd4df8472b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34aa94365beb4fda8e028ed4b2e49ffa_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtNC0xLTEtMA_dd754d37-f62d-49fe-98c5-184d3eebe2fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie634e5d883a246c0b675b67cb23000bd_I20210630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtNi0xLTEtMA_af3d9719-83c9-4f60-a29a-685bc7a4ba85">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bf6089dd044188988a26b040ff65c0_I20210630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtOC0xLTEtMA_d26756c1-688a-4c54-b2c7-34b03aa82dd5">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02324c19886a4c18b6067d16ace402b5_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtMTAtMS0xLTA_d9afe522-45fc-4d49-affb-5f80cd9a34bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ed0ac879e24c8088076f9f0f8287ed_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtMTItMS0xLTA_a7e73549-6a44-4dd7-b6ba-b64c030708d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9760653085dd4b7393829a3480ed5ec0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtMTQtMS0xLTA_b96ea876-6a46-4055-a852-8d100312e59f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba7989e6f5e8482ab0daf120805cca55_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtMTYtMS0xLTA_0185a97e-c908-419f-9012-ba0955562414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21134d594d0f44a3b592bd03f3304d4b_I20210630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtMi0xLTEtMA_3bde67ff-f49b-459e-a65d-6169a0492fb1">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd625ffa45724705a1055f34d130688c_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtNC0xLTEtMA_2d203319-70f7-44bb-8849-27bfd9ca00bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46d7fa3ab3de4bd0993ae0388c003976_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtNi0xLTEtMA_7d774d22-9228-4fa9-95a3-7f31aa192786">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ab8e64374244574bfba15d1172a7cd3_I20210630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtOC0xLTEtMA_c076e8df-d05a-4bb9-a79f-864d5f84d5be">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i357340a5b0324e1e9aaa75a5ef7abab6_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtMTAtMS0xLTA_8cdc4030-0dd7-405f-988a-854620ad074b">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfb293f7d7a4cc58fc7ee43b5c0eb61_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtMTItMS0xLTA_a7e0c24d-1afd-4919-8388-689268156d53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0358d88a74ec408bbf376519526abff1_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtMTQtMS0xLTA_1b0e7d12-084a-469f-920d-4baa99550914">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41bb3ed9de1d46d79072d907dbbcda90_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtMTYtMS0xLTA_3def1cdd-8711-4ab1-87b2-e0a084abe6d2">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a0c0c9f6f014f8fb72f8cf92bde8fc0_I20210630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtMi0xLTEtMA_bcb8c5f2-0a75-47ac-a4f0-a5a6a4534d9c">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i557878bd28b741ac8242fc9594c33f79_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtNC0xLTEtMA_bd43df7c-655c-4c5e-adeb-33c1ee623f12">3,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f8e521dfd304b559210391763ef8967_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtNi0xLTEtMA_59502239-f0c2-418e-9ee2-13f8c55a2d5d">10,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38789c05639047e786b0f44cd1f81a54_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtOC0xLTEtMA_3e807cb4-7d13-4988-94fe-ec915a135738">14,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic89b647aa620475b919305bbfb902e88_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtMTAtMS0xLTA_25027e71-a10a-49c1-a35c-0099fdc17506">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib05226da6d8b49729bf12cbb13f48688_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtMTItMS0xLTA_ae5fae2d-0b97-407c-abb8-ca5e0191edb1">3,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dab2c8b54fd4ca4bd5583431d596fda_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtMTQtMS0xLTA_f45dd3bd-1b64-456f-83a1-f01486dac8e6">45,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib033d6a72993457c9d1212af5e26a84d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtMTYtMS0xLTA_875e80e5-0316-4d30-af0e-99a58b2d9d36">49,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Investment in Viking warrants, which we received as a result of Viking&#8217;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. During the six months ended June&#160;30, 2021, we exercised all of the outstanding Viking warrants. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders <ix:nonFraction unitRef="contingent_value_right" contextRef="i4756268078d14fac936133a04e156f01_D20100101-20100131" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMjQ5OA_f574e389-ef4e-4e91-bf5c-ace5c1733704">four</ix:nonFraction> tradable CVRs, <ix:nonFraction unitRef="contingent_value_right" contextRef="i4756268078d14fac936133a04e156f01_D20100101-20100131" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMjUxNg_e823948c-2932-4d79-913b-19f7d92a1210">one</ix:nonFraction> CVR from each of <ix:nonFraction unitRef="contingent_value_right_series" contextRef="if487bbb8057a47a2bfafd87e853aa62f_D20100101-20100131" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:NumberOfContingentValueRightsSeries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMjUzNg_9e096943-a473-4adb-a187-6a955ea3685b">four</ix:nonFraction> respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every <ix:nonNumeric contextRef="i4756268078d14fac936133a04e156f01_D20100101-20100131" format="ixt-sec:durwordsen" name="lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMjY3MQ_893c7ffa-1898-45a3-a986-9104e07595de">six months</ix:nonNumeric> as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $<ix:nonFraction unitRef="usd" contextRef="ifa9602c2fb6e4bc0a7dfeb7bb5e534d8_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMzQ3Mw_570eea21-59a0-4b56-8612-c5a56d523a5d">375</ix:nonFraction> million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $<ix:nonFraction unitRef="usd" contextRef="i21a47f508af74c0c94d611302c008270_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMzU4OA_1e3fe902-b356-41aa-995f-fd367d564a6d">10</ix:nonFraction> million payment upon initiation of a Phase 3 clinical trial. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the six months ended June&#160;30, 2021, we paid $<ix:nonFraction unitRef="usd" contextRef="ifa422606d00d4484ad76a52ce224d9f1_D20210101-20210630" decimals="-4" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMTA5OTUxMTYzNzgwNw_5189a8f1-2886-441f-903d-c81733eb2943">1.1</ix:nonFraction>&#160;million contingent liability based on revenue milestones to former Icagen shareholders.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Pfenex contingent liabilities was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of the Company. During the three and six months ended June&#160;30, 2021, we reduced the contingent liability by $<ix:nonFraction unitRef="usd" contextRef="i3819ef5e99824efb8df9aa305cf4213a_D20210401-20210630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMTA5OTUxMTYzODE1MA_65682680-be00-4c8f-b8cd-39e7fca40736">34.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i382dac6fd2e349f5804856ab5f5e6561_D20210101-20210630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMTA5OTUxMTYzNzkxMA_4bff3a8e-74d4-4b04-8704-e73463557c9c">33.8</ix:nonFraction>&#160;million, respectively, primarily due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR. See further detail on Pfenex CVR in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Note 3, Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="id9fdc0a08ef8430bb9c00dc7f3d9efdc" continuedAt="i14c93d5a8a2a43ba820d9b3561314fe1">7.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"><ix:continuation id="i14c93d5a8a2a43ba820d9b3561314fe1">The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the first quarter of 2021, management recorded an earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement.</ix:continuation> </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ib91b0bfbc16945a6bb65a927a70a24ed" continuedAt="if268fda0ab384a53827142f9dc1de161"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfNTkzOQ_bd008fcc-f9ab-44b3-b886-4b93a69965da" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of June&#160;30, 2021 is as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30b9d60f80524037808096d46cfdd9bf_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOjY5MWExMDcwNzFiODQ5MWFiNGFmYWQyYTVhNzg3NjM5L3RhYmxlcmFuZ2U6NjkxYTEwNzA3MWI4NDkxYWI0YWZhZDJhNWE3ODc2MzlfMC0xLTEtMS0w_e1693bd3-4e5e-4db9-a860-d0e7a40f4dfa">45,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49489b4312d24480aa69abea662ae37a_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="lgnd:PaymentsToContingentValueRightHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOjY5MWExMDcwNzFiODQ5MWFiNGFmYWQyYTVhNzg3NjM5L3RhYmxlcmFuZ2U6NjkxYTEwNzA3MWI4NDkxYWI0YWZhZDJhNWE3ODc2MzlfMS0xLTEtMS0xMjg3_d513bcf3-5df2-42fd-9916-03638389bef6">1,050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49489b4312d24480aa69abea662ae37a_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOjY5MWExMDcwNzFiODQ5MWFiNGFmYWQyYTVhNzg3NjM5L3RhYmxlcmFuZ2U6NjkxYTEwNzA3MWI4NDkxYWI0YWZhZDJhNWE3ODc2MzlfMS0xLTEtMS0w_e6167853-128c-4540-a29f-5186573643cd">33,661</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49489b4312d24480aa69abea662ae37a_D20210101-20210630" decimals="-3" name="lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOjY5MWExMDcwNzFiODQ5MWFiNGFmYWQyYTVhNzg3NjM5L3RhYmxlcmFuZ2U6NjkxYTEwNzA3MWI4NDkxYWI0YWZhZDJhNWE3ODc2MzlfMi0xLTEtMS0w_0a98767e-aa36-4e4c-b86a-5e33e57767a8">240</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of June&#160;30, 2021</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4e0652f35f242c6a35f9468106a365d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOjY5MWExMDcwNzFiODQ5MWFiNGFmYWQyYTVhNzg3NjM5L3RhYmxlcmFuZ2U6NjkxYTEwNzA3MWI4NDkxYWI0YWZhZDJhNWE3ODc2MzlfMy0xLTEtMS0w_a50e7ea2-8b99-4abd-8fee-bc2a5331a22a">10,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="text-indent:22pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the second quarter of 2021, in connection with the Pfenex CVR fair value evaluation, we also evaluated the related indefinite-lived contractual relationship intangible for recoverability and concluded there was no impairment.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if268fda0ab384a53827142f9dc1de161">Other than the above mentioned triggering event, there were no other triggering events identified and no indication of impairment of our goodwill, indefinite-lived intangible assets, or long-lived assets during the three and six months ended June&#160;30, 2021.</ix:continuation> </span></div><div><span><br/></span></div><div id="i934841341d8f4620843d0f6fb5e931d1_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.  <ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTA4NjA_ff5cc4ac-78ba-4922-84aa-442212b67e06" continuedAt="i74af131284a343b289b883c6737a7e80" escape="true">Acquisitions</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i74af131284a343b289b883c6737a7e80" continuedAt="ic4fcd89a55584633ac5cf878222ef991"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Pfenex Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On October 1, 2020, we acquired Pfenex, which develops next-generation and novel protein therapeutics to improve existing therapies and create new therapies for biological targets linked to critical, unmet diseases using a protein expression technology platform.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preliminary purchase price of $<ix:nonFraction unitRef="usd" contextRef="ie650f5facb7d4c908578773f98df20f6_D20201001-20201001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMzQx_66e439cb-8a36-4099-9cda-024aaf5e531c">465.1</ix:nonFraction>&#160;million included $<ix:nonFraction unitRef="usd" contextRef="ie650f5facb7d4c908578773f98df20f6_D20201001-20201001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMzUz_e273c12c-f533-451b-a15b-8afda5741117">429.6</ix:nonFraction>&#160;million cash consideration paid upon acquisition, and a contingent CVR payment of up to $<ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNDM2_94893d9c-3836-4611-b939-b129b4f8f723">77.8</ix:nonFraction>&#160;million in cash based on a certain specified milestone with an estimated initial fair value of $<ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTI2_33bf227b-187a-4871-be2c-b98c42d08640">37.0</ix:nonFraction>&#160;million. The CVR will only be paid in full if the milestone is achieved by December&#160;31, 2021. The amount of the CVR included in the purchase price was reduced by $<ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjY4_49a99e7f-4cd1-4885-b6a9-8893f643c41b">1.5</ix:nonFraction>&#160;million that was determined to be post-combination expense. The fair value of the CVR liability was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on market participants' cost of debt reflective of the Company, which was <ix:nonFraction unitRef="pure" contextRef="ic3e711d6bdc94af7b6ee030579f78de0_I20201001" decimals="3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTc3_38914e8c-d157-48a5-abd1-fcf0c340ca46">7.1</ix:nonFraction>%. The liability is periodically assessed based on events and circumstances related to the underlying milestone, and any change in fair value is recorded in our consolidated statements of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the acquisition, a portion of Pfenex's equity awards that were outstanding and unvested prior to the acquisition became fully vested per the terms of the merger agreement. The acceleration of vesting required us to allocate the fair value of the equity attributable to pre-combination service to the purchase price and the remaining amount was considered our post-combination expense. We paid $<ix:nonFraction unitRef="usd" contextRef="ie650f5facb7d4c908578773f98df20f6_D20201001-20201001" decimals="-5" format="ixt:numdotdecimal" name="lgnd:PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTU5MQ_b7172f74-4318-430b-976b-09e7ed6dda74">17.3</ix:nonFraction>&#160;million in cash for equity compensation, which is attributable to pre-combination services and is reflected as a component of the total purchase price paid of $<ix:nonFraction unitRef="usd" contextRef="ie650f5facb7d4c908578773f98df20f6_D20201001-20201001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTc0NQ_e273c12c-f533-451b-a15b-8afda5741117">429.6</ix:nonFraction>&#160;million. In addition, the fair value of equity compensation attributable to the post-combination service period was $<ix:nonFraction unitRef="usd" contextRef="i7b809d8e899c48f8b512ad46a079ce18_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTg1Ng_e36407bd-5b8b-4891-8891-afe40354416a">8.7</ix:nonFraction>&#160;million. These amounts were associated with the accelerated vesting of stock options previously granted to Pfenex employees and were fully paid in cash, which was recognized as general and administrative expenses during the fourth quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTA4NTg_fe703dc2-821b-4eb7-a8f1-ea8b3949d787" continuedAt="i3f2ee4c60271431da387e8bd1a4480e4" escape="true">The following table sets forth an allocation of the preliminary purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ic4fcd89a55584633ac5cf878222ef991" continuedAt="ieca574fd48a7433fabadaca49b73b13c"><div><ix:continuation id="i3f2ee4c60271431da387e8bd1a4480e4" continuedAt="i18ddf21ef49c46e0bc4fbda9425d6f86"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMC0xLTEtMS0w_49dd2b24-01fa-41ce-98d0-7dd63e623c27">51,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-3" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMS0xLTEtMS0w_1f18ee1a-669c-4d41-bf5d-3c51b3698bc7">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts and unbilled receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMi0xLTEtMS0w_bfb1fca9-544a-4e4f-92a7-68415e6853aa">1,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMy0xLTEtMS0w_426b6dde-f64d-418e-af82-85b52a735074">7,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-3" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfNC0xLTEtMS0w_f6a7cdb7-f093-4ee2-9e57-7e80dc5be634">3,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfNS0xLTEtMS0w_1f0fae60-da61-42bb-b140-3868a3b9e6b0">1,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangibles acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-3" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfNi0xLTEtMS0w_47d68d4f-2e82-41a8-91cf-c61d75cc5e06">385,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfNy0xLTEtMS0w_3139a286-484a-4423-b345-a904be147247">91,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfOC0xLTEtMS0w_2b955d2e-206c-4d4e-adeb-92aa625e0e69">6,814</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-3" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfOS0xLTEtMS0w_853ef130-4690-4bad-b7b7-e6d02d6d4684">8,455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMTAtMS0xLTEtMA_3b315b4c-e086-43be-9aa1-e2c9017c7433">3,908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-3" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMTEtMS0xLTEtMA_2871dee7-ddad-4b64-8b3e-d187e31a939d">3,070</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMTItMS0xLTEtMA_5d212508-051b-4f23-bf1b-161a819754b8">1,382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMTMtMS0xLTEtMA_c54a3c9b-9e0d-4ba9-b82c-dc1d382a63cf">53,296</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMTQtMS0xLTEtMA_8083c662-beee-4219-9709-8c17a593db83">465,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"><ix:continuation id="i18ddf21ef49c46e0bc4fbda9425d6f86">(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. <ix:nonFraction unitRef="usd" contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMjU4MA_3cc51242-743b-464b-936d-a1ecb7549321">None</ix:nonFraction> of the goodwill is expected to be deductible for tax purposes.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired intangibles include $<ix:nonFraction unitRef="usd" contextRef="icce7f0fe51bb4d6a83a6b3c726ccf985_I20201001" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMjY3Nw_594fba00-79d7-457a-9ad3-4ae6ed4a306b">362</ix:nonFraction>&#160;million of contractual relationships and $<ix:nonFraction unitRef="usd" contextRef="i37ee9bbba7f147d591042cb6d0e8f335_I20201001" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMjcxMw_184c4fbd-080a-4778-822d-0b69b95b118b">23</ix:nonFraction>&#160;million of core technology. The fair values of the contractual relationships were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated contractual relationship period. The fair value of the contractual relationships is being amortized on a straight-line basis over the weighted average estimated useful life of <ix:nonNumeric contextRef="iede1f068bfc44082bd810dcfb2a02ad5_D20201001-20201001" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMzE5Ng_f55a686a-1ff8-4073-86b9-1d72200c1a67">12.9</ix:nonNumeric> years. The fair values of the acquired technologies were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated useful lives. These projected cash flows were discounted to present value using discount rate, which varies from <ix:nonFraction unitRef="number" contextRef="i1ad6d1665fee4888888e6df28a252048_D20201001-20201001" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMzU5Mw_2ddf221d-a3fc-4a55-b04a-83ab5f42ffb4">12</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i4154c45af47f4f888c6561a6c50b57a6_D20201001-20201001" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMzU5OQ_2e236834-dabb-484f-8c10-1e358444e0ba">15</ix:nonFraction>%. The total acquired intangibles are being amortized on a straight-line basis over the weighted average estimated useful life of <ix:nonNumeric contextRef="ie650f5facb7d4c908578773f98df20f6_D20201001-20201001" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMzczMA_40c93403-17fb-4dca-985a-19615c58f61f">13.0</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The estimated fair values of assets acquired and liabilities assumed, including deferred tax assets and liabilities, and purchased intangibles are provisional. The accounting for these amounts falls within the measurement period and therefore we may adjust these provisional amounts to reflect new information obtained about facts and circumstances that existed as of the acquisition date.  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTA4NTk_2c660700-f4d0-43a6-bb5f-5f891e783748" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following summary presents our unaudited pro forma consolidated results of operations for the three and six months ended June 30, 2020 as if the Pfenex acquisition had occurred on January 1, 2020, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and share based compensation expense for retained Pfenex employees. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.469%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i373622f14721402a91753acb36279106_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfMS0xLTEtMS0yMDY2_6a1f73f7-106c-4262-bc18-a5177dfeee22">42,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3c7a4ec156b450fb7575fa2881109f7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfMS0xLTEtMS0w_7e30172a-f434-4d12-bfc2-ae5e15f1c069">76,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i373622f14721402a91753acb36279106_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfMi0xLTEtMS0yMDY2_de391745-a924-426f-b780-309f272db74e">7,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3c7a4ec156b450fb7575fa2881109f7_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfMi0xLTEtMS0w_21a33523-8df5-4413-ad78-b5210af263d4">30,505</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i373622f14721402a91753acb36279106_D20200401-20200630" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfNC0xLTEtMS0yMDYy_9ff3cb55-807d-4c02-9d49-89b5d647a800">0.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie3c7a4ec156b450fb7575fa2881109f7_D20200101-20200630" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfNC0zLTEtMS0yMDU1_02f1f631-39d5-43c4-b198-4ee30fffed76">1.87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i373622f14721402a91753acb36279106_D20200401-20200630" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfNS0xLTEtMS0yMDYy_2b464d02-7acc-42d9-93a5-86110fc511d8">0.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie3c7a4ec156b450fb7575fa2881109f7_D20200101-20200630" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfNC0xLTEtMS0w_f8cc89e9-4682-4b65-bd40-2963fd826c65">1.87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Taurus Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 9, 2020, we acquired Taurus, which discovers and develops novel antibodies from immunized cows and cow-derived libraries. The purchase price of $<ix:nonFraction unitRef="usd" contextRef="ia9de9ff92177493894947aa870f1fdb1_D20200909-20200909" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNDk2MQ_4c23172d-afd7-4918-99c8-6901924affcd">5.1</ix:nonFraction> million included $<ix:nonFraction unitRef="usd" contextRef="ia9de9ff92177493894947aa870f1fdb1_D20200909-20200909" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNDk3Mw_39925992-6020-4b87-94b2-e00825900efb">4.6</ix:nonFraction> million in cash, and a $<ix:nonFraction unitRef="usd" contextRef="ia9de9ff92177493894947aa870f1fdb1_D20200909-20200909" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationConsiderationTransferredHoldback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNDk5MQ_942a069e-d2de-4f77-a51c-e688c5204aae">0.5</ix:nonFraction> million holdback to satisfy indemnification obligations which will be settled by September 2021.  We also issued nontransferable CVRs for up to $<ix:nonFraction unitRef="usd" contextRef="i38e92ae2ce0a452cb6846f90bf759997_I20200909" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTEzMA_2ff01b6e-0a84-41c2-a348-d477be3c31d6">4.5</ix:nonFraction> million tied to partnered and internal research and development and for up to $<ix:nonFraction unitRef="usd" contextRef="i7615fe6e6d454f0fbf707d6edc90ebd9_I20200909" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTIwMw_71541ab3-29f8-42c0-99f9-999ba22a9fa9">25.0</ix:nonFraction> million as a <ix:nonFraction unitRef="number" contextRef="i1190b533a86e41eca453e2df75138ff0_D20200909-20200909" decimals="INF" name="lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTIxMQ_7dd8758a-e207-4b16-8dcc-18f95da227ee">25</ix:nonFraction>% share of post-clinical Taurus product revenues (including milestone payments) received by us. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of Taurus met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ieca574fd48a7433fabadaca49b73b13c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accordingly, we accounted for this transaction as an asset acquisition. Of the $<ix:nonFraction unitRef="usd" contextRef="ia9de9ff92177493894947aa870f1fdb1_D20200909-20200909" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTY4OQ_c01f77bd-b43e-4866-a81d-2353465a8978">5.1</ix:nonFraction> million consideration transferred, we recognized (1) $<ix:nonFraction unitRef="usd" contextRef="i7c18c4b370684d73aaaecae58235fa63_I20200909" decimals="-4" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTczNw_c1a48770-2e1c-4d3d-85be-2a3ce28e6d47">0.05</ix:nonFraction> million of tangible assets acquired, and (2) $<ix:nonFraction unitRef="usd" contextRef="i23e8adba85424e069fb3b94c160243e2_I20200909" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTc3Nw_93af0fbb-6458-4f2c-95cf-ec0f289c27ae">5.0</ix:nonFraction> million of core completed technology intangibles acquired. The core technology is being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="i877bb4cf5c014a2cb25d492e5c13e477_D20200909-20200909" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTkyOQ_f5beb862-fc34-4d70-816d-5945cf568486">10</ix:nonNumeric> years. We account for the CVRs in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. <ix:nonFraction unitRef="usd" contextRef="i7c18c4b370684d73aaaecae58235fa63_I20200909" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjA2OA_2f3083b5-5bd1-4a2e-b262-a2be47531979">None</ix:nonFraction> of the CVRs are recognized as of June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">xCella Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 8, 2020, we acquired xCella, an antibody discovery company. We paid $<ix:nonFraction unitRef="usd" contextRef="i9b82e3c101694a14a28cf38916f0faa7_D20200908-20200908" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjIxMQ_27d7d18c-84da-41ee-b002-d286e254c692">7.1</ix:nonFraction> million in cash (including a $<ix:nonFraction unitRef="usd" contextRef="i9b82e3c101694a14a28cf38916f0faa7_D20200908-20200908" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationConsiderationTransferredHoldback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjIzNQ_fec1deaa-e642-46d6-a728-eeb5db655326">0.5</ix:nonFraction> million holdback to satisfy indemnification obligations which will be settled by September 2021), and issued earnout rights for up to $<ix:nonFraction unitRef="usd" contextRef="i8e9a33faf4604184b79f97df731f1531_I20200908" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjM2NA_5991e27c-4c2e-4c55-a79b-ddc78f65a576">5.0</ix:nonFraction> million tied to our use of the xCella technology for partnered research and development and for up to $<ix:nonFraction unitRef="usd" contextRef="ia125689d8b6d45c8acc8d4e04a5c8dcb_I20200908" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjQ2MQ_f3d95fd7-bf7a-4475-9594-5fd359adb12f">25.75</ix:nonFraction> million as a <ix:nonFraction unitRef="number" contextRef="i104be1b5412749a98d1b83af0aa45462_D20200908-20200908" decimals="INF" name="lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjQ2OQ_62926eeb-c6ee-40cd-8d34-c3cc5bdab989">25</ix:nonFraction>% share of any future milestone payments we received under a certain existing xCella partner arrangement. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of xCella met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $<ix:nonFraction unitRef="usd" contextRef="i9b82e3c101694a14a28cf38916f0faa7_D20200908-20200908" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjk1Nw_4c8b0b48-5d4b-4f6f-be62-bc7483d2148b">7.1</ix:nonFraction> million consideration transferred, we recognized (1) $<ix:nonFraction unitRef="usd" contextRef="i54d5014ebd024ca98e929b3f83f093f0_I20200908" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNzAwNQ_5e87869e-901b-4315-979f-b1ae7213b5d1">0.2</ix:nonFraction> million of tangible assets acquired, (2) $(<ix:nonFraction unitRef="usd" contextRef="i54d5014ebd024ca98e929b3f83f093f0_I20200908" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNzA0MQ_1c2427b7-3890-4ac6-a0a0-c43f2407bcb9">0.1</ix:nonFraction>) million of liabilities assumed, (3) $<ix:nonFraction unitRef="usd" contextRef="if0c763244b8f494b9e10d8327366c0ac_I20200908" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNzA3Mg_3c710b16-3fcc-48f8-9dde-c1ba977bd5f6">7.8</ix:nonFraction> million of core completed technology acquired, and (4) $(<ix:nonFraction unitRef="usd" contextRef="i54d5014ebd024ca98e929b3f83f093f0_I20200908" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNzEyMg_c108fa5b-707e-47f2-99d2-957fd71581b7">0.8</ix:nonFraction>) million of deferred tax liability. The core technology is being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="i5723a94d9eda43fb8869b9e15a4fa617_D20200908-20200908" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNzI1MA_3cac84ce-70d2-4740-8401-be91ee5319f2">15</ix:nonNumeric> years. We account for the earnout rights in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. <ix:nonFraction unitRef="usd" contextRef="i54d5014ebd024ca98e929b3f83f093f0_I20200908" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNzM5OQ_6aef2362-b377-4ec1-9c35-cd58f1fe6294">None</ix:nonFraction> of the earnout rights are recognized as of the acquisition date. During the three months ended June&#160;30, 2021, <ix:nonFraction unitRef="usd" contextRef="ie8c72e7934ca467294335090971a29a5_D20210401-20210630" decimals="-5" format="ixt-sec:numwordsen" name="lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMzI5ODUzNDg5NDQ1Mg_99c426ce-7ce6-4eb5-8cb8-2fdf26763796">no</ix:nonFraction> contingencies were resolved during the period. During the six months ended June&#160;30, 2021, we recognized $<ix:nonFraction unitRef="usd" contextRef="icf2d939c66e240b384df46c32a7696cc_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNzQ5OQ_e3e164a8-16e0-4830-8c1e-816d4e2b11fb">0.2</ix:nonFraction> million in earnout rights when certain contingencies were resolved during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Icagen Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2020, we acquired the core assets, including its partnered programs and ion channel technology, from Icagen and certain of its affiliates. The acquisition was accounted for as a business combination and we applied the acquisition method of accounting. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. We did <ix:nonFraction unitRef="usd" contextRef="ie5cbd93c89514ab78b2dac40f63bcb20_D20200401-20200401" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfODAzOA_d8801b92-c284-4959-8a3a-487234780af9">no</ix:nonFraction>t incur any material acquisition-related costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purchase price of $<ix:nonFraction unitRef="usd" contextRef="ie5cbd93c89514ab78b2dac40f63bcb20_D20200401-20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfODExMQ_eca7cd50-fb61-48c8-ab7e-4be3b172aaab">19.9</ix:nonFraction> million included $<ix:nonFraction unitRef="usd" contextRef="ie5cbd93c89514ab78b2dac40f63bcb20_D20200401-20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfODEyMw_9df93022-40c9-49ed-9962-91760c21e4ed">15.1</ix:nonFraction> million cash consideration paid upon acquisition, and a contingent earn-out payment of up to $<ix:nonFraction unitRef="usd" contextRef="i7603e0f422424be9889ff1051524dfb0_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfODIxMQ_72bdc013-fe8c-4759-894d-c02ed655f450">25.0</ix:nonFraction>&#160;million of cash payments based on certain revenue milestones with an estimated fair value of $<ix:nonFraction unitRef="usd" contextRef="i7603e0f422424be9889ff1051524dfb0_I20200401" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfODI5OQ_65fb19ef-efe0-4ea7-8671-28af05e8d7ec">4.8</ix:nonFraction> million. The fair value of the earn-out liability was determined using a probability weighted income approach incorporating the estimated future cash flows from expected future milestones. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of Icagen. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 2, Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, for further discussion. The liability will be periodically assessed based on events and circumstances related to the underlying milestones, and any change in fair value will be recorded in our consolidated statements of operations. The carrying amount of the liability may fluctuate significantly and actual amount paid may be materially different than the carrying amount of the liability. As the acquisition is not considered significant, pro forma information has not been provided. The results of Icagen have been included in our results of operations since the date of acquisition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The allocation of the purchase price consisted of (1) $<ix:nonFraction unitRef="usd" contextRef="i7603e0f422424be9889ff1051524dfb0_I20200401" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTQxNg_332fd9a1-207d-4dd0-894c-f3e28fd656c0">1.8</ix:nonFraction> million of fair value of tangible assets acquired, (2) $(<ix:nonFraction unitRef="usd" contextRef="i7603e0f422424be9889ff1051524dfb0_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTQ2Ng_a81d16b2-2004-48df-b5d8-13064e40f9b4">0.8</ix:nonFraction>) million of liabilities assumed, (3) $<ix:nonFraction unitRef="usd" contextRef="i7603e0f422424be9889ff1051524dfb0_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTQ5Nw_8051ecdd-3d30-4544-b268-055d45c04ba5">12.8</ix:nonFraction> million of acquired intangibles, (4) $(<ix:nonFraction unitRef="usd" contextRef="i7603e0f422424be9889ff1051524dfb0_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTUyOQ_c9476366-a247-410d-b6b1-721449ea9fed">3.7</ix:nonFraction>) million of deferred revenue in connection with assumed performance obligations under a collaboration agreement, (5) $<ix:nonFraction unitRef="usd" contextRef="i7603e0f422424be9889ff1051524dfb0_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTY0MA_0370fc9f-b83b-4b6e-96e2-721abcf5a67d">0.8</ix:nonFraction> million of deferred tax asset associated with the deferred revenue, and (6) $<ix:nonFraction unitRef="usd" contextRef="ie5cbd93c89514ab78b2dac40f63bcb20_D20200401-20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTcxMQ_5e68a8f4-0c10-438d-80dc-2af2cec1d63d">9.0</ix:nonFraction> million of goodwill, the majority of which is deductible for tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired intangibles include $<ix:nonFraction unitRef="usd" contextRef="i6940e14a447b4533beb52b4a4a14f7dd_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTgxMg_d764938a-6bcd-4a36-8980-b972e53b7ded">11.1</ix:nonFraction> million of customer relationships and $<ix:nonFraction unitRef="usd" contextRef="i7aba352a45ca4f0e95b1673c0ce486b6_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTg0NQ_37b1d35b-1657-44e7-bf7f-3fc69a24e896">1.7</ix:nonFraction> million of core technology. The fair values of the customer relationships were based on a discounted cash flow analysis incorporating the estimated future cash flows from these relationships during the contractual term. These cash flows were then discounted to present value using a discount rate of <ix:nonFraction unitRef="number" contextRef="i0153378473074ebfa2f0f2c17278e656_D20200401-20200401" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTAxNDA_e7dbd0e5-145d-4c60-93f2-ef53d87f79f9">17</ix:nonFraction>%. The fair value of the customer relationships is being amortized on a straight-line basis over the weighted average estimated useful life of <ix:nonNumeric contextRef="i0153378473074ebfa2f0f2c17278e656_D20200401-20200401" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTAyODQ_36043d0b-b2b9-4548-9f03-f64bfb4cae34">9.6</ix:nonNumeric> years. The fair value of the core technology was based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, and collaboration revenue streams derived from the licensing of the related technologies. These projected cash flows were discounted to present value using a discount rate of <ix:nonFraction unitRef="number" contextRef="i34d2746d79d3442aafdf1a56d6430b2c_D20200401-20200401" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTA2MTk_c7a8f3e1-7451-4216-b14f-867b8f4465a1">17</ix:nonFraction>%. The fair value of the core technology is being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="i34d2746d79d3442aafdf1a56d6430b2c_D20200401-20200401" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTA3Mzk_13332049-5a72-401f-9425-ed0777bd3682">10</ix:nonNumeric> years. The total acquired intangibles are being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="ie5cbd93c89514ab78b2dac40f63bcb20_D20200401-20200401" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTA4NTM_97536027-d5ae-450d-bd90-5558da630999">9.7</ix:nonNumeric> years.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i934841341d8f4620843d0f6fb5e931d1_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.  <ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjY4OQ_fe5a68a0-fc81-45f7-8b10-e1203653b5a6" continuedAt="i4c8829546d374157bf014763c3697adc" escape="true">Convertible Senior Notes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4c8829546d374157bf014763c3697adc" continuedAt="ie871fa43e6a8440482002186ad06a548"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$<ix:nonFraction unitRef="usd" contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfOTk_ad5f9808-e956-45b5-96e6-da9d09d9c6f7">750.0</ix:nonFraction>&#160;million&#160;aggregate principal amount of&#160;<ix:nonFraction unitRef="number" contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTMy_a9f8323c-938b-4405-bb1c-97d0f66b9fa8">0.75</ix:nonFraction>%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $<ix:nonFraction unitRef="usd" contextRef="iaf96b8be4ae34fa8b6593ff5e5722455_D20180501-20180531" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMjg4_734a32fa-562d-429f-9f76-7dd3c6b7121b">733.1</ix:nonFraction> million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjA5_bcdee17b-97a0-4689-985c-e4cacc7c32c5">248.48</ix:nonFraction> per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least <ix:nonFraction unitRef="d" contextRef="i12aec736c95f4baa8c48022ee88902a7_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfOTQy_c8af93fd-fcc5-4d0b-8ba5-bd90cb3c739a">20</ix:nonFraction> trading days (whether or not consecutive) during the <ix:nonFraction unitRef="d" contextRef="i12aec736c95f4baa8c48022ee88902a7_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfOTk4_f7b61b18-b06b-4758-9665-9e83e6671a66">30</ix:nonFraction> consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than <ix:nonFraction unitRef="number" contextRef="i12aec736c95f4baa8c48022ee88902a7_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTE5Mw_d4f4a682-542c-41bb-a86e-25cb71cedc01">130</ix:nonFraction>% of the conversion price on such trading day; </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the <ix:nonFraction unitRef="d" contextRef="i1f99d4ba56e34f949157def3cb48d44b_D20180501-20180531" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTI1OA_26a22722-2ea7-4f48-b87b-a0636b3c5b21">five</ix:nonFraction> business day period immediately following any <ix:nonFraction unitRef="d" contextRef="i1f99d4ba56e34f949157def3cb48d44b_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTMwNw_06f0853d-c3c6-47f4-845c-de714606a28d">10</ix:nonFraction> consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than <ix:nonFraction unitRef="number" contextRef="i1f99d4ba56e34f949157def3cb48d44b_D20180501-20180531" decimals="INF" name="lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTQxNg_06f59d7e-e01b-43db-9d7f-c877cc93afcb">98</ix:nonFraction>% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTg0MA_9f3c1833-2e61-4253-9c32-04f630c9114c">248.48</ix:nonFraction>. As of June&#160;30, 2021, the &#8220;if-converted value&#8221; did not exceed the principal amount of the 2023 Notes. In connection with the issuance of the 2023 Notes, we incurred $<ix:nonFraction unitRef="usd" contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTk5Nw_f6cd0043-2d97-425b-a628-a6435e96f8c5">16.9</ix:nonFraction> million of issuance costs, which primarily consisted of underwriting, legal and other professional fees. The portion of these costs allocated to the liability component totaling $<ix:nonFraction unitRef="usd" contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMjE3MA_c312c14a-1706-437d-9bec-442192d57c90">13.7</ix:nonFraction> million is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2021, we repurchased $<ix:nonFraction unitRef="usd" contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MDc3MQ_2ea21198-26a4-4f3a-ae42-1af58c4a4699">149.6</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="i63b28b3736b54b859065e5e8a9af5595_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MDgwNQ_0e0517a1-2787-4287-9eca-004ee93f95ca">153.7</ix:nonFraction> million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i63b28b3736b54b859065e5e8a9af5595_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MDgyNw_0a28593a-2f11-44cf-b73c-9a902b43708d">0.3</ix:nonFraction> million. We accounted for the repurchase as a debt extinguishment, which resulted in (1) a loss of $<ix:nonFraction unitRef="usd" contextRef="i63b28b3736b54b859065e5e8a9af5595_D20210101-20210630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MDg1OQ_32213877-ba70-426d-bfc4-92ab23040a56">7.2</ix:nonFraction> million reflected in other income (expense), net, in our condensed consolidated statement of operations for the six months ended June&#160;30, 2021, (2) a $<ix:nonFraction unitRef="usd" contextRef="i63b28b3736b54b859065e5e8a9af5595_D20210101-20210630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="lgnd:IncreaseDecreaseInDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MDgzOA_2d4f64e4-8626-4381-ba23-a88965541190">13.5</ix:nonFraction> million reduction in debt discount, and (3) a $<ix:nonFraction unitRef="usd" contextRef="i63b28b3736b54b859065e5e8a9af5595_D20210101-20210630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MDg0OQ_f78a54af-393b-42f3-a0f5-f7efcc7868ed">10.2</ix:nonFraction> million reduction to additional paid in capital, net of tax, related to the reacquisition of the equity component in our condensed consolidated balance sheet as of June&#160;30, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering <ix:nonFraction unitRef="shares" contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMzM1MA_aac73096-fd48-4aab-ab61-44686df8098c">3,018,327</ix:nonFraction> shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMzYyNA_b1d1cc13-60d5-480d-80d0-9d7c34285d65">248.48</ix:nonFraction> per share and are exercisable when and if the 2023 Notes are converted. We paid $<ix:nonFraction unitRef="usd" contextRef="iaf96b8be4ae34fa8b6593ff5e5722455_D20180501-20180531" decimals="-5" format="ixt:numdotdecimal" name="lgnd:PaymentsForConvertibleBondHedges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMzcwNw_cf44d102-ea25-415c-b2a8-36ebd57e9075">140.3</ix:nonFraction> million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately <ix:nonFraction unitRef="shares" contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNDYwNw_f84473cb-0001-4951-9207-7756c3a5f345">3,018,327</ix:nonFraction> shares of common stock with an exercise price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNDY3Mw_f7a9d621-a256-4e69-86cf-01f4f70782c0">315.38</ix:nonFraction> per share, subject to certain adjustments. We received $<ix:nonFraction unitRef="usd" contextRef="iaf96b8be4ae34fa8b6593ff5e5722455_D20180501-20180531" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNDczMQ_68315e87-49e1-4802-b0eb-ce5c863cfa98">90.0</ix:nonFraction> million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ie871fa43e6a8440482002186ad06a548"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, in connection with the repurchases of $<ix:nonFraction unitRef="usd" contextRef="i9523ea7760f1491383b68be5f294a2a0_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MjEyOQ_b6ceccc7-262d-4ad0-9e5a-673e4a0186d5">104.5</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ib669b81f00fd49af94c6193b9b28b3e4_D20210301-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MjEzMw_f01a662c-b523-4091-80eb-ac46d103c336">109.1</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ib669b81f00fd49af94c6193b9b28b3e4_D20210301-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MjEzNw_ae8a15b8-2c53-4d63-ba02-c68416ddff36">0.2</ix:nonFraction>&#160;million, during the quarter ended March 31, 2021, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $<ix:nonFraction unitRef="usd" contextRef="i11b1244fd6124eb2b9e0ee4aa2f36ac9_D20210301-20210331" decimals="-5" format="ixt:numdotdecimal" name="lgnd:PaymentsToUnwindWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjE5NQ_aa70d577-9174-49a6-a529-c2c5a8772862">16.5</ix:nonFraction>&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from <ix:nonFraction unitRef="shares" contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjMwNA_aac73096-fd48-4aab-ab61-44686df8098c">3,018,327</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="i9523ea7760f1491383b68be5f294a2a0_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjMxMA_522d2d18-d965-4893-8a5a-9dce257c0ade">2,597,750</ix:nonFraction>. We received $<ix:nonFraction unitRef="usd" contextRef="i11b1244fd6124eb2b9e0ee4aa2f36ac9_D20210301-20210331" decimals="-5" format="ixt:numdotdecimal" name="lgnd:ProceedsFromUnwindingConvertibleBondHedges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjMyNg_b430bb6e-39e5-400a-a1dc-ad4899777f56">16.9</ix:nonFraction>&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to <ix:nonFraction unitRef="option" contextRef="i60594d6045784168a055ecf56059a566_I20210331" decimals="INF" format="ixt:numdotdecimal" name="lgnd:NumberOfOptionsUnderConvertibleBondHedges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjQ0Nw_e6fdda17-739c-4f49-b6b6-d8e97480b57b">645,500</ix:nonFraction>. These unwind transactions resulted in a $<ix:nonFraction unitRef="usd" contextRef="i11b1244fd6124eb2b9e0ee4aa2f36ac9_D20210301-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjQ5MQ_98b06135-56ff-40e5-b0b6-176813c48617">0.4</ix:nonFraction>&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of March 31, 2021.</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjY4Nw_f4afd141-5aab-4842-8a44-4954aef845aa" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:67.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.907%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfMS0xLTEtMS0w_dbc486d7-5366-4d4e-973a-1fb2fe71db71">345,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ad33f4bc734bcd93b25da90e7b9a20_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfMS0zLTEtMS0w_03a827f8-fd7f-4c4d-ac0f-d673dcc7af2f">495,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfMi0xLTEtMS0w_aab22db9-4497-4648-8c1b-3f85e3b88a37">30,411</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5ad33f4bc734bcd93b25da90e7b9a20_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfMi0zLTEtMS0w_dc390413-fd85-4c12-83a5-e578caff2bb6">52,987</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfMy0xLTEtMS0w_258dc349-40ae-4b56-bf1a-907f8d9c54ce">315,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ad33f4bc734bcd93b25da90e7b9a20_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfMy0zLTEtMS0w_d3b88f93-c41e-4980-a9c5-1413cf5e38c0">442,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carrying value of equity component of the 2023 Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfNS0xLTEtMS0w_5870fb59-bbf2-4758-9614-ddda0442cf63">27,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ad33f4bc734bcd93b25da90e7b9a20_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfNS0zLTEtMS0w_81167d49-7121-474a-9072-fe45a10b44a2">48,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfNi0xLTEtMS0w_565ec1fe-4a00-460c-873d-01e0183f4276">341,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ad33f4bc734bcd93b25da90e7b9a20_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfNi0zLTEtMS0w_2db88ba3-c867-4291-82d9-dea4b6ebe124">466,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i934841341d8f4620843d0f6fb5e931d1_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.  <ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80OS9mcmFnOmYyZTc5NTdiNzM5NTRkOWY4ZDFkMzcwOTdjNWZjNzQxL3RleHRyZWdpb246ZjJlNzk1N2I3Mzk1NGQ5ZjhkMWQzNzA5N2M1ZmM3NDFfNzg4_d27b5a85-03c3-40e7-9d8d-6d267f58690e" continuedAt="i7d19d642ddb14c71b9cd75923683ffa2" escape="true">Income Tax</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i7d19d642ddb14c71b9cd75923683ffa2">Our effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three and six months ended June&#160;30, 2021 was <ix:nonFraction unitRef="number" contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80OS9mcmFnOmYyZTc5NTdiNzM5NTRkOWY4ZDFkMzcwOTdjNWZjNzQxL3RleHRyZWdpb246ZjJlNzk1N2I3Mzk1NGQ5ZjhkMWQzNzA5N2M1ZmM3NDFfNDM4_2504889b-0680-47a9-b6d6-05d7a351b6cf">7.7</ix:nonFraction>% and (<ix:nonFraction unitRef="number" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80OS9mcmFnOmYyZTc5NTdiNzM5NTRkOWY4ZDFkMzcwOTdjNWZjNzQxL3RleHRyZWdpb246ZjJlNzk1N2I3Mzk1NGQ5ZjhkMWQzNzA5N2M1ZmM3NDFfMTY0OTI2NzQ0MjQ2NQ_09a0e7e9-9a29-49f9-9863-2efdc0aa93a5">25.0</ix:nonFraction>)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three and six months ended June&#160;30, 2021 was significantly impacted by tax benefits related to (1) a $<ix:nonFraction unitRef="usd" contextRef="i3819ef5e99824efb8df9aa305cf4213a_D20210401-20210630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80OS9mcmFnOmYyZTc5NTdiNzM5NTRkOWY4ZDFkMzcwOTdjNWZjNzQxL3RleHRyZWdpb246ZjJlNzk1N2I3Mzk1NGQ5ZjhkMWQzNzA5N2M1ZmM3NDFfMTA5OTUxMTYyOTUwOQ_65682680-be00-4c8f-b8cd-39e7fca40736">34.1</ix:nonFraction>&#160;million Pfenex CVR adjustment recorded during the second quarter of 2021 due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR, and (2) net excess tax windfalls from share-based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period. The effective tax rate for the three and six months ended June 30, 2020 was <ix:nonFraction unitRef="number" contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80OS9mcmFnOmYyZTc5NTdiNzM5NTRkOWY4ZDFkMzcwOTdjNWZjNzQxL3RleHRyZWdpb246ZjJlNzk1N2I3Mzk1NGQ5ZjhkMWQzNzA5N2M1ZmM3NDFfMTY0OTI2NzQ0Mjk0Mg_162b97ac-f137-4c65-bb3f-e53a6ec3710c">21.5</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80OS9mcmFnOmYyZTc5NTdiNzM5NTRkOWY4ZDFkMzcwOTdjNWZjNzQxL3RleHRyZWdpb246ZjJlNzk1N2I3Mzk1NGQ5ZjhkMWQzNzA5N2M1ZmM3NDFfMTY0OTI2NzQ0Mjk1MA_8f9b16eb-eedc-499a-a591-f2d1c4a45a75">10.9</ix:nonFraction>%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three and six months ended June 30, 2020 were primarily attributable to the mix of earnings in the jurisdictions with lower statutory rates than the U.S. offset by tax deductions related to stock award activities and tax deductions related to foreign derived intangible income tax credits.</ix:continuation></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i934841341d8f4620843d0f6fb5e931d1_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.  <ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfMTU3NA_1c15114e-4c24-4e03-80c6-452721991ae1" continuedAt="i466ddc069efa457eb99a45e0dd26feb2" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i466ddc069efa457eb99a45e0dd26feb2" continuedAt="ie373e3b151df4160a55b556b386fe82e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements in our 2020 Annual Report.</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfMTU3Ng_5683e912-c1fa-4c63-9610-839a64ef1976" escape="true"><ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfMTU3OQ_2d262738-1835-41f1-b054-8d18c1e385bc" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa6b8e5ef49e44a1a9aa9d047df544ce_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMi0xLTEtMS0w_423f962f-81fc-4923-919c-ef254bd65111">2,561,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifa6b8e5ef49e44a1a9aa9d047df544ce_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMi0zLTEtMS0w_28069ee1-b206-4c2a-be0c-4107165184f7">85.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ce65c3cba6d4e1c8557dd4dafca661d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMi01LTEtMS0w_1f0bd779-dfb9-4f47-836c-a3ea1a5ebc9f">206,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ce65c3cba6d4e1c8557dd4dafca661d_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMi03LTEtMS0w_62f5cc81-566e-459e-9057-b86bd2ea65d5">106.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12c4ed3b655b4b9f9e07ed3bc8c69079_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMy0xLTEtMS0w_d5e961e3-662f-4640-aca6-9c3eb0600a0b">318,381</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12c4ed3b655b4b9f9e07ed3bc8c69079_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMy0zLTEtMS0w_729cf240-7e1b-4009-b32d-43ca2172f4f2">164.30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMy01LTEtMS0w_2e0673c8-dbef-445e-a39d-9065c70c182c">158,456</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMy03LTEtMS0w_b5b25f5e-9ed4-4133-806b-ebf0c9ed96a7">171.44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i12c4ed3b655b4b9f9e07ed3bc8c69079_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNC0xLTEtMS0w_eae29d1c-b92b-4eb2-8b16-758187afd966">533,451</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12c4ed3b655b4b9f9e07ed3bc8c69079_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNC0zLTEtMS0w_1a28073e-1a89-4ecc-ae6c-4dddd726fba8">52.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNC01LTEtMS0w_0d29355c-e44d-4049-a2c0-94edf8c8732f">95,607</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNC03LTEtMS0w_dc8a1e28-e87c-47a4-8254-d6ee0e04c853">126.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i12c4ed3b655b4b9f9e07ed3bc8c69079_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNS0xLTEtMS0w_72b73e53-0ba6-45a5-9787-cefb7386a258">83,489</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12c4ed3b655b4b9f9e07ed3bc8c69079_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNS0zLTEtMS0w_5d70424f-ba03-4375-962d-933db262ebcc">106.98</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNS01LTEtMS0w_1f6ffef4-d0b2-4bbe-888b-27a8605a77d7">6,790</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNS03LTEtMS0w_d7136538-2bfe-48d9-aeb6-89550b26c3c3">126.23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia96af39bd7604591ab7fc340e359673e_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNi0xLTEtMS0w_e6f79f3c-152f-40cb-bbfa-50ec16e6e7ee">2,263,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia96af39bd7604591ab7fc340e359673e_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNi0zLTEtMS0w_d8d15ac2-e6cc-4eb1-8c9f-873733bf992e">103.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2b7db7eef844718bf3f53433cde626e_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNi01LTEtMS0w_e9dd8063-58ea-4b92-acc8-8ef8800e9439">262,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2b7db7eef844718bf3f53433cde626e_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNi03LTEtMS0w_f3f5647b-12da-4fcd-906f-61ba91b12281">138.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, outstanding options to purchase <ix:nonFraction unitRef="shares" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfNDUx_8954170a-8aae-4d2a-99d3-0cd0416785f6">1.3</ix:nonFraction> million shares were exercisable with a weighted average exercise price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfNTMw_34a827e6-b5d5-4b2b-babe-baa308a37405">91.50</ix:nonFraction>.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to <ix:nonFraction unitRef="number" contextRef="i1e79a2e6b67647f882b54599c4f29c87_D20210101-20210630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfNjc5_03e0186c-d753-42de-a2dc-328183062133">85</ix:nonFraction>% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of June&#160;30, 2021, <ix:nonFraction unitRef="shares" contextRef="i1e79a2e6b67647f882b54599c4f29c87_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfODA2_3b182177-0a75-4f76-913b-6c35ff604556">46,866</ix:nonFraction> shares were available for future purchases under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did <ix:nonFraction unitRef="usd" contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfODk1_ef1ca43e-98db-4d75-b8d0-221ee9b60d9a">no</ix:nonFraction>t have any share repurchases during the six months ended June&#160;30, 2021.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie373e3b151df4160a55b556b386fe82e">On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="i89e8971a9fce47b4a1bcea09039305ed_I20190911" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfMTEwMA_edec14b8-6afe-4094-a17e-b94f00a327f8">500.0</ix:nonFraction> million of our common stock from time to time over the next <ix:nonNumeric contextRef="i74efa80b6d414949ba31e1e709cc19df_D20190911-20190911" format="ixt-sec:durwordsen" name="us-gaap:StockRepurchaseProgramPeriodInForce1" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfMTE1NQ_0236afa8-901e-4e46-92a9-80745e1afb21">three years</ix:nonNumeric>. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. Authorization to repurchase $<ix:nonFraction unitRef="usd" contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfMTUyMg_f4db5d40-92ed-4925-a0f0-4a27fc888d34">248.8</ix:nonFraction> million of our common stock remained available as of June&#160;30, 2021.</ix:continuation> </span></div><div><span><br/></span></div><div id="i934841341d8f4620843d0f6fb5e931d1_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.  <ix:nonNumeric contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81NS9mcmFnOjNiZWQxNjY2ZTJkZDRjMDA4OGFmZTYyNzIxNGM4Nzk1L3RleHRyZWdpb246M2JlZDE2NjZlMmRkNGMwMDg4YWZlNjI3MjE0Yzg3OTVfNzcyOA_dfcf3fdb-50d6-4db2-953b-dde9565549a1" continuedAt="ie47cb28b1589429a916712495bd4a8e6" escape="true">Commitment and Contingencies: Legal Proceedings</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie47cb28b1589429a916712495bd4a8e6" continuedAt="i784a0dac454f4d06beafad9a4e34b268"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 9, 2019, CyDex, our wholly-owned subsidiary, received a Paragraph IV certification Notice Letter from Alembic Global Holdings SA (&#8220;Alembic&#8221;) stating that Alembic had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> prior to the expiration of any of the &#8217;077 patent; the &#8217;088 patent, the &#8217;582 patent, or U.S. Patent No. 10,040,872 (&#8220;the &#8217;872 patent&#8221;), and alleging that these patents, each of which relates to Captisol, are invalid, unenforceable, and/or would not be infringed by Alembic&#8217;s ANDA product. On May 23, 2019, CyDex filed a complaint against Alembic, Alembic Pharmaceuticals, Ltd., and Alembic Pharmaceuticals, Inc. in the U.S. District Court for the District of Delaware, asserting that the filing of Alembic&#8217;s ANDA constitutes infringement of each of the &#8217;088 patent and the &#8217;582 patent. The parties entered into a settlement agreement on June 1, 2021 and the lawsuit has been dismissed.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 16, 2019, CyDex received a Paragraph IV certification Notice Letter from Lupin Ltd. (&#8220;Lupin&#8221;) stating that Lupin had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> prior to the expiration of any of the &#8217;077 patent; the &#8217;088 patent, the &#8217;582 patent, or the &#8217;872 patent, and alleging </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i784a0dac454f4d06beafad9a4e34b268" continuedAt="ib7972e1155a549f2a2996ce12d29d0bc"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that these patents, each of which relates to Captisol, are invalid, unenforceable, and/or would not be infringed by Lupin&#8217;s ANDA product. CyDex filed a complaint on October 29, 2019, alleging patent infringement against Lupin. Lupin filed an answer on December 11, 2019 and counterclaimed for declaratory judgments of invalidity and non-infringement as to all <ix:nonFraction unitRef="patent" contextRef="i3d23921891db45d19e297bbe9bbe585a_D20191029-20191029" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81NS9mcmFnOjNiZWQxNjY2ZTJkZDRjMDA4OGFmZTYyNzIxNGM4Nzk1L3RleHRyZWdpb246M2JlZDE2NjZlMmRkNGMwMDg4YWZlNjI3MjE0Yzg3OTVfMzM4Nw_8b657981-58c7-4f36-b812-039e28eac9c5">four</ix:nonFraction> patents and CyDex filed its answer to Lupin&#8217;s counterclaims on January 2, 2020. The parties entered into a settlement agreement on April 26, 2021 and the lawsuit has been dismissed.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received <ix:nonFraction unitRef="civil_complaint" contextRef="i90fc81e184454d969b54196ebc6b39a6_D20191031-20191031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81NS9mcmFnOjNiZWQxNjY2ZTJkZDRjMDA4OGFmZTYyNzIxNGM4Nzk1L3RleHRyZWdpb246M2JlZDE2NjZlMmRkNGMwMDg4YWZlNjI3MjE0Yzg3OTVfMzYwNg_991bb2ac-4315-4e10-bb83-94437ea65e75">three</ix:nonFraction> civil complaints filed in the US District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the company and no individualized factual allegations have been advanced against us in any of the <ix:nonFraction unitRef="civil_complaint" contextRef="i90fc81e184454d969b54196ebc6b39a6_D20191031-20191031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81NS9mcmFnOjNiZWQxNjY2ZTJkZDRjMDA4OGFmZTYyNzIxNGM4Nzk1L3RleHRyZWdpb246M2JlZDE2NjZlMmRkNGMwMDg4YWZlNjI3MjE0Yzg3OTVfNDE5MQ_6a1ffe06-24a3-45a1-9d85-8676444ea26b">three</ix:nonFraction> complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May and August of 2019, Pfenex Inc., which was acquired by us in October 2020, filed <ix:nonFraction unitRef="petition" contextRef="i89c035f5c0114d94bb9957d60b37cba3_D20190501-20190831" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:NumberOfPetitionsFiled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81NS9mcmFnOjNiZWQxNjY2ZTJkZDRjMDA4OGFmZTYyNzIxNGM4Nzk1L3RleHRyZWdpb246M2JlZDE2NjZlMmRkNGMwMDg4YWZlNjI3MjE0Yzg3OTVfNDM4OA_b6cfbe3a-dd98-44e2-9ab2-7a013d48ce70">three</ix:nonFraction> petitions (IPR2019- 01027, IPR2019-01028 and IPR2019-01478) for inter partes review of U.S. Patent No. 9,422,345 (&#8220;the &#8216;345 patent,&#8221; entitled &#8220;Expression System&#8221;), which is owned by GlaxoSmithKline Biologicals S.A. (&#8220;GSK&#8221;), with the Patent Trial and Appeal Board (&#8220;PTAB&#8221;) of the U.S. Patent and Trademark Office. In November 2019 and February 2020, the Board instituted trial on invalidity grounds in IPR2019-01028, but exercised its discretion not to institute trial on IPR2019-01027 or IPR2019-01478. In May 2020, GSK filed <ix:nonFraction unitRef="petition" contextRef="i8a9e8cc6b16b4c0e8960c2d7f31c2aaa_D20200501-20200531" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:NumberOfPetitionsFiled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81NS9mcmFnOjNiZWQxNjY2ZTJkZDRjMDA4OGFmZTYyNzIxNGM4Nzk1L3RleHRyZWdpb246M2JlZDE2NjZlMmRkNGMwMDg4YWZlNjI3MjE0Yzg3OTVfNDkxOA_adde9308-180c-4282-a403-2cb26f82922c">two</ix:nonFraction> petitions (IPR2020-00890 and IPR2020-00962) for inter partes review of U.S. Patent No. 8,530,171 (&#8220;the &#8216;171 patent,&#8221; entitled &#8220;High Level Expression of Recombinant Toxin Proteins&#8221;), which is owned by Pfenex, with the PTAB of the U.S. Patent and Trademark Office. On June 29, 2020, GSK filed a motion to withdraw IPR2020-00890, which was granted on August 28, 2020. In October 2020, Pfenex and GSK executed a confidential settlement agreement agreeing to terminate the proceedings before the PTAB resolving these issues. Pfenex and GSK filed a joint motion to terminate IPR2019-01028 and IPR2020-00962 on October 30, 2020, and an amended joint motion to terminate on November 4, 2020. A decision granting the parties&#8217; joint motion to terminate in IPR2019-01028 was issued on November 12, 2020. The PTAB subsequently granted the parties&#8217; joint motion to terminate in IPR2020-00962 on December 30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2021, Abvivo submitted a JAMS arbitration demand naming the Company as respondent. Abvivo claimed that the Company was in violation of the assignment provision of that certain Commercial Platform License and Services Agreement (&#8220;CPLSA&#8221;), dated October 9, 2019, by and among OMT and Crystal, on the one hand, and Abvivo, on the other hand because the Company allegedly withheld its consent to a proposed assignment required for Abvivo to negotiate a discovery and development alliance with certain third parties. On January 26, 2021, we submitted a response to the demand, denying all claims and alleging counterclaims against Abvivo and Brian Lundstrom, a Company employee and the sole owner of Abvivo. We alleged that Mr. Lundstrom breached his fiduciary duty of loyalty to the Company and that Abvivo and Mr. Lundstrom fraudulently induced the Company, OMT and Crystal into certain business transactions and contracts. Abvivo and Mr. Lundstrom&#8217;s response to these counterclaims was due on February 9, 2021, but they did not submit a response. Under JAMS rules, the counterclaims were deemed denied. On February 22, 2021, Abvivo submitted documents to JAMS which indicated that it sought to dismiss its claim without prejudice. On February 25, 2021, we submitted additional counterclaims against Abvivo and Mr. Lundstrom.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These counterclaims alleged that Abvivo and Mr. Lundstrom made false promises regarding the CPLSA, Abvivo&#8217;s breach of and failure to perform under the CPLSA, and Abvivo&#8217;s infringement of certain Ligand trademarks.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2021, Abvivo and Mr. Lundstrom submitted an answer to our amended counterclaims denying all of the claims and asserting various affirmative defenses. On June 21, 2021, the parties executed a confidential settlement agreement that settled all claims in this arbitration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 29, 2021, the parties jointly submitted to JAMS a dismissal with prejudice of all claims by all parties in the arbitration.</span></div></ix:continuation><div><span><br/></span></div><div><ix:continuation id="ib7972e1155a549f2a2996ce12d29d0bc" continuedAt="ie519646a2bb8480ab04340269b7fc733"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CyDex and Baxter Healthcare Corp. (&#8220;Baxter&#8221;) are parties to a license agreement relating to Ligand&#8217;s Captisol</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie519646a2bb8480ab04340269b7fc733">technology and, more specifically, relating to Captisol-enabled Nexterone (amiodarone HCl premixed injection). Baxter contends that it has overpaid royalties for several years, and seeks both refunds of those overpayment and a reduced royalty going forward. CyDex contends that Baxter has not paid the royalties due to CyDex under the terms of the license agreement. On April 6, 2021, Baxter initiated an arbitration with the American Arbitration Association pursuant to the arbitration provision of the license agreement. On April 21, 2021, CyDex filed an Answering Statement and Counterdemand. On May 5, 2021, Baxter filed an Answering Statement in response to CyDex&#8217;s Counterdemand. On June 30, 2021, the parties&#8217; held a Preliminary Hearing before the arbitrator. The arbitration is in its early stages.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i934841341d8f4620843d0f6fb5e931d1_58"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. &#160;&#160;&#160;&#160;Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Caution:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">  This discussion and analysis may contain predictions, estimates and other forward-looking statements that involve a number of risks and uncertainties, including those discussed in Part II, Item 1A. Risk Factors. This outlook represents our current judgment on the future direction of our business. These statements include those related to our Captisol-related revenues and manufacturing capacity, our Kyprolis and other product royalty revenues, the impact of COVID-19, product returns, and product development. Actual events or results may differ materially from our expectations. For example, there can be no assurance that our revenues or expenses will meet any expectations or follow any trend(s), that we will be able to retain our key employees or that we will be able to enter into any strategic partnerships or other transactions. We cannot assure you that we will receive expected Kyprolis, Captisol and other product revenues to support our ongoing business or that our internal or partnered pipeline products will progress in their development, gain marketing approval or achieve success in the market. In addition, ongoing or future arbitration, litigation or disputes with third parties may have a material adverse effect on us. Such risks and uncertainties, and others, could cause actual results to differ materially from any future performance suggested. We undertake no obligation to make any revisions to these forward-looking statements to reflect events or circumstances arising after the date of this quarterly report. This caution is made under the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">We use our trademarks, trade names and services marks in this report as well as trademarks, trade names and service marks that are the property of other organizations. Solely for convenience, trademarks and trade names referred to in this report appear without the &#174; and &#8482; symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the applicable owner will not assert its rights, to these trade marks and trade names.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References to &#8220;Ligand Pharmaceuticals Incorporated,&#8221; &#8220;Ligand,&#8221; the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;our&#8221; include Ligand Pharmaceuticals Incorporated and our wholly owned subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt"><span><br/></span></div><div id="i934841341d8f4620843d0f6fb5e931d1_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We employ research technologies such as antibody discovery technologies, ion channel discovery technology, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pseudomonas fluorescens </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. We currently have partnerships and license agreements with over 130 pharmaceutical and biotechnology companies. Over 300 programs are in various stages of commercialization, development or research and are fully funded by our collaboration partners and licensees. We have contributed novel research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and postpartum depression, among others. Our collaboration partners and licensees have programs currently in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others. We have over 1,400 issued patents worldwide.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have assembled our large portfolio of fully-funded programs either by licensing our own proprietary drug development programs, licensing our platform technologies such as Captisol or OmniAb to partners for use with their proprietary programs, or acquiring existing partnered programs from other companies. Fully-funded programs, which we refer to as "shots on goal," are those for which our partners pay all of the development and commercialization costs. For our internal programs, we generally plan to advance drug candidates through early-stage drug development or clinical proof-of-concept and then seek partners to continue development and potential commercialization.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Our business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation and partnering. We partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately generate our revenue. We believe that focusing on discovery and early-stage drug development while benefiting from our partners&#8217; development and commercialization expertise will reduce our internal expenses and allow us to have a larger number of drug candidates progress to later stages of drug development.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue consists of three primary elements: royalties from commercialized products, sale of Captisol material, and contract revenue from license, milestone and other service payments. In addition to discovering and developing our own </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proprietary drugs, we selectively pursue acquisitions to bring in new assets, pipelines, and technologies to aid in generating additional potential new revenue streams.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19 Pandemic</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> described in Item 1. Condensed Consolidated Financial Statements - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For additional information on the various risks posed by the COVID-19 pandemic, please read Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Risk Factors"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this report and in our 2020 Annual Report.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Portfolio Program Updates </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OmniAb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Platform Updates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OmniAb is our industry-leading, AI- and BI- (Biological Intelligence) powered multi-species antibody platform for the discovery of mono and bispecific therapeutic human antibodies. As of June 30, 2021, 19 different OmniAb-derived antibodies have been studied in approximately 77 active or completed clinical trials. We expect the first regulatory approvals for  OmniAb-derived antibodies in 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Arcus Biosciences announced initial efficacy and safety from one of the cohorts in ARC-6, a randomized Phase 1b/2 platform study evaluating the combination of etrumadenant (dual adenosine A2a/A2b receptor antagonist) plus zimberelimab (an OmniAb-derived, anti-PD1 antibody) and docetaxel in people with taxane-na&#239;ve metastatic castration-resistant prostate cancer. Arcus also announced encouraging clinical results from an interim analysis of the Phase 2 ARC-7 study evaluating the safety and efficacy of anti-TIGIT mAb domvanalimab-based combinations with or without zimberelimab as a first-line treatment of PDL1-high non-small cell lung cancer (NSCLC). The zimberelimab monotherapy arm showed activity similar to that of marketed anti-PD-1 antibodies studied by other companies in this setting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Janssen provided an update on their Phase 1 trial results for teclistamab in heavily pretreated patients with multiple myeloma suggesting deep and durable responses, and also announced FDA Breakthrough Therapy Designation for teclistamab for the treatment of relapsed or refractory multiple myeloma. Teclistamab is an OmniAb-derived bispecific antibody targeting BCMA and CD3.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CStone Pharmaceuticals announced OmniAb-derived anti-PD-L1 antibody sugemalimab met its primary endpoint in the first-in-class registrational clinical trial for Stage III NSCLC and plans to submit a New Drug Application in China for this expanded indication.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aptevo Therapeutics announced positive Phase 1 clinical data for APVO436 from the dose-escalation portion of their Phase 1 trial in adults with relapsed acute myeloid leukemia, and initiation of the expansion phase of the study using the recommended dose identified in Part 1. APVO436 is an OmniAb-derived bispecific antibody targeting CD123 and CD3 for the potential treatment of hematological malignancies.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Harbour BioMed reported positive topline results for the Phase 2 proof-of-concept trial of batoclimab, a novel anti-FcRn antibody, in Chinese patients with generalized myasthenia gravis. Harbor BioMed plans to initiate a Phase 3 study in this indication in the second half of 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021,we entered into OmniAb licensing agreements with GenScript Biotech and ImmuNext.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pelican Platform Updates</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pelican Expression Technology&#8482; is our proprietary Pseudomonas fluorescens protein expression technology that has major collaborations with Jazz Pharmaceuticals, Merck, Serum Institute of India and Alvogen, each of which has potential to contribute meaningfully to our royalty revenue. In addition, large pharma and small biotech partners continue to expand their use of our PeliCRM&#8482; (CRM197), a non-toxic mutant diphtheria toxin vaccine carrier protein produced using Pelican Expression Technology, adding to near-term revenue.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jazz Pharmaceuticals recently received FDA approval for Rylaze&#8482;, formerly JZP458, for the treatment of acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL). Rylaze is a recombinant Erwinia asparaginase used as a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">component of a multi-agent chemotherapeutic regimen for the treatment of pediatric and adult patients with ALL or LBL who are hypersensitive to E. coli-derived asparaginase products. In July, Jazz launched Rylaze and announced that the National Comprehensive Cancer Network&#174; (NCCN) added Rylaze to the Clinical Practice Guidelines in Oncology (NCCN Guidelines&#174;) for ALL in pediatric and adult patients.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Merck received FDA approval for VAXNEUVANCE&#8482;, formerly V114, for the prevention of pneumococcal disease in adults. VAXNEUVANCE is a 15-valent pneumococcal vaccine utilizing our CRM197 vaccine carrier protein produced using the Pelican Expression Technology platform. Additionally, Merck announced positive results from initial Phase 3 pediatric clinical trials for VAXNEUVANCE in pneumococcal disease. CRM197, produced by the Pelican Expression Technology&#8482;, is also used by Merck in its investigational vaccine candidates, including V116.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:99%">Other Business Updates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BeiGene received approval in China of Kyprolis (carfilzomib) in combination with dexamethasone for adult patients with relapsed or refractory multiple myeloma who have received at least two prior therapies, including a proteasome inhibitor and an immunomodulatory agent. This is the first approval of Kyprolis in China. BeiGene licensed Kyprolis in 2019 for commercialization and development in China under a strategic collaboration with Amgen.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Roche and Ligand expanded an existing collaboration agreement utilizing the Icagen Ion Channel Technology platform to a third program for the development and commercialization of small molecule ion channel modulators for the treatment of neurological diseases. Roche made an upfront cash payment to us and will also provide research funding. In addition, we are eligible to receive up to $274 million in research, development and commercial milestone payments, as well as royalties on net sales should a drug from the collaboration be commercialized.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Travere Therapeutics announced completion of enrollment in the pivotal Phase 3 PROTECT clinical trial to evaluate the long-term nephroprotective potential of sparsentan in IgA nephropathy. Travere anticipates topline interim efficacy data in the third quarter of 2021. In May 2021, Travere announced that the FDA indicated the available data from the interim assessment in the pivotal, Phase 3 DUPLEX study in focal segmental glomerulosclerosis would not be adequate to support an accelerated approval at this time. The FDA indicated an application for accelerated approval may be possible after additional eGFR data accrue in the first-half of 2022.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Novan announced positive topline results from the pivotal Phase 3 B-SIMPLE5 trial of SB206, a topical antiviral gel, for the treatment of molluscum contagiosum. The clinical trial achieved statistical significance (p&lt;0.0001) for the primary endpoint of complete clearance of all lesions at Week 12, and statistical significance for all secondary endpoints including proportion achieving a lesion count of 0 or 1 at Week 12, proportion achieving &#8805;90% clearance of lesions at Week 12 and complete clearances of all lesions at Week 8. Novan intends to submit an NDA by the third quarter of 2022.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sermonix Pharmaceuticals announced complete enrollment in its Phase 2 clinical trial studying lasofoxifene in combination with Eli Lilly&#8217;s FDA-approved CDK 4 and 6 inhibitor abemaciclib to treat ESR1-mutated metastatic breast and gynecological cancers. Lasofoxifene is an investigational, nonsteroidal selective estrogen receptor modulator. Sermonix expects initial data from the trial to be available in the first half of 2022.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div id="i934841341d8f4620843d0f6fb5e931d1_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="text-indent:14pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.097%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,616</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15,728</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,982&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">62,509</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">93,781</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13,550</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">30,316</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">84,675</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,420&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,255&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">139,825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,581&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,244&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Royalty revenue is a function of our partners&#8217; product sales and the applicable royalty rate. Kyprolis royalty rates are under a tiered royalty rate structure with the highest tier being 3.0%. Evomela has a fixed royalty rate of 20%. Contract revenue includes service revenue, license fees and development, regulatory and sales based milestone payments.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents royalty revenue by program:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:23.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2021 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2021 Royalty Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2020 Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2020 Royalty Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">266.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">269.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">318.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">315.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:23.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021 Royalty Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020 Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020 Royalty Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">527.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">555.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">22.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">68.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">617.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">655.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Q2 2021 vs. Q2 2020</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total revenue increased by $43.3 million, or 104%, to $84.7 million in Q2 2021 compared to $41.4 million in Q2 2020 primarily reflecting higher sales of Captisol for use in the manufacturing of remdesivir. Contract revenue increased in Q2 2021 compared to Q1 2020, with the increase primarily attributable to (1) the timing of partner milestone events and (2) the additional contract revenue of $5.2 million from our Pelican Expression Technology, acquired in October 2020.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">YTD 2021 vs. YTD 2020</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total revenue increased by $65.2 million, or 87%, to $139.8 million in YTD 2021 compared to $74.6 million in the same period last year primarily reflecting higher sales of Captisol for use in the manufacturing of remdesivir. Contract revenue increased in the first half of 2021 compared to the same period last year, with the increase primarily attributable to (1) the timing of partner milestone events and (2) the additional contract revenue of $8.0 million and $8.5 million from the acquisitions of Icagen in April 2020 and Pfenex in October 2020, respectively.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Costs and Expenses</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of Captisol</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">30,593</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">38,746</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,779</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">23,565</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15,953</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">33,832</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,711</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">27,028</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other operating income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(34,100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(33,800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">38,936</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,320&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">89,371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,693&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Q2 2021 vs. Q2 2020</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating costs and expenses during Q2 2021 increased by $4.6 million, or 13%, compared to Q2 2020 primarily due to additional operating costs attributable to Pfenex, which we acquired on October 1, 2020, as well as an increase in Captisol sales for the current period. The increase was partially offset by a $34.1 million non-cash valuation adjustment recorded in the second quarter of 2021 to reduce the Pfenex CVR liability. See additional information on the Pfenex CVR liability in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 2, Fair Value Measurements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cost of Captisol increased primarily due to higher Captisol sales during Q2 2021 compared to Q2 2020. Cost of Captisol as a percentage of Captisol revenue was 49% in Q2 2021 compared to 31% in Q2 2020, with the increase primarily due to the significant sales to the Gilead consortium partners in India who had sales prices lower than other customers during Q2 2021.  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangibles increased in Q2 2021 compared to the same period in 2020 primarily due to the amortization of contractual relationships and technologies acquired from Pfenex in October 2020. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any one time, we are working on multiple programs. As such, we generally do not track our R&amp;D expenses on a specific program basis. Our R&amp;D expenses increased year over year in Q2 2021 due to the $4.2 million costs associated with our Pfenex acquisition, which primarily consisted of salaries and lab costs.  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased in Q2 2021 compared to the same period in 2020 primarily due to the additional expenses from the Pfenex acquisition as well as increased share-based compensation expense.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating income in Q2 2021 included a $34.1 million non-cash valuation adjustment to reduce the Pfenex CVR liability. The decrease in Pfenex CVR liability is due to an expected lower probability of achieving the required milestone under the Pfenex CVR Agreement, which provides for payment to Pfenex CVR holders upon notice from the FDA that teriparatide injection receives an &#8220;A&#8221; therapeutic equivalence designation relative to the listed drug, FORTEO, by December 31, 2021. Based on feedback from the FDA, our commercial partner, Alvogen, will perform and submit to the FDA the results from an assessment to address concerns relating to potential innate immunogenicity, reducing the probability of achieving the milestone by December 31, 2021. There were no items recorded in other operating income in Q2 2020.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">YTD 2021 vs. YTD 2020</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating costs and expenses during YTD 2021 increased by $25.7 million, or 40%, compared to YTD 2020 primarily due to additional operating costs attributable to Icagen and Pfenex, as well as higher Captisol sales during YTD 2021. The increases were partially offset a $34.1 million non-cash valuation adjustment to reduce the Pfenex CVR liability. See additional disclosure on the Pfenex CVR liability in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 2, Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cost of Captisol increased primarily due to higher Captisol sales during YTD 2021 compared to YTD 2020. Cost of Captisol as a percentage of Captisol revenue was 41% in YTD 2021 compared to 27% in YTD 2020, with the increase primarily due to the significant sales to the Gilead consortium partners in India who had sales prices lower than other customers during Q2 2021.  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangibles increased in YTD 2021 compared to the same period in 2020 primarily due to the amortization of contractual relationships and technologies acquired from Icagen in April 2020 and Pfenex in October 2020. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any one time, we are working on multiple programs. As such, we generally do not track our R&amp;D expenses on a specific program basis. Our R&amp;D expenses increased year over year in YTD 2021 due to the $9.2 million costs associated with our Pfenex acquisition, which primarily consisted of salaries and lab costs.  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased in YTD 2021 compared to the same period in 2020 primarily due to the additional expenses from the Pfenex and Icagen acquisitions as well as increased share-based compensation expense.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating income in YTD 2021 primarily included a $34.1 million non-cash valuation adjustment to reduce the Pfenex CVR liability during Q2 2021 as mentioned above. There were no items recorded in other operating income in YTD 2020.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) from short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(6,864)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30,324)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,281)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">233</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,736)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">529</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,699&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,170)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(4,883)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(10,714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(924)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,727)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(7,401)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,159&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,560)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(12,438)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33,457)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,389)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,184)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,795&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Q2 2021 vs. Q2 2020</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fluctuation in the gain (loss) from short-term investments is primarily driven by the changes in the fair value of our ownership in Viking common stock and warrants (an unrealized loss of $8.3 million in Q2 2021 as compared to an unrealized gain of $23.5 million in Q2 2020). </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists primarily of interest earned on our short-term investments. The decrease over the prior period was due to the decrease in our short-term investment balance.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the 0.75% coupon cash interest expense in addition to the non-cash accretion of discount (including the amortization of debt issuance cost) on our 2023 Notes for the three months ended June&#160;30, 2021. The decrease was primarily due to lower average debt outstanding balance during Q2 2021 as compared to Q2 2020. In Q2 2021, we repurchased $45.1&#160;million in principal of the 2023 Notes for $44.6&#160;million in cash, including accrued interest of $0.03&#160;million. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net, in Q2 2021 included a $2.3&#160;million loss on debt extinguishment in connection with the 2023 Notes repurchase during the three months ended June&#160;30, 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">YTD 2021 vs. YTD 2020</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The fluctuation in the gain (loss) from short-term investments is primarily driven by the changes in the fair value of our ownership in Viking common stock and warrants (an unrealized gain of $0.9 million in YTD 2021 as compared to an unrealized loss of $6.2 million in YTD 2020). </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists primarily of interest earned on our short-term investments. The decrease over the prior period was due to the decrease in our short-term investment balance.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the 0.75% coupon cash interest expense in addition to the non-cash accretion of discount (including the amortization of debt issuance cost) on our 2023 Notes for the six months ended June&#160;30, 2021. The decrease was primarily due to lower average debt outstanding balance during YTD 2021 as compared to YTD 2020. During YTD 2021, we repurchased $149.6 million in principal of the 2023 Notes for $153.7 million in cash, including accrued interest of $0.3 million. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net, in YTD 2021 included a $7.2 million loss on debt extinguishment in connection with the 2023 Notes repurchase during the six months ended June&#160;30, 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Benefit (Expense)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">33,301</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">39,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,296)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,576)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,033)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,457&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,766</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,515&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">30,725</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">48,831</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,045)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute our income tax provision by applying the estimated annual effective tax rate to income from operations and adding the effects of any discrete income tax items specific to the period. The effective tax rate for the three and six months ended June&#160;30, 2021 was 7.7% and (25.0)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three and six months ended June&#160;30, 2021 was significantly impacted by tax benefits related to (1) a $34.1&#160;million Pfenex CVR adjustment recorded during the second quarter of 2021 due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR, and (2) net excess tax windfalls from share-based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period. The effective tax rate for the three and six months ended June 30, 2020 was 21.5% and 10.9%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three and six months ended June 30, 2020 were primarily attributable to the mix of earnings in the jurisdictions with lower statutory rates than the U.S. offset by tax deductions related to stock award activities and tax deductions related to foreign derived intangible income tax credits. </span></div><div><span><br/></span></div><div id="i934841341d8f4620843d0f6fb5e931d1_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Liquidity and Capital Resources </span></div><div style="text-indent:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, our cash, cash equivalents, and short-term investments totaled $301.8 million, which decreased by $109.4&#160;million from the end of last year due to factors described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. Our primary source of liquidity, other than our holdings of cash, cash equivalents, and short-term investments, has been cash flows from operations. Our ability to generate cash from operations provides us with the financial flexibility we need to meet operating, investing, and financing needs.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have liquidated our short-term investments and/or issued debt and equity securities to finance our business needs as a supplement to cash provided by operating activities. Our short-term investments include U.S. government </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">debt securities, investment-grade corporate debt securities, mutual funds and certificates of deposit. We have established guidelines relative to diversification and maturities of our investments in order to provide both safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates. Additionally, we own certain securities which are classified as short-term investments that we received as a result of a milestone and an upfront license payment as well as 6.7 million shares of common stock in Viking.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued an aggregate principal amount of $750.0 million of the 2023 Notes. In conjunction of the 2023 Notes offering, we used a portion of the proceeds from such issuance totaling $49.7 million to repurchase 260,000 shares of our common stock. During the six months ended June&#160;30, 2021, we repurchased $149.6 million in principal of the 2023 Notes for $153.7 million in cash, including accrued interest of $0.3 million. After the repurchases, $345.7 million in principal amount of the 2023 Notes remain outstanding. We may continue to use cash on hand to repurchase additional 2023 Notes through open-market transactions, including through Rule 10b5-1 trading plan to facilitate open-market repurchases, or otherwise, from time to time. The timing and amount of repurchase transactions will be determined by management based on the evaluation of market conditions, trading price of the 2023 Notes, legal requirements and other factors. The 2023 Notes were not convertible as of June&#160;30, 2021. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing funds, cash generated from operations and existing sources of and access to financing are adequate to fund our need for working capital, capital expenditures, debt service requirements, continued advancement of research and development efforts, potential stock repurchases and other business initiatives we plan to strategically pursue, including acquisitions and strategic investments.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, we had $14.8 million in fair value of contingent consideration liabilities associated with prior acquisitions to be settled in future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases and Off-Balance Sheet Arrangements</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease our office facilities under operating lease arrangements with varying terms through September 2026. In addition, we signed our new Emeryville office lease in June 2021 as discussed below under the "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" section. The lease agreements provide for increases in annual rents based on changes in the Consumer Price Index or fixed percentage increases between 3.0% to 4.0%. We had no off-balance sheet arrangements at June&#160;30, 2021 and December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Summary</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Investing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Financing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(141,540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(279,310)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2021, we repurchased $149.6 million in principal of the 2023 Notes for $153.7 million in cash, including accrued interest of $0.3 million. During the six months ended June&#160;30, 2020, we repurchased $234.4 million in principal of the 2023 Notes for $203.8 million in cash, including accrued interest of $0.6 million, used $73.3 million to repurchase our common stock, and paid $15.1 million in cash for the Icagen acquisition.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Contractual Obligations</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes outside the ordinary course of business to the Contractual Obligations table set forth in our 2020 Annual Report, other than our operating lease obligation will increase by approximately $22 million (undiscounted cash outflow) in connection with our new Emeryville office lease signed in June 2021 with projected commencement dates of July 2021 for the first phase of occupancy and April 2022 for the second phase over the next 10 year term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our policies require the application of management judgment in making estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Those estimates and assumptions are based on historical experience and various other factors deemed applicable and reasonable under the circumstances. The use of judgment in determining such estimates and assumptions is by nature, subject to a degree of uncertainty. Accordingly, actual results could differ materially from the estimates made. There have been no material changes in our critical accounting policies and estimates as compared to the critical accounting policies and estimates described in our 2020 Annual Report, other than the adoption of the Accounting Standards Updates described in Item 1. Condensed consolidated Financial Statements - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to allowance for credit losses.</span></div><div style="text-indent:14pt"><span><br/></span></div><div id="i934841341d8f4620843d0f6fb5e931d1_70"></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="text-indent:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no substantial changes to our market risks in the three and six months ended June&#160;30, 2021, when compared to the disclosures in Item 7A of our 2020 Annual Report.</span></div><div><span><br/></span></div><div id="i934841341d8f4620843d0f6fb5e931d1_73"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of June&#160;30, 2021 were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the quarter ended June&#160;30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i934841341d8f4620843d0f6fb5e931d1_76"></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i934841341d8f4620843d0f6fb5e931d1_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information that updates the disclosures set forth under Part I. Item 3. Legal Proceedings in our 2020 Annual Report, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 7, Commitment and Contingencies: Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Condensed Consolidated Financial Statements contained in Part I. Item 1. of this report.</span></div><div><span><br/></span></div><div id="i934841341d8f4620843d0f6fb5e931d1_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.  Risk Factors</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the risk factors included in Part I. Item 1A. Risk Factors in our 2020 Annual Report, other than as set forth below:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future revenue from sales of Captisol material to our license partners may be lower than expected.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of Captisol material to our collaborative partners, including Amgen, Gilead and the Gilead consortium, represent a significant portion of our current revenues. Any setback that may occur with respect to Captisol could significantly impair our operating results and/or reduce the market price of our stock. Setbacks for Captisol could include problems with shipping, distribution, manufacturing, product safety, marketing, government regulation or reimbursement, licenses and approvals, intellectual property rights, competition with existing or new products and physician or patient acceptance of the products using Captisol. In addition, revenue from Captisol sales related to remdesivir may not continue or materially increase due to a number of factors, including: if Gilead successfully develops or manufactures an alternative formulation of remdesivir that does not incorporate Captisol or uses less Captisol in such formulation; if remdesivir is later shown to not be effective or safe for the treatment of COVID-19; the FDA revises or revokes its approval of remdesivir; if alternative therapies or vaccines are approved; or the risk of COVID-19 infection significantly diminishes, in which case the commercial opportunity could be materially and adversely affected. For example, Gilead has announced plans to develop an </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inhaled dosage form of remdesivir that uses less Captisol than the current formulation and expects result from an ongoing proof-of-concept study later this year.  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If products or product candidates incorporating Captisol material were to cause any unexpected adverse events, the perception of Captisol safety could be seriously harmed. If this were to occur, we may not be able to sell Captisol unless and until we are able to demonstrate that the adverse event was unrelated to Captisol, which we may not be able to do. Further, the FDA could require us to submit additional information for regulatory review or approval, including data from extensive safety testing or clinical testing of products using Captisol. This would be expensive and it may delay the marketing of Captisol-enabled products and receipt of revenue related to those products, which could significantly impair our operating results and/or reduce the market price of our stock.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain Captisol from Hovione, our third party manufacturer, primarily at their facilities in Ireland and Portugal. If Hovione were to cease to be able, for any reason, to supply Captisol to us in the amounts we require, or decline to supply Captisol to us, we would be required to seek an alternative source, which could potentially take a considerable length of time and impact our revenue and customer relationships. In the event of a Captisol supply interruption, we are permitted to designate and, with Hovione&#8217;s assistance, qualify one or more alternate suppliers, although there is no assurance that we could do so timely or at an acceptable cost, if at all. In addition to manufacturing at Hovione&#8217;s facilities in Ireland and Portugal, we have now added final step processing capacity for Captisol in both the United States and England.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain inventory of Captisol, which has a five year shelf life, at three geographically dispersed storage locations in the United States and Europe. If we were to encounter problems maintaining our inventory, such as natural disasters, at one or more of these locations, it could lead to supply interruptions. In addition, we will rely on Hovione to expand manufacturing capacity of Captisol and any failure by Hovione to timely implement such increased capacity could adversely affect our ability to supply Captisol to our partners. While we believe we maintain adequate inventory of Captisol to meet our current partner needs, and our planned expansion of Captisol capacity will be sufficient to meet future partner needs, our estimates and projections for Captisol demand may not be correct and any supply interruptions could materially adversely impact our operating results. In addition, our plan to invest additional capital for the expansion of Captisol manufacturing capacity may not yield a return on investment if future Captisol sales fall below our expectations.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently depend on our arrangements with our partners and licensees to sell products using our Captisol technology. These agreements generally provide that our partners may terminate the agreements at will. If our partners discontinue sales of products using Captisol, fail to obtain regulatory approval for products using Captisol, fail to satisfy their obligations under their agreements with us, choose to utilize a competing product, or if we are unable to establish new licensing and marketing relationships, our financial results and growth prospects would be materially affected. Furthermore, we maintain significant accounts receivable balances with certain customers purchasing Captisol materials, which may result in the concentration of credit risk. We generally do not require any collateral from our customers to secure payment of these accounts receivable. If any of our major customers were to default in the payment of their obligations to us, our business, operating results and cash flows could be adversely affected.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, under most of our Captisol outlicenses, the amount of royalties we receive will be reduced or will cease when the relevant patent expires. Our low-chloride patents and foreign equivalents are not expected to expire until 2033, our high purity patents and foreign equivalents are not expected to expire until 2029 and our morphology patents and foreign equivalents are not expected to expire until 2026 in United States, but the initially filed patents relating to Captisol expired starting in 2010 in the United States and in 2016 in most countries outside the United States. If our other intellectual property rights are not sufficient to prevent a generic form of Captisol from coming to market and if in such case our partners choose to terminate their agreements with us, our Captisol revenue may decrease significantly.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our OmniAb antibody platform faces specific risks, including the fact that no product using antibodies from the platform has been approved by the FDA or similar regulatory agency.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">None of our collaboration partners using our OmniAb antibody platform have received approval from the FDA or similar regulatory agency to market a product discovered from our platform. In addition, only a subset of our collaboration partners&#8217; product candidates have been tested in late stage clinical trials. If one of our OmniAb collaboration partners&#8217; product candidates fails during preclinical studies or clinical trials, our other OmniAb collaboration partners may decide to abandon product candidates using antibodies generated from the OmniAb platform, whether or not such failure is attributable to the platform. OmniAb collaboration partners may terminate their programs without penalty. In addition, our OmniAb platform is covered by 167 patents worldwide (including 32 patents within the U.S. and 7 patents in the European Union)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and are subject to the same risks as our patent portfolio discussed elsewhere in this report and our 2020 Annual Report, including the risk that our patents may infringe on third party patent rights or that our patents may be invalidated. As of a result of these factors, the future </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">revenue generated from this platform may be materially lower than what we currently anticipate. Further, we face significant competition from other companies selling human antibody-generating rodents, especially mice which compete with our OmniMouse platform, including the VelocImmune mouse, the AlivaMab mouse, the Alloy mouse and the Kymouse. Many of our competitors have greater financial, technical and human resources than we do and may be better equipped to develop, manufacture and market competing antibody platforms. Our competitors may render our OmniAb antibody platform obsolete, or limit the commercial value of any product candidates developed using our platform, by advances in existing technological approaches or the development of new or different approaches, potentially eliminating the advantages that we believe our platform offers.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Third party intellectual property may prevent us or our partners from developing our potential products; our and our partners&#8217; intellectual property may not prevent competition; and any intellectual property issues may be expensive and time consuming to resolve.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacture, use or sale of our potential products or our licensees' products or potential products may infringe the patent rights of others. If others obtain patents with conflicting claims, we may be required to obtain licenses to those patents or to develop or obtain alternative technology. We may not be able to obtain any such licenses on acceptable terms, or at all. Any failure to obtain such licenses could delay or prevent us from pursuing the development or commercialization of our potential products.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, our success will depend on our ability and the ability of our partners to obtain and maintain patents and other intellectual property rights for our and their potential products.  Our patent position is uncertain and involves complex legal and technical questions for which legal principles are unresolved.  Even if we or our partners do obtain patents, such patents may not adequately protect the technology we own or have licensed. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We permit our partners to list our patents that cover their branded products in the Orange Book. If a third party files an NDA or ANDA for a generic drug product that relies in whole or in part on studies contained in our partner&#8217;s NDA for their branded product, the third party will have the option to certify to the FDA that, in the opinion of that third party, the patents listed in the Orange Book for our partner&#8217;s branded product are invalid, unenforceable, or will not be infringed by the manufacture, use or sale of the third party&#8217;s generic drug product. A third party certification that a new product will not infringe Orange Book-listed patents, or that such patents are invalid, is called a paragraph IV patent certification. If the third party submits a paragraph IV patent certification to the FDA, a notice of the paragraph IV patent certification must be sent to the NDA owner and the owner of the patents that are subject to the paragraph IV patent certification notice once the third-party&#8217;s NDA or ANDA is accepted for filing by the FDA. A lawsuit may then be initiated to defend the patents identified in the notice. The filing of a patent infringement lawsuit within 45 days of the receipt of notice of a paragraph IV patent certification automatically prevents the FDA from approving the generic NDA or ANDA until the earlier of the expiration of a 30-month period, the expiration of the patents, the entry of a settlement order stating that the patents are invalid or not infringed, a decision in the infringement case that is favorable to the NDA or ANDA applicant, or such shorter or longer period as the court may order. If a patent infringement lawsuit is not initiated within the required 45-day period, the third-party&#8217;s NDA or ANDA will not be subject to the 30-month stay.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several third-parties have challenged, and additional third parties may challenge, the patents covering our partner&#8217;s branded products, including Kyprolis and Evomela, which could result in the invalidation or unenforceability of some or all of the relevant patent claims. We may from time to time become party to litigation or other proceedings as a result of Paragraph IV certifications. For example, as a result of the settlement of one such matter, Teva will be permitted to market a generic version of Evomela&#174; in the United States on June 1, 2026 or earlier under certain circumstances. The terms of the settlement agreement are otherwise confidential. Also, as noted above, Amgen has settled patent litigation related to Kyprolis on confidential terms with several parties, but it has been publicly reported that the U.S. launch date for at least Breckenridge Pharmaceuticals&#8217; applicable generic product will be &#8220;on a date that is held as confidential in 2027 or sooner, depending on certain occurrences&#8221;.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we cannot assure you that all of the potentially relevant prior art information that was or is deemed available to a person of skill in the relevant art prior to the priority date of the claimed invention-relating to our and our partners&#8217; patents and patent applications has been found. If such prior art exists, it can invalidate a patent or prevent a patent from issuing from a pending patent application, and we or our partners may be subject to a third party pre-issuance submission of prior art to the United States Patent and Trademark Office. Even if patents do successfully issue and even if such patents cover our or our partner&#8217;s products or potential products, third parties may initiate litigation or opposition, interference, re-examination, post-grant review, inter partes review, nullification or derivation action in court or before patent offices, or similar proceedings challenging the validity, enforceability or scope of such patents, which may result in the patent claims being narrowed or invalidated, may allow third parties to commercialize our or our partners&#8217; products and compete directly with us and our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partners, without payment to us or our partners, or limit the duration of the patent protection of our and our partners&#8217; technology and products.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation or other proceedings to enforce or defend intellectual property rights are often very complex in nature, may be very expensive and time-consuming, may divert our management&#8217;s attention from our core business, and may result in unfavorable results that could adversely impact our ability to prevent third parties from competing with our partner&#8217;s products. Any adverse outcome of such litigation or other proceedings could result in one or more or our patents being held invalid or unenforceable, which could adversely affect our ability to successfully execute our business strategy and negatively impact our financial condition and results of operations. However, given the unpredictability inherent in litigation, we cannot predict or guarantee the outcome of these matters or any other litigation. Regardless of how these matters are ultimately resolved, these matters may be costly, time-consuming and distracting to our management, which could have a material adverse effect on our business.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on patents and or applications will be due to the U.S. and various foreign patent offices at various points over the lifetime of our and our licensees&#8217; patents and/or applications. We have systems in place to remind us to pay these fees, and we rely on our outside patent annuity service to pay these fees when due. Additionally, the U.S. and various foreign patent offices require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. We employ reputable law firms and other professionals to help us comply, and in many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with rules applicable to the particular jurisdiction. However, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. If such an event were to occur, it could have a material adverse effect on our business.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any conflicts with the patent rights of others could significantly reduce the coverage of our patents or limit our ability to obtain meaningful patent protection. For example, our European patent related to Agglomerated forms of Captisol was limited during an opposition proceeding, and the rejection of our European patent application related to High Purity Captisol was upheld on appeal. In addition, any determination that our patent rights are invalid may result in early termination of our agreements with our license partners and could adversely affect our ability to enter into new license agreements. We also rely on unpatented trade secrets and know-how to protect and maintain our competitive position. We require our employees, consultants, licensees and others to sign confidentiality agreements when they begin their relationship with us. These agreements may be breached, and we may not have adequate remedies for any breach. In addition, our competitors may independently discover our trade secrets.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also need to initiate litigation, which could be time-consuming and expensive, to enforce our proprietary rights or to determine the scope and validity of others' rights. If this occurs, a court may find our patents or those of our licensors invalid or may find that we have infringed on a competitor's rights. In addition, if any of our competitors have filed patent applications in the United States which claim technology we also have invented, the United States Patent and Trademark Office may require us to participate in expensive interference proceedings to determine who has the right to a patent for the technology.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of any of the foregoing problems could be time-consuming and expensive and could adversely affect our financial position, liquidity and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The occurrence of a catastrophic disaster could disrupt our business, damage our facilities beyond insurance limits or increase our costs and expenses.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are vulnerable to damage and business disruptions from natural or man-made disasters, such as earthquakes, tornadoes, severe weather conditions, power loss, fire, floods and similar events, as well as from accidental loss or destruction. If any disaster were to occur, our ability to operate our business could be seriously impaired. We have property, liability, and business interruption insurance which may not be adequate to cover our losses resulting from disasters or other similar significant business interruptions, and we do not plan to purchase additional insurance to cover such losses due to the cost of obtaining such coverage. Any significant losses that are not recoverable under our insurance policies could seriously impair our business, financial condition and prospects. Our ability to obtain Captisol supply from our third-party manufactures could be disrupted if the operations of these manufacturers were affected by a natural or man-made disaster or other business interruption. In addition, we rely on our partners to generate most of our revenues through royalties, Captisol sales and development activities and any disruptions to their business as a result of such disasters could negatively impact our revenues.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i934841341d8f4620843d0f6fb5e931d1_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">None.</span></div><div id="i934841341d8f4620843d0f6fb5e931d1_88"></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i934841341d8f4620843d0f6fb5e931d1_91"></div><div><span><br/></span></div><div style="text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">   Item 4.  Mine Safety Disclosures</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i934841341d8f4620843d0f6fb5e931d1_94"></div><div><span><br/></span></div><div style="text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;Other Information</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i934841341d8f4620843d0f6fb5e931d1_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.108%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_63021exhibit311.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification by Principal Executive Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_63021exhibit312.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification by Principal Financial Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_63021exhibit321.htm">32.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications by Principal Executive Officer and Principal Financial Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following financial information from our Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2021, formatted in iXBRL (inline eXtensible Business Reporting Language): (i) Consolidated Condensed Balance Sheets, (ii) Consolidated Condensed Statements of Operations, (iii) Consolidated Condensed Statement of Comprehensive Income, (iv) Consolidated Condensed Statements of Stockholders' Equity, (v) Consolidated Condensed Statements of Cash Flows, and (vi) the Notes to Consolidated Condensed Financial Statements.*</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2021, formatted in Inline XBRL and contained in Exhibit 101.</span></div></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">          </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Filed herewith.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div id="i934841341d8f4620843d0f6fb5e931d1_100"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Matthew Korenberg</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Korenberg</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Finance and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Duly Authorized Officer and Principal Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">37</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>lgnd_63021exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i5d02b13e6c6a4ad49439e27159ea8972_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, John L. Higgins, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.064%"><tr><td style="width:1.0%"></td><td style="width:11.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;&#160;&#160;&#160;August&#160;3, 2021 </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.166%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:-2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John L. Higgins</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John L. Higgins</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:-2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>lgnd_63021exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i8b7ccb5a92be4e2bb3bab74109aeeaea_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, Matthew Korenberg, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;&#160;&#160;&#160;&#160;August&#160;3, 2021 </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.416%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Matthew Korenberg</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Korenberg</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Finance and Chief Financial Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>lgnd_63021exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i2e755a090f6445ce9d72770e11a4192b_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 32.1</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended June&#160;30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, John L. Higgins, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.944%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John L. Higgins</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John L. Higgins<br>Chief Executive Officer <br>(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended June&#160;30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Matthew Korenberg, Executive Vice President, Finance and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:10.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Matthew Korenberg</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Matthew Korenberg<br>Executive Vice President, Finance and Chief Financial Officer<br>(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>lgnd-20210630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:28a37576-9b75-439f-9e08-1e286b83ffe6,g:5715a2c1-e324-41f6-868f-ac2db6a81a2a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lgnd="http://www.ligand.com/20210630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ligand.com/20210630">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.ligand.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
        <link:definition>2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
        <link:definition>2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails">
        <link:definition>2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
        <link:definition>2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails">
        <link:definition>2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails">
        <link:definition>2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
        <link:definition>2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails">
        <link:definition>2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails">
        <link:definition>2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.ligand.com/role/FairValueMeasurements">
        <link:definition>2114102 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.ligand.com/role/FairValueMeasurementsTables">
        <link:definition>2315302 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>2416411 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails">
        <link:definition>2417412 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.ligand.com/role/Acquisitions">
        <link:definition>2118103 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://www.ligand.com/role/AcquisitionsTables">
        <link:definition>2319303 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails">
        <link:definition>2420413 - Disclosure - Acquisitions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>2421414 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsProFormaFinancialInformationDetails" roleURI="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails">
        <link:definition>2422415 - Disclosure - Acquisitions - Pro Forma Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotes" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes">
        <link:definition>2123104 - Disclosure - Convertible Senior Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesTables" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables">
        <link:definition>2324304 - Disclosure - Convertible Senior Notes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNarrativeDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails">
        <link:definition>2425416 - Disclosure - Convertible Senior Notes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNotesPayableDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails">
        <link:definition>2426417 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTax" roleURI="http://www.ligand.com/role/IncomeTax">
        <link:definition>2127105 - Disclosure - Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxDetails" roleURI="http://www.ligand.com/role/IncomeTaxDetails">
        <link:definition>2428418 - Disclosure - Income Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.ligand.com/role/StockholdersEquity">
        <link:definition>2129106 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.ligand.com/role/StockholdersEquityTables">
        <link:definition>2330305 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
        <link:definition>2431419 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>2432420 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLegalProceedings" roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings">
        <link:definition>2133107 - Disclosure - Commitment and Contingencies: Legal Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLegalProceedingsDetails" roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails">
        <link:definition>2434421 - Disclosure - Commitment and Contingencies: Legal Proceedings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lgnd_MilestoneMember" abstract="true" name="MilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" abstract="false" name="ForecastedCashFlowsEffectiveInterestRatePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_TaurusBiosciencesLLCMember" abstract="true" name="TaurusBiosciencesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LicenseeAccrualCurrent" abstract="false" name="LicenseeAccrualCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsForConvertibleBondHedges" abstract="false" name="PaymentsForConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolMember" abstract="true" name="MaterialSalesCaptisolMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ContingentValueRightOnProductRevenuesMember" abstract="true" name="ContingentValueRightOnProductRevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_CommercialLicenseRights" abstract="false" name="CommercialLicenseRights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" abstract="false" name="ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_AmortizationOfOtherEconomicRights" abstract="false" name="AmortizationOfOtherEconomicRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ProceedsFromUnwindingConvertibleBondHedges" abstract="false" name="ProceedsFromUnwindingConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CurrentPortionOfLiabilityForContingentValueRights" abstract="false" name="CurrentPortionOfLiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" abstract="false" name="COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" abstract="true" name="LiabilityForContingentValueRightsCompanyPfenexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_Phase3ClinicalTrialMember" abstract="true" name="Phase3ClinicalTrialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationConsiderationTransferredHoldback" abstract="false" name="BusinessCombinationConsiderationTransferredHoldback" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_KyprolisMember" abstract="true" name="KyprolisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AziyoAndCorMatrixMember" abstract="true" name="AziyoAndCorMatrixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BasisOfPresentationLineItems" abstract="true" name="BasisOfPresentationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_RoyaltyOtherMember" abstract="true" name="RoyaltyOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_PfenexMember" abstract="true" name="PfenexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NumberOfContingentValueRightsSeries" abstract="false" name="NumberOfContingentValueRightsSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases" abstract="false" name="CreditsAppliedOnAdvancesOnInventoryPurchases" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LupinPatentInfringementMember" abstract="true" name="LupinPatentInfringementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" abstract="false" name="ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_ConvertibleSeniorNotesDue2023Member" abstract="true" name="ConvertibleSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_NumberOfPetitionsFiled" abstract="false" name="NumberOfPetitionsFiled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" abstract="true" name="DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" abstract="false" name="CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyCydexMember" abstract="true" name="LiabilityForContingentValueRightsCompanyCydexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" abstract="true" name="ContingentValueRightForInternalResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" abstract="false" name="ScheduleOfCommercialLicenseRightsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_ContractRevenueMember" abstract="true" name="ContractRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ContractRevenueServiceMember" abstract="true" name="ContractRevenueServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_MilestonePaymentsMember" abstract="true" name="MilestonePaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BasisOfPresentationTable" abstract="true" name="BasisOfPresentationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" abstract="true" name="EarnoutRightsForPartnerResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" abstract="true" name="LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" abstract="true" name="LiabilityForContingentValueRightsCompanyIcagenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" abstract="true" name="LiabilityForContingentValueRightsCompanyXCellaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" abstract="false" name="BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NumberOfOptionsUnderConvertibleBondHedges" abstract="false" name="NumberOfOptionsUnderConvertibleBondHedges" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" abstract="false" name="NonCashChangeInEstimatedFairValueOfContingentValueRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanAbstract" abstract="true" name="EmployeeStockPurchasePlanAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRights" abstract="false" name="LiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_XCellaBiosciencesIncMember" abstract="true" name="XCellaBiosciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" abstract="true" name="LiabilityForContingentValueRightsCompanyCrystalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" abstract="true" name="LiabilityForContingentValueRightsCompanyMetabasisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" abstract="false" name="BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lgnd_InterPartesReviewOfPatentMember" abstract="true" name="InterPartesReviewOfPatentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AziyoMember" abstract="true" name="AziyoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" abstract="true" name="CommercialLicenseAndOtherEconomicRightsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_SelexisMember" abstract="true" name="SelexisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_SelexisAndDianomiMember" abstract="true" name="SelexisAndDianomiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHolders" abstract="false" name="PaymentsToContingentValueRightHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_GainLossOnShortTermInvestments" abstract="false" name="GainLossOnShortTermInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" abstract="false" name="ScheduleOfShortTermInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_PaymentsToUnwindWarrants" abstract="false" name="PaymentsToUnwindWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AccruedSubcontractorExpensesCurrent" abstract="false" name="AccruedSubcontractorExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MetabasisMember" abstract="true" name="MetabasisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_GlaxoSmithKlineBiologicalsSAMember" abstract="true" name="GlaxoSmithKlineBiologicalsSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" abstract="false" name="PaymentsToContingentValueRightHoldersFinancingActivity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AccruedSupplierExpensesCurrent" abstract="false" name="AccruedSupplierExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AccruedAssetAcquisitionsCurrent" abstract="false" name="AccruedAssetAcquisitionsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LicenseFeesMember" abstract="true" name="LicenseFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AccruedInventoryPurchases" abstract="false" name="AccruedInventoryPurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_EvomelaMember" abstract="true" name="EvomelaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_IncreaseDecreaseInDebtDiscount" abstract="false" name="IncreaseDecreaseInDebtDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" abstract="false" name="DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" abstract="false" name="DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" abstract="false" name="PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ReturnsAccrual" abstract="false" name="ReturnsAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" abstract="true" name="LicenseFeesMilestonesAndProductOtherProductOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" abstract="true" name="USDistrictCourtForTheNorthernDistrictOfOhioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_IcagenMember" abstract="true" name="IcagenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>lgnd-20210630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:28a37576-9b75-439f-9e08-1e286b83ffe6,g:5715a2c1-e324-41f6-868f-ac2db6a81a2a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="lgnd-20210630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d51c910d-c160-4fd4-a3d6-ee76e1ea25a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_dd5641a9-c8de-44ad-a5da-394e58e318e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d51c910d-c160-4fd4-a3d6-ee76e1ea25a4" xlink:to="loc_us-gaap_LiabilitiesCurrent_dd5641a9-c8de-44ad-a5da-394e58e318e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_1040260a-13a4-40b4-9dbb-4aae28bc034e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d51c910d-c160-4fd4-a3d6-ee76e1ea25a4" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_1040260a-13a4-40b4-9dbb-4aae28bc034e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_be1625a6-e95e-4641-83d1-76d9394c49e3" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d51c910d-c160-4fd4-a3d6-ee76e1ea25a4" xlink:to="loc_lgnd_LiabilityForContingentValueRights_be1625a6-e95e-4641-83d1-76d9394c49e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3b7abf51-af6b-4328-92b8-df5f2660ec60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d51c910d-c160-4fd4-a3d6-ee76e1ea25a4" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3b7abf51-af6b-4328-92b8-df5f2660ec60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a48cc2bb-49c0-4b54-bbe3-d0542c4417ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d51c910d-c160-4fd4-a3d6-ee76e1ea25a4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a48cc2bb-49c0-4b54-bbe3-d0542c4417ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1365eb2b-dc2f-42a1-97ea-a2b147fc8fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d51c910d-c160-4fd4-a3d6-ee76e1ea25a4" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1365eb2b-dc2f-42a1-97ea-a2b147fc8fa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9688f6be-80d3-46e0-a657-e9211cb8fea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_914d1d91-8781-41b1-a598-bb25669687ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9688f6be-80d3-46e0-a657-e9211cb8fea7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_914d1d91-8781-41b1-a598-bb25669687ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_63dae45c-0dc7-4e8e-9531-fcbfdc2ef4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9688f6be-80d3-46e0-a657-e9211cb8fea7" xlink:to="loc_us-gaap_CommonStockValue_63dae45c-0dc7-4e8e-9531-fcbfdc2ef4ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_3da34806-0da1-4d94-8298-91d2eeefc192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9688f6be-80d3-46e0-a657-e9211cb8fea7" xlink:to="loc_us-gaap_AdditionalPaidInCapital_3da34806-0da1-4d94-8298-91d2eeefc192" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1f97d2fc-a1b1-461c-9625-db8a4fa6ef87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9688f6be-80d3-46e0-a657-e9211cb8fea7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1f97d2fc-a1b1-461c-9625-db8a4fa6ef87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_1d724afc-87db-4bf6-8df1-bfdff869e0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9688f6be-80d3-46e0-a657-e9211cb8fea7" xlink:to="loc_us-gaap_PreferredStockValue_1d724afc-87db-4bf6-8df1-bfdff869e0c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0e627cc-1299-4740-b82c-1dfb36dc8096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5730fbd6-bd2a-4598-ba36-f8ce04d00c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0e627cc-1299-4740-b82c-1dfb36dc8096" xlink:to="loc_us-gaap_Liabilities_5730fbd6-bd2a-4598-ba36-f8ce04d00c9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a77bc771-d370-4ccf-9656-38fdd3e7b39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0e627cc-1299-4740-b82c-1dfb36dc8096" xlink:to="loc_us-gaap_StockholdersEquity_a77bc771-d370-4ccf-9656-38fdd3e7b39e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_9196da88-dbcd-4846-99c6-3dce712d9dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0e627cc-1299-4740-b82c-1dfb36dc8096" xlink:to="loc_us-gaap_CommitmentsAndContingencies_9196da88-dbcd-4846-99c6-3dce712d9dae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_90d4bd47-ead0-4bda-9a57-8b97809d2aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d44a9600-20be-464e-9798-081450f2ace8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_90d4bd47-ead0-4bda-9a57-8b97809d2aca" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d44a9600-20be-464e-9798-081450f2ace8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_3742a46b-0a68-469e-a6db-d8f6f28d5dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_90d4bd47-ead0-4bda-9a57-8b97809d2aca" xlink:to="loc_us-gaap_ShortTermInvestments_3742a46b-0a68-469e-a6db-d8f6f28d5dca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e5c69407-c046-4cbc-9e06-ac1ae1bf70b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_90d4bd47-ead0-4bda-9a57-8b97809d2aca" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e5c69407-c046-4cbc-9e06-ac1ae1bf70b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7ff142b4-4f28-4bdc-a9a7-5bf00bc1a0c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_90d4bd47-ead0-4bda-9a57-8b97809d2aca" xlink:to="loc_us-gaap_InventoryNet_7ff142b4-4f28-4bdc-a9a7-5bf00bc1a0c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_cbaac880-e43f-45e6-883e-6c3db0e9d33f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_90d4bd47-ead0-4bda-9a57-8b97809d2aca" xlink:to="loc_us-gaap_IncomeTaxesReceivable_cbaac880-e43f-45e6-883e-6c3db0e9d33f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_d8bccda3-ca7e-468e-8ac7-79b936016e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_90d4bd47-ead0-4bda-9a57-8b97809d2aca" xlink:to="loc_us-gaap_OtherAssetsCurrent_d8bccda3-ca7e-468e-8ac7-79b936016e33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3ebf977f-5307-4006-8d93-64bef3ef4aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6de2faa9-24ff-4eeb-90d0-026b59b9dd57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ebf977f-5307-4006-8d93-64bef3ef4aa0" xlink:to="loc_us-gaap_Goodwill_6de2faa9-24ff-4eeb-90d0-026b59b9dd57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f42e1501-5854-409a-802d-ccc12a5f2cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ebf977f-5307-4006-8d93-64bef3ef4aa0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f42e1501-5854-409a-802d-ccc12a5f2cd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_39c4bc79-a24f-4aba-83da-336f2fa5e31c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ebf977f-5307-4006-8d93-64bef3ef4aa0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_39c4bc79-a24f-4aba-83da-336f2fa5e31c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ec3e7d59-f42d-44a5-b9ef-0cf8a7d7169a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ebf977f-5307-4006-8d93-64bef3ef4aa0" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ec3e7d59-f42d-44a5-b9ef-0cf8a7d7169a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_12969798-dd6d-48fb-9400-cbbba7b36859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ebf977f-5307-4006-8d93-64bef3ef4aa0" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_12969798-dd6d-48fb-9400-cbbba7b36859" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_b7306450-f7d1-422d-b657-df90057108a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ebf977f-5307-4006-8d93-64bef3ef4aa0" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_b7306450-f7d1-422d-b657-df90057108a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4cc416bb-a825-4111-9161-469d4d2924fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ebf977f-5307-4006-8d93-64bef3ef4aa0" xlink:to="loc_us-gaap_AssetsCurrent_4cc416bb-a825-4111-9161-469d4d2924fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_d0884c93-1929-4dab-bb72-e2341ad13dad" xlink:href="lgnd-20210630.xsd#lgnd_CommercialLicenseRights"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ebf977f-5307-4006-8d93-64bef3ef4aa0" xlink:to="loc_lgnd_CommercialLicenseRights_d0884c93-1929-4dab-bb72-e2341ad13dad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0f989305-a0ea-4a7b-bef0-7257a302b893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ebf977f-5307-4006-8d93-64bef3ef4aa0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0f989305-a0ea-4a7b-bef0-7257a302b893" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5449562c-11d0-439c-842c-e4bba9577802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_1a1b2b50-47da-4209-9ff4-889fd7b78e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5449562c-11d0-439c-842c-e4bba9577802" xlink:to="loc_us-gaap_AccountsPayableCurrent_1a1b2b50-47da-4209-9ff4-889fd7b78e4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_32fc9737-9be7-473c-859b-4fbca7d34c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5449562c-11d0-439c-842c-e4bba9577802" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_32fc9737-9be7-473c-859b-4fbca7d34c28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_d4aaf3cb-25c7-45a5-a644-3899755b9d17" xlink:href="lgnd-20210630.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5449562c-11d0-439c-842c-e4bba9577802" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_d4aaf3cb-25c7-45a5-a644-3899755b9d17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5f14c72c-8dc6-49ea-a742-0a1bda58fd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5449562c-11d0-439c-842c-e4bba9577802" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5f14c72c-8dc6-49ea-a742-0a1bda58fd6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c8f87841-a16c-474c-9d0b-ff3d8bfafdae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5449562c-11d0-439c-842c-e4bba9577802" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c8f87841-a16c-474c-9d0b-ff3d8bfafdae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_a6b0015b-9a75-4c45-bd4d-35a84bf7c401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5449562c-11d0-439c-842c-e4bba9577802" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_a6b0015b-9a75-4c45-bd4d-35a84bf7c401" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="lgnd-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_49a8194e-5279-4eec-b659-95f76f05fb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_897ccc2a-37df-4f1f-b5d8-9b02082a95cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_49a8194e-5279-4eec-b659-95f76f05fb3d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_897ccc2a-37df-4f1f-b5d8-9b02082a95cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1f68fff9-21fe-4190-aba6-fad2217baeda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_49a8194e-5279-4eec-b659-95f76f05fb3d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1f68fff9-21fe-4190-aba6-fad2217baeda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_99c05eb6-1d6c-4f56-a677-013954cf6758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4d307372-44cd-434a-a04a-62593e3d2778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_99c05eb6-1d6c-4f56-a677-013954cf6758" xlink:to="loc_us-gaap_OperatingIncomeLoss_4d307372-44cd-434a-a04a-62593e3d2778" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_26afb10b-ce2a-40cd-95fc-4d21adbd893f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_99c05eb6-1d6c-4f56-a677-013954cf6758" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_26afb10b-ce2a-40cd-95fc-4d21adbd893f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_edc11661-b8a0-4b0d-912e-8b781bd066ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_09baee66-c1d4-4888-9e41-e9e37250e9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_edc11661-b8a0-4b0d-912e-8b781bd066ef" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_09baee66-c1d4-4888-9e41-e9e37250e9c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_4185858d-30ca-4370-bd82-496c357b1090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_edc11661-b8a0-4b0d-912e-8b781bd066ef" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_4185858d-30ca-4370-bd82-496c357b1090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_405e20ca-68bb-495a-9f67-e97ad66697d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_75a2098e-31c5-49cc-a35b-98fe645be6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_405e20ca-68bb-495a-9f67-e97ad66697d1" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_75a2098e-31c5-49cc-a35b-98fe645be6d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1b01aa01-d6cd-41e0-ac33-2002007efde1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_405e20ca-68bb-495a-9f67-e97ad66697d1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1b01aa01-d6cd-41e0-ac33-2002007efde1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_28f8ea52-d370-47f5-a38c-e92e4face295" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_405e20ca-68bb-495a-9f67-e97ad66697d1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_28f8ea52-d370-47f5-a38c-e92e4face295" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_10c1e319-a377-4089-ab94-488db6dc89d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_405e20ca-68bb-495a-9f67-e97ad66697d1" xlink:to="loc_us-gaap_CostDirectMaterial_10c1e319-a377-4089-ab94-488db6dc89d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncome_8f8b6ca5-e1ee-4882-ad42-ebbb90b285ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncome"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_405e20ca-68bb-495a-9f67-e97ad66697d1" xlink:to="loc_us-gaap_OtherOperatingIncome_8f8b6ca5-e1ee-4882-ad42-ebbb90b285ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_e5cd6fab-17e3-4548-9159-471d1c422f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_82366f08-db43-4f99-a5f5-bba82a1cb1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e5cd6fab-17e3-4548-9159-471d1c422f61" xlink:to="loc_us-gaap_GainLossOnInvestments_82366f08-db43-4f99-a5f5-bba82a1cb1eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c6603ea4-9f67-4df1-96cd-f3edac88bde3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e5cd6fab-17e3-4548-9159-471d1c422f61" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c6603ea4-9f67-4df1-96cd-f3edac88bde3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_db523ab7-cde0-4bd2-b554-e7eac3b576aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e5cd6fab-17e3-4548-9159-471d1c422f61" xlink:to="loc_us-gaap_InterestExpense_db523ab7-cde0-4bd2-b554-e7eac3b576aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_df8f9ba6-4437-4fce-93d6-cc1c2d5b80a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e5cd6fab-17e3-4548-9159-471d1c422f61" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_df8f9ba6-4437-4fce-93d6-cc1c2d5b80a7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" xlink:type="simple" xlink:href="lgnd-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_61dce818-d005-40e8-8fb4-791df0abcc98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_821eadc5-63c1-46a4-8078-695e44845994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_61dce818-d005-40e8-8fb4-791df0abcc98" xlink:to="loc_us-gaap_NetIncomeLoss_821eadc5-63c1-46a4-8078-695e44845994" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_55c28569-35b9-4093-850a-5bbc596424e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_61dce818-d005-40e8-8fb4-791df0abcc98" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_55c28569-35b9-4093-850a-5bbc596424e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9f2d7683-5b52-42f8-a4ee-ea92212a02d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_61dce818-d005-40e8-8fb4-791df0abcc98" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9f2d7683-5b52-42f8-a4ee-ea92212a02d4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="lgnd-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_987df2ff-4ed1-4169-8236-8e4c30700d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f8f34182-65a1-445e-a6c7-bfa00c6e5822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_987df2ff-4ed1-4169-8236-8e4c30700d9d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f8f34182-65a1-445e-a6c7-bfa00c6e5822" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7f3d2b9d-7e05-4ecc-acc6-7a1af9e711c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_987df2ff-4ed1-4169-8236-8e4c30700d9d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7f3d2b9d-7e05-4ecc-acc6-7a1af9e711c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6dc2d45-4ac6-41a3-8afb-a9939e63b013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_987df2ff-4ed1-4169-8236-8e4c30700d9d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6dc2d45-4ac6-41a3-8afb-a9939e63b013" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a498290-80a8-4888-8f3f-08d8f61f36e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_987df2ff-4ed1-4169-8236-8e4c30700d9d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a498290-80a8-4888-8f3f-08d8f61f36e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4fa4644f-a9bc-4e12-a889-645663eeda1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_us-gaap_ProfitLoss_4fa4644f-a9bc-4e12-a889-645663eeda1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_be1f7d6a-c658-4483-bc79-9b4cf34cf419" xlink:href="lgnd-20210630.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_be1f7d6a-c658-4483-bc79-9b4cf34cf419" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6f7ac139-7cea-4067-b5fc-b1ad349b7777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6f7ac139-7cea-4067-b5fc-b1ad349b7777" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_fb3d91c8-8196-4305-91e8-6f97dccd9ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_fb3d91c8-8196-4305-91e8-6f97dccd9ebc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_3d3dc276-42cb-4573-bcec-65430f56920f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_3d3dc276-42cb-4573-bcec-65430f56920f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfOtherEconomicRights_85f16127-7d54-4562-a159-c9169ca2def1" xlink:href="lgnd-20210630.xsd#lgnd_AmortizationOfOtherEconomicRights"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_lgnd_AmortizationOfOtherEconomicRights_85f16127-7d54-4562-a159-c9169ca2def1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3a6032a7-8be1-49c1-92f2-859aa4e20783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3a6032a7-8be1-49c1-92f2-859aa4e20783" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4655a398-06dc-43b1-a430-e5507141e159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_us-gaap_ShareBasedCompensation_4655a398-06dc-43b1-a430-e5507141e159" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_24be2cfe-7eb9-4bb9-98a1-2b0a6d25d433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_24be2cfe-7eb9-4bb9-98a1-2b0a6d25d433" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_5affe14b-a685-4f34-88bf-cdbcda69ace3" xlink:href="lgnd-20210630.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_5affe14b-a685-4f34-88bf-cdbcda69ace3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4144c045-75e0-45bd-b544-30a2a953e041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4144c045-75e0-45bd-b544-30a2a953e041" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6f9f798c-28a6-4044-bed5-bb28f937ecd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6f9f798c-28a6-4044-bed5-bb28f937ecd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b709aa02-5493-45b1-9952-307f6f0e3428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b709aa02-5493-45b1-9952-307f6f0e3428" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_e2e964eb-40e0-4faa-afda-78f1b619a531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_e2e964eb-40e0-4faa-afda-78f1b619a531" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_28f47cc1-76fb-4411-bebd-ca0447173e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_28f47cc1-76fb-4411-bebd-ca0447173e0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_3dd77e54-092a-4fb3-9597-56c3e8c68e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_3dd77e54-092a-4fb3-9597-56c3e8c68e9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_49b615eb-fdc4-431d-9151-b21432815ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3dcd0a4-b63f-4979-8b22-949fc0bd507b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_49b615eb-fdc4-431d-9151-b21432815ef6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e02aeea-c0db-4a8f-8337-13fb7ed2c7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_9b35cc07-10af-4073-b050-e07ceb1f404d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e02aeea-c0db-4a8f-8337-13fb7ed2c7b1" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_9b35cc07-10af-4073-b050-e07ceb1f404d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_9fed8a3e-512b-419e-95e7-1c1fcc347b24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e02aeea-c0db-4a8f-8337-13fb7ed2c7b1" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_9fed8a3e-512b-419e-95e7-1c1fcc347b24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3fba21d6-10d0-477f-aef5-390cbfad4314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e02aeea-c0db-4a8f-8337-13fb7ed2c7b1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3fba21d6-10d0-477f-aef5-390cbfad4314" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_dd35d625-c0a5-4626-957c-4b3d17f26a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e02aeea-c0db-4a8f-8337-13fb7ed2c7b1" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_dd35d625-c0a5-4626-957c-4b3d17f26a4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d6ca2cd7-be29-47a0-bbf1-dbf4d46cb3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e02aeea-c0db-4a8f-8337-13fb7ed2c7b1" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d6ca2cd7-be29-47a0-bbf1-dbf4d46cb3b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_361c22f3-17e7-4e5e-a637-106164823eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e02aeea-c0db-4a8f-8337-13fb7ed2c7b1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_361c22f3-17e7-4e5e-a637-106164823eed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c52e99f-9e05-4723-b942-e2586c8d8973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_72b900d3-a898-4e42-bb64-c55851a731c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c52e99f-9e05-4723-b942-e2586c8d8973" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_72b900d3-a898-4e42-bb64-c55851a731c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_674fd6d8-62f5-4d3d-867d-1604362b0726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c52e99f-9e05-4723-b942-e2586c8d8973" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_674fd6d8-62f5-4d3d-867d-1604362b0726" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_d2ef003a-d198-4cfa-9a5a-e2a6b4a765c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c52e99f-9e05-4723-b942-e2586c8d8973" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_d2ef003a-d198-4cfa-9a5a-e2a6b4a765c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_6a6db928-98ea-447b-a265-c4e65876c305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c52e99f-9e05-4723-b942-e2586c8d8973" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_6a6db928-98ea-447b-a265-c4e65876c305" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_87054d6a-958d-40f9-8089-a25b2128b9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c52e99f-9e05-4723-b942-e2586c8d8973" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_87054d6a-958d-40f9-8089-a25b2128b9f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_37020788-3c6e-4bb2-8502-e132d6ba4682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c52e99f-9e05-4723-b942-e2586c8d8973" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_37020788-3c6e-4bb2-8502-e132d6ba4682" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_61a3c1bb-3029-4fe6-a3a6-59348bbe4507" xlink:href="lgnd-20210630.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c52e99f-9e05-4723-b942-e2586c8d8973" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_61a3c1bb-3029-4fe6-a3a6-59348bbe4507" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1260ef9e-dc3a-47fd-a939-2860357f617b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c52e99f-9e05-4723-b942-e2586c8d8973" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1260ef9e-dc3a-47fd-a939-2860357f617b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6fb55ac1-2922-4754-b882-60a954ca816a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7e4af530-aa55-47ff-a543-21ea80a7bb5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6fb55ac1-2922-4754-b882-60a954ca816a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7e4af530-aa55-47ff-a543-21ea80a7bb5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_61cc80ef-2feb-4a0f-9aad-3a3770b49734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6fb55ac1-2922-4754-b882-60a954ca816a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_61cc80ef-2feb-4a0f-9aad-3a3770b49734" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_41fadfc6-6eff-4143-938a-845690e740d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6fb55ac1-2922-4754-b882-60a954ca816a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_41fadfc6-6eff-4143-938a-845690e740d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_35018630-7f3f-4951-bdf9-165530bb3773" xlink:href="lgnd-20210630.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_e6cee359-6519-436f-931c-1883fe3815ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_35018630-7f3f-4951-bdf9-165530bb3773" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_e6cee359-6519-436f-931c-1883fe3815ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3aa147c7-6040-4070-843b-64ba56ce03c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_35018630-7f3f-4951-bdf9-165530bb3773" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3aa147c7-6040-4070-843b-64ba56ce03c2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_f00c5e65-910a-46d5-a2b7-5a4d90c2667a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_3cfbc7dd-4875-4b17-829b-ec0a00612f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_f00c5e65-910a-46d5-a2b7-5a4d90c2667a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_3cfbc7dd-4875-4b17-829b-ec0a00612f0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_70c24eea-565a-40f4-bb1c-90125fe32262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_f00c5e65-910a-46d5-a2b7-5a4d90c2667a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_70c24eea-565a-40f4-bb1c-90125fe32262" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_eac143b8-c816-4760-9be8-03ea0742e45c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_7f0ab73d-d348-4260-af15-650bdf4fd87c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_eac143b8-c816-4760-9be8-03ea0742e45c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_7f0ab73d-d348-4260-af15-650bdf4fd87c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_1e4d48ae-bd1b-4bd3-abe8-cc6b586b7070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_eac143b8-c816-4760-9be8-03ea0742e45c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_1e4d48ae-bd1b-4bd3-abe8-cc6b586b7070" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_98e1603d-d677-475d-b756-f7fb1a08d619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_87eded96-5569-4720-ba18-a1c07118133f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_98e1603d-d677-475d-b756-f7fb1a08d619" xlink:to="loc_us-gaap_Goodwill_87eded96-5569-4720-ba18-a1c07118133f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4d6d67a5-40dc-40a2-8dbb-afc5ab9f3cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_98e1603d-d677-475d-b756-f7fb1a08d619" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4d6d67a5-40dc-40a2-8dbb-afc5ab9f3cd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_800c0f24-7989-49e7-a7c7-c797b9d69d53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_98e1603d-d677-475d-b756-f7fb1a08d619" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_800c0f24-7989-49e7-a7c7-c797b9d69d53" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_259be92c-1043-46d2-8b10-326c03116605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_531fb2c4-4baf-4b5b-aae7-4cf16b34b646" xlink:href="lgnd-20210630.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_259be92c-1043-46d2-8b10-326c03116605" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_531fb2c4-4baf-4b5b-aae7-4cf16b34b646" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d526f02d-a31c-42fc-89cf-557598a1bf9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_259be92c-1043-46d2-8b10-326c03116605" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d526f02d-a31c-42fc-89cf-557598a1bf9b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4e36e8bb-ac5b-4ffa-98d8-8aa4b7b6141e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0af9d948-dbf1-42d2-85e5-ea87509d7f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4e36e8bb-ac5b-4ffa-98d8-8aa4b7b6141e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0af9d948-dbf1-42d2-85e5-ea87509d7f8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_2825a086-2230-4704-8db5-3547fb74032c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4e36e8bb-ac5b-4ffa-98d8-8aa4b7b6141e" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_2825a086-2230-4704-8db5-3547fb74032c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_2262aeea-0d40-4155-a486-23231a84c795" xlink:href="lgnd-20210630.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4e36e8bb-ac5b-4ffa-98d8-8aa4b7b6141e" xlink:to="loc_lgnd_LicenseeAccrualCurrent_2262aeea-0d40-4155-a486-23231a84c795" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_77cbe6a9-43d6-4ed1-8b58-c1ee4a2e9f37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4e36e8bb-ac5b-4ffa-98d8-8aa4b7b6141e" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_77cbe6a9-43d6-4ed1-8b58-c1ee4a2e9f37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual_e3a763a8-7dea-45bd-b623-d7f0d224efff" xlink:href="lgnd-20210630.xsd#lgnd_ReturnsAccrual"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4e36e8bb-ac5b-4ffa-98d8-8aa4b7b6141e" xlink:to="loc_lgnd_ReturnsAccrual_e3a763a8-7dea-45bd-b623-d7f0d224efff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent_0bf9c3d4-003f-47a9-870b-99a5c80986cd" xlink:href="lgnd-20210630.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4e36e8bb-ac5b-4ffa-98d8-8aa4b7b6141e" xlink:to="loc_lgnd_AccruedAssetAcquisitionsCurrent_0bf9c3d4-003f-47a9-870b-99a5c80986cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent_0d692823-fe5e-4917-81ab-1d4e6025f9e2" xlink:href="lgnd-20210630.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4e36e8bb-ac5b-4ffa-98d8-8aa4b7b6141e" xlink:to="loc_lgnd_AccruedSubcontractorExpensesCurrent_0d692823-fe5e-4917-81ab-1d4e6025f9e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent_df29c880-e224-40de-9b37-9669fb79968f" xlink:href="lgnd-20210630.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4e36e8bb-ac5b-4ffa-98d8-8aa4b7b6141e" xlink:to="loc_lgnd_AccruedSupplierExpensesCurrent_df29c880-e224-40de-9b37-9669fb79968f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_ed1ae8d1-b23d-40f0-88ce-d94e583d184e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4e36e8bb-ac5b-4ffa-98d8-8aa4b7b6141e" xlink:to="loc_us-gaap_InterestPayableCurrent_ed1ae8d1-b23d-40f0-88ce-d94e583d184e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_9a8dc430-efb7-42db-916b-39722ffcacd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4e36e8bb-ac5b-4ffa-98d8-8aa4b7b6141e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_9a8dc430-efb7-42db-916b-39722ffcacd0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_09429f37-a39e-4df7-bb7b-0e54d234f9df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_970767df-f14b-428c-92f7-bfd5131c2157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_09429f37-a39e-4df7-bb7b-0e54d234f9df" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_970767df-f14b-428c-92f7-bfd5131c2157" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_5e072022-08a6-4756-b75b-e6a68c41e83a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_09429f37-a39e-4df7-bb7b-0e54d234f9df" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_5e072022-08a6-4756-b75b-e6a68c41e83a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ab758c3d-1dea-4dbd-9a6f-e458f1af6946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_09429f37-a39e-4df7-bb7b-0e54d234f9df" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ab758c3d-1dea-4dbd-9a6f-e458f1af6946" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d79d28c-7676-47ce-b456-4558868565b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_fa867eb7-861c-4975-9522-47a7809bad6d" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d79d28c-7676-47ce-b456-4558868565b8" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_fa867eb7-861c-4975-9522-47a7809bad6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_a535d915-1195-4319-9e8a-436bb3d93ca9" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d79d28c-7676-47ce-b456-4558868565b8" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_a535d915-1195-4319-9e8a-436bb3d93ca9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_28ef098c-209b-42e9-8ac1-5ef749871e91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d79d28c-7676-47ce-b456-4558868565b8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_28ef098c-209b-42e9-8ac1-5ef749871e91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_e746f038-9301-49e6-a686-e4c0347112bd" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d79d28c-7676-47ce-b456-4558868565b8" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_e746f038-9301-49e6-a686-e4c0347112bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_a47dacde-52e5-4aea-9070-373100093f53" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d79d28c-7676-47ce-b456-4558868565b8" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_a47dacde-52e5-4aea-9070-373100093f53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_893db41c-8731-46ac-baa8-62e8ffca4c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d79d28c-7676-47ce-b456-4558868565b8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_893db41c-8731-46ac-baa8-62e8ffca4c86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_614c3bb7-fb17-43fc-980e-7975b2da365b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d79d28c-7676-47ce-b456-4558868565b8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_614c3bb7-fb17-43fc-980e-7975b2da365b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_11c7de45-af22-4533-bcc6-ee542a7875e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d79d28c-7676-47ce-b456-4558868565b8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_11c7de45-af22-4533-bcc6-ee542a7875e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_bb527fd1-96b3-4df5-ad4b-8a72227fb225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d79d28c-7676-47ce-b456-4558868565b8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_bb527fd1-96b3-4df5-ad4b-8a72227fb225" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_fc365873-a149-4267-8ca3-901b0c0c313e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d79d28c-7676-47ce-b456-4558868565b8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_fc365873-a149-4267-8ca3-901b0c0c313e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_89206aff-fe85-44cc-8f8e-077547702727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d79d28c-7676-47ce-b456-4558868565b8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_89206aff-fe85-44cc-8f8e-077547702727" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ef9eab7a-7bf8-4154-a929-802156bb7972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d79d28c-7676-47ce-b456-4558868565b8" xlink:to="loc_us-gaap_Goodwill_ef9eab7a-7bf8-4154-a929-802156bb7972" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_f6fb6346-6ec7-4cb7-a5b8-5b95408fbd83" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d79d28c-7676-47ce-b456-4558868565b8" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_f6fb6346-6ec7-4cb7-a5b8-5b95408fbd83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_efe64f81-0bfa-4cb0-a99a-9648cb149510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d79d28c-7676-47ce-b456-4558868565b8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_efe64f81-0bfa-4cb0-a99a-9648cb149510" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_8f36ac49-d26f-442c-9748-1069d3ab77b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_24a45f06-3611-4903-a90a-b92e8968466c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_8f36ac49-d26f-442c-9748-1069d3ab77b8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_24a45f06-3611-4903-a90a-b92e8968466c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_c06a877d-a1fc-420c-be7c-d59ccd9f4439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_8f36ac49-d26f-442c-9748-1069d3ab77b8" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_c06a877d-a1fc-420c-be7c-d59ccd9f4439" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>lgnd-20210630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:28a37576-9b75-439f-9e08-1e286b83ffe6,g:5715a2c1-e324-41f6-868f-ac2db6a81a2a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.ligand.com/role/Cover" xlink:type="simple" xlink:href="lgnd-20210630.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/Cover" xlink:type="extended" id="i1249a010e302443a95cc8e0c3e1d9497_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_afb8f392-afb1-4198-89aa-91ccc2f04d9e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_DocumentType_afb8f392-afb1-4198-89aa-91ccc2f04d9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_b634e5aa-e84b-44a2-a27d-2d41dd39cac8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_DocumentQuarterlyReport_b634e5aa-e84b-44a2-a27d-2d41dd39cac8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8c73c773-4280-4fe7-b6df-7d049ac6c621" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_DocumentPeriodEndDate_8c73c773-4280-4fe7-b6df-7d049ac6c621" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_becdf00a-41ff-41f9-9411-d837c46a71e6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_DocumentTransitionReport_becdf00a-41ff-41f9-9411-d837c46a71e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_365bd2a6-649c-42f2-af8c-71feb8cd429c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityFileNumber_365bd2a6-649c-42f2-af8c-71feb8cd429c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_73ac109c-3615-4149-8797-a288fce2d361" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityRegistrantName_73ac109c-3615-4149-8797-a288fce2d361" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0865b3b7-e5b9-4c5e-9f87-04ca60943b72" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0865b3b7-e5b9-4c5e-9f87-04ca60943b72" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_68fbd6f2-f59d-4969-94d1-9900f6ee0c08" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityTaxIdentificationNumber_68fbd6f2-f59d-4969-94d1-9900f6ee0c08" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_bb7c186f-1237-4492-b331-dd454ab089bb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityAddressAddressLine1_bb7c186f-1237-4492-b331-dd454ab089bb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_adaaf506-592c-4809-8d11-3f12d988722c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityAddressCityOrTown_adaaf506-592c-4809-8d11-3f12d988722c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6a453664-1944-45d2-b39c-d91cac01aec8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityAddressStateOrProvince_6a453664-1944-45d2-b39c-d91cac01aec8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7702ec0c-cf91-4f22-979b-866bc28fa84e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityAddressPostalZipCode_7702ec0c-cf91-4f22-979b-866bc28fa84e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_86590678-7d1f-47fb-81b1-422d46a259f0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_CityAreaCode_86590678-7d1f-47fb-81b1-422d46a259f0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ad78e9f6-2f5d-4ecb-8d5c-0d2f4fa2b9ec" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_LocalPhoneNumber_ad78e9f6-2f5d-4ecb-8d5c-0d2f4fa2b9ec" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e7a36ca9-83fa-436b-8e05-e88d0e881671" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_Security12bTitle_e7a36ca9-83fa-436b-8e05-e88d0e881671" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cf70c521-c42f-4ff1-a918-b3402b8e089d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_TradingSymbol_cf70c521-c42f-4ff1-a918-b3402b8e089d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_6afa7687-5cef-4381-bea4-8ea390bc5e17" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_SecurityExchangeName_6afa7687-5cef-4381-bea4-8ea390bc5e17" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ee707fe0-c410-459e-9f47-4e11bbf89ba3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityCurrentReportingStatus_ee707fe0-c410-459e-9f47-4e11bbf89ba3" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_f75c2c01-828d-44c5-85d2-701c6d5ee03a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityInteractiveDataCurrent_f75c2c01-828d-44c5-85d2-701c6d5ee03a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_afcbd3f6-beb9-444b-825c-6da919684427" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityFilerCategory_afcbd3f6-beb9-444b-825c-6da919684427" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_c37ebdf7-eaf7-4916-8356-92453526a776" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntitySmallBusiness_c37ebdf7-eaf7-4916-8356-92453526a776" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_cb1184b9-2d85-4757-b195-f6bed19490f3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityEmergingGrowthCompany_cb1184b9-2d85-4757-b195-f6bed19490f3" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_7eedc360-419d-46c8-a22b-c5113d5f5554" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityShellCompany_7eedc360-419d-46c8-a22b-c5113d5f5554" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9c03df03-b6bd-460c-8a1b-d3574bfa57e3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_9c03df03-b6bd-460c-8a1b-d3574bfa57e3" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_53353196-9142-4357-8162-7fe22b786198" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_AmendmentFlag_53353196-9142-4357-8162-7fe22b786198" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4c05e317-5ec4-4e3a-950f-efe056ee5220" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_DocumentFiscalYearFocus_4c05e317-5ec4-4e3a-950f-efe056ee5220" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_61e753fc-dbe4-44cf-9de8-19094e297e91" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_61e753fc-dbe4-44cf-9de8-19094e297e91" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_1e637cc1-0973-4915-9fc6-e5c0d3afe503" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityCentralIndexKey_1e637cc1-0973-4915-9fc6-e5c0d3afe503" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_8280ad51-7585-4648-b86f-73c08f5dda46" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_CurrentFiscalYearEndDate_8280ad51-7585-4648-b86f-73c08f5dda46" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesTable_3a3a61a1-3ccb-49b7-b7a7-82ba93a51314" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityAddressesTable_3a3a61a1-3ccb-49b7-b7a7-82ba93a51314" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_86a0c43d-bd60-4882-aed2-b29429994661" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntityAddressesTable_3a3a61a1-3ccb-49b7-b7a7-82ba93a51314" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_86a0c43d-bd60-4882-aed2-b29429994661" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_86a0c43d-bd60-4882-aed2-b29429994661_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_86a0c43d-bd60-4882-aed2-b29429994661" xlink:to="loc_dei_AddressTypeDomain_86a0c43d-bd60-4882-aed2-b29429994661_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_e61ae06b-59c0-476b-8300-42b3fd0efc17" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_86a0c43d-bd60-4882-aed2-b29429994661" xlink:to="loc_dei_AddressTypeDomain_e61ae06b-59c0-476b-8300-42b3fd0efc17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_FormerAddressMember_39b7c876-f5ef-405f-9f13-35672f608954" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_FormerAddressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_e61ae06b-59c0-476b-8300-42b3fd0efc17" xlink:to="loc_dei_FormerAddressMember_39b7c876-f5ef-405f-9f13-35672f608954" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="lgnd-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended" id="i0b94dd3c76de4a43bbcf9cf26faac7f2_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_7b181c09-bb8c-4213-9e2b-729ef3580a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_RevenuesAbstract_7b181c09-bb8c-4213-9e2b-729ef3580a2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7ac12b8d-c17b-4253-b2ab-c2af30cb40f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_7b181c09-bb8c-4213-9e2b-729ef3580a2e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7ac12b8d-c17b-4253-b2ab-c2af30cb40f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_e34feaf6-652e-479e-840d-be28e3e14743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:to="loc_us-gaap_CostDirectMaterial_e34feaf6-652e-479e-840d-be28e3e14743" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_343a7d9e-74ad-4478-8246-0247851a6f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_343a7d9e-74ad-4478-8246-0247851a6f3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_970a566d-1ebf-4be1-a9d4-28ee0151ea3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_970a566d-1ebf-4be1-a9d4-28ee0151ea3f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_bb1224f7-b457-4d7b-bf8d-72bbf677bf0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_bb1224f7-b457-4d7b-bf8d-72bbf677bf0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncome_36e7ab91-f356-4d54-a2db-44c2311771dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:to="loc_us-gaap_OtherOperatingIncome_36e7ab91-f356-4d54-a2db-44c2311771dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_4608697f-6a9f-45bd-9f89-cccf6793356c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_4608697f-6a9f-45bd-9f89-cccf6793356c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1aa68b9c-93a4-4139-a35d-61664e90aee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_OperatingIncomeLoss_1aa68b9c-93a4-4139-a35d-61664e90aee5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e93e457e-015a-4764-a6a0-6669711241d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e93e457e-015a-4764-a6a0-6669711241d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_d51a6031-8f9b-460e-807d-6efcf2fc9530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e93e457e-015a-4764-a6a0-6669711241d5" xlink:to="loc_us-gaap_GainLossOnInvestments_d51a6031-8f9b-460e-807d-6efcf2fc9530" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_248af3a0-c27a-42fe-91ec-a0b805cf3f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e93e457e-015a-4764-a6a0-6669711241d5" xlink:to="loc_us-gaap_InvestmentIncomeInterest_248af3a0-c27a-42fe-91ec-a0b805cf3f6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_da9501bc-f90b-49b0-8e26-3e62065b5e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e93e457e-015a-4764-a6a0-6669711241d5" xlink:to="loc_us-gaap_InterestExpense_da9501bc-f90b-49b0-8e26-3e62065b5e3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1ac714d8-bcb1-4fd7-a077-a5819011b754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e93e457e-015a-4764-a6a0-6669711241d5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1ac714d8-bcb1-4fd7-a077-a5819011b754" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_edc7ac94-b38c-4128-ab99-3c402a43506f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e93e457e-015a-4764-a6a0-6669711241d5" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_edc7ac94-b38c-4128-ab99-3c402a43506f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_68de0f55-b8bd-4822-b8cf-9521dbc0c7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_68de0f55-b8bd-4822-b8cf-9521dbc0c7a5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_17893509-b473-484d-87bb-62414b2adc69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_17893509-b473-484d-87bb-62414b2adc69" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d7081b4c-87fb-4d8c-b518-74bbcacf206c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_NetIncomeLoss_d7081b4c-87fb-4d8c-b518-74bbcacf206c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6014ae22-b433-48e9-bcea-9b9ba6068cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6014ae22-b433-48e9-bcea-9b9ba6068cb5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ffcc67c5-170a-48ef-83ff-97ba5c32868a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6014ae22-b433-48e9-bcea-9b9ba6068cb5" xlink:to="loc_us-gaap_EarningsPerShareBasic_ffcc67c5-170a-48ef-83ff-97ba5c32868a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8f52397b-b680-486a-8320-38c11f08bbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6014ae22-b433-48e9-bcea-9b9ba6068cb5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8f52397b-b680-486a-8320-38c11f08bbb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_842e2c9a-b923-44c6-a366-baa4460c607c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6014ae22-b433-48e9-bcea-9b9ba6068cb5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_842e2c9a-b923-44c6-a366-baa4460c607c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63c58dee-488f-4aa2-aebc-4510d5ccf009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6014ae22-b433-48e9-bcea-9b9ba6068cb5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63c58dee-488f-4aa2-aebc-4510d5ccf009" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_62003c18-14ee-44f2-9500-551d7dc97ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_StatementTable_62003c18-14ee-44f2-9500-551d7dc97ea2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4febd29d-01c9-4371-a89c-b06dae95ae04" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_62003c18-14ee-44f2-9500-551d7dc97ea2" xlink:to="loc_srt_ProductOrServiceAxis_4febd29d-01c9-4371-a89c-b06dae95ae04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4febd29d-01c9-4371-a89c-b06dae95ae04_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4febd29d-01c9-4371-a89c-b06dae95ae04" xlink:to="loc_srt_ProductsAndServicesDomain_4febd29d-01c9-4371-a89c-b06dae95ae04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b062ac62-0064-48ad-8405-8aadbd6c18f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4febd29d-01c9-4371-a89c-b06dae95ae04" xlink:to="loc_srt_ProductsAndServicesDomain_b062ac62-0064-48ad-8405-8aadbd6c18f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_2f450d17-5459-4019-a312-6e4a4c92e2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b062ac62-0064-48ad-8405-8aadbd6c18f4" xlink:to="loc_us-gaap_RoyaltyMember_2f450d17-5459-4019-a312-6e4a4c92e2b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_8fb49abb-d1d9-4e0e-b578-a450c4b0d28b" xlink:href="lgnd-20210630.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b062ac62-0064-48ad-8405-8aadbd6c18f4" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_8fb49abb-d1d9-4e0e-b578-a450c4b0d28b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_3173cd18-e2c7-408f-8c20-0506e34e5997" xlink:href="lgnd-20210630.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b062ac62-0064-48ad-8405-8aadbd6c18f4" xlink:to="loc_lgnd_ContractRevenueMember_3173cd18-e2c7-408f-8c20-0506e34e5997" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="lgnd-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended" id="ic9379c3a66dd4238924308fff7481eb4_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7d47f542-1059-4714-a2e9-620faeb7e4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7d47f542-1059-4714-a2e9-620faeb7e4f4" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_0358333f-d8a0-4fff-9356-4db999a90b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_SharesIssued_0358333f-d8a0-4fff-9356-4db999a90b4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f69f875d-80f3-4e20-a859-4c0cea887bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_StockholdersEquity_f69f875d-80f3-4e20-a859-4c0cea887bbc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1f1db6b8-320a-4186-9003-be144616a1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1f1db6b8-320a-4186-9003-be144616a1d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_90b7f401-14e9-49b2-b60e-86d86c11631d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_90b7f401-14e9-49b2-b60e-86d86c11631d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_444ecaf2-0d85-46f3-9ef1-f9fb58ebd6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_444ecaf2-0d85-46f3-9ef1-f9fb58ebd6e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_8c8b16bc-4d3c-4dc1-9b93-acb668dde362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_8c8b16bc-4d3c-4dc1-9b93-acb668dde362" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_2826c2ae-1114-4ddc-94e9-69044a0be9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_2826c2ae-1114-4ddc-94e9-69044a0be9fa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_5556e0a8-7165-4337-b46a-171ccb298af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_5556e0a8-7165-4337-b46a-171ccb298af2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_1fdb72d9-5e7e-49b7-b6de-b358356570be" xlink:href="lgnd-20210630.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_1fdb72d9-5e7e-49b7-b6de-b358356570be" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_eef212a6-a7d9-482d-b797-d963561404ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_eef212a6-a7d9-482d-b797-d963561404ce" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_24b36e1a-e2fa-4292-a993-329c1697394c" xlink:href="lgnd-20210630.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_24b36e1a-e2fa-4292-a993-329c1697394c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_4a59a2ae-de40-4c28-ac76-090b079e254f" xlink:href="lgnd-20210630.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_4a59a2ae-de40-4c28-ac76-090b079e254f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_04964de0-2735-4a0f-8305-b0038074813d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_04964de0-2735-4a0f-8305-b0038074813d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_30be6d7f-81d6-4b5e-a0bd-b77b902069a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_NetIncomeLoss_30be6d7f-81d6-4b5e-a0bd-b77b902069a9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_2fad77df-d384-42fa-ad45-595968475685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ff81764b-fe22-4a77-b5a1-7ee1c03a92ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_a6f1a2f7-3072-4167-bbc7-a1d16d2bb3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7d47f542-1059-4714-a2e9-620faeb7e4f4" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_a6f1a2f7-3072-4167-bbc7-a1d16d2bb3c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_992159c9-ec05-47a3-be18-54e7b233dade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7d47f542-1059-4714-a2e9-620faeb7e4f4" xlink:to="loc_us-gaap_StatementTable_992159c9-ec05-47a3-be18-54e7b233dade" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_54f431ef-57ae-4005-a73a-47e627606439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_992159c9-ec05-47a3-be18-54e7b233dade" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_54f431ef-57ae-4005-a73a-47e627606439" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_54f431ef-57ae-4005-a73a-47e627606439_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_54f431ef-57ae-4005-a73a-47e627606439" xlink:to="loc_us-gaap_EquityComponentDomain_54f431ef-57ae-4005-a73a-47e627606439_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_755389f6-07ba-476a-a475-1047d4528312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_54f431ef-57ae-4005-a73a-47e627606439" xlink:to="loc_us-gaap_EquityComponentDomain_755389f6-07ba-476a-a475-1047d4528312" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d20b41a0-bd51-447d-8b45-008f4a61c48a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_755389f6-07ba-476a-a475-1047d4528312" xlink:to="loc_us-gaap_CommonStockMember_d20b41a0-bd51-447d-8b45-008f4a61c48a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1fa8bd51-a6ae-48c9-bc18-3dc7d9fb4fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_755389f6-07ba-476a-a475-1047d4528312" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1fa8bd51-a6ae-48c9-bc18-3dc7d9fb4fbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a3cf4e96-be62-49c9-8bcd-9424c8bd8a22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_755389f6-07ba-476a-a475-1047d4528312" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a3cf4e96-be62-49c9-8bcd-9424c8bd8a22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_033e479b-13bb-4bad-b39a-7cb71d7c4b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_755389f6-07ba-476a-a475-1047d4528312" xlink:to="loc_us-gaap_RetainedEarningsMember_033e479b-13bb-4bad-b39a-7cb71d7c4b9b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_494f8919-2c0f-44e3-808a-92fdc255f504" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_992159c9-ec05-47a3-be18-54e7b233dade" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_494f8919-2c0f-44e3-808a-92fdc255f504" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_494f8919-2c0f-44e3-808a-92fdc255f504_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_494f8919-2c0f-44e3-808a-92fdc255f504" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_494f8919-2c0f-44e3-808a-92fdc255f504_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b2b3bd00-c543-43f3-a8f6-5235eafcc5a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_494f8919-2c0f-44e3-808a-92fdc255f504" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b2b3bd00-c543-43f3-a8f6-5235eafcc5a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9aa419ad-6b5e-42e0-87ad-ab35a8cf3cef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b2b3bd00-c543-43f3-a8f6-5235eafcc5a1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9aa419ad-6b5e-42e0-87ad-ab35a8cf3cef" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="ie061028558c648a7ab9582a0f8bf3d66_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e3246a73-3c87-4e52-a2a3-0ff69c6d67cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e3246a73-3c87-4e52-a2a3-0ff69c6d67cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0050b25b-5540-4c43-ae1f-586726b03760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0050b25b-5540-4c43-ae1f-586726b03760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a59bb801-ca8e-461b-b582-4f8820b928d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a59bb801-ca8e-461b-b582-4f8820b928d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_01a89cd3-27eb-4a56-85e6-0e40b51e904b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_01a89cd3-27eb-4a56-85e6-0e40b51e904b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_a030dad3-b3e8-4dc0-b3e3-98a7d6b8861e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_a030dad3-b3e8-4dc0-b3e3-98a7d6b8861e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_443f8e27-07e1-4330-94c3-554179b4ddb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_443f8e27-07e1-4330-94c3-554179b4ddb8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_2b23f170-2038-4fc7-aced-412960c2d431" xlink:href="lgnd-20210630.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_2b23f170-2038-4fc7-aced-412960c2d431" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesOnInventoryPurchases_6be5c8ff-2793-46dc-ad99-ec1d9800e89a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvancesOnInventoryPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_AdvancesOnInventoryPurchases_6be5c8ff-2793-46dc-ad99-ec1d9800e89a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases_e8e91cc8-4d5a-4b52-aaa4-6bc384518614" xlink:href="lgnd-20210630.xsd#lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases_e8e91cc8-4d5a-4b52-aaa4-6bc384518614" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_ba864b85-34c0-4b7a-9ce4-449a5ee766c1" xlink:href="lgnd-20210630.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_ba864b85-34c0-4b7a-9ce4-449a5ee766c1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_1e1391ac-0273-4c48-9e0f-95e7101bd608" xlink:href="lgnd-20210630.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_1e1391ac-0273-4c48-9e0f-95e7101bd608" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_3ee49e63-a352-4463-bec4-ee9076e12b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_3ee49e63-a352-4463-bec4-ee9076e12b1e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_4f373b30-1016-4d99-aac1-e2253abb4a06" xlink:href="lgnd-20210630.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_4f373b30-1016-4d99-aac1-e2253abb4a06" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4be2cecc-6b06-4d5e-be36-1b0c9bb4d8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4be2cecc-6b06-4d5e-be36-1b0c9bb4d8ae" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_26d527bd-87ee-4ad8-a868-10a9fa661057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_26d527bd-87ee-4ad8-a868-10a9fa661057" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_26d527bd-87ee-4ad8-a868-10a9fa661057_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_26d527bd-87ee-4ad8-a868-10a9fa661057" xlink:to="loc_us-gaap_RelatedPartyDomain_26d527bd-87ee-4ad8-a868-10a9fa661057_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ff7bca5c-97dc-47a9-ac1c-4aad3010705f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_26d527bd-87ee-4ad8-a868-10a9fa661057" xlink:to="loc_us-gaap_RelatedPartyDomain_ff7bca5c-97dc-47a9-ac1c-4aad3010705f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_6be123e2-3adb-4372-be17-f8903fc4014f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_ff7bca5c-97dc-47a9-ac1c-4aad3010705f" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_6be123e2-3adb-4372-be17-f8903fc4014f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1490937e-c902-4683-a4b2-7ee96091bc01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1490937e-c902-4683-a4b2-7ee96091bc01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1490937e-c902-4683-a4b2-7ee96091bc01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1490937e-c902-4683-a4b2-7ee96091bc01" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1490937e-c902-4683-a4b2-7ee96091bc01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf62bbe2-6365-45eb-a786-b9d8e3edfaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1490937e-c902-4683-a4b2-7ee96091bc01" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf62bbe2-6365-45eb-a786-b9d8e3edfaa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c1f44140-40ae-4eec-b6d4-e7e0bf54e39f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf62bbe2-6365-45eb-a786-b9d8e3edfaa4" xlink:to="loc_us-gaap_CommonStockMember_c1f44140-40ae-4eec-b6d4-e7e0bf54e39f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_c82f8c21-f135-4ec1-96e8-16b4c3cc40b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf62bbe2-6365-45eb-a786-b9d8e3edfaa4" xlink:to="loc_us-gaap_WarrantMember_c82f8c21-f135-4ec1-96e8-16b4c3cc40b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b8aac536-a82c-4ec3-8517-b9ee84b27772" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b8aac536-a82c-4ec3-8517-b9ee84b27772" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b8aac536-a82c-4ec3-8517-b9ee84b27772_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b8aac536-a82c-4ec3-8517-b9ee84b27772" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b8aac536-a82c-4ec3-8517-b9ee84b27772_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a8214983-c71b-4bbb-8201-8b52959ff570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b8aac536-a82c-4ec3-8517-b9ee84b27772" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a8214983-c71b-4bbb-8201-8b52959ff570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_e08893af-e1cc-4917-8416-feb4cc4c0ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a8214983-c71b-4bbb-8201-8b52959ff570" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_e08893af-e1cc-4917-8416-feb4cc4c0ef1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd02e586-3de3-435e-bf6d-fd9179d7be41" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_srt_RangeAxis_dd02e586-3de3-435e-bf6d-fd9179d7be41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd02e586-3de3-435e-bf6d-fd9179d7be41_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dd02e586-3de3-435e-bf6d-fd9179d7be41" xlink:to="loc_srt_RangeMember_dd02e586-3de3-435e-bf6d-fd9179d7be41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e21bc73a-97af-49cd-957a-ebb5405778c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dd02e586-3de3-435e-bf6d-fd9179d7be41" xlink:to="loc_srt_RangeMember_e21bc73a-97af-49cd-957a-ebb5405778c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3bc8bb85-af31-40f0-b9ab-4d5e9ddfcd4f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e21bc73a-97af-49cd-957a-ebb5405778c4" xlink:to="loc_srt_MaximumMember_3bc8bb85-af31-40f0-b9ab-4d5e9ddfcd4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b23cb439-4da1-484a-b36d-5bdab79c6ce2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e21bc73a-97af-49cd-957a-ebb5405778c4" xlink:to="loc_srt_MinimumMember_b23cb439-4da1-484a-b36d-5bdab79c6ce2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2fc24133-566f-4624-8cfb-c78a48414bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2fc24133-566f-4624-8cfb-c78a48414bec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2fc24133-566f-4624-8cfb-c78a48414bec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2fc24133-566f-4624-8cfb-c78a48414bec" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2fc24133-566f-4624-8cfb-c78a48414bec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f181831f-a14a-4dbe-9f73-597f63b3a328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2fc24133-566f-4624-8cfb-c78a48414bec" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f181831f-a14a-4dbe-9f73-597f63b3a328" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember_d6ba0bf8-3b7d-421d-aaa2-9fc87c8924a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f181831f-a14a-4dbe-9f73-597f63b3a328" xlink:to="loc_us-gaap_RoyaltyAgreementsMember_d6ba0bf8-3b7d-421d-aaa2-9fc87c8924a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_802f3aec-7d4e-456e-8eb5-36a83f84d6ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_srt_CounterpartyNameAxis_802f3aec-7d4e-456e-8eb5-36a83f84d6ab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_802f3aec-7d4e-456e-8eb5-36a83f84d6ab_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_802f3aec-7d4e-456e-8eb5-36a83f84d6ab" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_802f3aec-7d4e-456e-8eb5-36a83f84d6ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c481f803-1a9e-4234-a1b9-318198f50a4b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_802f3aec-7d4e-456e-8eb5-36a83f84d6ab" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c481f803-1a9e-4234-a1b9-318198f50a4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember_66552b82-046a-43ba-905b-280b1e5e6f63" xlink:href="lgnd-20210630.xsd#lgnd_AziyoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c481f803-1a9e-4234-a1b9-318198f50a4b" xlink:to="loc_lgnd_AziyoMember_66552b82-046a-43ba-905b-280b1e5e6f63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisMember_af45d573-8de3-4229-a37d-e84390b5025a" xlink:href="lgnd-20210630.xsd#lgnd_SelexisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c481f803-1a9e-4234-a1b9-318198f50a4b" xlink:to="loc_lgnd_SelexisMember_af45d573-8de3-4229-a37d-e84390b5025a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_adc4076d-2cf5-48b6-b2c9-2796d9afc6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_us-gaap_AwardTypeAxis_adc4076d-2cf5-48b6-b2c9-2796d9afc6d2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_adc4076d-2cf5-48b6-b2c9-2796d9afc6d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_adc4076d-2cf5-48b6-b2c9-2796d9afc6d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_adc4076d-2cf5-48b6-b2c9-2796d9afc6d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e098a52-0408-4a13-91a2-12bf715f09ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_adc4076d-2cf5-48b6-b2c9-2796d9afc6d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e098a52-0408-4a13-91a2-12bf715f09ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9bd9e86d-09ca-4cbc-92df-ceb4bf864585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e098a52-0408-4a13-91a2-12bf715f09ce" xlink:to="loc_us-gaap_RestrictedStockMember_9bd9e86d-09ca-4cbc-92df-ceb4bf864585" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3ccac90e-5cf3-4641-b69e-1ec591358fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3ccac90e-5cf3-4641-b69e-1ec591358fb3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3ccac90e-5cf3-4641-b69e-1ec591358fb3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3ccac90e-5cf3-4641-b69e-1ec591358fb3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3ccac90e-5cf3-4641-b69e-1ec591358fb3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1013386b-8888-43ff-b67e-a8f774f61bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3ccac90e-5cf3-4641-b69e-1ec591358fb3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1013386b-8888-43ff-b67e-a8f774f61bf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_a848b252-aaba-452a-ae6b-1cbe9d07bb62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1013386b-8888-43ff-b67e-a8f774f61bf0" xlink:to="loc_us-gaap_StockCompensationPlanMember_a848b252-aaba-452a-ae6b-1cbe9d07bb62" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended" id="ia35392111d3d447894cb6b3cb9603495_BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0a8e3241-6c38-4ec6-9985-191bb6d6b5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_34641d81-1355-4e1c-918c-3f8ce21d17a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0a8e3241-6c38-4ec6-9985-191bb6d6b5f0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_34641d81-1355-4e1c-918c-3f8ce21d17a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_9951a79c-e149-4476-ac56-41605ebf1f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0a8e3241-6c38-4ec6-9985-191bb6d6b5f0" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_9951a79c-e149-4476-ac56-41605ebf1f32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_80e22797-f0eb-4264-bdf6-93b9bca805a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9951a79c-e149-4476-ac56-41605ebf1f32" xlink:to="loc_srt_ProductOrServiceAxis_80e22797-f0eb-4264-bdf6-93b9bca805a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_80e22797-f0eb-4264-bdf6-93b9bca805a7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_80e22797-f0eb-4264-bdf6-93b9bca805a7" xlink:to="loc_srt_ProductsAndServicesDomain_80e22797-f0eb-4264-bdf6-93b9bca805a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d1aa9fd1-d6b1-4891-8368-4825828fd1c6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_80e22797-f0eb-4264-bdf6-93b9bca805a7" xlink:to="loc_srt_ProductsAndServicesDomain_d1aa9fd1-d6b1-4891-8368-4825828fd1c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_913c73e6-4906-4e05-9bb6-6d71525934a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d1aa9fd1-d6b1-4891-8368-4825828fd1c6" xlink:to="loc_us-gaap_RoyaltyMember_913c73e6-4906-4e05-9bb6-6d71525934a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_cbe9173b-1f48-4d09-b606-f6c16e9bb3a8" xlink:href="lgnd-20210630.xsd#lgnd_KyprolisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_913c73e6-4906-4e05-9bb6-6d71525934a8" xlink:to="loc_lgnd_KyprolisMember_cbe9173b-1f48-4d09-b606-f6c16e9bb3a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_370404eb-18bc-43a3-b9ea-c7c746c020b9" xlink:href="lgnd-20210630.xsd#lgnd_EvomelaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_913c73e6-4906-4e05-9bb6-6d71525934a8" xlink:to="loc_lgnd_EvomelaMember_370404eb-18bc-43a3-b9ea-c7c746c020b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_138a78e9-2506-41a0-8185-389b9548a5ff" xlink:href="lgnd-20210630.xsd#lgnd_RoyaltyOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_913c73e6-4906-4e05-9bb6-6d71525934a8" xlink:to="loc_lgnd_RoyaltyOtherMember_138a78e9-2506-41a0-8185-389b9548a5ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_2ca7e9b1-5d69-4fad-b957-30bfefbac1fd" xlink:href="lgnd-20210630.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d1aa9fd1-d6b1-4891-8368-4825828fd1c6" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_2ca7e9b1-5d69-4fad-b957-30bfefbac1fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_6198df1d-e2ea-4de0-9a5b-de6ffc0f3c55" xlink:href="lgnd-20210630.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d1aa9fd1-d6b1-4891-8368-4825828fd1c6" xlink:to="loc_lgnd_ContractRevenueMember_6198df1d-e2ea-4de0-9a5b-de6ffc0f3c55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember_d734d05a-af21-4614-af7c-a649d1eeac4a" xlink:href="lgnd-20210630.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_6198df1d-e2ea-4de0-9a5b-de6ffc0f3c55" xlink:to="loc_lgnd_ContractRevenueServiceMember_d734d05a-af21-4614-af7c-a649d1eeac4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_c4d023cd-0f88-4f4d-acb8-21502e797946" xlink:href="lgnd-20210630.xsd#lgnd_LicenseFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_6198df1d-e2ea-4de0-9a5b-de6ffc0f3c55" xlink:to="loc_lgnd_LicenseFeesMember_c4d023cd-0f88-4f4d-acb8-21502e797946" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_3cc4f4ea-9c39-49ac-b3f2-0d61f0560b87" xlink:href="lgnd-20210630.xsd#lgnd_MilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_6198df1d-e2ea-4de0-9a5b-de6ffc0f3c55" xlink:to="loc_lgnd_MilestoneMember_3cc4f4ea-9c39-49ac-b3f2-0d61f0560b87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_89960b99-ca10-4b13-b5fb-9e7344be9a13" xlink:href="lgnd-20210630.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_6198df1d-e2ea-4de0-9a5b-de6ffc0f3c55" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_89960b99-ca10-4b13-b5fb-9e7344be9a13" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended" id="i7d4af9cada72494fa4415e4b3aa30fd4_BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3d97f41d-5362-4c15-9cc4-45f8e4c7cc61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3d97f41d-5362-4c15-9cc4-45f8e4c7cc61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_484537a2-9cfe-4f06-8dff-a8da2a806ade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_484537a2-9cfe-4f06-8dff-a8da2a806ade" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8525305c-ce2d-4c21-98fe-15ab39003f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8525305c-ce2d-4c21-98fe-15ab39003f2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_86bd967e-f5d9-441c-9aef-552b14d5fc93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_86bd967e-f5d9-441c-9aef-552b14d5fc93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_0d08f1a6-e857-4cc5-8580-abbc59c02d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_0d08f1a6-e857-4cc5-8580-abbc59c02d8f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_80bc9066-8529-4043-884d-4464ba70bdc8" xlink:href="lgnd-20210630.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_80bc9066-8529-4043-884d-4464ba70bdc8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_71a2711b-6f95-48cb-89ea-da33ae11d2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_71a2711b-6f95-48cb-89ea-da33ae11d2e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1c8b6c62-d941-4ddb-8bc8-9779cd844c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_71a2711b-6f95-48cb-89ea-da33ae11d2e5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1c8b6c62-d941-4ddb-8bc8-9779cd844c47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8b6c62-d941-4ddb-8bc8-9779cd844c47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1c8b6c62-d941-4ddb-8bc8-9779cd844c47" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8b6c62-d941-4ddb-8bc8-9779cd844c47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1c8b6c62-d941-4ddb-8bc8-9779cd844c47" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_e547702c-b761-4cc4-a2f6-8bb3c0fd9593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_DemandDepositsMember_e547702c-b761-4cc4-a2f6-8bb3c0fd9593" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_06dabc4e-5852-4dd9-b499-a5fc5b277998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_06dabc4e-5852-4dd9-b499-a5fc5b277998" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AgencySecuritiesMember_9e51ae2d-86ae-4b65-9fcd-ce3f7b0d7bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AgencySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_AgencySecuritiesMember_9e51ae2d-86ae-4b65-9fcd-ce3f7b0d7bf8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_5aa96aa8-e9b7-4dac-89ad-f846b3907495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_CommercialPaperMember_5aa96aa8-e9b7-4dac-89ad-f846b3907495" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_27504043-9c62-4be2-8e7e-af99637b4320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_EquitySecuritiesMember_27504043-9c62-4be2-8e7e-af99637b4320" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_899c998b-56ba-434f-9fcc-c5f5234b7aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_MutualFundMember_899c998b-56ba-434f-9fcc-c5f5234b7aa9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_439cc485-dce2-43a5-90e8-632af74a5492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_439cc485-dce2-43a5-90e8-632af74a5492" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_35088d43-fccc-4dda-a7f3-848a36807f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_WarrantMember_35088d43-fccc-4dda-a7f3-848a36807f06" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3ddb5937-5f9e-4a8d-876d-7bab0b345836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_CommonStockMember_3ddb5937-5f9e-4a8d-876d-7bab0b345836" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended" id="ic49860733895457baf682ffb6c70a842_BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c7bb82d-aba6-4777-ae4f-12b7194413cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_6d42d42b-324d-4670-940f-83b01574c5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c7bb82d-aba6-4777-ae4f-12b7194413cc" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_6d42d42b-324d-4670-940f-83b01574c5cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_17861ce8-30cc-497c-95b4-b0e3baeb3b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_6d42d42b-324d-4670-940f-83b01574c5cb" xlink:to="loc_us-gaap_Goodwill_17861ce8-30cc-497c-95b4-b0e3baeb3b94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_26815527-0747-476f-a652-e6bd4f5cd016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_6d42d42b-324d-4670-940f-83b01574c5cb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_26815527-0747-476f-a652-e6bd4f5cd016" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a4b2636e-a3e2-428c-bc1a-e0fba186c0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_6d42d42b-324d-4670-940f-83b01574c5cb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a4b2636e-a3e2-428c-bc1a-e0fba186c0f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_104fa89c-c527-43e5-8d71-9697dfe3374b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_6d42d42b-324d-4670-940f-83b01574c5cb" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_104fa89c-c527-43e5-8d71-9697dfe3374b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4247b857-10e4-4661-b14b-68781d705263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c7bb82d-aba6-4777-ae4f-12b7194413cc" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4247b857-10e4-4661-b14b-68781d705263" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d60425d0-fa33-4508-9031-86b0387394c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4247b857-10e4-4661-b14b-68781d705263" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d60425d0-fa33-4508-9031-86b0387394c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d60425d0-fa33-4508-9031-86b0387394c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d60425d0-fa33-4508-9031-86b0387394c3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d60425d0-fa33-4508-9031-86b0387394c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_816ed5b6-7c63-4fad-95f3-5275b8318fed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d60425d0-fa33-4508-9031-86b0387394c3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_816ed5b6-7c63-4fad-95f3-5275b8318fed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_52329258-7c4a-4c64-9fcd-446945369bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_816ed5b6-7c63-4fad-95f3-5275b8318fed" xlink:to="loc_us-gaap_PatentedTechnologyMember_52329258-7c4a-4c64-9fcd-446945369bfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_e6c0b836-dd77-41a8-8eea-33a999d049c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_816ed5b6-7c63-4fad-95f3-5275b8318fed" xlink:to="loc_us-gaap_TradeNamesMember_e6c0b836-dd77-41a8-8eea-33a999d049c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_f45dba92-e3fd-411a-9938-7c5c5bab309f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_816ed5b6-7c63-4fad-95f3-5275b8318fed" xlink:to="loc_us-gaap_CustomerRelationshipsMember_f45dba92-e3fd-411a-9938-7c5c5bab309f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_a1bc1df3-c976-414d-bd6f-6258e8c1766b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_816ed5b6-7c63-4fad-95f3-5275b8318fed" xlink:to="loc_us-gaap_ContractualRightsMember_a1bc1df3-c976-414d-bd6f-6258e8c1766b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="extended" id="i52c720b70c434438b0825ce91f05ca87_BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_82df5cf4-1c7d-4e28-ac7c-28c2d9a4e5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c658388d-13c1-4267-a826-ffef539d2227" xlink:href="lgnd-20210630.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_82df5cf4-1c7d-4e28-ac7c-28c2d9a4e5b0" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c658388d-13c1-4267-a826-ffef539d2227" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1b0425e6-3f6f-41ee-915c-514b9e620ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c658388d-13c1-4267-a826-ffef539d2227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1b0425e6-3f6f-41ee-915c-514b9e620ea0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_a0c99f72-b2f9-4c98-a8b6-44286ade5a00" xlink:href="lgnd-20210630.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c658388d-13c1-4267-a826-ffef539d2227" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_a0c99f72-b2f9-4c98-a8b6-44286ade5a00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_23c5ea0d-a64e-4fa6-bdd4-41ca05c0c970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c658388d-13c1-4267-a826-ffef539d2227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_23c5ea0d-a64e-4fa6-bdd4-41ca05c0c970" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cbcb3cf2-4762-44ba-8e51-9727914cd4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c658388d-13c1-4267-a826-ffef539d2227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cbcb3cf2-4762-44ba-8e51-9727914cd4c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_d56133e5-b2ee-4893-a7d6-2839aa1cd605" xlink:href="lgnd-20210630.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c658388d-13c1-4267-a826-ffef539d2227" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_d56133e5-b2ee-4893-a7d6-2839aa1cd605" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_dc8ba246-ace3-4ec0-a75a-710eaa918c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_82df5cf4-1c7d-4e28-ac7c-28c2d9a4e5b0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_dc8ba246-ace3-4ec0-a75a-710eaa918c7a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_baa3acc2-31af-457c-a040-de1da1e2a3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_dc8ba246-ace3-4ec0-a75a-710eaa918c7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_baa3acc2-31af-457c-a040-de1da1e2a3b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_baa3acc2-31af-457c-a040-de1da1e2a3b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_baa3acc2-31af-457c-a040-de1da1e2a3b3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_baa3acc2-31af-457c-a040-de1da1e2a3b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f063dac-9d3e-4fec-945d-83bc0b58afd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_baa3acc2-31af-457c-a040-de1da1e2a3b3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f063dac-9d3e-4fec-945d-83bc0b58afd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_0154b2d2-5224-4b8d-a8fb-bd197fdcb50e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f063dac-9d3e-4fec-945d-83bc0b58afd2" xlink:to="loc_us-gaap_LicensingAgreementsMember_0154b2d2-5224-4b8d-a8fb-bd197fdcb50e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_8df4b82b-c344-4226-bde8-7bfafdf7326c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_dc8ba246-ace3-4ec0-a75a-710eaa918c7a" xlink:to="loc_srt_CounterpartyNameAxis_8df4b82b-c344-4226-bde8-7bfafdf7326c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8df4b82b-c344-4226-bde8-7bfafdf7326c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_8df4b82b-c344-4226-bde8-7bfafdf7326c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8df4b82b-c344-4226-bde8-7bfafdf7326c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a01d549d-46c0-46e1-bcb2-0a1920a36831" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_8df4b82b-c344-4226-bde8-7bfafdf7326c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a01d549d-46c0-46e1-bcb2-0a1920a36831" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_74b17da4-2e72-4284-a075-1dba9260d818" xlink:href="lgnd-20210630.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a01d549d-46c0-46e1-bcb2-0a1920a36831" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_74b17da4-2e72-4284-a075-1dba9260d818" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_305d2049-ac3a-4688-a6ac-b4cb9971801c" xlink:href="lgnd-20210630.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a01d549d-46c0-46e1-bcb2-0a1920a36831" xlink:to="loc_lgnd_SelexisAndDianomiMember_305d2049-ac3a-4688-a6ac-b4cb9971801c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended" id="i21718866ba95459798293273195521b9_BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_e32eed31-a10d-4008-8d31-97d0127d54a0" xlink:href="lgnd-20210630.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e61f5387-ff12-4e10-aaaa-121a29ec3878" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_e32eed31-a10d-4008-8d31-97d0127d54a0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e61f5387-ff12-4e10-aaaa-121a29ec3878" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_e3ade036-61f9-4415-96e8-5d873b6470e3" xlink:href="lgnd-20210630.xsd#lgnd_BasisOfPresentationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_lgnd_BasisOfPresentationLineItems_e32eed31-a10d-4008-8d31-97d0127d54a0" xlink:to="loc_lgnd_BasisOfPresentationTable_e3ade036-61f9-4415-96e8-5d873b6470e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_740f32f5-2224-48e4-91ff-573d514e6401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_e3ade036-61f9-4415-96e8-5d873b6470e3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_740f32f5-2224-48e4-91ff-573d514e6401" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_740f32f5-2224-48e4-91ff-573d514e6401_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_740f32f5-2224-48e4-91ff-573d514e6401" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_740f32f5-2224-48e4-91ff-573d514e6401_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cc612ebb-2054-4fc0-979c-a2a966c6081d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_740f32f5-2224-48e4-91ff-573d514e6401" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cc612ebb-2054-4fc0-979c-a2a966c6081d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_37af62d0-5df4-45c5-ab81-fcd7d3f36993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cc612ebb-2054-4fc0-979c-a2a966c6081d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_37af62d0-5df4-45c5-ab81-fcd7d3f36993" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_cd9a0180-5a9e-498a-b080-fded796a91e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cc612ebb-2054-4fc0-979c-a2a966c6081d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_cd9a0180-5a9e-498a-b080-fded796a91e6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="i3fab06cbc50d41dd811caf0884c05d66_FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ec75aa7e-716e-4728-ab1d-11282f64f899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ec75aa7e-716e-4728-ab1d-11282f64f899" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_d612484c-b52c-4649-9124-d82a503f4e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_d612484c-b52c-4649-9124-d82a503f4e03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_06b7a236-2949-410b-9c23-2ddef00bef6c" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_06b7a236-2949-410b-9c23-2ddef00bef6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_14cc019d-d950-41c6-aa5e-d54cf42e1dcd" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_14cc019d-d950-41c6-aa5e-d54cf42e1dcd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_b4840328-bc5d-4c76-a098-dbc6308e0dd8" xlink:href="lgnd-20210630.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_b4840328-bc5d-4c76-a098-dbc6308e0dd8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_7d3323a4-bea4-4fd3-956d-72ec3c894ab5" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_7d3323a4-bea4-4fd3-956d-72ec3c894ab5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_46383bc2-c613-4170-8675-5882ced13085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_us-gaap_Investments_46383bc2-c613-4170-8675-5882ced13085" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_9e90d2c7-58d7-40b4-a51c-1957cfd89e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_9e90d2c7-58d7-40b4-a51c-1957cfd89e27" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_a4c93a1b-65fd-4982-b898-a0a6588eee72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_a4c93a1b-65fd-4982-b898-a0a6588eee72" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b4b8478f-bf0e-4241-93a6-73a18d00d079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b4b8478f-bf0e-4241-93a6-73a18d00d079" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d254c75c-8128-4a7f-acfc-c9a8e9b0d5ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d254c75c-8128-4a7f-acfc-c9a8e9b0d5ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d254c75c-8128-4a7f-acfc-c9a8e9b0d5ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d254c75c-8128-4a7f-acfc-c9a8e9b0d5ba" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d254c75c-8128-4a7f-acfc-c9a8e9b0d5ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3c5d4475-bdf2-471c-aa1d-6691959d8fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d254c75c-8128-4a7f-acfc-c9a8e9b0d5ba" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3c5d4475-bdf2-471c-aa1d-6691959d8fd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d5fabc3c-a068-4bee-ac5e-d19d53382327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3c5d4475-bdf2-471c-aa1d-6691959d8fd3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d5fabc3c-a068-4bee-ac5e-d19d53382327" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fdf443ac-32c0-4de0-b363-e74c7c7187bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fdf443ac-32c0-4de0-b363-e74c7c7187bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fdf443ac-32c0-4de0-b363-e74c7c7187bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fdf443ac-32c0-4de0-b363-e74c7c7187bf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fdf443ac-32c0-4de0-b363-e74c7c7187bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3ece9399-3d56-4715-9a1a-104f8fe6c985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fdf443ac-32c0-4de0-b363-e74c7c7187bf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3ece9399-3d56-4715-9a1a-104f8fe6c985" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_dffaba7d-dd33-4171-aac3-1604def6263d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3ece9399-3d56-4715-9a1a-104f8fe6c985" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_dffaba7d-dd33-4171-aac3-1604def6263d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b725a674-457e-4c00-941e-a464f2a9fb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3ece9399-3d56-4715-9a1a-104f8fe6c985" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b725a674-457e-4c00-941e-a464f2a9fb6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_da47663e-e942-4010-bf63-07e84792a25d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3ece9399-3d56-4715-9a1a-104f8fe6c985" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_da47663e-e942-4010-bf63-07e84792a25d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b38f2b8b-2679-41ba-898c-b59375814085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b38f2b8b-2679-41ba-898c-b59375814085" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b38f2b8b-2679-41ba-898c-b59375814085_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b38f2b8b-2679-41ba-898c-b59375814085" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b38f2b8b-2679-41ba-898c-b59375814085_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a43ca1aa-ff49-438e-a865-aaf7c1f09d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b38f2b8b-2679-41ba-898c-b59375814085" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a43ca1aa-ff49-438e-a865-aaf7c1f09d6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_0bb8f24b-9cb1-4323-9831-30bdeb3e9907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a43ca1aa-ff49-438e-a865-aaf7c1f09d6b" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_0bb8f24b-9cb1-4323-9831-30bdeb3e9907" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_8bd9bc1f-44e8-4425-b8c0-01609bd5216a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a43ca1aa-ff49-438e-a865-aaf7c1f09d6b" xlink:to="loc_us-gaap_EquitySecuritiesMember_8bd9bc1f-44e8-4425-b8c0-01609bd5216a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_14bf9d5d-be79-471a-8c0a-da91ee5e6fae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a43ca1aa-ff49-438e-a865-aaf7c1f09d6b" xlink:to="loc_us-gaap_WarrantMember_14bf9d5d-be79-471a-8c0a-da91ee5e6fae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_33a35d2b-4528-45dc-b33f-fac08c6501c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_33a35d2b-4528-45dc-b33f-fac08c6501c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_33a35d2b-4528-45dc-b33f-fac08c6501c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_33a35d2b-4528-45dc-b33f-fac08c6501c4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_33a35d2b-4528-45dc-b33f-fac08c6501c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_33a35d2b-4528-45dc-b33f-fac08c6501c4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_69075c66-8cd3-4d6c-aa07-f9d05d726bd5" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyCrystalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_69075c66-8cd3-4d6c-aa07-f9d05d726bd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_d11dc117-1659-48c5-b764-b308b0aeaa79" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_d11dc117-1659-48c5-b764-b308b0aeaa79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_63d74443-82aa-49e5-8e42-88fab377ce74" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_63d74443-82aa-49e5-8e42-88fab377ce74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_7e7e1ef2-ae18-46a4-ab9d-8d49739cf86f" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_7e7e1ef2-ae18-46a4-ab9d-8d49739cf86f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_94c48d1c-603c-4623-9e08-df3c9af15e55" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyPfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_94c48d1c-603c-4623-9e08-df3c9af15e55" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_b30f2b98-4e60-4e35-a370-3e572e2c9aaf" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyXCellaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_b30f2b98-4e60-4e35-a370-3e572e2c9aaf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_8ad91216-b1e6-4bae-b842-c1f6b6a471f7" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:to="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_8ad91216-b1e6-4bae-b842-c1f6b6a471f7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ace4ce39-2a84-4f83-947d-0cb2f8eb0f77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ace4ce39-2a84-4f83-947d-0cb2f8eb0f77" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ace4ce39-2a84-4f83-947d-0cb2f8eb0f77_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ace4ce39-2a84-4f83-947d-0cb2f8eb0f77" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ace4ce39-2a84-4f83-947d-0cb2f8eb0f77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed4264be-11d1-4295-9f56-94a7f6e21ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ace4ce39-2a84-4f83-947d-0cb2f8eb0f77" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed4264be-11d1-4295-9f56-94a7f6e21ca6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_2cee14ac-e734-4c3a-92de-6c5f8512d015" xlink:href="lgnd-20210630.xsd#lgnd_MetabasisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed4264be-11d1-4295-9f56-94a7f6e21ca6" xlink:to="loc_lgnd_MetabasisMember_2cee14ac-e734-4c3a-92de-6c5f8512d015" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ad62b421-c4fb-4658-a51e-ca4a6f9b9add" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_srt_RangeAxis_ad62b421-c4fb-4658-a51e-ca4a6f9b9add" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ad62b421-c4fb-4658-a51e-ca4a6f9b9add_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ad62b421-c4fb-4658-a51e-ca4a6f9b9add" xlink:to="loc_srt_RangeMember_ad62b421-c4fb-4658-a51e-ca4a6f9b9add_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4100fee0-2e82-4b0d-98ca-1f82bb93b96a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ad62b421-c4fb-4658-a51e-ca4a6f9b9add" xlink:to="loc_srt_RangeMember_4100fee0-2e82-4b0d-98ca-1f82bb93b96a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a73daadb-7aea-4202-84c9-aff8b8f9b256" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4100fee0-2e82-4b0d-98ca-1f82bb93b96a" xlink:to="loc_srt_MaximumMember_a73daadb-7aea-4202-84c9-aff8b8f9b256" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ee99db6c-769e-4720-b05a-2e67521d8c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ee99db6c-769e-4720-b05a-2e67521d8c12" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_ee99db6c-769e-4720-b05a-2e67521d8c12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ee99db6c-769e-4720-b05a-2e67521d8c12" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_ee99db6c-769e-4720-b05a-2e67521d8c12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d8403553-1d19-45d6-bd6a-ed0da6794038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ee99db6c-769e-4720-b05a-2e67521d8c12" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d8403553-1d19-45d6-bd6a-ed0da6794038" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_eff663f8-4779-435a-b132-87ea79d27756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d8403553-1d19-45d6-bd6a-ed0da6794038" xlink:to="loc_us-gaap_TransferredOverTimeMember_eff663f8-4779-435a-b132-87ea79d27756" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d5f61ab7-9368-4ecd-b235-3fbfc8e3267e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_srt_ProductOrServiceAxis_d5f61ab7-9368-4ecd-b235-3fbfc8e3267e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d5f61ab7-9368-4ecd-b235-3fbfc8e3267e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d5f61ab7-9368-4ecd-b235-3fbfc8e3267e" xlink:to="loc_srt_ProductsAndServicesDomain_d5f61ab7-9368-4ecd-b235-3fbfc8e3267e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1d2b4f82-ad26-4fb1-b6dd-927721340e7d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d5f61ab7-9368-4ecd-b235-3fbfc8e3267e" xlink:to="loc_srt_ProductsAndServicesDomain_1d2b4f82-ad26-4fb1-b6dd-927721340e7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_cfab4218-2d3b-41d6-815e-5868566be728" xlink:href="lgnd-20210630.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1d2b4f82-ad26-4fb1-b6dd-927721340e7d" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_cfab4218-2d3b-41d6-815e-5868566be728" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_e7394ec0-da20-460f-9b42-a31ca79aa24e" xlink:href="lgnd-20210630.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1d2b4f82-ad26-4fb1-b6dd-927721340e7d" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_e7394ec0-da20-460f-9b42-a31ca79aa24e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended" id="icddc961b3e5e4db6b779bbdb8b3537b8_FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c59e4f44-81b3-4a56-81fc-13880d3e9623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e9cb44ae-db6d-4efb-a925-b25913825ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c59e4f44-81b3-4a56-81fc-13880d3e9623" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e9cb44ae-db6d-4efb-a925-b25913825ec0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b2ffa6ae-9707-477b-afdf-4aa5c226f92d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e9cb44ae-db6d-4efb-a925-b25913825ec0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b2ffa6ae-9707-477b-afdf-4aa5c226f92d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders_5fd208e2-38ef-4b7d-ae06-d9584d896d6f" xlink:href="lgnd-20210630.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e9cb44ae-db6d-4efb-a925-b25913825ec0" xlink:to="loc_lgnd_PaymentsToContingentValueRightHolders_5fd208e2-38ef-4b7d-ae06-d9584d896d6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f68ba9dc-4851-4863-b5dd-de90c06eb87b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e9cb44ae-db6d-4efb-a925-b25913825ec0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f68ba9dc-4851-4863-b5dd-de90c06eb87b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_c36dbdcf-4723-4d8a-a941-aa45133fb1d4" xlink:href="lgnd-20210630.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e9cb44ae-db6d-4efb-a925-b25913825ec0" xlink:to="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_c36dbdcf-4723-4d8a-a941-aa45133fb1d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_70092e62-4883-4361-b3f1-aa846b5a2fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_370d4f7f-5edd-4f5e-a20d-b642dfff274e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c59e4f44-81b3-4a56-81fc-13880d3e9623" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_370d4f7f-5edd-4f5e-a20d-b642dfff274e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22a4f1c6-f59e-4a95-b783-4622f899149b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_370d4f7f-5edd-4f5e-a20d-b642dfff274e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22a4f1c6-f59e-4a95-b783-4622f899149b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_22a4f1c6-f59e-4a95-b783-4622f899149b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22a4f1c6-f59e-4a95-b783-4622f899149b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_22a4f1c6-f59e-4a95-b783-4622f899149b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_08d97e94-6aa6-45e7-b55d-961bfd61335c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22a4f1c6-f59e-4a95-b783-4622f899149b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_08d97e94-6aa6-45e7-b55d-961bfd61335c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5ea1728f-27cd-45c6-938b-b6be108e0398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_08d97e94-6aa6-45e7-b55d-961bfd61335c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5ea1728f-27cd-45c6-938b-b6be108e0398" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#AcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="extended" id="ia9de65874f8c4ce09b337f3e34604c32_AcquisitionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a35b5583-841b-4a0b-8ee5-ffb25ba4216c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a35b5583-841b-4a0b-8ee5-ffb25ba4216c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_403276f3-b9b5-4610-aeeb-a90b1c78fa09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_403276f3-b9b5-4610-aeeb-a90b1c78fa09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_50fdf3e9-d67b-4cdb-ba35-b795572fd258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_50fdf3e9-d67b-4cdb-ba35-b795572fd258" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_5ba34a5a-50fc-4bc7-8b72-063eb6aea73c" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_5ba34a5a-50fc-4bc7-8b72-063eb6aea73c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_e9b87ca4-4a3b-42f0-aa31-d9b412f3e559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_e9b87ca4-4a3b-42f0-aa31-d9b412f3e559" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_df95dd32-3596-4e56-8337-f05ba1304e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_df95dd32-3596-4e56-8337-f05ba1304e8a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_53b5f512-2882-4cec-aa7a-8b18cf01887d" xlink:href="lgnd-20210630.xsd#lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_53b5f512-2882-4cec-aa7a-8b18cf01887d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_e94ad173-5038-43c5-9ca2-cce609e89562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_e94ad173-5038-43c5-9ca2-cce609e89562" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_eab3c90e-f947-47dd-8a92-9b7d6100a2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_eab3c90e-f947-47dd-8a92-9b7d6100a2d2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_1649ae0f-8c27-42da-9440-2b29d8dac17b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_1649ae0f-8c27-42da-9440-2b29d8dac17b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_3b0ea951-363d-460d-88f7-314a36e08af5" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_3b0ea951-363d-460d-88f7-314a36e08af5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_7a54d5db-303c-4ac2-8e44-93f1ab17c3c8" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationConsiderationTransferredHoldback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_7a54d5db-303c-4ac2-8e44-93f1ab17c3c8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_8988aa4c-a1f7-4969-b1a7-0fc5d83c2b59" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_8988aa4c-a1f7-4969-b1a7-0fc5d83c2b59" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_e599266a-c523-4050-b698-8de558d43f06" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_e599266a-c523-4050-b698-8de558d43f06" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_419f4bb3-44dd-41bc-9b08-974ffbe4772d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_419f4bb3-44dd-41bc-9b08-974ffbe4772d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_739b66a5-36ab-42ef-9bf0-e5764c178237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_739b66a5-36ab-42ef-9bf0-e5764c178237" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_99c1e69d-6e5a-46b3-b321-5ddc67a4b542" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_99c1e69d-6e5a-46b3-b321-5ddc67a4b542" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_31b861d4-e084-4440-958c-390e3539fc77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_31b861d4-e084-4440-958c-390e3539fc77" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_6170932f-4e7c-4eb9-a5fb-166bfb6f3d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_6170932f-4e7c-4eb9-a5fb-166bfb6f3d9a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_8be27a41-ccc1-4bab-80e1-f37d0e59f3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_8be27a41-ccc1-4bab-80e1-f37d0e59f3cb" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_918ee7a2-ade5-468d-b455-c07238d1257c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_918ee7a2-ade5-468d-b455-c07238d1257c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_197fb7b6-2770-494b-a9f0-b83ca42ef939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_197fb7b6-2770-494b-a9f0-b83ca42ef939" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3d87f92d-86d9-4d91-b4cf-1fe9335e3083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_197fb7b6-2770-494b-a9f0-b83ca42ef939" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3d87f92d-86d9-4d91-b4cf-1fe9335e3083" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3d87f92d-86d9-4d91-b4cf-1fe9335e3083_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3d87f92d-86d9-4d91-b4cf-1fe9335e3083" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3d87f92d-86d9-4d91-b4cf-1fe9335e3083_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4b9de3d-6bd3-4b41-8cfc-4e971948afa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3d87f92d-86d9-4d91-b4cf-1fe9335e3083" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4b9de3d-6bd3-4b41-8cfc-4e971948afa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_21f58b21-ad47-412a-8002-07d32334b8af" xlink:href="lgnd-20210630.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4b9de3d-6bd3-4b41-8cfc-4e971948afa7" xlink:to="loc_lgnd_PfenexMember_21f58b21-ad47-412a-8002-07d32334b8af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TaurusBiosciencesLLCMember_a499940f-596b-4855-b19c-188f5f5f5e82" xlink:href="lgnd-20210630.xsd#lgnd_TaurusBiosciencesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4b9de3d-6bd3-4b41-8cfc-4e971948afa7" xlink:to="loc_lgnd_TaurusBiosciencesLLCMember_a499940f-596b-4855-b19c-188f5f5f5e82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_145b57f3-1aee-402c-84d5-97e623f2e6eb" xlink:href="lgnd-20210630.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4b9de3d-6bd3-4b41-8cfc-4e971948afa7" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_145b57f3-1aee-402c-84d5-97e623f2e6eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IcagenMember_5efa4246-98b2-4142-a455-52b949510372" xlink:href="lgnd-20210630.xsd#lgnd_IcagenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4b9de3d-6bd3-4b41-8cfc-4e971948afa7" xlink:to="loc_lgnd_IcagenMember_5efa4246-98b2-4142-a455-52b949510372" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1efaddf6-6171-4090-841b-04578aa2397f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_197fb7b6-2770-494b-a9f0-b83ca42ef939" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1efaddf6-6171-4090-841b-04578aa2397f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1efaddf6-6171-4090-841b-04578aa2397f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1efaddf6-6171-4090-841b-04578aa2397f" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1efaddf6-6171-4090-841b-04578aa2397f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_22af1621-3ab9-4fd0-b5c5-0f8ad51b930f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1efaddf6-6171-4090-841b-04578aa2397f" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_22af1621-3ab9-4fd0-b5c5-0f8ad51b930f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_f446c53e-56cd-4e42-bfed-f6a8c3c4cc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_22af1621-3ab9-4fd0-b5c5-0f8ad51b930f" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_f446c53e-56cd-4e42-bfed-f6a8c3c4cc8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f4f14832-ca23-441c-ab66-b08051859abf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_197fb7b6-2770-494b-a9f0-b83ca42ef939" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f4f14832-ca23-441c-ab66-b08051859abf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f4f14832-ca23-441c-ab66-b08051859abf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f4f14832-ca23-441c-ab66-b08051859abf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f4f14832-ca23-441c-ab66-b08051859abf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_845ebfe8-df68-4733-aacc-08f29d7c4665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f4f14832-ca23-441c-ab66-b08051859abf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_845ebfe8-df68-4733-aacc-08f29d7c4665" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_995fe712-e06f-4dda-baa1-abd2fbec0fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_845ebfe8-df68-4733-aacc-08f29d7c4665" xlink:to="loc_us-gaap_ContractualRightsMember_995fe712-e06f-4dda-baa1-abd2fbec0fb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_250ea516-f89d-4420-8298-cb1acbbd2143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_845ebfe8-df68-4733-aacc-08f29d7c4665" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_250ea516-f89d-4420-8298-cb1acbbd2143" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_83eb94d2-e7e5-4e18-b0fa-b442528dba24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_845ebfe8-df68-4733-aacc-08f29d7c4665" xlink:to="loc_us-gaap_CustomerRelationshipsMember_83eb94d2-e7e5-4e18-b0fa-b442528dba24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ad543047-b557-4ef7-8ae3-285f007a80f9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_197fb7b6-2770-494b-a9f0-b83ca42ef939" xlink:to="loc_srt_RangeAxis_ad543047-b557-4ef7-8ae3-285f007a80f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ad543047-b557-4ef7-8ae3-285f007a80f9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ad543047-b557-4ef7-8ae3-285f007a80f9" xlink:to="loc_srt_RangeMember_ad543047-b557-4ef7-8ae3-285f007a80f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bdaa0c1c-9bd7-44b1-8ee9-2c3ddd48b751" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ad543047-b557-4ef7-8ae3-285f007a80f9" xlink:to="loc_srt_RangeMember_bdaa0c1c-9bd7-44b1-8ee9-2c3ddd48b751" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d8a97b80-d2f3-4831-a201-5766beca3785" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bdaa0c1c-9bd7-44b1-8ee9-2c3ddd48b751" xlink:to="loc_srt_MinimumMember_d8a97b80-d2f3-4831-a201-5766beca3785" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0c7d676d-0fc8-4d57-bf6b-d4cdb1526fb6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bdaa0c1c-9bd7-44b1-8ee9-2c3ddd48b751" xlink:to="loc_srt_MaximumMember_0c7d676d-0fc8-4d57-bf6b-d4cdb1526fb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_ffad0694-2d6b-43d6-bb76-e22e482f2a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_197fb7b6-2770-494b-a9f0-b83ca42ef939" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_ffad0694-2d6b-43d6-bb76-e22e482f2a2e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_ffad0694-2d6b-43d6-bb76-e22e482f2a2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_ffad0694-2d6b-43d6-bb76-e22e482f2a2e" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_ffad0694-2d6b-43d6-bb76-e22e482f2a2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_6fba37f3-a2ce-4178-abf4-4b5a8385398b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_ffad0694-2d6b-43d6-bb76-e22e482f2a2e" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_6fba37f3-a2ce-4178-abf4-4b5a8385398b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_796600f6-ad73-4ee2-b792-5faaa44cff2a" xlink:href="lgnd-20210630.xsd#lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_6fba37f3-a2ce-4178-abf4-4b5a8385398b" xlink:to="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_796600f6-ad73-4ee2-b792-5faaa44cff2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightOnProductRevenuesMember_6633a03b-36f3-4712-91a3-6b952fc1d34a" xlink:href="lgnd-20210630.xsd#lgnd_ContingentValueRightOnProductRevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_6fba37f3-a2ce-4178-abf4-4b5a8385398b" xlink:to="loc_lgnd_ContingentValueRightOnProductRevenuesMember_6633a03b-36f3-4712-91a3-6b952fc1d34a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_36f4813b-79d4-4c4b-9ee4-042f0e9822fa" xlink:href="lgnd-20210630.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_6fba37f3-a2ce-4178-abf4-4b5a8385398b" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_36f4813b-79d4-4c4b-9ee4-042f0e9822fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestonePaymentsMember_d7014d6b-b89b-438f-af66-5ccc4762b093" xlink:href="lgnd-20210630.xsd#lgnd_MilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_6fba37f3-a2ce-4178-abf4-4b5a8385398b" xlink:to="loc_lgnd_MilestonePaymentsMember_d7014d6b-b89b-438f-af66-5ccc4762b093" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="ie4dc11de1861476e8a95273f72194f7b_AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_a467d1d6-1cb6-4e23-8742-9c420c2e8957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_a467d1d6-1cb6-4e23-8742-9c420c2e8957" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_f96351a4-64ad-4473-a765-c04068f73722" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_f96351a4-64ad-4473-a765-c04068f73722" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_f707283e-3419-4fac-9451-98adead3e261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_f707283e-3419-4fac-9451-98adead3e261" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a35d63ca-dd85-4420-a163-8324662103a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a35d63ca-dd85-4420-a163-8324662103a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_202ea05f-e1ea-4b67-97a5-6e4ab50f0b9a" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_202ea05f-e1ea-4b67-97a5-6e4ab50f0b9a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_770f260d-e4b9-4906-a98f-945338304aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_770f260d-e4b9-4906-a98f-945338304aaa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_2b755a3e-4a27-47d9-9f30-e5206cc04827" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_2b755a3e-4a27-47d9-9f30-e5206cc04827" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3f9ceec8-3115-4ddb-9f28-4ce5468f9392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_Goodwill_3f9ceec8-3115-4ddb-9f28-4ce5468f9392" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_dd30b292-81e5-4d3e-8bd9-37cde0cb3ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_dd30b292-81e5-4d3e-8bd9-37cde0cb3ee8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_a078b0a7-547d-4f7b-a81a-c9d92f36d353" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_a078b0a7-547d-4f7b-a81a-c9d92f36d353" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_8f15c579-1a5b-4581-84c5-8b63b626d380" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_8f15c579-1a5b-4581-84c5-8b63b626d380" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_baea0193-f5b3-4d92-a3fa-ad31fc05fd42" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_baea0193-f5b3-4d92-a3fa-ad31fc05fd42" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_f28ac3af-4af7-482e-a4b4-208e0484739d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_f28ac3af-4af7-482e-a4b4-208e0484739d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_292e4ee2-e30d-458a-9d09-b483ac6d04b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_292e4ee2-e30d-458a-9d09-b483ac6d04b8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e9a3667a-7a62-4585-8a54-6a082356d108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e9a3667a-7a62-4585-8a54-6a082356d108" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_e8a9cd77-ebe0-4e63-9350-933ca96fb16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_e8a9cd77-ebe0-4e63-9350-933ca96fb16c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_df33bec1-9041-421a-b2e1-c97e1cb0c9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_df33bec1-9041-421a-b2e1-c97e1cb0c9f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_79b84663-eeec-4007-81b2-365df432304b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_df33bec1-9041-421a-b2e1-c97e1cb0c9f3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_79b84663-eeec-4007-81b2-365df432304b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_79b84663-eeec-4007-81b2-365df432304b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_79b84663-eeec-4007-81b2-365df432304b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_79b84663-eeec-4007-81b2-365df432304b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81c41adc-6698-4356-967d-a438d1a0cefd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_79b84663-eeec-4007-81b2-365df432304b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81c41adc-6698-4356-967d-a438d1a0cefd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_b4357bd8-fa08-48b7-b933-1d8a93eb9671" xlink:href="lgnd-20210630.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81c41adc-6698-4356-967d-a438d1a0cefd" xlink:to="loc_lgnd_PfenexMember_b4357bd8-fa08-48b7-b933-1d8a93eb9671" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#AcquisitionsProFormaFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="extended" id="i28314a277fe34a3498d519c8f2e65d06_AcquisitionsProFormaFinancialInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e74dc910-a455-4c20-8db5-a964f441708c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_022b11a6-fe58-4687-92c0-0c02020e71dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e74dc910-a455-4c20-8db5-a964f441708c" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_022b11a6-fe58-4687-92c0-0c02020e71dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_83f02dfe-2ae5-4ca2-85f8-167195fd9a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e74dc910-a455-4c20-8db5-a964f441708c" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_83f02dfe-2ae5-4ca2-85f8-167195fd9a1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareProFormaAbstract_a250b7d7-b5fe-4165-a915-6eee509c2a03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareProFormaAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e74dc910-a455-4c20-8db5-a964f441708c" xlink:to="loc_us-gaap_EarningsPerShareProFormaAbstract_a250b7d7-b5fe-4165-a915-6eee509c2a03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_902ddce4-8318-49d7-9ade-f99fd645a67a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_a250b7d7-b5fe-4165-a915-6eee509c2a03" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_902ddce4-8318-49d7-9ade-f99fd645a67a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_42cc9256-6f19-41f6-9652-38fd5e8ed92f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_a250b7d7-b5fe-4165-a915-6eee509c2a03" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_42cc9256-6f19-41f6-9652-38fd5e8ed92f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc00fc4b-8ab8-4512-a6d7-aa508088a778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e74dc910-a455-4c20-8db5-a964f441708c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc00fc4b-8ab8-4512-a6d7-aa508088a778" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b7ee11ba-d7c1-45a5-8c90-e18f73711a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc00fc4b-8ab8-4512-a6d7-aa508088a778" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b7ee11ba-d7c1-45a5-8c90-e18f73711a9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ee11ba-d7c1-45a5-8c90-e18f73711a9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b7ee11ba-d7c1-45a5-8c90-e18f73711a9b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ee11ba-d7c1-45a5-8c90-e18f73711a9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fdbf2c40-a6c0-4905-89a4-64280fd5517c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b7ee11ba-d7c1-45a5-8c90-e18f73711a9b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fdbf2c40-a6c0-4905-89a4-64280fd5517c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_11d38e54-294b-41f2-b812-b749b556c447" xlink:href="lgnd-20210630.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fdbf2c40-a6c0-4905-89a4-64280fd5517c" xlink:to="loc_lgnd_PfenexMember_11d38e54-294b-41f2-b812-b749b556c447" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended" id="iab7ce1b761f64871bdca91c9c923503b_ConvertibleSeniorNotesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_d8638565-2d17-4895-aa7f-47133a810249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_d8638565-2d17-4895-aa7f-47133a810249" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c7fd3dd4-f59d-4e2d-8895-7981b52b6675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c7fd3dd4-f59d-4e2d-8895-7981b52b6675" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_b69d828b-bef3-46c0-acb7-b0e7929f9f01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_b69d828b-bef3-46c0-acb7-b0e7929f9f01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_e53c3a72-fa7f-4907-8b05-8678366fb5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_e53c3a72-fa7f-4907-8b05-8678366fb5b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_2395f830-5bba-4339-b216-f83e556d9262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_2395f830-5bba-4339-b216-f83e556d9262" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_74cb7974-8f59-4c63-b000-e771bbe4f55d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_74cb7974-8f59-4c63-b000-e771bbe4f55d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_28cf7b0c-c40e-4361-809c-c47a27429303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_28cf7b0c-c40e-4361-809c-c47a27429303" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_9412cba4-d79e-4e3f-93a8-d7f46128e578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_9412cba4-d79e-4e3f-93a8-d7f46128e578" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_d2d012a6-dd27-4682-bceb-f433da0c5fd9" xlink:href="lgnd-20210630.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_d2d012a6-dd27-4682-bceb-f433da0c5fd9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_86f220ea-0614-440f-8f9c-5916201f8afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_86f220ea-0614-440f-8f9c-5916201f8afc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_ab4f006b-f173-4a20-b91f-8be8a6816a08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_ab4f006b-f173-4a20-b91f-8be8a6816a08" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_23bb409f-1e0d-432f-a38e-9216f7cfa351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_23bb409f-1e0d-432f-a38e-9216f7cfa351" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_75642437-a75d-481e-b3b8-2fa179974c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_75642437-a75d-481e-b3b8-2fa179974c41" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_96b3e4c3-df6f-4f18-9d7d-6e931503436a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_96b3e4c3-df6f-4f18-9d7d-6e931503436a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6c928d4a-49aa-49e7-ac9d-e05338c44228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6c928d4a-49aa-49e7-ac9d-e05338c44228" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_7b3b2578-db12-4435-bc76-0e480c17bc2e" xlink:href="lgnd-20210630.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_7b3b2578-db12-4435-bc76-0e480c17bc2e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_253eb29e-51be-412b-8f93-02c54ccbe185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_253eb29e-51be-412b-8f93-02c54ccbe185" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9660a079-66ef-47ce-8b1d-dd9a11a8e4df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9660a079-66ef-47ce-8b1d-dd9a11a8e4df" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_f15c2c7d-9297-47b9-baa9-95e4d69e846f" xlink:href="lgnd-20210630.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_f15c2c7d-9297-47b9-baa9-95e4d69e846f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a07f2dac-f58c-4f17-a918-d1fe8c1b8e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a07f2dac-f58c-4f17-a918-d1fe8c1b8e21" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_ec6c8c1a-eb0d-4739-a132-4616df841e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_ec6c8c1a-eb0d-4739-a132-4616df841e02" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_44d88cc6-9eee-47a8-ad04-d22d966a6aae" xlink:href="lgnd-20210630.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_44d88cc6-9eee-47a8-ad04-d22d966a6aae" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_34b43e24-b278-4156-bc3f-23e654570437" xlink:href="lgnd-20210630.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_34b43e24-b278-4156-bc3f-23e654570437" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_14dd64b1-b318-4491-9827-52f08b112e4a" xlink:href="lgnd-20210630.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_14dd64b1-b318-4491-9827-52f08b112e4a" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9ade0351-398a-40ed-955b-351993557c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentTable_9ade0351-398a-40ed-955b-351993557c11" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_54f554f6-dfa6-45df-8919-e5af05829a91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9ade0351-398a-40ed-955b-351993557c11" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_54f554f6-dfa6-45df-8919-e5af05829a91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_54f554f6-dfa6-45df-8919-e5af05829a91_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_54f554f6-dfa6-45df-8919-e5af05829a91" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_54f554f6-dfa6-45df-8919-e5af05829a91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3c1fe275-69d8-4e0d-91b9-2844ce176b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_54f554f6-dfa6-45df-8919-e5af05829a91" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3c1fe275-69d8-4e0d-91b9-2844ce176b8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_041e1ebb-46d0-46b8-b9f5-9a5759147864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3c1fe275-69d8-4e0d-91b9-2844ce176b8d" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_041e1ebb-46d0-46b8-b9f5-9a5759147864" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_02effb6c-20d4-4b41-b62b-9c128e363d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9ade0351-398a-40ed-955b-351993557c11" xlink:to="loc_us-gaap_DebtInstrumentAxis_02effb6c-20d4-4b41-b62b-9c128e363d20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_02effb6c-20d4-4b41-b62b-9c128e363d20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_02effb6c-20d4-4b41-b62b-9c128e363d20" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_02effb6c-20d4-4b41-b62b-9c128e363d20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_25b33570-e0b2-40e5-ad28-e774bcdc23e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_02effb6c-20d4-4b41-b62b-9c128e363d20" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_25b33570-e0b2-40e5-ad28-e774bcdc23e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_ba6ea24d-2902-44b9-a67a-fbec43c5a84c" xlink:href="lgnd-20210630.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_25b33570-e0b2-40e5-ad28-e774bcdc23e3" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_ba6ea24d-2902-44b9-a67a-fbec43c5a84c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d12c01e2-77b2-45d9-a92d-05e654b3d002" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9ade0351-398a-40ed-955b-351993557c11" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d12c01e2-77b2-45d9-a92d-05e654b3d002" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d12c01e2-77b2-45d9-a92d-05e654b3d002_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d12c01e2-77b2-45d9-a92d-05e654b3d002" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d12c01e2-77b2-45d9-a92d-05e654b3d002_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_724a966c-bc73-4c89-90e7-795c774c9651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d12c01e2-77b2-45d9-a92d-05e654b3d002" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_724a966c-bc73-4c89-90e7-795c774c9651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_4983b7bc-6776-426a-bb83-0603a39e09a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_724a966c-bc73-4c89-90e7-795c774c9651" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_4983b7bc-6776-426a-bb83-0603a39e09a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_3853a58d-ab60-452f-b044-4734f0a19db6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_724a966c-bc73-4c89-90e7-795c774c9651" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_3853a58d-ab60-452f-b044-4734f0a19db6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended" id="if41d1986e43b45e6a36f0cb25341a893_ConvertibleSeniorNotesNotesPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5ba442f9-0d07-4a0b-8108-37d1bf506eef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_88343f0f-c013-4e59-9fb0-df48258782b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5ba442f9-0d07-4a0b-8108-37d1bf506eef" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_88343f0f-c013-4e59-9fb0-df48258782b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_91323c36-110e-4d17-b246-42aaf8204f20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_88343f0f-c013-4e59-9fb0-df48258782b8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_91323c36-110e-4d17-b246-42aaf8204f20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_77eba0ad-1d9b-4746-9968-526d8b6991b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_88343f0f-c013-4e59-9fb0-df48258782b8" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_77eba0ad-1d9b-4746-9968-526d8b6991b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_9560104b-e68b-42cd-bd64-4cf5aea36fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_88343f0f-c013-4e59-9fb0-df48258782b8" xlink:to="loc_us-gaap_LongTermNotesPayable_9560104b-e68b-42cd-bd64-4cf5aea36fe8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_2dbeb051-7219-416a-820f-8beee7aa7fad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5ba442f9-0d07-4a0b-8108-37d1bf506eef" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_2dbeb051-7219-416a-820f-8beee7aa7fad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_1fb3a3f2-80d6-42e9-bb3c-3eae443093af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5ba442f9-0d07-4a0b-8108-37d1bf506eef" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_1fb3a3f2-80d6-42e9-bb3c-3eae443093af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_084bcf46-f7b9-4497-b224-7d20d39ff0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5ba442f9-0d07-4a0b-8108-37d1bf506eef" xlink:to="loc_us-gaap_DebtInstrumentTable_084bcf46-f7b9-4497-b224-7d20d39ff0c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ab1dcf8e-1b99-4f62-805b-db521c9941da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_084bcf46-f7b9-4497-b224-7d20d39ff0c9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ab1dcf8e-1b99-4f62-805b-db521c9941da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ab1dcf8e-1b99-4f62-805b-db521c9941da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ab1dcf8e-1b99-4f62-805b-db521c9941da" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ab1dcf8e-1b99-4f62-805b-db521c9941da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c6fff79a-b8d7-42a9-852f-ea168a6d55ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ab1dcf8e-1b99-4f62-805b-db521c9941da" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c6fff79a-b8d7-42a9-852f-ea168a6d55ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_165d4d3b-f672-4de1-b5f8-7c2f2fb89eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c6fff79a-b8d7-42a9-852f-ea168a6d55ad" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_165d4d3b-f672-4de1-b5f8-7c2f2fb89eaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9de0cd8b-8b12-442e-ad95-4b2e41754a70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_084bcf46-f7b9-4497-b224-7d20d39ff0c9" xlink:to="loc_us-gaap_DebtInstrumentAxis_9de0cd8b-8b12-442e-ad95-4b2e41754a70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9de0cd8b-8b12-442e-ad95-4b2e41754a70_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9de0cd8b-8b12-442e-ad95-4b2e41754a70" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9de0cd8b-8b12-442e-ad95-4b2e41754a70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d5e72bfa-608e-47c8-bad6-28ae4c3b1038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9de0cd8b-8b12-442e-ad95-4b2e41754a70" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d5e72bfa-608e-47c8-bad6-28ae4c3b1038" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_1f955df8-b147-4fa5-b48e-2d2e9dfd6b55" xlink:href="lgnd-20210630.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d5e72bfa-608e-47c8-bad6-28ae4c3b1038" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_1f955df8-b147-4fa5-b48e-2d2e9dfd6b55" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#IncomeTaxDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="extended" id="i21a4cc81323e42768a839120a71c9d00_IncomeTaxDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_8db40199-4526-4708-8b57-2d6e1ac17ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f9b54eea-7cac-430f-a38b-f1038edfed3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_8db40199-4526-4708-8b57-2d6e1ac17ace" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f9b54eea-7cac-430f-a38b-f1038edfed3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_651ab050-15b0-4b9a-8297-a4a796e3d7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_8db40199-4526-4708-8b57-2d6e1ac17ace" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_651ab050-15b0-4b9a-8297-a4a796e3d7cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_562a3027-4f49-4d7a-8364-6ec510573fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_8db40199-4526-4708-8b57-2d6e1ac17ace" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_562a3027-4f49-4d7a-8364-6ec510573fc8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_9c364cf2-f7c8-4eb7-986c-20b3369887cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_562a3027-4f49-4d7a-8364-6ec510573fc8" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_9c364cf2-f7c8-4eb7-986c-20b3369887cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9c364cf2-f7c8-4eb7-986c-20b3369887cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_9c364cf2-f7c8-4eb7-986c-20b3369887cb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9c364cf2-f7c8-4eb7-986c-20b3369887cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9556d4b3-58f8-4f83-add6-422a7a8b9802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_9c364cf2-f7c8-4eb7-986c-20b3369887cb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9556d4b3-58f8-4f83-add6-422a7a8b9802" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_270d87c7-03a1-4fad-81fd-e95d0e6a28e5" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyPfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9556d4b3-58f8-4f83-add6-422a7a8b9802" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_270d87c7-03a1-4fad-81fd-e95d0e6a28e5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended" id="i085b14ac7344411585314f40e8553ded_StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_5edf66f0-eaaf-44f5-a4cf-179e3ff0a284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7442df57-9d0d-4507-88c2-baf57e6201ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_5edf66f0-eaaf-44f5-a4cf-179e3ff0a284" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7442df57-9d0d-4507-88c2-baf57e6201ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f2ee050f-ec74-4efa-a3f2-18be7166670f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7442df57-9d0d-4507-88c2-baf57e6201ca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f2ee050f-ec74-4efa-a3f2-18be7166670f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d615eee1-ef2c-455b-bb5a-3c6e5d0224cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7442df57-9d0d-4507-88c2-baf57e6201ca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d615eee1-ef2c-455b-bb5a-3c6e5d0224cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c5900ca0-5fc4-480d-b1a5-fd46afcca36b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7442df57-9d0d-4507-88c2-baf57e6201ca" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c5900ca0-5fc4-480d-b1a5-fd46afcca36b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c795b1ba-bddc-4a25-9fa4-5b921548c1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7442df57-9d0d-4507-88c2-baf57e6201ca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c795b1ba-bddc-4a25-9fa4-5b921548c1c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3e0f88d3-d52e-4b75-8adb-5b5457d85619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f1fe15d8-98df-4b5c-891c-dfbec6d83b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_5edf66f0-eaaf-44f5-a4cf-179e3ff0a284" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f1fe15d8-98df-4b5c-891c-dfbec6d83b7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f81f0560-d1f8-46b6-b0b3-97df80c1330d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f1fe15d8-98df-4b5c-891c-dfbec6d83b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f81f0560-d1f8-46b6-b0b3-97df80c1330d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cd3cac57-acd2-40c4-a21e-4e064810a497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f1fe15d8-98df-4b5c-891c-dfbec6d83b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cd3cac57-acd2-40c4-a21e-4e064810a497" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6112ae52-0105-4a0b-bcd4-c9526b37ecf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f1fe15d8-98df-4b5c-891c-dfbec6d83b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6112ae52-0105-4a0b-bcd4-c9526b37ecf6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_eff4f4fe-6404-4d4e-8175-4435fffe93dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f1fe15d8-98df-4b5c-891c-dfbec6d83b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_eff4f4fe-6404-4d4e-8175-4435fffe93dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2945b4d6-7d98-4c4c-97cb-e424f66056b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fe8bc40e-b4ee-4aab-931c-ad1c3ba3a0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_5edf66f0-eaaf-44f5-a4cf-179e3ff0a284" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fe8bc40e-b4ee-4aab-931c-ad1c3ba3a0cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_755d699f-1f3c-43c1-824f-4cfd191efed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fe8bc40e-b4ee-4aab-931c-ad1c3ba3a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_755d699f-1f3c-43c1-824f-4cfd191efed9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fc08262e-ea6e-4d8c-b134-d0f83cf298ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fe8bc40e-b4ee-4aab-931c-ad1c3ba3a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fc08262e-ea6e-4d8c-b134-d0f83cf298ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4c0b2d29-db24-413a-bc23-ea382bed6224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fe8bc40e-b4ee-4aab-931c-ad1c3ba3a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4c0b2d29-db24-413a-bc23-ea382bed6224" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_27c9cbd5-de09-4869-960f-43a71b33952f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fe8bc40e-b4ee-4aab-931c-ad1c3ba3a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_27c9cbd5-de09-4869-960f-43a71b33952f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a54abc53-c904-4e21-b3ac-49a6e5c4a062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cb85933a-37de-4ac8-8e87-d27ce420ab01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_5edf66f0-eaaf-44f5-a4cf-179e3ff0a284" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cb85933a-37de-4ac8-8e87-d27ce420ab01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8e27546b-f7a2-471d-ac78-b45d790274a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cb85933a-37de-4ac8-8e87-d27ce420ab01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8e27546b-f7a2-471d-ac78-b45d790274a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9be763c9-f05e-4c0a-a5c6-2f982d270261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cb85933a-37de-4ac8-8e87-d27ce420ab01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9be763c9-f05e-4c0a-a5c6-2f982d270261" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1652d7bc-e179-46f4-88bf-c7440a8f1b12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cb85933a-37de-4ac8-8e87-d27ce420ab01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1652d7bc-e179-46f4-88bf-c7440a8f1b12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_50eb9328-117f-4cf5-a68e-269aef8613a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cb85933a-37de-4ac8-8e87-d27ce420ab01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_50eb9328-117f-4cf5-a68e-269aef8613a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6a1d4148-c1f3-4783-8ebc-cd6783da7bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_714bbfaa-8c29-4e07-bd42-2bcb273b41cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_5edf66f0-eaaf-44f5-a4cf-179e3ff0a284" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_714bbfaa-8c29-4e07-bd42-2bcb273b41cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0abe83d8-6449-4bf6-9341-8b2eabf1e74e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_714bbfaa-8c29-4e07-bd42-2bcb273b41cc" xlink:to="loc_us-gaap_AwardTypeAxis_0abe83d8-6449-4bf6-9341-8b2eabf1e74e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0abe83d8-6449-4bf6-9341-8b2eabf1e74e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0abe83d8-6449-4bf6-9341-8b2eabf1e74e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0abe83d8-6449-4bf6-9341-8b2eabf1e74e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_887ec9e7-d295-4618-ba65-2e91eb42f6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0abe83d8-6449-4bf6-9341-8b2eabf1e74e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_887ec9e7-d295-4618-ba65-2e91eb42f6cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b799822f-69e7-4762-b33e-5e94f9725b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_887ec9e7-d295-4618-ba65-2e91eb42f6cb" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b799822f-69e7-4762-b33e-5e94f9725b30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9102b1e2-5fbd-4bc3-a831-9fccfd208cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_887ec9e7-d295-4618-ba65-2e91eb42f6cb" xlink:to="loc_us-gaap_RestrictedStockMember_9102b1e2-5fbd-4bc3-a831-9fccfd208cb7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="i968e05b2d51443208492bd9ed50ad345_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_dd56b410-8f09-4b51-9b8a-9921a94b8929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_dd56b410-8f09-4b51-9b8a-9921a94b8929" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c903e088-5062-41bb-8eda-a780def1b3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c903e088-5062-41bb-8eda-a780def1b3ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_c49728a5-194a-4ccc-b994-ca9a12c16bfe" xlink:href="lgnd-20210630.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_c49728a5-194a-4ccc-b994-ca9a12c16bfe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_529b5f2f-5b8a-4719-94f0-1befdb79abd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_c49728a5-194a-4ccc-b994-ca9a12c16bfe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_529b5f2f-5b8a-4719-94f0-1befdb79abd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_a7a402f4-463a-4545-8c47-f7fac4a72378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_c49728a5-194a-4ccc-b994-ca9a12c16bfe" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_a7a402f4-463a-4545-8c47-f7fac4a72378" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_7e4179da-0541-40ae-9728-10c9209aaf83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_7e4179da-0541-40ae-9728-10c9209aaf83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_cfb49768-8340-4050-8aba-037e4fffeadb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_cfb49768-8340-4050-8aba-037e4fffeadb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_492ccc0a-9cef-4054-bfeb-1ca165afcbf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_492ccc0a-9cef-4054-bfeb-1ca165afcbf2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_d06e91aa-c9b6-4ce6-8690-7efdba9936b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_d06e91aa-c9b6-4ce6-8690-7efdba9936b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa6118d3-5a46-4407-8d0c-57ea234b9c32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa6118d3-5a46-4407-8d0c-57ea234b9c32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_136aea4e-8d8c-433a-943b-c9c910076d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa6118d3-5a46-4407-8d0c-57ea234b9c32" xlink:to="loc_us-gaap_PlanNameAxis_136aea4e-8d8c-433a-943b-c9c910076d4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_136aea4e-8d8c-433a-943b-c9c910076d4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_136aea4e-8d8c-433a-943b-c9c910076d4c" xlink:to="loc_us-gaap_PlanNameDomain_136aea4e-8d8c-433a-943b-c9c910076d4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_acb55d15-5b08-4adf-b701-cf9bac86b85d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_136aea4e-8d8c-433a-943b-c9c910076d4c" xlink:to="loc_us-gaap_PlanNameDomain_acb55d15-5b08-4adf-b701-cf9bac86b85d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_b9cd0157-53ad-4d3d-bd55-ec2c262f7737" xlink:href="lgnd-20210630.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_acb55d15-5b08-4adf-b701-cf9bac86b85d" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_b9cd0157-53ad-4d3d-bd55-ec2c262f7737" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#CommitmentandContingenciesLegalProceedingsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="extended" id="ibdd91abd90c44e65a9992d43eef42143_CommitmentandContingenciesLegalProceedingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems_eb25b1b1-cf20-4dcd-810d-04d394ba2879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_d442b345-8db0-4896-98e3-cd0fa459e8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_eb25b1b1-cf20-4dcd-810d-04d394ba2879" xlink:to="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_d442b345-8db0-4896-98e3-cd0fa459e8ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_23c9f7f3-968a-4bed-a339-74da685db7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_eb25b1b1-cf20-4dcd-810d-04d394ba2879" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_23c9f7f3-968a-4bed-a339-74da685db7bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfPetitionsFiled_b207ee38-3633-4834-9991-2ba21cfe7827" xlink:href="lgnd-20210630.xsd#lgnd_NumberOfPetitionsFiled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_eb25b1b1-cf20-4dcd-810d-04d394ba2879" xlink:to="loc_lgnd_NumberOfPetitionsFiled_b207ee38-3633-4834-9991-2ba21cfe7827" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable_768a8498-ef32-453a-a6e1-70ca9c01f0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GainContingenciesLineItems_eb25b1b1-cf20-4dcd-810d-04d394ba2879" xlink:to="loc_us-gaap_GainContingenciesTable_768a8498-ef32-453a-a6e1-70ca9c01f0c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_299c3bce-8a42-439d-a194-2ea715974317" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_GainContingenciesTable_768a8498-ef32-453a-a6e1-70ca9c01f0c4" xlink:to="loc_srt_LitigationCaseAxis_299c3bce-8a42-439d-a194-2ea715974317" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_299c3bce-8a42-439d-a194-2ea715974317_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_299c3bce-8a42-439d-a194-2ea715974317" xlink:to="loc_srt_LitigationCaseTypeDomain_299c3bce-8a42-439d-a194-2ea715974317_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b5d56cc2-536f-4abe-b37d-99160313ef25" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_299c3bce-8a42-439d-a194-2ea715974317" xlink:to="loc_srt_LitigationCaseTypeDomain_b5d56cc2-536f-4abe-b37d-99160313ef25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LupinPatentInfringementMember_788e0e95-e71f-4451-b486-0029a9132bf5" xlink:href="lgnd-20210630.xsd#lgnd_LupinPatentInfringementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b5d56cc2-536f-4abe-b37d-99160313ef25" xlink:to="loc_lgnd_LupinPatentInfringementMember_788e0e95-e71f-4451-b486-0029a9132bf5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_59371ea9-899e-4021-a7d5-6a255d9444e8" xlink:href="lgnd-20210630.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b5d56cc2-536f-4abe-b37d-99160313ef25" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_59371ea9-899e-4021-a7d5-6a255d9444e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_InterPartesReviewOfPatentMember_3d48b88d-bbf9-4b49-80a0-d77de8d91d84" xlink:href="lgnd-20210630.xsd#lgnd_InterPartesReviewOfPatentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b5d56cc2-536f-4abe-b37d-99160313ef25" xlink:to="loc_lgnd_InterPartesReviewOfPatentMember_3d48b88d-bbf9-4b49-80a0-d77de8d91d84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a7494297-2237-4e48-ad9c-e90a7b6852c1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_GainContingenciesTable_768a8498-ef32-453a-a6e1-70ca9c01f0c4" xlink:to="loc_dei_LegalEntityAxis_a7494297-2237-4e48-ad9c-e90a7b6852c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a7494297-2237-4e48-ad9c-e90a7b6852c1_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_a7494297-2237-4e48-ad9c-e90a7b6852c1" xlink:to="loc_dei_EntityDomain_a7494297-2237-4e48-ad9c-e90a7b6852c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b65b7572-924b-45df-8a44-e77ecd577804" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_a7494297-2237-4e48-ad9c-e90a7b6852c1" xlink:to="loc_dei_EntityDomain_b65b7572-924b-45df-8a44-e77ecd577804" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_ca995a86-fa8a-4072-9d2f-af9a858b68f2" xlink:href="lgnd-20210630.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_b65b7572-924b-45df-8a44-e77ecd577804" xlink:to="loc_lgnd_PfenexMember_ca995a86-fa8a-4072-9d2f-af9a858b68f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GlaxoSmithKlineBiologicalsSAMember_5900a634-0400-4fdb-ba73-ea6ed70fc92f" xlink:href="lgnd-20210630.xsd#lgnd_GlaxoSmithKlineBiologicalsSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_b65b7572-924b-45df-8a44-e77ecd577804" xlink:to="loc_lgnd_GlaxoSmithKlineBiologicalsSAMember_5900a634-0400-4fdb-ba73-ea6ed70fc92f" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>lgnd-20210630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:28a37576-9b75-439f-9e08-1e286b83ffe6,g:5715a2c1-e324-41f6-868f-ac2db6a81a2a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_lgnd_PfenexMember_24378f7a-5a8e-4359-84d9-8f86dc9bf3f3_terseLabel_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex</link:label>
    <link:label id="lab_lgnd_PfenexMember_label_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex [Member]</link:label>
    <link:label id="lab_lgnd_PfenexMember_documentation_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember" xlink:href="lgnd-20210630.xsd#lgnd_PfenexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PfenexMember" xlink:to="lab_lgnd_PfenexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_41ba98df-363d-4e78-b672-d1e16792094f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_cea5c235-deba-487e-9380-017f5e9f6064_terseLabel_en-US" xlink:label="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate for forecasted cash flows (as a percent)</link:label>
    <link:label id="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_label_en-US" xlink:label="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecasted Cash Flows, Effective Interest Rate, Percent</link:label>
    <link:label id="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_documentation_en-US" xlink:label="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecasted Cash Flows, Effective Interest Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:href="lgnd-20210630.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:to="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_19c0dd03-0276-4ab5-bd05-a804a6b3668f_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized stock repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_8839f661-0d33-4163-9394-15041a514974_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_76473b22-14fd-4ea5-a79e-8fa5c44b72be_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f66a4e67-d946-4d21-8ed7-998a2a92706a_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f6632184-b002-49fb-8213-75a19ba79004_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_42990126-8631-4784-bcf4-ae58ad839793_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_a1d64761-3f0b-4d33-8c05-26e49155c202_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss):</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_bf9de1e6-9bed-4bf7-a306-d9b771f2c70e_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_2e25eb58-0552-4dcd-a86e-399fe8c199cc_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_1b8371a2-b94b-4685-a49a-6e034612d44c_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_f924b942-06a5-4194-a39d-4f8c5db93cb5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_e698d2bc-624d-490e-bf6a-ee614f2e9963_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_85163246-8001-44a1-a8de-870a8be1bb07_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_3ec252fe-c34f-42d0-be13-5c012fd951b1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_b1573df5-7a03-47d2-b2a1-90d8ef2e599d_negatedLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:href="lgnd-20210630.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:to="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_f57a69b9-54ca-4473-9b94-2bd5ec58b697_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_67b3f945-c214-41af-bee2-b33b1d5a2a45_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_56af5009-fbf4-4f73-817c-cf99e9b8cd7c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization on finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_fc0d1423-ffd2-42a4-86d5-d8665a3cb997_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c864f4bf-dc99-40f2-b9a9-a688bf228368_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_a001acc7-0422-40a8-a8ce-cad9ad386f73_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_54406414-cb16-4cb0-90a7-9d49ead8da2d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price (USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_eca5121f-c202-4310-87a0-6580d9022be9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_e0b76c87-7b0a-4d0f-8f07-bc9693c11949_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share purchase price as percent of market price (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_b4633955-e04c-4e98-8e0b-479500976783_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_93df8d0b-532a-4d27-9751-8190ec318d11_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_260f4780-120d-4462-9643-49756e94b328_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a8f3c62e-72ff-4d09-b3b1-37ac1f4fbe27_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_ad91fe11-4a0a-44bd-ac5a-9d6fbf5790da_verboseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_label_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights [Abstract]</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:href="lgnd-20210630.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:to="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1eb23ad8-d330-431f-9ba6-c582cb2668fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e3cf3d4-5d57-4ab3-a074-17a48c6706e3_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_FormerAddressMember_8566a604-5fed-45e0-859f-ff5561d8d00f_terseLabel_en-US" xlink:label="lab_dei_FormerAddressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Address</link:label>
    <link:label id="lab_dei_FormerAddressMember_label_en-US" xlink:label="lab_dei_FormerAddressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Address [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_FormerAddressMember" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_FormerAddressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_FormerAddressMember" xlink:to="lab_dei_FormerAddressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2711d6eb-386c-48a7-af0e-1c682b455389_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a88be90d-4c55-472c-85f8-14c8a7293851_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_db49e656-9fcb-4be9-93ec-c5be566ba7d1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_7e1c0ab6-3abd-4f1d-8b8c-0fd652b7392b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable and payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d28411d6-81ac-406b-ba7a-de84eac2dcc3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments to contingent liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_085785bd-185e-4079-b0c3-a6e699cbce3a_verboseLabel_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complete technology</link:label>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_label_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patented Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentedTechnologyMember" xlink:to="lab_us-gaap_PatentedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_a3cb40e6-b54f-4b6e-90ec-4b57f9d1edc9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_f311f22d-01a0-45a0-b0b2-60e1cde57d78_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5308ea51-d257-4825-a17d-e47062fdb7af_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability acquired in connection with the acquired intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_581171f7-875f-4787-88d5-319f87de2724_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_3846ae5b-e75a-4a2d-9406-81ea738f569a_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average estimated useful life of finite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_245c62da-f499-4fa9-862d-8b2f9752d579_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized stock repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a15456c9-d556-42e0-949b-d63d19f8cb47_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_54482be8-b117-4119-9be9-d88481b9a98a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized from milestone method revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_51900a08-6270-4161-b2ff-baad6f3c0866_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_3d569e02-0ff2-4187-bba6-b1a53d0cca25_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c5162b30-182c-4990-af48-4340950c4ab3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_395321df-e38d-4c19-88c8-d8e9247e7dcb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_aaa1fd8c-33ff-4524-80e9-f6b52fb2f232_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationTable" xlink:to="lab_us-gaap_IncomeTaxExaminationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_ed40b377-ad0f-40ef-8025-8d5373a50ec2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:to="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_8263c723-787a-4abb-8fb3-8ab8f3c8cc29_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for convertible bond hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:href="lgnd-20210630.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:to="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_60cd6955-d0b1-4489-8b28-3210a591135a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_4dd94d1c-d1c4-484f-9e0b-435e02357060_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term portion of notes payable</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_f1dec4ba-d030-4c81-9383-bd261da21db1_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_24c21024-594e-4083-91aa-ac7ed6175d17_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b3050ff1-87c6-46b0-ad2b-0ee3f35bfc62_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_bba15218-c4a6-413b-970d-59dcfdddf9c9_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible assets acquired</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_39f111e2-7c0b-4fad-ad4f-5ad28b30f87f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_5980352e-329e-4c97-8e91-0ac9ace362c3_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent earn-out payment</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_af6c08d8-c620-470a-a4bb-fe280945e34f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at June&#160;30, 2021 and December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ReturnsAccrual_ea9349d9-6962-499e-a426-9e53d34e0ac6_terseLabel_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return reserve</link:label>
    <link:label id="lab_lgnd_ReturnsAccrual_label_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns Accrual</link:label>
    <link:label id="lab_lgnd_ReturnsAccrual_documentation_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual" xlink:href="lgnd-20210630.xsd#lgnd_ReturnsAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ReturnsAccrual" xlink:to="lab_lgnd_ReturnsAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9f40b9e6-313c-4321-8c2b-a909e34f39e0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8e038f5b-cb3b-45a9-a779-aecfd3a7c373_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_67fb804f-8c87-489f-9ee6-076bb1309a1b_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_ca58a424-a610-4ca3-9ada-f4ac5953699b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_422b1eb9-dccf-4cff-9c36-a90e91817b7b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_573d1513-8bd2-48e5-bf4a-945f15e4c46e_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_ffe3942f-e0ae-418d-8802-e85199d77eea_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings (Accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_430a475e-5d43-4c05-b1d3-aa44b0b7f92d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyAgreementsMember_810c3e14-003e-43ba-a008-c7cd89aea1fa_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Agreements</link:label>
    <link:label id="lab_us-gaap_RoyaltyAgreementsMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyAgreementsMember" xlink:to="lab_us-gaap_RoyaltyAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0fb03825-9e8c-491f-9970-144b4cc9a43e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment and Contingencies: Legal Proceedings</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_3ad4401c-a534-4f53-8e04-700015fc8ef2_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_cc405414-a86a-43b2-8137-7ffedff0da46_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability, measurement input (as a percent)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_bbab5a34-a0e8-4ef1-a2f4-9fb4df099d4c_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems" xlink:href="lgnd-20210630.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationLineItems" xlink:to="lab_lgnd_BasisOfPresentationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_c972df4a-fe78-4d36-9a4c-f2a5bcc4ee4a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_05a7a9e9-36c2-4a65-a50e-9cd650ae935d_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued fixed asset purchases</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_5dfa34ca-5649-4333-aaa4-7c809495f3cc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_d7c3ee88-8f5a-46eb-b0e8-385f50747c42_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_bef0020f-5a0e-4f73-8868-467ade460bd1_terseLabel_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensees</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_label_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_documentation_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent" xlink:href="lgnd-20210630.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseeAccrualCurrent" xlink:to="lab_lgnd_LicenseeAccrualCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_c2b55205-b371-42b2-88af-86c4a8289891_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_861d4758-64a4-471a-af83-232a0915e9df_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_8e6017fc-75fb-474e-aa32-eb3a34417ab9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under financing lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_48f3747c-a64d-41e4-95e3-96c1c3ac90d0_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_07fafffd-da65-4bc9-8218-c6424b0b4d08_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_3bf9e480-78cc-4142-a5bd-be3cef3568df_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_4b4fa3a8-7e54-4395-8410-3564ec8cc841_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_67a34dcd-a0e8-46ba-ab5d-46803210bf4f_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_39271d7e-2b82-4238-a95b-0e8761c270dc_terseLabel_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_label_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_documentation_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:href="lgnd-20210630.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:to="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_e4e884b2-a55e-4ea2-8d81-f979f391e6d0_terseLabel_en-US" xlink:label="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right for Internal Research and Development</link:label>
    <link:label id="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_label_en-US" xlink:label="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right for Internal Research and Development [Member]</link:label>
    <link:label id="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right for Internal Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:href="lgnd-20210630.xsd#lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:to="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_11e980e2-5cee-4f1b-be3d-6187a557e07d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d28ea65a-c379-4435-83d3-c0d1ad43cb60_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a52b64b6-afcd-49d4-a00f-16af1c135798_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments as of December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bf81eede-c7b8-4a7e-885b-90f48c64f97f_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments as of June&#160;30, 2021</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ef0d052c-38df-479d-a6c2-610464494e49_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_b7b8e968-599b-4a4a-82eb-5de48df41fdb_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_84474f35-eb28-4093-bcf9-ef534b05f841_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_c9762dea-bdfd-4114-85a7-4740f8cf6b91_negatedLabel_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimated fair value of contingent liabilities</link:label>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_label_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NonCashChangeInEstimatedFairValueOfContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:href="lgnd-20210630.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:to="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_ea6c3a24-49bb-423b-8ced-a290212097a3_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Source</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6187ce7-578d-4bff-ada2-284ba3fccd6e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesLineItems_7250412d-a461-4988-8ede-55dcf2fab5e4_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_GainContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesLineItems" xlink:to="lab_us-gaap_GainContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_72dc39d5-9b22-4cc5-8a98-8d3ce819a4de_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_cf3bc8ff-0c37-410e-b9ed-f344849a81b0_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_c3d18c04-070f-4cfe-ae95-a97fc533ad21_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_899934ad-e465-459c-b8a7-c0d9fc9241b4_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_23845215-f015-408b-b22a-49ea61c84fb7_terseLabel_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from unwinding convertible bond hedges</link:label>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Unwinding Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Unwinding Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:href="lgnd-20210630.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:to="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_d8a1482c-5308-4d46-b791-97022bba0189_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred in acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_907d5c03-fe89-414d-bc9c-77bd09926173_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_dd227ae9-47a9-4609-bd54-b046ebdf73c3_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued per acquiree share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_fee1d72c-954b-4709-bb05-2a72176fade9_terseLabel_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_label_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial [Member]</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_documentation_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember" xlink:href="lgnd-20210630.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_Phase3ClinicalTrialMember" xlink:to="lab_lgnd_Phase3ClinicalTrialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_ded8987d-ca98-46e7-a6bb-58ea411435dd_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_dbb6c282-1962-4768-836a-3313ba9608d1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SelexisMember_04176d5a-0ccb-4832-9d55-32f53a8ee708_terseLabel_en-US" xlink:label="lab_lgnd_SelexisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis</link:label>
    <link:label id="lab_lgnd_SelexisMember_label_en-US" xlink:label="lab_lgnd_SelexisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis [Member]</link:label>
    <link:label id="lab_lgnd_SelexisMember_documentation_en-US" xlink:label="lab_lgnd_SelexisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisMember" xlink:href="lgnd-20210630.xsd#lgnd_SelexisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SelexisMember" xlink:to="lab_lgnd_SelexisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_e00ddd47-943b-45a3-b9ca-6f975b36ce50_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AziyoMember_f294c75d-7db3-4ceb-8f6e-98d1dcaeb0ff_terseLabel_en-US" xlink:label="lab_lgnd_AziyoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo</link:label>
    <link:label id="lab_lgnd_AziyoMember_label_en-US" xlink:label="lab_lgnd_AziyoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AziyoMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember" xlink:href="lgnd-20210630.xsd#lgnd_AziyoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AziyoMember" xlink:to="lab_lgnd_AziyoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_937fe7c1-c956-419d-9181-8e44c81f0da3_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_657c3ec1-2455-476b-b38b-18da47b70088_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5fab7651-e074-49a1-82c5-213b310f5931_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_05052f01-5caf-4fd5-9415-26de6fd07769_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_44cc87cc-8d50-43ad-a477-c044c1fe5a75_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases_9d25ec95-aaea-4f9d-b209-ac0bbd5efd04_terseLabel_en-US" xlink:label="lab_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits applied on advances on inventory purchases</link:label>
    <link:label id="lab_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases_label_en-US" xlink:label="lab_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits Applied on Advances on Inventory Purchases</link:label>
    <link:label id="lab_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases_documentation_en-US" xlink:label="lab_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits Applied on Advances on Inventory Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases" xlink:href="lgnd-20210630.xsd#lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases" xlink:to="lab_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_2b6d4c34-b027-405f-8f5b-2be39c384c4c_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_63203ad2-8aa9-445d-868d-7995bd77213e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_7d5f56c4-ef7f-44aa-bc91-85960c4f62af_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_fedb0e7f-8b79-4b76-a91e-7d3591f2ed7f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_ae9d9e11-1a4a-470c-8619-e5135f2bfffd_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_e3252014-a857-4de8-bcaa-760473efbc36_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_fe7bd415-b471-4130-98ce-f23f6e9d6aac_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_51655180-99f0-4ee8-9d77-6f73a779a0ee_terseLabel_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related liabilities</link:label>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_label_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Asset Acquisitions, Current</link:label>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Asset Acquisitions, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent" xlink:href="lgnd-20210630.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedAssetAcquisitionsCurrent" xlink:to="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4a8c371-b7ea-4317-a515-e527d0513bd7_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_138fe6a5-f737-427c-aef9-41a2ed844a22_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_a44873e3-6569-4f54-a255-148e3abc3288_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash to settle unvested stock options recognized as share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cash Used to Settle Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_e40d80d1-74b7-4d79-90cb-cf910cb98f30_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_47e738b7-43f3-4b89-887c-946affc9cda8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of equity component of the 2023 Notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_c345b0d9-6c1d-40f8-aef3-ee310bdc445a_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Crystal</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Crystal [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Crystal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyCrystalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_3b2d4b2b-11aa-43b4-bea0-bf1257ccce0d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_272b5b00-c202-4926-bbc3-04ac6a7ff39d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in contingent liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_a3e5bd96-53f1-44b7-b005-19d921c1879a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_0da24e4b-cfad-46ae-ac94-ccb28c735954_verboseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term contingent liabilities</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRights" xlink:to="lab_lgnd_LiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationTable_6a22589f-f1cb-4e14-a2f7-45cb57913f33_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable" xlink:href="lgnd-20210630.xsd#lgnd_BasisOfPresentationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationTable" xlink:to="lab_lgnd_BasisOfPresentationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dd423242-b8d0-49ec-b4b9-e7549fdb4f0a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_4f9cc7c8-ae4d-4f3f-982e-bd75c6a4db0a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate (shares per $1,000)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_05b78baa-0236-4e52-81d4-faffe3d67028_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_GlaxoSmithKlineBiologicalsSAMember_b428654e-54d1-473b-929a-15a4687d9cd6_terseLabel_en-US" xlink:label="lab_lgnd_GlaxoSmithKlineBiologicalsSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GSK</link:label>
    <link:label id="lab_lgnd_GlaxoSmithKlineBiologicalsSAMember_label_en-US" xlink:label="lab_lgnd_GlaxoSmithKlineBiologicalsSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GlaxoSmithKline Biologicals S.A. [Member]</link:label>
    <link:label id="lab_lgnd_GlaxoSmithKlineBiologicalsSAMember_documentation_en-US" xlink:label="lab_lgnd_GlaxoSmithKlineBiologicalsSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GlaxoSmithKline Biologicals S.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GlaxoSmithKlineBiologicalsSAMember" xlink:href="lgnd-20210630.xsd#lgnd_GlaxoSmithKlineBiologicalsSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_GlaxoSmithKlineBiologicalsSAMember" xlink:to="lab_lgnd_GlaxoSmithKlineBiologicalsSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_2341a407-4f6f-40c9-9946-929409684123_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate used to value intangible assets acquired (as a percent)</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_b659f8f4-5505-40d0-99dd-7280b3efd5d8_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7af1757a-d12d-47be-a870-98aff0979d4a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_f4e41037-7e5e-4fc9-a843-35620d159267_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_88d0ab90-7785-4a1b-b958-298b0962dc35_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e4749b2b-3fb6-49d9-8a44-2151fef21192_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_03cb744e-e613-4026-b56a-faeca8406e6e_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_c1cbaaab-c5fa-4b01-9241-37183456777f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_fdcb8615-c17d-4910-8199-4789be8100c2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_6497d538-1a97-4f79-ab84-0e56d78ab793_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_98581b34-7104-46fd-bda5-a6aebdafb403_negatedTerseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_83b67b08-1afe-4f6d-9a48-582e5f4e7502_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_509ebfb7-606d-4a14-9370-bc743e1c09d5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisition, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_0552f3f5-86ad-459c-b33c-6885ec7ebc53_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_04f9dfb4-0d41-4b9c-b240-bdd9cb49df59_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable, weighted average exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_886681b4-1645-4ae8-ad57-8b823b8701a9_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_40ccc3e1-e101-4269-9f11-bb1df03c1c92_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_43bb6330-4633-44e0-bd4c-8c202b8422db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_c9a86dda-f40e-4d46-afd8-1976a6261112_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_3a83a519-ada6-4f4e-a0d3-a62139cf7283_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_3007b6de-5ee8-42fa-aae2-2ff20368affa_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Viking common stock</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueMember_5aa7924f-d0d2-4055-bcc7-7048085bad0c_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract revenue</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember" xlink:href="lgnd-20210630.xsd#lgnd_ContractRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueMember" xlink:to="lab_lgnd_ContractRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_2d3144fa-5e1f-489d-ba61-3cbd09071d51_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_3c6ab952-8240-477a-b535-2f76c48b25c6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_5aa40dbf-d41d-4b2b-a29a-b6ae7c9466f8_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; 60,000 shares authorized; 16,676 and 16,080 shares issued and outstanding at June&#160;30, 2021 and December&#160;31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_d27906cb-e0e9-439c-a8c7-61869d9f2274_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_cc001e38-012d-43eb-90f8-a6dbb8d6fe30_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (loss), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_153a8ebd-2643-4fcb-98eb-98ec0f0bbe26_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_75ad4160-be18-41b5-92e8-e25f203d258a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_db2f5b29-7758-425c-9121-39c603f3c390_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a74ddb8a-2613-4b1a-885b-2ce636c9cb29_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_3a05b90c-6622-42bc-904d-389b6f68fb0d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_b2efe6bb-a2b2-4b1c-9cfd-940293fe920a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual relationships</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_951c13a5-64d9-4b22-88f6-bcb54cc49c4e_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6f8c2d20-cd9f-471b-9c92-d503e12fefdf_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_7311cb4b-1274-41c3-a0d4-8e43d7da3ba0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_a124d815-1e35-4dac-9854-2532bc81a6e2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_102f5b6d-72e4-4fa5-a461-0c03c13f2428_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_5168a79d-fe76-40eb-9338-786db94f0127_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGross" xlink:to="lab_us-gaap_ContractWithCustomerAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_e10832e3-29a3-4e0b-b5ee-ae47ff692691_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_f86a3c3a-611d-4ad1-a238-a44ba0aa45b2_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_5573bf5d-eaee-42d8-97a6-3da8d0c15bde_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_97c18bd4-c2c8-48ac-9835-84dba20266e9_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_0cd0ad0b-945b-4d8c-8988-6f08da06eb98_terseLabel_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subcontractor</link:label>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_label_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Subcontractor Expenses, Current</link:label>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Subcontractor Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent" xlink:href="lgnd-20210630.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedSubcontractorExpensesCurrent" xlink:to="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_03c7b116-f433-400e-ad15-8631f221e7c4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9ac7e227-ec69-4d17-a7cd-c71c74c35116_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_95769445-2864-4f05-9e93-511b28cbbeef_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options under convertible bond hedges</link:label>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options under Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options under Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:href="lgnd-20210630.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:to="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_292508f1-50bc-4fec-b16c-3406d2aa1dda_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_e36a1f6a-0b28-4aa7-b320-ae6434e63939_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_07610403-1f52-4c01-984a-92b07a124f5a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_f27710d3-9703-44ac-a9d8-8b965f67fc3a_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_744711f6-172c-4970-9093-b974f3d7bfb2_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_2559565e-6653-4fe7-9585-79ad6b6bb177_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:href="lgnd-20210630.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:to="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MilestonePaymentsMember_efa954f1-659c-4b66-a2eb-431cd3e65192_terseLabel_en-US" xlink:label="lab_lgnd_MilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments</link:label>
    <link:label id="lab_lgnd_MilestonePaymentsMember_label_en-US" xlink:label="lab_lgnd_MilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments [Member]</link:label>
    <link:label id="lab_lgnd_MilestonePaymentsMember_documentation_en-US" xlink:label="lab_lgnd_MilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestonePaymentsMember" xlink:href="lgnd-20210630.xsd#lgnd_MilestonePaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MilestonePaymentsMember" xlink:to="lab_lgnd_MilestonePaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_e3891fe0-a8cd-4b08-958f-832e31b54991_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_f5535816-edd8-4211-9cf0-640d110b2ff1_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License and Other Economic Rights</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:href="lgnd-20210630.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_779674a6-855b-405a-bdb3-e889e3cec1cb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_78a4c51f-11e9-40bf-96ed-221eb2b0ecdd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMember_bb9dc3b4-76ce-47eb-b7ed-2bd9c7240f53_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember" xlink:href="lgnd-20210630.xsd#lgnd_LicenseFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMember" xlink:to="lab_lgnd_LicenseFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesTable_1f313ae3-aa37-4fe3-ba9c-653fd2c07283_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses [Table]</link:label>
    <link:label id="lab_dei_EntityAddressesTable_label_en-US" xlink:label="lab_dei_EntityAddressesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesTable" xlink:to="lab_dei_EntityAddressesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_96d46bef-6f15-4198-814b-7e4fc17fcf8b_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_9626fbbd-1c9b-4d4c-a2ba-866ab6039606_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_9975f82c-6e12-4c92-b1fb-c20437873847_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_aee4deeb-9865-445c-bfcb-d6550435ea9c_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_189c1596-1040-4e90-b70e-826648307373_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_f5f2248f-73ad-4b93-b656-4ba7189416d8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_dfdc29a7-70e3-4eac-b5ef-86b4782797d6_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_6d2f9a27-c5bf-4540-bf31-f592cda9351e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_4b0f1556-8e8a-49c9-b15a-034827bf8ed4_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued from each CVR series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_db7755bd-7cd3-40c5-b0c7-b9b72900f9ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_0a16a9da-b13a-433e-85b3-07aae3b58e3c_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period in force of stock repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ae17b7d0-875f-4e3e-8163-c20566cf1f24_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_4f2bb4ac-9ab0-4893-ac7f-fac4ee1d4da4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_89f03a73-62da-4def-8833-62b8062ee879_negatedLabel_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in debt discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_label_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_documentation_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:href="lgnd-20210630.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:to="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5f067023-c09b-4bd7-8485-15b3d1537193_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_f643db36-1ca5-49fe-9c46-09af926e5851_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_452896eb-761e-4210-8394-b707ba53a632_negatedTerseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect for 2023 Notes transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:href="lgnd-20210630.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1856fae3-3986-4647-82af-d9c3a4953f7a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_a8c14443-8b0d-4b1e-89bd-8b30cdba5870_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_7ae380b0-03e4-4d23-80b0-f93b9eb60a0a_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_06ef675e-6927-49c7-94e1-e568e664c356_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_64016578-e260-4f96-ad31-ad7c8b0ab0de_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_c62334d1-4ac5-4768-9750-ea6aef8dd2c2_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of milestone payments (as a percent)</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_e4c3851e-3622-4d38-ac76-af666676b107_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_08a73dc8-bf6f-45a5-8856-e1c1fc642985_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_4c27876d-163f-4be8-9ec5-76d33daafd0b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_7ec18f08-979b-4539-a1b7-ff851ac9a215_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to unwind warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_label_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_documentation_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants" xlink:href="lgnd-20210630.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToUnwindWarrants" xlink:to="lab_lgnd_PaymentsToUnwindWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_e03033d5-3c4e-4b29-a502-90547914636f_verboseLabel_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current contingent liabilities</link:label>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CurrentPortionOfLiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:href="lgnd-20210630.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:to="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_320873a5-f02a-4d15-a520-05b66aead22d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_5338a811-0798-484f-b4f8-e16b4d1ae81d_netLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding warrants to purchase shares of Viking's common stock (shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c831c5c3-ef94-4623-bbb2-b005ceb176f3_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants issued in public offering (shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_dc08ae0d-df0a-46f2-9e07-e02aa77e63ec_negatedTerseLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR holders and other contingent payments</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders" xlink:href="lgnd-20210630.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHolders" xlink:to="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_8fd0ddf5-3054-4660-b0cf-ab1fa2ba8014_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_label_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights, Allowance for Credit Loss</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:href="lgnd-20210630.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:to="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2b43a7f0-2e74-4601-b093-1e33af6f9f62_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_80412432-e6b9-4db2-9eb2-3015688e8d62_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_78bcd849-5dc4-4145-8cb2-513fb318af59_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_3267b748-6644-4972-891a-d4ec35127fb6_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_f11a59fb-eab0-4ba4-a135-8ca54aae4299_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_0ada817c-e005-4ff7-a215-c69057997ae1_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_9481292e-cd2d-4148-828c-af46ed105881_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_KyprolisMember_3791807f-2efd-484c-b53f-1f0eee159ca8_terseLabel_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:label id="lab_lgnd_KyprolisMember_label_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis [Member]</link:label>
    <link:label id="lab_lgnd_KyprolisMember_documentation_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember" xlink:href="lgnd-20210630.xsd#lgnd_KyprolisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_KyprolisMember" xlink:to="lab_lgnd_KyprolisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_5388f7b6-c0af-49a0-9bb9-9f169d7b516e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturity of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_878e6c95-698a-4db0-8802-e6839861fafb_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_61c7fcd5-8a1f-4b64-aeb1-83d0d5f3f720_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7e7473aa-798d-430b-989f-c28d8b7751b3_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_85bf153b-336b-4d2b-9d84-bd8a79a6197b_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_1ebc861a-aa86-4cd0-9fd0-3859916a5af7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_80e80a1b-2726-47ba-817f-76dd3f7f8e92_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_6a4a1ac5-58bd-4ab2-a231-b017bc342951_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_192a2a55-edd4-4517-ab0d-1d610ae7d5d5_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f2c01713-9169-45ad-b963-8bfc955ff3a2_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_73fa8e1f-178a-4174-b843-dd094053ee6b_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_6d35f02a-2d91-4738-af0b-bc904d5b1307_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_14af09ed-e1cd-4277-bca5-f01ca4be759c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareProFormaAbstract_40a9b814-96f9-4b0c-928c-b580af6bbbe9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareProFormaAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareProFormaAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareProFormaAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Pro Forma [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareProFormaAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareProFormaAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract" xlink:to="lab_us-gaap_EarningsPerShareProFormaAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfPetitionsFiled_424340b0-66e3-4df8-ab73-fc2d230869a5_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfPetitionsFiled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of petitions filed</link:label>
    <link:label id="lab_lgnd_NumberOfPetitionsFiled_label_en-US" xlink:label="lab_lgnd_NumberOfPetitionsFiled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Petitions Filed</link:label>
    <link:label id="lab_lgnd_NumberOfPetitionsFiled_documentation_en-US" xlink:label="lab_lgnd_NumberOfPetitionsFiled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Petitions Filed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfPetitionsFiled" xlink:href="lgnd-20210630.xsd#lgnd_NumberOfPetitionsFiled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfPetitionsFiled" xlink:to="lab_lgnd_NumberOfPetitionsFiled" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_03fee29c-5e98-4256-9b3a-9b208bd68c1d_terseLabel_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payout range (as a percent)</link:label>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_label_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</link:label>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_documentation_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:href="lgnd-20210630.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:to="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_1db0b45b-2912-49b0-8dab-005b34d8fc3a_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_63bdd871-fef0-4d0d-b80a-fa90a20c0805_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_2d13c32a-2a28-4a21-b8d0-26df577f2bb4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_bd988864-3d09-4eaa-932b-9b347b017351_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_df733a29-3e1f-4f83-84c4-20b5cadbb6c1_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_label_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:to="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_dab2e358-c9a0-4824-8670-3812583c23f3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchased amount of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_533c3690-de72-4cc4-9250-c2684130317b_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental schedule of non-cash activity:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_0c2637c5-2eaf-4dd1-8d6d-227cee3b12a9_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_0a1d3209-d66f-4ded-8085-a0ea1b46bde0_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_df94ae12-3e71-4d79-b615-16bb3076fff1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_8d114474-b41f-4717-866a-d62a2fb22686_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_784713b4-ade7-4936-b942-66a7c07fa506_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_2626366d-cc4d-4c2f-8df0-6739b4a565bd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount of the 2023 Notes outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_57883d98-14b0-43b4-b099-5d37ba41f105_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_79aafe26-b116-4074-90eb-d43eb5713e72_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license rights</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_9c5dd598-fb8f-460b-930f-4e7bd2d9b926_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_40ebb3b0-6867-4952-8ffb-67bad3718cd9_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_fc19e07e-06ab-4190-9b2e-5f9aeed8886c_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_8964c937-3dcb-40d7-9bd3-fef4f49011f0_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_19ab418b-81a8-49d6-ac69-63d6554ad687_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:to="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_1ea8f6c6-9505-41d4-8057-3ff4c5e58c14_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - xCella</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, xCella [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, xCella</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyXCellaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_79cc417f-14a5-454e-881d-10aa6eaec566_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5e860bf8-3eda-4123-9850-09aae513b8b7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_2834f61d-797b-4220-8a5d-b8065a392e05_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_514a4f7d-f45d-4d15-824f-055a29cd2182_verboseLabel_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounting for Share-Based Compensation</link:label>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:href="lgnd-20210630.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:to="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_0c14cef9-1983-4b95-8370-c0677e689144_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) from short-term investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseRights_022adf2b-98ea-4a38-a7c5-d856a3614cb0_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license and other economic rights, net</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRights_label_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CommercialLicenseRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights" xlink:href="lgnd-20210630.xsd#lgnd_CommercialLicenseRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseRights" xlink:to="lab_lgnd_CommercialLicenseRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6bc25045-867d-4c2f-a6af-0044df57e3e9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_0058f443-48ca-4a03-ae80-f2baf80b624d_terseLabel_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella</link:label>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_label_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella Biosciences, Inc. [Member]</link:label>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_documentation_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella Biosciences, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember" xlink:href="lgnd-20210630.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_XCellaBiosciencesIncMember" xlink:to="lab_lgnd_XCellaBiosciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EvomelaMember_f3ef07ea-5275-4f36-b6aa-096d9ca11be1_terseLabel_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:label id="lab_lgnd_EvomelaMember_label_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela [Member]</link:label>
    <link:label id="lab_lgnd_EvomelaMember_documentation_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember" xlink:href="lgnd-20210630.xsd#lgnd_EvomelaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EvomelaMember" xlink:to="lab_lgnd_EvomelaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_926aefc2-eb3a-476f-a2f7-b9bc6d8cdf22_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury bill</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_6843c0cf-98f1-450b-b497-86d6ea462995_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_f9ba8f47-3bbf-4f36-b6c3-1803ebddcf16_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from convertible bond hedge settlement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_92f4c98a-650e-40a6-8a05-b436fa980ba7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_b9df4d1a-d7c6-4b1c-beb2-86985c8758ce_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2fb4657d-6b81-4617-9e3c-0ec7f20ed5f5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Level 3 Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_4ed07593-01ec-49f9-8f14-397540066c0b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and unbilled receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncome_4e2a3252-a219-47d3-928c-ca7121b9efdc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncome_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncome" xlink:to="lab_us-gaap_OtherOperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LupinPatentInfringementMember_bafae041-b7e1-4ada-82eb-a43df0daec23_terseLabel_en-US" xlink:label="lab_lgnd_LupinPatentInfringementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lupin Patent Infringement</link:label>
    <link:label id="lab_lgnd_LupinPatentInfringementMember_label_en-US" xlink:label="lab_lgnd_LupinPatentInfringementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lupin Patent Infringement [Member]</link:label>
    <link:label id="lab_lgnd_LupinPatentInfringementMember_documentation_en-US" xlink:label="lab_lgnd_LupinPatentInfringementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lupin Patent Infringement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LupinPatentInfringementMember" xlink:href="lgnd-20210630.xsd#lgnd_LupinPatentInfringementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LupinPatentInfringementMember" xlink:to="lab_lgnd_LupinPatentInfringementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_fe0dddf0-60a9-43dc-bcd8-5df14830137b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from stock option exercises and ESPP</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_d80b4e45-325f-4c33-92af-a0406940e54f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7d9a7eae-38f5-483c-a650-366b9fa85812_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4936be59-5579-4957-a52f-f9008326a41d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9e1423b5-5a4d-43dc-852d-4502183d087c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_8121bdae-e77e-4e01-9856-d7259dfc4819_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_61f99027-60b4-46b2-8c1d-0a7fef5348f4_terseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:href="lgnd-20210630.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_8619e990-05a6-4a11-b812-d7b093de12d2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_d0fa0f4e-3dae-46dc-b988-9cfc807592ed_terseLabel_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued inventory purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_label_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_documentation_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases" xlink:href="lgnd-20210630.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedInventoryPurchases" xlink:to="lab_lgnd_AccruedInventoryPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_46c2640b-b987-4655-839c-43dd89820d5b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_82354a8e-c3bd-4953-b860-b14fc610f576_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frequency of cash payments to CVR holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_label_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:to="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_dbb147be-f1d3-42a3-84bc-694a883d340a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_00ec34cf-89f6-4eda-b4da-31a4af5966f3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_859565e5-7250-42c3-bd63-735c5a9fac66_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_92311e9c-64a9-470f-8326-24b51d1da142_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ec5d25ce-1f57-40f4-96b6-85ece72df5a5_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_3c62059f-2aa4-4479-94a3-481f2edc379c_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_9eeee6bf-6367-48cf-a1bc-143fcf8b29d1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_218796c0-220c-425e-a1bc-2c16f3a28fa3_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_310fea7b-a89d-4fd9-83ff-085e0331184d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_8d2fa09b-2290-4a94-8d48-f45b2e034f38_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to additional paid-in-capital from warrants</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_2f6dde16-f0f7-4494-a37d-fc453c19a57c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_dd415d0a-c634-4997-8c05-38198440baed_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_16aa407f-7e4d-4e32-adcb-2b39353d3d41_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3c244a65-0468-4615-bee8-b86e889e580e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_b17588fc-3a17-44cb-844d-2e112dc7cdaa_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_2271bf18-e138-4054-aeac-6a2542f61a65_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_6152e89a-99f0-43d2-be43-225664b197f3_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ca43690e-48cb-4aeb-8ed3-c3ab8e51162d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_bb394651-f638-4e2c-ab90-7fafd2e5fe8b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_41039adf-2e88-4b85-8908-dae823eb3f11_verboseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember" xlink:href="lgnd-20210630.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolMember" xlink:to="lab_lgnd_MaterialSalesCaptisolMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_53bfb868-efcb-4fa9-a471-2f8eb687da04_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_a63b6a4d-50f4-43fc-bb2c-6cb3e0dcfcd9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_f0544ce6-6704-4688-86fc-b7a92f4b0a86_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_36be34f4-21ca-4644-b991-a4fb77bea03f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_InterPartesReviewOfPatentMember_57ea991e-0139-45a0-a175-b32886377b54_terseLabel_en-US" xlink:label="lab_lgnd_InterPartesReviewOfPatentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inter Partes Review of Patent</link:label>
    <link:label id="lab_lgnd_InterPartesReviewOfPatentMember_label_en-US" xlink:label="lab_lgnd_InterPartesReviewOfPatentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inter Partes Review of Patent [Member]</link:label>
    <link:label id="lab_lgnd_InterPartesReviewOfPatentMember_documentation_en-US" xlink:label="lab_lgnd_InterPartesReviewOfPatentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inter Partes Review of Patent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_InterPartesReviewOfPatentMember" xlink:href="lgnd-20210630.xsd#lgnd_InterPartesReviewOfPatentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_InterPartesReviewOfPatentMember" xlink:to="lab_lgnd_InterPartesReviewOfPatentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_5beb7258-1a6f-484d-a4bf-6d17b77ca530_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVR Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_label_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_documentation_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:href="lgnd-20210630.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:to="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_9ffd5c94-dc92-44ca-8ce0-01e41c84c56d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_ad13abe2-5e74-446e-80a0-31e2a9dcbe24_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_25552415-5043-4ad9-b8c0-7ba9869b837a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_f7ea7030-e64c-404e-b6e7-b866af623f2f_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_fd45e599-dd01-4860-84bb-5b916235e9c0_terseLabel_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional allowance for credit losses recorded related to COVID-19</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_label_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:href="lgnd-20210630.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:to="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cddf7da3-0556-42b4-a007-a647e6ee1b19_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_6a937d53-3731-491f-acf5-ee080355cfbe_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_19f77ae0-94e0-4f44-b01d-f4e3517a2bd9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_abbbee96-e479-45cf-92b4-d31cb47ec66f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_26ee6526-3832-4fd5-87a1-8276d50b2fe7_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_documentation_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:href="lgnd-20210630.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:to="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_d00985a0-2b4d-4735-874d-992018db515c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_c74aa24c-397b-4ae5-8adc-73a0944665cc_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_816e0f92-42ae-41a0-ac09-6784401dbf0b_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_d4d83b57-0767-43ea-88a2-ae0f1e7666f6_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the 2023 Notes outstanding (Level 2)</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_7138c35f-789b-4ae6-b8ac-18c7326d8f66_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles acquired</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_b083a6d0-0dda-48e5-b8e5-8427a4f45d20_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_57bf3efb-2192-40a3-9301-01c1adecf873_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_95fb6fac-a0d0-47e2-b4e0-deac3ddeb1be_verboseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - CyDex</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Cydex [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Cydex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RoyaltyOtherMember_1ebe56be-793d-480d-aff3-f11ef264b033_terseLabel_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_label_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other [Member]</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_documentation_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember" xlink:href="lgnd-20210630.xsd#lgnd_RoyaltyOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RoyaltyOtherMember" xlink:to="lab_lgnd_RoyaltyOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_fe6004c2-f616-45d5-8a51-686d5efc082a_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_823fa5ac-af6c-4fc4-a91d-8a1d803b41c7_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_f85e6e5b-2843-4b83-8d1a-6add395645ea_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_23e13805-8e06-4ac0-9da1-6f551bf8900a_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_364879f6-c720-4401-b49c-d21e16604dea_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_67ef6bbd-53b0-489b-a9d0-b2a6488a64ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_0a65d05d-69d6-428c-9b44-d9dbc58d7625_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Pfenex</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Pfenex [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Pfenex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyPfenexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_0ef7a4ed-1605-497f-82c4-fa3ed4c2a028_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3d0a3fac-32cc-4916-96ea-3a31b189675c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2877ccc1-2d9d-46fa-ae12-3bd717e1b88b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_e1bad321-af26-44d2-a65f-a756cf362cff_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_1ca34cb3-7ec6-413e-a454-2c7d3a404a74_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_32525b10-fb33-4dde-a169-e75aad26c059_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_c4220ee6-e620-41e4-94a8-181dfb240825_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AgencySecuritiesMember_23e4e52c-2485-4377-844f-93cfd3728cc6_terseLabel_en-US" xlink:label="lab_us-gaap_AgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency bonds</link:label>
    <link:label id="lab_us-gaap_AgencySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AgencySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AgencySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AgencySecuritiesMember" xlink:to="lab_us-gaap_AgencySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_8270ee04-3c38-428d-957f-abbbb4979b72_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvancesOnInventoryPurchases_050e3c51-9830-4e38-9b7c-a36ea785216a_terseLabel_en-US" xlink:label="lab_us-gaap_AdvancesOnInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances on inventory purchases</link:label>
    <link:label id="lab_us-gaap_AdvancesOnInventoryPurchases_label_en-US" xlink:label="lab_us-gaap_AdvancesOnInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances on Inventory Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesOnInventoryPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvancesOnInventoryPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvancesOnInventoryPurchases" xlink:to="lab_us-gaap_AdvancesOnInventoryPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_555a370a-645a-4549-ab1f-8159c4966b77_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_5b3a790d-1d71-4c1b-b75a-1c85cb2403b1_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_0550bcb8-8d28-427d-ba5c-c4fadb9cb8c4_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_47dcd94a-3b17-4ae1-91eb-f394918cbd69_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_65b6c6e2-44ed-4a64-bb39-6de90827db05_terseLabel_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier</link:label>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_label_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Supplier Expenses, Current</link:label>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Supplier Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent" xlink:href="lgnd-20210630.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedSupplierExpensesCurrent" xlink:to="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_bbaac0c1-defc-4bbe-a446-f87541487790_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_484a11b9-479a-4b51-b00d-7bfc8890628a_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_2aaf5e8b-9655-4e8d-b48f-e2c9b88883f8_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future purchases (shares)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_8b626732-18b5-4b3d-8858-9ca4b3b16a37_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_1bb2fcea-0515-468f-a743-754e3ad26c9f_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_4e51d9eb-958a-42df-8362-d8c24ef52072_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_c1bb4191-dc4a-443d-926f-1e0ed01f651c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_339226c0-3ae9-4daf-9d08-d0ec4cbcfa13_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out payment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22214d33-64e6-403c-9e8d-1a13408af839_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MetabasisMember_0548529e-cccd-4112-8ab3-8f49ae69160c_terseLabel_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:label id="lab_lgnd_MetabasisMember_label_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis [Member]</link:label>
    <link:label id="lab_lgnd_MetabasisMember_documentation_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember" xlink:href="lgnd-20210630.xsd#lgnd_MetabasisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MetabasisMember" xlink:to="lab_lgnd_MetabasisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_13d2c2e5-8cd8-4659-954d-8a514ccf2cbb_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_b022af2f-02c2-419e-8fab-e8cabd0d3f2d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_10dd9aa5-109c-47e9-8761-c2170d725414_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_17a851f1-a927-414c-a246-6b4b4c91c3b5_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patents allegedly infringed upon</link:label>
    <link:label id="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_label_en-US" xlink:label="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Patents Allegedly Infringed upon, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:to="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_1994d07b-09af-48af-80b9-8b37354bc80d_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a43d515b-f24a-4ec8-9d41-dd053d358610_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_a4a2c2f4-f5c1-4540-b3a4-f3cec2a2ebbf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_d2ad4c70-28cf-4d9c-b46b-3216ce006898_terseLabel_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development</link:label>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_label_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development [Member]</link:label>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:href="lgnd-20210630.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:to="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b1f2791d-66bb-4f9d-9b37-b658fa218ee6_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_b9465a98-01dc-4f9e-800f-c0420731f4ba_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8be3caad-d442-422a-a97c-33a87c8cdd98_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in basic per share calculations (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4fa3325f-7e49-4dfb-80e6-22dab56e15c4_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_TaurusBiosciencesLLCMember_318b5f74-bc37-4d9f-ab12-0f977440cd51_terseLabel_en-US" xlink:label="lab_lgnd_TaurusBiosciencesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taurus</link:label>
    <link:label id="lab_lgnd_TaurusBiosciencesLLCMember_label_en-US" xlink:label="lab_lgnd_TaurusBiosciencesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taurus Biosciences, LLC [Member]</link:label>
    <link:label id="lab_lgnd_TaurusBiosciencesLLCMember_documentation_en-US" xlink:label="lab_lgnd_TaurusBiosciencesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taurus Biosciences, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TaurusBiosciencesLLCMember" xlink:href="lgnd-20210630.xsd#lgnd_TaurusBiosciencesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_TaurusBiosciencesLLCMember" xlink:to="lab_lgnd_TaurusBiosciencesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_395fee98-ba40-4fe8-afac-0e19dfd1cec3_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and issuance fees</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_ef3c22cc-533f-4af8-a2f8-92717d14b678_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price trigger to classify convertible debt as current (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_6ffeaa6f-aa30-4713-91de-c1681fd7ab0e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_6a3a7f80-66c2-435f-b8cd-b91916cf3f90_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_d6f816ec-54fe-441d-9669-e6728e41b028_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_eeda1ef5-e53e-4552-8bac-2172393d9523_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired that is expected to be deductible for tax purposes</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_5c25e469-caf6-41ec-93c9-8247bf52e2fc_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on AFS investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_a3f40661-ebdd-4ff4-a90e-6ca7d03b6e90_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_be0bb398-a27a-437a-88df-1d30e5956631_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_415d43c4-51c7-4f19-864c-3333d334ce86_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Metabasis</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Metabasis [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Metabasis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_fd262d51-6951-49da-95f9-fc1ddca01cf2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_cb64e28b-2aa9-4f59-8bea-3c81a51cab39_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_37d8f313-d414-4012-b6ad-46a0d7bbb758_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_2cf3d55e-778c-442b-ad67-bb2464ad9324_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContingentValueRightOnProductRevenuesMember_6eb936f4-ca47-438f-99a6-a360febc4efc_terseLabel_en-US" xlink:label="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right on Product Revenues</link:label>
    <link:label id="lab_lgnd_ContingentValueRightOnProductRevenuesMember_label_en-US" xlink:label="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right on Product Revenues [Member]</link:label>
    <link:label id="lab_lgnd_ContingentValueRightOnProductRevenuesMember_documentation_en-US" xlink:label="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right on Product Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:href="lgnd-20210630.xsd#lgnd_ContingentValueRightOnProductRevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:to="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_c6598a7c-4f2c-4b8f-ac39-31d2b596cda2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_2a883c9e-611b-4e79-be31-331d3a2ddacf_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_4fe123da-73a1-4e7d-9380-2ced4dee2d80_terseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant and bond hedge unwind transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:href="lgnd-20210630.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AmortizationOfOtherEconomicRights_d1a4f2ec-d1b9-4ad1-b137-06442864d005_verboseLabel_en-US" xlink:label="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of commercial license and other economic rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfOtherEconomicRights_label_en-US" xlink:label="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Economic Rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfOtherEconomicRights_documentation_en-US" xlink:label="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfOtherEconomicRights" xlink:href="lgnd-20210630.xsd#lgnd_AmortizationOfOtherEconomicRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AmortizationOfOtherEconomicRights" xlink:to="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_c043d7d6-b276-410b-bb38-351e6b3cf09e_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d19f274d-6bc2-4ea1-bf8a-1e7a491b6b02_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_29b07cf2-1518-473a-a3ca-29846403f57c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_a735a2a4-2a1c-4f2c-976a-a38475e6be08_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties owed to third parties</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesLineItems_ce61f4d5-37ff-48af-a79b-e28b1d705823_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
    <link:label id="lab_dei_EntityAddressesLineItems_label_en-US" xlink:label="lab_dei_EntityAddressesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesLineItems" xlink:to="lab_dei_EntityAddressesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_41de2fbd-ff17-44a8-9548-6cfa235eb51c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_57d148c9-d95a-493d-83e3-2bf6296147f0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1145c060-fe67-4864-a304-8c42fd0c4540_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_196b436a-e039-4815-9785-17c10f7bad80_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_997df71c-1a0b-495a-89e8-d508d4f77e98_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout rights recognized</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_a5443765-288c-424b-9824-59985f6431e2_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Investments</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:href="lgnd-20210630.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_cc5c337a-0b54-49b0-a441-974d954064cc_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net gain (loss) on available-for-sale securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ec335e21-bbbc-40b1-9158-244fdebef947_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_32ec6937-530a-4057-9ccb-9289fef2c566_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Icagen</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Icagen [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Icagen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_0b714c00-728e-4cfb-a341-5d2cbf48c9e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_58b579b0-3203-43f7-b7c0-978915691e08_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_8764f30c-60c0-43fb-85ad-5083e4ac049d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_b7c76629-d977-4830-ae15-6a58cb336a6c_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_a54b4f2b-f08d-47d2-a14e-b8e9200524c0_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_5816e352-cc7c-4c81-8fee-7d3a18f982cc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-combination expense</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_78946980-497c-4a62-b59a-40e4da6f4a73_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_2734b02e-8caa-4897-b8db-d03fdb43ce9b_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensor</link:label>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_label_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Restricted Investments Owed to Former Licensees [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Restricted Investments Owed to Former Licensees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:to="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_912b97e5-d8ca-4adf-afd0-33c1b75a837b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_0c1e1096-e8eb-4178-9c64-d3863c2600fe_terseLabel_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_label_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi [Member]</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_documentation_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember" xlink:href="lgnd-20210630.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SelexisAndDianomiMember" xlink:to="lab_lgnd_SelexisAndDianomiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostDirectMaterial_ab338754-daec-4f75-be33-0efc2a4691c0_terseLabel_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Captisol</link:label>
    <link:label id="lab_us-gaap_CostDirectMaterial_label_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Direct Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostDirectMaterial" xlink:to="lab_us-gaap_CostDirectMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_f3015f56-087a-4114-b5bf-b6bfceefb6bf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_39df978f-caf8-40ed-9b57-7809dbe5ab4e_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of 2023 Notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_0cd5b67a-0871-436f-94cf-bbd8a471d371_negatedLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit loss adjustments of finite-lived intangible assets</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:href="lgnd-20210630.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_e20428cd-9268-44dc-97c3-cd1b31cf792e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viking Therapeutics, Inc.</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvesteeMember" xlink:to="lab_us-gaap_EquityMethodInvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_237432c4-d9c0-44c5-a5ec-49af3c42e242_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_c19279fa-ae9d-497e-bab8-2a35306d4483_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_34436e12-0967-486e-90fa-fca0576fd3e1_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_6745e109-9d46-4304-82f7-0fa90176c7f6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt premium</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ad5d6c5e-c4d4-4f26-9000-b875461c5969_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a8cf5cbe-1139-48f8-ac70-d0365c9535a8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_8b35d0ef-ed23-43aa-ac2e-7d299cc7c796_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_1868c50a-e817-41b0-9c18-bbc084792f67_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_97146fc6-18da-4cc9-9910-e620ed06ec39_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_c9da04ca-578e-4112-a72d-cd95fceaf931_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of positions in an unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_9e4e99cf-26bd-485e-8366-2b232eb4450c_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total goodwill and other identifiable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MilestoneMember_432bbe9f-493e-4d30-9abb-1e9647dcaa89_terseLabel_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:label id="lab_lgnd_MilestoneMember_label_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone [Member]</link:label>
    <link:label id="lab_lgnd_MilestoneMember_documentation_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember" xlink:href="lgnd-20210630.xsd#lgnd_MilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MilestoneMember" xlink:to="lab_lgnd_MilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_89591156-9157-4fa6-ab0e-41a35124e6d1_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_b852bdb7-9bcf-4005-848a-1c5ec57f3a64_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of computation of basic and diluted net income (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_78290752-cb8f-4701-86fa-42029e7e50f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_0c1620a2-4a06-4236-aacf-b440ad83a278_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_59fbfc27-72fa-414a-9f72-6cbb3d60becd_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback_a6ca8e31-ae71-48d4-8c9c-be53d376073e_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback from acquisition</link:label>
    <link:label id="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback_label_en-US" xlink:label="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Holdback</link:label>
    <link:label id="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationConsiderationTransferredHoldback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:to="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_417516d9-1808-4019-95db-80998f842993_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_77c3f624-ef27-4fba-bc7a-ff5aec61a8ca_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_2787e21e-03e4-449b-a430-6252a4767290_terseLabel_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum threshold of debt trading price trigger (as a percent)</link:label>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_label_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:href="lgnd-20210630.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:to="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_aae8a7e5-4204-4cd0-beb1-9297658c62f3_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium (discount) on investments, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_826125f1-06fd-419e-acb2-035a64a5cfef_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash in other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_3fb1584e-4c75-4ab7-a855-6759bd37a85c_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_29905c76-2cd0-4528-aa58-40250406546c_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_39cbf28c-527f-4080-a7c5-273e92bbd4db_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_43bffb02-33e4-40ee-917d-9f658c344710_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_8ef0fe88-7394-45c8-b018-e910610c4a9f_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_489bd67a-075b-4d45-9a14-07fb1e94e799_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_59a3ddc6-39c7-4b23-997d-e97d09c3e8c1_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_28e14e9c-c0a8-4b83-be40-9edcb68851b2_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_1d1fdb31-ef23-4380-affc-5db3e6e88b21_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit losses related to available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_ad7cca75-5a24-4fa6-9206-4effad4894ac_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_c5180161-fb83-41b7-b84f-993b35acbedd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_efd5befe-f141-41a8-a85b-be14833d2f24_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_b0dc7d5e-1ede-4e3f-9f0e-4cc53bd76156_netLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_5bbf97e8-99ba-4efd-960d-bd2017d9d556_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to convertible bond holders for warrant purchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:to="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_addedeaa-38c4-4c54-a48b-b0817b853efe_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_7d8c283e-f5c9-4347-8fb2-f56c147f317d_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9bf2dce8-5219-4e7e-805a-e2e299fce82e_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a8bde926-b4c6-4f04-92b7-a82891599004_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_1979b2ed-3eaf-42d7-bb61-e901c899a125_terseLabel_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Convertible Senior Notes</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_label_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023 [Member]</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:href="lgnd-20210630.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:to="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_db565b27-b5b3-4fc2-91e0-1d17991ee8d5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in diluted per share calculations (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_902b8202-f7d1-4daa-8eb8-b3e3492f414a_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute diluted income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_b95414e8-f39f-4a54-8fb4-0e670e519133_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EmployeeStockPurchasePlanMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:href="lgnd-20210630.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:to="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_23118382-3234-45a0-bfdb-0f3653f5868a_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_a61a5cd1-52a6-4676-a42b-7ff6a8531d43_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_617df200-521d-46de-88df-fbc9e7faf39a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_feb04920-e1d2-4f58-95ad-f7facf70c3ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period for awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_95b127b5-c318-4022-bb13-e6f7fa2c67a7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_7c7c296f-1874-4567-bec7-9e5d8cef540c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_0ee9ea20-31ec-4217-8037-7bb26ee12a9d_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2fdbd933-b343-41b2-9f7c-a3f441e3a10f_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Plan Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DemandDepositsMember_e1833864-452e-47eb-a5be-c456a0291292_terseLabel_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank deposits</link:label>
    <link:label id="lab_us-gaap_DemandDepositsMember_label_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demand Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DemandDepositsMember" xlink:to="lab_us-gaap_DemandDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_84c3be12-b23a-446e-91cf-912da156ebfa_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7ee7a1d8-d615-4a26-94c3-f304f61f6109_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_c00cf77e-d16c-410d-8f20-c2d3f7381d5a_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reacquisition of equity due to 2023 debt extinguishment, net of tax</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_2afe28a9-b2fa-4577-a266-885ba665f651_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to additional paid in capital, equity component of convertible debt</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_a9e982dd-1ab2-4100-bfac-e977afc1beb8_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue, Service [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue, Service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember" xlink:href="lgnd-20210630.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueServiceMember" xlink:to="lab_lgnd_ContractRevenueServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_5b1a8338-c697-4bf3-9396-2133580f2b9a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf67d88b-3062-4381-8f7a-7c70644f79d0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_58892e63-6880-41f3-a4fa-d9036f1169ae_verboseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_fb0588bb-a220-4237-b61a-865b62d031fc_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1e82eaaf-7231-4483-b692-a2502de46f17_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d7c72895-08c1-44ad-979a-aa8a17fd6a5e_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_72a42585-cfbd-46a2-b713-27dc513f5361_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_1870115c-39ba-41cc-99ca-ee86b3062d54_negatedLabel_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) from short-term investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_label_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_documentation_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments" xlink:href="lgnd-20210630.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_GainLossOnShortTermInvestments" xlink:to="lab_lgnd_GainLossOnShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_76bf8975-a237-4791-92d3-f76cd58bb66a_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0ce9c876-29a7-4044-a312-e19de147c16c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_1257ed4c-c274-4df1-9c47-20defa10ef6b_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_ca017dc5-5d7c-4194-a0d2-24e5604e6804_terseLabel_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix</link:label>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_label_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix [Member]</link:label>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_documentation_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember" xlink:href="lgnd-20210630.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AziyoAndCorMatrixMember" xlink:to="lab_lgnd_AziyoAndCorMatrixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3d94f8db-d444-4f8d-845a-7d1fd18c1de5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_8ed71165-ccc8-4ace-ba0c-a4873876d712_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e6a570f9-2bb0-4ce2-8f01-078823bd0276_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_340b7e1b-85c0-4d95-8897-ed1a5ba6b5f6_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments for acquisition</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_be188b36-a714-489a-a2ac-0c114e136ba0_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_06351341-5e25-4d4c-a5cc-17374467f089_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross payments to acquire business attributable to vested portion of stock options</link:label>
    <link:label id="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_label_en-US" xlink:label="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options</link:label>
    <link:label id="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_documentation_en-US" xlink:label="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:href="lgnd-20210630.xsd#lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:to="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_cceef2ea-ca8e-46d5-a069-8795d717ae58_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_abfa823c-c8f1-4dd6-8fd5-2d7c8f8d69e2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_32a00bcd-a367-4186-895a-e78504a8a49a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IcagenMember_34b89288-d196-432c-ac2c-9832a23fd549_terseLabel_en-US" xlink:label="lab_lgnd_IcagenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen</link:label>
    <link:label id="lab_lgnd_IcagenMember_label_en-US" xlink:label="lab_lgnd_IcagenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen [Member]</link:label>
    <link:label id="lab_lgnd_IcagenMember_documentation_en-US" xlink:label="lab_lgnd_IcagenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IcagenMember" xlink:href="lgnd-20210630.xsd#lgnd_IcagenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IcagenMember" xlink:to="lab_lgnd_IcagenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_b774560b-98c0-4904-ae02-68bea4dc0ee4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_28c6577e-2c40-43ec-a0f7-a807b33657dc_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_e6fd5c69-89f8-4962-9055-4c4259f948de_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_09475e11-8342-4f40-9e87-2923c3e18ddd_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual fund</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_6aa39c63-8b67-45b2-ad51-0028df60c6fc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_8c7059d2-7a58-4cf1-8db6-0e49c3cb09c9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1af4f120-194a-4ad3-a65e-ff0a79aa2485_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_721ee4ee-b190-4e55-b04b-adec94f7a4f2_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares:</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_f6093eec-487d-4ab0-be3d-902b36a5ede3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_dc73d1cd-b22c-4240-911f-362efe921f5c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of civil complaints filed against entity</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_46de09ca-df52-4949-a1f8-4c2331a7c817_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_9853450b-b3f7-4d32-826d-20f850eb1b3e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment on reacquisition of equity due to 2023 debt extinguishment, net of tax</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_e424a5d1-65d0-4ea0-b71b-e129906a0e20_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_2f6a6f0b-2c75-4fb7-99ff-3b7b7ff2fed6_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_30dcd25d-50f5-4cdb-92f6-3e1d0611f643_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_ba3539ce-f9d5-46cb-aa35-42a0e9f54e7d_terseLabel_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities from xCella asset acquisition</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_label_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_documentation_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:href="lgnd-20210630.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:to="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_a0b22867-297e-47ce-843b-15dcc9f6f6ac_terseLabel_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_label_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio [Member]</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_documentation_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:href="lgnd-20210630.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:to="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a1dc54f7-3ad0-4a84-a68c-4642c5b52417_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_e904f388-2a76-42cf-9727-7dc11ea668d1_negatedTerseLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:href="lgnd-20210630.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_c5d7c19a-d237-499b-bf15-9a6ff3234061_totalLabel_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_label_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale and Equity Securities, FV-NI</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_documentation_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:href="lgnd-20210630.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:to="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesTable_d4e7ec8d-8ee3-4781-9883-3fdaa743fc6e_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesTable_label_en-US" xlink:label="lab_us-gaap_GainContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesTable" xlink:to="lab_us-gaap_GainContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_3cfa6161-37be-4b86-8f2a-a859470d7747_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_6b4639f9-d83d-41ad-bb4d-fcdeb9b6ea8d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount (including unamortized debt issuance cost)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_c6c01944-59b8-402c-a846-7b6d6fa3c77e_negatedTerseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a042e3ca-bc33-4787-abca-983bebcb2bbd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_ca185bbc-22c6-473d-80eb-8b4662f17e00_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair-Value Options Awarded to Employees and Directors</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>lgnd-20210630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:28a37576-9b75-439f-9e08-1e286b83ffe6,g:5715a2c1-e324-41f6-868f-ac2db6a81a2a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/Cover" xlink:type="simple" xlink:href="lgnd-20210630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_1bcbfd4b-bcff-4995-985f-adf5558da2aa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesTable_3a3a61a1-3ccb-49b7-b7a7-82ba93a51314" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1bcbfd4b-bcff-4995-985f-adf5558da2aa" xlink:to="loc_dei_EntityAddressesTable_3a3a61a1-3ccb-49b7-b7a7-82ba93a51314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_86a0c43d-bd60-4882-aed2-b29429994661" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesTable_3a3a61a1-3ccb-49b7-b7a7-82ba93a51314" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_86a0c43d-bd60-4882-aed2-b29429994661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_e61ae06b-59c0-476b-8300-42b3fd0efc17" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_86a0c43d-bd60-4882-aed2-b29429994661" xlink:to="loc_dei_AddressTypeDomain_e61ae06b-59c0-476b-8300-42b3fd0efc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_FormerAddressMember_39b7c876-f5ef-405f-9f13-35672f608954" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_FormerAddressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_e61ae06b-59c0-476b-8300-42b3fd0efc17" xlink:to="loc_dei_FormerAddressMember_39b7c876-f5ef-405f-9f13-35672f608954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesTable_3a3a61a1-3ccb-49b7-b7a7-82ba93a51314" xlink:to="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_afb8f392-afb1-4198-89aa-91ccc2f04d9e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_DocumentType_afb8f392-afb1-4198-89aa-91ccc2f04d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_b634e5aa-e84b-44a2-a27d-2d41dd39cac8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_DocumentQuarterlyReport_b634e5aa-e84b-44a2-a27d-2d41dd39cac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8c73c773-4280-4fe7-b6df-7d049ac6c621" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_DocumentPeriodEndDate_8c73c773-4280-4fe7-b6df-7d049ac6c621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_becdf00a-41ff-41f9-9411-d837c46a71e6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_DocumentTransitionReport_becdf00a-41ff-41f9-9411-d837c46a71e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_365bd2a6-649c-42f2-af8c-71feb8cd429c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityFileNumber_365bd2a6-649c-42f2-af8c-71feb8cd429c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_73ac109c-3615-4149-8797-a288fce2d361" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityRegistrantName_73ac109c-3615-4149-8797-a288fce2d361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0865b3b7-e5b9-4c5e-9f87-04ca60943b72" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0865b3b7-e5b9-4c5e-9f87-04ca60943b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_68fbd6f2-f59d-4969-94d1-9900f6ee0c08" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityTaxIdentificationNumber_68fbd6f2-f59d-4969-94d1-9900f6ee0c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_bb7c186f-1237-4492-b331-dd454ab089bb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityAddressAddressLine1_bb7c186f-1237-4492-b331-dd454ab089bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_adaaf506-592c-4809-8d11-3f12d988722c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityAddressCityOrTown_adaaf506-592c-4809-8d11-3f12d988722c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6a453664-1944-45d2-b39c-d91cac01aec8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityAddressStateOrProvince_6a453664-1944-45d2-b39c-d91cac01aec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7702ec0c-cf91-4f22-979b-866bc28fa84e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityAddressPostalZipCode_7702ec0c-cf91-4f22-979b-866bc28fa84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_86590678-7d1f-47fb-81b1-422d46a259f0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_CityAreaCode_86590678-7d1f-47fb-81b1-422d46a259f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ad78e9f6-2f5d-4ecb-8d5c-0d2f4fa2b9ec" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_LocalPhoneNumber_ad78e9f6-2f5d-4ecb-8d5c-0d2f4fa2b9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e7a36ca9-83fa-436b-8e05-e88d0e881671" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_Security12bTitle_e7a36ca9-83fa-436b-8e05-e88d0e881671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cf70c521-c42f-4ff1-a918-b3402b8e089d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_TradingSymbol_cf70c521-c42f-4ff1-a918-b3402b8e089d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_6afa7687-5cef-4381-bea4-8ea390bc5e17" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_SecurityExchangeName_6afa7687-5cef-4381-bea4-8ea390bc5e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ee707fe0-c410-459e-9f47-4e11bbf89ba3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityCurrentReportingStatus_ee707fe0-c410-459e-9f47-4e11bbf89ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_f75c2c01-828d-44c5-85d2-701c6d5ee03a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityInteractiveDataCurrent_f75c2c01-828d-44c5-85d2-701c6d5ee03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_afcbd3f6-beb9-444b-825c-6da919684427" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityFilerCategory_afcbd3f6-beb9-444b-825c-6da919684427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_c37ebdf7-eaf7-4916-8356-92453526a776" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntitySmallBusiness_c37ebdf7-eaf7-4916-8356-92453526a776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_cb1184b9-2d85-4757-b195-f6bed19490f3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityEmergingGrowthCompany_cb1184b9-2d85-4757-b195-f6bed19490f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_7eedc360-419d-46c8-a22b-c5113d5f5554" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityShellCompany_7eedc360-419d-46c8-a22b-c5113d5f5554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9c03df03-b6bd-460c-8a1b-d3574bfa57e3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_9c03df03-b6bd-460c-8a1b-d3574bfa57e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_53353196-9142-4357-8162-7fe22b786198" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_AmendmentFlag_53353196-9142-4357-8162-7fe22b786198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4c05e317-5ec4-4e3a-950f-efe056ee5220" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_DocumentFiscalYearFocus_4c05e317-5ec4-4e3a-950f-efe056ee5220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_61e753fc-dbe4-44cf-9de8-19094e297e91" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_61e753fc-dbe4-44cf-9de8-19094e297e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_1e637cc1-0973-4915-9fc6-e5c0d3afe503" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_EntityCentralIndexKey_1e637cc1-0973-4915-9fc6-e5c0d3afe503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_8280ad51-7585-4648-b86f-73c08f5dda46" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_71cfd2d4-e672-4411-b4c1-b84a1e12d9b0" xlink:to="loc_dei_CurrentFiscalYearEndDate_8280ad51-7585-4648-b86f-73c08f5dda46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="lgnd-20210630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_b4cb6361-7184-4ecc-ae29-956a4fd9378c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_1a1bdbc9-c2ff-4b5c-a303-088a69b5989d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b4cb6361-7184-4ecc-ae29-956a4fd9378c" xlink:to="loc_us-gaap_AssetsAbstract_1a1bdbc9-c2ff-4b5c-a303-088a69b5989d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_0f4c23f3-4933-4c35-9261-1e80d7e0fafd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a1bdbc9-c2ff-4b5c-a303-088a69b5989d" xlink:to="loc_us-gaap_AssetsCurrentAbstract_0f4c23f3-4933-4c35-9261-1e80d7e0fafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bd40cd96-97d7-42a5-90b0-95ca96f91450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0f4c23f3-4933-4c35-9261-1e80d7e0fafd" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bd40cd96-97d7-42a5-90b0-95ca96f91450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_32e3d284-da79-4817-8b0d-838090f8737e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0f4c23f3-4933-4c35-9261-1e80d7e0fafd" xlink:to="loc_us-gaap_ShortTermInvestments_32e3d284-da79-4817-8b0d-838090f8737e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_14340a10-7886-4fcc-b252-1b9fe4fcb132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0f4c23f3-4933-4c35-9261-1e80d7e0fafd" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_14340a10-7886-4fcc-b252-1b9fe4fcb132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d5b73115-8a1b-4258-82b5-43b37e9d4ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0f4c23f3-4933-4c35-9261-1e80d7e0fafd" xlink:to="loc_us-gaap_InventoryNet_d5b73115-8a1b-4258-82b5-43b37e9d4ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_3b75b746-24ce-4de7-b08d-f1c2ea809569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0f4c23f3-4933-4c35-9261-1e80d7e0fafd" xlink:to="loc_us-gaap_IncomeTaxesReceivable_3b75b746-24ce-4de7-b08d-f1c2ea809569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_c2f5091c-a653-47a7-a144-edee8a495166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0f4c23f3-4933-4c35-9261-1e80d7e0fafd" xlink:to="loc_us-gaap_OtherAssetsCurrent_c2f5091c-a653-47a7-a144-edee8a495166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_afe8e7d9-5d2e-43b2-9ffc-f51a90f3b756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0f4c23f3-4933-4c35-9261-1e80d7e0fafd" xlink:to="loc_us-gaap_AssetsCurrent_afe8e7d9-5d2e-43b2-9ffc-f51a90f3b756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_c1b1f476-66de-44f5-b038-986c15611f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a1bdbc9-c2ff-4b5c-a303-088a69b5989d" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_c1b1f476-66de-44f5-b038-986c15611f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0e0dffcf-b098-4cf3-bf30-8a7dd615fe95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a1bdbc9-c2ff-4b5c-a303-088a69b5989d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0e0dffcf-b098-4cf3-bf30-8a7dd615fe95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_12992f23-befb-4440-b5d7-54c628df62c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a1bdbc9-c2ff-4b5c-a303-088a69b5989d" xlink:to="loc_us-gaap_Goodwill_12992f23-befb-4440-b5d7-54c628df62c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_7e0680f8-0d61-45d3-b424-ee0253709968" xlink:href="lgnd-20210630.xsd#lgnd_CommercialLicenseRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a1bdbc9-c2ff-4b5c-a303-088a69b5989d" xlink:to="loc_lgnd_CommercialLicenseRights_7e0680f8-0d61-45d3-b424-ee0253709968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8914c7bd-6fb9-400e-80ee-667b1977eef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a1bdbc9-c2ff-4b5c-a303-088a69b5989d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8914c7bd-6fb9-400e-80ee-667b1977eef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_bc638215-d7c0-415b-8818-42e29a217d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a1bdbc9-c2ff-4b5c-a303-088a69b5989d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_bc638215-d7c0-415b-8818-42e29a217d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_7acd3b0f-4da1-4f59-8fbe-fb8229a22dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a1bdbc9-c2ff-4b5c-a303-088a69b5989d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_7acd3b0f-4da1-4f59-8fbe-fb8229a22dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f7a47a45-6c96-408d-8b81-06c55a655a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a1bdbc9-c2ff-4b5c-a303-088a69b5989d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f7a47a45-6c96-408d-8b81-06c55a655a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_276b0c30-6b8b-46b7-8246-2c689be38a36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a1bdbc9-c2ff-4b5c-a303-088a69b5989d" xlink:to="loc_us-gaap_Assets_276b0c30-6b8b-46b7-8246-2c689be38a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_57bbffdf-b9c4-4ceb-940a-f7a924959831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b4cb6361-7184-4ecc-ae29-956a4fd9378c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_57bbffdf-b9c4-4ceb-940a-f7a924959831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_ca13b1fe-f4ad-454e-86a3-921f9d1e3dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_57bbffdf-b9c4-4ceb-940a-f7a924959831" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_ca13b1fe-f4ad-454e-86a3-921f9d1e3dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_b2365460-3aed-4067-9cea-884a8c2934fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ca13b1fe-f4ad-454e-86a3-921f9d1e3dd3" xlink:to="loc_us-gaap_AccountsPayableCurrent_b2365460-3aed-4067-9cea-884a8c2934fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ae130ce7-650d-40c7-80dd-162063d3a109" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ca13b1fe-f4ad-454e-86a3-921f9d1e3dd3" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ae130ce7-650d-40c7-80dd-162063d3a109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_1c51c101-0cd6-4f3b-af43-1d27d399e5d3" xlink:href="lgnd-20210630.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ca13b1fe-f4ad-454e-86a3-921f9d1e3dd3" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_1c51c101-0cd6-4f3b-af43-1d27d399e5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bda8edc4-b66c-4855-abc1-1b5ecac6b18f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ca13b1fe-f4ad-454e-86a3-921f9d1e3dd3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bda8edc4-b66c-4855-abc1-1b5ecac6b18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_acf64f9d-4419-46f6-b73e-97cc77780a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ca13b1fe-f4ad-454e-86a3-921f9d1e3dd3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_acf64f9d-4419-46f6-b73e-97cc77780a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_b87fa3b4-cb4a-4f56-a993-fb0f92095220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ca13b1fe-f4ad-454e-86a3-921f9d1e3dd3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_b87fa3b4-cb4a-4f56-a993-fb0f92095220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_531001fc-f357-47d2-b9d5-1a5653881cce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ca13b1fe-f4ad-454e-86a3-921f9d1e3dd3" xlink:to="loc_us-gaap_LiabilitiesCurrent_531001fc-f357-47d2-b9d5-1a5653881cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_1f1762e8-6c9d-4bb0-a6be-bdf0d46a2566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_57bbffdf-b9c4-4ceb-940a-f7a924959831" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_1f1762e8-6c9d-4bb0-a6be-bdf0d46a2566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_5a6a0dcc-c73e-4e72-af8e-5bf7671cec8b" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_57bbffdf-b9c4-4ceb-940a-f7a924959831" xlink:to="loc_lgnd_LiabilityForContingentValueRights_5a6a0dcc-c73e-4e72-af8e-5bf7671cec8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3065f4c9-2646-492f-9b59-9a37e84f137a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_57bbffdf-b9c4-4ceb-940a-f7a924959831" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3065f4c9-2646-492f-9b59-9a37e84f137a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0bfc1da1-8579-4650-983f-a96a994bcf0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_57bbffdf-b9c4-4ceb-940a-f7a924959831" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0bfc1da1-8579-4650-983f-a96a994bcf0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f09687a0-d0ed-4398-8a93-78aaec1a6544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_57bbffdf-b9c4-4ceb-940a-f7a924959831" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f09687a0-d0ed-4398-8a93-78aaec1a6544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_498f4dd5-f003-4002-9d9a-2413c879595e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_57bbffdf-b9c4-4ceb-940a-f7a924959831" xlink:to="loc_us-gaap_Liabilities_498f4dd5-f003-4002-9d9a-2413c879595e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2b158b32-10e9-4479-98ee-86361e0fca0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_57bbffdf-b9c4-4ceb-940a-f7a924959831" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2b158b32-10e9-4479-98ee-86361e0fca0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_ff22a24b-954d-4748-87f1-7a5f42620a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_57bbffdf-b9c4-4ceb-940a-f7a924959831" xlink:to="loc_us-gaap_StockholdersEquityAbstract_ff22a24b-954d-4748-87f1-7a5f42620a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_142fa422-2912-4bf6-91a1-b4e4f6617c02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ff22a24b-954d-4748-87f1-7a5f42620a7c" xlink:to="loc_us-gaap_PreferredStockValue_142fa422-2912-4bf6-91a1-b4e4f6617c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_097ed799-3f65-4798-9ec8-8412e5dec32f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ff22a24b-954d-4748-87f1-7a5f42620a7c" xlink:to="loc_us-gaap_CommonStockValue_097ed799-3f65-4798-9ec8-8412e5dec32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_64de970e-5c17-4a0f-acda-d85c7aea6ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ff22a24b-954d-4748-87f1-7a5f42620a7c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_64de970e-5c17-4a0f-acda-d85c7aea6ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e21596b4-6de5-4b32-b667-ac9cb8e1deef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ff22a24b-954d-4748-87f1-7a5f42620a7c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e21596b4-6de5-4b32-b667-ac9cb8e1deef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e72404ee-1b22-4de2-87f3-422383433877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ff22a24b-954d-4748-87f1-7a5f42620a7c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e72404ee-1b22-4de2-87f3-422383433877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ff2ca198-efe5-4e03-bd56-21e171fda3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ff22a24b-954d-4748-87f1-7a5f42620a7c" xlink:to="loc_us-gaap_StockholdersEquity_ff2ca198-efe5-4e03-bd56-21e171fda3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_548445e9-ff0c-4aef-af37-0118c492b51c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_57bbffdf-b9c4-4ceb-940a-f7a924959831" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_548445e9-ff0c-4aef-af37-0118c492b51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="simple" xlink:href="lgnd-20210630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_49c21560-b260-4107-9b82-c26fcb64a37f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_c73859ce-2e88-4c49-a6a1-4196ab148101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_49c21560-b260-4107-9b82-c26fcb64a37f" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_c73859ce-2e88-4c49-a6a1-4196ab148101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_80acce72-7d98-484e-8723-c46561b749ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_49c21560-b260-4107-9b82-c26fcb64a37f" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_80acce72-7d98-484e-8723-c46561b749ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_aeac56d5-e62a-4d1d-b74b-a47a6f3dbeaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_49c21560-b260-4107-9b82-c26fcb64a37f" xlink:to="loc_us-gaap_PreferredStockSharesIssued_aeac56d5-e62a-4d1d-b74b-a47a6f3dbeaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_a1d57748-7254-4f3d-9062-74f22b179892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_49c21560-b260-4107-9b82-c26fcb64a37f" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_a1d57748-7254-4f3d-9062-74f22b179892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_026655ea-ccdf-4fef-a83d-922554407d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_49c21560-b260-4107-9b82-c26fcb64a37f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_026655ea-ccdf-4fef-a83d-922554407d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b1be1cff-9dda-4c3c-b71f-b986b4f98baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_49c21560-b260-4107-9b82-c26fcb64a37f" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b1be1cff-9dda-4c3c-b71f-b986b4f98baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_8759e515-dd0d-4a63-a9b4-ac4bec6d3f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_49c21560-b260-4107-9b82-c26fcb64a37f" xlink:to="loc_us-gaap_CommonStockSharesIssued_8759e515-dd0d-4a63-a9b4-ac4bec6d3f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_93469c02-0791-46ed-bb16-6e7e16527b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_49c21560-b260-4107-9b82-c26fcb64a37f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_93469c02-0791-46ed-bb16-6e7e16527b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="lgnd-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_c182ef59-17ee-4200-b544-1eb74f60a296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_62003c18-14ee-44f2-9500-551d7dc97ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c182ef59-17ee-4200-b544-1eb74f60a296" xlink:to="loc_us-gaap_StatementTable_62003c18-14ee-44f2-9500-551d7dc97ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4febd29d-01c9-4371-a89c-b06dae95ae04" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_62003c18-14ee-44f2-9500-551d7dc97ea2" xlink:to="loc_srt_ProductOrServiceAxis_4febd29d-01c9-4371-a89c-b06dae95ae04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b062ac62-0064-48ad-8405-8aadbd6c18f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4febd29d-01c9-4371-a89c-b06dae95ae04" xlink:to="loc_srt_ProductsAndServicesDomain_b062ac62-0064-48ad-8405-8aadbd6c18f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_2f450d17-5459-4019-a312-6e4a4c92e2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b062ac62-0064-48ad-8405-8aadbd6c18f4" xlink:to="loc_us-gaap_RoyaltyMember_2f450d17-5459-4019-a312-6e4a4c92e2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_8fb49abb-d1d9-4e0e-b578-a450c4b0d28b" xlink:href="lgnd-20210630.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b062ac62-0064-48ad-8405-8aadbd6c18f4" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_8fb49abb-d1d9-4e0e-b578-a450c4b0d28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_3173cd18-e2c7-408f-8c20-0506e34e5997" xlink:href="lgnd-20210630.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b062ac62-0064-48ad-8405-8aadbd6c18f4" xlink:to="loc_lgnd_ContractRevenueMember_3173cd18-e2c7-408f-8c20-0506e34e5997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_62003c18-14ee-44f2-9500-551d7dc97ea2" xlink:to="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_7b181c09-bb8c-4213-9e2b-729ef3580a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_RevenuesAbstract_7b181c09-bb8c-4213-9e2b-729ef3580a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7ac12b8d-c17b-4253-b2ab-c2af30cb40f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_7b181c09-bb8c-4213-9e2b-729ef3580a2e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7ac12b8d-c17b-4253-b2ab-c2af30cb40f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_e34feaf6-652e-479e-840d-be28e3e14743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:to="loc_us-gaap_CostDirectMaterial_e34feaf6-652e-479e-840d-be28e3e14743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_343a7d9e-74ad-4478-8246-0247851a6f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_343a7d9e-74ad-4478-8246-0247851a6f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_970a566d-1ebf-4be1-a9d4-28ee0151ea3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_970a566d-1ebf-4be1-a9d4-28ee0151ea3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_bb1224f7-b457-4d7b-bf8d-72bbf677bf0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_bb1224f7-b457-4d7b-bf8d-72bbf677bf0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncome_36e7ab91-f356-4d54-a2db-44c2311771dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:to="loc_us-gaap_OtherOperatingIncome_36e7ab91-f356-4d54-a2db-44c2311771dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_4608697f-6a9f-45bd-9f89-cccf6793356c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_66b636bf-c9d0-42f3-92c3-60b082c0c73e" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_4608697f-6a9f-45bd-9f89-cccf6793356c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1aa68b9c-93a4-4139-a35d-61664e90aee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_OperatingIncomeLoss_1aa68b9c-93a4-4139-a35d-61664e90aee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e93e457e-015a-4764-a6a0-6669711241d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e93e457e-015a-4764-a6a0-6669711241d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_d51a6031-8f9b-460e-807d-6efcf2fc9530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e93e457e-015a-4764-a6a0-6669711241d5" xlink:to="loc_us-gaap_GainLossOnInvestments_d51a6031-8f9b-460e-807d-6efcf2fc9530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_248af3a0-c27a-42fe-91ec-a0b805cf3f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e93e457e-015a-4764-a6a0-6669711241d5" xlink:to="loc_us-gaap_InvestmentIncomeInterest_248af3a0-c27a-42fe-91ec-a0b805cf3f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_da9501bc-f90b-49b0-8e26-3e62065b5e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e93e457e-015a-4764-a6a0-6669711241d5" xlink:to="loc_us-gaap_InterestExpense_da9501bc-f90b-49b0-8e26-3e62065b5e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1ac714d8-bcb1-4fd7-a077-a5819011b754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e93e457e-015a-4764-a6a0-6669711241d5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1ac714d8-bcb1-4fd7-a077-a5819011b754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_edc7ac94-b38c-4128-ab99-3c402a43506f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e93e457e-015a-4764-a6a0-6669711241d5" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_edc7ac94-b38c-4128-ab99-3c402a43506f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_68de0f55-b8bd-4822-b8cf-9521dbc0c7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_68de0f55-b8bd-4822-b8cf-9521dbc0c7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_17893509-b473-484d-87bb-62414b2adc69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_17893509-b473-484d-87bb-62414b2adc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d7081b4c-87fb-4d8c-b518-74bbcacf206c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_NetIncomeLoss_d7081b4c-87fb-4d8c-b518-74bbcacf206c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6014ae22-b433-48e9-bcea-9b9ba6068cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_38dd32af-ccba-482a-8331-730bc6f70136" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6014ae22-b433-48e9-bcea-9b9ba6068cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ffcc67c5-170a-48ef-83ff-97ba5c32868a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6014ae22-b433-48e9-bcea-9b9ba6068cb5" xlink:to="loc_us-gaap_EarningsPerShareBasic_ffcc67c5-170a-48ef-83ff-97ba5c32868a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8f52397b-b680-486a-8320-38c11f08bbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6014ae22-b433-48e9-bcea-9b9ba6068cb5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8f52397b-b680-486a-8320-38c11f08bbb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_842e2c9a-b923-44c6-a366-baa4460c607c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6014ae22-b433-48e9-bcea-9b9ba6068cb5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_842e2c9a-b923-44c6-a366-baa4460c607c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63c58dee-488f-4aa2-aebc-4510d5ccf009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6014ae22-b433-48e9-bcea-9b9ba6068cb5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63c58dee-488f-4aa2-aebc-4510d5ccf009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" xlink:type="simple" xlink:href="lgnd-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_288e109a-03f0-46fe-b358-e5db10d24d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f6322831-475b-4e64-8ab7-1bfea0206b03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_288e109a-03f0-46fe-b358-e5db10d24d23" xlink:to="loc_us-gaap_NetIncomeLoss_f6322831-475b-4e64-8ab7-1bfea0206b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_42a88cdf-3ccf-41c3-b1b6-586172650429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_288e109a-03f0-46fe-b358-e5db10d24d23" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_42a88cdf-3ccf-41c3-b1b6-586172650429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d4ce69de-7a05-4763-827c-5b8294fdcdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_288e109a-03f0-46fe-b358-e5db10d24d23" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d4ce69de-7a05-4763-827c-5b8294fdcdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d913bdf1-954f-456e-9e8c-f2fa6c81a0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_288e109a-03f0-46fe-b358-e5db10d24d23" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_d913bdf1-954f-456e-9e8c-f2fa6c81a0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="lgnd-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_31cb63e7-5d6c-496d-8a19-bb511d5f6292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_992159c9-ec05-47a3-be18-54e7b233dade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_31cb63e7-5d6c-496d-8a19-bb511d5f6292" xlink:to="loc_us-gaap_StatementTable_992159c9-ec05-47a3-be18-54e7b233dade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_54f431ef-57ae-4005-a73a-47e627606439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_992159c9-ec05-47a3-be18-54e7b233dade" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_54f431ef-57ae-4005-a73a-47e627606439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_755389f6-07ba-476a-a475-1047d4528312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_54f431ef-57ae-4005-a73a-47e627606439" xlink:to="loc_us-gaap_EquityComponentDomain_755389f6-07ba-476a-a475-1047d4528312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d20b41a0-bd51-447d-8b45-008f4a61c48a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_755389f6-07ba-476a-a475-1047d4528312" xlink:to="loc_us-gaap_CommonStockMember_d20b41a0-bd51-447d-8b45-008f4a61c48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1fa8bd51-a6ae-48c9-bc18-3dc7d9fb4fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_755389f6-07ba-476a-a475-1047d4528312" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1fa8bd51-a6ae-48c9-bc18-3dc7d9fb4fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a3cf4e96-be62-49c9-8bcd-9424c8bd8a22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_755389f6-07ba-476a-a475-1047d4528312" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a3cf4e96-be62-49c9-8bcd-9424c8bd8a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_033e479b-13bb-4bad-b39a-7cb71d7c4b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_755389f6-07ba-476a-a475-1047d4528312" xlink:to="loc_us-gaap_RetainedEarningsMember_033e479b-13bb-4bad-b39a-7cb71d7c4b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_494f8919-2c0f-44e3-808a-92fdc255f504" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_992159c9-ec05-47a3-be18-54e7b233dade" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_494f8919-2c0f-44e3-808a-92fdc255f504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b2b3bd00-c543-43f3-a8f6-5235eafcc5a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_494f8919-2c0f-44e3-808a-92fdc255f504" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b2b3bd00-c543-43f3-a8f6-5235eafcc5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9aa419ad-6b5e-42e0-87ad-ab35a8cf3cef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b2b3bd00-c543-43f3-a8f6-5235eafcc5a1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9aa419ad-6b5e-42e0-87ad-ab35a8cf3cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7d47f542-1059-4714-a2e9-620faeb7e4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_992159c9-ec05-47a3-be18-54e7b233dade" xlink:to="loc_us-gaap_StatementLineItems_7d47f542-1059-4714-a2e9-620faeb7e4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7d47f542-1059-4714-a2e9-620faeb7e4f4" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_0358333f-d8a0-4fff-9356-4db999a90b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_SharesIssued_0358333f-d8a0-4fff-9356-4db999a90b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f69f875d-80f3-4e20-a859-4c0cea887bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_StockholdersEquity_f69f875d-80f3-4e20-a859-4c0cea887bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1f1db6b8-320a-4186-9003-be144616a1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1f1db6b8-320a-4186-9003-be144616a1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_90b7f401-14e9-49b2-b60e-86d86c11631d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_90b7f401-14e9-49b2-b60e-86d86c11631d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_444ecaf2-0d85-46f3-9ef1-f9fb58ebd6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_444ecaf2-0d85-46f3-9ef1-f9fb58ebd6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_8c8b16bc-4d3c-4dc1-9b93-acb668dde362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_8c8b16bc-4d3c-4dc1-9b93-acb668dde362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_2826c2ae-1114-4ddc-94e9-69044a0be9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_2826c2ae-1114-4ddc-94e9-69044a0be9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_5556e0a8-7165-4337-b46a-171ccb298af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_5556e0a8-7165-4337-b46a-171ccb298af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_1fdb72d9-5e7e-49b7-b6de-b358356570be" xlink:href="lgnd-20210630.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_1fdb72d9-5e7e-49b7-b6de-b358356570be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_eef212a6-a7d9-482d-b797-d963561404ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_eef212a6-a7d9-482d-b797-d963561404ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_24b36e1a-e2fa-4292-a993-329c1697394c" xlink:href="lgnd-20210630.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_24b36e1a-e2fa-4292-a993-329c1697394c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_4a59a2ae-de40-4c28-ac76-090b079e254f" xlink:href="lgnd-20210630.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_4a59a2ae-de40-4c28-ac76-090b079e254f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_04964de0-2735-4a0f-8305-b0038074813d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_04964de0-2735-4a0f-8305-b0038074813d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_30be6d7f-81d6-4b5e-a0bd-b77b902069a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_NetIncomeLoss_30be6d7f-81d6-4b5e-a0bd-b77b902069a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_2fad77df-d384-42fa-ad45-595968475685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_SharesIssued_2fad77df-d384-42fa-ad45-595968475685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ff81764b-fe22-4a77-b5a1-7ee1c03a92ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1070fd21-28c5-4b94-a1e9-4a8bb8817f34" xlink:to="loc_us-gaap_StockholdersEquity_ff81764b-fe22-4a77-b5a1-7ee1c03a92ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_a6f1a2f7-3072-4167-bbc7-a1d16d2bb3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7d47f542-1059-4714-a2e9-620faeb7e4f4" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_a6f1a2f7-3072-4167-bbc7-a1d16d2bb3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="lgnd-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_8fe51816-5d66-45e8-859a-0d7ed310481d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6d2a439f-e64d-4957-94e6-3494732e311e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fe51816-5d66-45e8-859a-0d7ed310481d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6d2a439f-e64d-4957-94e6-3494732e311e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d84ddad8-c526-4d4c-98ab-77fe51830272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6d2a439f-e64d-4957-94e6-3494732e311e" xlink:to="loc_us-gaap_ProfitLoss_d84ddad8-c526-4d4c-98ab-77fe51830272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a8d0c837-ac29-46d4-9b08-28bcba148952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6d2a439f-e64d-4957-94e6-3494732e311e" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a8d0c837-ac29-46d4-9b08-28bcba148952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_e121b892-e160-4b4b-bb37-b87d1b8960bd" xlink:href="lgnd-20210630.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a8d0c837-ac29-46d4-9b08-28bcba148952" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_e121b892-e160-4b4b-bb37-b87d1b8960bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9a9be2eb-9ee3-4aca-bfd5-c2fb30fb63b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a8d0c837-ac29-46d4-9b08-28bcba148952" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9a9be2eb-9ee3-4aca-bfd5-c2fb30fb63b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_12a0fff9-7bbf-4920-9208-0d2340c624c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a8d0c837-ac29-46d4-9b08-28bcba148952" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_12a0fff9-7bbf-4920-9208-0d2340c624c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8eb8a7fe-250d-421e-8eb8-f6e965fe035b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a8d0c837-ac29-46d4-9b08-28bcba148952" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8eb8a7fe-250d-421e-8eb8-f6e965fe035b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfOtherEconomicRights_7c580e1e-1c56-471c-a1e9-c701cf787cb6" xlink:href="lgnd-20210630.xsd#lgnd_AmortizationOfOtherEconomicRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a8d0c837-ac29-46d4-9b08-28bcba148952" xlink:to="loc_lgnd_AmortizationOfOtherEconomicRights_7c580e1e-1c56-471c-a1e9-c701cf787cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_37e5f7cc-0e5d-4b90-8f9f-7d4bcebc32a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a8d0c837-ac29-46d4-9b08-28bcba148952" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_37e5f7cc-0e5d-4b90-8f9f-7d4bcebc32a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_14ece4b9-7c9e-4872-8b3a-3e3cd5cfb6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a8d0c837-ac29-46d4-9b08-28bcba148952" xlink:to="loc_us-gaap_ShareBasedCompensation_14ece4b9-7c9e-4872-8b3a-3e3cd5cfb6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f2e3756c-74b4-45fc-8fb4-235a4a3732c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a8d0c837-ac29-46d4-9b08-28bcba148952" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f2e3756c-74b4-45fc-8fb4-235a4a3732c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_b25abb78-6d0d-405b-9e8c-17888af59055" xlink:href="lgnd-20210630.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a8d0c837-ac29-46d4-9b08-28bcba148952" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_b25abb78-6d0d-405b-9e8c-17888af59055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a9ebf81b-c33c-4dfe-a94e-9d052353afa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a8d0c837-ac29-46d4-9b08-28bcba148952" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a9ebf81b-c33c-4dfe-a94e-9d052353afa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b62244d1-cb65-4eeb-8e62-f25afca092cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6d2a439f-e64d-4957-94e6-3494732e311e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b62244d1-cb65-4eeb-8e62-f25afca092cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_58a8964f-5ba6-486f-b08c-9558ee0484dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b62244d1-cb65-4eeb-8e62-f25afca092cd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_58a8964f-5ba6-486f-b08c-9558ee0484dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_df64be3e-2cc9-4e5c-b3ab-0415eb38b052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b62244d1-cb65-4eeb-8e62-f25afca092cd" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_df64be3e-2cc9-4e5c-b3ab-0415eb38b052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c0db933c-e8e4-4fce-8e55-593f6d02f20c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b62244d1-cb65-4eeb-8e62-f25afca092cd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c0db933c-e8e4-4fce-8e55-593f6d02f20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_98190090-34d9-445f-9d85-600db2323bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b62244d1-cb65-4eeb-8e62-f25afca092cd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_98190090-34d9-445f-9d85-600db2323bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b923565a-c6e1-4d13-aa20-7fc58990a24d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b62244d1-cb65-4eeb-8e62-f25afca092cd" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b923565a-c6e1-4d13-aa20-7fc58990a24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4b1da0ab-4e45-40da-b03b-e913037a274b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b62244d1-cb65-4eeb-8e62-f25afca092cd" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4b1da0ab-4e45-40da-b03b-e913037a274b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36d706c8-9394-4df6-96c3-68f474795f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6d2a439f-e64d-4957-94e6-3494732e311e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36d706c8-9394-4df6-96c3-68f474795f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_be92efea-f71c-4a5e-a150-32be303a3ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fe51816-5d66-45e8-859a-0d7ed310481d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_be92efea-f71c-4a5e-a150-32be303a3ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_d39d95c3-90ac-47ba-be80-15ada6804d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_be92efea-f71c-4a5e-a150-32be303a3ddc" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_d39d95c3-90ac-47ba-be80-15ada6804d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_995450a4-a237-46e4-a0b2-68243975c9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_be92efea-f71c-4a5e-a150-32be303a3ddc" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_995450a4-a237-46e4-a0b2-68243975c9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_a60dbf65-6d8a-4130-8301-c8649278cb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_be92efea-f71c-4a5e-a150-32be303a3ddc" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_a60dbf65-6d8a-4130-8301-c8649278cb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ff5ac3a3-f04a-46af-9d07-1a05577f2659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_be92efea-f71c-4a5e-a150-32be303a3ddc" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ff5ac3a3-f04a-46af-9d07-1a05577f2659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_68810bdf-1bce-49a2-a4e3-3b4aa7e4ed3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_be92efea-f71c-4a5e-a150-32be303a3ddc" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_68810bdf-1bce-49a2-a4e3-3b4aa7e4ed3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2836703a-4fd1-4f99-93e3-4e13c86fae08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_be92efea-f71c-4a5e-a150-32be303a3ddc" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2836703a-4fd1-4f99-93e3-4e13c86fae08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_db88cf4b-b682-4408-aafa-4eec7d4ff095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_be92efea-f71c-4a5e-a150-32be303a3ddc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_db88cf4b-b682-4408-aafa-4eec7d4ff095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f1512f10-0106-4f81-89a2-17c70015eefa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fe51816-5d66-45e8-859a-0d7ed310481d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f1512f10-0106-4f81-89a2-17c70015eefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_35337cb1-4ba6-45b4-ad74-68e8c8021325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f1512f10-0106-4f81-89a2-17c70015eefa" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_35337cb1-4ba6-45b4-ad74-68e8c8021325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_6c33bb41-078f-4e6d-b857-068667127c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f1512f10-0106-4f81-89a2-17c70015eefa" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_6c33bb41-078f-4e6d-b857-068667127c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_26eba44d-645f-4567-86cd-0b0d9e07b0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f1512f10-0106-4f81-89a2-17c70015eefa" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_26eba44d-645f-4567-86cd-0b0d9e07b0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_9cea8509-4c68-4ed8-9b29-048e12fffec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f1512f10-0106-4f81-89a2-17c70015eefa" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_9cea8509-4c68-4ed8-9b29-048e12fffec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_8526b46b-adb9-49d9-ba19-27e2d5a91112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f1512f10-0106-4f81-89a2-17c70015eefa" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_8526b46b-adb9-49d9-ba19-27e2d5a91112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_20210cde-6ced-4b74-bf06-d9c7e0793213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f1512f10-0106-4f81-89a2-17c70015eefa" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_20210cde-6ced-4b74-bf06-d9c7e0793213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7f01ee36-cac4-41ed-bc62-de4665394fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f1512f10-0106-4f81-89a2-17c70015eefa" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7f01ee36-cac4-41ed-bc62-de4665394fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_686b077d-2076-48e6-bf90-30c26f370b27" xlink:href="lgnd-20210630.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f1512f10-0106-4f81-89a2-17c70015eefa" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_686b077d-2076-48e6-bf90-30c26f370b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c9d09acc-0d78-4011-8d2f-91d5a2ce84a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f1512f10-0106-4f81-89a2-17c70015eefa" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c9d09acc-0d78-4011-8d2f-91d5a2ce84a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7483cd77-b996-47e3-9764-dc2b41689c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fe51816-5d66-45e8-859a-0d7ed310481d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7483cd77-b996-47e3-9764-dc2b41689c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7ccda331-cb77-492e-8895-d337e8404370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fe51816-5d66-45e8-859a-0d7ed310481d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7ccda331-cb77-492e-8895-d337e8404370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_79bcd6db-65e8-4cc0-b908-37b53b6149fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fe51816-5d66-45e8-859a-0d7ed310481d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_79bcd6db-65e8-4cc0-b908-37b53b6149fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_47d9bf20-c210-4459-84a2-e3f7b4587669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fe51816-5d66-45e8-859a-0d7ed310481d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_47d9bf20-c210-4459-84a2-e3f7b4587669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_a14ab71c-74d8-48bc-8dc1-69dc4628651e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fe51816-5d66-45e8-859a-0d7ed310481d" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_a14ab71c-74d8-48bc-8dc1-69dc4628651e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_2065e9b9-eb70-4786-bcc9-182a087b5d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a14ab71c-74d8-48bc-8dc1-69dc4628651e" xlink:to="loc_us-gaap_InterestPaidNet_2065e9b9-eb70-4786-bcc9-182a087b5d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_089edcbc-6975-4f29-8f0f-ae7c635184af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a14ab71c-74d8-48bc-8dc1-69dc4628651e" xlink:to="loc_us-gaap_IncomeTaxesPaid_089edcbc-6975-4f29-8f0f-ae7c635184af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_eaeb0058-b16f-457d-a68b-aa82a1cccdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a14ab71c-74d8-48bc-8dc1-69dc4628651e" xlink:to="loc_us-gaap_RestrictedCashCurrent_eaeb0058-b16f-457d-a68b-aa82a1cccdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_08394181-3053-4bca-ab80-54ddd62e793b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fe51816-5d66-45e8-859a-0d7ed310481d" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_08394181-3053-4bca-ab80-54ddd62e793b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_2646292a-6dd9-47f7-b8dd-55fa8ac16fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_08394181-3053-4bca-ab80-54ddd62e793b" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_2646292a-6dd9-47f7-b8dd-55fa8ac16fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases_f7bc194e-8c62-47b3-b91e-deb867d55efd" xlink:href="lgnd-20210630.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_08394181-3053-4bca-ab80-54ddd62e793b" xlink:to="loc_lgnd_AccruedInventoryPurchases_f7bc194e-8c62-47b3-b91e-deb867d55efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_2d3e7417-76dd-446d-943b-f6e7b3901785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_08394181-3053-4bca-ab80-54ddd62e793b" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_2d3e7417-76dd-446d-943b-f6e7b3901785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_52101fa3-bc73-4486-a676-f6938921f578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_cd65c8e3-720e-49ad-9c21-02302a55410c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_52101fa3-bc73-4486-a676-f6938921f578" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_cd65c8e3-720e-49ad-9c21-02302a55410c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_033d9d25-8f67-4b7c-9006-e24cb4d1dd73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c2aeb45e-8bd6-416d-bc20-224e73fef0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_033d9d25-8f67-4b7c-9006-e24cb4d1dd73" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c2aeb45e-8bd6-416d-bc20-224e73fef0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_2a213d69-fa18-4421-ba73-7af82f3b7d17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_033d9d25-8f67-4b7c-9006-e24cb4d1dd73" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_2a213d69-fa18-4421-ba73-7af82f3b7d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_3896e15a-8201-4d0e-818e-af7250ea9bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_033d9d25-8f67-4b7c-9006-e24cb4d1dd73" xlink:to="loc_us-gaap_UseOfEstimates_3896e15a-8201-4d0e-818e-af7250ea9bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_098cd908-49f3-49fb-a08a-42e9e9104935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_033d9d25-8f67-4b7c-9006-e24cb4d1dd73" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_098cd908-49f3-49fb-a08a-42e9e9104935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_570eafc0-fcbd-4376-8ad2-aef0d2f1db8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_033d9d25-8f67-4b7c-9006-e24cb4d1dd73" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_570eafc0-fcbd-4376-8ad2-aef0d2f1db8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_ad75d112-67ac-43bc-89be-eb32e01026d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_033d9d25-8f67-4b7c-9006-e24cb4d1dd73" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_ad75d112-67ac-43bc-89be-eb32e01026d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d7abc632-e6b6-4365-b10c-c8111a5c76f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_033d9d25-8f67-4b7c-9006-e24cb4d1dd73" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d7abc632-e6b6-4365-b10c-c8111a5c76f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_9345d4e5-675a-457b-9688-0020b6a49812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_033d9d25-8f67-4b7c-9006-e24cb4d1dd73" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_9345d4e5-675a-457b-9688-0020b6a49812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7df24bc-e0cf-42f2-b0a9-6702aad98b35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_700392d0-92b2-4ee9-950f-04f561257b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7df24bc-e0cf-42f2-b0a9-6702aad98b35" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_700392d0-92b2-4ee9-950f-04f561257b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_b2761904-3980-4b41-af99-03e19a78c04d" xlink:href="lgnd-20210630.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7df24bc-e0cf-42f2-b0a9-6702aad98b35" xlink:to="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_b2761904-3980-4b41-af99-03e19a78c04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_4a7234f6-bbbf-4fe3-bca6-12b06e210dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7df24bc-e0cf-42f2-b0a9-6702aad98b35" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_4a7234f6-bbbf-4fe3-bca6-12b06e210dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_032b4b5a-c0be-4ee4-ae0a-f10e035af5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7df24bc-e0cf-42f2-b0a9-6702aad98b35" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_032b4b5a-c0be-4ee4-ae0a-f10e035af5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_3a05f0ab-1d37-44c4-91ad-35972eed7436" xlink:href="lgnd-20210630.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7df24bc-e0cf-42f2-b0a9-6702aad98b35" xlink:to="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_3a05f0ab-1d37-44c4-91ad-35972eed7436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_55ba3c42-45b0-44f2-9877-183c61598dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7df24bc-e0cf-42f2-b0a9-6702aad98b35" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_55ba3c42-45b0-44f2-9877-183c61598dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_d189f7a1-5553-4cf7-8315-ddca85b82f25" xlink:href="lgnd-20210630.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7df24bc-e0cf-42f2-b0a9-6702aad98b35" xlink:to="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_d189f7a1-5553-4cf7-8315-ddca85b82f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_81597ec4-1133-4b58-b762-987c38635470" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7df24bc-e0cf-42f2-b0a9-6702aad98b35" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_81597ec4-1133-4b58-b762-987c38635470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_bbfcc008-baa9-4b0d-9187-5703e8745e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7df24bc-e0cf-42f2-b0a9-6702aad98b35" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_bbfcc008-baa9-4b0d-9187-5703e8745e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb559cc4-810f-43c8-a68f-b987c99925ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb559cc4-810f-43c8-a68f-b987c99925ec" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_26d527bd-87ee-4ad8-a868-10a9fa661057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_26d527bd-87ee-4ad8-a868-10a9fa661057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ff7bca5c-97dc-47a9-ac1c-4aad3010705f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_26d527bd-87ee-4ad8-a868-10a9fa661057" xlink:to="loc_us-gaap_RelatedPartyDomain_ff7bca5c-97dc-47a9-ac1c-4aad3010705f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_6be123e2-3adb-4372-be17-f8903fc4014f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_ff7bca5c-97dc-47a9-ac1c-4aad3010705f" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_6be123e2-3adb-4372-be17-f8903fc4014f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1490937e-c902-4683-a4b2-7ee96091bc01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1490937e-c902-4683-a4b2-7ee96091bc01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf62bbe2-6365-45eb-a786-b9d8e3edfaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1490937e-c902-4683-a4b2-7ee96091bc01" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf62bbe2-6365-45eb-a786-b9d8e3edfaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c1f44140-40ae-4eec-b6d4-e7e0bf54e39f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf62bbe2-6365-45eb-a786-b9d8e3edfaa4" xlink:to="loc_us-gaap_CommonStockMember_c1f44140-40ae-4eec-b6d4-e7e0bf54e39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_c82f8c21-f135-4ec1-96e8-16b4c3cc40b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf62bbe2-6365-45eb-a786-b9d8e3edfaa4" xlink:to="loc_us-gaap_WarrantMember_c82f8c21-f135-4ec1-96e8-16b4c3cc40b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b8aac536-a82c-4ec3-8517-b9ee84b27772" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b8aac536-a82c-4ec3-8517-b9ee84b27772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a8214983-c71b-4bbb-8201-8b52959ff570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b8aac536-a82c-4ec3-8517-b9ee84b27772" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a8214983-c71b-4bbb-8201-8b52959ff570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_e08893af-e1cc-4917-8416-feb4cc4c0ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a8214983-c71b-4bbb-8201-8b52959ff570" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_e08893af-e1cc-4917-8416-feb4cc4c0ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd02e586-3de3-435e-bf6d-fd9179d7be41" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_srt_RangeAxis_dd02e586-3de3-435e-bf6d-fd9179d7be41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e21bc73a-97af-49cd-957a-ebb5405778c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dd02e586-3de3-435e-bf6d-fd9179d7be41" xlink:to="loc_srt_RangeMember_e21bc73a-97af-49cd-957a-ebb5405778c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3bc8bb85-af31-40f0-b9ab-4d5e9ddfcd4f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e21bc73a-97af-49cd-957a-ebb5405778c4" xlink:to="loc_srt_MaximumMember_3bc8bb85-af31-40f0-b9ab-4d5e9ddfcd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b23cb439-4da1-484a-b36d-5bdab79c6ce2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e21bc73a-97af-49cd-957a-ebb5405778c4" xlink:to="loc_srt_MinimumMember_b23cb439-4da1-484a-b36d-5bdab79c6ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2fc24133-566f-4624-8cfb-c78a48414bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2fc24133-566f-4624-8cfb-c78a48414bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f181831f-a14a-4dbe-9f73-597f63b3a328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2fc24133-566f-4624-8cfb-c78a48414bec" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f181831f-a14a-4dbe-9f73-597f63b3a328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember_d6ba0bf8-3b7d-421d-aaa2-9fc87c8924a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f181831f-a14a-4dbe-9f73-597f63b3a328" xlink:to="loc_us-gaap_RoyaltyAgreementsMember_d6ba0bf8-3b7d-421d-aaa2-9fc87c8924a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_802f3aec-7d4e-456e-8eb5-36a83f84d6ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_srt_CounterpartyNameAxis_802f3aec-7d4e-456e-8eb5-36a83f84d6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c481f803-1a9e-4234-a1b9-318198f50a4b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_802f3aec-7d4e-456e-8eb5-36a83f84d6ab" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c481f803-1a9e-4234-a1b9-318198f50a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember_66552b82-046a-43ba-905b-280b1e5e6f63" xlink:href="lgnd-20210630.xsd#lgnd_AziyoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c481f803-1a9e-4234-a1b9-318198f50a4b" xlink:to="loc_lgnd_AziyoMember_66552b82-046a-43ba-905b-280b1e5e6f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisMember_af45d573-8de3-4229-a37d-e84390b5025a" xlink:href="lgnd-20210630.xsd#lgnd_SelexisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c481f803-1a9e-4234-a1b9-318198f50a4b" xlink:to="loc_lgnd_SelexisMember_af45d573-8de3-4229-a37d-e84390b5025a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_adc4076d-2cf5-48b6-b2c9-2796d9afc6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_us-gaap_AwardTypeAxis_adc4076d-2cf5-48b6-b2c9-2796d9afc6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e098a52-0408-4a13-91a2-12bf715f09ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_adc4076d-2cf5-48b6-b2c9-2796d9afc6d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e098a52-0408-4a13-91a2-12bf715f09ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9bd9e86d-09ca-4cbc-92df-ceb4bf864585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e098a52-0408-4a13-91a2-12bf715f09ce" xlink:to="loc_us-gaap_RestrictedStockMember_9bd9e86d-09ca-4cbc-92df-ceb4bf864585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3ccac90e-5cf3-4641-b69e-1ec591358fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3ccac90e-5cf3-4641-b69e-1ec591358fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1013386b-8888-43ff-b67e-a8f774f61bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3ccac90e-5cf3-4641-b69e-1ec591358fb3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1013386b-8888-43ff-b67e-a8f774f61bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_a848b252-aaba-452a-ae6b-1cbe9d07bb62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1013386b-8888-43ff-b67e-a8f774f61bf0" xlink:to="loc_us-gaap_StockCompensationPlanMember_a848b252-aaba-452a-ae6b-1cbe9d07bb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0149ad99-703b-449e-b2e2-1bcb9f4897bf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e3246a73-3c87-4e52-a2a3-0ff69c6d67cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e3246a73-3c87-4e52-a2a3-0ff69c6d67cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0050b25b-5540-4c43-ae1f-586726b03760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0050b25b-5540-4c43-ae1f-586726b03760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a59bb801-ca8e-461b-b582-4f8820b928d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a59bb801-ca8e-461b-b582-4f8820b928d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_01a89cd3-27eb-4a56-85e6-0e40b51e904b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_01a89cd3-27eb-4a56-85e6-0e40b51e904b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_a030dad3-b3e8-4dc0-b3e3-98a7d6b8861e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_a030dad3-b3e8-4dc0-b3e3-98a7d6b8861e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_443f8e27-07e1-4330-94c3-554179b4ddb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_443f8e27-07e1-4330-94c3-554179b4ddb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_2b23f170-2038-4fc7-aced-412960c2d431" xlink:href="lgnd-20210630.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_2b23f170-2038-4fc7-aced-412960c2d431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesOnInventoryPurchases_6be5c8ff-2793-46dc-ad99-ec1d9800e89a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvancesOnInventoryPurchases"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_AdvancesOnInventoryPurchases_6be5c8ff-2793-46dc-ad99-ec1d9800e89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases_e8e91cc8-4d5a-4b52-aaa4-6bc384518614" xlink:href="lgnd-20210630.xsd#lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases_e8e91cc8-4d5a-4b52-aaa4-6bc384518614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_ba864b85-34c0-4b7a-9ce4-449a5ee766c1" xlink:href="lgnd-20210630.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_ba864b85-34c0-4b7a-9ce4-449a5ee766c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_1e1391ac-0273-4c48-9e0f-95e7101bd608" xlink:href="lgnd-20210630.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_1e1391ac-0273-4c48-9e0f-95e7101bd608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_3ee49e63-a352-4463-bec4-ee9076e12b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_3ee49e63-a352-4463-bec4-ee9076e12b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_4f373b30-1016-4d99-aac1-e2253abb4a06" xlink:href="lgnd-20210630.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_4f373b30-1016-4d99-aac1-e2253abb4a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4be2cecc-6b06-4d5e-be36-1b0c9bb4d8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7bc9149-b254-4b23-af20-c58811f3a8c1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4be2cecc-6b06-4d5e-be36-1b0c9bb4d8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d0bf6774-9a44-41af-848e-d74f395b50a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_9951a79c-e149-4476-ac56-41605ebf1f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d0bf6774-9a44-41af-848e-d74f395b50a1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_9951a79c-e149-4476-ac56-41605ebf1f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_80e22797-f0eb-4264-bdf6-93b9bca805a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9951a79c-e149-4476-ac56-41605ebf1f32" xlink:to="loc_srt_ProductOrServiceAxis_80e22797-f0eb-4264-bdf6-93b9bca805a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d1aa9fd1-d6b1-4891-8368-4825828fd1c6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_80e22797-f0eb-4264-bdf6-93b9bca805a7" xlink:to="loc_srt_ProductsAndServicesDomain_d1aa9fd1-d6b1-4891-8368-4825828fd1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_913c73e6-4906-4e05-9bb6-6d71525934a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d1aa9fd1-d6b1-4891-8368-4825828fd1c6" xlink:to="loc_us-gaap_RoyaltyMember_913c73e6-4906-4e05-9bb6-6d71525934a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_cbe9173b-1f48-4d09-b606-f6c16e9bb3a8" xlink:href="lgnd-20210630.xsd#lgnd_KyprolisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_913c73e6-4906-4e05-9bb6-6d71525934a8" xlink:to="loc_lgnd_KyprolisMember_cbe9173b-1f48-4d09-b606-f6c16e9bb3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_370404eb-18bc-43a3-b9ea-c7c746c020b9" xlink:href="lgnd-20210630.xsd#lgnd_EvomelaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_913c73e6-4906-4e05-9bb6-6d71525934a8" xlink:to="loc_lgnd_EvomelaMember_370404eb-18bc-43a3-b9ea-c7c746c020b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_138a78e9-2506-41a0-8185-389b9548a5ff" xlink:href="lgnd-20210630.xsd#lgnd_RoyaltyOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_913c73e6-4906-4e05-9bb6-6d71525934a8" xlink:to="loc_lgnd_RoyaltyOtherMember_138a78e9-2506-41a0-8185-389b9548a5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_2ca7e9b1-5d69-4fad-b957-30bfefbac1fd" xlink:href="lgnd-20210630.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d1aa9fd1-d6b1-4891-8368-4825828fd1c6" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_2ca7e9b1-5d69-4fad-b957-30bfefbac1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_6198df1d-e2ea-4de0-9a5b-de6ffc0f3c55" xlink:href="lgnd-20210630.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d1aa9fd1-d6b1-4891-8368-4825828fd1c6" xlink:to="loc_lgnd_ContractRevenueMember_6198df1d-e2ea-4de0-9a5b-de6ffc0f3c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember_d734d05a-af21-4614-af7c-a649d1eeac4a" xlink:href="lgnd-20210630.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_6198df1d-e2ea-4de0-9a5b-de6ffc0f3c55" xlink:to="loc_lgnd_ContractRevenueServiceMember_d734d05a-af21-4614-af7c-a649d1eeac4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_c4d023cd-0f88-4f4d-acb8-21502e797946" xlink:href="lgnd-20210630.xsd#lgnd_LicenseFeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_6198df1d-e2ea-4de0-9a5b-de6ffc0f3c55" xlink:to="loc_lgnd_LicenseFeesMember_c4d023cd-0f88-4f4d-acb8-21502e797946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_3cc4f4ea-9c39-49ac-b3f2-0d61f0560b87" xlink:href="lgnd-20210630.xsd#lgnd_MilestoneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_6198df1d-e2ea-4de0-9a5b-de6ffc0f3c55" xlink:to="loc_lgnd_MilestoneMember_3cc4f4ea-9c39-49ac-b3f2-0d61f0560b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_89960b99-ca10-4b13-b5fb-9e7344be9a13" xlink:href="lgnd-20210630.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_6198df1d-e2ea-4de0-9a5b-de6ffc0f3c55" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_89960b99-ca10-4b13-b5fb-9e7344be9a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0a8e3241-6c38-4ec6-9985-191bb6d6b5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9951a79c-e149-4476-ac56-41605ebf1f32" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_0a8e3241-6c38-4ec6-9985-191bb6d6b5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_34641d81-1355-4e1c-918c-3f8ce21d17a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0a8e3241-6c38-4ec6-9985-191bb6d6b5f0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_34641d81-1355-4e1c-918c-3f8ce21d17a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2fff971f-8df5-4725-9757-7b375ec46794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_71a2711b-6f95-48cb-89ea-da33ae11d2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2fff971f-8df5-4725-9757-7b375ec46794" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_71a2711b-6f95-48cb-89ea-da33ae11d2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1c8b6c62-d941-4ddb-8bc8-9779cd844c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_71a2711b-6f95-48cb-89ea-da33ae11d2e5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1c8b6c62-d941-4ddb-8bc8-9779cd844c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1c8b6c62-d941-4ddb-8bc8-9779cd844c47" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_e547702c-b761-4cc4-a2f6-8bb3c0fd9593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_DemandDepositsMember_e547702c-b761-4cc4-a2f6-8bb3c0fd9593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_06dabc4e-5852-4dd9-b499-a5fc5b277998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_06dabc4e-5852-4dd9-b499-a5fc5b277998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AgencySecuritiesMember_9e51ae2d-86ae-4b65-9fcd-ce3f7b0d7bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AgencySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_AgencySecuritiesMember_9e51ae2d-86ae-4b65-9fcd-ce3f7b0d7bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_5aa96aa8-e9b7-4dac-89ad-f846b3907495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_CommercialPaperMember_5aa96aa8-e9b7-4dac-89ad-f846b3907495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_27504043-9c62-4be2-8e7e-af99637b4320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_EquitySecuritiesMember_27504043-9c62-4be2-8e7e-af99637b4320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_899c998b-56ba-434f-9fcc-c5f5234b7aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_MutualFundMember_899c998b-56ba-434f-9fcc-c5f5234b7aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_439cc485-dce2-43a5-90e8-632af74a5492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_439cc485-dce2-43a5-90e8-632af74a5492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_35088d43-fccc-4dda-a7f3-848a36807f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_WarrantMember_35088d43-fccc-4dda-a7f3-848a36807f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3ddb5937-5f9e-4a8d-876d-7bab0b345836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e353221a-a9b4-42df-afea-5492ecc6c303" xlink:to="loc_us-gaap_CommonStockMember_3ddb5937-5f9e-4a8d-876d-7bab0b345836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_71a2711b-6f95-48cb-89ea-da33ae11d2e5" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3d97f41d-5362-4c15-9cc4-45f8e4c7cc61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3d97f41d-5362-4c15-9cc4-45f8e4c7cc61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_484537a2-9cfe-4f06-8dff-a8da2a806ade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_484537a2-9cfe-4f06-8dff-a8da2a806ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8525305c-ce2d-4c21-98fe-15ab39003f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8525305c-ce2d-4c21-98fe-15ab39003f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_86bd967e-f5d9-441c-9aef-552b14d5fc93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_86bd967e-f5d9-441c-9aef-552b14d5fc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_0d08f1a6-e857-4cc5-8580-abbc59c02d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_0d08f1a6-e857-4cc5-8580-abbc59c02d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_80bc9066-8529-4043-884d-4464ba70bdc8" xlink:href="lgnd-20210630.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4397d190-8109-4063-8891-a5fc04732882" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_80bc9066-8529-4043-884d-4464ba70bdc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8a71be42-14ab-4ca8-8a1a-4366411624ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_b0fbe618-24f9-4d1e-a6cc-fac339d1af8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8a71be42-14ab-4ca8-8a1a-4366411624ac" xlink:to="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_b0fbe618-24f9-4d1e-a6cc-fac339d1af8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_a7c2c67a-e41e-4048-98ac-db3c1208a016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_b0fbe618-24f9-4d1e-a6cc-fac339d1af8f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_a7c2c67a-e41e-4048-98ac-db3c1208a016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_0d6a2dd0-c8b3-47da-9546-b35bedaefc72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_b0fbe618-24f9-4d1e-a6cc-fac339d1af8f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_0d6a2dd0-c8b3-47da-9546-b35bedaefc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_390c171c-2edf-4795-a43e-ad48dce5b94d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_b0fbe618-24f9-4d1e-a6cc-fac339d1af8f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_390c171c-2edf-4795-a43e-ad48dce5b94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_02cd7152-4ec3-482e-af98-01a79b4113f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8a71be42-14ab-4ca8-8a1a-4366411624ac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_02cd7152-4ec3-482e-af98-01a79b4113f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_c1e7e8d4-5243-4664-96ff-fa782eaf2da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_02cd7152-4ec3-482e-af98-01a79b4113f9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_c1e7e8d4-5243-4664-96ff-fa782eaf2da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_2ada5ed6-76e2-44ca-aa11-cb42e8c49a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_02cd7152-4ec3-482e-af98-01a79b4113f9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_2ada5ed6-76e2-44ca-aa11-cb42e8c49a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_87cca9c4-328e-4100-b9c7-93ec35f81394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_02cd7152-4ec3-482e-af98-01a79b4113f9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_87cca9c4-328e-4100-b9c7-93ec35f81394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_60532d92-3cc4-48fd-94d9-93c483346d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4247b857-10e4-4661-b14b-68781d705263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_60532d92-3cc4-48fd-94d9-93c483346d7b" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4247b857-10e4-4661-b14b-68781d705263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d60425d0-fa33-4508-9031-86b0387394c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4247b857-10e4-4661-b14b-68781d705263" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d60425d0-fa33-4508-9031-86b0387394c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_816ed5b6-7c63-4fad-95f3-5275b8318fed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d60425d0-fa33-4508-9031-86b0387394c3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_816ed5b6-7c63-4fad-95f3-5275b8318fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_52329258-7c4a-4c64-9fcd-446945369bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_816ed5b6-7c63-4fad-95f3-5275b8318fed" xlink:to="loc_us-gaap_PatentedTechnologyMember_52329258-7c4a-4c64-9fcd-446945369bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_e6c0b836-dd77-41a8-8eea-33a999d049c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_816ed5b6-7c63-4fad-95f3-5275b8318fed" xlink:to="loc_us-gaap_TradeNamesMember_e6c0b836-dd77-41a8-8eea-33a999d049c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_f45dba92-e3fd-411a-9938-7c5c5bab309f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_816ed5b6-7c63-4fad-95f3-5275b8318fed" xlink:to="loc_us-gaap_CustomerRelationshipsMember_f45dba92-e3fd-411a-9938-7c5c5bab309f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_a1bc1df3-c976-414d-bd6f-6258e8c1766b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_816ed5b6-7c63-4fad-95f3-5275b8318fed" xlink:to="loc_us-gaap_ContractualRightsMember_a1bc1df3-c976-414d-bd6f-6258e8c1766b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c7bb82d-aba6-4777-ae4f-12b7194413cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4247b857-10e4-4661-b14b-68781d705263" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c7bb82d-aba6-4777-ae4f-12b7194413cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_6d42d42b-324d-4670-940f-83b01574c5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c7bb82d-aba6-4777-ae4f-12b7194413cc" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_6d42d42b-324d-4670-940f-83b01574c5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_17861ce8-30cc-497c-95b4-b0e3baeb3b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_6d42d42b-324d-4670-940f-83b01574c5cb" xlink:to="loc_us-gaap_Goodwill_17861ce8-30cc-497c-95b4-b0e3baeb3b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_26815527-0747-476f-a652-e6bd4f5cd016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_6d42d42b-324d-4670-940f-83b01574c5cb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_26815527-0747-476f-a652-e6bd4f5cd016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a4b2636e-a3e2-428c-bc1a-e0fba186c0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_6d42d42b-324d-4670-940f-83b01574c5cb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a4b2636e-a3e2-428c-bc1a-e0fba186c0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_104fa89c-c527-43e5-8d71-9697dfe3374b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_6d42d42b-324d-4670-940f-83b01574c5cb" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_104fa89c-c527-43e5-8d71-9697dfe3374b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fe4512b8-66ae-4037-8c53-956f10bed07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_dc8ba246-ace3-4ec0-a75a-710eaa918c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fe4512b8-66ae-4037-8c53-956f10bed07d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_dc8ba246-ace3-4ec0-a75a-710eaa918c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_baa3acc2-31af-457c-a040-de1da1e2a3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_dc8ba246-ace3-4ec0-a75a-710eaa918c7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_baa3acc2-31af-457c-a040-de1da1e2a3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f063dac-9d3e-4fec-945d-83bc0b58afd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_baa3acc2-31af-457c-a040-de1da1e2a3b3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f063dac-9d3e-4fec-945d-83bc0b58afd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_0154b2d2-5224-4b8d-a8fb-bd197fdcb50e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f063dac-9d3e-4fec-945d-83bc0b58afd2" xlink:to="loc_us-gaap_LicensingAgreementsMember_0154b2d2-5224-4b8d-a8fb-bd197fdcb50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_8df4b82b-c344-4226-bde8-7bfafdf7326c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_dc8ba246-ace3-4ec0-a75a-710eaa918c7a" xlink:to="loc_srt_CounterpartyNameAxis_8df4b82b-c344-4226-bde8-7bfafdf7326c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a01d549d-46c0-46e1-bcb2-0a1920a36831" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_8df4b82b-c344-4226-bde8-7bfafdf7326c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a01d549d-46c0-46e1-bcb2-0a1920a36831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_74b17da4-2e72-4284-a075-1dba9260d818" xlink:href="lgnd-20210630.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a01d549d-46c0-46e1-bcb2-0a1920a36831" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_74b17da4-2e72-4284-a075-1dba9260d818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_305d2049-ac3a-4688-a6ac-b4cb9971801c" xlink:href="lgnd-20210630.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a01d549d-46c0-46e1-bcb2-0a1920a36831" xlink:to="loc_lgnd_SelexisAndDianomiMember_305d2049-ac3a-4688-a6ac-b4cb9971801c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_82df5cf4-1c7d-4e28-ac7c-28c2d9a4e5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_dc8ba246-ace3-4ec0-a75a-710eaa918c7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_82df5cf4-1c7d-4e28-ac7c-28c2d9a4e5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c658388d-13c1-4267-a826-ffef539d2227" xlink:href="lgnd-20210630.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_82df5cf4-1c7d-4e28-ac7c-28c2d9a4e5b0" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c658388d-13c1-4267-a826-ffef539d2227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1b0425e6-3f6f-41ee-915c-514b9e620ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c658388d-13c1-4267-a826-ffef539d2227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1b0425e6-3f6f-41ee-915c-514b9e620ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_a0c99f72-b2f9-4c98-a8b6-44286ade5a00" xlink:href="lgnd-20210630.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c658388d-13c1-4267-a826-ffef539d2227" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_a0c99f72-b2f9-4c98-a8b6-44286ade5a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_23c5ea0d-a64e-4fa6-bdd4-41ca05c0c970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c658388d-13c1-4267-a826-ffef539d2227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_23c5ea0d-a64e-4fa6-bdd4-41ca05c0c970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cbcb3cf2-4762-44ba-8e51-9727914cd4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c658388d-13c1-4267-a826-ffef539d2227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cbcb3cf2-4762-44ba-8e51-9727914cd4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_d56133e5-b2ee-4893-a7d6-2839aa1cd605" xlink:href="lgnd-20210630.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c658388d-13c1-4267-a826-ffef539d2227" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_d56133e5-b2ee-4893-a7d6-2839aa1cd605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_222ceb61-8660-41c3-9901-d9d9c928d5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_73658b5b-afdf-4a46-9128-bcf2833a9a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_222ceb61-8660-41c3-9901-d9d9c928d5b1" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_73658b5b-afdf-4a46-9128-bcf2833a9a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7fe8e153-b4c0-4870-aed4-5db521df7db6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_73658b5b-afdf-4a46-9128-bcf2833a9a2d" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7fe8e153-b4c0-4870-aed4-5db521df7db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_01b87adf-a40d-46e8-8630-9635a0a7de10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_73658b5b-afdf-4a46-9128-bcf2833a9a2d" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_01b87adf-a40d-46e8-8630-9635a0a7de10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_6d9d979b-e1ce-4ae7-a8b2-c014c7a902b2" xlink:href="lgnd-20210630.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_73658b5b-afdf-4a46-9128-bcf2833a9a2d" xlink:to="loc_lgnd_LicenseeAccrualCurrent_6d9d979b-e1ce-4ae7-a8b2-c014c7a902b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_bf26cb11-17ba-4b6e-8a98-f45c595d730b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_73658b5b-afdf-4a46-9128-bcf2833a9a2d" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_bf26cb11-17ba-4b6e-8a98-f45c595d730b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual_c40fee97-a316-469f-bf39-4438c0754bdf" xlink:href="lgnd-20210630.xsd#lgnd_ReturnsAccrual"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_73658b5b-afdf-4a46-9128-bcf2833a9a2d" xlink:to="loc_lgnd_ReturnsAccrual_c40fee97-a316-469f-bf39-4438c0754bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent_89381271-71f3-4b80-9049-815ed9407b6b" xlink:href="lgnd-20210630.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_73658b5b-afdf-4a46-9128-bcf2833a9a2d" xlink:to="loc_lgnd_AccruedAssetAcquisitionsCurrent_89381271-71f3-4b80-9049-815ed9407b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent_febbc7c3-21a9-42d2-8834-27a3ce921c25" xlink:href="lgnd-20210630.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_73658b5b-afdf-4a46-9128-bcf2833a9a2d" xlink:to="loc_lgnd_AccruedSubcontractorExpensesCurrent_febbc7c3-21a9-42d2-8834-27a3ce921c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent_56e68d0b-d5dd-4f42-93a0-37492e69fb2f" xlink:href="lgnd-20210630.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_73658b5b-afdf-4a46-9128-bcf2833a9a2d" xlink:to="loc_lgnd_AccruedSupplierExpensesCurrent_56e68d0b-d5dd-4f42-93a0-37492e69fb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_9a4070e0-ee39-49fc-bc05-5a843300847c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_73658b5b-afdf-4a46-9128-bcf2833a9a2d" xlink:to="loc_us-gaap_InterestPayableCurrent_9a4070e0-ee39-49fc-bc05-5a843300847c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cce29a20-e325-4ab5-9cc4-30cd74eecfba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_73658b5b-afdf-4a46-9128-bcf2833a9a2d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cce29a20-e325-4ab5-9cc4-30cd74eecfba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_64c72cbe-83cf-44e2-9f7f-9682266108fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_73658b5b-afdf-4a46-9128-bcf2833a9a2d" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_64c72cbe-83cf-44e2-9f7f-9682266108fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_19e6dded-aab9-4437-bca5-981911bf2867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_e3ade036-61f9-4415-96e8-5d873b6470e3" xlink:href="lgnd-20210630.xsd#lgnd_BasisOfPresentationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_19e6dded-aab9-4437-bca5-981911bf2867" xlink:to="loc_lgnd_BasisOfPresentationTable_e3ade036-61f9-4415-96e8-5d873b6470e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_740f32f5-2224-48e4-91ff-573d514e6401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_e3ade036-61f9-4415-96e8-5d873b6470e3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_740f32f5-2224-48e4-91ff-573d514e6401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cc612ebb-2054-4fc0-979c-a2a966c6081d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_740f32f5-2224-48e4-91ff-573d514e6401" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cc612ebb-2054-4fc0-979c-a2a966c6081d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_37af62d0-5df4-45c5-ab81-fcd7d3f36993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cc612ebb-2054-4fc0-979c-a2a966c6081d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_37af62d0-5df4-45c5-ab81-fcd7d3f36993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_cd9a0180-5a9e-498a-b080-fded796a91e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cc612ebb-2054-4fc0-979c-a2a966c6081d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_cd9a0180-5a9e-498a-b080-fded796a91e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_e32eed31-a10d-4008-8d31-97d0127d54a0" xlink:href="lgnd-20210630.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_e3ade036-61f9-4415-96e8-5d873b6470e3" xlink:to="loc_lgnd_BasisOfPresentationLineItems_e32eed31-a10d-4008-8d31-97d0127d54a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e61f5387-ff12-4e10-aaaa-121a29ec3878" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_e32eed31-a10d-4008-8d31-97d0127d54a0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e61f5387-ff12-4e10-aaaa-121a29ec3878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_71bf7176-c107-42d8-8469-5c09194bd389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5a6b77b8-2356-485d-a48e-cfd61b6f28db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_71bf7176-c107-42d8-8469-5c09194bd389" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5a6b77b8-2356-485d-a48e-cfd61b6f28db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_90b7eadb-12cb-4b4e-92cf-44f44885b569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_71bf7176-c107-42d8-8469-5c09194bd389" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_90b7eadb-12cb-4b4e-92cf-44f44885b569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6c666108-e536-4974-ac0e-b562f3f05a65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_71bf7176-c107-42d8-8469-5c09194bd389" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6c666108-e536-4974-ac0e-b562f3f05a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_16f6f14f-243f-48e0-9361-d09349b3f31c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_71bf7176-c107-42d8-8469-5c09194bd389" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_16f6f14f-243f-48e0-9361-d09349b3f31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fa8b9264-61b0-47af-bb00-ef3558c4778f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_441aaff7-bcc6-4069-91b1-99cc0568f148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fa8b9264-61b0-47af-bb00-ef3558c4778f" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_441aaff7-bcc6-4069-91b1-99cc0568f148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_865c6a03-64f8-488f-bfc1-8b63ff35f0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_441aaff7-bcc6-4069-91b1-99cc0568f148" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_865c6a03-64f8-488f-bfc1-8b63ff35f0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_01caa6bd-10f6-4a39-a891-062f0fce1c49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_441aaff7-bcc6-4069-91b1-99cc0568f148" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_01caa6bd-10f6-4a39-a891-062f0fce1c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_d8c91f06-325f-43de-8750-0951510065e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_01caa6bd-10f6-4a39-a891-062f0fce1c49" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_d8c91f06-325f-43de-8750-0951510065e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_cd76bea3-7605-4233-8568-7ec4d3e7abec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_01caa6bd-10f6-4a39-a891-062f0fce1c49" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_cd76bea3-7605-4233-8568-7ec4d3e7abec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8da014de-3a40-4ad4-9ac8-f9b99580457b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_01caa6bd-10f6-4a39-a891-062f0fce1c49" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8da014de-3a40-4ad4-9ac8-f9b99580457b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_69d7e3cc-afc9-4460-ad61-e16d69f905d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_441aaff7-bcc6-4069-91b1-99cc0568f148" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_69d7e3cc-afc9-4460-ad61-e16d69f905d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="lgnd-20210630.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a3cdd1fe-dbb4-4510-b23f-eaeb240fa39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_df17e53d-4519-482e-b081-7303fcc4ae38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a3cdd1fe-dbb4-4510-b23f-eaeb240fa39e" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_df17e53d-4519-482e-b081-7303fcc4ae38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="lgnd-20210630.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_45cd09be-1d24-4da7-b15b-0b9e45295111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_842a0960-689e-4d3f-be22-61885be5757d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_45cd09be-1d24-4da7-b15b-0b9e45295111" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_842a0960-689e-4d3f-be22-61885be5757d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_00d49ba3-627e-405a-8111-35d48dc5a272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_45cd09be-1d24-4da7-b15b-0b9e45295111" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_00d49ba3-627e-405a-8111-35d48dc5a272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d713518d-63f4-4a73-bfa1-3fee34365a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d713518d-63f4-4a73-bfa1-3fee34365a10" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d254c75c-8128-4a7f-acfc-c9a8e9b0d5ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d254c75c-8128-4a7f-acfc-c9a8e9b0d5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3c5d4475-bdf2-471c-aa1d-6691959d8fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d254c75c-8128-4a7f-acfc-c9a8e9b0d5ba" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3c5d4475-bdf2-471c-aa1d-6691959d8fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d5fabc3c-a068-4bee-ac5e-d19d53382327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3c5d4475-bdf2-471c-aa1d-6691959d8fd3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d5fabc3c-a068-4bee-ac5e-d19d53382327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fdf443ac-32c0-4de0-b363-e74c7c7187bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fdf443ac-32c0-4de0-b363-e74c7c7187bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3ece9399-3d56-4715-9a1a-104f8fe6c985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fdf443ac-32c0-4de0-b363-e74c7c7187bf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3ece9399-3d56-4715-9a1a-104f8fe6c985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_dffaba7d-dd33-4171-aac3-1604def6263d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3ece9399-3d56-4715-9a1a-104f8fe6c985" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_dffaba7d-dd33-4171-aac3-1604def6263d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b725a674-457e-4c00-941e-a464f2a9fb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3ece9399-3d56-4715-9a1a-104f8fe6c985" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b725a674-457e-4c00-941e-a464f2a9fb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_da47663e-e942-4010-bf63-07e84792a25d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3ece9399-3d56-4715-9a1a-104f8fe6c985" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_da47663e-e942-4010-bf63-07e84792a25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b38f2b8b-2679-41ba-898c-b59375814085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b38f2b8b-2679-41ba-898c-b59375814085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a43ca1aa-ff49-438e-a865-aaf7c1f09d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b38f2b8b-2679-41ba-898c-b59375814085" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a43ca1aa-ff49-438e-a865-aaf7c1f09d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_0bb8f24b-9cb1-4323-9831-30bdeb3e9907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a43ca1aa-ff49-438e-a865-aaf7c1f09d6b" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_0bb8f24b-9cb1-4323-9831-30bdeb3e9907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_8bd9bc1f-44e8-4425-b8c0-01609bd5216a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a43ca1aa-ff49-438e-a865-aaf7c1f09d6b" xlink:to="loc_us-gaap_EquitySecuritiesMember_8bd9bc1f-44e8-4425-b8c0-01609bd5216a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_14bf9d5d-be79-471a-8c0a-da91ee5e6fae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a43ca1aa-ff49-438e-a865-aaf7c1f09d6b" xlink:to="loc_us-gaap_WarrantMember_14bf9d5d-be79-471a-8c0a-da91ee5e6fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_33a35d2b-4528-45dc-b33f-fac08c6501c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_33a35d2b-4528-45dc-b33f-fac08c6501c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_33a35d2b-4528-45dc-b33f-fac08c6501c4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_69075c66-8cd3-4d6c-aa07-f9d05d726bd5" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyCrystalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_69075c66-8cd3-4d6c-aa07-f9d05d726bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_d11dc117-1659-48c5-b764-b308b0aeaa79" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_d11dc117-1659-48c5-b764-b308b0aeaa79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_63d74443-82aa-49e5-8e42-88fab377ce74" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_63d74443-82aa-49e5-8e42-88fab377ce74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_7e7e1ef2-ae18-46a4-ab9d-8d49739cf86f" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_7e7e1ef2-ae18-46a4-ab9d-8d49739cf86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_94c48d1c-603c-4623-9e08-df3c9af15e55" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyPfenexMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_94c48d1c-603c-4623-9e08-df3c9af15e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_b30f2b98-4e60-4e35-a370-3e572e2c9aaf" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyXCellaMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_b30f2b98-4e60-4e35-a370-3e572e2c9aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_8ad91216-b1e6-4bae-b842-c1f6b6a471f7" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2a103644-5f18-4ecf-bf6b-03bcc7c52c34" xlink:to="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_8ad91216-b1e6-4bae-b842-c1f6b6a471f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ace4ce39-2a84-4f83-947d-0cb2f8eb0f77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ace4ce39-2a84-4f83-947d-0cb2f8eb0f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed4264be-11d1-4295-9f56-94a7f6e21ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ace4ce39-2a84-4f83-947d-0cb2f8eb0f77" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed4264be-11d1-4295-9f56-94a7f6e21ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_2cee14ac-e734-4c3a-92de-6c5f8512d015" xlink:href="lgnd-20210630.xsd#lgnd_MetabasisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed4264be-11d1-4295-9f56-94a7f6e21ca6" xlink:to="loc_lgnd_MetabasisMember_2cee14ac-e734-4c3a-92de-6c5f8512d015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ad62b421-c4fb-4658-a51e-ca4a6f9b9add" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_srt_RangeAxis_ad62b421-c4fb-4658-a51e-ca4a6f9b9add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4100fee0-2e82-4b0d-98ca-1f82bb93b96a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ad62b421-c4fb-4658-a51e-ca4a6f9b9add" xlink:to="loc_srt_RangeMember_4100fee0-2e82-4b0d-98ca-1f82bb93b96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a73daadb-7aea-4202-84c9-aff8b8f9b256" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4100fee0-2e82-4b0d-98ca-1f82bb93b96a" xlink:to="loc_srt_MaximumMember_a73daadb-7aea-4202-84c9-aff8b8f9b256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ee99db6c-769e-4720-b05a-2e67521d8c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ee99db6c-769e-4720-b05a-2e67521d8c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d8403553-1d19-45d6-bd6a-ed0da6794038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ee99db6c-769e-4720-b05a-2e67521d8c12" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d8403553-1d19-45d6-bd6a-ed0da6794038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_eff663f8-4779-435a-b132-87ea79d27756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d8403553-1d19-45d6-bd6a-ed0da6794038" xlink:to="loc_us-gaap_TransferredOverTimeMember_eff663f8-4779-435a-b132-87ea79d27756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d5f61ab7-9368-4ecd-b235-3fbfc8e3267e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_srt_ProductOrServiceAxis_d5f61ab7-9368-4ecd-b235-3fbfc8e3267e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1d2b4f82-ad26-4fb1-b6dd-927721340e7d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d5f61ab7-9368-4ecd-b235-3fbfc8e3267e" xlink:to="loc_srt_ProductsAndServicesDomain_1d2b4f82-ad26-4fb1-b6dd-927721340e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_cfab4218-2d3b-41d6-815e-5868566be728" xlink:href="lgnd-20210630.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1d2b4f82-ad26-4fb1-b6dd-927721340e7d" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_cfab4218-2d3b-41d6-815e-5868566be728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_e7394ec0-da20-460f-9b42-a31ca79aa24e" xlink:href="lgnd-20210630.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1d2b4f82-ad26-4fb1-b6dd-927721340e7d" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_e7394ec0-da20-460f-9b42-a31ca79aa24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe56aeaa-8922-4cb8-ad7e-9b51de4221d3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ec75aa7e-716e-4728-ab1d-11282f64f899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ec75aa7e-716e-4728-ab1d-11282f64f899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_d612484c-b52c-4649-9124-d82a503f4e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_d612484c-b52c-4649-9124-d82a503f4e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_06b7a236-2949-410b-9c23-2ddef00bef6c" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_06b7a236-2949-410b-9c23-2ddef00bef6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_14cc019d-d950-41c6-aa5e-d54cf42e1dcd" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_14cc019d-d950-41c6-aa5e-d54cf42e1dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_b4840328-bc5d-4c76-a098-dbc6308e0dd8" xlink:href="lgnd-20210630.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_b4840328-bc5d-4c76-a098-dbc6308e0dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_7d3323a4-bea4-4fd3-956d-72ec3c894ab5" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_7d3323a4-bea4-4fd3-956d-72ec3c894ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_46383bc2-c613-4170-8675-5882ced13085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_us-gaap_Investments_46383bc2-c613-4170-8675-5882ced13085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_9e90d2c7-58d7-40b4-a51c-1957cfd89e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_9e90d2c7-58d7-40b4-a51c-1957cfd89e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_a4c93a1b-65fd-4982-b898-a0a6588eee72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_a4c93a1b-65fd-4982-b898-a0a6588eee72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b4b8478f-bf0e-4241-93a6-73a18d00d079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d18fd16e-4f4e-4386-9c63-77f9736e0da4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b4b8478f-bf0e-4241-93a6-73a18d00d079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1b5f33c9-727d-4258-9c9e-c811a2c74a36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_370d4f7f-5edd-4f5e-a20d-b642dfff274e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1b5f33c9-727d-4258-9c9e-c811a2c74a36" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_370d4f7f-5edd-4f5e-a20d-b642dfff274e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22a4f1c6-f59e-4a95-b783-4622f899149b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_370d4f7f-5edd-4f5e-a20d-b642dfff274e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22a4f1c6-f59e-4a95-b783-4622f899149b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_08d97e94-6aa6-45e7-b55d-961bfd61335c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22a4f1c6-f59e-4a95-b783-4622f899149b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_08d97e94-6aa6-45e7-b55d-961bfd61335c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5ea1728f-27cd-45c6-938b-b6be108e0398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_08d97e94-6aa6-45e7-b55d-961bfd61335c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5ea1728f-27cd-45c6-938b-b6be108e0398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c59e4f44-81b3-4a56-81fc-13880d3e9623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_370d4f7f-5edd-4f5e-a20d-b642dfff274e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c59e4f44-81b3-4a56-81fc-13880d3e9623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e9cb44ae-db6d-4efb-a925-b25913825ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c59e4f44-81b3-4a56-81fc-13880d3e9623" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e9cb44ae-db6d-4efb-a925-b25913825ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b2ffa6ae-9707-477b-afdf-4aa5c226f92d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e9cb44ae-db6d-4efb-a925-b25913825ec0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b2ffa6ae-9707-477b-afdf-4aa5c226f92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders_5fd208e2-38ef-4b7d-ae06-d9584d896d6f" xlink:href="lgnd-20210630.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e9cb44ae-db6d-4efb-a925-b25913825ec0" xlink:to="loc_lgnd_PaymentsToContingentValueRightHolders_5fd208e2-38ef-4b7d-ae06-d9584d896d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f68ba9dc-4851-4863-b5dd-de90c06eb87b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e9cb44ae-db6d-4efb-a925-b25913825ec0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f68ba9dc-4851-4863-b5dd-de90c06eb87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_c36dbdcf-4723-4d8a-a941-aa45133fb1d4" xlink:href="lgnd-20210630.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e9cb44ae-db6d-4efb-a925-b25913825ec0" xlink:to="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_c36dbdcf-4723-4d8a-a941-aa45133fb1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_70092e62-4883-4361-b3f1-aa846b5a2fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e9cb44ae-db6d-4efb-a925-b25913825ec0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_70092e62-4883-4361-b3f1-aa846b5a2fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/Acquisitions" xlink:type="simple" xlink:href="lgnd-20210630.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9aa6bdfa-ead1-49b5-a475-c034dc8f6b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_9887129e-0e36-47bd-b211-8fd78bcb1e13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9aa6bdfa-ead1-49b5-a475-c034dc8f6b83" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_9887129e-0e36-47bd-b211-8fd78bcb1e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="lgnd-20210630.xsd#AcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c709a23f-58d4-4061-a261-0e5dfb235ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_94946fd8-bedf-4fef-bf7c-2b3beaf23921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c709a23f-58d4-4061-a261-0e5dfb235ed6" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_94946fd8-bedf-4fef-bf7c-2b3beaf23921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_f10ea21b-7720-415f-8e2b-d1bc7abafc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c709a23f-58d4-4061-a261-0e5dfb235ed6" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_f10ea21b-7720-415f-8e2b-d1bc7abafc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#AcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_424c38a3-d6ae-4e21-aa58-f71f679d8b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_197fb7b6-2770-494b-a9f0-b83ca42ef939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_424c38a3-d6ae-4e21-aa58-f71f679d8b9f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_197fb7b6-2770-494b-a9f0-b83ca42ef939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3d87f92d-86d9-4d91-b4cf-1fe9335e3083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_197fb7b6-2770-494b-a9f0-b83ca42ef939" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3d87f92d-86d9-4d91-b4cf-1fe9335e3083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4b9de3d-6bd3-4b41-8cfc-4e971948afa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3d87f92d-86d9-4d91-b4cf-1fe9335e3083" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4b9de3d-6bd3-4b41-8cfc-4e971948afa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_21f58b21-ad47-412a-8002-07d32334b8af" xlink:href="lgnd-20210630.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4b9de3d-6bd3-4b41-8cfc-4e971948afa7" xlink:to="loc_lgnd_PfenexMember_21f58b21-ad47-412a-8002-07d32334b8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TaurusBiosciencesLLCMember_a499940f-596b-4855-b19c-188f5f5f5e82" xlink:href="lgnd-20210630.xsd#lgnd_TaurusBiosciencesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4b9de3d-6bd3-4b41-8cfc-4e971948afa7" xlink:to="loc_lgnd_TaurusBiosciencesLLCMember_a499940f-596b-4855-b19c-188f5f5f5e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_145b57f3-1aee-402c-84d5-97e623f2e6eb" xlink:href="lgnd-20210630.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4b9de3d-6bd3-4b41-8cfc-4e971948afa7" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_145b57f3-1aee-402c-84d5-97e623f2e6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IcagenMember_5efa4246-98b2-4142-a455-52b949510372" xlink:href="lgnd-20210630.xsd#lgnd_IcagenMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4b9de3d-6bd3-4b41-8cfc-4e971948afa7" xlink:to="loc_lgnd_IcagenMember_5efa4246-98b2-4142-a455-52b949510372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1efaddf6-6171-4090-841b-04578aa2397f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_197fb7b6-2770-494b-a9f0-b83ca42ef939" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1efaddf6-6171-4090-841b-04578aa2397f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_22af1621-3ab9-4fd0-b5c5-0f8ad51b930f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1efaddf6-6171-4090-841b-04578aa2397f" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_22af1621-3ab9-4fd0-b5c5-0f8ad51b930f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_f446c53e-56cd-4e42-bfed-f6a8c3c4cc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_22af1621-3ab9-4fd0-b5c5-0f8ad51b930f" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_f446c53e-56cd-4e42-bfed-f6a8c3c4cc8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f4f14832-ca23-441c-ab66-b08051859abf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_197fb7b6-2770-494b-a9f0-b83ca42ef939" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f4f14832-ca23-441c-ab66-b08051859abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_845ebfe8-df68-4733-aacc-08f29d7c4665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f4f14832-ca23-441c-ab66-b08051859abf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_845ebfe8-df68-4733-aacc-08f29d7c4665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_995fe712-e06f-4dda-baa1-abd2fbec0fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_845ebfe8-df68-4733-aacc-08f29d7c4665" xlink:to="loc_us-gaap_ContractualRightsMember_995fe712-e06f-4dda-baa1-abd2fbec0fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_250ea516-f89d-4420-8298-cb1acbbd2143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_845ebfe8-df68-4733-aacc-08f29d7c4665" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_250ea516-f89d-4420-8298-cb1acbbd2143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_83eb94d2-e7e5-4e18-b0fa-b442528dba24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_845ebfe8-df68-4733-aacc-08f29d7c4665" xlink:to="loc_us-gaap_CustomerRelationshipsMember_83eb94d2-e7e5-4e18-b0fa-b442528dba24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ad543047-b557-4ef7-8ae3-285f007a80f9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_197fb7b6-2770-494b-a9f0-b83ca42ef939" xlink:to="loc_srt_RangeAxis_ad543047-b557-4ef7-8ae3-285f007a80f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bdaa0c1c-9bd7-44b1-8ee9-2c3ddd48b751" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ad543047-b557-4ef7-8ae3-285f007a80f9" xlink:to="loc_srt_RangeMember_bdaa0c1c-9bd7-44b1-8ee9-2c3ddd48b751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d8a97b80-d2f3-4831-a201-5766beca3785" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bdaa0c1c-9bd7-44b1-8ee9-2c3ddd48b751" xlink:to="loc_srt_MinimumMember_d8a97b80-d2f3-4831-a201-5766beca3785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0c7d676d-0fc8-4d57-bf6b-d4cdb1526fb6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bdaa0c1c-9bd7-44b1-8ee9-2c3ddd48b751" xlink:to="loc_srt_MaximumMember_0c7d676d-0fc8-4d57-bf6b-d4cdb1526fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_ffad0694-2d6b-43d6-bb76-e22e482f2a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_197fb7b6-2770-494b-a9f0-b83ca42ef939" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_ffad0694-2d6b-43d6-bb76-e22e482f2a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_6fba37f3-a2ce-4178-abf4-4b5a8385398b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_ffad0694-2d6b-43d6-bb76-e22e482f2a2e" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_6fba37f3-a2ce-4178-abf4-4b5a8385398b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_796600f6-ad73-4ee2-b792-5faaa44cff2a" xlink:href="lgnd-20210630.xsd#lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_6fba37f3-a2ce-4178-abf4-4b5a8385398b" xlink:to="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_796600f6-ad73-4ee2-b792-5faaa44cff2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightOnProductRevenuesMember_6633a03b-36f3-4712-91a3-6b952fc1d34a" xlink:href="lgnd-20210630.xsd#lgnd_ContingentValueRightOnProductRevenuesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_6fba37f3-a2ce-4178-abf4-4b5a8385398b" xlink:to="loc_lgnd_ContingentValueRightOnProductRevenuesMember_6633a03b-36f3-4712-91a3-6b952fc1d34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_36f4813b-79d4-4c4b-9ee4-042f0e9822fa" xlink:href="lgnd-20210630.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_6fba37f3-a2ce-4178-abf4-4b5a8385398b" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_36f4813b-79d4-4c4b-9ee4-042f0e9822fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestonePaymentsMember_d7014d6b-b89b-438f-af66-5ccc4762b093" xlink:href="lgnd-20210630.xsd#lgnd_MilestonePaymentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_6fba37f3-a2ce-4178-abf4-4b5a8385398b" xlink:to="loc_lgnd_MilestonePaymentsMember_d7014d6b-b89b-438f-af66-5ccc4762b093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_197fb7b6-2770-494b-a9f0-b83ca42ef939" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a35b5583-841b-4a0b-8ee5-ffb25ba4216c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a35b5583-841b-4a0b-8ee5-ffb25ba4216c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_403276f3-b9b5-4610-aeeb-a90b1c78fa09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_403276f3-b9b5-4610-aeeb-a90b1c78fa09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_50fdf3e9-d67b-4cdb-ba35-b795572fd258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_50fdf3e9-d67b-4cdb-ba35-b795572fd258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_5ba34a5a-50fc-4bc7-8b72-063eb6aea73c" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_5ba34a5a-50fc-4bc7-8b72-063eb6aea73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_e9b87ca4-4a3b-42f0-aa31-d9b412f3e559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_e9b87ca4-4a3b-42f0-aa31-d9b412f3e559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_df95dd32-3596-4e56-8337-f05ba1304e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_df95dd32-3596-4e56-8337-f05ba1304e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_53b5f512-2882-4cec-aa7a-8b18cf01887d" xlink:href="lgnd-20210630.xsd#lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_53b5f512-2882-4cec-aa7a-8b18cf01887d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_e94ad173-5038-43c5-9ca2-cce609e89562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_e94ad173-5038-43c5-9ca2-cce609e89562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_eab3c90e-f947-47dd-8a92-9b7d6100a2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_eab3c90e-f947-47dd-8a92-9b7d6100a2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_1649ae0f-8c27-42da-9440-2b29d8dac17b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_1649ae0f-8c27-42da-9440-2b29d8dac17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_3b0ea951-363d-460d-88f7-314a36e08af5" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_3b0ea951-363d-460d-88f7-314a36e08af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_7a54d5db-303c-4ac2-8e44-93f1ab17c3c8" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationConsiderationTransferredHoldback"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_7a54d5db-303c-4ac2-8e44-93f1ab17c3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_8988aa4c-a1f7-4969-b1a7-0fc5d83c2b59" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_8988aa4c-a1f7-4969-b1a7-0fc5d83c2b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_e599266a-c523-4050-b698-8de558d43f06" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_e599266a-c523-4050-b698-8de558d43f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_419f4bb3-44dd-41bc-9b08-974ffbe4772d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_419f4bb3-44dd-41bc-9b08-974ffbe4772d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_739b66a5-36ab-42ef-9bf0-e5764c178237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_739b66a5-36ab-42ef-9bf0-e5764c178237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_99c1e69d-6e5a-46b3-b321-5ddc67a4b542" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_99c1e69d-6e5a-46b3-b321-5ddc67a4b542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_31b861d4-e084-4440-958c-390e3539fc77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_31b861d4-e084-4440-958c-390e3539fc77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_6170932f-4e7c-4eb9-a5fb-166bfb6f3d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_6170932f-4e7c-4eb9-a5fb-166bfb6f3d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_8be27a41-ccc1-4bab-80e1-f37d0e59f3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_8be27a41-ccc1-4bab-80e1-f37d0e59f3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_918ee7a2-ade5-468d-b455-c07238d1257c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc3aee6d-1707-458c-8d5c-67f966cc8057" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_918ee7a2-ade5-468d-b455-c07238d1257c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_218bbacb-3aa5-4cdc-8eaa-f56cea09ac13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_df33bec1-9041-421a-b2e1-c97e1cb0c9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_218bbacb-3aa5-4cdc-8eaa-f56cea09ac13" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_df33bec1-9041-421a-b2e1-c97e1cb0c9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_79b84663-eeec-4007-81b2-365df432304b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_df33bec1-9041-421a-b2e1-c97e1cb0c9f3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_79b84663-eeec-4007-81b2-365df432304b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81c41adc-6698-4356-967d-a438d1a0cefd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_79b84663-eeec-4007-81b2-365df432304b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81c41adc-6698-4356-967d-a438d1a0cefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_b4357bd8-fa08-48b7-b933-1d8a93eb9671" xlink:href="lgnd-20210630.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81c41adc-6698-4356-967d-a438d1a0cefd" xlink:to="loc_lgnd_PfenexMember_b4357bd8-fa08-48b7-b933-1d8a93eb9671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_df33bec1-9041-421a-b2e1-c97e1cb0c9f3" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_a467d1d6-1cb6-4e23-8742-9c420c2e8957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_a467d1d6-1cb6-4e23-8742-9c420c2e8957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_f96351a4-64ad-4473-a765-c04068f73722" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_f96351a4-64ad-4473-a765-c04068f73722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_f707283e-3419-4fac-9451-98adead3e261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_f707283e-3419-4fac-9451-98adead3e261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a35d63ca-dd85-4420-a163-8324662103a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a35d63ca-dd85-4420-a163-8324662103a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_202ea05f-e1ea-4b67-97a5-6e4ab50f0b9a" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_202ea05f-e1ea-4b67-97a5-6e4ab50f0b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_770f260d-e4b9-4906-a98f-945338304aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_770f260d-e4b9-4906-a98f-945338304aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_2b755a3e-4a27-47d9-9f30-e5206cc04827" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_2b755a3e-4a27-47d9-9f30-e5206cc04827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3f9ceec8-3115-4ddb-9f28-4ce5468f9392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_Goodwill_3f9ceec8-3115-4ddb-9f28-4ce5468f9392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_dd30b292-81e5-4d3e-8bd9-37cde0cb3ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_dd30b292-81e5-4d3e-8bd9-37cde0cb3ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_a078b0a7-547d-4f7b-a81a-c9d92f36d353" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_a078b0a7-547d-4f7b-a81a-c9d92f36d353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_8f15c579-1a5b-4581-84c5-8b63b626d380" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_8f15c579-1a5b-4581-84c5-8b63b626d380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_baea0193-f5b3-4d92-a3fa-ad31fc05fd42" xlink:href="lgnd-20210630.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_baea0193-f5b3-4d92-a3fa-ad31fc05fd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_f28ac3af-4af7-482e-a4b4-208e0484739d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_f28ac3af-4af7-482e-a4b4-208e0484739d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_292e4ee2-e30d-458a-9d09-b483ac6d04b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_292e4ee2-e30d-458a-9d09-b483ac6d04b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e9a3667a-7a62-4585-8a54-6a082356d108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e9a3667a-7a62-4585-8a54-6a082356d108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_e8a9cd77-ebe0-4e63-9350-933ca96fb16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5c0e7f03-5cef-43f2-b049-c06ff3b99422" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_e8a9cd77-ebe0-4e63-9350-933ca96fb16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#AcquisitionsProFormaFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6f41c5ca-574d-48e2-abaa-62b127c9d51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc00fc4b-8ab8-4512-a6d7-aa508088a778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6f41c5ca-574d-48e2-abaa-62b127c9d51a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc00fc4b-8ab8-4512-a6d7-aa508088a778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b7ee11ba-d7c1-45a5-8c90-e18f73711a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc00fc4b-8ab8-4512-a6d7-aa508088a778" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b7ee11ba-d7c1-45a5-8c90-e18f73711a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fdbf2c40-a6c0-4905-89a4-64280fd5517c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b7ee11ba-d7c1-45a5-8c90-e18f73711a9b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fdbf2c40-a6c0-4905-89a4-64280fd5517c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_11d38e54-294b-41f2-b812-b749b556c447" xlink:href="lgnd-20210630.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fdbf2c40-a6c0-4905-89a4-64280fd5517c" xlink:to="loc_lgnd_PfenexMember_11d38e54-294b-41f2-b812-b749b556c447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e74dc910-a455-4c20-8db5-a964f441708c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fc00fc4b-8ab8-4512-a6d7-aa508088a778" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e74dc910-a455-4c20-8db5-a964f441708c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_022b11a6-fe58-4687-92c0-0c02020e71dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e74dc910-a455-4c20-8db5-a964f441708c" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_022b11a6-fe58-4687-92c0-0c02020e71dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_83f02dfe-2ae5-4ca2-85f8-167195fd9a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e74dc910-a455-4c20-8db5-a964f441708c" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_83f02dfe-2ae5-4ca2-85f8-167195fd9a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareProFormaAbstract_a250b7d7-b5fe-4165-a915-6eee509c2a03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareProFormaAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e74dc910-a455-4c20-8db5-a964f441708c" xlink:to="loc_us-gaap_EarningsPerShareProFormaAbstract_a250b7d7-b5fe-4165-a915-6eee509c2a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_902ddce4-8318-49d7-9ade-f99fd645a67a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_a250b7d7-b5fe-4165-a915-6eee509c2a03" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_902ddce4-8318-49d7-9ade-f99fd645a67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_42cc9256-6f19-41f6-9652-38fd5e8ed92f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_a250b7d7-b5fe-4165-a915-6eee509c2a03" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_42cc9256-6f19-41f6-9652-38fd5e8ed92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="simple" xlink:href="lgnd-20210630.xsd#ConvertibleSeniorNotes"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9fff7a81-adda-4c14-9053-d2a22c2ba984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_6eb378ed-6d4a-48af-9632-c988e50a7ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9fff7a81-adda-4c14-9053-d2a22c2ba984" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_6eb378ed-6d4a-48af-9632-c988e50a7ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="simple" xlink:href="lgnd-20210630.xsd#ConvertibleSeniorNotesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_801232e7-6afb-4e70-bcf5-d712633ca2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_93a90afd-ff05-426b-b6b7-0db3f31353c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_801232e7-6afb-4e70-bcf5-d712633ca2bc" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_93a90afd-ff05-426b-b6b7-0db3f31353c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c5de7ef1-dc4c-481c-bb40-9f36359d3c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9ade0351-398a-40ed-955b-351993557c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c5de7ef1-dc4c-481c-bb40-9f36359d3c98" xlink:to="loc_us-gaap_DebtInstrumentTable_9ade0351-398a-40ed-955b-351993557c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_54f554f6-dfa6-45df-8919-e5af05829a91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9ade0351-398a-40ed-955b-351993557c11" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_54f554f6-dfa6-45df-8919-e5af05829a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3c1fe275-69d8-4e0d-91b9-2844ce176b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_54f554f6-dfa6-45df-8919-e5af05829a91" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3c1fe275-69d8-4e0d-91b9-2844ce176b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_041e1ebb-46d0-46b8-b9f5-9a5759147864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3c1fe275-69d8-4e0d-91b9-2844ce176b8d" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_041e1ebb-46d0-46b8-b9f5-9a5759147864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_02effb6c-20d4-4b41-b62b-9c128e363d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9ade0351-398a-40ed-955b-351993557c11" xlink:to="loc_us-gaap_DebtInstrumentAxis_02effb6c-20d4-4b41-b62b-9c128e363d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_25b33570-e0b2-40e5-ad28-e774bcdc23e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_02effb6c-20d4-4b41-b62b-9c128e363d20" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_25b33570-e0b2-40e5-ad28-e774bcdc23e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_ba6ea24d-2902-44b9-a67a-fbec43c5a84c" xlink:href="lgnd-20210630.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_25b33570-e0b2-40e5-ad28-e774bcdc23e3" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_ba6ea24d-2902-44b9-a67a-fbec43c5a84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d12c01e2-77b2-45d9-a92d-05e654b3d002" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9ade0351-398a-40ed-955b-351993557c11" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d12c01e2-77b2-45d9-a92d-05e654b3d002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_724a966c-bc73-4c89-90e7-795c774c9651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d12c01e2-77b2-45d9-a92d-05e654b3d002" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_724a966c-bc73-4c89-90e7-795c774c9651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_4983b7bc-6776-426a-bb83-0603a39e09a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_724a966c-bc73-4c89-90e7-795c774c9651" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_4983b7bc-6776-426a-bb83-0603a39e09a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_3853a58d-ab60-452f-b044-4734f0a19db6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_724a966c-bc73-4c89-90e7-795c774c9651" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_3853a58d-ab60-452f-b044-4734f0a19db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9ade0351-398a-40ed-955b-351993557c11" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_d8638565-2d17-4895-aa7f-47133a810249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_d8638565-2d17-4895-aa7f-47133a810249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c7fd3dd4-f59d-4e2d-8895-7981b52b6675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c7fd3dd4-f59d-4e2d-8895-7981b52b6675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_b69d828b-bef3-46c0-acb7-b0e7929f9f01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_b69d828b-bef3-46c0-acb7-b0e7929f9f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_e53c3a72-fa7f-4907-8b05-8678366fb5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_e53c3a72-fa7f-4907-8b05-8678366fb5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_2395f830-5bba-4339-b216-f83e556d9262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_2395f830-5bba-4339-b216-f83e556d9262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_74cb7974-8f59-4c63-b000-e771bbe4f55d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_74cb7974-8f59-4c63-b000-e771bbe4f55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_28cf7b0c-c40e-4361-809c-c47a27429303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_28cf7b0c-c40e-4361-809c-c47a27429303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_9412cba4-d79e-4e3f-93a8-d7f46128e578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_9412cba4-d79e-4e3f-93a8-d7f46128e578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_d2d012a6-dd27-4682-bceb-f433da0c5fd9" xlink:href="lgnd-20210630.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_d2d012a6-dd27-4682-bceb-f433da0c5fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_86f220ea-0614-440f-8f9c-5916201f8afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_86f220ea-0614-440f-8f9c-5916201f8afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_ab4f006b-f173-4a20-b91f-8be8a6816a08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_ab4f006b-f173-4a20-b91f-8be8a6816a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_23bb409f-1e0d-432f-a38e-9216f7cfa351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_23bb409f-1e0d-432f-a38e-9216f7cfa351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_75642437-a75d-481e-b3b8-2fa179974c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_75642437-a75d-481e-b3b8-2fa179974c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_96b3e4c3-df6f-4f18-9d7d-6e931503436a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_96b3e4c3-df6f-4f18-9d7d-6e931503436a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6c928d4a-49aa-49e7-ac9d-e05338c44228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6c928d4a-49aa-49e7-ac9d-e05338c44228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_7b3b2578-db12-4435-bc76-0e480c17bc2e" xlink:href="lgnd-20210630.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_7b3b2578-db12-4435-bc76-0e480c17bc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_253eb29e-51be-412b-8f93-02c54ccbe185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_253eb29e-51be-412b-8f93-02c54ccbe185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9660a079-66ef-47ce-8b1d-dd9a11a8e4df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9660a079-66ef-47ce-8b1d-dd9a11a8e4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_f15c2c7d-9297-47b9-baa9-95e4d69e846f" xlink:href="lgnd-20210630.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_f15c2c7d-9297-47b9-baa9-95e4d69e846f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a07f2dac-f58c-4f17-a918-d1fe8c1b8e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a07f2dac-f58c-4f17-a918-d1fe8c1b8e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_ec6c8c1a-eb0d-4739-a132-4616df841e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_ec6c8c1a-eb0d-4739-a132-4616df841e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_44d88cc6-9eee-47a8-ad04-d22d966a6aae" xlink:href="lgnd-20210630.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_44d88cc6-9eee-47a8-ad04-d22d966a6aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_34b43e24-b278-4156-bc3f-23e654570437" xlink:href="lgnd-20210630.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_34b43e24-b278-4156-bc3f-23e654570437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_14dd64b1-b318-4491-9827-52f08b112e4a" xlink:href="lgnd-20210630.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d25a1172-31ad-46f7-ac8e-3fc13bdb0d37" xlink:to="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_14dd64b1-b318-4491-9827-52f08b112e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_aad5e0e0-0b21-4331-a708-2579b06227ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_084bcf46-f7b9-4497-b224-7d20d39ff0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_aad5e0e0-0b21-4331-a708-2579b06227ad" xlink:to="loc_us-gaap_DebtInstrumentTable_084bcf46-f7b9-4497-b224-7d20d39ff0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ab1dcf8e-1b99-4f62-805b-db521c9941da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_084bcf46-f7b9-4497-b224-7d20d39ff0c9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ab1dcf8e-1b99-4f62-805b-db521c9941da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c6fff79a-b8d7-42a9-852f-ea168a6d55ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ab1dcf8e-1b99-4f62-805b-db521c9941da" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c6fff79a-b8d7-42a9-852f-ea168a6d55ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_165d4d3b-f672-4de1-b5f8-7c2f2fb89eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c6fff79a-b8d7-42a9-852f-ea168a6d55ad" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_165d4d3b-f672-4de1-b5f8-7c2f2fb89eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9de0cd8b-8b12-442e-ad95-4b2e41754a70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_084bcf46-f7b9-4497-b224-7d20d39ff0c9" xlink:to="loc_us-gaap_DebtInstrumentAxis_9de0cd8b-8b12-442e-ad95-4b2e41754a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d5e72bfa-608e-47c8-bad6-28ae4c3b1038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9de0cd8b-8b12-442e-ad95-4b2e41754a70" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d5e72bfa-608e-47c8-bad6-28ae4c3b1038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_1f955df8-b147-4fa5-b48e-2d2e9dfd6b55" xlink:href="lgnd-20210630.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d5e72bfa-608e-47c8-bad6-28ae4c3b1038" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_1f955df8-b147-4fa5-b48e-2d2e9dfd6b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5ba442f9-0d07-4a0b-8108-37d1bf506eef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_084bcf46-f7b9-4497-b224-7d20d39ff0c9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5ba442f9-0d07-4a0b-8108-37d1bf506eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_88343f0f-c013-4e59-9fb0-df48258782b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5ba442f9-0d07-4a0b-8108-37d1bf506eef" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_88343f0f-c013-4e59-9fb0-df48258782b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_91323c36-110e-4d17-b246-42aaf8204f20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_88343f0f-c013-4e59-9fb0-df48258782b8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_91323c36-110e-4d17-b246-42aaf8204f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_77eba0ad-1d9b-4746-9968-526d8b6991b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_88343f0f-c013-4e59-9fb0-df48258782b8" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_77eba0ad-1d9b-4746-9968-526d8b6991b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_9560104b-e68b-42cd-bd64-4cf5aea36fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_88343f0f-c013-4e59-9fb0-df48258782b8" xlink:to="loc_us-gaap_LongTermNotesPayable_9560104b-e68b-42cd-bd64-4cf5aea36fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_2dbeb051-7219-416a-820f-8beee7aa7fad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5ba442f9-0d07-4a0b-8108-37d1bf506eef" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_2dbeb051-7219-416a-820f-8beee7aa7fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_1fb3a3f2-80d6-42e9-bb3c-3eae443093af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5ba442f9-0d07-4a0b-8108-37d1bf506eef" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_1fb3a3f2-80d6-42e9-bb3c-3eae443093af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTax" xlink:type="simple" xlink:href="lgnd-20210630.xsd#IncomeTax"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTax" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_94bf6b6f-8b0a-4c33-a8a9-9d1a4908e382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_091e9fe9-751c-4c13-ba4f-4254b80aa48d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_94bf6b6f-8b0a-4c33-a8a9-9d1a4908e382" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_091e9fe9-751c-4c13-ba4f-4254b80aa48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#IncomeTaxDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_05246b0b-ff8f-45bf-96a4-f309b7c3e612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_562a3027-4f49-4d7a-8364-6ec510573fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_05246b0b-ff8f-45bf-96a4-f309b7c3e612" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_562a3027-4f49-4d7a-8364-6ec510573fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_9c364cf2-f7c8-4eb7-986c-20b3369887cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_562a3027-4f49-4d7a-8364-6ec510573fc8" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_9c364cf2-f7c8-4eb7-986c-20b3369887cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9556d4b3-58f8-4f83-add6-422a7a8b9802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_9c364cf2-f7c8-4eb7-986c-20b3369887cb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9556d4b3-58f8-4f83-add6-422a7a8b9802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_270d87c7-03a1-4fad-81fd-e95d0e6a28e5" xlink:href="lgnd-20210630.xsd#lgnd_LiabilityForContingentValueRightsCompanyPfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9556d4b3-58f8-4f83-add6-422a7a8b9802" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_270d87c7-03a1-4fad-81fd-e95d0e6a28e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_8db40199-4526-4708-8b57-2d6e1ac17ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_562a3027-4f49-4d7a-8364-6ec510573fc8" xlink:to="loc_us-gaap_IncomeTaxExaminationLineItems_8db40199-4526-4708-8b57-2d6e1ac17ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f9b54eea-7cac-430f-a38b-f1038edfed3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_8db40199-4526-4708-8b57-2d6e1ac17ace" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f9b54eea-7cac-430f-a38b-f1038edfed3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_651ab050-15b0-4b9a-8297-a4a796e3d7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_8db40199-4526-4708-8b57-2d6e1ac17ace" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_651ab050-15b0-4b9a-8297-a4a796e3d7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lgnd-20210630.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e6edad4a-0c69-4089-adaa-cfd8a8014849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_981a6ed4-87bb-43af-a7dc-91d6bc7bd330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e6edad4a-0c69-4089-adaa-cfd8a8014849" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_981a6ed4-87bb-43af-a7dc-91d6bc7bd330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="lgnd-20210630.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_de9901dd-6278-409b-8525-37fd8aedc7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_702a05a9-d96d-4fb0-b413-32a46d1c509b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_de9901dd-6278-409b-8525-37fd8aedc7b6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_702a05a9-d96d-4fb0-b413-32a46d1c509b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_8b0d6cfa-5ac6-4e68-877c-01d0fda029e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_de9901dd-6278-409b-8525-37fd8aedc7b6" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_8b0d6cfa-5ac6-4e68-877c-01d0fda029e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0c70f354-6743-4d8f-99ad-f5ed600693e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_714bbfaa-8c29-4e07-bd42-2bcb273b41cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0c70f354-6743-4d8f-99ad-f5ed600693e5" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_714bbfaa-8c29-4e07-bd42-2bcb273b41cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0abe83d8-6449-4bf6-9341-8b2eabf1e74e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_714bbfaa-8c29-4e07-bd42-2bcb273b41cc" xlink:to="loc_us-gaap_AwardTypeAxis_0abe83d8-6449-4bf6-9341-8b2eabf1e74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_887ec9e7-d295-4618-ba65-2e91eb42f6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0abe83d8-6449-4bf6-9341-8b2eabf1e74e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_887ec9e7-d295-4618-ba65-2e91eb42f6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b799822f-69e7-4762-b33e-5e94f9725b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_887ec9e7-d295-4618-ba65-2e91eb42f6cb" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b799822f-69e7-4762-b33e-5e94f9725b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9102b1e2-5fbd-4bc3-a831-9fccfd208cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_887ec9e7-d295-4618-ba65-2e91eb42f6cb" xlink:to="loc_us-gaap_RestrictedStockMember_9102b1e2-5fbd-4bc3-a831-9fccfd208cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_5edf66f0-eaaf-44f5-a4cf-179e3ff0a284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_714bbfaa-8c29-4e07-bd42-2bcb273b41cc" xlink:to="loc_us-gaap_ClassOfStockLineItems_5edf66f0-eaaf-44f5-a4cf-179e3ff0a284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7442df57-9d0d-4507-88c2-baf57e6201ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5edf66f0-eaaf-44f5-a4cf-179e3ff0a284" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7442df57-9d0d-4507-88c2-baf57e6201ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f2ee050f-ec74-4efa-a3f2-18be7166670f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7442df57-9d0d-4507-88c2-baf57e6201ca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f2ee050f-ec74-4efa-a3f2-18be7166670f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d615eee1-ef2c-455b-bb5a-3c6e5d0224cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7442df57-9d0d-4507-88c2-baf57e6201ca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d615eee1-ef2c-455b-bb5a-3c6e5d0224cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c5900ca0-5fc4-480d-b1a5-fd46afcca36b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7442df57-9d0d-4507-88c2-baf57e6201ca" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c5900ca0-5fc4-480d-b1a5-fd46afcca36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c795b1ba-bddc-4a25-9fa4-5b921548c1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7442df57-9d0d-4507-88c2-baf57e6201ca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c795b1ba-bddc-4a25-9fa4-5b921548c1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3e0f88d3-d52e-4b75-8adb-5b5457d85619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7442df57-9d0d-4507-88c2-baf57e6201ca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3e0f88d3-d52e-4b75-8adb-5b5457d85619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f1fe15d8-98df-4b5c-891c-dfbec6d83b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5edf66f0-eaaf-44f5-a4cf-179e3ff0a284" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f1fe15d8-98df-4b5c-891c-dfbec6d83b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f81f0560-d1f8-46b6-b0b3-97df80c1330d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f1fe15d8-98df-4b5c-891c-dfbec6d83b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f81f0560-d1f8-46b6-b0b3-97df80c1330d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cd3cac57-acd2-40c4-a21e-4e064810a497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f1fe15d8-98df-4b5c-891c-dfbec6d83b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cd3cac57-acd2-40c4-a21e-4e064810a497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6112ae52-0105-4a0b-bcd4-c9526b37ecf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f1fe15d8-98df-4b5c-891c-dfbec6d83b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6112ae52-0105-4a0b-bcd4-c9526b37ecf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_eff4f4fe-6404-4d4e-8175-4435fffe93dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f1fe15d8-98df-4b5c-891c-dfbec6d83b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_eff4f4fe-6404-4d4e-8175-4435fffe93dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2945b4d6-7d98-4c4c-97cb-e424f66056b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f1fe15d8-98df-4b5c-891c-dfbec6d83b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2945b4d6-7d98-4c4c-97cb-e424f66056b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fe8bc40e-b4ee-4aab-931c-ad1c3ba3a0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5edf66f0-eaaf-44f5-a4cf-179e3ff0a284" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fe8bc40e-b4ee-4aab-931c-ad1c3ba3a0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_755d699f-1f3c-43c1-824f-4cfd191efed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fe8bc40e-b4ee-4aab-931c-ad1c3ba3a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_755d699f-1f3c-43c1-824f-4cfd191efed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fc08262e-ea6e-4d8c-b134-d0f83cf298ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fe8bc40e-b4ee-4aab-931c-ad1c3ba3a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fc08262e-ea6e-4d8c-b134-d0f83cf298ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4c0b2d29-db24-413a-bc23-ea382bed6224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fe8bc40e-b4ee-4aab-931c-ad1c3ba3a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4c0b2d29-db24-413a-bc23-ea382bed6224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_27c9cbd5-de09-4869-960f-43a71b33952f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fe8bc40e-b4ee-4aab-931c-ad1c3ba3a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_27c9cbd5-de09-4869-960f-43a71b33952f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a54abc53-c904-4e21-b3ac-49a6e5c4a062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fe8bc40e-b4ee-4aab-931c-ad1c3ba3a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a54abc53-c904-4e21-b3ac-49a6e5c4a062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cb85933a-37de-4ac8-8e87-d27ce420ab01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5edf66f0-eaaf-44f5-a4cf-179e3ff0a284" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cb85933a-37de-4ac8-8e87-d27ce420ab01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8e27546b-f7a2-471d-ac78-b45d790274a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cb85933a-37de-4ac8-8e87-d27ce420ab01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8e27546b-f7a2-471d-ac78-b45d790274a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9be763c9-f05e-4c0a-a5c6-2f982d270261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cb85933a-37de-4ac8-8e87-d27ce420ab01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9be763c9-f05e-4c0a-a5c6-2f982d270261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1652d7bc-e179-46f4-88bf-c7440a8f1b12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cb85933a-37de-4ac8-8e87-d27ce420ab01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1652d7bc-e179-46f4-88bf-c7440a8f1b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_50eb9328-117f-4cf5-a68e-269aef8613a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cb85933a-37de-4ac8-8e87-d27ce420ab01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_50eb9328-117f-4cf5-a68e-269aef8613a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6a1d4148-c1f3-4783-8ebc-cd6783da7bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cb85933a-37de-4ac8-8e87-d27ce420ab01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6a1d4148-c1f3-4783-8ebc-cd6783da7bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6262c01c-db13-4ebd-b026-5f3add0691c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa6118d3-5a46-4407-8d0c-57ea234b9c32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6262c01c-db13-4ebd-b026-5f3add0691c4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa6118d3-5a46-4407-8d0c-57ea234b9c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_136aea4e-8d8c-433a-943b-c9c910076d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa6118d3-5a46-4407-8d0c-57ea234b9c32" xlink:to="loc_us-gaap_PlanNameAxis_136aea4e-8d8c-433a-943b-c9c910076d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_acb55d15-5b08-4adf-b701-cf9bac86b85d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_136aea4e-8d8c-433a-943b-c9c910076d4c" xlink:to="loc_us-gaap_PlanNameDomain_acb55d15-5b08-4adf-b701-cf9bac86b85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_b9cd0157-53ad-4d3d-bd55-ec2c262f7737" xlink:href="lgnd-20210630.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_acb55d15-5b08-4adf-b701-cf9bac86b85d" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_b9cd0157-53ad-4d3d-bd55-ec2c262f7737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa6118d3-5a46-4407-8d0c-57ea234b9c32" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_dd56b410-8f09-4b51-9b8a-9921a94b8929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_dd56b410-8f09-4b51-9b8a-9921a94b8929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c903e088-5062-41bb-8eda-a780def1b3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c903e088-5062-41bb-8eda-a780def1b3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_c49728a5-194a-4ccc-b994-ca9a12c16bfe" xlink:href="lgnd-20210630.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_c49728a5-194a-4ccc-b994-ca9a12c16bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_529b5f2f-5b8a-4719-94f0-1befdb79abd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_c49728a5-194a-4ccc-b994-ca9a12c16bfe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_529b5f2f-5b8a-4719-94f0-1befdb79abd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_a7a402f4-463a-4545-8c47-f7fac4a72378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_c49728a5-194a-4ccc-b994-ca9a12c16bfe" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_a7a402f4-463a-4545-8c47-f7fac4a72378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_7e4179da-0541-40ae-9728-10c9209aaf83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_7e4179da-0541-40ae-9728-10c9209aaf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_cfb49768-8340-4050-8aba-037e4fffeadb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_cfb49768-8340-4050-8aba-037e4fffeadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_492ccc0a-9cef-4054-bfeb-1ca165afcbf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_492ccc0a-9cef-4054-bfeb-1ca165afcbf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_d06e91aa-c9b6-4ce6-8690-7efdba9936b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3385de7a-0580-4242-aaaf-659c566a6d87" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_d06e91aa-c9b6-4ce6-8690-7efdba9936b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="simple" xlink:href="lgnd-20210630.xsd#CommitmentandContingenciesLegalProceedings"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fb76bab6-d139-4838-82b0-45b16dbd357e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_910fe340-2ecd-422a-b305-2ec9815ee65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fb76bab6-d139-4838-82b0-45b16dbd357e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_910fe340-2ecd-422a-b305-2ec9815ee65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="simple" xlink:href="lgnd-20210630.xsd#CommitmentandContingenciesLegalProceedingsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3af7cf59-9e05-42c1-9aff-dc349014642f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable_768a8498-ef32-453a-a6e1-70ca9c01f0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3af7cf59-9e05-42c1-9aff-dc349014642f" xlink:to="loc_us-gaap_GainContingenciesTable_768a8498-ef32-453a-a6e1-70ca9c01f0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_299c3bce-8a42-439d-a194-2ea715974317" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_768a8498-ef32-453a-a6e1-70ca9c01f0c4" xlink:to="loc_srt_LitigationCaseAxis_299c3bce-8a42-439d-a194-2ea715974317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b5d56cc2-536f-4abe-b37d-99160313ef25" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_299c3bce-8a42-439d-a194-2ea715974317" xlink:to="loc_srt_LitigationCaseTypeDomain_b5d56cc2-536f-4abe-b37d-99160313ef25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LupinPatentInfringementMember_788e0e95-e71f-4451-b486-0029a9132bf5" xlink:href="lgnd-20210630.xsd#lgnd_LupinPatentInfringementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b5d56cc2-536f-4abe-b37d-99160313ef25" xlink:to="loc_lgnd_LupinPatentInfringementMember_788e0e95-e71f-4451-b486-0029a9132bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_59371ea9-899e-4021-a7d5-6a255d9444e8" xlink:href="lgnd-20210630.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b5d56cc2-536f-4abe-b37d-99160313ef25" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_59371ea9-899e-4021-a7d5-6a255d9444e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_InterPartesReviewOfPatentMember_3d48b88d-bbf9-4b49-80a0-d77de8d91d84" xlink:href="lgnd-20210630.xsd#lgnd_InterPartesReviewOfPatentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b5d56cc2-536f-4abe-b37d-99160313ef25" xlink:to="loc_lgnd_InterPartesReviewOfPatentMember_3d48b88d-bbf9-4b49-80a0-d77de8d91d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a7494297-2237-4e48-ad9c-e90a7b6852c1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_768a8498-ef32-453a-a6e1-70ca9c01f0c4" xlink:to="loc_dei_LegalEntityAxis_a7494297-2237-4e48-ad9c-e90a7b6852c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b65b7572-924b-45df-8a44-e77ecd577804" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_a7494297-2237-4e48-ad9c-e90a7b6852c1" xlink:to="loc_dei_EntityDomain_b65b7572-924b-45df-8a44-e77ecd577804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_ca995a86-fa8a-4072-9d2f-af9a858b68f2" xlink:href="lgnd-20210630.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_b65b7572-924b-45df-8a44-e77ecd577804" xlink:to="loc_lgnd_PfenexMember_ca995a86-fa8a-4072-9d2f-af9a858b68f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GlaxoSmithKlineBiologicalsSAMember_5900a634-0400-4fdb-ba73-ea6ed70fc92f" xlink:href="lgnd-20210630.xsd#lgnd_GlaxoSmithKlineBiologicalsSAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_b65b7572-924b-45df-8a44-e77ecd577804" xlink:to="loc_lgnd_GlaxoSmithKlineBiologicalsSAMember_5900a634-0400-4fdb-ba73-ea6ed70fc92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems_eb25b1b1-cf20-4dcd-810d-04d394ba2879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_768a8498-ef32-453a-a6e1-70ca9c01f0c4" xlink:to="loc_us-gaap_GainContingenciesLineItems_eb25b1b1-cf20-4dcd-810d-04d394ba2879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_d442b345-8db0-4896-98e3-cd0fa459e8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_eb25b1b1-cf20-4dcd-810d-04d394ba2879" xlink:to="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_d442b345-8db0-4896-98e3-cd0fa459e8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_23c9f7f3-968a-4bed-a339-74da685db7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_eb25b1b1-cf20-4dcd-810d-04d394ba2879" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_23c9f7f3-968a-4bed-a339-74da685db7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfPetitionsFiled_b207ee38-3633-4834-9991-2ba21cfe7827" xlink:href="lgnd-20210630.xsd#lgnd_NumberOfPetitionsFiled"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_eb25b1b1-cf20-4dcd-810d-04d394ba2879" xlink:to="loc_lgnd_NumberOfPetitionsFiled_b207ee38-3633-4834-9991-2ba21cfe7827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>lgnd-20210630_g1.jpg
<TEXT>
begin 644 lgnd-20210630_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!817AI9@  34T *@    @ ! $Q  (
M   1    /E$0  $    ! 0   %$1  0    !   N(U$2  0    !   N(P
M  !!9&]B92!);6%G95)E861Y  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" (+!<8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\IP<88*1\RY%?E!^TU\ /%G_  3Z_:3BM;74;J":PE74O#^M0#RS<Q;CM?N
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MIKEW/?W/A359-+M[B9R\CV_E1RQJS'DE2[*,]%"CM7UM7PQ_P09_Y-T\8_\
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M(UST 29R /0"OV;HI\P'YL? K_@@]?2WD5U\1_%UM#;J06T_05:1Y!GH9Y5
M7W C;KP1BOO[X/\ P4\+? /P7!X?\(Z+9Z)I<'/EP*2\S="\CG+2.?[S$G@<
M\5U-%%P"BBBD!_./1116@!1110 4444 ?JC_ ,$&?^3=/&/_ &,9_P#26&ON
M>OAC_@@S_P FZ>,?^QC/_I+#7W/4/< HHHI %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !6#XW^*/AKX:VPF\0Z_HVAQL-RF^O(X-X_V0Q!/X5\?_P#!0/\ X**Z
MCX*\37G@7P#="UO;%C#JVK( SPR=X(>H#+T9^H;(&"":^#]:UR]\2:I-?:C>
M75_>W#;Y;BYE:664^K,Q))^IK\CXH\5\+EV(E@\#3]K.+LVW:*?9;MVZ[+S9
M^Q<*>$6*S+#QQF/J>RA)722O)KHWLHWZ;OR1^KVN?\%'?@QH3LC^-(;B11D+
M;6%U,&^C+&5_6LK_ (>C?!K_ *&"_P#_  57/_Q%?E917P,_&7.F[QITDO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "OYQZ_HXK^<>JB 44450!1110 5^WG_!+S_DPOX=?]><
M_P#Z5S5^(=?MY_P2\_Y,+^'7_7G/_P"E<U*0'OE%%%0 4444 %%%% !1110
M4444 %%%% !1110!_./1116@!1110 4444 ?JC_P09_Y-T\8_P#8QG_TEAK[
MGKX8_P""#/\ R;IXQ_[&,_\ I+#7W/4/< HHHI %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7\X]?T<5_./51 ****H HHHH *_;S_@EY_P F%_#K
M_KSG_P#2N:OQ#K]O/^"7G_)A?PZ_Z\Y__2N:E(#WRBBBH **** "BBB@ HHH
MH **** "BBB@ HHHH _G'HHHK0 HHHH **** /U1_P""#/\ R;IXQ_[&,_\
MI+#7W/7PQ_P09_Y-T\8_]C&?_26&ON>H>X!1112 **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%<AXH_:"\!>!Y3'K7C?PAH[J<%;W6;>W(/T=Q0!U]%
M>/:A_P % _@IIJJ9/B9X2;?T\J]$OY[,X_&C3_\ @H'\%-25C'\3/"2[.OFW
MHB_+?C/X4 >PT5P.A?M6?"_Q.R+IWQ&\"WLCA2(X==M6?GH"H?(/L1FNVTS5
MK76K19[.YM[N!NDD,@D0]^HX[T 6**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BL_P 0>+=*\)VXFU74]/TR
M$\A[NX2%?S8@5PVL_MC_  E\/LRW?Q-\!Q2*0&C&NVSR+D9&55R1Q[4 >DT5
MXU>_\%#/@E83^7)\2_"S,!G,=SYJ_FH(JSIO[>WP7U98S%\3O!J>:VT>=J4<
M.#G'.\C ]S@4 >N45R_A7XW^"_';JNA^+_"^LL^-HL=5@N"V>F-C&NHH ***
M* "BBB@ HHHH *_G'K^CBOYQZJ(!1115 %%%% !7[>?\$O/^3"_AU_UYS_\
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MGFM;JV<2PS0N4DB<'(96'((/((K]9?\ @F)_P4I3]H[3X/ _C6XA@\<V,/\
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M $U^\?X=N-S?GW<W,E[<R332/+-*Q=W=BS.Q.223R23WIE%6D 4444 %%%%
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M $KFK\0Z_;S_ ()>?\F%_#K_ *\Y_P#TKFI2 ]\HHHJ "BBB@ HHHH ****
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M110 4444 ?SCT445H 4444 %%%% 'ZH_\$&?^3=/&/\ V,9_])8:^YZ^&/\
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M=^TG)\3/@3J'@74KCS-3\#2+]C+M\TEC,6*#GD^7('7T"M&*_)ZOH+_@E_\
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M]I/_ ).+\??]C'J/_I5)7%5H@"BBB@ HHHH **** "BBNK^"_P $_$W[07Q
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M544 ?@-^T3^S'XR_9:\;MH7C#2GLIGRUM=1YDM+] <;X9, ,.F1PPR,@'BN
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MS_Z2PU]SU#W ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQS^SSX$UIFWOJOAZPNW.>=SV\;,#R>02<\GFNTK, HHHH **** /Y_/VD_\
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M110 4444 %%%% !1110 4444 ?S^?M)_\G%^/O\ L8]1_P#2J2N*KM?VD_\
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M HHHH **** -CX?^ -8^*?C73?#N@6$^IZQJ\XM[6VB&6D8_H !DDG@ $D@
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MU:8!1113 **** "OV\_X)>?\F%_#K_KSG_\ 2N:OQ#K]O/\ @EY_R87\.O\
MKSG_ /2N:E(#WRBBBH **** "BBB@ HHHH **** "BBB@ HHHH _G'HHHK0
MHHHH **** /U1_X(,_\ )NGC'_L8S_Z2PU]SU\,?\$&?^3=/&/\ V,9_])8:
M^YZA[@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?_26&ON>H>X!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG_TEAK[GJ'N 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@L/%>BVNI:7>VFHZ=>QB:WNK:5989T/1E=20P/J#4- 7****0!1110 4444
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M(Y]V/)JO113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F/\
M@CO_ ,F&>&/^OR__ /2J2OJ"OE__ (([_P#)AGAC_K\O_P#TJDKZ@J& 4444
M@"BBB@#^?S]I/_DXOQ]_V,>H_P#I5)7%5VO[2?\ R<7X^_[&/4?_ $JDKBJT
M0!1110 4444 ?M5_P23_ .4?/P__ .XC_P"G*ZKZ.KYQ_P""2?\ RCY^'_\
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M<=.5-? WQA^./BSX_>+7USQAKM_KNHL"J/</\D"YSLC086-,_P *@"N4HII
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MO_@YM/\ XNC_ (<[_'K_ *%?3?\ P<VG_P 71<#Y?HKZ@_X<[_'K_H5]-_\
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M% 'ZH_\ !!G_ )-T\8_]C&?_ $EAK[GKX8_X(,_\FZ>,?^QC/_I+#7W/4/<
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MA7>Y520BY R?09(&?<4R@ HHHH **** "BBB@ HHHH **** "BBB@ HH +$
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MX[U3XG^-M5\1:W=O>ZMK5T]W=3/U>1R2<#L!T '   ' K(JT@"BBBF 4444
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M"VABMX(AM2.- B(/0 <"I:*0!1110 4444 %%%% !1110!^$'[=W_)YOQ/\
M^QDO?_1K5Y-7K/[=W_)YOQ/_ .QDO?\ T:U>35H@"BBB@ HHHH _9C_@CO\
M\F&>&/\ K\O_ /TJDKZ@KY?_ ."._P#R89X8_P"OR_\ _2J2OJ"H8!1112 *
M*** /Y_/VD_^3B_'W_8QZC_Z525Q5=K^TG_R<7X^_P"QCU'_ -*I*XJM$ 44
M44 %%%% '[5?\$D_^4?/P_\ ^XC_ .G*ZKZ.KYQ_X))_\H^?A_\ ]Q'_ -.5
MU7T=4, HHHI %%%% !1110 4444 %%%% !1110 4444 ?./_  5L_P"4?/Q
M_P"X=_Z<K6OQ5K]JO^"MG_*/GX@?]P[_ -.5K7XJU<0"BBBF 4444 =K^S9_
MR<7X!_[&/3O_ $JCK^@.OY_/V;/^3B_ /_8QZ=_Z51U_0'4R ****D HHHH
M_-7_ (+]Z:8O$OPPO-J!9[;4H0P^\2CVQP?8>8,?4U^>-?IK_P %]=!^T?#W
MX<ZGLR+/4;RUW;,X\V*)L9[9\GIWQ[5^956M@"BBBF 4444 =I^S?K1\-_M$
M> M1!(-AXCT^Y! R1LN8VZ'KTK^@2OYS+"]?3;Z&XB($MO(LB9&1D'(_E7]%
M.AZO%X@T6SOX#F"]@2XC.<Y5U##]#4R M4445(!1110 4444 %%%% !1110
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MHJ "BBB@ HHHH **** "BBB@ HHHH **** /YQZ***T **** "BBB@#]4?\
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M%7P?PUI\N-;OX),KJLZ'(@0CK"C#)/1W QPH+?"-6D 4444P"BBB@ K]O/\
M@EY_R87\.O\ KSG_ /2N:OQ#K]O/^"7G_)A?PZ_Z\Y__ $KFI2 ]\HHHJ "B
MBB@ HHHH **** "BBB@ HHHH **** /YQZ***T **** "BBB@#]4?^"#/_)N
MGC'_ +&,_P#I+#7W/7PQ_P $&?\ DW3QC_V,9_\ 26&ON>H>X!1112 ****
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MW!'_ '[_ -[[OY5W-S)>W,DTTCRS2L7=W8LSL3DDD\DD]ZI(!E%%%4 4444
M%%%% !7[>?\ !+S_ ),+^'7_ %YS_P#I7-7XAU^WG_!+S_DPOX=?]><__I7-
M2D![Y1114 %%%% !1110 4444 %%%% !1110 4444 ?SCT445H 4444 %%%%
M 'ZH_P#!!G_DW3QC_P!C&?\ TEAK[GKX8_X(,_\ )NGC'_L8S_Z2PU]SU#W
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M@_;:_IS0VVL6H6#6=,#Y?3[C![=3&^"4;N,C[RL!Z[68!1110 4444 %%%%
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M:K_@DG_RCY^'_P#W$?\ TY75?1U?./\ P23_ .4?/P__ .XC_P"G*ZKZ.J&
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MDDD)9F8Y+$]23W--HHJ@"BBB@ HHHH **** "OV\_P""7G_)A?PZ_P"O.?\
M]*YJ_$.OV\_X)>?\F%_#K_KSG_\ 2N:E(#WRBBBH **** "BBB@ HHHH ***
M* "BBB@ HHHH _G'HHHK0 HHHH **** /:?V9_V^?B%^R9X4O]%\'W.E0V.I
M7?VV875DL[&38J<$G@84<5Z3_P /I/CA_P __AO_ ,%*?XU\FT4K ?67_#Z3
MXX?\_P#X;_\ !2G^-'_#Z3XX?\__ (;_ /!2G^-?)M%%D!]9?\/I/CA_S_\
MAO\ \%*?XT?\/I/CA_S_ /AO_P %*?XU\FT460'UE_P^D^.'_/\ ^&__  4I
M_C1_P^D^.'_/_P"&_P#P4I_C7R;119 ?67_#Z3XX?\__ (;_ /!2G^-'_#Z3
MXX?\_P#X;_\ !2G^-?)M%%D!]9?\/I/CA_S_ /AO_P %*?XT?\/I/CA_S_\
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MA!)%+$X=)5(R&5AP01W%35^+'[#O_!23Q=^R%JT.FW4EQXB\#ROB?2)I<M:
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M?_*/GX?_ /<1_P#3E=5]'5\X_P#!)/\ Y1\_#_\ [B/_ *<KJOHZH8!1112
M**** "BBB@ HHHH **** "BBB@ HHHH ^<?^"MG_ "CY^('_ '#O_3E:U^*M
M?M5_P5L_Y1\_$#_N'?\ IRM:_%6KB 4444P"BBB@#M?V;/\ DXOP#_V,>G?^
ME4=?T!U_/Y^S9_R<7X!_[&/3O_2J.OZ ZF0!1114@%%%% !1110!A?$_X<:5
M\7_AYK/AC7+<7.DZ[:/9W*=#M88W*>S*<$'L0#VK\&?VB/@9K'[-WQBUSP=K
M:'[7I$Y2.8*52\A/,<R9_A=2#[9(/(-?T!U\B_\ !63]B!OVD_A:GBSP[:"3
MQIX2A9ECC7,FJ68RSP<<EU.70>I=<9<$-,#\@:*""I((((ZBBK **** "BBB
M@"2TNY;"ZBG@EDAGA<21R1L5>-@<A@1R"#W%?=7['W_!:C7?AW;6N@_%&UN_
M%.E18CCUFWP=2@7MYJDA9QT^;*OU)+GBOA&BBP'[[?!']JOX>_M%Z>DW@_Q5
MI6K2LNYK,2^5>1<<[H'Q(O?G;CC@FO0J_G*M[B2TG26)WBEB8.CH2K(0<@@C
MH17K?P__ &^/C+\,(HX](^(OB588L>7%>7'VZ) .@"3AU ]L8J>4#]VJ*_&W
M1_\ @LC\=M,AV3:_H^H-@#?<:/;JW'?]VJ#GZ=N,5->_\%F_CG=P%(]7T&V;
M.=\>D1%OI\V1^E+E8'[&5SWQ$^+/ACX1Z,VH>*/$&CZ!9J,^;?W:0!_9=Q!8
M^@&2:_%?QM_P4B^./Q A:._^(^O0(W4:=Y>G'\[=$/ZUXYKOB"_\4:E)>ZG?
M7FHWDO+SW4S32O\ 5F))I\H'Z>?M+?\ !</PMX2@N=.^&FE3>*-2P534[]'M
MM/B;LRQG$LOT/ECIR:_.WXZ?M%^,_P!I+Q:=9\9:[=ZQ=+D01N0D%HI/W(HE
MPJ#IT&3C))/-<3132 ****8!1110 5V?AWX"^)?$OP<\0^/8K%HO"_AR6&WG
MO9<JD\\LB(L,?]YAOW-CA1C)!90?6?\ @G[_ ,$_=:_;*\:?:[O[1I7@72I@
M-2U(+AKAA@_9X,\&0C&6Y" Y.255OO/_ (*C_#W1?A3_ ,$V=6\/>'M.M]*T
M;2IM/@MK:!<+&HNH_P 2Q.26.2Q)))))I-@?D!1113 **** "OV\_P""7G_)
MA?PZ_P"O.?\ ]*YJ_$.OV\_X)>?\F%_#K_KSG_\ 2N:E(#WRBBBH **** "B
MBB@ HHHH **** "BBB@ HHHH _G'HI]Q ]K.\4BLDD;%65A@J1P0:96@!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 =;\ ]
M3;1?CKX*O$!+VFO6,R@'&2MQ&1SVZ5_077\^'P-LGU+XU^#[:+!EN-;LHTR<
M#)G0#^=?T'U,@"BBBI **** /Y_/VD_^3B_'W_8QZC_Z525Q5=K^TG_R<7X^
M_P"QCU'_ -*I*XJM$ 4444 %%%% '[5?\$D_^4?/P_\ ^XC_ .G*ZKZ.KYQ_
MX))_\H^?A_\ ]Q'_ -.5U7T=4, HHHI %%%% !117YM?\%1/^"HG]I?VC\-?
MAKJ/^C?-;:YKEL_^N[-;6[#^'J'D'WN57C)9I =;_P %%O\ @K3%\.I]0\"_
M"ZZANM>C+6^I:ZN'BTUAD-%!V>4="_*IR!EN4_,;5-4N=;U*XO+VXGO+R[D:
M:>>>0R23.QRS,QY9B222>34%%4D 4444P"BBM;P+X$UGXF^+;'0?#^FW>KZQ
MJ<HBMK2VC+R2MUZ=@ "23@  DD $T 9-%?I3\'?^"$&EW7@.SG\=^+-7MO$4
MX\R>VTCROL]H#TCWNC%V'=A@9X (&X[E[_P03\$R3YMO'7BF*+'W9+>"1L_4
M!?Y4KH#\NJ*_3&Z_X($:&]PQ@^)6JQQ'[JOI$;L/J1*,_D*S)O\ @W]1IG,?
MQ998R3M5O#&X@=@3]K&3[X%%T!^<-%?H4_\ P0&U@9V_$S33Z9T5QG_R-67-
M_P $$?&*PN8_'OAEI IVJUI.H)[ GG ]\&BZ ^":*^X[K_@@Y\2TMV,'BWP-
M)*/NJ\MTBGZD0G'Y5F7G_!"OXP6MN737/A[<L/\ EG'J%V&/_?5L!^M%T!\7
MT5]>7_\ P1*^-5G"&C/A&Z8G&R+5&!'O\T:C'X]ZRM4_X(U_'6P13%H6C7Q(
M)(AUB $8[?.5Z_T[470'RQ17N/BW_@FO\=/!<;M>?#?79@@R?L#17YZ \"!W
M)Z]O?T->2>+_  %KOP^U$V>O:+JVB78_Y8:A9R6TG_?+@&F!DT444 %%%% !
M1110 5[;^P]^VQK_ .QG\3H]0M&GO_#6HNJ:SI._Y;J,<>8F>%F0$E6XS]T\
M$UXE10!_0]\.?B'H_P 6? VE^)/#]]%J.C:S;K<VMQ'T=3V(/*L#D%3RI!!
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M\_Y,+^'7_7G/_P"E<U?B'7[>?\$O/^3"_AU_UYS_ /I7-2D![Y1114 %%%%
M!1110 4444 %%%% !1110 4444 ?AK_P4.^ =W^SU^UCXKTR6W>+3-5NY-7T
MN0KA);:=V<!3WV,6C/O&:\1K]XOVL_V//"'[8G@1-'\302PWED6DTW4[;"W6
MGR,!DJ2,,C8&Y#PV!T(5A^8WQY_X(_?%[X1:G.^BZ;%XYT9,F.[TIE$^.P>V
M8^8&]DWC_:JTP/E:BO2'_8W^+L;E3\+/B-E3CCPW>$?GY=)_PQU\7?\ HE?Q
M'_\ ":O?_C=,#SBBO1_^&.OB[_T2OXC_ /A-7O\ \;H_X8Z^+O\ T2OXC_\
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M?%FAZ=KVF2\^3=Q!]C8QN1OO(WHRD$>M-,#^>JBOTI_:,_X(56=^]QJ'PO\
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MG>$_"6E^!/#MII&BZ?9Z5I=A&(K>UM85BAA4=E5>!6C114@9OC+_ )%#5?\
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M HHJYH7AW4/%.I)9Z98WFHWDGW(+6%II&^BJ"30!U/[-G_)Q?@'_ +&/3O\
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M#P3_ .".U_\ B*U?#WPG\*^$9$?2?#7A_2WCY5K33H8"O.>-JC'(!^HKH**
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M+_X(<^#FU[]KK4=49#Y.A>'[B4/C@222Q1*/Q5I#_P !-)@?K;1114 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^&?^"SG[&LO
MQ1\ P?$SP_:F76_"D!BU:&-,O=6 );S..2T)))_V&8Y^0"ON:FRQ+/&R.JNC
M@JRL,A@>H(H3 _G)HK[5_P""GW_!-.Y^ VKWOC[P19O/X(O93+?642DMH,C'
MGC_GW)/!_@)VGC:3\55H 4444 %%%% !1110!K>#_'FN?#S51?Z!K.K:'?+P
M+C3[N2VE'_ D(/ZU[W\.O^"L_P <_AY%'"?%J:];1=(M7LHKDGZR@+*?Q>OF
MZB@#[V\'_P#!>WQE8J@U_P !^&M3(^\;"ZGL=PR/[_G8XS^?X5Z'H'_!?/PS
M<*G]J?#O7;,G&_[+J45SMXYQN2///T_"OS&HI60'ZO6?_!=[X4O;@W'ACXA1
M2]UCM+.11^)N5_E6JG_!<+X,N@)L_&ZDC.#IL.1[<35^1E%'*@/UKU#_ (+G
M_!ZS91'I'C^[W=3%IUL-OUWW"_I6)J__  7F^'D)?[!X-\:7(!&W[1]F@R.^
M=LKX_6OROHHY4!^BWBC_ (+\SNI31?AG#&>TM[K1<'_@"0C_ -"KR3X@?\%K
MOC/XOA>+3'\,^%T8;0^GZ=YLH]\W#2#/T45\B4460'9_%/\ :+\>?&V4GQ9X
MN\0:]'NWK#=WKO A]5BSL7\%%<9113 **** "BBB@ HHJSHVBWGB/5K:PT^U
MN+Z^O)%A@MX(S)+,Y. JJ,DDGL* ((87N)DCC1I))"%55&2Q/0 =S7ZU?\$K
M?^">#?LX^'QXY\8V2+XYU>';:VLB@MH=NPY7VF<?>/55^7C+YRO^";W_  2M
MM_@D;+QS\1K6WO/&"E9].TTL)(=%XR'?^%YP3QC*H0""6P1]PU+8!1114@%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1WEG#J
M-G+;W$4<]O.ACEBD4,DBD8*L#P01P0:_.;]N[_@C:\EQ>>*_A!;H5<F:[\,L
MX7;W+6C'C_MDQ]=IZ)7Z.T4TP/YT=;T.]\-:O<Z?J-G=:??V<ABGMKF)HIH'
M'!5D8 J1Z$9JK7[N?M.?L/\ P[_:RTUAXIT55U9(_+M]8LB(+^W]/G (<#LL
M@9?:OSK_ &D?^"+OQ&^%,DU]X-EA\>Z,GS;(%%OJ,0]X6.']/W;%C_=%4F!\
M;T5=\1>&M1\(:Q-IVK:?>Z7J%LVV:VNX&@FB/HR, 0?J*I4P"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **]7^ 7[$?Q._:5EB?PMX5OYM.E/.
MIW0^RV*C."?-? ?'<)N;VK[[_9@_X(D>$OA^\&I_$C4?^$PU-"&&G6I>#38C
M_M'B2;GUV*>A4TFP/@+]F/\ 8R\??M:>(1:>%-(<V$3[+K5KO,5A9_[TF#N;
MD?(@9^^,9-?J]^Q9_P $Y/!7['NGQW\2#Q!XRECVW&M748!BR.4MTY$2=B<E
MFYRV, >\>'/#6G>#M#MM,TFPL]+TVR3R[>UM(5AA@7^ZJ*  /H*NU+8!1112
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH Y7XI_ WP=\;M*^Q>+?#.B^(8%!5/MMJLDD.?[CXW(?=2#7R
MA\8?^"&WPV\9/-<>$M9UWP;<R'*0L1J-G']$D(E_.4U]LT47 _(SXH?\$2/B
M[X->230)O#OBZV&?+6VO/LEPP]TF"H#["0UX)X]_8W^*WPR=_P"V_A[XLM(X
MSAIUTZ2: ?\ ;6,,G_CU?O=15<P'\Y4]O):S-'*CQR(=K*PPRGT(IE?T0^*/
MA]H'C>/9K6AZ1JZ8QMO;..X&/^!@UYSXC_8&^"_BK?\ :OAEX/C+@@FTT]+,
M\C'_ "RVX/OZ\]:.8#\)**_8GXP?\$O?@5I&@?;;7P'';W#SHA,>K7ZKC:>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>lgnd-20210630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lgnd="http://www.ligand.com/20210630"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lgnd-20210630.xsd" xlink:type="simple"/>
    <context id="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie37d0cd029f04b4cba79dd56d4faa880_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iafdc6efe6f0a42d7882e9db52eca6047_I20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="ieb2751225b4e422c8601c5b45f74edf0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idc03d6d6660e4832837b896fd4ac920c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i007aacf643a441dfb068465b043a79cf_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifd7a926ec01f44e1afa9cce80d7a71fe_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i451635563e0745a3903ab950f8d8acd1_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia82ef50770684157a9c74a354fbf2b24_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i83e26ee83c2f49b7b63a20e39c84e036_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i84dcdf4aa51446079e98d1cae23cc101_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia00ad653a232412cbc7060be9d5a8bf2_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4e8ad17c667349d89a149e25562db6da_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3ee54dca82994576be877ebf09f7324d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie6a3f4144744455c937cf2f5a461ee71_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i99224b8f7551423ab53c0612ea730573_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i45213dff8ed44da68f68cf21fe41c95c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i30bc2fe5fa8a4a7399a14d8b760b85c8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i958b44c6e798443596d92cd43ad05dbd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia118fd0c458241d9b6713e222eab7ee8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i65849e650e524fdcb63b754a5d8436e0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibe754546a5d24b98b707f86af828e94b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5a1337c402e94895b3a0d72c858347c2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i345d86b3213949e0b68a46369dcbf41b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i076737849b6f47a39af33bac3b981eec_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7f4979e27b50488cb8e40ce52db2db15_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie64508fea3fa42acaa53e660fd2c7de1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if65dba4c92e94e468d530e1cd6f9b9ff_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i60594d6045784168a055ecf56059a566_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2464fae38d7345f798229c15c286e868_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iba8102507d454bf4a847fd7b3e3a852e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2ba2f1bd35304af6883bb88ec59143e5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id9237b34bcc649f7a15194fe8593ae0c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0fb3f6ec9b3240fe9fb304709b4784d0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0956ece74456424796eeb190e9b7d088_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i513fd4ed54aa4c60a395ce12b274185b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5faae008cb8d4fd182e505b46d24f42b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib66c936d8d3e4e1680b40926d0d9de06_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i69b5b44a870842ceac65db79dc5b09f5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i80771ca481e3433685a6e3d009b3f480_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i29c88524b8d54c90ad5687ff71a4c6d1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic5bc01a073dc4d9fba01b085fe94fb42_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8f7fffe49713495aad4f0ffcb6a85aa9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifb95b1f9e6304389b982e439c753ddd9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5b4603280525438abad9ba8b3910e9d8_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4b8c7b189adb4ef7941efd43c9855c73_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i26498571827b412fb7bbe064394179d2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic1527f605baa48ba80a450d04e29ba34_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i86d6ecfa583141c4b8e165924fdbabb5_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i14e87aa3f56d473daf037a89d1e3f4cb_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8b401019625b4ffc9c1541fcb02abdca_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id89030d89d1e4b54bedf38e99c30adf4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic33d37a4611e4bf98bb41808ea525923_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie81d0a0753f34755ba559ce7e8f8a2c3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie7eab6271f564f2dbb8e2c685ee1f69e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if602072ed0664abd9859c3de34709d83_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8d0edf9b3b234e2eb42a295c13b96ee1_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i314cfb6dd50443a9b34351d3b514793e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7e409ba4c7ff45558a246e22b72ee68b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i282a3b3636ac4fdbaf44b6dab63ac522_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i11a40d625e53441aabf546066d2672ec_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibaff82b7c098441c9ccc6088aa77f91a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i419faf2db8864f5abeee247d1e0449c9_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic303d3a8e76444c19a42764555e9621a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8ff799492511435995a4fcce3087275c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6e7b723bc7f4425da488009786365c0b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8ecd868de4b74f8fb09905823604d5a3_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifab045615fd245ceaa2d3d8f22a26ea6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i69fdb2d4d7f2476f80fef8c5512cf6f8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9f1d98186147425ba46323876656de3c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i122a78b066844d89aea3dff0b2ed8fc0_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2793aa187d4547d9a9b81510f2035315_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i45000082246d4ff88fd5232c1ee7a62a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i840f53fa92b64230898a1197eee37195_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia831e29650fd43b592b44596af1df346_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9fdca9e3dfed4bb6afcc9aab7e6b5e28_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i81a59b2059264ec5904d079ea451adab_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="idf215da56009467fb577f8853105c8ca_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4cf7fd73de2649c6adb87d065a4be327_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i30f51622e3664ef4a40338a9815f069d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic13ffc6f68cb4f39a642cd17209182cf_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia24e5130e49044f78de32bfba07a0e09_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if71a5d29e4fe413f9f12cd54d342dcf1_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic684af48acc3440ab9a6527375151fb9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if1af11ab5c0343348fe9016b5ad09b44_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icd9b8394e1cb440ab703e649cd6c4d17_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8ebfbf5b5a194d5c80780257ca423e45_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4b35216c25964eaabae221494b87f323_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i50c8a90801e942c69a8f8861a2ca9c65_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id4d14843835a4e1db7a4eae595d60048_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i33f395a11457480697177a292c67ad43_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3488c7dfa3bd403998e2bc139e4b788c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1d89a47caf084728b8ae0acda82c4344_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia2df301919454ee598ea1eabd11d48dd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i28f9aeb56b074a67bf4231acda630b3d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff698b58bad14579940ceafaf42bc7be_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i06dea07a8e6c455f9a6b50cac32e6c7c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7420190e386d412d822b09d22bd8ee99_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i866af78581cc419ba80616eb6a2a7b51_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idcd6f50d8ec2470fac2900fa32cb8766_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2b92f0d8a3fa48a89bf3fb7d5efaab75_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icafafbdd0712443dbec74d4e5dc99655_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3c2a17a99104485fbc33dea758b354d7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i801328559dbe4de794a22df113518552_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iabea906284394a2e93e98586744d1714_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75e0f0f3c8b544fd9ffdf8a0ffcba669_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i243763dadfd64bd1beb7dc20bccd336c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd477c8a2f304ec2a970e27dae002cd7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id1f3205f079b431c9d64b68d265849ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i996045b306724fc6bc06c217fc070834_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic4caf3a29a8642828078a62b68f39097_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4cf5accb7aa14841b150df8d3aea6ae1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaa1ef48af23941a2b697e7581d564363_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0cb11b6f09ff4422b4d9ab2c7d7dd6ff_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaceb341416e648418eb641df20734f0f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3597ace5860a420cae4ec7819bea418b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i527caad11f5c499cb6f93ad3f37d9a05_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaadeca50c0b443ee929d80b58fa9d325_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i232ee16f6b6b445ea405613e39346280_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i68df3e804e3343eb841aa45a3b23fc09_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id0c0c0cca6254ee68e1a5f7df5bf4c6b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i22bae2abb5014d60894b6b57f2d9642b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i77623f06245d4063b189951809382a54_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie2c3e0ab5c404e47a177e468672a1455_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i132e6a5556ef4b1d9a099d0161937187_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3d09f0c28ed43418f452c8a8c413e2c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id1f82d2c30024c07a9201d0f6c666c56_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id539ee77085d45f4865a0e6a9a962ff2_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="i39531d4ab7cf4f0aace79c3dc0eb299a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i78065ce772ec469298f8378f75ca1645_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifa63d1e101a04ca3930b9a6c58bb223c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i19e6852caf924e1e8b8bcb9b31317006_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6e1e3edd32274cfa9dee37913732cc3f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iedc8c2b179da4c57b0d69399b7319487_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i772dc85a5dae4c1d9ddf06f9992a3e6b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic946c1298336471283c1bde8dab683da_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i91c0aa1e995c4988b6700da4987ed2a2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i163d925374744dc19e90ee21d40ac455_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i939615bc911747ff91466aa044f7d705_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibf756f2501b74e0898048554c3c0783e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i796ab7b302fd449bb651ec4d41dac07e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7f8cf2a139e64d1198f5d67aa364f965_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4cf32622b6254648a6c2f68df210c48e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3eaf883d9af8472c83fe21fa31227a28_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d3c3bdb624f4891bf85269d85f85683_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8e00bcc4ceb456280e021abea879ec0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1e0a0c15e8e344eca24216baf962f264_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9bec0cdf729b451dafb85f5a25d8f563_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i61de52e98a8c4a8d83132e0c0db3dcd4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i47ef30b73058418caaaaff016ffeff78_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i005e8c3fac4c461bbb49bcb0b925f653_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6d2ea83589d04ffba237d02df0bd14ca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d8874a1883347ecba3086a56ff8551f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i387e213a06b04a448c4eb58b54ad09f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4c7d0cf9f5d9461997395ecfa5774eee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia045228d9b614876a5e504039e235ae7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i641d7897463648d593b3ca40dbd5ede9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i220a77d258c24676985ff3e94a5777f2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9d12e59c7f4c45f4a6acae8cdc855fd2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i84e9a9944b144829ad78f048f85f8b72_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i64737b59a93b4b3f8cbc8602eacded0f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id642d98b4ab5493492cd4d631e98f649_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i16091b8d48fe4aa7aed58abf316cf655_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8a0c0c9f6f014f8fb72f8cf92bde8fc0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i557878bd28b741ac8242fc9594c33f79_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2f8e521dfd304b559210391763ef8967_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i38789c05639047e786b0f44cd1f81a54_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic89b647aa620475b919305bbfb902e88_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib05226da6d8b49729bf12cbb13f48688_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0dab2c8b54fd4ca4bd5583431d596fda_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib033d6a72993457c9d1212af5e26a84d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iad453372414e43f4bbb5fa127bdfd4b6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9b51bff8800c428797e64c37e8bf037b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if895305c42ba4796b58e31d56a083e2b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id649b26944164f4f97db61669a9fa440_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8c5fd4abee7d4774b0069173b5ab7bd0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3981fc802cb453aa0560b2810a13ded_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i97950dc03de449d4b199d76fa33d7646_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id37a246dde494a62b12b0bcc3808a45c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib3247e24b5dd46618012805e016575c9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2739e8b8a37c4a40826744f663f3cd9b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i71af70fa404948bfa683daccf446fe4e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icdb36b5dd0ef4b7da44e14cd73f5fafb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i76cad1a6417044928d62c1e4ab27cda9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iedd025b870864e4d961da366b7b5528b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibda6b7d8020d42f3b17c4b1a9af44d12_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i51c7fde616a242b9b7b30c2c7b19b923_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b8df10c2682432983902baa864b9142_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idcd8f21f2f7c4238aa1325d72a7ebbdb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie3fe525c20524b7eb5724b9edf213b37_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i061f31e310da49b8bdef63bdf885268c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1b410efadd054a649b74fb4ab4b2541f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4a8f0d4449da4cd59d8a03eb8dc3f11d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i89c072c3ed814deabecf50119491b5cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iffd18f96992e4b7ca3b22e6376f529fe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5ab7b877600348b0a02624b9699a5469_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i19a4f05983fd4dc5b7709df1b833f9c6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic9ca0e4731fb4bb4993033661944bef4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3ffa5a29a71643c88ede85aeb0f07ae0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i75036d6e219044c292bf94448ff791de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9b46809a4a242e9b7e286c5f5853e33_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9bc7b23b98c24bcb97086aedb8f6b9a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i63e85efa2c7b4b8a8934c115e462671d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a6510d82770434b983d927bf24176d9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie905e4f33e8d4048b5cfaaf2621e7b22_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i253e61895f964faaa57258e78a2e242b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iee7f60369ff44dc690747a7ded9f7378_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2f492eb7b30f444ea91c469c951cac52_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3231b70ce9d74b739582396aea5f4596_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ac7ec1a94684eb4b17125ff94d45847_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i944386c5eaae4e9b9f6282141c8f6cd9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb2b256fccda44f789ccdb015560f400_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i34aa94365beb4fda8e028ed4b2e49ffa_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie634e5d883a246c0b675b67cb23000bd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i22bf6089dd044188988a26b040ff65c0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i02324c19886a4c18b6067d16ace402b5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if8ed0ac879e24c8088076f9f0f8287ed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9760653085dd4b7393829a3480ed5ec0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba7989e6f5e8482ab0daf120805cca55_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i21134d594d0f44a3b592bd03f3304d4b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifd625ffa45724705a1055f34d130688c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i46d7fa3ab3de4bd0993ae0388c003976_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2ab8e64374244574bfba15d1172a7cd3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i357340a5b0324e1e9aaa75a5ef7abab6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icbfb293f7d7a4cc58fc7ee43b5c0eb61_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0358d88a74ec408bbf376519526abff1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i41bb3ed9de1d46d79072d907dbbcda90_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4756268078d14fac936133a04e156f01_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="if487bbb8057a47a2bfafd87e853aa62f_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="ifa9602c2fb6e4bc0a7dfeb7bb5e534d8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i21a47f508af74c0c94d611302c008270_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifa422606d00d4484ad76a52ce224d9f1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3819ef5e99824efb8df9aa305cf4213a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i382dac6fd2e349f5804856ab5f5e6561_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i30b9d60f80524037808096d46cfdd9bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i49489b4312d24480aa69abea662ae37a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia4e0652f35f242c6a35f9468106a365d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie650f5facb7d4c908578773f98df20f6_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i0b069c2c100449aeadeb5889f43faee8_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="ic3e711d6bdc94af7b6ee030579f78de0_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="i7b809d8e899c48f8b512ad46a079ce18_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icce7f0fe51bb4d6a83a6b3c726ccf985_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="i37ee9bbba7f147d591042cb6d0e8f335_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="iede1f068bfc44082bd810dcfb2a02ad5_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i1ad6d1665fee4888888e6df28a252048_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i4154c45af47f4f888c6561a6c50b57a6_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i373622f14721402a91753acb36279106_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie3c7a4ec156b450fb7575fa2881109f7_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia9de9ff92177493894947aa870f1fdb1_D20200909-20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-09</startDate>
            <endDate>2020-09-09</endDate>
        </period>
    </context>
    <context id="i38e92ae2ce0a452cb6846f90bf759997_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightForInternalResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="i7615fe6e6d454f0fbf707d6edc90ebd9_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="i1190b533a86e41eca453e2df75138ff0_D20200909-20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-09</startDate>
            <endDate>2020-09-09</endDate>
        </period>
    </context>
    <context id="i7c18c4b370684d73aaaecae58235fa63_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="i23e8adba85424e069fb3b94c160243e2_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="i877bb4cf5c014a2cb25d492e5c13e477_D20200909-20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-09</startDate>
            <endDate>2020-09-09</endDate>
        </period>
    </context>
    <context id="i9b82e3c101694a14a28cf38916f0faa7_D20200908-20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-08</startDate>
            <endDate>2020-09-08</endDate>
        </period>
    </context>
    <context id="i8e9a33faf4604184b79f97df731f1531_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="ia125689d8b6d45c8acc8d4e04a5c8dcb_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="i104be1b5412749a98d1b83af0aa45462_D20200908-20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-08</startDate>
            <endDate>2020-09-08</endDate>
        </period>
    </context>
    <context id="i54d5014ebd024ca98e929b3f83f093f0_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="if0c763244b8f494b9e10d8327366c0ac_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="i5723a94d9eda43fb8869b9e15a4fa617_D20200908-20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-08</startDate>
            <endDate>2020-09-08</endDate>
        </period>
    </context>
    <context id="ie8c72e7934ca467294335090971a29a5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icf2d939c66e240b384df46c32a7696cc_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie5cbd93c89514ab78b2dac40f63bcb20_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i7603e0f422424be9889ff1051524dfb0_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i6940e14a447b4533beb52b4a4a14f7dd_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i7aba352a45ca4f0e95b1673c0ce486b6_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i0153378473074ebfa2f0f2c17278e656_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i34d2746d79d3442aafdf1a56d6430b2c_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="iaf96b8be4ae34fa8b6593ff5e5722455_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i12aec736c95f4baa8c48022ee88902a7_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i1f99d4ba56e34f949157def3cb48d44b_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i68aebd079e8d43ca8aaffead3aa479b9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i63b28b3736b54b859065e5e8a9af5595_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9523ea7760f1491383b68be5f294a2a0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib669b81f00fd49af94c6193b9b28b3e4_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i11b1244fd6124eb2b9e0ee4aa2f36ac9_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic5ad33f4bc734bcd93b25da90e7b9a20_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa6b8e5ef49e44a1a9aa9d047df544ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ce65c3cba6d4e1c8557dd4dafca661d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i12c4ed3b655b4b9f9e07ed3bc8c69079_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia96af39bd7604591ab7fc340e359673e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia2b7db7eef844718bf3f53433cde626e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1e79a2e6b67647f882b54599c4f29c87_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i89e8971a9fce47b4a1bcea09039305ed_I20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-09-11</instant>
        </period>
    </context>
    <context id="i74efa80b6d414949ba31e1e709cc19df_D20190911-20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-09-11</startDate>
            <endDate>2019-09-11</endDate>
        </period>
    </context>
    <context id="i3d23921891db45d19e297bbe9bbe585a_D20191029-20191029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:LupinPatentInfringementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-29</startDate>
            <endDate>2019-10-29</endDate>
        </period>
    </context>
    <context id="i90fc81e184454d969b54196ebc6b39a6_D20191031-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-31</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i89c035f5c0114d94bb9957d60b37cba3_D20190501-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:InterPartesReviewOfPatentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i8a9e8cc6b16b4c0e8960c2d7f31c2aaa_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:InterPartesReviewOfPatentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lgnd:GlaxoSmithKlineBiologicalsSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="position">
        <measure>lgnd:position</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="contingent_value_right">
        <measure>lgnd:contingent_value_right</measure>
    </unit>
    <unit id="contingent_value_right_series">
        <measure>lgnd:contingent_value_right_series</measure>
    </unit>
    <unit id="pure">
        <measure>lgnd:pure</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="option">
        <measure>lgnd:option</measure>
    </unit>
    <unit id="patent">
        <measure>lgnd:patent</measure>
    </unit>
    <unit id="civil_complaint">
        <measure>lgnd:civil_complaint</measure>
    </unit>
    <unit id="petition">
        <measure>lgnd:petition</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80L2ZyYWc6Mzk4M2E5ZjQ3M2ZjNDUxYWFmOTE0NjhhZjEyOWU5OWEvdGFibGU6ZjdiNWZlOWRiYTFmNDUzMWI0YjdiN2EzNTY5Y2E3ZTAvdGFibGVyYW5nZTpmN2I1ZmU5ZGJhMWY0NTMxYjRiN2I3YTM1NjljYTdlMF8yLTEtMS0xLTA_5dbc0f37-110f-4320-b181-00d2db5eb965">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80L2ZyYWc6Mzk4M2E5ZjQ3M2ZjNDUxYWFmOTE0NjhhZjEyOWU5OWEvdGFibGU6ZjdiNWZlOWRiYTFmNDUzMWI0YjdiN2EzNTY5Y2E3ZTAvdGFibGVyYW5nZTpmN2I1ZmU5ZGJhMWY0NTMxYjRiN2I3YTM1NjljYTdlMF8zLTEtMS0xLTA_4fa1c300-1b3c-41e5-9aa8-842098e262b1">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80L2ZyYWc6Mzk4M2E5ZjQ3M2ZjNDUxYWFmOTE0NjhhZjEyOWU5OWEvdGFibGU6ZjdiNWZlOWRiYTFmNDUzMWI0YjdiN2EzNTY5Y2E3ZTAvdGFibGVyYW5nZTpmN2I1ZmU5ZGJhMWY0NTMxYjRiN2I3YTM1NjljYTdlMF80LTEtMS0xLTA_1861bb00-3216-4081-afac-839d8e4f9a21">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80L2ZyYWc6Mzk4M2E5ZjQ3M2ZjNDUxYWFmOTE0NjhhZjEyOWU5OWEvdGFibGU6ZjdiNWZlOWRiYTFmNDUzMWI0YjdiN2EzNTY5Y2E3ZTAvdGFibGVyYW5nZTpmN2I1ZmU5ZGJhMWY0NTMxYjRiN2I3YTM1NjljYTdlMF81LTEtMS0xLTA_b47a421f-6a19-4968-abbd-15d22cbf9485">0000886163</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80L2ZyYWc6Mzk4M2E5ZjQ3M2ZjNDUxYWFmOTE0NjhhZjEyOWU5OWEvdGFibGU6ZjdiNWZlOWRiYTFmNDUzMWI0YjdiN2EzNTY5Y2E3ZTAvdGFibGVyYW5nZTpmN2I1ZmU5ZGJhMWY0NTMxYjRiN2I3YTM1NjljYTdlMF82LTEtMS0xLTA_cb72af3d-185b-47e8-a35f-29520b328394">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i4b8c7b189adb4ef7941efd43c9855c73_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfOS0wLTEtMS0w_4b78ef34-ac03-4169-9ec7-b34f5697db27">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="iaf96b8be4ae34fa8b6593ff5e5722455_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80Ni9mcmFnOjE2N2Q3MmIyOTk5NTRiZWRiNGRlYjA1NTgyNDJjODZjL3RhYmxlOmFiOGQzNDI0YmE4NjRmODliMTU1Yzg5NGNhMzkyMmI3L3RhYmxlcmFuZ2U6YWI4ZDM0MjRiYTg2NGY4OWIxNTVjODk0Y2EzOTIyYjdfMi0xLTEtMS0w_6fd202c2-e8c1-47d6-bebb-09172195eb2b"
      unitRef="number">0.0040244</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18xNzI_467753f2-fbad-45c9-8111-dd599d30356c">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6Njc2NjNlNjk3Mzc5NDUwMTg0NjVkZTE3NjEwMmU1YTEvdGFibGVyYW5nZTo2NzY2M2U2OTczNzk0NTAxODQ2NWRlMTc2MTAyZTVhMV8wLTAtMS0xLTA_febb8fa7-d23d-4b4f-a1fc-6d962438f71a">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yOTc_e5eb65dc-c47a-448c-9472-2581bad48976">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6ZWJlZjEyZWM5NmQxNDFjOWE1MjViMjAwZTk1NTVhOTgvdGFibGVyYW5nZTplYmVmMTJlYzk2ZDE0MWM5YTUyNWIyMDBlOTU1NWE5OF8wLTAtMS0xLTA_c49ec62c-5045-4367-9746-b08a600ea684">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yMTky_e0c2fe58-f724-423a-a75b-9be8cf044f8d">001-33093</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY180MDA_cf67d3e1-e48b-4f94-84dd-2f57c61b3204">LIGAND PHARMACEUTICALS INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NGIwM2ZiYTk3ZDc1NGUzYWJhYTc5YjE2NzFkYTI4YTMvdGFibGVyYW5nZTo0YjAzZmJhOTdkNzU0ZTNhYmFhNzliMTY3MWRhMjhhM18wLTAtMS0xLTA_80d6070d-773f-4b4a-8e79-317ebd5f13bb">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NGIwM2ZiYTk3ZDc1NGUzYWJhYTc5YjE2NzFkYTI4YTMvdGFibGVyYW5nZTo0YjAzZmJhOTdkNzU0ZTNhYmFhNzliMTY3MWRhMjhhM18wLTEtMS0xLTA_b612efaf-be21-4e20-854e-dd8db1d8ee62">77-0160744</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NGIwM2ZiYTk3ZDc1NGUzYWJhYTc5YjE2NzFkYTI4YTMvdGFibGVyYW5nZTo0YjAzZmJhOTdkNzU0ZTNhYmFhNzliMTY3MWRhMjhhM18zLTAtMS0xLTA_c2fa75c3-0f79-4b37-b6dd-965c675e9211">5980 Horton Street, Suite 405</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NGIwM2ZiYTk3ZDc1NGUzYWJhYTc5YjE2NzFkYTI4YTMvdGFibGVyYW5nZTo0YjAzZmJhOTdkNzU0ZTNhYmFhNzliMTY3MWRhMjhhM180LTAtMS0xLTA_e4ca5496-1834-4c9f-9303-dd0c1b6e7d53">Emeryville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NGIwM2ZiYTk3ZDc1NGUzYWJhYTc5YjE2NzFkYTI4YTMvdGFibGVyYW5nZTo0YjAzZmJhOTdkNzU0ZTNhYmFhNzliMTY3MWRhMjhhM181LTAtMS0xLTA_735a3802-90b8-4a32-a1ef-799ad8e59363">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NGIwM2ZiYTk3ZDc1NGUzYWJhYTc5YjE2NzFkYTI4YTMvdGFibGVyYW5nZTo0YjAzZmJhOTdkNzU0ZTNhYmFhNzliMTY3MWRhMjhhM181LTEtMS0xLTA_7be5c597-5ddf-471c-8f0f-516fa50fb4c5">94608</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yMTkz_e703c283-6491-4885-b98b-3d2c25348295">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yMTk0_f49dcede-8281-45de-9275-580e6e1e8a26">550-7500</dei:LocalPhoneNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ie37d0cd029f04b4cba79dd56d4faa880_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18zMjk4NTM0ODg1ODgy_8eaa5ba5-c32c-4a32-ac23-65c920c17dc0">3911 Sorrento Valley Boulevard, Suite 110</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ie37d0cd029f04b4cba79dd56d4faa880_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18zMjk4NTM0ODg1ODg0_2a0769b7-d1c1-44b3-95d1-a4d1d37ffc2b">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ie37d0cd029f04b4cba79dd56d4faa880_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18zMjk4NTM0ODg1ODg2_c903fe0d-9969-44e3-9cff-01ae93cb88c9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ie37d0cd029f04b4cba79dd56d4faa880_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18zMjk4NTM0ODg1ODg4_9e368346-e813-48f0-9969-825ae6c35d8d">92121</dei:EntityAddressPostalZipCode>
    <dei:Security12bTitle
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6MjcxMjFmNGVjZjEyNGFmMGEwODQ2ZGIyNzMzMjNmMWUvdGFibGVyYW5nZToyNzEyMWY0ZWNmMTI0YWYwYTA4NDZkYjI3MzMyM2YxZV8xLTAtMS0xLTA_65ce4bf8-3ac0-47ad-8d73-72e6d90bd9e4">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6MjcxMjFmNGVjZjEyNGFmMGEwODQ2ZGIyNzMzMjNmMWUvdGFibGVyYW5nZToyNzEyMWY0ZWNmMTI0YWYwYTA4NDZkYjI3MzMyM2YxZV8xLTEtMS0xLTA_bf7f9b4e-bcb3-406b-ba38-5ede3d5b1536">LGND</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6MjcxMjFmNGVjZjEyNGFmMGEwODQ2ZGIyNzMzMjNmMWUvdGFibGVyYW5nZToyNzEyMWY0ZWNmMTI0YWYwYTA4NDZkYjI3MzMyM2YxZV8xLTItMS0xLTA_bc507074-116d-44b4-b06f-4decda117ef4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yMTk1_c6a88c48-6b34-46c7-9e10-ffd4de436ad4">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yMTk2_d520f547-f9f6-4ee7-bf70-e1149d82ef0e">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NzYzNWRkMzBkMDI5NDY5Y2IwM2IxYjg5NmI5MGQ0OTIvdGFibGVyYW5nZTo3NjM1ZGQzMGQwMjk0NjljYjAzYjFiODk2YjkwZDQ5Ml8wLTAtMS0xLTA_95d741e9-79a0-4615-9053-3622f76a38b9">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NzYzNWRkMzBkMDI5NDY5Y2IwM2IxYjg5NmI5MGQ0OTIvdGFibGVyYW5nZTo3NjM1ZGQzMGQwMjk0NjljYjAzYjFiODk2YjkwZDQ5Ml8xLTQtMS0xLTA_57e5db07-d9bd-4e85-a2ff-78f5fce3e5ef">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGFibGU6NzYzNWRkMzBkMDI5NDY5Y2IwM2IxYjg5NmI5MGQ0OTIvdGFibGVyYW5nZTo3NjM1ZGQzMGQwMjk0NjljYjAzYjFiODk2YjkwZDQ5Ml8yLTEtMS0xLTA_8329a7e1-f988-41c6-b100-ebe40b44c814">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yMTkx_3699606b-c867-4bed-be5c-1c563b2a596e">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="iafdc6efe6f0a42d7882e9db52eca6047_I20210730"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xL2ZyYWc6NzI4OTM3YzE3OGQyNDViODk0MDc3ZDNiYTQwOTJmZWMvdGV4dHJlZ2lvbjo3Mjg5MzdjMTc4ZDI0NWI4OTQwNzdkM2JhNDA5MmZlY18yMTU0_acf96b22-75e1-47b0-829e-44210426e5a5"
      unitRef="shares">16676532</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMy0xLTEtMS0w_b6153bc4-ab34-497e-acce-9bc44e17ff25"
      unitRef="usd">21863000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMy0zLTEtMS0w_73a2234a-fa18-47d5-ac83-7ad7612f7a72"
      unitRef="usd">47619000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNC0xLTEtMS0w_5abca571-c7a4-4e1a-b34d-4c522edda02e"
      unitRef="usd">279972000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNC0zLTEtMS0w_b5cb0aaf-7780-4bd9-ac64-ce87f0a80d45"
      unitRef="usd">363567000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNS0xLTEtMS0w_22ca116d-f6e5-4579-9ed6-4cafdad83ae3"
      unitRef="usd">58156000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNS0zLTEtMS0w_33dfc72b-7a29-47cb-a5eb-f5f6219f73a9"
      unitRef="usd">56847000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNi0xLTEtMS0w_ce24bcb4-2738-47df-9929-312e8840e442"
      unitRef="usd">39946000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNi0zLTEtMS0w_e9f2840d-0af0-4be3-9159-241d8e356c08"
      unitRef="usd">26487000</us-gaap:InventoryNet>
    <us-gaap:IncomeTaxesReceivable
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNy0xLTEtMS0w_0e8d3fe0-b919-4bb4-a3f3-31809531e245"
      unitRef="usd">4694000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNy0zLTEtMS0w_ee259a66-119e-4703-b399-0de4dcd69eef"
      unitRef="usd">2217000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfOC0xLTEtMS0w_f4e0ea9d-8e84-4d60-8837-c67a38cb817f"
      unitRef="usd">6270000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfOC0zLTEtMS0w_571573d4-1960-4c1d-bb31-b4d99f1d77b4"
      unitRef="usd">3822000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfOS0xLTEtMS0w_fbe66311-17e5-4362-9e52-5e8829b77669"
      unitRef="usd">410901000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfOS0zLTEtMS0w_d35065c0-9df8-4769-8303-f5daa8030a41"
      unitRef="usd">500559000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTAtMS0xLTEtMA_5fc2c540-3bd5-454e-9a35-d0f0eff363f6"
      unitRef="usd">27882000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTAtMy0xLTEtMA_f65799d2-e58b-4f80-ad42-5cda58abc01a"
      unitRef="usd">24320000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTEtMS0xLTEtMA_58b727e1-f332-47ec-94cd-da383e53d5db"
      unitRef="usd">572006000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTEtMy0xLTEtMA_93e87ff6-8507-470a-a755-b011d3b291d3"
      unitRef="usd">595330000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTItMS0xLTEtMA_819ce23a-75ae-4562-ac9b-8fe636c1c175"
      unitRef="usd">190517000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTItMy0xLTEtMA_1ff5fe29-6ca2-4e2c-8c57-999760976861"
      unitRef="usd">189662000</us-gaap:Goodwill>
    <lgnd:CommercialLicenseRights
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTMtMS0xLTEtMA_c62ccc58-5923-45cc-b567-15a171470955"
      unitRef="usd">10638000</lgnd:CommercialLicenseRights>
    <lgnd:CommercialLicenseRights
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTMtMy0xLTEtMA_49b96a0c-6e04-4227-a97e-dc85c9e09d0a"
      unitRef="usd">10979000</lgnd:CommercialLicenseRights>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTQtMS0xLTEtMA_f1c9353f-d422-4838-a3b1-43a3a95d1e4f"
      unitRef="usd">17628000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTQtMy0xLTEtMA_f6d81b98-c14a-43c8-bf6f-5c6baee5efef"
      unitRef="usd">14434000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTUtMS0xLTEtMA_bac26062-4eca-4c24-a548-5e79f2c029a2"
      unitRef="usd">6500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTUtMy0xLTEtMA_a6f7c97b-7bae-4340-bfcf-ec6fe54f7aca"
      unitRef="usd">6892000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTYtMS0xLTEtMA_449494f3-2e82-4150-b820-137fc35c2625"
      unitRef="usd">17383000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTYtMy0xLTEtMA_3989a8c2-a4bc-4d3f-92cc-539c3be6c529"
      unitRef="usd">15842000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTctMS0xLTEtMA_a186bcd7-fede-4d45-8b20-92a3c79e3c27"
      unitRef="usd">2828000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTctMy0xLTEtMA_3293f479-9e2c-4f6f-b8af-1e9af0465df2"
      unitRef="usd">4267000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTgtMS0xLTEtMA_aed60434-1b8e-459b-aa1f-fa51495a9712"
      unitRef="usd">1256283000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMTgtMy0xLTEtMA_cf3b1a9b-08ef-47b8-87ea-b1abc51a5746"
      unitRef="usd">1362285000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjEtMS0xLTEtMA_c79a0148-42e2-444e-b0bf-7269351f5a41"
      unitRef="usd">17273000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjEtMy0xLTEtMA_047d5fbc-e002-4e21-9777-627bff82fc03"
      unitRef="usd">3784000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjItMS0xLTEtMA_90ba07e4-f2c5-4b24-b708-2d33b1585240"
      unitRef="usd">10107000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjItMy0xLTEtMA_21d4c484-4301-4d06-b4f4-cf7de22a42ab"
      unitRef="usd">18530000</us-gaap:AccruedLiabilitiesCurrent>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjMtMS0xLTEtMA_83acf710-a5e7-4ca0-8d6e-f598628510b6"
      unitRef="usd">5650000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjMtMy0xLTEtMA_d4465600-15b3-4eff-bdb7-9edc5d2ef49e"
      unitRef="usd">39884000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjQtMS0xLTEtMA_b77cc548-2d5a-47cd-a340-cd0626ba646d"
      unitRef="usd">17147000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjQtMy0xLTEtMA_9f2e5c2a-8a74-40d5-8a1a-34f03ad1609f"
      unitRef="usd">29435000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjUtMS0xLTEtMA_2d0265e3-fa27-4f20-b3ff-2fe150ffca19"
      unitRef="usd">2275000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjUtMy0xLTEtMA_9ddc1267-89d0-4c82-a139-374162c91653"
      unitRef="usd">1885000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjYtMS0xLTEtMA_64651f67-f0e7-4a25-9594-efdbeb1a3ae5"
      unitRef="usd">45000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjYtMy0xLTEtMA_114d6fad-86a9-41a9-818f-99f649df274d"
      unitRef="usd">6593000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjctMS0xLTEtMA_4ac76338-55b3-4bf0-97e6-5efb5459d6b0"
      unitRef="usd">52497000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjctMy0xLTEtMA_81b3ae54-2f93-4380-aa18-be43130e9086"
      unitRef="usd">100111000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjgtMS0xLTEtMA_37e8c8b2-ad22-4bbb-8b54-9988d8939522"
      unitRef="usd">315318000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjgtMy0xLTEtMA_ab3fcff1-df97-48e3-92e4-1a376f787b4c"
      unitRef="usd">442293000</us-gaap:ConvertibleDebtNoncurrent>
    <lgnd:LiabilityForContingentValueRights
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjktMS0xLTEtMA_a560eba1-2196-4455-ac98-7360c3f36c9f"
      unitRef="usd">9121000</lgnd:LiabilityForContingentValueRights>
    <lgnd:LiabilityForContingentValueRights
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMjktMy0xLTEtMA_187d6410-6b11-41df-a976-ad2a18a973c3"
      unitRef="usd">9249000</lgnd:LiabilityForContingentValueRights>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzAtMS0xLTEtMA_6ab22983-bd06-4067-9660-6df9a8cc78e4"
      unitRef="usd">60053000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzAtMy0xLTEtMA_33a183b0-f4f5-4b30-b769-bdc5bcecac55"
      unitRef="usd">64598000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzEtMS0xLTEtMA_16e32bca-b0dd-4ccd-944f-f0164449daab"
      unitRef="usd">4771000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzEtMy0xLTEtMA_3acf8ce0-0fb9-4040-9c1a-de81e136885c"
      unitRef="usd">5643000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzItMS0xLTEtMA_b16a78be-e0aa-43c8-ae5b-53d204de4850"
      unitRef="usd">28006000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzItMy0xLTEtMA_a493dd12-057d-4a36-9366-a30bf527530d"
      unitRef="usd">30866000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzMtMS0xLTEtMA_689cc08e-d2f6-44e5-89c4-4054b26e1fc1"
      unitRef="usd">469766000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzMtMy0xLTEtMA_a024a10d-d464-49fa-b96d-5ecaaf8aac36"
      unitRef="usd">652760000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzQtMS0xLTEtMA_e16befd5-3796-4caa-8221-a8623e347873"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzQtMy0xLTEtMA_189d7623-8de6-400d-b438-728f91423a5f"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzI0_615a499c-8198-48eb-b3d2-458164739e92"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzI0_8e147206-862c-43a0-a2fb-7af1633e86d7"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzM4_114edf08-ca02-4f98-a27d-b1383cc7b0b9"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzM4_f90b41f7-2731-48c7-893a-4738c5fcf2ef"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzYw_8463505b-6a1a-4a6d-bcd9-4d1959e1331c"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzYw_8b1d3e7f-6c2e-4b38-9553-b258667adfd6"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzYw_cb783802-d19b-4849-a06e-8b5d3bb14cbd"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjY4MDI2OGM5MjM5MTQ1OTdhNzBjZWFiNmEzYTA4MTMzXzYw_cd47bbed-fed9-4266-be6b-14e38f551b9f"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMS0xLTEtMA_7924bfa0-9a79-4bdc-bce4-97ec01463218"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzYtMy0xLTEtMA_7619d045-afa7-48fd-8a72-60e7d4586b46"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzIx_098ce082-1f9d-4d1b-ab6c-bb5112a6a7f0"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzIx_9a45b776-baea-4a43-a186-b8e717d8d4dd"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzM1_911c048e-20f6-4739-acf2-037626e8207e"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzM1_daabf55f-0e95-459b-809c-25099265d9a4"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzU3_460c3913-06a7-4010-89fd-abb065fa6a6b"
      unitRef="shares">16676000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzU3_7e099ddd-780f-4549-ac4c-014977cde92f"
      unitRef="shares">16676000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzY1_2b5f354a-c759-4ed7-860b-ef48768f6332"
      unitRef="shares">16080000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjAwMmNjZTEwMmE5MjQ4YjVhMjY0NDYzODFmYTVkNTY1XzY1_3d0df102-1eb7-47d8-b84f-864398e2933b"
      unitRef="shares">16080000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMS0xLTEtMA_856933d3-7993-45e9-9eb7-81677a329b70"
      unitRef="usd">17000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzctMy0xLTEtMA_66b8e482-4f90-44ac-a37e-dbdb59129f10"
      unitRef="usd">16000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzgtMS0xLTEtMA_b984c281-4c13-4400-93ae-24eabed1e06c"
      unitRef="usd">346578000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzgtMy0xLTEtMA_23d0f330-c1ac-48e9-acef-bb450238f678"
      unitRef="usd">318358000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzktMS0xLTEtMA_e63acbb3-d384-4044-a3b9-d158cb1e007e"
      unitRef="usd">-861000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfMzktMy0xLTEtMA_978f7a7e-0d44-46aa-ac5d-97a3533e7454"
      unitRef="usd">-801000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNDAtMS0xLTEtMA_5deb00c8-6383-4fe1-ab98-d7a175c5f694"
      unitRef="usd">440783000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNDAtMy0xLTEtMA_e65748bf-8acc-4057-a122-80e30b888faa"
      unitRef="usd">391952000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNDEtMS0xLTEtMA_992fa464-72b5-4e2c-b7ca-0cf6c5192117"
      unitRef="usd">786517000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNDEtMy0xLTEtMA_0dfcb5b9-54b7-4d38-911c-56fcf6e26775"
      unitRef="usd">709525000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNDItMS0xLTEtMA_c5c923dc-9b76-44af-bfbd-0af2f36c3aa1"
      unitRef="usd">1256283000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xNi9mcmFnOjJlNGYxZDlhMTgwYjRhYjE5NGRkOWZjNWM0ZWMyNDY3L3RhYmxlOjA4NGYwYjI1ZDBkNzRhMjk4MGI1NDkzNTc5NTAzODBmL3RhYmxlcmFuZ2U6MDg0ZjBiMjVkMGQ3NGEyOTgwYjU0OTM1Nzk1MDM4MGZfNDItMy0xLTEtMA_f5289c00-0978-4e5c-a52d-ee1919e1fb6e"
      unitRef="usd">1362285000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idc03d6d6660e4832837b896fd4ac920c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNC0xLTEtMS0w_579b2159-fd92-439f-a28b-0adb106e646e"
      unitRef="usd">8616000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i007aacf643a441dfb068465b043a79cf_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNC0zLTEtMS0w_9818f62d-abd0-40c8-9912-5bf24e5d84e2"
      unitRef="usd">7181000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifd7a926ec01f44e1afa9cce80d7a71fe_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNC00LTEtMS0w_f3a2b8b2-0f95-4bc8-a626-b442a0685fd2"
      unitRef="usd">15728000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i451635563e0745a3903ab950f8d8acd1_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNC02LTEtMS0w_c1b45031-1197-4c5a-a4a1-6ffaa0995d2f"
      unitRef="usd">13746000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia82ef50770684157a9c74a354fbf2b24_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNS0xLTEtMS0w_41ef9340-8e54-4e96-a3bc-51410ba2bce8"
      unitRef="usd">62509000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i83e26ee83c2f49b7b63a20e39c84e036_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNS0zLTEtMS0w_22a856a9-2083-44e1-9a64-cddc89a42ca3"
      unitRef="usd">24468000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i84dcdf4aa51446079e98d1cae23cc101_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNS00LTEtMS0w_51a65ea4-acc9-4daa-8904-cbf500acd954"
      unitRef="usd">93781000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia00ad653a232412cbc7060be9d5a8bf2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNS02LTEtMS0w_5000b3ed-eda2-4d30-8d49-7ec0eede9eac"
      unitRef="usd">45577000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4e8ad17c667349d89a149e25562db6da_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNi0xLTEtMS0w_67d57973-3117-4b1c-8b23-2bdc6fcdd50f"
      unitRef="usd">13550000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3ee54dca82994576be877ebf09f7324d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNi0zLTEtMS0w_1c6110a9-679e-4ab6-aecf-0ae0db810e54"
      unitRef="usd">9771000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie6a3f4144744455c937cf2f5a461ee71_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNi00LTEtMS0w_ddb0ea14-d2d5-4b86-8d77-fbb543542f61"
      unitRef="usd">30316000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i99224b8f7551423ab53c0612ea730573_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNi02LTEtMS0w_60a75404-1cd7-4042-ac9b-119eda86869c"
      unitRef="usd">15258000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNy0xLTEtMS0w_f12c62a0-95dd-4b40-af69-11feeaa2fa5e"
      unitRef="usd">84675000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNy0zLTEtMS0w_4d7e9042-79cd-45d4-8d29-a629dd575645"
      unitRef="usd">41420000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNy00LTEtMS0w_5c657c1c-b73c-4b21-82c2-49c3323f3430"
      unitRef="usd">139825000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfNy02LTEtMS0w_c6bef1b2-c1f3-40fc-96c6-132aa6099410"
      unitRef="usd">74581000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostDirectMaterial
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfOS0xLTEtMS0w_de86684e-4873-42d5-b6c6-7785b9048b0c"
      unitRef="usd">30593000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfOS0zLTEtMS0w_6cccd826-cc35-45ca-89c6-9b53301ee310"
      unitRef="usd">7644000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfOS00LTEtMS0w_a5a3b15f-031c-4aba-a8c9-b927febc1677"
      unitRef="usd">38746000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfOS02LTEtMS0w_53807827-cef8-4653-a462-180927374e98"
      unitRef="usd">12327000</us-gaap:CostDirectMaterial>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTAtMS0xLTEtMA_851b39e7-36be-4884-a0ce-0801422ca7d5"
      unitRef="usd">11779000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTAtMy0xLTEtMA_672c6a4a-35d8-478e-b7fc-16a3626b2f5e"
      unitRef="usd">3875000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTAtNC0xLTEtMA_2d52c5ec-5e52-4f49-9d04-8ea32626ee10"
      unitRef="usd">23565000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTAtNi0xLTEtMA_ed8f9fb0-f1ac-46b1-86a7-0304b69fd53a"
      unitRef="usd">7410000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTEtMS0xLTEtMA_79cbafd8-14cf-4c4c-a1fe-dd5300d8684b"
      unitRef="usd">15953000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTEtMy0xLTEtMA_fb9a8e0f-1de5-4044-ba57-de2f07801a4b"
      unitRef="usd">12732000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTEtNC0xLTEtMA_60ddfbe0-975e-4532-941c-d5f8b1ee8ead"
      unitRef="usd">33832000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTEtNi0xLTEtMA_5a12422f-7c8c-44ea-ba95-11f59a857c5e"
      unitRef="usd">24623000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTItMS0xLTEtMA_46fee031-8291-4d6e-8acd-1e00d3dce154"
      unitRef="usd">14711000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTItMy0xLTEtMA_4fb7149d-9c62-4923-8259-131cfa72fd16"
      unitRef="usd">10069000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTItNC0xLTEtMA_292521bc-4c15-4a78-8f92-ec9fcd824b86"
      unitRef="usd">27028000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTItNi0xLTEtMA_9c9d4526-f960-4b97-9562-52eb68d356f7"
      unitRef="usd">19333000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherOperatingIncome
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtMS0xLTEtMjczMQ_6d5432e8-ad85-43a5-8271-9bc21363d0b4"
      unitRef="usd">34100000</us-gaap:OtherOperatingIncome>
    <us-gaap:OtherOperatingIncome
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtMy0xLTEtMjczNg_017c28d6-99f8-4422-a56b-8cc611bff50d"
      unitRef="usd">0</us-gaap:OtherOperatingIncome>
    <us-gaap:OtherOperatingIncome
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtNS0xLTEtMjcyNw_525dc2d0-10d8-43e9-aa0d-8c5dc3ee727e"
      unitRef="usd">33800000</us-gaap:OtherOperatingIncome>
    <us-gaap:OtherOperatingIncome
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtNy0xLTEtMjc0MA_cad6a262-0668-43bc-8558-c35a98373315"
      unitRef="usd">0</us-gaap:OtherOperatingIncome>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtMS0xLTEtMA_5df9bd15-198a-4816-b4d9-b1f84e53e9ab"
      unitRef="usd">38936000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtMy0xLTEtMA_dcc0f8a7-d555-46f9-a465-03c48babe32b"
      unitRef="usd">34320000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtNC0xLTEtMA_ac207514-65b1-40ee-a387-e0ac2256d226"
      unitRef="usd">89371000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTMtNi0xLTEtMA_54165082-46fd-46d3-ac49-6f83c0a35972"
      unitRef="usd">63693000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTQtMS0xLTEtMA_f381b1a7-3948-4ea2-8225-f0ee5fa6d0e9"
      unitRef="usd">45739000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTQtMy0xLTEtMA_36572f7a-ee47-46a4-801a-5add815912cc"
      unitRef="usd">7100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTQtNC0xLTEtMA_8798f051-f812-40dd-8c67-976b547880e6"
      unitRef="usd">50454000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTQtNi0xLTEtMA_8b4cb758-f94f-47c5-855d-5eefef5765d7"
      unitRef="usd">10888000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnInvestments
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTYtMS0xLTEtMA_c2be8118-b89b-43f6-82e9-ae3af624f288"
      unitRef="usd">-6864000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTYtMy0xLTEtMA_3cba9033-07bf-42c8-8cb4-c4a1c7e0eb86"
      unitRef="usd">23460000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTYtNC0xLTEtMA_9e69285c-9213-44d7-94b5-89270cff0d06"
      unitRef="usd">6197000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTYtNi0xLTEtMA_478545ad-858c-495e-985e-9150d7b1ea0f"
      unitRef="usd">-7281000</us-gaap:GainLossOnInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTctMS0xLTEtMA_c15b9ecc-a61b-4141-88c3-1d534e1b9a88"
      unitRef="usd">233000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTctMy0xLTEtMA_bc39855f-6751-485c-b1b7-72109d6c52bf"
      unitRef="usd">1969000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTctNC0xLTEtMA_09bd8b1a-cd66-42ed-85ad-e30545408d82"
      unitRef="usd">529000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTctNi0xLTEtMA_85af2df9-80fc-4918-811a-af2925ad53be"
      unitRef="usd">6699000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTgtMS0xLTEtMA_c2e78880-70bd-4256-a53a-5c69d976b0e5"
      unitRef="usd">4883000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTgtMy0xLTEtMA_a1792c58-ad42-479e-95c4-2c08c9544a5b"
      unitRef="usd">6213000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTgtNC0xLTEtMA_cd51854b-e04c-4ef3-ac28-907f679a4d56"
      unitRef="usd">10714000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTgtNi0xLTEtMA_b7ec0c71-34f6-4c02-8215-0db72643f699"
      unitRef="usd">14761000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTktMS0xLTEtMA_a7133db0-08b6-40a2-95a6-3ea432825afe"
      unitRef="usd">-924000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTktMy0xLTEtMA_b09924bf-7173-4762-a5dd-59a16cb54782"
      unitRef="usd">1803000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTktNC0xLTEtMA_951caedc-ceac-473b-9db1-484c8d193bcb"
      unitRef="usd">-7401000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMTktNi0xLTEtMA_fe4e61d5-11f2-4ff3-89f3-f748f422e18c"
      unitRef="usd">2159000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjAtMS0xLTEtMA_e48baad2-939a-47dd-8be4-26922d602c82"
      unitRef="usd">-12438000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjAtMy0xLTEtMA_0ea44324-67a2-4072-b3ab-030c6e4e990e"
      unitRef="usd">21019000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjAtNC0xLTEtMA_f303ea40-b937-45d3-8137-9e7c6290e91a"
      unitRef="usd">-11389000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjAtNi0xLTEtMA_17894053-c2e0-40da-ba53-3ef4b7188ff1"
      unitRef="usd">-13184000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjEtMS0xLTEtMA_40c5b873-39c8-48ef-b8d1-c44160ab491e"
      unitRef="usd">33301000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjEtMy0xLTEtMA_7fa66aee-5449-445a-a896-9ec614fd3a2e"
      unitRef="usd">28119000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjEtNC0xLTEtMA_3ac46eac-d0af-4d16-96d3-2d0d095e7482"
      unitRef="usd">39065000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjEtNi0xLTEtMA_a4f0a9c7-d6f1-44e5-ad0d-b9ab6dc3bfd4"
      unitRef="usd">-2296000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjItMS0xLTEtMA_be6c0173-65e7-4687-bcd9-1d8e18f66f2f"
      unitRef="usd">2576000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjItMy0xLTEtMA_dd3a1e7e-04b2-4d54-9e5c-94ae3bb839a5"
      unitRef="usd">6033000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjItNC0xLTEtMA_c2916afb-aea4-46d7-953d-1179be6dad74"
      unitRef="usd">-9766000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjItNi0xLTEtMA_551986b0-7b5c-4782-a7b6-ca477c11f61a"
      unitRef="usd">-251000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjMtMS0xLTEtMA_79f6b5ac-dc1a-43e7-86b9-481c96b1476c"
      unitRef="usd">30725000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjMtMy0xLTEtMA_1a96e21b-b13a-4f04-9c6f-462621288dbc"
      unitRef="usd">22086000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjMtNC0xLTEtMA_cbf22bc1-8940-42bc-bdcb-4cf1306c8f40"
      unitRef="usd">48831000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjMtNi0xLTEtMA_7dd9f418-d462-46ac-ba24-3e3687183d1a"
      unitRef="usd">-2045000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjUtMS0xLTEtMA_f509d717-44e9-46af-a5e1-e4c27f2f81b6"
      unitRef="usdPerShare">1.84</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjUtMy0xLTEtMA_f234141e-497e-458f-8b23-560fcdcc8488"
      unitRef="usdPerShare">1.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjUtNC0xLTEtMA_bce6fb35-16d3-4aad-979f-dc03b3f675a2"
      unitRef="usdPerShare">2.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjUtNi0xLTEtMA_232d18d5-17ab-4f8c-9d20-5673080d5f2f"
      unitRef="usdPerShare">-0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjYtMS0xLTEtMA_37181abe-9555-45a3-b129-5d4f8d3dc5dd"
      unitRef="shares">16659000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjYtMy0xLTEtMA_2650f859-b5ca-4cc0-9f0b-d3203e201957"
      unitRef="shares">16055000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjYtNC0xLTEtMA_2bf89553-5054-4754-b146-4d56096cfe57"
      unitRef="shares">16548000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjYtNi0xLTEtMA_662d922f-c84e-4d0d-9e3e-757276090169"
      unitRef="shares">16292000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjgtMS0xLTEtMA_411629f7-25f8-4ff0-a245-e9a7bd034917"
      unitRef="usdPerShare">1.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjgtMy0xLTEtMA_8877161b-18cf-4ee0-9784-39fbae2174ff"
      unitRef="usdPerShare">1.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjgtNC0xLTEtMA_a90452c6-c8ab-4d4f-be5f-33579bd7f447"
      unitRef="usdPerShare">2.84</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjgtNi0xLTEtMA_3cbf59b8-2691-4d03-9bd5-c9df6d5d33d5"
      unitRef="usdPerShare">-0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjktMS0xLTEtMA_30036ad2-f587-4e66-9bef-100bc57b1a9a"
      unitRef="shares">17172000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjktMy0xLTEtMA_2d24b64b-86a7-43d8-9b07-920ca4dc34f4"
      unitRef="shares">16694000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjktNC0xLTEtMA_fdffb41c-aff7-4292-ba5e-7413814f2294"
      unitRef="shares">17210000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8xOS9mcmFnOjZhMjg5OWZhY2ZmMDRmZTJiZmU3NDBkYTM1ZGI4ODY5L3RhYmxlOjFlM2RkMDE5MjQ3YzRhZDFiODhhYTMxN2VhYTlhZjgxL3RhYmxlcmFuZ2U6MWUzZGQwMTkyNDdjNGFkMWI4OGFhMzE3ZWFhOWFmODFfMjktNi0xLTEtMA_9ba655de-cc49-4309-aa19-6ee3bd764fe2"
      unitRef="shares">16292000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfMy0xLTEtMS0w_e7711b78-5113-4aa0-90df-1c260a41094c"
      unitRef="usd">30725000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfMy0zLTEtMS0w_0d2dabc2-5579-48a5-a20f-516968b3a982"
      unitRef="usd">22086000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfMy00LTEtMS0w_bd4ee157-8958-43a8-b0d7-b58ccae9f4ab"
      unitRef="usd">48831000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfMy02LTEtMS0w_1613a84b-32f8-4d81-bea6-224769b57d43"
      unitRef="usd">-2045000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNC0xLTEtMS0w_72829c45-59ce-44b6-9895-40e1a615e50b"
      unitRef="usd">-5000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNC0zLTEtMS0w_c34121ef-a360-45ef-bd37-2619901e695e"
      unitRef="usd">2742000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNC00LTEtMS0w_25fdaa5d-226f-4f60-b38b-6d7e9767a0a4"
      unitRef="usd">-60000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNC02LTEtMS0w_e68ce798-0b20-45fc-837f-abf93fa04970"
      unitRef="usd">-30000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNS0xLTEtMS0w_47981a8f-4d28-4ef1-a780-eba4b76668d2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNS0zLTEtMS0w_925d4340-1d2f-49f3-bf4c-0993b02b70cc"
      unitRef="usd">-185000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNS00LTEtMS0w_03cd53d0-55d0-40f6-8eee-420c3b59e867"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNS02LTEtMS0w_54b4326e-bbc9-4e30-9012-9853986de6a5"
      unitRef="usd">-2064000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNy0xLTEtMS0w_6c62abdc-5816-491c-bef2-4c5677ab1fb6"
      unitRef="usd">30720000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNy0zLTEtMS0w_54a976f5-83b0-4071-807d-bb965ee7503e"
      unitRef="usd">24643000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNy00LTEtMS0w_1a5b4fa5-2d7e-4a07-9600-f7224d88ae7b"
      unitRef="usd">48771000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yMi9mcmFnOjc5NjQ3ZDVkYjBkYjRlOGZhNmIxMTc5MjUyNmQ1OGMwL3RhYmxlOjcxZjQzMjJiOWNkNTQ4NzJiZmUwNjlkMjRhYmQ3YTZmL3RhYmxlcmFuZ2U6NzFmNDMyMmI5Y2Q1NDg3MmJmZTA2OWQyNGFiZDdhNmZfNy02LTEtMS0w_dc96b4b3-57b7-4cd3-b34e-83459e0ed2c1"
      unitRef="usd">-4139000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i45213dff8ed44da68f68cf21fe41c95c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMi0xLTEtMS0w_cdf3e569-f0d3-4a2a-8b08-9fa4db5ffff6"
      unitRef="shares">16080000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i45213dff8ed44da68f68cf21fe41c95c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMi0yLTEtMS0w_a16d2359-faa5-4e7e-aad9-701e206ccba9"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i30bc2fe5fa8a4a7399a14d8b760b85c8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMi0zLTEtMS0w_1db6ab09-988b-4f9a-9200-0a6f23f584b8"
      unitRef="usd">318358000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i958b44c6e798443596d92cd43ad05dbd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMi00LTEtMS0w_87981fae-33ad-495e-8ea8-c8c199b611f5"
      unitRef="usd">-801000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia118fd0c458241d9b6713e222eab7ee8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMi01LTEtMS0w_b24e2b3d-f2f7-45a3-b9bb-f2272841d805"
      unitRef="usd">391952000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMi02LTEtMS0w_0bc89441-8d66-41fe-a119-5349bd239d1e"
      unitRef="usd">709525000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i65849e650e524fdcb63b754a5d8436e0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMy0xLTEtMS0w_db6ee282-5f44-4570-b496-ff6d3d59e326"
      unitRef="shares">572000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i65849e650e524fdcb63b754a5d8436e0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMy0yLTEtMS0w_36fff678-1ecc-4871-b85a-66e6e88ed066"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ibe754546a5d24b98b707f86af828e94b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMy0zLTEtMS0w_f73468dc-a85e-45ae-a559-51c5e6b9e840"
      unitRef="usd">20580000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMy02LTEtMS0w_dff76159-8c0c-43b3-9f77-6a92f9e21377"
      unitRef="usd">20581000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibe754546a5d24b98b707f86af828e94b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNC0zLTEtMS0w_28346e55-8afb-4868-a7a0-e344fac53984"
      unitRef="usd">8405000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNC02LTEtMS0w_f774429d-bd39-468f-9a7b-85ee1ab89d21"
      unitRef="usd">8405000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i5a1337c402e94895b3a0d72c858347c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNS00LTEtMS0w_bbea0197-07ab-4b88-9f20-890fb8d7aa01"
      unitRef="usd">-55000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNS02LTEtMS0w_894f40c5-2819-4821-b72d-ba5b77ce9319"
      unitRef="usd">-55000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="ibe754546a5d24b98b707f86af828e94b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNi0zLTEtMS0w_e374bacd-e78a-48c6-8105-da1c6a040ea8"
      unitRef="usd">-9086000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNi02LTEtMS0w_5e303efd-59f5-4fcc-a02d-927ac378a1dd"
      unitRef="usd">-9086000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="ibe754546a5d24b98b707f86af828e94b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNy0zLTEtMS0w_99d06f8c-8854-40d7-8117-ffb67f79b6f6"
      unitRef="usd">396000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfNy02LTEtMS0w_4d281c26-20a1-466c-b1bb-b885edbac7ff"
      unitRef="usd">396000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions
      contextRef="ibe754546a5d24b98b707f86af828e94b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfOC0zLTEtMS0w_83c893dd-8954-416a-a086-31bcf8eb01ae"
      unitRef="usd">2032000</lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions
      contextRef="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfOC02LTEtMS0w_39f3aa6e-e6ae-4b8c-9b9f-a71339c3c3ff"
      unitRef="usd">2032000</lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions>
    <us-gaap:NetIncomeLoss
      contextRef="i345d86b3213949e0b68a46369dcbf41b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfOS01LTEtMS0w_b2188026-fd1d-47f1-a5fd-3691b5b18446"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8562b1e9369e4fe2ab1ad68d05b9e2b2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfOS02LTEtMS0w_51a3470f-5f4a-4557-a074-9232626cd544"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i076737849b6f47a39af33bac3b981eec_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTAtMS0xLTEtMA_aadd59fb-53e8-445d-afae-68c3081c4ced"
      unitRef="shares">16652000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i076737849b6f47a39af33bac3b981eec_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTAtMi0xLTEtMA_86b430aa-271b-4f7c-9a2d-ab939e59aa5e"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7f4979e27b50488cb8e40ce52db2db15_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTAtMy0xLTEtMA_c45944ed-f49a-4dd4-ace5-120dde249c36"
      unitRef="usd">336621000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie64508fea3fa42acaa53e660fd2c7de1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTAtNC0xLTEtMA_19036322-c8eb-4f41-acdf-4fb1801b4cce"
      unitRef="usd">-856000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if65dba4c92e94e468d530e1cd6f9b9ff_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTAtNS0xLTEtMA_4bf40473-f974-4d89-bf2f-6d537c7abca8"
      unitRef="usd">410058000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i60594d6045784168a055ecf56059a566_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTAtNi0xLTEtMA_360abb41-e5c9-4762-9dcd-b66fedeaf0a9"
      unitRef="usd">745840000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i2464fae38d7345f798229c15c286e868_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTEtMS0xLTEtMTky_5d6cd037-6eaf-4ced-adee-3464802bfabf"
      unitRef="shares">24000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iba8102507d454bf4a847fd7b3e3a852e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTEtMy0xLTEtMjAw_ec91f7ec-dde7-4161-8993-a78a8f2ac991"
      unitRef="usd">1103000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTEtNi0xLTEtMTA3Mg_03ac122d-16ac-48a7-8ada-1563b484d6d1"
      unitRef="usd">1103000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iba8102507d454bf4a847fd7b3e3a852e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTItMy0xLTEtMjAw_1a46a79c-0b0b-44cf-b681-8806734df174"
      unitRef="usd">10216000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTItNi0xLTEtMTA3NA_85c6ab46-7a69-40d5-b13d-2b99fcb46d45"
      unitRef="usd">10216000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i2ba2f1bd35304af6883bb88ec59143e5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTQtNC0xLTEtMjA2_53062674-1ed3-4b1a-8f3d-c7ebbadf7abe"
      unitRef="usd">-5000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTQtNi0xLTEtMTA3OA_687cb28b-25dd-44e9-a568-6d2682fd2706"
      unitRef="usd">-5000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="iba8102507d454bf4a847fd7b3e3a852e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTQtMy0xLTEtMjUxMA_9ca777dc-cc15-4074-abfd-f82a63cd0581"
      unitRef="usd">-1073000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTQtNi0xLTEtMjYzNw_fdc12f1c-88a8-40b3-8854-e0c576461a11"
      unitRef="usd">-1073000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions
      contextRef="iba8102507d454bf4a847fd7b3e3a852e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTUtMy0xLTEtMjUxMA_ae4f9eac-4f6c-4236-8f8f-079786fff2e3"
      unitRef="usd">289000</lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTUtNi0xLTEtMjYzOQ_48d87bb2-2815-4ae4-a572-b43b5b9c7e76"
      unitRef="usd">289000</lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions>
    <us-gaap:NetIncomeLoss
      contextRef="id9237b34bcc649f7a15194fe8593ae0c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTUtNS0xLTEtMjE0_4b9b8574-daa2-42aa-9e85-5388264c204f"
      unitRef="usd">30725000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTUtNi0xLTEtMTA2OA_841ac514-87a2-4101-b501-6155b9350d58"
      unitRef="usd">30725000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i0fb3f6ec9b3240fe9fb304709b4784d0_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTYtMS0xLTEtMTA4MA_05cba441-1eaa-4d39-9570-47247dc4bbea"
      unitRef="shares">16676000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i0fb3f6ec9b3240fe9fb304709b4784d0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTYtMi0xLTEtMTA4MA_fe3c9236-f190-41d6-8e82-e848b64d2d81"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0956ece74456424796eeb190e9b7d088_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTYtMy0xLTEtMTA4MA_c5af2afe-14ef-43d7-8c23-c57a00add1f4"
      unitRef="usd">346578000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i513fd4ed54aa4c60a395ce12b274185b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTYtNC0xLTEtMTA4MA_7d97d822-86b0-4a18-bb13-998091eae4cb"
      unitRef="usd">-861000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5faae008cb8d4fd182e505b46d24f42b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTYtNS0xLTEtMTA4MA_d4de3d35-e334-4ec1-994a-4d8f5a7e31b5"
      unitRef="usd">440783000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjEyOGU4MzM2ODE2NTQ0YmQ4ODNhM2I0MDg1MTRhYWZkL3RhYmxlcmFuZ2U6MTI4ZTgzMzY4MTY1NDRiZDg4M2EzYjQwODUxNGFhZmRfMTYtNi0xLTEtMTA4MA_3e294117-608b-4672-9819-73ef71cc9d2c"
      unitRef="usd">786517000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ib66c936d8d3e4e1680b40926d0d9de06_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMi0xLTEtMS0w_236c7ede-a975-4f2c-b228-cbcdd160203d"
      unitRef="shares">16823000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib66c936d8d3e4e1680b40926d0d9de06_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMi0yLTEtMS0w_9072a07d-fc34-427f-adfc-e13968531c14"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i69b5b44a870842ceac65db79dc5b09f5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMi0zLTEtMS0w_5b882bc6-1a5f-4853-a4c0-d7dd90146eca"
      unitRef="usd">367326000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i80771ca481e3433685a6e3d009b3f480_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMi00LTEtMS0w_2ab55f1d-2714-4146-9899-0c3b2dc1f2ac"
      unitRef="usd">-216000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i29c88524b8d54c90ad5687ff71a4c6d1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMi01LTEtMS0w_68bbf169-842e-41f9-982a-b95c2dc6a67d"
      unitRef="usd">400105000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic5bc01a073dc4d9fba01b085fe94fb42_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMi02LTEtMS0w_95f78288-a67e-4d2f-b7d6-4dc02add675a"
      unitRef="usd">767232000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i8f7fffe49713495aad4f0ffcb6a85aa9_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMy0xLTEtMS0w_a03872d3-887a-4790-b401-491c6004f486"
      unitRef="shares">105000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifb95b1f9e6304389b982e439c753ddd9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMy0zLTEtMS0w_89e28e17-9357-447f-8d0b-cf2851dc2808"
      unitRef="usd">-1008000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMy02LTEtMS0w_46209537-5e87-4bba-8907-a9664d6843b9"
      unitRef="usd">-1008000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifb95b1f9e6304389b982e439c753ddd9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNC0zLTEtMS0w_404265d4-d4a0-4e2c-8322-8c188f24bd60"
      unitRef="usd">5653000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNC02LTEtMS0w_c4cf8f45-4b19-481a-83aa-a3e73cac3d40"
      unitRef="usd">5653000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i8f7fffe49713495aad4f0ffcb6a85aa9_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNS0xLTEtMS0w_d4d0d277-cf9e-4248-b380-09ac54aed17d"
      unitRef="shares">878000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i8f7fffe49713495aad4f0ffcb6a85aa9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNS0yLTEtMS0w_11137fad-25cb-4fdc-b673-2ebb50030a7b"
      unitRef="usd">1000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ifb95b1f9e6304389b982e439c753ddd9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNS0zLTEtMS0w_20c2b9ed-65ac-467f-ba27-2dc38aedce4a"
      unitRef="usd">73286000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNS02LTEtMS0w_8329505c-3f4e-482c-9fac-7cc28f02ce44"
      unitRef="usd">73287000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i5b4603280525438abad9ba8b3910e9d8_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNi00LTEtMS0w_3efdc4df-b420-40c8-8956-fb53dcfe246d"
      unitRef="usd">-2772000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNi02LTEtMS0w_f530b96f-fc9a-4881-b408-71ea8504212b"
      unitRef="usd">-2772000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="i5b4603280525438abad9ba8b3910e9d8_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNy00LTEtMS0w_4f7ebbcb-68ba-4350-a6f4-1807c4f2f86d"
      unitRef="usd">-1879000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfNy02LTEtMS0w_5e8b1cd9-fc0c-46dd-8059-0b1e7852ddb3"
      unitRef="usd">-1879000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="ifb95b1f9e6304389b982e439c753ddd9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfOC0zLTEtMS0w_f32f74fe-a8a8-4802-88b3-502b00449603"
      unitRef="usd">-2745000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfOC02LTEtMS0w_eb229fa2-8a16-4536-b750-3c684b5ec9c5"
      unitRef="usd">-2745000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:StockholdersEquity
      contextRef="i26498571827b412fb7bbe064394179d2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfOS01LTEtMS0w_5b923453-c64b-4b49-b8e4-7ef7ca1d4af6"
      unitRef="usd">-5167000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic1527f605baa48ba80a450d04e29ba34_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfOS02LTEtMS0w_e093361e-ea76-480c-bbd7-2dac53765204"
      unitRef="usd">-5167000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i86d6ecfa583141c4b8e165924fdbabb5_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTAtNS0xLTEtMA_d2a52d0c-e482-4c53-8627-f6c9eb0fcbbc"
      unitRef="usd">-24131000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4dcb67d7b3934765a538fe643f6151e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTAtNi0xLTEtMA_d2f8d42c-61d9-4e7a-895a-5a487ee1f920"
      unitRef="usd">-24131000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i14e87aa3f56d473daf037a89d1e3f4cb_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTEtMS0xLTEtMA_c48f6ff2-26b3-4050-9226-a450628a23b9"
      unitRef="shares">16050000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i14e87aa3f56d473daf037a89d1e3f4cb_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTEtMi0xLTEtMA_7fd85a21-74cb-4e0f-bbd3-5c817ebeaa03"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8b401019625b4ffc9c1541fcb02abdca_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTEtMy0xLTEtMA_2a464dd6-e388-48db-8198-a440cf063546"
      unitRef="usd">295940000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id89030d89d1e4b54bedf38e99c30adf4_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTEtNC0xLTEtMA_34800d65-154e-43eb-9372-2aca423ac670"
      unitRef="usd">-4867000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic33d37a4611e4bf98bb41808ea525923_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTEtNS0xLTEtMA_e858d64c-b7f4-4f74-8d2b-1b1ac0c03dfc"
      unitRef="usd">370807000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie81d0a0753f34755ba559ce7e8f8a2c3_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTEtNi0xLTEtMA_79524453-df89-486a-a0ff-15b47bd9e23c"
      unitRef="usd">661896000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ie7eab6271f564f2dbb8e2c685ee1f69e_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTItMS0xLTEtMTM3_9255cec8-a5c9-448f-8b7f-757f4a026df2"
      unitRef="shares">21000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if602072ed0664abd9859c3de34709d83_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTItMy0xLTEtMTQ1_4d149883-0545-45f1-8cad-bc91e6da1f1f"
      unitRef="usd">1128000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTItNi0xLTEtMA_22c9d9bc-06b0-45e5-872e-86749faa3527"
      unitRef="usd">1128000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if602072ed0664abd9859c3de34709d83_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTMtMy0xLTEtMTQ1_b1f4ef03-1ae0-4350-93ca-3227c4a6c64d"
      unitRef="usd">7359000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTMtNi0xLTEtMTA4NA_919ab34a-aeca-4749-879d-f67f7dbfcfc2"
      unitRef="usd">7359000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i8d0edf9b3b234e2eb42a295c13b96ee1_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTQtNC0xLTEtMTQ5_26cbf5e1-f81f-47ff-98d3-273c157358aa"
      unitRef="usd">2742000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTMtNi0xLTEtMA_2783a192-5204-4624-aadd-e01edf2b7d43"
      unitRef="usd">2742000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="i8d0edf9b3b234e2eb42a295c13b96ee1_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTUtNC0xLTEtMTQ5_46be267e-d82a-4fd7-99cd-457922aae803"
      unitRef="usd">-185000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTQtNi0xLTEtMA_73530c85-3384-4054-84e3-b2685475dab0"
      unitRef="usd">-185000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="if602072ed0664abd9859c3de34709d83_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTYtMy0xLTEtMTQ1_7ffa05c0-058a-43fe-8772-62c2420adfb6"
      unitRef="usd">-23000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTUtNi0xLTEtMA_1f8b8921-a3e4-4824-806e-90e0606f378c"
      unitRef="usd">-23000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:NetIncomeLoss
      contextRef="i314cfb6dd50443a9b34351d3b514793e_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTctNS0xLTEtMTUy_1d07b46a-2c3f-4728-be18-1a09e0ec5643"
      unitRef="usd">22086000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTYtNi0xLTEtMA_3a709b2f-7210-4869-8c4d-eb2c4f13f314"
      unitRef="usd">22086000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i7e409ba4c7ff45558a246e22b72ee68b_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTctMS0xLTEtMA_124cce07-9258-47a5-ab8d-9cb3545c3e5c"
      unitRef="shares">16071000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i7e409ba4c7ff45558a246e22b72ee68b_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTctMi0xLTEtMA_b250cd84-724d-4c3a-9e5d-bd2fce4a3b2a"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i282a3b3636ac4fdbaf44b6dab63ac522_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTctMy0xLTEtMA_df8a871a-b31d-4ec9-8d06-d44556f59e68"
      unitRef="usd">304404000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i11a40d625e53441aabf546066d2672ec_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTctNC0xLTEtMA_99048352-5915-4b89-a599-1927e6d863fd"
      unitRef="usd">-2310000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibaff82b7c098441c9ccc6088aa77f91a_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTctNS0xLTEtMA_4cb81830-912e-424a-89da-0b32b36f9045"
      unitRef="usd">392893000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i419faf2db8864f5abeee247d1e0449c9_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yNS9mcmFnOmNkNTkyODcxZTg4MzQzZjNiODFjZDVkYmZiYjIzMTNlL3RhYmxlOjU2MjVkMTc0OTc2YzQzNDBhNzg5NDhjMGZmZWM3M2IxL3RhYmxlcmFuZ2U6NTYyNWQxNzQ5NzZjNDM0MGE3ODk0OGMwZmZlYzczYjFfMTctNi0xLTEtMA_a40c6d18-c0aa-4c1b-977e-7c61fc99eed9"
      unitRef="usd">695003000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMy0xLTEtMS0w_b7ae6e37-c849-4cff-b885-d3a4bc31dfda"
      unitRef="usd">48831000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMy0zLTEtMS0w_8abb9d81-5d39-4a3b-bf80-b5dae62a4aac"
      unitRef="usd">-2045000</us-gaap:ProfitLoss>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNS0xLTEtMS0w_54903fb6-6d37-447e-b212-b19345d326f6"
      unitRef="usd">33502000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNS0zLTEtMS0w_c577d340-3674-4b80-b254-6472b823448e"
      unitRef="usd">371000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNi0xLTEtMS0w_68d6aee5-b51a-4549-b44a-5f69f88b8cfb"
      unitRef="usd">25179000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNi0zLTEtMS0w_a566c246-5513-4cf2-8a23-e39b52682402"
      unitRef="usd">7869000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNy0xLTEtMS0w_b8a85f0d-888f-4e6e-b284-c232c7aeac41"
      unitRef="usd">-109000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNy0zLTEtMS0w_5cd3dfdb-09d8-4f63-b50f-4f331b9328ac"
      unitRef="usd">-1198000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfOC0xLTEtMS0w_6f848eed-1b72-477c-8611-a8c8abd10192"
      unitRef="usd">9073000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfOC0zLTEtMS0w_2fb3b8e6-42b4-4a39-89b5-0043e9111322"
      unitRef="usd">12442000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <lgnd:AmortizationOfOtherEconomicRights
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfOS0xLTEtMS0w_2a981c40-b111-4b11-b457-de215ab09e06"
      unitRef="usd">206000</lgnd:AmortizationOfOtherEconomicRights>
    <lgnd:AmortizationOfOtherEconomicRights
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfOS0zLTEtMS0w_6744b566-8c8f-4ec4-b367-5f8991c80fcf"
      unitRef="usd">2733000</lgnd:AmortizationOfOtherEconomicRights>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTAtMS0xLTEtMA_c9ee906b-05cf-4634-9df3-3be023b797f4"
      unitRef="usd">-7175000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTAtMy0xLTEtMA_793d65d3-c201-4dac-8c39-6f760fdb8997"
      unitRef="usd">659000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTEtMS0xLTEtMA_498d31a5-b572-464a-9e1b-3d7ad678e9f0"
      unitRef="usd">18621000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTEtMy0xLTEtMA_af3215eb-b070-4c7b-a7ce-d7aea8375b1f"
      unitRef="usd">13012000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTItMS0xLTEtMA_e43302b1-3213-471d-9d37-1f65402b734c"
      unitRef="usd">9766000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTItMy0xLTEtMA_45ac31a5-b214-4b50-9174-7e23c0c75984"
      unitRef="usd">8890000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTMtMS0xLTEtMA_83d9e508-896b-41b3-846e-28f1b5eec403"
      unitRef="usd">6197000</lgnd:GainLossOnShortTermInvestments>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTMtMy0xLTEtMA_bc40b726-b999-4ed0-ac28-44f3cb27c12e"
      unitRef="usd">-7281000</lgnd:GainLossOnShortTermInvestments>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTQtMS0xLTEtMA_a14fd2b7-72d0-4657-b24a-1d43bf39fa45"
      unitRef="usd">595000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTQtMy0xLTEtMA_ca788208-1086-41cd-b8ad-5687b907ffaa"
      unitRef="usd">-1499000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTYtMS0xLTEtMA_b0f5a34e-960c-4ce6-b93d-055c3295a6dd"
      unitRef="usd">2659000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTYtMy0xLTEtMA_55f3ca1b-aeaa-4bcb-8fa9-e8790edce7cf"
      unitRef="usd">11466000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTctMS0xLTEtMA_c6ed8028-b7f7-4d66-aa66-a8331819a40f"
      unitRef="usd">2326000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTctMy0xLTEtMA_3da57535-d0b6-42f6-8468-8d9abf3172ca"
      unitRef="usd">-6977000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTgtMS0xLTEtMA_03f58b52-3c72-43ca-b70b-dfa4400de819"
      unitRef="usd">-4340000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTgtMy0xLTEtMA_b9ba578a-06f2-4cd2-9a0f-5ca1a3c405ed"
      unitRef="usd">2909000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTktMS0xLTEtMA_392f2bd7-0606-4334-84e0-dc12195f753c"
      unitRef="usd">-2477000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMTktMy0xLTEtMA_ce0ed31f-ea9b-4084-9436-6f7a95a03168"
      unitRef="usd">8673000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjAtMS0xLTEtMA_1cd08679-dc23-466a-a31c-4b88b1c62b2b"
      unitRef="usd">-14605000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjAtMy0xLTEtMA_824ce34f-2868-4499-8cae-71f28cdbfe6f"
      unitRef="usd">7268000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjEtMS0xLTEtMA_840bcfde-95f2-4cb1-8fa1-152732c72693"
      unitRef="usd">2786000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjEtMy0xLTEtMA_883bce09-2c01-4648-ab2f-5eea00b33793"
      unitRef="usd">4128000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjItMS0xLTEtMA_8ebd8a5f-6b16-4ce0-9e44-514e08857510"
      unitRef="usd">31131000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjItMy0xLTEtMA_023c2ec1-3bf0-478d-a114-b92f088a2367"
      unitRef="usd">41304000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjUtMS0xLTEtMA_78db6edc-c513-4fd6-a3ef-dc2e0e3d9952"
      unitRef="usd">96136000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjUtMy0xLTEtMA_6729d976-92ee-42b9-aa94-96d9051ff056"
      unitRef="usd">336726000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjYtMS0xLTEtMA_33712f05-c7b9-488c-9df5-14addf912623"
      unitRef="usd">150648000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjYtMy0xLTEtMA_324a7b05-f143-469c-8650-28d3e1c9906e"
      unitRef="usd">179431000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjctMS0xLTEtMA_5df0493c-0786-4649-8d76-21ba3d7d1806"
      unitRef="usd">34600000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjctMy0xLTEtMA_2743b910-f9f8-4b99-919f-dc4c394b3425"
      unitRef="usd">452405000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjgtMS0xLTEtMA_fb020062-de34-4e1b-920e-e6cc610fb638"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMjgtMy0xLTEtMA_733b9c16-542e-424c-8ec7-63855f2a0a91"
      unitRef="usd">15140000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzEtMS0xLTEtMzAyOA_6d153d13-a34e-4dae-a5a6-68a8c4153ff5"
      unitRef="usd">4794000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzEtMy0xLTEtMzAzMQ_90627d80-c040-49c3-9e1d-2e554cc6170f"
      unitRef="usd">791000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzAtMS0xLTEtMA_d6952ae1-e915-475f-b538-ac52012e6120"
      unitRef="usd">-135000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzAtMy0xLTEtMA_7ba33c62-e40f-4d76-9600-476498e50748"
      unitRef="usd">-2600000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzEtMS0xLTEtMA_77577308-f1ab-4cb5-884a-2323804ecdf2"
      unitRef="usd">84453000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzEtMy0xLTEtMA_972abdf7-3edd-4cac-817c-b8a000127204"
      unitRef="usd">281779000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzQtMS0xLTEtMA_f440b0a8-51ef-4e9d-9bae-8869b94a1cb5"
      unitRef="usd">153381000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzQtMy0xLTEtMA_6694cdf0-3939-4951-88d7-4dc20042d38f"
      unitRef="usd">203210000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzUtMS0xLTEtMA_6cc791d9-1e96-4902-ba38-965e8ee35b80"
      unitRef="usd">9188000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzUtMy0xLTEtMA_1e3590e1-294a-447c-ab71-6d11b2866cb3"
      unitRef="usd">1134000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzYtMS0xLTEtMA_fa80d48d-713d-4c42-bf94-2d89c36113ef"
      unitRef="usd">16855000</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzYtMy0xLTEtMA_69005e63-2825-4118-a499-90128af809f1"
      unitRef="usd">0</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzctMS0xLTEtMA_fede5e0e-80f4-41dd-8b82-3afacccf50df"
      unitRef="usd">16459000</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzctMy0xLTEtMA_aa2ecd09-ea6b-446a-a40f-1eab0fe8bba6"
      unitRef="usd">0</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzgtMS0xLTEtMA_09c512ec-5505-4e65-a265-f61bdf8729fe"
      unitRef="usd">27584000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzgtMy0xLTEtMA_83e7c294-99d3-4f6c-9cfc-5298671c1682"
      unitRef="usd">1550000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzktMS0xLTEtMA_3e699fa4-9902-4476-a8ea-b2e1b175e098"
      unitRef="usd">5901000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfMzktMy0xLTEtMA_d6b2b139-6fef-4962-b61d-dd87fd40a89a"
      unitRef="usd">1429000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDAtMS0xLTEtMA_694bf311-0189-4e8f-a137-5fe460c8d325"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDAtMy0xLTEtMA_6434a4cd-670e-4408-adfd-bbe037c58b69"
      unitRef="usd">73287000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDEtMS0xLTEtMA_3e1f6724-d9b6-44ae-9b4d-36ada1ebd213"
      unitRef="usd">1050000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDEtMy0xLTEtMA_da039f24-4f22-4f4f-b8c7-7693c8a35eba"
      unitRef="usd">1800000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDMtMS0xLTEtMA_34def0c5-014f-4e55-9400-745510615251"
      unitRef="usd">-141540000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDMtMy0xLTEtMA_3a1e3e48-2420-4da1-8b14-f9d5116abb1b"
      unitRef="usd">-279310000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDQtMS0xLTEtMA_4a04033c-c72f-4b80-9596-a64b784e8b68"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDQtMy0xLTEtMA_2f1be615-6039-4ed2-bf40-8cb379e382fd"
      unitRef="usd">-160000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDUtMS0xLTEtMA_b0ac0099-789d-4036-aba9-ee5722a28e0a"
      unitRef="usd">-25956000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDUtMy0xLTEtMA_f06b029a-28e8-48ac-8b8c-2ff673880306"
      unitRef="usd">43613000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDYtMS0xLTEtMA_a3a99aaa-a73c-4711-9d95-bb918552028e"
      unitRef="usd">47963000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic5bc01a073dc4d9fba01b085fe94fb42_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDYtMy0xLTEtMA_bb923afd-e98b-4e1a-a700-bc7b29714d98"
      unitRef="usd">72273000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDctMS0xLTEtMA_ce73d9b5-87ce-4dc4-99e9-4185eba26073"
      unitRef="usd">22007000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i419faf2db8864f5abeee247d1e0449c9_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjcwNDM3ZDU4YjAxOTQ5YTk4ZjZhZTZkOGQzOGQxZmFjL3RhYmxlcmFuZ2U6NzA0MzdkNThiMDE5NDlhOThmNmFlNmQ4ZDM4ZDFmYWNfNDctMy0xLTEtMA_8ccb8d96-f07a-4edc-a3fd-45c1722f67ae"
      unitRef="usd">115886000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMS0xLTEtMS0w_a1a88a8b-5fa5-4a88-a6bd-9d8370dea245"
      unitRef="usd">1737000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMS0zLTEtMS0w_afdc55d2-b884-415a-8ecb-24b97e081c69"
      unitRef="usd">2531000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMi0xLTEtMS0w_57c30978-c394-4acd-b6cd-3648a3e9e954"
      unitRef="usd">3552000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMi0zLTEtMS0w_e698386e-35a7-41a9-b958-0561e94158a0"
      unitRef="usd">0</us-gaap:IncomeTaxesPaid>
    <us-gaap:RestrictedCashCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMy0xLTEtMS0w_190bda26-5740-4c38-8346-4cbf1c02c099"
      unitRef="usd">144000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i419faf2db8864f5abeee247d1e0449c9_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMy0zLTEtMS0w_9c1209bb-84c6-4701-8d05-c52da013668a"
      unitRef="usd">730000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfOS0xLTEtMS0w_5c466fad-e78b-4ebd-a34a-da823c6cba8b"
      unitRef="usd">359000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfOS0zLTEtMS0w_f43fe679-d9ad-496f-8795-cf0ac3994070"
      unitRef="usd">292000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <lgnd:AccruedInventoryPurchases
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMTEtMS0xLTEtMA_3df7be6f-1b02-427b-87c5-212924c7fe37"
      unitRef="usd">12695000</lgnd:AccruedInventoryPurchases>
    <lgnd:AccruedInventoryPurchases
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMTEtMy0xLTEtMA_1ca7c5f5-c1fa-4af2-88f4-e51e31085414"
      unitRef="usd">3553000</lgnd:AccruedInventoryPurchases>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMTMtMS0xLTEtMA_2b2e075a-c1fa-4c0d-9757-2c3e4bd1f2fa"
      unitRef="usd">-60000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8yOC9mcmFnOmI4MzkxZGUzMWExYzQ3MDA5NWM2YTRmMGZlNjdlYzhmL3RhYmxlOjA5NjAwMDRmODAxODQ2YzU4MDBkOGVkMTVlMGJhNTlkL3RhYmxlcmFuZ2U6MDk2MDAwNGY4MDE4NDZjNTgwMGQ4ZWQxNWUwYmE1OWRfMTMtMy0xLTEtMA_b915fa53-bc46-4b7b-881b-3d69ad9fc0e9"
      unitRef="usd">-38000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MTM_82416faa-edbe-4922-a725-e2c45e8c40d5">Basis of Presentation and Summary of Significant Accounting Policies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2020 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#x201c;contract revenue&#x201d; and &#x201c;service revenue&#x201d; presented in the condensed consolidated statement of operations for the three and six months ended June&#160;30, 2021 have been combined into &#x201c;contract revenue&#x201d; in the condensed consolidated statement of operations to conform with the current period presentation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have described our significant accounting policies in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 1, Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the Notes to Consolidated Financial Statements in our 2020 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impact of COVID-19 Pandemic&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The current COVID-19 worldwide pandemic has presented substantial public health and economic challenges and is affecting our employees and partners, patients, communities and business operations, as well as the U.S. and global economy and financial markets. International and U.S. governmental authorities in impacted regions have taken actions in an effort to slow the spread of COVID-19, including issuing varying forms of &#x201c;stay-at-home&#x201d; orders, and restricting business functions outside of one&#x2019;s home. In response, we have restricted in-person access to our executive offices, our administrative employees are mostly working remotely, and we have limited the number of staff in our research and development laboratories and other facilities. The continued spread of the COVID-19 pandemic and the measures taken by the governments of countries have affected, and could continue to affect, our business and the business of our partners, including future disruptions to our supply chain and the manufacture or shipment of drug substance and finished drug product for Captisol, delays by us or our partners in the initiation or enrollment of patients in clinical trials, discontinuations by patients enrolled in clinical trials, difficulties launching or commercializing products and other related activities, which could delay ongoing clinical trials, increase development costs, reduce royalty revenues and have a material adverse effect on our business, financial condition and results of operations. Several of our partners have reported that their operations have been impacted including delays in research and development programs and deprioritizing clinical trials in favor of treating patients who have contracted the virus or to prevent the spread of the virus. This may lead to clinical trial protocol deviations or to discontinuation of treatment for patients who are currently enrolled in the clinical trials being conducted by us or our partners. In addition, certain of our partners have reported negative impacts on product sales which will impact our royalty revenues.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of our partners are working to develop drugs to treat COVID-19. For example, we are supplying Captisol to partners, including Gilead and the Gilead consortium (a consortium of manufacturing partners that Gilead is working with to bring efforts together to help maximize global supply) for remdesivir, the first FDA-approved treatment for COVID-19 for the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;treatment of patients with COVID-19 requiring hospitalization. In addition, certain of our OmniAb partners have initiated antibody discovery programs for the potential treatment of COVID-19.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, the businesses of our partners, our results of operations and our financial condition will depend on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning COVID-19, the actions taken to contain it or treat its impact, including the timing and extent of governments reopening or further restricting activities, the emergence and spread of COVID-19 variants, and the economic impact on local, regional, national and international markets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#x2019;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures. We intend to adopt this standard on January 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment.  These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three and six months ended June&#160;30, 2021, the amount recognized as revenue that was previously deferred was $10.3 million, and $16.1 million, respectively. During the three and six months ended June&#160;30, 2020, the amount recognized as revenue that was previously deferred was $2.0 million and $2.4 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation&#160;of&#160;Revenue &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-term Investments &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term investments consist of the following at June&#160;30, 2021 and December 31, 2020 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Treasury bill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;363,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2021, we exercised all outstanding Viking warrants to purchase 1.5 million shares of Viking's common stock at an exercise price of $1.50 per share. As of June&#160;30, 2021, we have zero Viking warrants outstanding.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three and six months ended June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of seven positions which were in an unrealized loss position as of June&#160;30, 2021. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three and six months ended June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three and six months ended June&#160;30, 2021, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the COVID-19 pandemic on our business and recorded an adjustment of $0.04&#160;million and $0.1 million of allowance for credit losses, respectively, as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, which consists of prepaid inventory and finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2021, we have made advanced payments for inventory from our supplier of Captisol totaling $50.2&#160;million. We have applied credits for such inventory purchases of $15.8&#160;million and will utilize the remaining advanced payments to offset a portion of the purchase price for future Captisol purchases.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Other Identifiable Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(63,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;762,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;784,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commercial License and Other Economic Rights&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license and other economic rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,412&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,871&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,638&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,979&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.0 million as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.3 million and credit loss adjustments of $6.0 million as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Commercial license and other economics rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis in April 2013 and April 2015, CorMatrix in May 2016, and Dianomi in January 2019. Commercial license rights acquired are accounted for as financial assets and other economic rights are accounted for as funded research and development as further discussed below and in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 1,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; of the Notes to Consolidated Financial Statements in our 2020 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In May 2017, we entered into a Royalty Agreement with Aziyo pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. We account for the Aziyo commercial license right as a financial asset, &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;and in accordance with ASC 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, we amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the Royalty Agreement with Aziyo as of June&#160;30, 2021 is 23%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received during the six months ended June&#160;30, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to 2020, we accounted for commercial license rights related to developmental pipeline products such as Selexis and Dianomi on a non-accrual basis. We continue to account for commercial license rights related to Dianomi on a non-accrual basis as of June&#160;30, 2021, but starting in 2020, given the expected cash flow from the Selexis program, we started to account for the Selexis commercial license right as a financial asset in accordance with ASC 310, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Selexis as of June&#160;30, 2021 is 21%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received during the six months ended June&#160;30, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We recorded a $5.5 million pre-tax reserve for credit losses upon adoption of the credit losses standard (ASU 2016-13) on January 1, 2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the six months ended June&#160;30, 2021, we further considered the current and expected future economic and market conditions surrounding novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Return reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subcontractor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period until the last tranche vests. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 4, Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 6, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six months ended June&#160;30, 2020, all of the 0.6&#160;million weighted average shares of outstanding equity awards as of June&#160;30, 2020 were anti-dilutive due to the net loss for the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3NDQ_18df6055-0ee8-4319-9f65-7a9417e5d4e8">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2020 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MDc_be7f3860-fd97-409b-b8da-e0b8f016f3ac">ReclassificationsCertain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#x201c;contract revenue&#x201d; and &#x201c;service revenue&#x201d; presented in the condensed consolidated statement of operations for the three and six months ended June&#160;30, 2021 have been combined into &#x201c;contract revenue&#x201d; in the condensed consolidated statement of operations to conform with the current period presentation.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3Mzc_ff920aab-a92a-4d79-beaa-6ce6fa1b00ef">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MzE_c5fc34f6-5b50-4dcd-b555-c53d9fe2898c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#x2019;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures. We intend to adopt this standard on January 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3Mjc_6bf4916d-5745-416d-b0aa-28ebfff5f9a0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment.  These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. &lt;/span&gt;&lt;/div&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTI2NTM_d4ef50c3-78e2-464d-a628-6efd45fc4de8"
      unitRef="usd">10300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY0OTI2NzQ2NDQ2NA_214db473-f4ab-42d4-b533-c58a78d96385"
      unitRef="usd">16100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTI3NTE_5f89277f-ae14-4e76-88b6-ec14658311ed"
      unitRef="usd">2000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY0OTI2NzQ2NDQ3Mg_03c53186-4085-4cc4-9662-e36a92d11437"
      unitRef="usd">2400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3NDg_0ed9df5e-1b56-49dc-bfdb-6e4cb6c2f20b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic303d3a8e76444c19a42764555e9621a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNC0yLTEtMS0w_922eaffb-00df-4ee2-97b2-bc52517c494c"
      unitRef="usd">5440000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8ff799492511435995a4fcce3087275c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNC00LTEtMS0w_247e743d-a7c5-4c4b-8c42-9d48b4702430"
      unitRef="usd">5481000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6e7b723bc7f4425da488009786365c0b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNC02LTEtMS0zMjc_6d43f0d3-d652-49a0-8723-97df2e66d3bf"
      unitRef="usd">9727000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8ecd868de4b74f8fb09905823604d5a3_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNC04LTEtMS0zMDA_45cbc4d9-7177-4d15-a1bc-ea81d84e2036"
      unitRef="usd">9886000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifab045615fd245ceaa2d3d8f22a26ea6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNS0yLTEtMS0w_8e80e741-0dab-4a72-bb62-cd4cec77331d"
      unitRef="usd">2193000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i69fdb2d4d7f2476f80fef8c5512cf6f8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNS00LTEtMS0w_3c9ac788-0f9e-49d6-abdb-b45787a4e189"
      unitRef="usd">1199000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9f1d98186147425ba46323876656de3c_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNS02LTEtMS0zMjc_1904ae0d-da7c-45a9-bcbe-de16dbe9e8f6"
      unitRef="usd">4526000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i122a78b066844d89aea3dff0b2ed8fc0_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNS04LTEtMS0zMDA_3cda9219-b42a-427b-94dc-399397bff47c"
      unitRef="usd">2775000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2793aa187d4547d9a9b81510f2035315_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNi0yLTEtMS0w_c63ef872-540e-41c2-9add-7b5d38e7870c"
      unitRef="usd">983000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i45000082246d4ff88fd5232c1ee7a62a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNi00LTEtMS0w_770a90af-26df-469a-8dcb-2228edf8aa32"
      unitRef="usd">501000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i840f53fa92b64230898a1197eee37195_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNi02LTEtMS0zMjc_391853f6-ca07-4177-b2f7-b82f83eebcd0"
      unitRef="usd">1475000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia831e29650fd43b592b44596af1df346_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNi04LTEtMS0zMDA_e483c965-b826-444c-82ed-72c9820d5b9b"
      unitRef="usd">1085000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idc03d6d6660e4832837b896fd4ac920c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNy0yLTEtMS0w_fb396381-1ff8-48c8-b552-0c2b4ee7bf85"
      unitRef="usd">8616000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i007aacf643a441dfb068465b043a79cf_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNy00LTEtMS0w_11bd49cc-a25f-44fc-9d05-72c30b4bb57b"
      unitRef="usd">7181000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifd7a926ec01f44e1afa9cce80d7a71fe_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNy02LTEtMS0zMDg_a2630457-d54f-4646-ad73-6e3387c23479"
      unitRef="usd">15728000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i451635563e0745a3903ab950f8d8acd1_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfNy04LTEtMS0zMDY_23b5ef7d-c478-4c3e-bc44-34f0b4fd8fba"
      unitRef="usd">13746000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia82ef50770684157a9c74a354fbf2b24_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfOS0yLTEtMS0w_41ef9340-8e54-4e96-a3bc-51410ba2bce8"
      unitRef="usd">62509000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i83e26ee83c2f49b7b63a20e39c84e036_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfOS00LTEtMS0w_940ff571-21f3-48ea-9f53-edf259fa0411"
      unitRef="usd">24468000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i84dcdf4aa51446079e98d1cae23cc101_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfOS02LTEtMS0zMjM_171396be-15b7-41ac-9f91-904439c22878"
      unitRef="usd">93781000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia00ad653a232412cbc7060be9d5a8bf2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfOS04LTEtMS0zMTk_479a171e-0d30-4c15-8c79-afa8f0afa372"
      unitRef="usd">45577000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9fdca9e3dfed4bb6afcc9aab7e6b5e28_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTItMi0xLTEtMA_48253d2c-55c4-427b-83b0-efdac76cdf3c"
      unitRef="usd">7360000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i81a59b2059264ec5904d079ea451adab_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTItNC0xLTEtMA_26ab1d52-e122-4b23-9a9a-dfdc4efa3514"
      unitRef="usd">4582000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idf215da56009467fb577f8853105c8ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTItNi0xLTEtMzMz_f953260f-7ef4-40ec-ab0d-273b78f525b7"
      unitRef="usd">12822000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4cf7fd73de2649c6adb87d065a4be327_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTItOC0xLTEtMzM4_e48a9010-3116-46ed-926c-6389cc60025d"
      unitRef="usd">7939000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i30f51622e3664ef4a40338a9815f069d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTMtMi0xLTEtMA_abeb4146-e96a-4ecf-a416-aa1e9bd88cae"
      unitRef="usd">1050000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic13ffc6f68cb4f39a642cd17209182cf_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTMtNC0xLTEtMA_980b133f-c0f9-49a5-8a6c-29284dd1c2ca"
      unitRef="usd">660000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia24e5130e49044f78de32bfba07a0e09_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTMtNi0xLTEtMzMz_43aaf2b4-dc25-4b49-b88c-55000a504850"
      unitRef="usd">2093000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if71a5d29e4fe413f9f12cd54d342dcf1_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTMtOC0xLTEtMzM4_3d29f21d-490a-4685-88b7-3add159d1004"
      unitRef="usd">1635000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic684af48acc3440ab9a6527375151fb9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTQtMi0xLTEtMA_a7e513c2-f192-4448-b0e2-06a42a7a70a7"
      unitRef="usd">3600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if1af11ab5c0343348fe9016b5ad09b44_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTQtNC0xLTEtMA_dd496bd3-1b30-4935-a056-5bf3210812ef"
      unitRef="usd">3472000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icd9b8394e1cb440ab703e649cd6c4d17_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTQtNi0xLTEtMzMz_b3fcd5f0-88c5-45b9-9528-71a9d63ce1da"
      unitRef="usd">12017000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8ebfbf5b5a194d5c80780257ca423e45_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTQtOC0xLTEtMzM4_e7016e40-b4d2-44d2-99e6-6ea0ab16bdba"
      unitRef="usd">3806000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4b35216c25964eaabae221494b87f323_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTUtMi0xLTEtMA_6aeb9617-dd59-4a21-bb07-626b060bf25f"
      unitRef="usd">1540000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i50c8a90801e942c69a8f8861a2ca9c65_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTUtNC0xLTEtMA_c6caeec1-0366-46fb-a211-b801b8415fc7"
      unitRef="usd">1057000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id4d14843835a4e1db7a4eae595d60048_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTUtNi0xLTEtMzMz_2cfbe0f2-fa79-4f2b-987d-53b79eba35c9"
      unitRef="usd">3384000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i33f395a11457480697177a292c67ad43_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTUtOC0xLTEtMzM4_1b92f478-7779-417b-afe1-52af1e23f0ab"
      unitRef="usd">1878000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4e8ad17c667349d89a149e25562db6da_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTYtMi0xLTEtMA_f306d348-05c0-4aee-9515-26a5b7065fb8"
      unitRef="usd">13550000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3ee54dca82994576be877ebf09f7324d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTYtNC0xLTEtMA_0e4ba977-a4e6-4472-b854-5cf9f7f2af1b"
      unitRef="usd">9771000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie6a3f4144744455c937cf2f5a461ee71_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTYtNi0xLTEtMzQ0_0765d464-3677-4948-8949-03adf2938819"
      unitRef="usd">30316000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i99224b8f7551423ab53c0612ea730573_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTYtOC0xLTEtMzQ1_9a478b1b-c09f-4be2-a8a2-5a61655cd35c"
      unitRef="usd">15258000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTgtMi0xLTEtMA_90e1b0ed-d063-4e96-8d86-f5ab9605bc8c"
      unitRef="usd">84675000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTgtNC0xLTEtMA_a599ec45-f59b-4865-935b-3db9c845282e"
      unitRef="usd">41420000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTgtNi0xLTEtMzQ5_6b2e732a-cac8-4107-bf09-e9f7b03d54f2"
      unitRef="usd">139825000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjQ4NWM0ZDA4Y2ZjOTQ2YzBiOTkxNTViOThmZmQyM2FlL3RhYmxlcmFuZ2U6NDg1YzRkMDhjZmM5NDZjMGI5OTE1NWI5OGZmZDIzYWVfMTgtOC0xLTEtMzU0_dc396031-8c64-45cd-968d-138bd5e1e523"
      unitRef="usd">74581000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <lgnd:ScheduleOfShortTermInvestmentsTableTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3Mzg_1f41a79f-52b0-4bdd-8824-ac85c6ebe9e6">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term investments consist of the following at June&#160;30, 2021 and December 31, 2020 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Treasury bill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;363,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</lgnd:ScheduleOfShortTermInvestmentsTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3488c7dfa3bd403998e2bc139e4b788c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy0xLTEtMS0w_cce80387-9b22-4e24-9282-66eca3a29728"
      unitRef="usd">33560000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3488c7dfa3bd403998e2bc139e4b788c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy0zLTEtMS0w_53470d99-0756-4c64-8292-db6818cd1f10"
      unitRef="usd">13000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3488c7dfa3bd403998e2bc139e4b788c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy01LTEtMS0w_0b7c4ffa-8875-4e39-9368-2dcaca624105"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3488c7dfa3bd403998e2bc139e4b788c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy03LTEtMS0w_03fc0d14-9b92-40fd-8506-210f0e574296"
      unitRef="usd">33571000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1d89a47caf084728b8ae0acda82c4344_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy05LTEtMS0w_27d22a0b-7852-4fe2-8505-286dcb599d73"
      unitRef="usd">84120000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1d89a47caf084728b8ae0acda82c4344_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy0xMS0xLTEtMA_ddc36d76-a649-40df-a182-b8da538a690f"
      unitRef="usd">35000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1d89a47caf084728b8ae0acda82c4344_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy0xMy0xLTEtMA_2d7f4c5b-ba51-49ff-badb-d6b18da4655e"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1d89a47caf084728b8ae0acda82c4344_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMy0xNS0xLTEtMA_b594284c-32c9-4fca-873b-58e43c1b11e1"
      unitRef="usd">84154000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia2df301919454ee598ea1eabd11d48dd_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC0xLTEtMS0w_de9fe05a-0602-4006-b44f-fa9abd873733"
      unitRef="usd">25965000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia2df301919454ee598ea1eabd11d48dd_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC0zLTEtMS0w_4e1ee1e0-e62b-4fd4-b922-900cb9eb3380"
      unitRef="usd">62000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia2df301919454ee598ea1eabd11d48dd_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC01LTEtMS0w_b5c6c53b-8a85-407d-8d74-528bed84b486"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia2df301919454ee598ea1eabd11d48dd_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC03LTEtMS0w_62f017ea-065b-4c43-b1bc-e3b81554ca95"
      unitRef="usd">26025000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i28f9aeb56b074a67bf4231acda630b3d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC05LTEtMS0w_3b31d3a2-cfe8-45cf-97d6-960c25f18a7d"
      unitRef="usd">30512000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i28f9aeb56b074a67bf4231acda630b3d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC0xMS0xLTEtMA_809b0ab2-68c9-48d0-9cf9-a7a30ddbd564"
      unitRef="usd">99000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i28f9aeb56b074a67bf4231acda630b3d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC0xMy0xLTEtMA_9f1cff0f-0068-49ab-84c1-34d980bc5fec"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i28f9aeb56b074a67bf4231acda630b3d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNC0xNS0xLTEtMA_7d8a4dfb-fa05-499c-956f-aa5a6379ab95"
      unitRef="usd">30610000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iff698b58bad14579940ceafaf42bc7be_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS0xLTEtMS0w_316b452f-7c08-455a-9361-6782028ed422"
      unitRef="usd">2500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iff698b58bad14579940ceafaf42bc7be_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS0zLTEtMS0w_f00e1e3f-4262-4347-a7a5-9a692615a64b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iff698b58bad14579940ceafaf42bc7be_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS01LTEtMS0w_d07ee6d2-f6d3-488d-b84b-ac9ccd912826"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iff698b58bad14579940ceafaf42bc7be_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS03LTEtMS0w_5fc68863-52e0-4449-9292-9d0fbc32ccbe"
      unitRef="usd">2499000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i06dea07a8e6c455f9a6b50cac32e6c7c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS05LTEtMS0w_69be1a5f-96f8-4ccb-9a69-f85b76e81cf9"
      unitRef="usd">4499000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i06dea07a8e6c455f9a6b50cac32e6c7c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS0xMS0xLTEtMA_451bf339-61f3-4e9c-b709-ba49c8d0a6ae"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i06dea07a8e6c455f9a6b50cac32e6c7c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS0xMy0xLTEtMA_3431759d-fc34-4722-8397-12d1d4c02879"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i06dea07a8e6c455f9a6b50cac32e6c7c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNS0xNS0xLTEtMA_bb548adb-de12-4281-be14-907718af8fd1"
      unitRef="usd">4501000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7420190e386d412d822b09d22bd8ee99_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi0xLTEtMS0w_5608cef7-256c-4260-85fa-e0f96ac01c4f"
      unitRef="usd">19258000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7420190e386d412d822b09d22bd8ee99_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi0zLTEtMS0w_0bebb1ef-0ffa-4b05-b81c-0433b287015b"
      unitRef="usd">12000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7420190e386d412d822b09d22bd8ee99_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi01LTEtMS0w_655ba3b7-8871-419d-bff2-9979ab60d6cb"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7420190e386d412d822b09d22bd8ee99_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi03LTEtMS0w_2bb22e32-926a-44b6-a847-9eb1ef5b244c"
      unitRef="usd">19270000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i866af78581cc419ba80616eb6a2a7b51_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi05LTEtMS0w_f86f2d42-d2e8-4e29-9f2f-725fbbbec309"
      unitRef="usd">45459000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i866af78581cc419ba80616eb6a2a7b51_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi0xMS0xLTEtMA_971f1285-949b-46b3-984e-7ff8e054b74a"
      unitRef="usd">27000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i866af78581cc419ba80616eb6a2a7b51_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi0xMy0xLTEtMA_8d4c34d9-9b6b-439a-ba4b-0b722da9b9dc"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i866af78581cc419ba80616eb6a2a7b51_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNi0xNS0xLTEtMA_8d0c649f-057f-4746-a13e-85c840f979f6"
      unitRef="usd">45485000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="idcd6f50d8ec2470fac2900fa32cb8766_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy0xLTEtMS0w_87af0dd3-a4dd-42f0-9d4f-3325679219bf"
      unitRef="usd">5807000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idcd6f50d8ec2470fac2900fa32cb8766_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy0zLTEtMS0w_8cfc224d-28be-4f06-a02b-0713e2ba8cbe"
      unitRef="usd">172000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idcd6f50d8ec2470fac2900fa32cb8766_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy01LTEtMS0w_22dcf9a7-153a-4361-ba8f-4e440e726809"
      unitRef="usd">310000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idcd6f50d8ec2470fac2900fa32cb8766_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy03LTEtMS0w_fe2c4d66-5275-4559-95ed-7002d33f0671"
      unitRef="usd">5669000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2b92f0d8a3fa48a89bf3fb7d5efaab75_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy05LTEtMS0w_9af04e38-0688-4ca8-a23a-5759610d0c3b"
      unitRef="usd">4466000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2b92f0d8a3fa48a89bf3fb7d5efaab75_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy0xMS0xLTEtMA_0dcae70f-ccef-4f9f-ac75-ce7af9d17dc7"
      unitRef="usd">360000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2b92f0d8a3fa48a89bf3fb7d5efaab75_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy0xMy0xLTEtMA_6927b1bc-ed48-4eda-bd90-a0bbf581e9b2"
      unitRef="usd">1388000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2b92f0d8a3fa48a89bf3fb7d5efaab75_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfNy0xNS0xLTEtMA_c146122a-8123-4038-ac47-e405a275fd26"
      unitRef="usd">3438000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="icafafbdd0712443dbec74d4e5dc99655_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC0xLTEtMS0w_2f49f42c-7a19-4ba7-970e-ed528b19056f"
      unitRef="usd">151949000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icafafbdd0712443dbec74d4e5dc99655_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC0zLTEtMS0w_c0ae8288-00b8-43f3-9f24-aa5697c91ca6"
      unitRef="usd">53000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icafafbdd0712443dbec74d4e5dc99655_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC01LTEtMS0w_98bd1aef-67b9-423e-be2e-e8ea40c4d2f6"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icafafbdd0712443dbec74d4e5dc99655_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC03LTEtMS0w_ba872218-ba4c-4b6a-b82c-0806c8eec294"
      unitRef="usd">152002000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3c2a17a99104485fbc33dea758b354d7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC05LTEtMS0w_8750ca5b-0db9-4d03-a8bb-27e758060dfe"
      unitRef="usd">151512000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3c2a17a99104485fbc33dea758b354d7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC0xMS0xLTEtMA_ac807f0e-4132-4f8f-853a-914845acd40a"
      unitRef="usd">386000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3c2a17a99104485fbc33dea758b354d7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC0xMy0xLTEtMA_87118661-6f45-4b47-a984-42c715e25b3f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3c2a17a99104485fbc33dea758b354d7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOC0xNS0xLTEtMA_17a783b9-504b-4e0e-a4ca-19daf304a05f"
      unitRef="usd">151898000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i801328559dbe4de794a22df113518552_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS0xLTEtMS0w_2aff873c-6072-47f3-8e32-014cd62f7b85"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i801328559dbe4de794a22df113518552_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS0zLTEtMS0w_1dd8dbdf-5cff-4f5d-bc84-a5f19e48dd92"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i801328559dbe4de794a22df113518552_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS01LTEtMS0w_777aa1eb-337a-42d8-8944-a20780e6b907"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i801328559dbe4de794a22df113518552_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS03LTEtMS0w_24658072-6254-4e4c-89a0-cef256e067b3"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iabea906284394a2e93e98586744d1714_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS05LTEtMS0w_3dcf8abc-c58a-437e-82fe-a98fbd1e5f7e"
      unitRef="usd">3999000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iabea906284394a2e93e98586744d1714_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS0xMS0xLTEtMA_bfda019b-e9d0-422c-af56-76a1bd9f4441"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iabea906284394a2e93e98586744d1714_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS0xMy0xLTEtMA_9a94d7d2-cee4-4bd9-b34e-5a88c4800013"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iabea906284394a2e93e98586744d1714_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfOS0xNS0xLTEtMA_34ecfc4a-4219-40f9-a11f-69df51efa8b7"
      unitRef="usd">3999000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i75e0f0f3c8b544fd9ffdf8a0ffcba669_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtMS0xLTEtMA_871d02c8-9ae1-4dae-b48a-18e6346d7af9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i75e0f0f3c8b544fd9ffdf8a0ffcba669_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtMy0xLTEtMA_111e4ee4-7cd9-4cdf-9bd3-5eaa0f86f726"
      unitRef="usd">713000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i75e0f0f3c8b544fd9ffdf8a0ffcba669_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtNS0xLTEtMA_79eac30f-8d8c-4a97-8642-b88edffc383e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i75e0f0f3c8b544fd9ffdf8a0ffcba669_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtNy0xLTEtMA_522a9e3a-967f-4779-8450-de663b276127"
      unitRef="usd">713000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i243763dadfd64bd1beb7dc20bccd336c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtOS0xLTEtMA_6202736d-66c3-463d-bdad-847701d8f314"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i243763dadfd64bd1beb7dc20bccd336c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtMTEtMS0xLTA_9daa0a10-b9a8-4f1a-bfc3-16e5eefb4d2e"
      unitRef="usd">393000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i243763dadfd64bd1beb7dc20bccd336c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtMTMtMS0xLTA_8337a497-7497-43ba-a75e-ac84d83a09e5"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i243763dadfd64bd1beb7dc20bccd336c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTAtMTUtMS0xLTA_d258955a-4a5a-4a71-ae05-c81ae40b775c"
      unitRef="usd">393000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtMS0xLTEtMA_5274dcc2-57b8-4311-abfa-27d69fde62d1"
      unitRef="usd">239039000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtMy0xLTEtMA_34768f31-d123-4bc1-a568-0ddb5569f0fd"
      unitRef="usd">1025000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtNS0xLTEtMA_c6617292-c365-4c29-a94c-d865666df57d"
      unitRef="usd">315000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtNy0xLTEtMA_c1a33018-9ad7-48c3-9c5f-564f39ed0391"
      unitRef="usd">239749000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtOS0xLTEtMA_a74b0f29-cd13-43d8-85bf-472cdfa65ba2"
      unitRef="usd">324567000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtMTEtMS0xLTA_cc7138dc-5b0f-430e-b14c-c20cf5c38c01"
      unitRef="usd">1302000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtMTMtMS0xLTA_4cc2549f-e641-48df-899a-93f8bb530448"
      unitRef="usd">1391000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTEtMTUtMS0xLTA_3fc6a8b2-3b8e-4c74-be65-293b5f609fd8"
      unitRef="usd">324478000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ibd477c8a2f304ec2a970e27dae002cd7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTItNy0xLTEtMA_1cd5cf43-e86e-4493-a321-7e9797fc7bbc"
      unitRef="usd">40223000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id1f3205f079b431c9d64b68d265849ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTItMTUtMS0xLTA_8871b439-f8b0-442a-acad-7877f27581d0"
      unitRef="usd">32763000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i75e0f0f3c8b544fd9ffdf8a0ffcba669_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTMtNy0xLTEtMA_dc48e03c-ab2c-4d98-a36d-6e59b9560057"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i243763dadfd64bd1beb7dc20bccd336c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTMtMTUtMS0xLTA_d7ccb6a8-755e-4f9d-ab43-0bafad3c8306"
      unitRef="usd">6326000</us-gaap:EquitySecuritiesFvNi>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTQtNy0xLTEtMA_80481ee4-2ea6-4b73-8152-3dbe8df03ffb"
      unitRef="usd">279972000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjA4Mjk3ZDg5NTM2MjQzMDc5ZDE0Mzg5ODg5NDllMTI5L3RhYmxlcmFuZ2U6MDgyOTdkODk1MzYyNDMwNzlkMTQzODk4ODk0OWUxMjlfMTQtMTUtMS0xLTA_2e61a54b-d44c-4d0a-aa78-aea8474ae8a6"
      unitRef="usd">363567000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i996045b306724fc6bc06c217fc070834_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTMyMjA_68b5e47b-cb04-4307-aa52-11d9f99ded25"
      unitRef="shares">1500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ic4caf3a29a8642828078a62b68f39097_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTMyNzk_9999c9e5-39d6-4095-b684-1c370fcabcf3"
      unitRef="usdPerShare">1.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTMzMTE_610952a2-a8ae-4714-becf-79cbc40dd1bc"
      unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MTE_cf5f48d5-24da-4251-acc8-b578ced1fa0a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmEyODliYzNkYTNiZDQ2NTFhZjFiOGMzNGI1N2Y4MDQ5L3RhYmxlcmFuZ2U6YTI4OWJjM2RhM2JkNDY1MWFmMWI4YzM0YjU3ZjgwNDlfMi0xLTEtMS0w_dfab9e98-8cef-4020-b553-32cb2761f809"
      unitRef="usd">57997000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmEyODliYzNkYTNiZDQ2NTFhZjFiOGMzNGI1N2Y4MDQ5L3RhYmxlcmFuZ2U6YTI4OWJjM2RhM2JkNDY1MWFmMWI4YzM0YjU3ZjgwNDlfMi0zLTEtMS0w_42e44022-9e12-4e88-ae0b-58b977588c9f"
      unitRef="usd">58050000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmEyODliYzNkYTNiZDQ2NTFhZjFiOGMzNGI1N2Y4MDQ5L3RhYmxlcmFuZ2U6YTI4OWJjM2RhM2JkNDY1MWFmMWI4YzM0YjU3ZjgwNDlfMy0xLTEtMS0w_2174994d-6b84-4eae-bfcd-fb288fb10696"
      unitRef="usd">23286000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmEyODliYzNkYTNiZDQ2NTFhZjFiOGMzNGI1N2Y4MDQ5L3RhYmxlcmFuZ2U6YTI4OWJjM2RhM2JkNDY1MWFmMWI4YzM0YjU3ZjgwNDlfMy0zLTEtMS0w_c11c59ec-766a-49d5-be63-42fcb32dada9"
      unitRef="usd">23316000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmEyODliYzNkYTNiZDQ2NTFhZjFiOGMzNGI1N2Y4MDQ5L3RhYmxlcmFuZ2U6YTI4OWJjM2RhM2JkNDY1MWFmMWI4YzM0YjU3ZjgwNDlfNC0xLTEtMS0w_b2b0b8d6-0d88-46f5-b1dc-fc3b0d4024d2"
      unitRef="usd">81283000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmEyODliYzNkYTNiZDQ2NTFhZjFiOGMzNGI1N2Y4MDQ5L3RhYmxlcmFuZ2U6YTI4OWJjM2RhM2JkNDY1MWFmMWI4YzM0YjU3ZjgwNDlfNC0zLTEtMS0w_dd7d032b-b297-4ff2-9042-b4bc4a027ff0"
      unitRef="usd">81366000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY0OTI2NzQ2NTI5Nw_6a212f66-d900-49b7-8868-c3808799a814"
      unitRef="position">7</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTQ5MDE_2d78a107-98c6-4c6f-a55e-1dc72bf412c3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMzI5ODUzNDkwNzUzOA_d6dbfe1a-b2a5-4168-8393-fdc65d4b494c">Accounts Receivable and Allowance for Credit LossesOur accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY0OTI2NzQ2NTkzNw_9e2bb07a-e685-493a-8d6e-1d0fc90ebfd9"
      unitRef="usd">40000.00</lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease>
    <lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY0OTI2NzQ2NTk2NA_46af2e14-e322-4831-a369-7a94e509fd9a"
      unitRef="usd">100000</lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:AdvancesOnInventoryPurchases
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfNDM5ODA0NjU0MTYyOQ_f4bcd614-5ad1-4a50-bb19-093538b23268"
      unitRef="usd">50200000</us-gaap:AdvancesOnInventoryPurchases>
    <lgnd:CreditsAppliedOnAdvancesOnInventoryPurchases
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfNDM5ODA0NjU0MTY0NA_7181c1b8-0c38-4522-8857-c655731db451"
      unitRef="usd">15800000</lgnd:CreditsAppliedOnAdvancesOnInventoryPurchases>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3NDA_93e2cfdb-86b2-4ace-86c4-6f0b84790ab3">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(63,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;762,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;784,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMy0xLTEtMS0w_819ce23a-75ae-4562-ac9b-8fe636c1c175"
      unitRef="usd">190517000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMy0zLTEtMS0w_1021cf99-b220-491f-916f-a25f2ae7cccf"
      unitRef="usd">189662000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4cf5accb7aa14841b150df8d3aea6ae1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfNS0xLTEtMS0w_351c18a0-90c9-4ca9-8601-b2640c9453b8"
      unitRef="usd">277980000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iaa1ef48af23941a2b697e7581d564363_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfNS0zLTEtMS0w_2951f8f0-21eb-4923-b20a-99326c4a33d9"
      unitRef="usd">277740000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4cf5accb7aa14841b150df8d3aea6ae1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfNi0xLTEtMS0w_733c91b8-1813-44fc-b9d2-42c58d6fa061"
      unitRef="usd">71276000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaa1ef48af23941a2b697e7581d564363_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfNi0zLTEtMS0w_9854c8d3-1f8c-4f40-8d8c-48d18d030dac"
      unitRef="usd">63600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0cb11b6f09ff4422b4d9ab2c7d7dd6ff_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfNy0xLTEtMS0w_5b3ae1ec-a03f-4628-b11f-4faf7a48830f"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iaceb341416e648418eb641df20734f0f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfNy0zLTEtMS0w_46d93fc0-e164-4e6d-b900-63130668f538"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0cb11b6f09ff4422b4d9ab2c7d7dd6ff_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfOC0xLTEtMS0w_fc4d8ccc-16ac-4bbb-8e85-47f7abf797df"
      unitRef="usd">1378000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaceb341416e648418eb641df20734f0f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfOC0zLTEtMS0w_a45c6d63-5f47-4e89-afa9-c593ab2bd1df"
      unitRef="usd">1312000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3597ace5860a420cae4ec7819bea418b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfOS0xLTEtMS0w_7a3b7ea2-de8d-419a-ba56-7dbbd5440dc2"
      unitRef="usd">40700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i527caad11f5c499cb6f93ad3f37d9a05_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfOS0zLTEtMS0w_c49853f9-17a2-46c3-abdb-7802467e5775"
      unitRef="usd">40700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3597ace5860a420cae4ec7819bea418b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTAtMS0xLTEtMA_1e9aeea6-8e6f-43ce-a74a-80f8dd9a1120"
      unitRef="usd">16932000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i527caad11f5c499cb6f93ad3f37d9a05_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTAtMy0xLTEtMA_26313d96-c1ae-4d11-8f27-241ba43f994b"
      unitRef="usd">15597000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iaadeca50c0b443ee929d80b58fa9d325_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTEtMS0xLTEtMA_16b16f2e-230f-4122-b8ec-a89d6c865f19"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i232ee16f6b6b445ea405613e39346280_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTEtMy0xLTEtMA_7f20dd34-c597-4133-8577-391a40faedab"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaadeca50c0b443ee929d80b58fa9d325_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTItMS0xLTEtMA_1076216d-bcf1-44e7-bc56-0a8d76efb8d1"
      unitRef="usd">21730000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i232ee16f6b6b445ea405613e39346280_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTItMy0xLTEtMA_5c7d0867-c529-4069-8648-ffe00661095a"
      unitRef="usd">7243000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTMtMS0xLTEtMA_07d0fc25-6b0d-4453-aa91-a4bb111147e8"
      unitRef="usd">762523000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjdmZmFjNGIwOWFhMjQ5ODk5NGFjNjE2ZmMyMzY0NzQ3L3RhYmxlcmFuZ2U6N2ZmYWM0YjA5YWEyNDk4OTk0YWM2MTZmYzIzNjQ3NDdfMTMtMy0xLTEtMA_867473ad-3439-43b9-bebb-3df41537b1d3"
      unitRef="usd">784992000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI2OTk_6dbf89ee-c988-4f76-abd3-a65e1ac309f9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license and other economic rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,412&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,871&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,638&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,979&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.0 million as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.3 million and credit loss adjustments of $6.0 million as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i68df3e804e3343eb841aa45a3b23fc09_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMi0yLTEtMS0w_2deb96f8-653e-46b7-8dae-59103c391899"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i68df3e804e3343eb841aa45a3b23fc09_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMi00LTEtMS0w_c6c5dad8-bd0f-4701-aad0-1a405599e19f"
      unitRef="usd">9470000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i68df3e804e3343eb841aa45a3b23fc09_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMi02LTEtMS0w_af2c64ef-aec9-4815-af8b-131a915aaeaf"
      unitRef="usd">8226000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id0c0c0cca6254ee68e1a5f7df5bf4c6b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMi04LTEtMS0w_2c24ff5e-3a01-4aa3-abdb-eb236d45135d"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="id0c0c0cca6254ee68e1a5f7df5bf4c6b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMi0xMC0xLTEtMA_fcfe4493-0f5f-45dc-9b61-ff6ad82c051c"
      unitRef="usd">9588000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id0c0c0cca6254ee68e1a5f7df5bf4c6b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMi0xMi0xLTEtMA_8e4748ac-752e-40df-bcf5-b2c1187154d1"
      unitRef="usd">8108000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i22bae2abb5014d60894b6b57f2d9642b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMy0yLTEtMS0w_092c8585-e59c-4f64-93c4-fb001d92e7d0"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i22bae2abb5014d60894b6b57f2d9642b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMy00LTEtMS0w_84aff11c-44e3-4d5e-a893-a8c9d41c7e06"
      unitRef="usd">8190000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i22bae2abb5014d60894b6b57f2d9642b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMy02LTEtMS0w_483b7ed3-44f9-474a-937c-ac3737088a3b"
      unitRef="usd">2412000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i77623f06245d4063b189951809382a54_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMy04LTEtMS0w_36c3f9a2-917b-48df-aac3-f6c950b173ba"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i77623f06245d4063b189951809382a54_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMy0xMC0xLTEtMA_d2294cf3-1804-498e-b99e-ad48c5aa382f"
      unitRef="usd">7731000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i77623f06245d4063b189951809382a54_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfMy0xMi0xLTEtMA_ec1c3b3d-5408-4f20-8bdd-24f99f91ffba"
      unitRef="usd">2871000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie2c3e0ab5c404e47a177e468672a1455_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfNC0yLTEtMS0w_41765a69-0f83-4c00-bf3e-630fc388c5b0"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="ie2c3e0ab5c404e47a177e468672a1455_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfNC00LTEtMS0w_c7980f15-5355-44d9-96dc-fc9e5b806849"
      unitRef="usd">17660000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie2c3e0ab5c404e47a177e468672a1455_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfNC02LTEtMS0w_05f72798-5d9e-41fe-b185-5b7910ce3766"
      unitRef="usd">10638000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i132e6a5556ef4b1d9a099d0161937187_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfNC04LTEtMS0w_4befb27c-7736-4f58-bb5e-4485d73316e9"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i132e6a5556ef4b1d9a099d0161937187_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfNC0xMC0xLTEtMA_ccecd806-061f-4fac-8584-2e523d7bbcc5"
      unitRef="usd">17319000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i132e6a5556ef4b1d9a099d0161937187_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjk5MGYxYzJhMWU4NzQxNmM4NTBlYWFmN2NkNTZjMzYwL3RhYmxlcmFuZ2U6OTkwZjFjMmExZTg3NDE2Yzg1MGVhYWY3Y2Q1NmMzNjBfNC0xMi0xLTEtMA_53ff1c11-cd8a-43f6-99de-1876f8cc2a9c"
      unitRef="usd">10979000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie2c3e0ab5c404e47a177e468672a1455_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY1NjM_a7450921-245b-4291-ab52-2048032a186a"
      unitRef="usd">11700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="ie2c3e0ab5c404e47a177e468672a1455_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY1OTc_71615eca-2085-4566-9eb1-43a3c164535f"
      unitRef="usd">6000000.0</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i132e6a5556ef4b1d9a099d0161937187_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY2NzM_5624514b-2fa0-4d1d-9e18-a38e77ca8932"
      unitRef="usd">11300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="i132e6a5556ef4b1d9a099d0161937187_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTY3MDc_e458f27f-a17f-49e3-8348-7a1bfc4cecae"
      unitRef="usd">6000000.0</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <lgnd:ForecastedCashFlowsEffectiveInterestRatePercent
      contextRef="ia3d09f0c28ed43418f452c8a8c413e2c_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTc4OTA_59d2150c-f22e-4dd5-a7b7-30f7691c10b1"
      unitRef="number">0.23</lgnd:ForecastedCashFlowsEffectiveInterestRatePercent>
    <lgnd:ForecastedCashFlowsEffectiveInterestRatePercent
      contextRef="id1f82d2c30024c07a9201d0f6c666c56_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTg4MDk_d3f8e4e1-31bc-4722-8970-f98c84d5a260"
      unitRef="number">0.21</lgnd:ForecastedCashFlowsEffectiveInterestRatePercent>
    <lgnd:CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss
      contextRef="id539ee77085d45f4865a0e6a9a962ff2_I20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTkwODE_e874a843-8613-4c21-b9ac-9a47d238be0b"
      unitRef="usd">5500000</lgnd:CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MjI_77494ed8-da13-4071-ae61-5876b11e861d">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Return reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subcontractor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMi0xLTEtMS0w_0b171fa4-d519-4940-a800-38c6e0b620f5"
      unitRef="usd">3684000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMi0zLTEtMS0w_3e208064-b0fc-4fa1-897d-fa908a0f52ae"
      unitRef="usd">8810000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMy0xLTEtMS0w_d60fa0ff-97bc-4dc6-9a23-c2239731ed29"
      unitRef="usd">977000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMy0zLTEtMS0w_74011838-898f-41c4-a913-8fcd2de7a7e7"
      unitRef="usd">977000</us-gaap:AccruedProfessionalFeesCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNC0xLTEtMS0w_97e3c076-9461-4a42-a2b5-d1ae20b90152"
      unitRef="usd">446000</lgnd:LicenseeAccrualCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNC0zLTEtMS0w_6fa34f37-8efe-403e-a924-362d0953501e"
      unitRef="usd">421000</lgnd:LicenseeAccrualCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNS0xLTEtMS0w_74eca5a5-c3fd-45c9-b2ea-db842c794b50"
      unitRef="usd">52000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNS0zLTEtMS0w_7e336ae0-ac2e-4ee9-9eec-a36cf1bf1cf4"
      unitRef="usd">693000</us-gaap:AccruedRoyaltiesCurrent>
    <lgnd:ReturnsAccrual
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNi0xLTEtMS0w_073f68dc-2082-4b6b-932c-16b4bb15249e"
      unitRef="usd">105000</lgnd:ReturnsAccrual>
    <lgnd:ReturnsAccrual
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNi0zLTEtMS0w_668f3e3d-7ab0-4f00-b7bf-b5883d17a971"
      unitRef="usd">687000</lgnd:ReturnsAccrual>
    <lgnd:AccruedAssetAcquisitionsCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNy0xLTEtMS0w_3388cb97-7b5d-4bfd-b004-16ae85a6fa74"
      unitRef="usd">1500000</lgnd:AccruedAssetAcquisitionsCurrent>
    <lgnd:AccruedAssetAcquisitionsCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfNy0zLTEtMS0w_f02c2da5-e781-488e-a40a-6b42c40df2ea"
      unitRef="usd">1500000</lgnd:AccruedAssetAcquisitionsCurrent>
    <lgnd:AccruedSubcontractorExpensesCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfOC0xLTEtMS0w_46cdaaac-c2e0-498e-b789-194402287f7c"
      unitRef="usd">0</lgnd:AccruedSubcontractorExpensesCurrent>
    <lgnd:AccruedSubcontractorExpensesCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfOC0zLTEtMS0w_aeceabf3-a60a-4bb8-b23d-850f386c14fa"
      unitRef="usd">733000</lgnd:AccruedSubcontractorExpensesCurrent>
    <lgnd:AccruedSupplierExpensesCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfOS0xLTEtMS0w_ae8867cd-0e31-44de-b36d-386ec35bc0d6"
      unitRef="usd">681000</lgnd:AccruedSupplierExpensesCurrent>
    <lgnd:AccruedSupplierExpensesCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfOS0zLTEtMS0w_5e0b1df5-70cd-4af5-b56b-3ffea96a35e0"
      unitRef="usd">604000</lgnd:AccruedSupplierExpensesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMTAtMS0xLTEtMA_6ea4ef06-ea13-4a1b-b752-9e455a18cefe"
      unitRef="usd">295000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMTAtMy0xLTEtMA_282b54e5-fd3a-4155-9ead-6bc2c34b331c"
      unitRef="usd">464000</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMTEtMS0xLTEtMA_57d1860e-baab-41db-abb4-4007d30425ef"
      unitRef="usd">2367000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMTEtMy0xLTEtMA_40d2f9d8-e1fa-4d4e-aa7a-8f5935093c72"
      unitRef="usd">3641000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMTItMS0xLTEtMA_2fa5d27e-b3c1-419a-8225-5f11198e6b93"
      unitRef="usd">10107000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="idefe5b12f6c7488d8121bb3c251b2ea1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjliMjliYzMyMDllMDQ4YWJiNmQ2ZjY4ZGNhMmJkYjBmL3RhYmxlcmFuZ2U6OWIyOWJjMzIwOWUwNDhhYmI2ZDZmNjhkY2EyYmRiMGZfMTItMy0xLTEtMA_896ea038-cb4a-450a-b9b7-68fa1e94bb81"
      unitRef="usd">18530000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3NTA_689d618c-72c8-493a-9a4f-0b626f395f8f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period until the last tranche vests. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3Mzk_ac14325b-7c45-48ba-9a87-08f8cbdfd1da">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i39531d4ab7cf4f0aace79c3dc0eb299a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfMy0xLTEtMS0w_7c3bb7a0-8830-48d6-94ad-ec94e134b43a"
      unitRef="usd">4556000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i78065ce772ec469298f8378f75ca1645_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfMy0zLTEtMS0w_e4e4d6dd-88aa-4cd0-8bc1-962ade5297c1"
      unitRef="usd">3019000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ifa63d1e101a04ca3930b9a6c58bb223c_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfMy05LTEtMS0w_58d01368-14d7-4513-8689-ff330e921c26"
      unitRef="usd">8495000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i19e6852caf924e1e8b8bcb9b31317006_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfMy0xMS0xLTEtMA_7de21dd1-2405-4fa3-bf0c-694a7e2ce991"
      unitRef="usd">5416000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i6e1e3edd32274cfa9dee37913732cc3f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNC0xLTEtMS0w_a0fde784-3325-47f8-aa32-71c02f41236a"
      unitRef="usd">5660000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="iedc8c2b179da4c57b0d69399b7319487_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNC0zLTEtMS0w_4e1830de-f5da-41b5-9098-2e5e894377c4"
      unitRef="usd">4340000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i772dc85a5dae4c1d9ddf06f9992a3e6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNC05LTEtMS0w_80189a7b-2454-4e11-af39-0dd609471694"
      unitRef="usd">10126000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ic946c1298336471283c1bde8dab683da_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNC0xMS0xLTEtMA_8bc97d0a-dd29-4465-93de-7524957312c0"
      unitRef="usd">7596000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNS0xLTEtMS0w_4e4ddac5-3de4-4f53-a4ea-fe4dd97d6801"
      unitRef="usd">10216000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNS0zLTEtMS0w_55479b69-9987-4ad4-9fe6-10af7a4c9f84"
      unitRef="usd">7359000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNS05LTEtMS0w_15f0e458-e16b-4907-a03f-7d3a5d12a2dd"
      unitRef="usd">18621000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOjg3Y2NlOGI4ZTlkNjRjMWU5N2EwNzAwYWY3ODU4NWU2L3RhYmxlcmFuZ2U6ODdjY2U4YjhlOWQ2NGMxZTk3YTA3MDBhZjc4NTg1ZTZfNS0xMS0xLTEtMA_43d02796-0bcc-4161-9849-626380eed8a6"
      unitRef="usd">13012000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3NDM_1a60615c-5812-4f81-a35f-d603007fbacc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfMy0xLTEtMS0w_b0b0eb7b-b63f-4303-84a3-c8cbe4f36a10"
      unitRef="number">0.009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfMy0zLTEtMS0w_ad587af4-08b8-4419-b199-32d077871ed1"
      unitRef="number">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfMy01LTEtMS00Nzk_55fe57c9-c356-4c73-8ffa-dd2e2f143359"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfMy03LTEtMS00NzU_676f5041-75da-46fd-999b-5908f37400f8"
      unitRef="number">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNC0xLTEtMS0w_b7efee62-5e2b-43d7-87d3-d0cd76620b5b"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNC0zLTEtMS0w_33321d1a-a801-4a19-92d3-405c144e580e"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNC01LTEtMS00Nzk_81e4c885-dc06-4e14-a019-0dbf9d639597"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNC03LTEtMS00NzU_8c153cf6-f85e-4d32-8d7e-54898d43f07a"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNS0xLTEtMS0w_05b66096-5b86-4768-aebc-85ff9dca0e55"
      unitRef="number">0.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNS0zLTEtMS0w_79aa6214-c73d-4f39-b32a-85f3989a622a"
      unitRef="number">0.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNS01LTEtMS00Nzk_fb018770-0be6-44d3-a61f-a0e180701c7c"
      unitRef="number">0.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNS03LTEtMS00NzU_3407db09-2e67-4fdf-b16f-8140e2200bc4"
      unitRef="number">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNi0xLTEtMS0w_d931c39e-7890-4c9e-9cbe-9f2e1b326f8c">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNi0zLTEtMS0w_441ba9b5-c156-4d1d-9ec8-c1cb776bad71">P5Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNi01LTEtMS00Nzk_aa3f101b-1c08-46a5-a283-d6ea27792191">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmVlYjFlNmRlZTJmNTQ5YTVhNzc0M2VjNWVmOGE4MzYwL3RhYmxlcmFuZ2U6ZWViMWU2ZGVlMmY1NDlhNWE3NzQzZWM1ZWY4YTgzNjBfNi03LTEtMS00NzU_5b098ba1-ed3b-4d18-99e2-b1a69b93deb2">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MzM_34ec15eb-4c02-47c0-9dbd-a0a6f211ed94">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent
      contextRef="i91c0aa1e995c4988b6700da4987ed2a2_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjA5Njc_6328a771-15eb-4ebd-8f5a-7b624e5fcf45"
      unitRef="number">0</lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent>
    <lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent
      contextRef="i163d925374744dc19e90ee21d40ac455_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjA5NzM_ec63d4cc-654d-4bc2-93b1-0d4f7abdfffd"
      unitRef="number">2</lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MDE_6f77bf85-820a-4d4b-8de2-11b8ad3c4f21">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 4, Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 6, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMjI3MDQ_ec0e35d4-43bc-44c8-8d19-101f1f1077e4">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfMy0xLTEtMS0w_137e2acb-f0f3-4794-8f1b-923078ab9830"
      unitRef="shares">16659000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfMy0zLTEtMS0w_ff4ad5b3-1120-481f-a156-425cb44d7e80"
      unitRef="shares">16055000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfMy01LTEtMS01Mjc_1cdd49e4-3144-4477-bd43-3eae00d642c4"
      unitRef="shares">16548000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfMy03LTEtMS01MTY_94067bb6-7ea4-4efc-87eb-3ba7d5a0af2e"
      unitRef="shares">16292000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNS0xLTEtMS0w_bcc22b9c-0053-48f7-9a5f-0593fe81a70a"
      unitRef="shares">69000</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNS0zLTEtMS0w_131094fb-e402-4d4e-8445-156222e11272"
      unitRef="shares">40000</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNS01LTEtMS01MzE_7292d54f-0648-4392-ac22-6b850883374e"
      unitRef="shares">90000</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNS03LTEtMS01MjA_f4ef5300-81e4-4159-b205-35f85620f34a"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNi0xLTEtMS0w_3dca6f15-87d3-4d60-94d2-4fdeb17b0e7b"
      unitRef="shares">444000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNi0zLTEtMS0w_41048fcb-f4e9-4406-a677-dc46fae00785"
      unitRef="shares">599000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNi01LTEtMS01MzE_595ae22a-d82c-40be-9dd9-49712ddaae18"
      unitRef="shares">572000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNi03LTEtMS01MjA_d4ac708d-6da3-42dd-92c8-0d9aeecee3dd"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNy0xLTEtMS0w_2070d25f-f9a6-4067-a630-8e4de12c85a1"
      unitRef="shares">17172000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNy0zLTEtMS0w_070b43d7-2730-47cc-a96b-0b25232d47f7"
      unitRef="shares">16694000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNy01LTEtMS0xMDkx_66231318-236a-435f-bc55-b1117ad73505"
      unitRef="shares">17210000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfNy03LTEtMS0xMDkz_1a867bf6-c0ae-4b7f-8c12-217ce28ff099"
      unitRef="shares">16292000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfOC0xLTEtMS0w_010f154d-c94f-43ec-bb31-ab5233c76f73"
      unitRef="shares">5087000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfOC0zLTEtMS0w_023c944d-d751-4183-8a2b-24542841b100"
      unitRef="shares">7832000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfOC01LTEtMS01MzY_6424a541-3408-4410-8d1e-862ec7a5cff1"
      unitRef="shares">4684000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RhYmxlOmQ1NTczMjJlYTZiYzRjYzhhNDA1ZmM3YjU0MGExZmYzL3RhYmxlcmFuZ2U6ZDU1NzMyMmVhNmJjNGNjOGE0MDVmYzdiNTQwYTFmZjNfOC03LTEtMS01MDc_28d2d4d8-fb2d-43dd-a182-9db23baf788a"
      unitRef="shares">8988000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i939615bc911747ff91466aa044f7d705_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNC9mcmFnOjVjNzc1YTgwN2U3ZjQ5ZjRhZWYxMTc3MzJhZjBjY2EyL3RleHRyZWdpb246NWM3NzVhODA3ZTdmNDlmNGFlZjExNzczMmFmMGNjYTJfMTA5OTUxMTY1NDUwNg_22579481-777d-4051-8f91-0d586919a7a2"
      unitRef="shares">600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfNTk0Mg_9fddf693-8761-458f-946b-da767913928c">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;233,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;239,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;320,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;324,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;233,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;279,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;320,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;363,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Crystal contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Icagen contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pfenex contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;xCella contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Investment in Viking warrants, which we received as a result of Viking&#x2019;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. During the six months ended June&#160;30, 2021, we exercised all of the outstanding Viking warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the six months ended June&#160;30, 2021, we paid $1.1&#160;million contingent liability based on revenue milestones to former Icagen shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Pfenex contingent liabilities was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of the Company. During the three and six months ended June&#160;30, 2021, we reduced the contingent liability by $34.1&#160;million and $33.8&#160;million, respectively, primarily due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR. See further detail on Pfenex CVR in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 3, Acquisitions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the first quarter of 2021, management recorded an earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of June&#160;30, 2021 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments to CVR holders and other contingent payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent liabilities from xCella asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of June&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Measured on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the second quarter of 2021, in connection with the Pfenex CVR fair value evaluation, we also evaluated the related indefinite-lived contractual relationship intangible for recoverability and concluded there was no impairment.&lt;/span&gt;&lt;/div&gt;Other than the above mentioned triggering event, there were no other triggering events identified and no indication of impairment of our goodwill, indefinite-lived intangible assets, or long-lived assets during the three and six months ended June&#160;30, 2021.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfNTk0Mw_f6a7208d-e744-4496-9788-38682ee0fa11">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;233,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;239,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;320,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;324,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;233,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;279,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;320,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;363,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Crystal contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Icagen contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pfenex contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;xCella contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Investment in Viking warrants, which we received as a result of Viking&#x2019;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. During the six months ended June&#160;30, 2021, we exercised all of the outstanding Viking warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the six months ended June&#160;30, 2021, we paid $1.1&#160;million contingent liability based on revenue milestones to former Icagen shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Pfenex contingent liabilities was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of the Company. During the three and six months ended June&#160;30, 2021, we reduced the contingent liability by $34.1&#160;million and $33.8&#160;million, respectively, primarily due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR. See further detail on Pfenex CVR in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 3, Acquisitions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;7.The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the first quarter of 2021, management recorded an earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement.</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibf756f2501b74e0898048554c3c0783e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy0yLTEtMS0w_fb439df9-b70d-4d47-a2e1-d53a72950c03"
      unitRef="usd">5669000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i796ab7b302fd449bb651ec4d41dac07e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy00LTEtMS0w_f5c78625-21f2-4920-a3a8-d215e86d53b1"
      unitRef="usd">233368000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7f8cf2a139e64d1198f5d67aa364f965_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy02LTEtMS0w_de44af58-9560-49d9-81ea-d7aff5e6f7d3"
      unitRef="usd">712000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4cf32622b6254648a6c2f68df210c48e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy04LTEtMS0w_374e98a2-2f62-4fbf-aca4-3503b177ca97"
      unitRef="usd">239749000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3eaf883d9af8472c83fe21fa31227a28_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy0xMC0xLTEtMA_19b863a6-2fdd-4ae9-80e4-173734e343fc"
      unitRef="usd">3438000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8d3c3bdb624f4891bf85269d85f85683_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy0xMi0xLTEtMA_617b21f9-bf12-41de-82fb-331eef6bced4"
      unitRef="usd">320647000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic8e00bcc4ceb456280e021abea879ec0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy0xNC0xLTEtMA_ef073cbe-24f0-417d-a9c3-7c66d1952a5b"
      unitRef="usd">393000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1e0a0c15e8e344eca24216baf962f264_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMy0xNi0xLTEtMA_bd9d0137-15b5-4c70-b182-d6d7ebf1e11e"
      unitRef="usd">324478000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9bec0cdf729b451dafb85f5a25d8f563_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC0yLTEtMS0w_5aec182a-9356-4252-a6f7-e885b91a4048"
      unitRef="usd">40223000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i61de52e98a8c4a8d83132e0c0db3dcd4_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC00LTEtMS0w_3ed570dc-9cba-454a-a185-4022b430fdff"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i47ef30b73058418caaaaff016ffeff78_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC02LTEtMS0w_1abab275-2aa9-4724-9d3b-f5e67bcb4ff4"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i005e8c3fac4c461bbb49bcb0b925f653_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC04LTEtMS0w_dd939a59-1c5d-42e5-86cb-0b738c90e70c"
      unitRef="usd">40223000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6d2ea83589d04ffba237d02df0bd14ca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC0xMC0xLTEtMA_925567cd-f553-4f1f-82a2-a30ceb3bb776"
      unitRef="usd">32763000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0d8874a1883347ecba3086a56ff8551f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC0xMi0xLTEtMA_41f9ded4-1980-44c4-8201-5c0fad5b4acc"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i387e213a06b04a448c4eb58b54ad09f9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC0xNC0xLTEtMA_1c11f881-e8b1-4a24-aa1e-7e0b1a2014e1"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4c7d0cf9f5d9461997395ecfa5774eee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNC0xNi0xLTEtMA_fde36c1e-521b-4bfc-8afe-24bd97878978"
      unitRef="usd">32763000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia045228d9b614876a5e504039e235ae7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS0yLTEtMS0w_015b25e0-e3de-4591-824f-e108b92cf299"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i641d7897463648d593b3ca40dbd5ede9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS00LTEtMS0w_9bd289f9-ebcf-4ac6-abf7-a033c3121b97"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i220a77d258c24676985ff3e94a5777f2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS02LTEtMS0w_e98af1f5-b4d4-48c1-8e0e-6358c9360e01"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9d12e59c7f4c45f4a6acae8cdc855fd2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS04LTEtMS0w_6ef41e79-f932-477b-8403-896b4792fe1b"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i84e9a9944b144829ad78f048f85f8b72_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS0xMC0xLTEtMA_dc3ae481-105d-4791-8e07-b19231a8840f"
      unitRef="usd">6326000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i64737b59a93b4b3f8cbc8602eacded0f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS0xMi0xLTEtMA_1880f60a-027a-4c2c-a7f1-0577c510f144"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id642d98b4ab5493492cd4d631e98f649_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS0xNC0xLTEtMA_4fed0ee2-33e5-4e81-9f8c-323eac667f52"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i16091b8d48fe4aa7aed58abf316cf655_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNS0xNi0xLTEtMA_a07cd89c-fb4f-43ba-abe5-bcaf963c795c"
      unitRef="usd">6326000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8a0c0c9f6f014f8fb72f8cf92bde8fc0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi0yLTEtMS0w_fcb7c2c6-8109-495d-a590-7bbe23595b9b"
      unitRef="usd">45892000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i557878bd28b741ac8242fc9594c33f79_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi00LTEtMS0w_faa332a1-8cbf-469b-aeb8-a350792ddd6d"
      unitRef="usd">233368000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2f8e521dfd304b559210391763ef8967_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi02LTEtMS0w_bd0bd287-e910-43e0-bac8-f26f515201c7"
      unitRef="usd">712000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i38789c05639047e786b0f44cd1f81a54_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi04LTEtMS0w_62f721b7-6d14-4de8-a6b5-b0dc9fa30b9d"
      unitRef="usd">279972000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic89b647aa620475b919305bbfb902e88_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi0xMC0xLTEtMA_0a12654b-da8e-480a-a097-98f327c587de"
      unitRef="usd">42527000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib05226da6d8b49729bf12cbb13f48688_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi0xMi0xLTEtMA_073784a3-9062-4fc5-9083-dfb36456ef30"
      unitRef="usd">320647000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0dab2c8b54fd4ca4bd5583431d596fda_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi0xNC0xLTEtMA_0bdde3ad-142c-48c6-840a-431d0b4d5600"
      unitRef="usd">393000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib033d6a72993457c9d1212af5e26a84d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfNi0xNi0xLTEtMA_e68323fc-06d6-4638-b2f1-4a51aad5cfd4"
      unitRef="usd">363567000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iad453372414e43f4bbb5fa127bdfd4b6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC0yLTEtMS0w_1f260522-0468-4a5a-b52b-ed303f1ddef8"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9b51bff8800c428797e64c37e8bf037b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC00LTEtMS0w_4c4cc94a-434d-41fb-824d-4d35f636b4e7"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if895305c42ba4796b58e31d56a083e2b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC02LTEtMS0w_57f1a730-49cf-42f3-a1a2-698c2cb738be"
      unitRef="usd">800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id649b26944164f4f97db61669a9fa440_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC04LTEtMS0w_9633090d-8f8f-4df0-a300-9b77a8b0f38d"
      unitRef="usd">800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8c5fd4abee7d4774b0069173b5ab7bd0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC0xMC0xLTEtMA_130e03f1-17a4-4d3d-98c3-0d79b950aebf"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia3981fc802cb453aa0560b2810a13ded_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC0xMi0xLTEtMA_0aa99040-787d-45cd-b201-7709221a2842"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i97950dc03de449d4b199d76fa33d7646_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC0xNC0xLTEtMA_9c4954a1-4c0b-4446-a4b8-04b3105850ae"
      unitRef="usd">800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id37a246dde494a62b12b0bcc3808a45c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOC0xNi0xLTEtMA_7c35a5c3-0a52-4990-85a8-614ff679b72d"
      unitRef="usd">800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib3247e24b5dd46618012805e016575c9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS0yLTEtMS0w_60ebcb2f-ad56-40b8-9853-df7a89c28054"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2739e8b8a37c4a40826744f663f3cd9b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS00LTEtMS0w_888c5368-4a01-49b8-a1ad-b76fba523bed"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i71af70fa404948bfa683daccf446fe4e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS02LTEtMS0w_286906f1-1444-4d0a-a9db-819c8074416f"
      unitRef="usd">376000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="icdb36b5dd0ef4b7da44e14cd73f5fafb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS04LTEtMS0w_12a1975d-5967-4887-914d-319d07c3815c"
      unitRef="usd">376000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i76cad1a6417044928d62c1e4ab27cda9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS0xMC0xLTEtMA_980c3f85-6c11-4e74-b411-2e1a7a949fa9"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iedd025b870864e4d961da366b7b5528b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS0xMi0xLTEtMA_46462a0d-271a-420c-9ec6-33f76fbd1898"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ibda6b7d8020d42f3b17c4b1a9af44d12_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS0xNC0xLTEtMA_8b6b0a16-eca4-4d3b-9693-99e16778b30c"
      unitRef="usd">508000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i51c7fde616a242b9b7b30c2c7b19b923_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfOS0xNi0xLTEtMA_ea539d4e-bf9b-4735-a4bb-ddc8dcfbb549"
      unitRef="usd">508000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0b8df10c2682432983902baa864b9142_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtMi0xLTEtMA_241b44a7-0f11-4d1e-9665-e5fa0bbb4a76"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="idcd8f21f2f7c4238aa1325d72a7ebbdb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtNC0xLTEtMA_b4fad447-cfce-46ea-980b-75cdbb7fee21"
      unitRef="usd">3930000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie3fe525c20524b7eb5724b9edf213b37_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtNi0xLTEtMA_bcadf28c-e616-4767-ad9b-e06a32d66a18"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i061f31e310da49b8bdef63bdf885268c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtOC0xLTEtMA_96f04578-b4a0-4946-b302-23f0146dd7b4"
      unitRef="usd">3930000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1b410efadd054a649b74fb4ab4b2541f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtMTAtMS0xLTA_16c49bc5-1d55-4d5d-a4f5-dce2523ee3b4"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4a8f0d4449da4cd59d8a03eb8dc3f11d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtMTItMS0xLTA_36643ebc-c441-466b-ba62-a5b3d59ab63d"
      unitRef="usd">3821000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i89c072c3ed814deabecf50119491b5cb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtMTQtMS0xLTA_9766a451-762c-4dc1-9933-220f41adfe8c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iffd18f96992e4b7ca3b22e6376f529fe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTAtMTYtMS0xLTA_cfe81e27-f368-48a9-8bbb-24e7c013f7d9"
      unitRef="usd">3821000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5ab7b877600348b0a02624b9699a5469_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtMi0xLTEtMA_ae662039-ca7c-4eb9-bf41-bb4d7e1d9755"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i19a4f05983fd4dc5b7709df1b833f9c6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtNC0xLTEtMA_e6557cef-8f8d-4cc9-b062-62a68d820a4c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic9ca0e4731fb4bb4993033661944bef4_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtNi0xLTEtMA_c7ae8c9c-a884-455b-9987-67beaaba08e9"
      unitRef="usd">5625000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3ffa5a29a71643c88ede85aeb0f07ae0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtOC0xLTEtMA_bba062d3-594a-4e8c-a519-f5ec6f35cb4d"
      unitRef="usd">5625000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i75036d6e219044c292bf94448ff791de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtMTAtMS0xLTA_790e0431-a5d0-4b71-b1eb-5d389c5a0a73"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia9b46809a4a242e9b7e286c5f5853e33_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtMTItMS0xLTA_35061103-1d20-4dff-b2ff-d28601ae5dde"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9bc7b23b98c24bcb97086aedb8f6b9a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtMTQtMS0xLTA_052da0e3-af44-4e5d-9553-4ed5f0655add"
      unitRef="usd">6404000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i63e85efa2c7b4b8a8934c115e462671d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTEtMTYtMS0xLTA_ca129634-9fe4-4486-b19e-150a66d8aa05"
      unitRef="usd">6404000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6a6510d82770434b983d927bf24176d9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItMi0xLTEtMA_78355400-5bce-432a-98c7-0fff4b4b6037"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie905e4f33e8d4048b5cfaaf2621e7b22_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItNC0xLTEtMA_be9fdb73-c89d-4df3-b76a-1dbfc61af16b"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i253e61895f964faaa57258e78a2e242b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItNi0xLTEtMA_dca453da-31e9-47f7-b86e-e2f8723dacb1"
      unitRef="usd">3800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iee7f60369ff44dc690747a7ded9f7378_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItOC0xLTEtMA_441d18a5-493b-45ba-88ce-c80304489aaf"
      unitRef="usd">3800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2f492eb7b30f444ea91c469c951cac52_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItMTAtMS0xLTA_f4c94f1c-003c-4f3c-971b-8c6862cdcb64"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3231b70ce9d74b739582396aea5f4596_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItMTItMS0xLTA_e48ce5bb-fe48-4a87-9942-89a60893ca6d"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6ac7ec1a94684eb4b17125ff94d45847_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItMTQtMS0xLTA_fba1fae4-fe90-4ce9-8723-2a1e5b27101c"
      unitRef="usd">37600000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i944386c5eaae4e9b9f6282141c8f6cd9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTItMTYtMS0xLTA_3e55a846-41d1-4667-b6ab-9219a095c709"
      unitRef="usd">37600000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ifb2b256fccda44f789ccdb015560f400_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtMi0xLTEtMA_6e9b9d15-5c24-4c73-a893-3dd4df8472b3"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i34aa94365beb4fda8e028ed4b2e49ffa_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtNC0xLTEtMA_dd754d37-f62d-49fe-98c5-184d3eebe2fd"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie634e5d883a246c0b675b67cb23000bd_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtNi0xLTEtMA_af3d9719-83c9-4f60-a29a-685bc7a4ba85"
      unitRef="usd">240000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i22bf6089dd044188988a26b040ff65c0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtOC0xLTEtMA_d26756c1-688a-4c54-b2c7-34b03aa82dd5"
      unitRef="usd">240000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i02324c19886a4c18b6067d16ace402b5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtMTAtMS0xLTA_d9afe522-45fc-4d49-affb-5f80cd9a34bd"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if8ed0ac879e24c8088076f9f0f8287ed_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtMTItMS0xLTA_a7e73549-6a44-4dd7-b6ba-b64c030708d6"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9760653085dd4b7393829a3480ed5ec0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtMTQtMS0xLTA_b96ea876-6a46-4055-a852-8d100312e59f"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iba7989e6f5e8482ab0daf120805cca55_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTMtMTYtMS0xLTA_0185a97e-c908-419f-9012-ba0955562414"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i21134d594d0f44a3b592bd03f3304d4b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtMi0xLTEtMA_3bde67ff-f49b-459e-a65d-6169a0492fb1"
      unitRef="usd">31000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ifd625ffa45724705a1055f34d130688c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtNC0xLTEtMA_2d203319-70f7-44bb-8849-27bfd9ca00bc"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i46d7fa3ab3de4bd0993ae0388c003976_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtNi0xLTEtMA_7d774d22-9228-4fa9-95a3-7f31aa192786"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2ab8e64374244574bfba15d1172a7cd3_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtOC0xLTEtMA_c076e8df-d05a-4bb9-a79f-864d5f84d5be"
      unitRef="usd">31000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i357340a5b0324e1e9aaa75a5ef7abab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtMTAtMS0xLTA_8cdc4030-0dd7-405f-988a-854620ad074b"
      unitRef="usd">60000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="icbfb293f7d7a4cc58fc7ee43b5c0eb61_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtMTItMS0xLTA_a7e0c24d-1afd-4919-8388-689268156d53"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0358d88a74ec408bbf376519526abff1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtMTQtMS0xLTA_1b0e7d12-084a-469f-920d-4baa99550914"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i41bb3ed9de1d46d79072d907dbbcda90_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTQtMTYtMS0xLTA_3def1cdd-8711-4ab1-87b2-e0a084abe6d2"
      unitRef="usd">60000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8a0c0c9f6f014f8fb72f8cf92bde8fc0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtMi0xLTEtMA_bcb8c5f2-0a75-47ac-a4f0-a5a6a4534d9c"
      unitRef="usd">31000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i557878bd28b741ac8242fc9594c33f79_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtNC0xLTEtMA_bd43df7c-655c-4c5e-adeb-33c1ee623f12"
      unitRef="usd">3930000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2f8e521dfd304b559210391763ef8967_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtNi0xLTEtMA_59502239-f0c2-418e-9ee2-13f8c55a2d5d"
      unitRef="usd">10841000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i38789c05639047e786b0f44cd1f81a54_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtOC0xLTEtMA_3e807cb4-7d13-4988-94fe-ec915a135738"
      unitRef="usd">14802000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic89b647aa620475b919305bbfb902e88_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtMTAtMS0xLTA_25027e71-a10a-49c1-a35c-0099fdc17506"
      unitRef="usd">60000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib05226da6d8b49729bf12cbb13f48688_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtMTItMS0xLTA_ae5fae2d-0b97-407c-abb8-ca5e0191edb1"
      unitRef="usd">3821000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0dab2c8b54fd4ca4bd5583431d596fda_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtMTQtMS0xLTA_f45dd3bd-1b64-456f-83a1-f01486dac8e6"
      unitRef="usd">45312000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib033d6a72993457c9d1212af5e26a84d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOmEyMGYxZmZiYTM3YTQzMWU5ZmI0MTdhOTQyZTIyYzIwL3RhYmxlcmFuZ2U6YTIwZjFmZmJhMzdhNDMxZTlmYjQxN2E5NDJlMjJjMjBfMTUtMTYtMS0xLTA_875e80e5-0316-4d30-af0e-99a58b2d9d36"
      unitRef="usd">49193000</us-gaap:LiabilitiesFairValueDisclosure>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare
      contextRef="i4756268078d14fac936133a04e156f01_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMjQ5OA_f574e389-ef4e-4e91-bf5c-ace5c1733704"
      unitRef="contingent_value_right">4</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries
      contextRef="i4756268078d14fac936133a04e156f01_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMjUxNg_e823948c-2932-4d79-913b-19f7d92a1210"
      unitRef="contingent_value_right">1</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries>
    <lgnd:NumberOfContingentValueRightsSeries
      contextRef="if487bbb8057a47a2bfafd87e853aa62f_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMjUzNg_9e096943-a473-4adb-a187-6a955ea3685b"
      unitRef="contingent_value_right_series">4</lgnd:NumberOfContingentValueRightsSeries>
    <lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders
      contextRef="i4756268078d14fac936133a04e156f01_D20100101-20100131"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMjY3MQ_893c7ffa-1898-45a3-a986-9104e07595de">P6M</lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders>
    <us-gaap:Investments
      contextRef="ifa9602c2fb6e4bc0a7dfeb7bb5e534d8_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMzQ3Mw_570eea21-59a0-4b56-8612-c5a56d523a5d"
      unitRef="usd">375000000</us-gaap:Investments>
    <us-gaap:ContractWithCustomerAssetGross
      contextRef="i21a47f508af74c0c94d611302c008270_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMzU4OA_1e3fe902-b356-41aa-995f-fd367d564a6d"
      unitRef="usd">10000000</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="ifa422606d00d4484ad76a52ce224d9f1_D20210101-20210630"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMTA5OTUxMTYzNzgwNw_5189a8f1-2886-441f-903d-c81733eb2943"
      unitRef="usd">1100000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i3819ef5e99824efb8df9aa305cf4213a_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMTA5OTUxMTYzODE1MA_65682680-be00-4c8f-b8cd-39e7fca40736"
      unitRef="usd">-34100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i382dac6fd2e349f5804856ab5f5e6561_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfMTA5OTUxMTYzNzkxMA_4bff3a8e-74d4-4b04-8704-e73463557c9c"
      unitRef="usd">-33800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RleHRyZWdpb246MzgzNWVkZmNmNDkxNGU5OGI2MzVmYTdiYjgyMzdkOTRfNTkzOQ_bd008fcc-f9ab-44b3-b886-4b93a69965da">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of June&#160;30, 2021 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments to CVR holders and other contingent payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent liabilities from xCella asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of June&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i30b9d60f80524037808096d46cfdd9bf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOjY5MWExMDcwNzFiODQ5MWFiNGFmYWQyYTVhNzg3NjM5L3RhYmxlcmFuZ2U6NjkxYTEwNzA3MWI4NDkxYWI0YWZhZDJhNWE3ODc2MzlfMC0xLTEtMS0w_e1693bd3-4e5e-4db9-a860-d0e7a40f4dfa"
      unitRef="usd">45312000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <lgnd:PaymentsToContingentValueRightHolders
      contextRef="i49489b4312d24480aa69abea662ae37a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOjY5MWExMDcwNzFiODQ5MWFiNGFmYWQyYTVhNzg3NjM5L3RhYmxlcmFuZ2U6NjkxYTEwNzA3MWI4NDkxYWI0YWZhZDJhNWE3ODc2MzlfMS0xLTEtMS0xMjg3_d513bcf3-5df2-42fd-9916-03638389bef6"
      unitRef="usd">1050000</lgnd:PaymentsToContingentValueRightHolders>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i49489b4312d24480aa69abea662ae37a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOjY5MWExMDcwNzFiODQ5MWFiNGFmYWQyYTVhNzg3NjM5L3RhYmxlcmFuZ2U6NjkxYTEwNzA3MWI4NDkxYWI0YWZhZDJhNWE3ODc2MzlfMS0xLTEtMS0w_e6167853-128c-4540-a29f-5186573643cd"
      unitRef="usd">-33661000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition
      contextRef="i49489b4312d24480aa69abea662ae37a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOjY5MWExMDcwNzFiODQ5MWFiNGFmYWQyYTVhNzg3NjM5L3RhYmxlcmFuZ2U6NjkxYTEwNzA3MWI4NDkxYWI0YWZhZDJhNWE3ODc2MzlfMi0xLTEtMS0w_0a98767e-aa36-4e4c-b86a-5e33e57767a8"
      unitRef="usd">240000</lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia4e0652f35f242c6a35f9468106a365d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV8zNy9mcmFnOjM4MzVlZGZjZjQ5MTRlOThiNjM1ZmE3YmI4MjM3ZDk0L3RhYmxlOjY5MWExMDcwNzFiODQ5MWFiNGFmYWQyYTVhNzg3NjM5L3RhYmxlcmFuZ2U6NjkxYTEwNzA3MWI4NDkxYWI0YWZhZDJhNWE3ODc2MzlfMy0xLTEtMS0w_a50e7ea2-8b99-4abd-8fee-bc2a5331a22a"
      unitRef="usd">10841000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTA4NjA_ff5cc4ac-78ba-4922-84aa-442212b67e06">Acquisitions&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Pfenex Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On October 1, 2020, we acquired Pfenex, which develops next-generation and novel protein therapeutics to improve existing therapies and create new therapies for biological targets linked to critical, unmet diseases using a protein expression technology platform.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The preliminary purchase price of $465.1&#160;million included $429.6&#160;million cash consideration paid upon acquisition, and a contingent CVR payment of up to $77.8&#160;million in cash based on a certain specified milestone with an estimated initial fair value of $37.0&#160;million. The CVR will only be paid in full if the milestone is achieved by December&#160;31, 2021. The amount of the CVR included in the purchase price was reduced by $1.5&#160;million that was determined to be post-combination expense. The fair value of the CVR liability was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on market participants' cost of debt reflective of the Company, which was 7.1%. The liability is periodically assessed based on events and circumstances related to the underlying milestone, and any change in fair value is recorded in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with the acquisition, a portion of Pfenex's equity awards that were outstanding and unvested prior to the acquisition became fully vested per the terms of the merger agreement. The acceleration of vesting required us to allocate the fair value of the equity attributable to pre-combination service to the purchase price and the remaining amount was considered our post-combination expense. We paid $17.3&#160;million in cash for equity compensation, which is attributable to pre-combination services and is reflected as a component of the total purchase price paid of $429.6&#160;million. In addition, the fair value of equity compensation attributable to the post-combination service period was $8.7&#160;million. These amounts were associated with the accelerated vesting of stock options previously granted to Pfenex employees and were fully paid in cash, which was recognized as general and administrative expenses during the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table sets forth an allocation of the preliminary purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts and unbilled receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intangibles acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,814)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(53,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;465,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is expected to be deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Acquired intangibles include $362&#160;million of contractual relationships and $23&#160;million of core technology. The fair values of the contractual relationships were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated contractual relationship period. The fair value of the contractual relationships is being amortized on a straight-line basis over the weighted average estimated useful life of 12.9 years. The fair values of the acquired technologies were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated useful lives. These projected cash flows were discounted to present value using discount rate, which varies from 12% to 15%. The total acquired intangibles are being amortized on a straight-line basis over the weighted average estimated useful life of 13.0 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The estimated fair values of assets acquired and liabilities assumed, including deferred tax assets and liabilities, and purchased intangibles are provisional. The accounting for these amounts falls within the measurement period and therefore we may adjust these provisional amounts to reflect new information obtained about facts and circumstances that existed as of the acquisition date.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following summary presents our unaudited pro forma consolidated results of operations for the three and six months ended June 30, 2020 as if the Pfenex acquisition had occurred on January 1, 2020, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and share based compensation expense for retained Pfenex employees. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;br/&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net income (loss) per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Taurus Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On September 9, 2020, we acquired Taurus, which discovers and develops novel antibodies from immunized cows and cow-derived libraries. The purchase price of $5.1 million included $4.6 million in cash, and a $0.5 million holdback to satisfy indemnification obligations which will be settled by September 2021.  We also issued nontransferable CVRs for up to $4.5 million tied to partnered and internal research and development and for up to $25.0 million as a 25% share of post-clinical Taurus product revenues (including milestone payments) received by us. We evaluated this acquisition in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, to discern whether the assets and operations of Taurus met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accordingly, we accounted for this transaction as an asset acquisition. Of the $5.1 million consideration transferred, we recognized (1) $0.05 million of tangible assets acquired, and (2) $5.0 million of core completed technology intangibles acquired. The core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. We account for the CVRs in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, when the contingency is resolved and the liability becomes payable. None of the CVRs are recognized as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;xCella Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On September 8, 2020, we acquired xCella, an antibody discovery company. We paid $7.1 million in cash (including a $0.5 million holdback to satisfy indemnification obligations which will be settled by September 2021), and issued earnout rights for up to $5.0 million tied to our use of the xCella technology for partnered research and development and for up to $25.75 million as a 25% share of any future milestone payments we received under a certain existing xCella partner arrangement. We evaluated this acquisition in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, to discern whether the assets and operations of xCella met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $7.1 million consideration transferred, we recognized (1) $0.2 million of tangible assets acquired, (2) $(0.1) million of liabilities assumed, (3) $7.8 million of core completed technology acquired, and (4) $(0.8) million of deferred tax liability. The core technology is being amortized on a straight-line basis over the estimated useful life of 15 years. We account for the earnout rights in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, when the contingency is resolved and the liability becomes payable. None of the earnout rights are recognized as of the acquisition date. During the three months ended June&#160;30, 2021, no contingencies were resolved during the period. During the six months ended June&#160;30, 2021, we recognized $0.2 million in earnout rights when certain contingencies were resolved during the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Icagen Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 1, 2020, we acquired the core assets, including its partnered programs and ion channel technology, from Icagen and certain of its affiliates. The acquisition was accounted for as a business combination and we applied the acquisition method of accounting. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. We did not incur any material acquisition-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The purchase price of $19.9 million included $15.1 million cash consideration paid upon acquisition, and a contingent earn-out payment of up to $25.0&#160;million of cash payments based on certain revenue milestones with an estimated fair value of $4.8 million. The fair value of the earn-out liability was determined using a probability weighted income approach incorporating the estimated future cash flows from expected future milestones. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of Icagen. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 2, Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, for further discussion. The liability will be periodically assessed based on events and circumstances related to the underlying milestones, and any change in fair value will be recorded in our consolidated statements of operations. The carrying amount of the liability may fluctuate significantly and actual amount paid may be materially different than the carrying amount of the liability. As the acquisition is not considered significant, pro forma information has not been provided. The results of Icagen have been included in our results of operations since the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The allocation of the purchase price consisted of (1) $1.8 million of fair value of tangible assets acquired, (2) $(0.8) million of liabilities assumed, (3) $12.8 million of acquired intangibles, (4) $(3.7) million of deferred revenue in connection with assumed performance obligations under a collaboration agreement, (5) $0.8 million of deferred tax asset associated with the deferred revenue, and (6) $9.0 million of goodwill, the majority of which is deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Acquired intangibles include $11.1 million of customer relationships and $1.7 million of core technology. The fair values of the customer relationships were based on a discounted cash flow analysis incorporating the estimated future cash flows from these relationships during the contractual term. These cash flows were then discounted to present value using a discount rate of 17%. The fair value of the customer relationships is being amortized on a straight-line basis over the weighted average estimated useful life of 9.6 years. The fair value of the core technology was based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, and collaboration revenue streams derived from the licensing of the related technologies. These projected cash flows were discounted to present value using a discount rate of 17%. The fair value of the core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. The total acquired intangibles are being amortized on a straight-line basis over the estimated useful life of 9.7 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ie650f5facb7d4c908578773f98df20f6_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMzQx_66e439cb-8a36-4099-9cda-024aaf5e531c"
      unitRef="usd">465100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ie650f5facb7d4c908578773f98df20f6_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMzUz_e273c12c-f533-451b-a15b-8afda5741117"
      unitRef="usd">429600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNDM2_94893d9c-3836-4611-b939-b129b4f8f723"
      unitRef="usd">77800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTI2_33bf227b-187a-4871-be2c-b98c42d08640"
      unitRef="usd">37000000.0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjY4_49a99e7f-4cd1-4885-b6a9-8893f643c41b"
      unitRef="usd">1500000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ic3e711d6bdc94af7b6ee030579f78de0_I20201001"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTc3_38914e8c-d157-48a5-abd1-fcf0c340ca46"
      unitRef="pure">0.071</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <lgnd:PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions
      contextRef="ie650f5facb7d4c908578773f98df20f6_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTU5MQ_b7172f74-4318-430b-976b-09e7ed6dda74"
      unitRef="usd">17300000</lgnd:PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ie650f5facb7d4c908578773f98df20f6_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTc0NQ_e273c12c-f533-451b-a15b-8afda5741117"
      unitRef="usd">429600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
      contextRef="i7b809d8e899c48f8b512ad46a079ce18_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTg1Ng_e36407bd-5b8b-4891-8891-afe40354416a"
      unitRef="usd">8700000</us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTA4NTg_fe703dc2-821b-4eb7-a8f1-ea8b3949d787">The following table sets forth an allocation of the preliminary purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts and unbilled receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intangibles acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,814)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(53,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;465,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is expected to be deductible for tax purposes.</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMC0xLTEtMS0w_49dd2b24-01fa-41ce-98d0-7dd63e623c27"
      unitRef="usd">51407000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMS0xLTEtMS0w_1f18ee1a-669c-4d41-bf5d-3c51b3698bc7"
      unitRef="usd">200000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMi0xLTEtMS0w_bfb1fca9-544a-4e4f-92a7-68415e6853aa"
      unitRef="usd">1359000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMy0xLTEtMS0w_426b6dde-f64d-418e-af82-85b52a735074"
      unitRef="usd">7823000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfNC0xLTEtMS0w_f6a7cdb7-f093-4ee2-9e57-7e80dc5be634"
      unitRef="usd">3070000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfNS0xLTEtMS0w_1f0fae60-da61-42bb-b140-3868a3b9e6b0"
      unitRef="usd">1338000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfNi0xLTEtMS0w_47d68d4f-2e82-41a8-91cf-c61d75cc5e06"
      unitRef="usd">385000000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets>
    <us-gaap:Goodwill
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfNy0xLTEtMS0w_3139a286-484a-4423-b345-a904be147247"
      unitRef="usd">91837000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfOC0xLTEtMS0w_2b955d2e-206c-4d4e-adeb-92aa625e0e69"
      unitRef="usd">6814000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfOS0xLTEtMS0w_853ef130-4690-4bad-b7b7-e6d02d6d4684"
      unitRef="usd">8455000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMTAtMS0xLTEtMA_3b315b4c-e086-43be-9aa1-e2c9017c7433"
      unitRef="usd">3908000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMTEtMS0xLTEtMA_2871dee7-ddad-4b64-8b3e-d187e31a939d"
      unitRef="usd">3070000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMTItMS0xLTEtMA_5d212508-051b-4f23-bf1b-161a819754b8"
      unitRef="usd">1382000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMTMtMS0xLTEtMA_c54a3c9b-9e0d-4ba9-b82c-dc1d382a63cf"
      unitRef="usd">53296000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmQ4Y2U0ODY2NWI4NDQ3ZTFiYjAyMmNhMTcyODkxZTdhL3RhYmxlcmFuZ2U6ZDhjZTQ4NjY1Yjg0NDdlMWJiMDIyY2ExNzI4OTFlN2FfMTQtMS0xLTEtMA_8083c662-beee-4219-9709-8c17a593db83"
      unitRef="usd">465109000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i0b069c2c100449aeadeb5889f43faee8_I20201001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMjU4MA_3cc51242-743b-464b-936d-a1ecb7549321"
      unitRef="usd">0</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="icce7f0fe51bb4d6a83a6b3c726ccf985_I20201001"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMjY3Nw_594fba00-79d7-457a-9ad3-4ae6ed4a306b"
      unitRef="usd">362000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i37ee9bbba7f147d591042cb6d0e8f335_I20201001"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMjcxMw_184c4fbd-080a-4778-822d-0b69b95b118b"
      unitRef="usd">23000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iede1f068bfc44082bd810dcfb2a02ad5_D20201001-20201001"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMzE5Ng_f55a686a-1ff8-4073-86b9-1d72200c1a67">P12Y10M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="i1ad6d1665fee4888888e6df28a252048_D20201001-20201001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMzU5Mw_2ddf221d-a3fc-4a55-b04a-83ab5f42ffb4"
      unitRef="number">0.12</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="i4154c45af47f4f888c6561a6c50b57a6_D20201001-20201001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMzU5OQ_2e236834-dabb-484f-8c10-1e358444e0ba"
      unitRef="number">0.15</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ie650f5facb7d4c908578773f98df20f6_D20201001-20201001"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMzczMA_40c93403-17fb-4dca-985a-19615c58f61f">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTA4NTk_2c660700-f4d0-43a6-bb5f-5f891e783748">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following summary presents our unaudited pro forma consolidated results of operations for the three and six months ended June 30, 2020 as if the Pfenex acquisition had occurred on January 1, 2020, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and share based compensation expense for retained Pfenex employees. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;br/&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net income (loss) per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i373622f14721402a91753acb36279106_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfMS0xLTEtMS0yMDY2_6a1f73f7-106c-4262-bc18-a5177dfeee22"
      unitRef="usd">42201000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ie3c7a4ec156b450fb7575fa2881109f7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfMS0xLTEtMS0w_7e30172a-f434-4d12-bfc2-ae5e15f1c069"
      unitRef="usd">76044000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i373622f14721402a91753acb36279106_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfMi0xLTEtMS0yMDY2_de391745-a924-426f-b780-309f272db74e"
      unitRef="usd">7435000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="ie3c7a4ec156b450fb7575fa2881109f7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfMi0xLTEtMS0w_21a33523-8df5-4413-ad78-b5210af263d4"
      unitRef="usd">-30505000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="i373622f14721402a91753acb36279106_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfNC0xLTEtMS0yMDYy_9ff3cb55-807d-4c02-9d49-89b5d647a800"
      unitRef="usdPerShare">0.46</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="ie3c7a4ec156b450fb7575fa2881109f7_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfNC0zLTEtMS0yMDU1_02f1f631-39d5-43c4-b198-4ee30fffed76"
      unitRef="usdPerShare">-1.87</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="i373622f14721402a91753acb36279106_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfNS0xLTEtMS0yMDYy_2b464d02-7acc-42d9-93a5-86110fc511d8"
      unitRef="usdPerShare">0.45</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="ie3c7a4ec156b450fb7575fa2881109f7_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RhYmxlOmJkODlhNmY5N2EyODQ1NTlhNjc0YmZmYzhhZWFhMDRkL3RhYmxlcmFuZ2U6YmQ4OWE2Zjk3YTI4NDU1OWE2NzRiZmZjOGFlYWEwNGRfNC0xLTEtMS0w_f8cc89e9-4682-4b65-bd40-2963fd826c65"
      unitRef="usdPerShare">-1.87</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ia9de9ff92177493894947aa870f1fdb1_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNDk2MQ_4c23172d-afd7-4918-99c8-6901924affcd"
      unitRef="usd">5100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia9de9ff92177493894947aa870f1fdb1_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNDk3Mw_39925992-6020-4b87-94b2-e00825900efb"
      unitRef="usd">4600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <lgnd:BusinessCombinationConsiderationTransferredHoldback
      contextRef="ia9de9ff92177493894947aa870f1fdb1_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNDk5MQ_942a069e-d2de-4f77-a51c-e688c5204aae"
      unitRef="usd">500000</lgnd:BusinessCombinationConsiderationTransferredHoldback>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i38e92ae2ce0a452cb6846f90bf759997_I20200909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTEzMA_2ff01b6e-0a84-41c2-a348-d477be3c31d6"
      unitRef="usd">4500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7615fe6e6d454f0fbf707d6edc90ebd9_I20200909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTIwMw_71541ab3-29f8-42c0-99f9-999ba22a9fa9"
      unitRef="usd">25000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues
      contextRef="i1190b533a86e41eca453e2df75138ff0_D20200909-20200909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTIxMQ_7dd8758a-e207-4b16-8dcc-18f95da227ee"
      unitRef="number">0.25</lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ia9de9ff92177493894947aa870f1fdb1_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTY4OQ_c01f77bd-b43e-4866-a81d-2353465a8978"
      unitRef="usd">5100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets
      contextRef="i7c18c4b370684d73aaaecae58235fa63_I20200909"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTczNw_c1a48770-2e1c-4d3d-85be-2a3ce28e6d47"
      unitRef="usd">50000.00</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i23e8adba85424e069fb3b94c160243e2_I20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTc3Nw_93af0fbb-6458-4f2c-95cf-ec0f289c27ae"
      unitRef="usd">5000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i877bb4cf5c014a2cb25d492e5c13e477_D20200909-20200909"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNTkyOQ_f5beb862-fc34-4d70-816d-5945cf568486">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7c18c4b370684d73aaaecae58235fa63_I20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjA2OA_2f3083b5-5bd1-4a2e-b262-a2be47531979"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i9b82e3c101694a14a28cf38916f0faa7_D20200908-20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjIxMQ_27d7d18c-84da-41ee-b002-d286e254c692"
      unitRef="usd">7100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <lgnd:BusinessCombinationConsiderationTransferredHoldback
      contextRef="i9b82e3c101694a14a28cf38916f0faa7_D20200908-20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjIzNQ_fec1deaa-e642-46d6-a728-eeb5db655326"
      unitRef="usd">500000</lgnd:BusinessCombinationConsiderationTransferredHoldback>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8e9a33faf4604184b79f97df731f1531_I20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjM2NA_5991e27c-4c2e-4c55-a79b-ddc78f65a576"
      unitRef="usd">5000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia125689d8b6d45c8acc8d4e04a5c8dcb_I20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjQ2MQ_f3d95fd7-bf7a-4475-9594-5fd359adb12f"
      unitRef="usd">25750000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues
      contextRef="i104be1b5412749a98d1b83af0aa45462_D20200908-20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjQ2OQ_62926eeb-c6ee-40cd-8d34-c3cc5bdab989"
      unitRef="number">0.25</lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i9b82e3c101694a14a28cf38916f0faa7_D20200908-20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNjk1Nw_4c8b0b48-5d4b-4f6f-be62-bc7483d2148b"
      unitRef="usd">7100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets
      contextRef="i54d5014ebd024ca98e929b3f83f093f0_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNzAwNQ_5e87869e-901b-4315-979f-b1ae7213b5d1"
      unitRef="usd">200000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i54d5014ebd024ca98e929b3f83f093f0_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNzA0MQ_1c2427b7-3890-4ac6-a0a0-c43f2407bcb9"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if0c763244b8f494b9e10d8327366c0ac_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNzA3Mg_3c710b16-3fcc-48f8-9dde-c1ba977bd5f6"
      unitRef="usd">7800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i54d5014ebd024ca98e929b3f83f093f0_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNzEyMg_c108fa5b-707e-47f2-99d2-957fd71581b7"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i5723a94d9eda43fb8869b9e15a4fa617_D20200908-20200908"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNzI1MA_3cac84ce-70d2-4740-8401-be91ee5319f2">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i54d5014ebd024ca98e929b3f83f093f0_I20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNzM5OQ_6aef2362-b377-4ec1-9c35-cd58f1fe6294"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency
      contextRef="ie8c72e7934ca467294335090971a29a5_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMzI5ODUzNDg5NDQ1Mg_99c426ce-7ce6-4eb5-8cb8-2fdf26763796"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency>
    <lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency
      contextRef="icf2d939c66e240b384df46c32a7696cc_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfNzQ5OQ_e3e164a8-16e0-4830-8c1e-816d4e2b11fb"
      unitRef="usd">200000</lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ie5cbd93c89514ab78b2dac40f63bcb20_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfODAzOA_d8801b92-c284-4959-8a3a-487234780af9"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ie5cbd93c89514ab78b2dac40f63bcb20_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfODExMQ_eca7cd50-fb61-48c8-ab7e-4be3b172aaab"
      unitRef="usd">19900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ie5cbd93c89514ab78b2dac40f63bcb20_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfODEyMw_9df93022-40c9-49ed-9962-91760c21e4ed"
      unitRef="usd">15100000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7603e0f422424be9889ff1051524dfb0_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfODIxMQ_72bdc013-fe8c-4759-894d-c02ed655f450"
      unitRef="usd">25000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i7603e0f422424be9889ff1051524dfb0_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfODI5OQ_65fb19ef-efe0-4ea7-8671-28af05e8d7ec"
      unitRef="usd">4800000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets
      contextRef="i7603e0f422424be9889ff1051524dfb0_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTQxNg_332fd9a1-207d-4dd0-894c-f3e28fd656c0"
      unitRef="usd">1800000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i7603e0f422424be9889ff1051524dfb0_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTQ2Ng_a81d16b2-2004-48df-b5d8-13064e40f9b4"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7603e0f422424be9889ff1051524dfb0_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTQ5Nw_8051ecdd-3d30-4544-b268-055d45c04ba5"
      unitRef="usd">12800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i7603e0f422424be9889ff1051524dfb0_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTUyOQ_c9476366-a247-410d-b6b1-721449ea9fed"
      unitRef="usd">3700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i7603e0f422424be9889ff1051524dfb0_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTY0MA_0370fc9f-b83b-4b6e-96e2-721abcf5a67d"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ie5cbd93c89514ab78b2dac40f63bcb20_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTcxMQ_5e68a8f4-0c10-438d-80dc-2af2cec1d63d"
      unitRef="usd">9000000.0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i6940e14a447b4533beb52b4a4a14f7dd_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTgxMg_d764938a-6bcd-4a36-8980-b972e53b7ded"
      unitRef="usd">11100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7aba352a45ca4f0e95b1673c0ce486b6_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfOTg0NQ_37b1d35b-1657-44e7-bf7f-3fc69a24e896"
      unitRef="usd">1700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="i0153378473074ebfa2f0f2c17278e656_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTAxNDA_e7dbd0e5-145d-4c60-93f2-ef53d87f79f9"
      unitRef="number">0.17</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i0153378473074ebfa2f0f2c17278e656_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTAyODQ_36043d0b-b2b9-4548-9f03-f64bfb4cae34">P9Y7M6D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="i34d2746d79d3442aafdf1a56d6430b2c_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTA2MTk_c7a8f3e1-7451-4216-b14f-867b8f4465a1"
      unitRef="number">0.17</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i34d2746d79d3442aafdf1a56d6430b2c_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTA3Mzk_13332049-5a72-401f-9425-ed0777bd3682">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ie5cbd93c89514ab78b2dac40f63bcb20_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80MC9mcmFnOjhmMzg2N2U3ZGU2NDQwODRhNGMwMzNhZWQ1MmYxZjZkL3RleHRyZWdpb246OGYzODY3ZTdkZTY0NDA4NGE0YzAzM2FlZDUyZjFmNmRfMTA4NTM_97536027-d5ae-450d-bd90-5558da630999">P9Y8M12D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjY4OQ_fe5a68a0-fc81-45f7-8b10-e1203653b5a6">Convertible Senior Notes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of&#160;0.75%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$248.48 per share.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than 130% of the conversion price on such trading day; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $248.48. As of June&#160;30, 2021, the &#x201c;if-converted value&#x201d; did not exceed the principal amount of the 2023 Notes. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees. The portion of these costs allocated to the liability component totaling $13.7 million is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2021, we repurchased $149.6&#160;million in principal of the 2023 Notes for $153.7 million in cash, including accrued interest of $0.3 million. We accounted for the repurchase as a debt extinguishment, which resulted in (1) a loss of $7.2 million reflected in other income (expense), net, in our condensed consolidated statement of operations for the six months ended June&#160;30, 2021, (2) a $13.5 million reduction in debt discount, and (3) a $10.2 million reduction to additional paid in capital, net of tax, related to the reacquisition of the equity component in our condensed consolidated balance sheet as of June&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Bond Hedge and Warrant Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $248.48 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp;amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, in connection with the repurchases of $104.5&#160;million in principal of the 2023 Notes for $109.1&#160;million in cash, including accrued interest of $0.2&#160;million, during the quarter ended March 31, 2021, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp;amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $16.5&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,597,750. We received $16.9&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 645,500. These unwind transactions resulted in a $0.4&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;345,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;442,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Carrying value of equity component of the 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfOTk_ad5f9808-e956-45b5-96e6-da9d09d9c6f7"
      unitRef="usd">750000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTMy_a9f8323c-938b-4405-bb1c-97d0f66b9fa8"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="iaf96b8be4ae34fa8b6593ff5e5722455_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMjg4_734a32fa-562d-429f-9f76-7dd3c6b7121b"
      unitRef="usd">733100000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjA5_bcdee17b-97a0-4689-985c-e4cacc7c32c5"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i12aec736c95f4baa8c48022ee88902a7_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfOTQy_c8af93fd-fcc5-4d0b-8ba5-bd90cb3c739a"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i12aec736c95f4baa8c48022ee88902a7_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfOTk4_f7b61b18-b06b-4758-9665-9e83e6671a66"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i12aec736c95f4baa8c48022ee88902a7_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTE5Mw_d4f4a682-542c-41bb-a86e-25cb71cedc01"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i1f99d4ba56e34f949157def3cb48d44b_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTI1OA_26a22722-2ea7-4f48-b87b-a0636b3c5b21"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i1f99d4ba56e34f949157def3cb48d44b_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTMwNw_06f0853d-c3c6-47f4-845c-de714606a28d"
      unitRef="d">10</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger
      contextRef="i1f99d4ba56e34f949157def3cb48d44b_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTQxNg_06f59d7e-e01b-43db-9d7f-c877cc93afcb"
      unitRef="number">0.98</lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTg0MA_9f3c1833-2e61-4253-9c32-04f630c9114c"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTk5Nw_f6cd0043-2d97-425b-a628-a6435e96f8c5"
      unitRef="usd">16900000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMjE3MA_c312c14a-1706-437d-9bec-442192d57c90"
      unitRef="usd">13700000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MDc3MQ_2ea21198-26a4-4f3a-ae42-1af58c4a4699"
      unitRef="usd">149600000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i63b28b3736b54b859065e5e8a9af5595_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MDgwNQ_0e0517a1-2787-4287-9eca-004ee93f95ca"
      unitRef="usd">153700000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="i63b28b3736b54b859065e5e8a9af5595_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MDgyNw_0a28593a-2f11-44cf-b73c-9a902b43708d"
      unitRef="usd">300000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i63b28b3736b54b859065e5e8a9af5595_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MDg1OQ_32213877-ba70-426d-bfc4-92ab23040a56"
      unitRef="usd">-7200000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <lgnd:IncreaseDecreaseInDebtDiscount
      contextRef="i63b28b3736b54b859065e5e8a9af5595_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MDgzOA_2d4f64e4-8626-4381-ba23-a88965541190"
      unitRef="usd">-13500000</lgnd:IncreaseDecreaseInDebtDiscount>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i63b28b3736b54b859065e5e8a9af5595_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MDg0OQ_f78a54af-393b-42f3-a0f5-f7efcc7868ed"
      unitRef="usd">-10200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMzM1MA_aac73096-fd48-4aab-ab61-44686df8098c"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMzYyNA_b1d1cc13-60d5-480d-80d0-9d7c34285d65"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <lgnd:PaymentsForConvertibleBondHedges
      contextRef="iaf96b8be4ae34fa8b6593ff5e5722455_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMzcwNw_cf44d102-ea25-415c-b2a8-36ebd57e9075"
      unitRef="usd">140300000</lgnd:PaymentsForConvertibleBondHedges>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNDYwNw_f84473cb-0001-4951-9207-7756c3a5f345"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNDY3Mw_f7a9d621-a256-4e69-86cf-01f4f70782c0"
      unitRef="usdPerShare">315.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="iaf96b8be4ae34fa8b6593ff5e5722455_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNDczMQ_68315e87-49e1-4802-b0eb-ce5c863cfa98"
      unitRef="usd">90000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i9523ea7760f1491383b68be5f294a2a0_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MjEyOQ_b6ceccc7-262d-4ad0-9e5a-673e4a0186d5"
      unitRef="usd">104500000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ib669b81f00fd49af94c6193b9b28b3e4_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MjEzMw_f01a662c-b523-4091-80eb-ac46d103c336"
      unitRef="usd">109100000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="ib669b81f00fd49af94c6193b9b28b3e4_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfMTY0OTI2NzQ1MjEzNw_ae8a15b8-2c53-4d63-ba02-c68416ddff36"
      unitRef="usd">200000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <lgnd:PaymentsToUnwindWarrants
      contextRef="i11b1244fd6124eb2b9e0ee4aa2f36ac9_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjE5NQ_aa70d577-9174-49a6-a529-c2c5a8772862"
      unitRef="usd">16500000</lgnd:PaymentsToUnwindWarrants>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i9cc9d62bc2cc48aeb870793a352d3fd8_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjMwNA_aac73096-fd48-4aab-ab61-44686df8098c"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i9523ea7760f1491383b68be5f294a2a0_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjMxMA_522d2d18-d965-4893-8a5a-9dce257c0ade"
      unitRef="shares">2597750</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <lgnd:ProceedsFromUnwindingConvertibleBondHedges
      contextRef="i11b1244fd6124eb2b9e0ee4aa2f36ac9_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjMyNg_b430bb6e-39e5-400a-a1dc-ad4899777f56"
      unitRef="usd">16900000</lgnd:ProceedsFromUnwindingConvertibleBondHedges>
    <lgnd:NumberOfOptionsUnderConvertibleBondHedges
      contextRef="i60594d6045784168a055ecf56059a566_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjQ0Nw_e6fdda17-739c-4f49-b6b6-d8e97480b57b"
      unitRef="option">645500</lgnd:NumberOfOptionsUnderConvertibleBondHedges>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i11b1244fd6124eb2b9e0ee4aa2f36ac9_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjQ5MQ_98b06135-56ff-40e5-b0b6-176813c48617"
      unitRef="usd">400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RleHRyZWdpb246ZGIzYzM4Y2RhMGQyNGUxYzg1ZjI5ODMxYjg2MDRkMjlfNjY4Nw_f4afd141-5aab-4842-8a44-4954aef845aa">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;345,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;442,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Carrying value of equity component of the 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfMS0xLTEtMS0w_dbc486d7-5366-4d4e-973a-1fb2fe71db71"
      unitRef="usd">345729000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic5ad33f4bc734bcd93b25da90e7b9a20_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfMS0zLTEtMS0w_03a827f8-fd7f-4c4d-ac0f-d673dcc7af2f"
      unitRef="usd">495280000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfMi0xLTEtMS0w_aab22db9-4497-4648-8c1b-3f85e3b88a37"
      unitRef="usd">30411000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ic5ad33f4bc734bcd93b25da90e7b9a20_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfMi0zLTEtMS0w_dc390413-fd85-4c12-83a5-e578caff2bb6"
      unitRef="usd">52987000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermNotesPayable
      contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfMy0xLTEtMS0w_258dc349-40ae-4b56-bf1a-907f8d9c54ce"
      unitRef="usd">315318000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="ic5ad33f4bc734bcd93b25da90e7b9a20_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfMy0zLTEtMS0w_d3b88f93-c41e-4980-a9c5-1413cf5e38c0"
      unitRef="usd">442293000</us-gaap:LongTermNotesPayable>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfNS0xLTEtMS0w_5870fb59-bbf2-4758-9614-ddda0442cf63"
      unitRef="usd">27776000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="ic5ad33f4bc734bcd93b25da90e7b9a20_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfNS0zLTEtMS0w_81167d49-7121-474a-9072-fe45a10b44a2"
      unitRef="usd">48397000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i68aebd079e8d43ca8aaffead3aa479b9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfNi0xLTEtMS0w_565ec1fe-4a00-460c-873d-01e0183f4276"
      unitRef="usd">341687000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="ic5ad33f4bc734bcd93b25da90e7b9a20_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80My9mcmFnOmRiM2MzOGNkYTBkMjRlMWM4NWYyOTgzMWI4NjA0ZDI5L3RhYmxlOmFiM2QxNDI0M2FiMTRmNTQ5ZjU2MDQ3MTAxNjMzYWJlL3RhYmxlcmFuZ2U6YWIzZDE0MjQzYWIxNGY1NDlmNTYwNDcxMDE2MzNhYmVfNi0zLTEtMS0w_2db88ba3-c867-4291-82d9-dea4b6ebe124"
      unitRef="usd">466053000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80OS9mcmFnOmYyZTc5NTdiNzM5NTRkOWY4ZDFkMzcwOTdjNWZjNzQxL3RleHRyZWdpb246ZjJlNzk1N2I3Mzk1NGQ5ZjhkMWQzNzA5N2M1ZmM3NDFfNzg4_d27b5a85-03c3-40e7-9d8d-6d267f58690e">Income TaxOur effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three and six months ended June&#160;30, 2021 was 7.7% and (25.0)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three and six months ended June&#160;30, 2021 was significantly impacted by tax benefits related to (1) a $34.1&#160;million Pfenex CVR adjustment recorded during the second quarter of 2021 due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR, and (2) net excess tax windfalls from share-based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period. The effective tax rate for the three and six months ended June 30, 2020 was 21.5% and 10.9%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three and six months ended June 30, 2020 were primarily attributable to the mix of earnings in the jurisdictions with lower statutory rates than the U.S. offset by tax deductions related to stock award activities and tax deductions related to foreign derived intangible income tax credits.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80OS9mcmFnOmYyZTc5NTdiNzM5NTRkOWY4ZDFkMzcwOTdjNWZjNzQxL3RleHRyZWdpb246ZjJlNzk1N2I3Mzk1NGQ5ZjhkMWQzNzA5N2M1ZmM3NDFfNDM4_2504889b-0680-47a9-b6d6-05d7a351b6cf"
      unitRef="number">0.077</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80OS9mcmFnOmYyZTc5NTdiNzM5NTRkOWY4ZDFkMzcwOTdjNWZjNzQxL3RleHRyZWdpb246ZjJlNzk1N2I3Mzk1NGQ5ZjhkMWQzNzA5N2M1ZmM3NDFfMTY0OTI2NzQ0MjQ2NQ_09a0e7e9-9a29-49f9-9863-2efdc0aa93a5"
      unitRef="number">-0.250</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i3819ef5e99824efb8df9aa305cf4213a_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80OS9mcmFnOmYyZTc5NTdiNzM5NTRkOWY4ZDFkMzcwOTdjNWZjNzQxL3RleHRyZWdpb246ZjJlNzk1N2I3Mzk1NGQ5ZjhkMWQzNzA5N2M1ZmM3NDFfMTA5OTUxMTYyOTUwOQ_65682680-be00-4c8f-b8cd-39e7fca40736"
      unitRef="usd">-34100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i22e27a20b9d4484c8767811c31740e39_D20200401-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80OS9mcmFnOmYyZTc5NTdiNzM5NTRkOWY4ZDFkMzcwOTdjNWZjNzQxL3RleHRyZWdpb246ZjJlNzk1N2I3Mzk1NGQ5ZjhkMWQzNzA5N2M1ZmM3NDFfMTY0OTI2NzQ0Mjk0Mg_162b97ac-f137-4c65-bb3f-e53a6ec3710c"
      unitRef="number">0.215</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i86fd20fc5a8e4aa3815d5653e5d348b7_D20200101-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV80OS9mcmFnOmYyZTc5NTdiNzM5NTRkOWY4ZDFkMzcwOTdjNWZjNzQxL3RleHRyZWdpb246ZjJlNzk1N2I3Mzk1NGQ5ZjhkMWQzNzA5N2M1ZmM3NDFfMTY0OTI2NzQ0Mjk1MA_8f9b16eb-eedc-499a-a591-f2d1c4a45a75"
      unitRef="number">0.109</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfMTU3NA_1c15114e-4c24-4e03-80c6-452721991ae1">Stockholders&#x2019; Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 9, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, of the Notes to Consolidated Financial Statements in our 2020 Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,561,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;318,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;164.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;171.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(533,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(83,489)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,263,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;262,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, outstanding options to purchase 1.3 million shares were exercisable with a weighted average exercise price per share of $91.50.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of June&#160;30, 2021, 46,866 shares were available for future purchases under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not have any share repurchases during the six months ended June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $500.0 million of our common stock from time to time over the next three years. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. Authorization to repurchase $248.8 million of our common stock remained available as of June&#160;30, 2021.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfMTU3Ng_5683e912-c1fa-4c63-9610-839a64ef1976">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,561,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;318,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;164.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;171.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(533,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(83,489)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,263,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;262,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfMTU3OQ_2d262738-1835-41f1-b054-8d18c1e385bc">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,561,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;318,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;164.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;171.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(533,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(83,489)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,263,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;262,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ifa6b8e5ef49e44a1a9aa9d047df544ce_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMi0xLTEtMS0w_423f962f-81fc-4923-919c-ef254bd65111"
      unitRef="shares">2561822</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ifa6b8e5ef49e44a1a9aa9d047df544ce_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMi0zLTEtMS0w_28069ee1-b206-4c2a-be0c-4107165184f7"
      unitRef="usdPerShare">85.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i6ce65c3cba6d4e1c8557dd4dafca661d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMi01LTEtMS0w_1f0bd779-dfb9-4f47-836c-a3ea1a5ebc9f"
      unitRef="shares">206202</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i6ce65c3cba6d4e1c8557dd4dafca661d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMi03LTEtMS0w_62f5cc81-566e-459e-9057-b86bd2ea65d5"
      unitRef="usdPerShare">106.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i12c4ed3b655b4b9f9e07ed3bc8c69079_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMy0xLTEtMS0w_d5e961e3-662f-4640-aca6-9c3eb0600a0b"
      unitRef="shares">318381</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i12c4ed3b655b4b9f9e07ed3bc8c69079_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMy0zLTEtMS0w_729cf240-7e1b-4009-b32d-43ca2172f4f2"
      unitRef="usdPerShare">164.30</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMy01LTEtMS0w_2e0673c8-dbef-445e-a39d-9065c70c182c"
      unitRef="shares">158456</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfMy03LTEtMS0w_b5b25f5e-9ed4-4133-806b-ebf0c9ed96a7"
      unitRef="usdPerShare">171.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i12c4ed3b655b4b9f9e07ed3bc8c69079_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNC0xLTEtMS0w_eae29d1c-b92b-4eb2-8b16-758187afd966"
      unitRef="shares">533451</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i12c4ed3b655b4b9f9e07ed3bc8c69079_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNC0zLTEtMS0w_1a28073e-1a89-4ecc-ae6c-4dddd726fba8"
      unitRef="usdPerShare">52.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNC01LTEtMS0w_0d29355c-e44d-4049-a2c0-94edf8c8732f"
      unitRef="shares">95607</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNC03LTEtMS0w_dc8a1e28-e87c-47a4-8254-d6ee0e04c853"
      unitRef="usdPerShare">126.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i12c4ed3b655b4b9f9e07ed3bc8c69079_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNS0xLTEtMS0w_72b73e53-0ba6-45a5-9787-cefb7386a258"
      unitRef="shares">83489</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i12c4ed3b655b4b9f9e07ed3bc8c69079_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNS0zLTEtMS0w_5d70424f-ba03-4375-962d-933db262ebcc"
      unitRef="usdPerShare">106.98</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNS01LTEtMS0w_1f6ffef4-d0b2-4bbe-888b-27a8605a77d7"
      unitRef="shares">6790</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ifc3149a5f83b49fe9415aee9faca7b8b_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNS03LTEtMS0w_d7136538-2bfe-48d9-aeb6-89550b26c3c3"
      unitRef="usdPerShare">126.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia96af39bd7604591ab7fc340e359673e_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNi0xLTEtMS0w_e6f79f3c-152f-40cb-bbfa-50ec16e6e7ee"
      unitRef="shares">2263263</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ia96af39bd7604591ab7fc340e359673e_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNi0zLTEtMS0w_d8d15ac2-e6cc-4eb1-8c9f-873733bf992e"
      unitRef="usdPerShare">103.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia2b7db7eef844718bf3f53433cde626e_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNi01LTEtMS0w_e9dd8063-58ea-4b92-acc8-8ef8800e9439"
      unitRef="shares">262261</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia2b7db7eef844718bf3f53433cde626e_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RhYmxlOjkxMTc4OTQ0MDUxZDQ5YjRhYzg0NmRjNjMyMjBmMDI3L3RhYmxlcmFuZ2U6OTExNzg5NDQwNTFkNDliNGFjODQ2ZGM2MzIyMGYwMjdfNi03LTEtMS0w_f3f5647b-12da-4fcd-906f-61ba91b12281"
      unitRef="usdPerShare">138.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfNDUx_8954170a-8aae-4d2a-99d3-0cd0416785f6"
      unitRef="shares">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfNTMw_34a827e6-b5d5-4b2b-babe-baa308a37405"
      unitRef="usdPerShare">91.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="i1e79a2e6b67647f882b54599c4f29c87_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfNjc5_03e0186c-d753-42de-a2dc-328183062133"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod
      contextRef="i1e79a2e6b67647f882b54599c4f29c87_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfODA2_3b182177-0a75-4f76-913b-6c35ff604556"
      unitRef="shares">46866</us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfODk1_ef1ca43e-98db-4d75-b8d0-221ee9b60d9a"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i89e8971a9fce47b4a1bcea09039305ed_I20190911"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfMTEwMA_edec14b8-6afe-4094-a17e-b94f00a327f8"
      unitRef="usd">500000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1
      contextRef="i74efa80b6d414949ba31e1e709cc19df_D20190911-20190911"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfMTE1NQ_0236afa8-901e-4e46-92a9-80745e1afb21">P3Y</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ieb2751225b4e422c8601c5b45f74edf0_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81Mi9mcmFnOmQ2ZWIyZTc3NmQwYzQ0Nzg4OTY5MGFlMDc5YWU0MmVmL3RleHRyZWdpb246ZDZlYjJlNzc2ZDBjNDQ3ODg5NjkwYWUwNzlhZTQyZWZfMTUyMg_f4db5d40-92ed-4925-a0f0-4a27fc888d34"
      unitRef="usd">248800000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81NS9mcmFnOjNiZWQxNjY2ZTJkZDRjMDA4OGFmZTYyNzIxNGM4Nzk1L3RleHRyZWdpb246M2JlZDE2NjZlMmRkNGMwMDg4YWZlNjI3MjE0Yzg3OTVfNzcyOA_dfcf3fdb-50d6-4db2-953b-dde9565549a1">Commitment and Contingencies: Legal Proceedings&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 450,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Contingencies&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 9, 2019, CyDex, our wholly-owned subsidiary, received a Paragraph IV certification Notice Letter from Alembic Global Holdings SA (&#x201c;Alembic&#x201d;) stating that Alembic had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; prior to the expiration of any of the &#x2019;077 patent; the &#x2019;088 patent, the &#x2019;582 patent, or U.S. Patent No. 10,040,872 (&#x201c;the &#x2019;872 patent&#x201d;), and alleging that these patents, each of which relates to Captisol, are invalid, unenforceable, and/or would not be infringed by Alembic&#x2019;s ANDA product. On May 23, 2019, CyDex filed a complaint against Alembic, Alembic Pharmaceuticals, Ltd., and Alembic Pharmaceuticals, Inc. in the U.S. District Court for the District of Delaware, asserting that the filing of Alembic&#x2019;s ANDA constitutes infringement of each of the &#x2019;088 patent and the &#x2019;582 patent. The parties entered into a settlement agreement on June 1, 2021 and the lawsuit has been dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 16, 2019, CyDex received a Paragraph IV certification Notice Letter from Lupin Ltd. (&#x201c;Lupin&#x201d;) stating that Lupin had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; prior to the expiration of any of the &#x2019;077 patent; the &#x2019;088 patent, the &#x2019;582 patent, or the &#x2019;872 patent, and alleging &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;that these patents, each of which relates to Captisol, are invalid, unenforceable, and/or would not be infringed by Lupin&#x2019;s ANDA product. CyDex filed a complaint on October 29, 2019, alleging patent infringement against Lupin. Lupin filed an answer on December 11, 2019 and counterclaimed for declaratory judgments of invalidity and non-infringement as to all four patents and CyDex filed its answer to Lupin&#x2019;s counterclaims on January 2, 2020. The parties entered into a settlement agreement on April 26, 2021 and the lawsuit has been dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 31, 2019, we received three civil complaints filed in the US District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#x201c;JPML&#x201d;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#x201c;MDL&#x201d;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May and August of 2019, Pfenex Inc., which was acquired by us in October 2020, filed three petitions (IPR2019- 01027, IPR2019-01028 and IPR2019-01478) for inter partes review of U.S. Patent No. 9,422,345 (&#x201c;the &#x2018;345 patent,&#x201d; entitled &#x201c;Expression System&#x201d;), which is owned by GlaxoSmithKline Biologicals S.A. (&#x201c;GSK&#x201d;), with the Patent Trial and Appeal Board (&#x201c;PTAB&#x201d;) of the U.S. Patent and Trademark Office. In November 2019 and February 2020, the Board instituted trial on invalidity grounds in IPR2019-01028, but exercised its discretion not to institute trial on IPR2019-01027 or IPR2019-01478. In May 2020, GSK filed two petitions (IPR2020-00890 and IPR2020-00962) for inter partes review of U.S. Patent No. 8,530,171 (&#x201c;the &#x2018;171 patent,&#x201d; entitled &#x201c;High Level Expression of Recombinant Toxin Proteins&#x201d;), which is owned by Pfenex, with the PTAB of the U.S. Patent and Trademark Office. On June 29, 2020, GSK filed a motion to withdraw IPR2020-00890, which was granted on August 28, 2020. In October 2020, Pfenex and GSK executed a confidential settlement agreement agreeing to terminate the proceedings before the PTAB resolving these issues. Pfenex and GSK filed a joint motion to terminate IPR2019-01028 and IPR2020-00962 on October 30, 2020, and an amended joint motion to terminate on November 4, 2020. A decision granting the parties&#x2019; joint motion to terminate in IPR2019-01028 was issued on November 12, 2020. The PTAB subsequently granted the parties&#x2019; joint motion to terminate in IPR2020-00962 on December 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 12, 2021, Abvivo submitted a JAMS arbitration demand naming the Company as respondent. Abvivo claimed that the Company was in violation of the assignment provision of that certain Commercial Platform License and Services Agreement (&#x201c;CPLSA&#x201d;), dated October 9, 2019, by and among OMT and Crystal, on the one hand, and Abvivo, on the other hand because the Company allegedly withheld its consent to a proposed assignment required for Abvivo to negotiate a discovery and development alliance with certain third parties. On January 26, 2021, we submitted a response to the demand, denying all claims and alleging counterclaims against Abvivo and Brian Lundstrom, a Company employee and the sole owner of Abvivo. We alleged that Mr. Lundstrom breached his fiduciary duty of loyalty to the Company and that Abvivo and Mr. Lundstrom fraudulently induced the Company, OMT and Crystal into certain business transactions and contracts. Abvivo and Mr. Lundstrom&#x2019;s response to these counterclaims was due on February 9, 2021, but they did not submit a response. Under JAMS rules, the counterclaims were deemed denied. On February 22, 2021, Abvivo submitted documents to JAMS which indicated that it sought to dismiss its claim without prejudice. On February 25, 2021, we submitted additional counterclaims against Abvivo and Mr. Lundstrom.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These counterclaims alleged that Abvivo and Mr. Lundstrom made false promises regarding the CPLSA, Abvivo&#x2019;s breach of and failure to perform under the CPLSA, and Abvivo&#x2019;s infringement of certain Ligand trademarks.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 11, 2021, Abvivo and Mr. Lundstrom submitted an answer to our amended counterclaims denying all of the claims and asserting various affirmative defenses. On June 21, 2021, the parties executed a confidential settlement agreement that settled all claims in this arbitration.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 29, 2021, the parties jointly submitted to JAMS a dismissal with prejudice of all claims by all parties in the arbitration.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CyDex and Baxter Healthcare Corp. (&#x201c;Baxter&#x201d;) are parties to a license agreement relating to Ligand&#x2019;s Captisol&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;technology and, more specifically, relating to Captisol-enabled Nexterone (amiodarone HCl premixed injection). Baxter contends that it has overpaid royalties for several years, and seeks both refunds of those overpayment and a reduced royalty going forward. CyDex contends that Baxter has not paid the royalties due to CyDex under the terms of the license agreement. On April 6, 2021, Baxter initiated an arbitration with the American Arbitration Association pursuant to the arbitration provision of the license agreement. On April 21, 2021, CyDex filed an Answering Statement and Counterdemand. On May 5, 2021, Baxter filed an Answering Statement in response to CyDex&#x2019;s Counterdemand. On June 30, 2021, the parties&#x2019; held a Preliminary Hearing before the arbitrator. The arbitration is in its early stages.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber
      contextRef="i3d23921891db45d19e297bbe9bbe585a_D20191029-20191029"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81NS9mcmFnOjNiZWQxNjY2ZTJkZDRjMDA4OGFmZTYyNzIxNGM4Nzk1L3RleHRyZWdpb246M2JlZDE2NjZlMmRkNGMwMDg4YWZlNjI3MjE0Yzg3OTVfMzM4Nw_8b657981-58c7-4f36-b812-039e28eac9c5"
      unitRef="patent">4</us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i90fc81e184454d969b54196ebc6b39a6_D20191031-20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81NS9mcmFnOjNiZWQxNjY2ZTJkZDRjMDA4OGFmZTYyNzIxNGM4Nzk1L3RleHRyZWdpb246M2JlZDE2NjZlMmRkNGMwMDg4YWZlNjI3MjE0Yzg3OTVfMzYwNg_991bb2ac-4315-4e10-bb83-94437ea65e75"
      unitRef="civil_complaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i90fc81e184454d969b54196ebc6b39a6_D20191031-20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81NS9mcmFnOjNiZWQxNjY2ZTJkZDRjMDA4OGFmZTYyNzIxNGM4Nzk1L3RleHRyZWdpb246M2JlZDE2NjZlMmRkNGMwMDg4YWZlNjI3MjE0Yzg3OTVfNDE5MQ_6a1ffe06-24a3-45a1-9d85-8676444ea26b"
      unitRef="civil_complaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <lgnd:NumberOfPetitionsFiled
      contextRef="i89c035f5c0114d94bb9957d60b37cba3_D20190501-20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81NS9mcmFnOjNiZWQxNjY2ZTJkZDRjMDA4OGFmZTYyNzIxNGM4Nzk1L3RleHRyZWdpb246M2JlZDE2NjZlMmRkNGMwMDg4YWZlNjI3MjE0Yzg3OTVfNDM4OA_b6cfbe3a-dd98-44e2-9ab2-7a013d48ce70"
      unitRef="petition">3</lgnd:NumberOfPetitionsFiled>
    <lgnd:NumberOfPetitionsFiled
      contextRef="i8a9e8cc6b16b4c0e8960c2d7f31c2aaa_D20200501-20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzNDg0MTM0MWQ4ZjQ2MjA4NDNkMGY2ZmI1ZTkzMWQxL3NlYzo5MzQ4NDEzNDFkOGY0NjIwODQzZDBmNmZiNWU5MzFkMV81NS9mcmFnOjNiZWQxNjY2ZTJkZDRjMDA4OGFmZTYyNzIxNGM4Nzk1L3RleHRyZWdpb246M2JlZDE2NjZlMmRkNGMwMDg4YWZlNjI3MjE0Yzg3OTVfNDkxOA_adde9308-180c-4282-a403-2cb26f82922c"
      unitRef="petition">2</lgnd:NumberOfPetitionsFiled>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958078385928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jul. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGAND PHARMACEUTICALS INCORPORATED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0160744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5980 Horton Street, Suite 405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Emeryville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">550-7500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LGND<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,676,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember', window );">Former Address</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3911 Sorrento Valley Boulevard, Suite 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958078251800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 21,863<span></span>
</td>
<td class="nump">$ 47,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">279,972<span></span>
</td>
<td class="nump">363,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">58,156<span></span>
</td>
<td class="nump">56,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">39,946<span></span>
</td>
<td class="nump">26,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">4,694<span></span>
</td>
<td class="nump">2,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">6,270<span></span>
</td>
<td class="nump">3,822<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">410,901<span></span>
</td>
<td class="nump">500,559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes, net</a></td>
<td class="nump">27,882<span></span>
</td>
<td class="nump">24,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">572,006<span></span>
</td>
<td class="nump">595,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">190,517<span></span>
</td>
<td class="nump">189,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseRights', window );">Commercial license and other economic rights, net</a></td>
<td class="nump">10,638<span></span>
</td>
<td class="nump">10,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">17,628<span></span>
</td>
<td class="nump">14,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">6,500<span></span>
</td>
<td class="nump">6,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Financing lease right-of-use assets</a></td>
<td class="nump">17,383<span></span>
</td>
<td class="nump">15,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">2,828<span></span>
</td>
<td class="nump">4,267<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,256,283<span></span>
</td>
<td class="nump">1,362,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">17,273<span></span>
</td>
<td class="nump">3,784<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">10,107<span></span>
</td>
<td class="nump">18,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights', window );">Current contingent liabilities</a></td>
<td class="nump">5,650<span></span>
</td>
<td class="nump">39,884<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">17,147<span></span>
</td>
<td class="nump">29,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">2,275<span></span>
</td>
<td class="nump">1,885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current financing lease liabilities</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">6,593<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">52,497<span></span>
</td>
<td class="nump">100,111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">2023 convertible senior notes, net</a></td>
<td class="nump">315,318<span></span>
</td>
<td class="nump">442,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LiabilityForContingentValueRights', window );">Long-term contingent liabilities</a></td>
<td class="nump">9,121<span></span>
</td>
<td class="nump">9,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes, net</a></td>
<td class="nump">60,053<span></span>
</td>
<td class="nump">64,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">4,771<span></span>
</td>
<td class="nump">5,643<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">28,006<span></span>
</td>
<td class="nump">30,866<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">469,766<span></span>
</td>
<td class="nump">652,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at June&#160;30, 2021 and December&#160;31, 2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 60,000 shares authorized; 16,676 and 16,080 shares issued and outstanding at June&#160;30, 2021 and December&#160;31, 2020, respectively</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">346,578<span></span>
</td>
<td class="nump">318,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(861)<span></span>
</td>
<td class="num">(801)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">440,783<span></span>
</td>
<td class="nump">391,952<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">786,517<span></span>
</td>
<td class="nump">709,525<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 1,256,283<span></span>
</td>
<td class="nump">$ 1,362,285<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CurrentPortionOfLiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958081869816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (shares)</a></td>
<td class="nump">60,000,000<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (shares)</a></td>
<td class="nump">16,676,000<span></span>
</td>
<td class="nump">16,080,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (shares)</a></td>
<td class="nump">16,676,000<span></span>
</td>
<td class="nump">16,080,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958178409720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 84,675<span></span>
</td>
<td class="nump">$ 41,420<span></span>
</td>
<td class="nump">$ 139,825<span></span>
</td>
<td class="nump">$ 74,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostDirectMaterial', window );">Cost of Captisol</a></td>
<td class="nump">30,593<span></span>
</td>
<td class="nump">7,644<span></span>
</td>
<td class="nump">38,746<span></span>
</td>
<td class="nump">12,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of intangibles</a></td>
<td class="nump">11,779<span></span>
</td>
<td class="nump">3,875<span></span>
</td>
<td class="nump">23,565<span></span>
</td>
<td class="nump">7,410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">15,953<span></span>
</td>
<td class="nump">12,732<span></span>
</td>
<td class="nump">33,832<span></span>
</td>
<td class="nump">24,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">14,711<span></span>
</td>
<td class="nump">10,069<span></span>
</td>
<td class="nump">27,028<span></span>
</td>
<td class="nump">19,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncome', window );">Other operating income</a></td>
<td class="num">(34,100)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(33,800)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">38,936<span></span>
</td>
<td class="nump">34,320<span></span>
</td>
<td class="nump">89,371<span></span>
</td>
<td class="nump">63,693<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">45,739<span></span>
</td>
<td class="nump">7,100<span></span>
</td>
<td class="nump">50,454<span></span>
</td>
<td class="nump">10,888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Gain (loss) from short-term investments</a></td>
<td class="num">(6,864)<span></span>
</td>
<td class="nump">23,460<span></span>
</td>
<td class="nump">6,197<span></span>
</td>
<td class="num">(7,281)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">233<span></span>
</td>
<td class="nump">1,969<span></span>
</td>
<td class="nump">529<span></span>
</td>
<td class="nump">6,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(4,883)<span></span>
</td>
<td class="num">(6,213)<span></span>
</td>
<td class="num">(10,714)<span></span>
</td>
<td class="num">(14,761)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(924)<span></span>
</td>
<td class="nump">1,803<span></span>
</td>
<td class="num">(7,401)<span></span>
</td>
<td class="nump">2,159<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (loss), net</a></td>
<td class="num">(12,438)<span></span>
</td>
<td class="nump">21,019<span></span>
</td>
<td class="num">(11,389)<span></span>
</td>
<td class="num">(13,184)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes</a></td>
<td class="nump">33,301<span></span>
</td>
<td class="nump">28,119<span></span>
</td>
<td class="nump">39,065<span></span>
</td>
<td class="num">(2,296)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(2,576)<span></span>
</td>
<td class="num">(6,033)<span></span>
</td>
<td class="nump">9,766<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 30,725<span></span>
</td>
<td class="nump">$ 22,086<span></span>
</td>
<td class="nump">$ 48,831<span></span>
</td>
<td class="num">$ (2,045)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 1.84<span></span>
</td>
<td class="nump">$ 1.38<span></span>
</td>
<td class="nump">$ 2.95<span></span>
</td>
<td class="num">$ (0.13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in basic per share calculations (in shares)</a></td>
<td class="nump">16,659<span></span>
</td>
<td class="nump">16,055<span></span>
</td>
<td class="nump">16,548<span></span>
</td>
<td class="nump">16,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 1.79<span></span>
</td>
<td class="nump">$ 1.32<span></span>
</td>
<td class="nump">$ 2.84<span></span>
</td>
<td class="num">$ (0.13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in diluted per share calculations (in shares)</a></td>
<td class="nump">17,172<span></span>
</td>
<td class="nump">16,694<span></span>
</td>
<td class="nump">17,210<span></span>
</td>
<td class="nump">16,292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 8,616<span></span>
</td>
<td class="nump">$ 7,181<span></span>
</td>
<td class="nump">$ 15,728<span></span>
</td>
<td class="nump">$ 13,746<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">62,509<span></span>
</td>
<td class="nump">24,468<span></span>
</td>
<td class="nump">93,781<span></span>
</td>
<td class="nump">45,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 13,550<span></span>
</td>
<td class="nump">$ 9,771<span></span>
</td>
<td class="nump">$ 30,316<span></span>
</td>
<td class="nump">$ 15,258<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostDirectMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of material used for good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostDirectMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958077107064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss):</a></td>
<td class="nump">$ 30,725<span></span>
</td>
<td class="nump">$ 22,086<span></span>
</td>
<td class="nump">$ 48,831<span></span>
</td>
<td class="num">$ (2,045)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net gain (loss) on available-for-sale securities, net of tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">2,742<span></span>
</td>
<td class="num">(60)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(185)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,064)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">$ 30,720<span></span>
</td>
<td class="nump">$ 24,643<span></span>
</td>
<td class="nump">$ 48,771<span></span>
</td>
<td class="num">$ (4,139)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958157376728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional paid in capital</div></th>
<th class="th"><div>Accumulated other comprehensive loss</div></th>
<th class="th"><div>Retained earnings (Accumulated deficit)</div></th>
<th class="th">
<div>Retained earnings (Accumulated deficit) </div>
<div>Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,823,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="nump">$ 767,232,000<span></span>
</td>
<td class="num">$ (5,167,000)<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">$ 367,326,000<span></span>
</td>
<td class="num">$ (216,000)<span></span>
</td>
<td class="nump">$ 400,105,000<span></span>
</td>
<td class="num">$ (5,167,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="num">(1,008,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,008,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">5,653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(878,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(73,287,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="num">(73,286,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(2,772,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,772,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment', window );">Foreign currency translation adjustment</a></td>
<td class="num">(1,879,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,879,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(2,745,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,745,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(24,131,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,131,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2020</a></td>
<td class="nump">661,896,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">295,940,000<span></span>
</td>
<td class="num">(4,867,000)<span></span>
</td>
<td class="nump">370,807,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,823,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="nump">767,232,000<span></span>
</td>
<td class="num">$ (5,167,000)<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">367,326,000<span></span>
</td>
<td class="num">(216,000)<span></span>
</td>
<td class="nump">400,105,000<span></span>
</td>
<td class="num">$ (5,167,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(2,045,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,071,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2020</a></td>
<td class="nump">695,003,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">304,404,000<span></span>
</td>
<td class="num">(2,310,000)<span></span>
</td>
<td class="nump">392,893,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2020</a></td>
<td class="nump">661,896,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">295,940,000<span></span>
</td>
<td class="num">(4,867,000)<span></span>
</td>
<td class="nump">370,807,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="nump">1,128,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,128,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">7,359,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,359,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="nump">2,742,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,742,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment', window );">Foreign currency translation adjustment</a></td>
<td class="num">(185,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(185,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Adjustment on reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(23,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">22,086,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,086,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,071,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2020</a></td>
<td class="nump">695,003,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">304,404,000<span></span>
</td>
<td class="num">(2,310,000)<span></span>
</td>
<td class="nump">392,893,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,080,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">709,525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">318,358,000<span></span>
</td>
<td class="num">(801,000)<span></span>
</td>
<td class="nump">391,952,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">572,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="nump">20,581,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">20,580,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">8,405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(55,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(9,086,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,086,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions', window );">Warrant and bond hedge unwind transactions</a></td>
<td class="nump">396,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions', window );">Tax effect for 2023 Notes transactions</a></td>
<td class="num">(2,032,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,032,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">18,106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,652,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2021</a></td>
<td class="nump">745,840,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">336,621,000<span></span>
</td>
<td class="num">(856,000)<span></span>
</td>
<td class="nump">410,058,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,080,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">709,525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">318,358,000<span></span>
</td>
<td class="num">(801,000)<span></span>
</td>
<td class="nump">391,952,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">48,831,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,676,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="nump">786,517,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">346,578,000<span></span>
</td>
<td class="num">(861,000)<span></span>
</td>
<td class="nump">440,783,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,652,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2021</a></td>
<td class="nump">745,840,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">336,621,000<span></span>
</td>
<td class="num">(856,000)<span></span>
</td>
<td class="nump">410,058,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="nump">1,103,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,103,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">10,216,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,216,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(1,073,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,073,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions', window );">Tax effect for 2023 Notes transactions</a></td>
<td class="num">(289,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(289,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">30,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,676,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="nump">$ 786,517,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">$ 346,578,000<span></span>
</td>
<td class="num">$ (861,000)<span></span>
</td>
<td class="nump">$ 440,783,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958163636088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 48,831<span></span>
</td>
<td class="num">$ (2,045)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights', window );">Change in estimated fair value of contingent liabilities</a></td>
<td class="num">(33,502)<span></span>
</td>
<td class="num">(371)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">25,179<span></span>
</td>
<td class="nump">7,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premium (discount) on investments, net</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">1,198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance fees</a></td>
<td class="nump">9,073<span></span>
</td>
<td class="nump">12,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AmortizationOfOtherEconomicRights', window );">Amortization of commercial license and other economic rights</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">2,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss (gain) on debt extinguishment</a></td>
<td class="nump">7,175<span></span>
</td>
<td class="num">(659)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">18,621<span></span>
</td>
<td class="nump">13,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="num">(9,766)<span></span>
</td>
<td class="num">(8,890)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_GainLossOnShortTermInvestments', window );">Loss (gain) from short-term investments</a></td>
<td class="num">(6,197)<span></span>
</td>
<td class="nump">7,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">595<span></span>
</td>
<td class="num">(1,499)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(2,659)<span></span>
</td>
<td class="num">(11,466)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(2,326)<span></span>
</td>
<td class="nump">6,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(4,340)<span></span>
</td>
<td class="nump">2,909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax receivable and payable</a></td>
<td class="num">(2,477)<span></span>
</td>
<td class="nump">8,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(14,605)<span></span>
</td>
<td class="nump">7,268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities</a></td>
<td class="num">(2,786)<span></span>
</td>
<td class="num">(4,128)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">31,131<span></span>
</td>
<td class="nump">41,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="num">(96,136)<span></span>
</td>
<td class="num">(336,726)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from sale of short-term investments</a></td>
<td class="nump">150,648<span></span>
</td>
<td class="nump">179,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">34,600<span></span>
</td>
<td class="nump">452,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisition, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(15,140)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(4,794)<span></span>
</td>
<td class="num">(791)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">84,453<span></span>
</td>
<td class="nump">281,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repurchase of 2023 Notes</a></td>
<td class="num">(153,381)<span></span>
</td>
<td class="num">(203,210)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments under financing lease obligations</a></td>
<td class="num">(9,188)<span></span>
</td>
<td class="num">(1,134)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeFinancingActivities', window );">Proceeds from convertible bond hedge settlement</a></td>
<td class="nump">16,855<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeFinancingActivities', window );">Payments to convertible bond holders for warrant purchases</a></td>
<td class="num">(16,459)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Net proceeds from stock option exercises and ESPP</a></td>
<td class="nump">27,584<span></span>
</td>
<td class="nump">1,550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(5,901)<span></span>
</td>
<td class="num">(1,429)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Share repurchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(73,287)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity', window );">Payments to CVR Holders</a></td>
<td class="num">(1,050)<span></span>
</td>
<td class="num">(1,800)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(141,540)<span></span>
</td>
<td class="num">(279,310)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(160)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(25,956)<span></span>
</td>
<td class="nump">43,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">47,963<span></span>
</td>
<td class="nump">72,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">22,007<span></span>
</td>
<td class="nump">115,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">1,737<span></span>
</td>
<td class="nump">2,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Taxes paid</a></td>
<td class="nump">3,552<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash in other current assets</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental schedule of non-cash activity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accrued fixed asset purchases</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedInventoryPurchases', window );">Accrued inventory purchases</a></td>
<td class="nump">12,695<span></span>
</td>
<td class="nump">3,553<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss on AFS investments</a></td>
<td class="num">$ (60)<span></span>
</td>
<td class="num">$ (38)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedInventoryPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Inventory Purchases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedInventoryPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AmortizationOfOtherEconomicRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AmortizationOfOtherEconomicRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_GainLossOnShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Short-term Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_GainLossOnShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders, Financing Activity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHoldersFinancingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958073253960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2020 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#8220;contract revenue&#8221; and &#8220;service revenue&#8221; presented in the condensed consolidated statement of operations for the three and six months ended June&#160;30, 2021 have been combined into &#8220;contract revenue&#8221; in the condensed consolidated statement of operations to conform with the current period presentation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2020 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19 Pandemic</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current COVID-19 worldwide pandemic has presented substantial public health and economic challenges and is affecting our employees and partners, patients, communities and business operations, as well as the U.S. and global economy and financial markets. International and U.S. governmental authorities in impacted regions have taken actions in an effort to slow the spread of COVID-19, including issuing varying forms of &#8220;stay-at-home&#8221; orders, and restricting business functions outside of one&#8217;s home. In response, we have restricted in-person access to our executive offices, our administrative employees are mostly working remotely, and we have limited the number of staff in our research and development laboratories and other facilities. The continued spread of the COVID-19 pandemic and the measures taken by the governments of countries have affected, and could continue to affect, our business and the business of our partners, including future disruptions to our supply chain and the manufacture or shipment of drug substance and finished drug product for Captisol, delays by us or our partners in the initiation or enrollment of patients in clinical trials, discontinuations by patients enrolled in clinical trials, difficulties launching or commercializing products and other related activities, which could delay ongoing clinical trials, increase development costs, reduce royalty revenues and have a material adverse effect on our business, financial condition and results of operations. Several of our partners have reported that their operations have been impacted including delays in research and development programs and deprioritizing clinical trials in favor of treating patients who have contracted the virus or to prevent the spread of the virus. This may lead to clinical trial protocol deviations or to discontinuation of treatment for patients who are currently enrolled in the clinical trials being conducted by us or our partners. In addition, certain of our partners have reported negative impacts on product sales which will impact our royalty revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our partners are working to develop drugs to treat COVID-19. For example, we are supplying Captisol to partners, including Gilead and the Gilead consortium (a consortium of manufacturing partners that Gilead is working with to bring efforts together to help maximize global supply) for remdesivir, the first FDA-approved treatment for COVID-19 for the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">treatment of patients with COVID-19 requiring hospitalization. In addition, certain of our OmniAb partners have initiated antibody discovery programs for the potential treatment of COVID-19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, the businesses of our partners, our results of operations and our financial condition will depend on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning COVID-19, the actions taken to contain it or treat its impact, including the timing and extent of governments reopening or further restricting activities, the emergence and spread of COVID-19 variants, and the economic impact on local, regional, national and international markets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#8217;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures. We intend to adopt this standard on January 1, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment.  These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Captisol Sales</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three and six months ended June&#160;30, 2021, the amount recognized as revenue that was previously deferred was $10.3 million, and $16.1 million, respectively. During the three and six months ended June&#160;30, 2020, the amount recognized as revenue that was previously deferred was $2.0 million and $2.4 million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,771&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,316&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,258&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,675&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,420&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139,825&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,581&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at June&#160;30, 2021 and December 31, 2020 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:21.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.410%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.509%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.359%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.909%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.359%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.509%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.659%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(310)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Treasury bill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,039&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(315)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,749&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,391)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,972&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363,567&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2021, we exercised all outstanding Viking warrants to purchase 1.5 million shares of Viking's common stock at an exercise price of $1.50 per share. As of June&#160;30, 2021, we have zero Viking warrants outstanding.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three and six months ended June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,283&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,366&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of seven positions which were in an unrealized loss position as of June&#160;30, 2021. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three and six months ended June&#160;30, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three and six months ended June&#160;30, 2021, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the COVID-19 pandemic on our business and recorded an adjustment of $0.04&#160;million and $0.1 million of allowance for credit losses, respectively, as of June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of prepaid inventory and finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2021, we have made advanced payments for inventory from our supplier of Captisol totaling $50.2&#160;million. We have applied credits for such inventory purchases of $15.8&#160;million and will utilize the remaining advanced payments to offset a portion of the purchase price for future Captisol purchases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,378)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,932)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,597)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">762,523&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">784,992&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial License and Other Economic Rights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license and other economic rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,470)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,226</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,588)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,412</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,731)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,871</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,660)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,638</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,319)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,979</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.0 million as of June&#160;30, 2021.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.3 million and credit loss adjustments of $6.0 million as of December&#160;31, 2020.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license and other economics rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis in April 2013 and April 2015, CorMatrix in May 2016, and Dianomi in January 2019. Commercial license rights acquired are accounted for as financial assets and other economic rights are accounted for as funded research and development as further discussed below and in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in our 2020 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2017, we entered into a Royalty Agreement with Aziyo pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. We account for the Aziyo commercial license right as a financial asset, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, we amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the Royalty Agreement with Aziyo as of June&#160;30, 2021 is 23%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received during the six months ended June&#160;30, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to 2020, we accounted for commercial license rights related to developmental pipeline products such as Selexis and Dianomi on a non-accrual basis. We continue to account for commercial license rights related to Dianomi on a non-accrual basis as of June&#160;30, 2021, but starting in 2020, given the expected cash flow from the Selexis program, we started to account for the Selexis commercial license right as a financial asset in accordance with ASC 310, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Selexis as of June&#160;30, 2021 is 21%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received during the six months ended June&#160;30, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We recorded a $5.5 million pre-tax reserve for credit losses upon adoption of the credit losses standard (ASU 2016-13) on January 1, 2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the six months ended June&#160;30, 2021, we further considered the current and expected future economic and market conditions surrounding novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accrued Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,107&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,530&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period until the last tranche vests. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,216&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,359&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,621&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,012&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,832&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,684&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,988&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2020, all of the 0.6&#160;million weighted average shares of outstanding equity awards as of June&#160;30, 2020 were anti-dilutive due to the net loss for the period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958167689528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">239,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">279,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">363,567&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pfenex contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,930&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,841&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,802&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,312&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Investment in Viking warrants, which we received as a result of Viking&#8217;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. During the six months ended June&#160;30, 2021, we exercised all of the outstanding Viking warrants. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the six months ended June&#160;30, 2021, we paid $1.1&#160;million contingent liability based on revenue milestones to former Icagen shareholders.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Pfenex contingent liabilities was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of the Company. During the three and six months ended June&#160;30, 2021, we reduced the contingent liability by $34.1&#160;million and $33.8&#160;million, respectively, primarily due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR. See further detail on Pfenex CVR in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Note 3, Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the first quarter of 2021, management recorded an earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of June&#160;30, 2021 is as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33,661)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of June&#160;30, 2021</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,841&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="text-indent:22pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the second quarter of 2021, in connection with the Pfenex CVR fair value evaluation, we also evaluated the related indefinite-lived contractual relationship intangible for recoverability and concluded there was no impairment.</span></div>Other than the above mentioned triggering event, there were no other triggering events identified and no indication of impairment of our goodwill, indefinite-lived intangible assets, or long-lived assets during the three and six months ended June&#160;30, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958073120232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">Acquisitions<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Pfenex Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On October 1, 2020, we acquired Pfenex, which develops next-generation and novel protein therapeutics to improve existing therapies and create new therapies for biological targets linked to critical, unmet diseases using a protein expression technology platform.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preliminary purchase price of $465.1&#160;million included $429.6&#160;million cash consideration paid upon acquisition, and a contingent CVR payment of up to $77.8&#160;million in cash based on a certain specified milestone with an estimated initial fair value of $37.0&#160;million. The CVR will only be paid in full if the milestone is achieved by December&#160;31, 2021. The amount of the CVR included in the purchase price was reduced by $1.5&#160;million that was determined to be post-combination expense. The fair value of the CVR liability was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on market participants' cost of debt reflective of the Company, which was 7.1%. The liability is periodically assessed based on events and circumstances related to the underlying milestone, and any change in fair value is recorded in our consolidated statements of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the acquisition, a portion of Pfenex's equity awards that were outstanding and unvested prior to the acquisition became fully vested per the terms of the merger agreement. The acceleration of vesting required us to allocate the fair value of the equity attributable to pre-combination service to the purchase price and the remaining amount was considered our post-combination expense. We paid $17.3&#160;million in cash for equity compensation, which is attributable to pre-combination services and is reflected as a component of the total purchase price paid of $429.6&#160;million. In addition, the fair value of equity compensation attributable to the post-combination service period was $8.7&#160;million. These amounts were associated with the accelerated vesting of stock options previously granted to Pfenex employees and were fully paid in cash, which was recognized as general and administrative expenses during the fourth quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table sets forth an allocation of the preliminary purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts and unbilled receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangibles acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,814)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,455)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,382)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(53,296)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">465,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is expected to be deductible for tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired intangibles include $362&#160;million of contractual relationships and $23&#160;million of core technology. The fair values of the contractual relationships were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated contractual relationship period. The fair value of the contractual relationships is being amortized on a straight-line basis over the weighted average estimated useful life of 12.9 years. The fair values of the acquired technologies were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated useful lives. These projected cash flows were discounted to present value using discount rate, which varies from 12% to 15%. The total acquired intangibles are being amortized on a straight-line basis over the weighted average estimated useful life of 13.0 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The estimated fair values of assets acquired and liabilities assumed, including deferred tax assets and liabilities, and purchased intangibles are provisional. The accounting for these amounts falls within the measurement period and therefore we may adjust these provisional amounts to reflect new information obtained about facts and circumstances that existed as of the acquisition date.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following summary presents our unaudited pro forma consolidated results of operations for the three and six months ended June 30, 2020 as if the Pfenex acquisition had occurred on January 1, 2020, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and share based compensation expense for retained Pfenex employees. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,505)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Taurus Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 9, 2020, we acquired Taurus, which discovers and develops novel antibodies from immunized cows and cow-derived libraries. The purchase price of $5.1 million included $4.6 million in cash, and a $0.5 million holdback to satisfy indemnification obligations which will be settled by September 2021.  We also issued nontransferable CVRs for up to $4.5 million tied to partnered and internal research and development and for up to $25.0 million as a 25% share of post-clinical Taurus product revenues (including milestone payments) received by us. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of Taurus met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accordingly, we accounted for this transaction as an asset acquisition. Of the $5.1 million consideration transferred, we recognized (1) $0.05 million of tangible assets acquired, and (2) $5.0 million of core completed technology intangibles acquired. The core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. We account for the CVRs in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. None of the CVRs are recognized as of June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">xCella Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 8, 2020, we acquired xCella, an antibody discovery company. We paid $7.1 million in cash (including a $0.5 million holdback to satisfy indemnification obligations which will be settled by September 2021), and issued earnout rights for up to $5.0 million tied to our use of the xCella technology for partnered research and development and for up to $25.75 million as a 25% share of any future milestone payments we received under a certain existing xCella partner arrangement. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of xCella met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $7.1 million consideration transferred, we recognized (1) $0.2 million of tangible assets acquired, (2) $(0.1) million of liabilities assumed, (3) $7.8 million of core completed technology acquired, and (4) $(0.8) million of deferred tax liability. The core technology is being amortized on a straight-line basis over the estimated useful life of 15 years. We account for the earnout rights in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. None of the earnout rights are recognized as of the acquisition date. During the three months ended June&#160;30, 2021, no contingencies were resolved during the period. During the six months ended June&#160;30, 2021, we recognized $0.2 million in earnout rights when certain contingencies were resolved during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Icagen Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2020, we acquired the core assets, including its partnered programs and ion channel technology, from Icagen and certain of its affiliates. The acquisition was accounted for as a business combination and we applied the acquisition method of accounting. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. We did not incur any material acquisition-related costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purchase price of $19.9 million included $15.1 million cash consideration paid upon acquisition, and a contingent earn-out payment of up to $25.0&#160;million of cash payments based on certain revenue milestones with an estimated fair value of $4.8 million. The fair value of the earn-out liability was determined using a probability weighted income approach incorporating the estimated future cash flows from expected future milestones. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of Icagen. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 2, Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, for further discussion. The liability will be periodically assessed based on events and circumstances related to the underlying milestones, and any change in fair value will be recorded in our consolidated statements of operations. The carrying amount of the liability may fluctuate significantly and actual amount paid may be materially different than the carrying amount of the liability. As the acquisition is not considered significant, pro forma information has not been provided. The results of Icagen have been included in our results of operations since the date of acquisition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The allocation of the purchase price consisted of (1) $1.8 million of fair value of tangible assets acquired, (2) $(0.8) million of liabilities assumed, (3) $12.8 million of acquired intangibles, (4) $(3.7) million of deferred revenue in connection with assumed performance obligations under a collaboration agreement, (5) $0.8 million of deferred tax asset associated with the deferred revenue, and (6) $9.0 million of goodwill, the majority of which is deductible for tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired intangibles include $11.1 million of customer relationships and $1.7 million of core technology. The fair values of the customer relationships were based on a discounted cash flow analysis incorporating the estimated future cash flows from these relationships during the contractual term. These cash flows were then discounted to present value using a discount rate of 17%. The fair value of the customer relationships is being amortized on a straight-line basis over the weighted average estimated useful life of 9.6 years. The fair value of the core technology was based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, and collaboration revenue streams derived from the licensing of the related technologies. These projected cash flows were discounted to present value using a discount rate of 17%. The fair value of the core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. The total acquired intangibles are being amortized on a straight-line basis over the estimated useful life of 9.7 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958074683128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Senior Notes</a></td>
<td class="text">Convertible Senior Notes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of&#160;0.75%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$248.48 per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than 130% of the conversion price on such trading day; </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $248.48. As of June&#160;30, 2021, the &#8220;if-converted value&#8221; did not exceed the principal amount of the 2023 Notes. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees. The portion of these costs allocated to the liability component totaling $13.7 million is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2021, we repurchased $149.6&#160;million in principal of the 2023 Notes for $153.7 million in cash, including accrued interest of $0.3 million. We accounted for the repurchase as a debt extinguishment, which resulted in (1) a loss of $7.2 million reflected in other income (expense), net, in our condensed consolidated statement of operations for the six months ended June&#160;30, 2021, (2) a $13.5 million reduction in debt discount, and (3) a $10.2 million reduction to additional paid in capital, net of tax, related to the reacquisition of the equity component in our condensed consolidated balance sheet as of June&#160;30, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $248.48 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, in connection with the repurchases of $104.5&#160;million in principal of the 2023 Notes for $109.1&#160;million in cash, including accrued interest of $0.2&#160;million, during the quarter ended March 31, 2021, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $16.5&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,597,750. We received $16.9&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 645,500. These unwind transactions resulted in a $0.4&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of March 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">345,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,411)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">442,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carrying value of equity component of the 2023 Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958074632760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax</a></td>
<td class="text">Income TaxOur effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three and six months ended June&#160;30, 2021 was 7.7% and (25.0)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three and six months ended June&#160;30, 2021 was significantly impacted by tax benefits related to (1) a $34.1&#160;million Pfenex CVR adjustment recorded during the second quarter of 2021 due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR, and (2) net excess tax windfalls from share-based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period. The effective tax rate for the three and six months ended June 30, 2020 was 21.5% and 10.9%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three and six months ended June 30, 2020 were primarily attributable to the mix of earnings in the jurisdictions with lower statutory rates than the U.S. offset by tax deductions related to stock award activities and tax deductions related to foreign derived intangible income tax credits.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958074683128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements in our 2020 Annual Report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,561,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318,381&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,456&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171.44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(533,451)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95,607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83,489)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,790)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,263,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262,261&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, outstanding options to purchase 1.3 million shares were exercisable with a weighted average exercise price per share of $91.50.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of June&#160;30, 2021, 46,866 shares were available for future purchases under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have any share repurchases during the six months ended June&#160;30, 2021.</span></div>On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $500.0 million of our common stock from time to time over the next three years. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. Authorization to repurchase $248.8 million of our common stock remained available as of June&#160;30, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958073120232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies: Legal Proceedings<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitment and Contingencies: Legal Proceedings</a></td>
<td class="text">Commitment and Contingencies: Legal Proceedings<div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 9, 2019, CyDex, our wholly-owned subsidiary, received a Paragraph IV certification Notice Letter from Alembic Global Holdings SA (&#8220;Alembic&#8221;) stating that Alembic had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> prior to the expiration of any of the &#8217;077 patent; the &#8217;088 patent, the &#8217;582 patent, or U.S. Patent No. 10,040,872 (&#8220;the &#8217;872 patent&#8221;), and alleging that these patents, each of which relates to Captisol, are invalid, unenforceable, and/or would not be infringed by Alembic&#8217;s ANDA product. On May 23, 2019, CyDex filed a complaint against Alembic, Alembic Pharmaceuticals, Ltd., and Alembic Pharmaceuticals, Inc. in the U.S. District Court for the District of Delaware, asserting that the filing of Alembic&#8217;s ANDA constitutes infringement of each of the &#8217;088 patent and the &#8217;582 patent. The parties entered into a settlement agreement on June 1, 2021 and the lawsuit has been dismissed.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 16, 2019, CyDex received a Paragraph IV certification Notice Letter from Lupin Ltd. (&#8220;Lupin&#8221;) stating that Lupin had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> prior to the expiration of any of the &#8217;077 patent; the &#8217;088 patent, the &#8217;582 patent, or the &#8217;872 patent, and alleging </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that these patents, each of which relates to Captisol, are invalid, unenforceable, and/or would not be infringed by Lupin&#8217;s ANDA product. CyDex filed a complaint on October 29, 2019, alleging patent infringement against Lupin. Lupin filed an answer on December 11, 2019 and counterclaimed for declaratory judgments of invalidity and non-infringement as to all four patents and CyDex filed its answer to Lupin&#8217;s counterclaims on January 2, 2020. The parties entered into a settlement agreement on April 26, 2021 and the lawsuit has been dismissed.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received three civil complaints filed in the US District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May and August of 2019, Pfenex Inc., which was acquired by us in October 2020, filed three petitions (IPR2019- 01027, IPR2019-01028 and IPR2019-01478) for inter partes review of U.S. Patent No. 9,422,345 (&#8220;the &#8216;345 patent,&#8221; entitled &#8220;Expression System&#8221;), which is owned by GlaxoSmithKline Biologicals S.A. (&#8220;GSK&#8221;), with the Patent Trial and Appeal Board (&#8220;PTAB&#8221;) of the U.S. Patent and Trademark Office. In November 2019 and February 2020, the Board instituted trial on invalidity grounds in IPR2019-01028, but exercised its discretion not to institute trial on IPR2019-01027 or IPR2019-01478. In May 2020, GSK filed two petitions (IPR2020-00890 and IPR2020-00962) for inter partes review of U.S. Patent No. 8,530,171 (&#8220;the &#8216;171 patent,&#8221; entitled &#8220;High Level Expression of Recombinant Toxin Proteins&#8221;), which is owned by Pfenex, with the PTAB of the U.S. Patent and Trademark Office. On June 29, 2020, GSK filed a motion to withdraw IPR2020-00890, which was granted on August 28, 2020. In October 2020, Pfenex and GSK executed a confidential settlement agreement agreeing to terminate the proceedings before the PTAB resolving these issues. Pfenex and GSK filed a joint motion to terminate IPR2019-01028 and IPR2020-00962 on October 30, 2020, and an amended joint motion to terminate on November 4, 2020. A decision granting the parties&#8217; joint motion to terminate in IPR2019-01028 was issued on November 12, 2020. The PTAB subsequently granted the parties&#8217; joint motion to terminate in IPR2020-00962 on December 30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2021, Abvivo submitted a JAMS arbitration demand naming the Company as respondent. Abvivo claimed that the Company was in violation of the assignment provision of that certain Commercial Platform License and Services Agreement (&#8220;CPLSA&#8221;), dated October 9, 2019, by and among OMT and Crystal, on the one hand, and Abvivo, on the other hand because the Company allegedly withheld its consent to a proposed assignment required for Abvivo to negotiate a discovery and development alliance with certain third parties. On January 26, 2021, we submitted a response to the demand, denying all claims and alleging counterclaims against Abvivo and Brian Lundstrom, a Company employee and the sole owner of Abvivo. We alleged that Mr. Lundstrom breached his fiduciary duty of loyalty to the Company and that Abvivo and Mr. Lundstrom fraudulently induced the Company, OMT and Crystal into certain business transactions and contracts. Abvivo and Mr. Lundstrom&#8217;s response to these counterclaims was due on February 9, 2021, but they did not submit a response. Under JAMS rules, the counterclaims were deemed denied. On February 22, 2021, Abvivo submitted documents to JAMS which indicated that it sought to dismiss its claim without prejudice. On February 25, 2021, we submitted additional counterclaims against Abvivo and Mr. Lundstrom.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These counterclaims alleged that Abvivo and Mr. Lundstrom made false promises regarding the CPLSA, Abvivo&#8217;s breach of and failure to perform under the CPLSA, and Abvivo&#8217;s infringement of certain Ligand trademarks.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2021, Abvivo and Mr. Lundstrom submitted an answer to our amended counterclaims denying all of the claims and asserting various affirmative defenses. On June 21, 2021, the parties executed a confidential settlement agreement that settled all claims in this arbitration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 29, 2021, the parties jointly submitted to JAMS a dismissal with prejudice of all claims by all parties in the arbitration.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CyDex and Baxter Healthcare Corp. (&#8220;Baxter&#8221;) are parties to a license agreement relating to Ligand&#8217;s Captisol</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span>technology and, more specifically, relating to Captisol-enabled Nexterone (amiodarone HCl premixed injection). Baxter contends that it has overpaid royalties for several years, and seeks both refunds of those overpayment and a reduced royalty going forward. CyDex contends that Baxter has not paid the royalties due to CyDex under the terms of the license agreement. On April 6, 2021, Baxter initiated an arbitration with the American Arbitration Association pursuant to the arbitration provision of the license agreement. On April 21, 2021, CyDex filed an Answering Statement and Counterdemand. On May 5, 2021, Baxter filed an Answering Statement in response to CyDex&#8217;s Counterdemand. On June 30, 2021, the parties&#8217; held a Preliminary Hearing before the arbitrator. The arbitration is in its early stages.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958072954632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2020 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text">ReclassificationsCertain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#8220;contract revenue&#8221; and &#8220;service revenue&#8221; presented in the condensed consolidated statement of operations for the three and six months ended June&#160;30, 2021 have been combined into &#8220;contract revenue&#8221; in the condensed consolidated statement of operations to conform with the current period presentation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Standards Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#8217;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures. We intend to adopt this standard on January 1, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment.  These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Captisol Sales</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. </span></div>The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable and Allowance for Credit Losses</a></td>
<td class="text">Accounts Receivable and Allowance for Credit LossesOur accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period until the last tranche vests. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,216&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,359&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,621&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,012&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958074434616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue by Source</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,771&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,316&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,258&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,675&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,420&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139,825&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,581&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock', window );">Schedule of Short-Term Investments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at June&#160;30, 2021 and December 31, 2020 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:21.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.410%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.509%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.359%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.909%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.359%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.509%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.659%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(310)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Treasury bill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,039&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(315)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,749&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,391)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,972&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363,567&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Available-for-Sale Debt Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,283&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,366&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Other Identifiable Intangible Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,378)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,932)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,597)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">762,523&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">784,992&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock', window );">Schedule of Commercial License and Other Economic Rights</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license and other economic rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,470)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,226</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,588)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,412</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,731)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,871</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,660)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,638</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,319)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,979</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.0 million as of June&#160;30, 2021.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.3 million and credit loss adjustments of $6.0 million as of December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,107&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,530&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock', window );">Schedule of Accounting for Share-Based Compensation</a></td>
<td class="text">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,216&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,359&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,621&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,012&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Fair-Value Options Awarded to Employees and Directors</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,832&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,684&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,988&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Commercial License Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Short-Term investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958074609768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">239,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">279,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">363,567&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pfenex contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,930&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,841&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,802&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,312&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Investment in Viking warrants, which we received as a result of Viking&#8217;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. During the six months ended June&#160;30, 2021, we exercised all of the outstanding Viking warrants. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the six months ended June&#160;30, 2021, we paid $1.1&#160;million contingent liability based on revenue milestones to former Icagen shareholders.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Pfenex contingent liabilities was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of the Company. During the three and six months ended June&#160;30, 2021, we reduced the contingent liability by $34.1&#160;million and $33.8&#160;million, respectively, primarily due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR. See further detail on Pfenex CVR in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Note 3, Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div>7.The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the first quarter of 2021, management recorded an earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Reconciliation of Level 3 Financial Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of June&#160;30, 2021 is as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33,661)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of June&#160;30, 2021</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,841&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958074615032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The following table sets forth an allocation of the preliminary purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts and unbilled receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangibles acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,814)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,455)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,382)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(53,296)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">465,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is expected to be deductible for tax purposes.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Schedule of Pro Forma Information</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following summary presents our unaudited pro forma consolidated results of operations for the three and six months ended June 30, 2020 as if the Pfenex acquisition had occurred on January 1, 2020, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and share based compensation expense for retained Pfenex employees. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended <br/>June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,505)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958074686312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">345,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,411)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">442,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carrying value of equity component of the 2023 Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958074615032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Plan Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,561,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318,381&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,456&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171.44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(533,451)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95,607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83,489)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,790)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,263,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262,261&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,561,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318,381&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,456&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171.44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(533,451)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95,607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83,489)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,790)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,263,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262,261&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958157732136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>position </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>position </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 01, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized from milestone method revenue</a></td>
<td class="nump">$ 10,300,000<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="nump">$ 16,100,000<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of positions in an unrealized loss position | position</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Credit losses related to available-for-sale debt securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease', window );">Additional allowance for credit losses recorded related to COVID-19</a></td>
<td class="nump">40,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvancesOnInventoryPurchases', window );">Advances on inventory purchases</a></td>
<td class="nump">50,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases', window );">Credits applied on advances on inventory purchases</a></td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss', window );">Allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares) | shares</a></td>
<td class="nump">5,087,000<span></span>
</td>
<td class="nump">7,832,000<span></span>
</td>
<td class="nump">4,684,000<span></span>
</td>
<td class="nump">8,988,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Share-based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Performance period for awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember', window );">Royalty Agreements | Aziyo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent', window );">Effective interest rate for forecasted cash flows (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember', window );">Royalty Agreements | Selexis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent', window );">Effective interest rate for forecasted cash flows (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent', window );">Payout range (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent', window );">Payout range (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember', window );">Viking Therapeutics, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (USD per share) | $ / shares</a></td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember', window );">Viking Therapeutics, Inc. | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Outstanding warrants to purchase shares of Viking's common stock (shares) | shares</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial License and Other Economic Rights, Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credits Applied on Advances on Inventory Purchases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Forecasted Cash Flows, Effective Interest Rate, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ForecastedCashFlowsEffectiveInterestRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvancesOnInventoryPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of capitalized payments made in advance for inventory that is expected to be received within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvancesOnInventoryPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_AziyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_AziyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_SelexisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_SelexisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958165412520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 84,675<span></span>
</td>
<td class="nump">$ 41,420<span></span>
</td>
<td class="nump">$ 139,825<span></span>
</td>
<td class="nump">$ 74,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">8,616<span></span>
</td>
<td class="nump">7,181<span></span>
</td>
<td class="nump">15,728<span></span>
</td>
<td class="nump">13,746<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember', window );">Kyprolis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">5,440<span></span>
</td>
<td class="nump">5,481<span></span>
</td>
<td class="nump">9,727<span></span>
</td>
<td class="nump">9,886<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember', window );">Evomela</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,193<span></span>
</td>
<td class="nump">1,199<span></span>
</td>
<td class="nump">4,526<span></span>
</td>
<td class="nump">2,775<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">983<span></span>
</td>
<td class="nump">501<span></span>
</td>
<td class="nump">1,475<span></span>
</td>
<td class="nump">1,085<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">62,509<span></span>
</td>
<td class="nump">24,468<span></span>
</td>
<td class="nump">93,781<span></span>
</td>
<td class="nump">45,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">13,550<span></span>
</td>
<td class="nump">9,771<span></span>
</td>
<td class="nump">30,316<span></span>
</td>
<td class="nump">15,258<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember', window );">Service Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">7,360<span></span>
</td>
<td class="nump">4,582<span></span>
</td>
<td class="nump">12,822<span></span>
</td>
<td class="nump">7,939<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember', window );">License Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,050<span></span>
</td>
<td class="nump">660<span></span>
</td>
<td class="nump">2,093<span></span>
</td>
<td class="nump">1,635<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember', window );">Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,600<span></span>
</td>
<td class="nump">3,472<span></span>
</td>
<td class="nump">12,017<span></span>
</td>
<td class="nump">3,806<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,540<span></span>
</td>
<td class="nump">$ 1,057<span></span>
</td>
<td class="nump">$ 3,384<span></span>
</td>
<td class="nump">$ 1,878<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_KyprolisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_EvomelaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958075759080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">$ 239,039<span></span>
</td>
<td class="nump">$ 324,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">1,025<span></span>
</td>
<td class="nump">1,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(315)<span></span>
</td>
<td class="num">(1,391)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">239,749<span></span>
</td>
<td class="nump">324,478<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI', window );">Estimated fair value</a></td>
<td class="nump">279,972<span></span>
</td>
<td class="nump">363,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember', window );">Bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">33,560<span></span>
</td>
<td class="nump">84,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">33,571<span></span>
</td>
<td class="nump">84,154<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">25,965<span></span>
</td>
<td class="nump">30,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">26,025<span></span>
</td>
<td class="nump">30,610<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AgencySecuritiesMember', window );">Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">4,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">2,499<span></span>
</td>
<td class="nump">4,501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">19,258<span></span>
</td>
<td class="nump">45,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">19,270<span></span>
</td>
<td class="nump">45,485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Corporate equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">5,807<span></span>
</td>
<td class="nump">4,466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(310)<span></span>
</td>
<td class="num">(1,388)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">5,669<span></span>
</td>
<td class="nump">3,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember', window );">Mutual fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">151,949<span></span>
</td>
<td class="nump">151,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">152,002<span></span>
</td>
<td class="nump">151,898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">Treasury bill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">713<span></span>
</td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">713<span></span>
</td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,326<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Estimated fair value</a></td>
<td class="nump">$ 40,223<span></span>
</td>
<td class="nump">$ 32,763<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available for Sale and Equity Securities, FV-NI</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AgencySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AgencySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958077366808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis', window );">Within one year</a></td>
<td class="nump">$ 57,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">After one year through five years</a></td>
<td class="nump">23,286<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis', window );">Total</a></td>
<td class="nump">81,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue', window );">Within one year</a></td>
<td class="nump">58,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">After one year through five years</a></td>
<td class="nump">23,316<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total</a></td>
<td class="nump">$ 81,366<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62586-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958075279560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 190,517<span></span>
</td>
<td class="nump">$ 189,662<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total goodwill and other identifiable intangible assets, net</a></td>
<td class="nump">762,523<span></span>
</td>
<td class="nump">784,992<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember', window );">Complete technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">277,980<span></span>
</td>
<td class="nump">277,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(71,276)<span></span>
</td>
<td class="num">(63,600)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">2,642<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(1,378)<span></span>
</td>
<td class="num">(1,312)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">40,700<span></span>
</td>
<td class="nump">40,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(16,932)<span></span>
</td>
<td class="num">(15,597)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Contractual relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">362,000<span></span>
</td>
<td class="nump">362,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">$ (21,730)<span></span>
</td>
<td class="num">$ (7,243)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958156791880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details) - Commercial license rights - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">$ 28,298<span></span>
</td>
<td class="nump">$ 28,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(17,660)<span></span>
</td>
<td class="num">(17,319)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">10,638<span></span>
</td>
<td class="nump">10,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization on finite-lived intangible assets</a></td>
<td class="num">(11,700)<span></span>
</td>
<td class="num">(11,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments', window );">Credit loss adjustments of finite-lived intangible assets</a></td>
<td class="num">(6,000)<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Aziyo and CorMatrix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">17,696<span></span>
</td>
<td class="nump">17,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(9,470)<span></span>
</td>
<td class="num">(9,588)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">8,226<span></span>
</td>
<td class="nump">8,108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Selexis and Dianomi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">10,602<span></span>
</td>
<td class="nump">10,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(8,190)<span></span>
</td>
<td class="num">(7,731)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 2,412<span></span>
</td>
<td class="nump">$ 2,871<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial License and Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseAndOtherEconomicRightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-lived Intangible Assets, Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958163675848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation</a></td>
<td class="nump">$ 3,684<span></span>
</td>
<td class="nump">$ 8,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">977<span></span>
</td>
<td class="nump">977<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LicenseeAccrualCurrent', window );">Amounts owed to former licensees</a></td>
<td class="nump">446<span></span>
</td>
<td class="nump">421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties owed to third parties</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ReturnsAccrual', window );">Return reserve</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedAssetAcquisitionsCurrent', window );">Acquisition related liabilities</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedSubcontractorExpensesCurrent', window );">Subcontractor</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedSupplierExpensesCurrent', window );">Supplier</a></td>
<td class="nump">681<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">2,367<span></span>
</td>
<td class="nump">3,641<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 10,107<span></span>
</td>
<td class="nump">$ 18,530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedAssetAcquisitionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Asset Acquisitions, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedAssetAcquisitionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedSubcontractorExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Subcontractor Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedSubcontractorExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedSupplierExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Supplier Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedSupplierExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LicenseeAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensee Accrual, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LicenseeAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ReturnsAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Returns Accrual</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ReturnsAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958081869816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 10,216<span></span>
</td>
<td class="nump">$ 7,359<span></span>
</td>
<td class="nump">$ 18,621<span></span>
</td>
<td class="nump">$ 13,012<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">SBC - Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">4,556<span></span>
</td>
<td class="nump">3,019<span></span>
</td>
<td class="nump">8,495<span></span>
</td>
<td class="nump">5,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">SBC - General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 5,660<span></span>
</td>
<td class="nump">$ 4,340<span></span>
</td>
<td class="nump">$ 10,126<span></span>
</td>
<td class="nump">$ 7,596<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958166906072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">54.00%<span></span>
</td>
<td class="nump">69.00%<span></span>
</td>
<td class="nump">62.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">5 years 1 month 6 days<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958157224568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Summary of computation of basic and diluted net income (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding (in shares)</a></td>
<td class="nump">16,659<span></span>
</td>
<td class="nump">16,055<span></span>
</td>
<td class="nump">16,548<span></span>
</td>
<td class="nump">16,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Restricted stock (in shares)</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options (in shares)</a></td>
<td class="nump">444<span></span>
</td>
<td class="nump">599<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted income per share (in shares)</a></td>
<td class="nump">17,172<span></span>
</td>
<td class="nump">16,694<span></span>
</td>
<td class="nump">17,210<span></span>
</td>
<td class="nump">16,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares)</a></td>
<td class="nump">5,087<span></span>
</td>
<td class="nump">7,832<span></span>
</td>
<td class="nump">4,684<span></span>
</td>
<td class="nump">8,988<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958070885416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2010 </div>
<div>contingent_value_right </div>
<div>contingent_value_right_series</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfContingentValueRightsSeries', window );">Number of CVR Series | contingent_value_right_series</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Transferred over Time | Phase 3 Clinical Trial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGross', window );">Gross contract asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Transferred over Time | Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000,000<span></span>
</td>
<td class="nump">375,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember', window );">Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare', window );">Number of CVRs issued per acquiree share | contingent_value_right</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries', window );">Number of CVRs issued from each CVR series | contingent_value_right</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders', window );">Frequency of cash payments to CVR holders</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyIcagenMember', window );">Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Payment for contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyPfenexMember', window );">Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reduction in contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,100,000<span></span>
</td>
<td class="nump">33,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">279,972,000<span></span>
</td>
<td class="nump">279,972,000<span></span>
</td>
<td class="nump">$ 363,567,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,802,000<span></span>
</td>
<td class="nump">14,802,000<span></span>
</td>
<td class="nump">49,193,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Crystal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376,000<span></span>
</td>
<td class="nump">376,000<span></span>
</td>
<td class="nump">508,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,930,000<span></span>
</td>
<td class="nump">3,930,000<span></span>
</td>
<td class="nump">3,821,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,625,000<span></span>
</td>
<td class="nump">5,625,000<span></span>
</td>
<td class="nump">6,404,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="nump">37,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,749,000<span></span>
</td>
<td class="nump">239,749,000<span></span>
</td>
<td class="nump">324,478,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,223,000<span></span>
</td>
<td class="nump">40,223,000<span></span>
</td>
<td class="nump">32,763,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,326,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,892,000<span></span>
</td>
<td class="nump">45,892,000<span></span>
</td>
<td class="nump">42,527,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - Crystal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,669,000<span></span>
</td>
<td class="nump">5,669,000<span></span>
</td>
<td class="nump">3,438,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,223,000<span></span>
</td>
<td class="nump">40,223,000<span></span>
</td>
<td class="nump">32,763,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,326,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">233,368,000<span></span>
</td>
<td class="nump">233,368,000<span></span>
</td>
<td class="nump">320,647,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,930,000<span></span>
</td>
<td class="nump">3,930,000<span></span>
</td>
<td class="nump">3,821,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - Crystal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,930,000<span></span>
</td>
<td class="nump">3,930,000<span></span>
</td>
<td class="nump">3,821,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">233,368,000<span></span>
</td>
<td class="nump">233,368,000<span></span>
</td>
<td class="nump">320,647,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">712,000<span></span>
</td>
<td class="nump">712,000<span></span>
</td>
<td class="nump">393,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,841,000<span></span>
</td>
<td class="nump">10,841,000<span></span>
</td>
<td class="nump">45,312,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - Crystal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376,000<span></span>
</td>
<td class="nump">376,000<span></span>
</td>
<td class="nump">508,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,625,000<span></span>
</td>
<td class="nump">5,625,000<span></span>
</td>
<td class="nump">6,404,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="nump">37,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">712,000<span></span>
</td>
<td class="nump">712,000<span></span>
</td>
<td class="nump">393,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfContingentValueRightsSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Contingent Value Rights Series</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfContingentValueRightsSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (ee)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyIcagenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyIcagenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyPfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyPfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCrystalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCrystalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCydexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCydexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyXCellaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyXCellaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958074375384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details) - Level 3<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments as of December&#160;31, 2020</a></td>
<td class="nump">$ 45,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHolders', window );">Payments to CVR holders and other contingent payments</a></td>
<td class="num">(1,050)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments to contingent liabilities</a></td>
<td class="num">(33,661)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition', window );">Contingent liabilities from xCella asset acquisition</a></td>
<td class="nump">240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments as of June&#160;30, 2021</a></td>
<td class="nump">$ 10,841<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958070264200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 09, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 08, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="nump">$ 465,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisition</a></td>
<td class="nump">429,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="nump">77,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Fair value of contingent earn-out payment</a></td>
<td class="nump">37,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Post-combination expense</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions', window );">Gross payments to acquire business attributable to vested portion of stock options</a></td>
<td class="nump">$ 17,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards', window );">Cash to settle unvested stock options recognized as share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability acquired in connection with the acquired intangibles</a></td>
<td class="num">$ (53,296,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue acquired</a></td>
<td class="num">(3,908,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Contractual Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="nump">$ 362,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">12 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="nump">$ 23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Core Technology | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Core Technology | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input (as a percent)</a></td>
<td class="nump">0.071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationConsiderationTransferredHoldback', window );">Holdback from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets', window );">Tangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus | Contingent Value Right for Internal Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus | Contingent Value Right on Product Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues', window );">Proportion of milestone payments (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationConsiderationTransferredHoldback', window );">Holdback from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets', window );">Tangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability acquired in connection with the acquired intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Earnout Rights for Partner Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency', window );">Earnout rights recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Milestone Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues', window );">Proportion of milestone payments (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember', window );">Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Fair value of contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets', window );">Tangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember', window );">Icagen | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember', window );">Icagen | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationConsiderationTransferredHoldback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Holdback</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationConsiderationTransferredHoldback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash paid by the entity during the period to settle equity instruments granted under equity-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightOnProductRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightOnProductRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_MilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_MilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958076374648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Assets Acquired and Liabilities Assumed (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 190,517,000<span></span>
</td>
<td class="nump">$ 189,662,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,407,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts and unbilled receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,359,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,823,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets', window );">Right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,070,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,338,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets', window );">Intangibles acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,837,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,814,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,455,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,908,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,070,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,382,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,296,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">465,109,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill acquired that is expected to be deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958079854984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Pro Forma Financial Information (Details) - Pfenex - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 42,201<span></span>
</td>
<td class="nump">$ 76,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 7,435<span></span>
</td>
<td class="num">$ (30,505)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareProFormaAbstract', window );"><strong>Net income (loss) per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="nump">$ 0.46<span></span>
</td>
<td class="num">$ (1.87)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="num">$ (1.87)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareProFormaAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareProFormaAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958077047448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>option </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>option </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,175,000<span></span>
</td>
<td class="num">$ (659,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Adjustments to additional paid in capital, equity component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,073,000<span></span>
</td>
<td class="nump">$ 9,086,000<span></span>
</td>
<td class="nump">$ 2,745,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to additional paid-in-capital from warrants</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToUnwindWarrants', window );">Payments to unwind warrants</a></td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ProceedsFromUnwindingConvertibleBondHedges', window );">Proceeds from unwinding convertible bond hedges</a></td>
<td class="nump">$ 16,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfOptionsUnderConvertibleBondHedges', window );">Number of options under convertible bond hedges | option</a></td>
<td class="nump">645,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">645,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
<td class="nump">345,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">345,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495,280,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 733,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate (shares per $1,000)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0040244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Repurchased amount of debt instrument</a></td>
<td class="nump">$ 104,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 149,600,000<span></span>
</td>
<td class="nump">$ 104,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes</a></td>
<td class="nump">109,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Accrued Interest</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_IncreaseDecreaseInDebtDiscount', window );">Increase (decrease) in debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Adjustments to additional paid in capital, equity component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued in public offering (shares) | shares</a></td>
<td class="nump">2,597,750<span></span>
</td>
<td class="nump">3,018,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,597,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsForConvertibleBondHedges', window );">Payments for convertible bond hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to additional paid-in-capital from warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Stock price trigger to classify convertible debt as current (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger', window );">Maximum threshold of debt trading price trigger (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_IncreaseDecreaseInDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Debt Discount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_IncreaseDecreaseInDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfOptionsUnderConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Options under Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfOptionsUnderConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsForConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsForConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToUnwindWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Unwind Warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToUnwindWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ProceedsFromUnwindingConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Unwinding Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ProceedsFromUnwindingConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958074939864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Senior Notes - Notes Payable (Details) - Convertible Notes - 2023 Convertible Senior Notes - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>May 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract', window );"><strong>Notes Payable, Current and Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of the 2023 Notes outstanding</a></td>
<td class="nump">$ 345,729,000<span></span>
</td>
<td class="nump">$ 495,280,000<span></span>
</td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount (including unamortized debt issuance cost)</a></td>
<td class="num">(30,411,000)<span></span>
</td>
<td class="num">(52,987,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Total long-term portion of notes payable</a></td>
<td class="nump">315,318,000<span></span>
</td>
<td class="nump">442,293,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Carrying value of equity component of the 2023 Notes</a></td>
<td class="nump">27,776,000<span></span>
</td>
<td class="nump">48,397,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of the 2023 Notes outstanding (Level 2)</a></td>
<td class="nump">$ 341,687,000<span></span>
</td>
<td class="nump">$ 466,053,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958254110488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate (as a percent)</a></td>
<td class="nump">7.70%<span></span>
</td>
<td class="nump">21.50%<span></span>
</td>
<td class="num">(25.00%)<span></span>
</td>
<td class="nump">10.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyPfenexMember', window );">Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reduction in contingent liability</a></td>
<td class="nump">$ 34.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyPfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyPfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958163664296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at beginning of period (shares) | shares</a></td>
<td class="nump">2,561,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (shares) | shares</a></td>
<td class="nump">318,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (shares) | shares</a></td>
<td class="num">(533,451)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(83,489)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at end of period (shares) | shares</a></td>
<td class="nump">2,263,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 85.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">164.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (USD per share) | $ / shares</a></td>
<td class="nump">52.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">106.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 103.79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Stock Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (shares) | shares</a></td>
<td class="nump">206,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares) | shares</a></td>
<td class="nump">158,456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs vested (shares) | shares</a></td>
<td class="num">(95,607)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(6,790)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (shares) | shares</a></td>
<td class="nump">262,261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 106.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">171.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">RSUs vested (USD per share) | $ / shares</a></td>
<td class="nump">126.49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">126.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 138.23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958074988808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 11, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Outstanding options that are exercisable (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Outstanding options that are exercisable, weighted average exercise price (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,287,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized stock repurchase amount</a></td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Period in force of stock repurchase program</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized stock repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate', window );">Share purchase price as percent of market price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod', window );">Shares available for future purchases (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,866<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EmployeeStockPurchasePlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EmployeeStockPurchasePlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on purchase date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958077082968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies: Legal Proceedings (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>civil_complaint</div>
</th>
<th class="th">
<div>Oct. 29, 2019 </div>
<div>patent</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>petition</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>petition</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=lgnd_LupinPatentInfringementMember', window );">Lupin Patent Infringement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber', window );">Number of patents allegedly infringed upon | patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember', window );">US District Court for the Northern District of Ohio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of civil complaints filed against entity | civil_complaint</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=lgnd_InterPartesReviewOfPatentMember', window );">Inter Partes Review of Patent | Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfPetitionsFiled', window );">Number of petitions filed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=lgnd_InterPartesReviewOfPatentMember', window );">Inter Partes Review of Patent | GSK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfPetitionsFiled', window );">Number of petitions filed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfPetitionsFiled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Petitions Filed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfPetitionsFiled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of entity's patents that another entity has allegedly infringed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=lgnd_LupinPatentInfringementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=lgnd_LupinPatentInfringementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=lgnd_InterPartesReviewOfPatentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=lgnd_InterPartesReviewOfPatentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=lgnd_GlaxoSmithKlineBiologicalsSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=lgnd_GlaxoSmithKlineBiologicalsSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139958072893912">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
<td class="text">Accounting Standards Update 2016-13 [Member]<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>54
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MI[AN'[_*5SHYSWMM\I@IL,M$:UIIG[M';N?(>C=F,W0ZG6ZG[=*!M2EC90R
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M^^?[$R76^1;TLU!*Q/GABK. 2_T W%\(H8XG^@7%7S&&_P%02P,$%     @
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M#H#K"\[5VT2?P=4[U_ O4$L#!!0    (  2? E,EQV G$@<  $,?   8
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M'QDNWY39O/[)VEU6EMFL?CE5$;A1)8#O[S-84\V;ZE=PJY]Z'OX?4$L#!!0
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MQ.$U"2!;\.'L2$\1IN>7&MI B):E#QH6!'DI=Z*"/9[SM;!B!*-X*1A1:2[
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M?.F:K7V%Z+KINF9C/ZYE 0LY8P"_KQIH?'=?S 7V;Z&=_A]02P,$%     @
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M?KUPH^1ZK\I&5V54J\UWS^Y&7[^<4'MN\#>M'IO@>T0K6575!_KQ-O_N64(
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M@*/M8=B8RD^+MEAKG_1=4;&+QS,3;DNV#GE9YU/\)\P*"H:-& ,I=\JK2#0
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M7%B,2X1$YZQ9Q40G+?CTQ>22\O/NH2_.@@NJS#Y:9^\UIWZD)%9,"F6*<!A
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M(_^(:MLDBED<_QDPDW\+F.DPL2 )D.EP<A5&W63;;:WLIF^<B/JM%[=J61A
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MB(^A/_6Y.CCTZX&+Z'<9?-)%B$/O'!%A_Q.-[F[W Y<;_[N.?KC_=<P;:9?
M'"#1 E.'@]GEB;#^%R?^HC9K_I7'W-2U*?GK2DF + W \X4!'H0+6J#[V<^S
M?P-02P,$%     @ !)\"4^G8PY%)#P  XC(  !D   !X;"]W;W)K<VAE971S
M+W-H965T,3 N>&ULY5MK;QLW%OTKA.&@-B#+>EIRD 1PW.UNBVT;)-WDPV(_
M4#.4Q&8THY(<V^JOWW,OR1%'#^?1)OU0H*FE&3XN+\\]]T'JV7UEWMNE4DX\
MK(K2/C]9.K=^>GEILZ5:2=NMUJK$FWEE5M+AJUE<VK51,N=.J^)RT.M=7:ZD
M+D]>/.-GK\R+9U7M"EVJ5T;8>K629O-2%=7]\Y/^27SP6B^6CAY<OGBVE@OU
M1KG_K%\9?+ML1LGU2I565Z4P:O[\Y*;_].6(VG.#MUK=V^2SH)7,JNH]??D^
M?W[2(X%4H3)'(TC\N5.WJBAH((CQ6QCSI)F2.J:?X^C?\=JQEIFTZK8JWNG<
M+9^?3$]$KN:R+MSKZOY?*JQG3.-E56'Y_^+>MQV/3D166U>M0F=(L-*E_RL?
M@AZ2#M/>D0Z#T&' <ON)6,IOI9,OGIGJ7AAJC='H R^5>T,X7=*FO'$&;S7Z
MN1<WV6^UMIHT9)]=.HQ(SR^ST/NE[STXTOM*_%B5;FG%/\I<Y>W^EY"D$6<0
MQ7DY>'3 '^JR*X:]CACT!OU'QALVRQOR>,,CX[VL+9Y8*VZKU4R7TB.AS,6-
MM4!\LGKQWYN9=08H^=\C\XZ:>4<\[^@SU?KQO<6KN2K50TO4G_%?YJJ9,J+/
MJH+"[A40CB9&Y:$+GBUUM@1&[V![:ROPS%TL\,IL]5!6>"G6IG)*E\(M\6ZM
M:J<S*UPE] IO[I10#]HZ72Y" ZTL=\Y  TYAW/OD!8A"S'155 N=R4(X:1;*
M68$UOH=H&#0S6 5>=41=KK )N;8*=F4%[=5"R$8:]0">L6S^3F7+DL;<B'4A
M'9%15_RR5&BK"@V[ *&(=6VR)4;"0YTI4<W%Z>AJW.W#;HJ"1M%E5M0 *IX/
MKKM7S?-,VJ7(H&R=1]VLI<Y%O6;>:!3?X55+:DK:4*43MV]?H^UF19\Q8;VF
M%9Y.)MUI,JN?@,@C%S2BR)1Q($QAURK3<XW':*Q@[*6"_;LEYA'XJL$Z>*=+
MS Y5SJ4VXDX6M5_;<-+MQ4F\,DB8>SS ),5&S)1?!>:9UWBHY[1+R4P:NY@M
M->"1B]E&?*LRM2),#3VH^GY0N:IJOS@7IFC4Z!&SJ_=[:4'7>9WY84_[W7&C
M"[>4CAODRBF#??.0(%$KZRZRQ$JQ^^!^Y85H+ST*4F@YTX5VF]TA$R3-0I,+
MF?\*.F6I,0W6M<9;K)\G@/"\1W,X*0M;,HHF*0F;&2W?BTEPI(WV@L1)8AMA
MR!B:78:/>P]TKZ4!VO5:ELY^ ^185F6N9HY\&CNGN^VBJA4:;J+ETJHFW?X3
MKX/M:K%Q:V5TE9,98:<ER,S2M,WDV%/,YXU4FZQ>62?+3-'&%#*LAB:LP=NF
MV-!"&EP$E)<;@5T%RAE 6_UK&B2K3 ! 51LVG:K0.8^,F9Q:\?18%:(';U&V
M*[XOJ649_#'CG&1H&QB 8/@].GL>^\8*A198M[R7)K<!1+1'B#)H83EO!(2N
MRSO%>PPD@H;"(I,)@+1,8O/)(#8B-@;FJ1W!Q\:M6"GPEA%R812O)AA#EB&@
M"!R!EC0"36Y4H-Z:>1.[4F6$!G<0NW$YSAD]JYV<%2K JV4!5ID[,JBPC!TS
MH_728Z,H]F(->$LEU$0R(S1@@XX;U[M $J?]27>X1UG$Y4%8]*8NTF^3QR<1
MR,>MP4.1H<.8AUR04O*H@-R67USEP'0[2V4)F<Y3VF9 R3P/R-E7]0')]^1E
MQ>YJ)RK>&QDK]'3:G;3(UD9F#'0!&ZPRS1:0(#N@!0\C4B 7K"Q[#\OP_AT:
MN]-5;8''A9&1:H+75ZMU46U4T!]/Y*$;F9VV*:4+,LU%J7_W"O;.OO &G8,;
M-84XS#@! :#-V@3/CNVN#43_K09G ?L0E6*+P, 5,'W/+5EWEIPZ\.&=50!\
ML KWN&,.:@<^X4;GVF\%F$;3!\9)N?UJ>:(FM*'7D0@Y#+%()U3>V2I=/604
M\#4<A=D6596S7SQCCP5E8QA[_E3<$LA/Q;C?&?4FXC6V" +2#C#ZD=@@[,K\
M)GMZP;P%7F-PI>](<(L(;#B^%J\,,1T9-=H1\-9$&AW$1DY,.M/!4'"^<U'-
M+VH;EB6&G=ZD)WZFV"DN%*,-IP!V5$"R].%TW.E!I'\VJ^F?B^M^9SJ<;,5$
M+,+Z/+OJ3/NC<WIA:M76V=FT,QJ/S^'PY\H87@[<!6SF;-BY[DW/Q;\I'FMW
M85'/@ZRM-Y!X.D@&<_(A;>!5<#8>=@;75^=0-D*R3K]WS=(W2S$J^%:;[F&$
MTDY<=Q?X.H78/LDFKNTC0=3=RG. V=B@,=!J1@B@7!/H]V$FV9+1JLR\,['D
MY&!T+EHQ8P)M&%IV YM<8-JN^(FBL"#N(IFZ:>M#HYR"*<?F0(1,"H9*P%HT
MQDU<E$XP$R(TQ(A7@X;4,1$%KI3BU++PD0 QT%*O/;Q/!\-V8XJ"FL![-Q!K
MMN?XH,Q734Q";9-XJHFWX&IAD[EWZ]NH-^QP$G!%." [*#D@-M5&%AYD3?2"
MS\B)"SFKDBP'D1ZIL $Z[%S)%86,1E/T.S?5BL<N +#2!I[VWC7$2U$/A)<&
M@5MICRDA^)!C4>QQW0$&,Q6\.@*BWV/J0 3.3$))(RE7)_+<<Q&"$(XG<I$*
M"-:!Y\ "YSQY?]"]%ALEC3VZKXVYM-;^-]K31F5WRD:?CUE_55EKK4$G'TX5
M6HE"=-IWTG#63-+V!T^H;W\<(GX?#,E#%BYI%[XD/H9(+A-\;!ON(.6C';3G
M)-9#ZBIB_W8WGX-$XM]?.I4E-%4&9-$$YJ1:&IXYLA6@S1&>6(X00L:Z@H.K
M#<?U,<@+X33B4Z*]>[21<.:<,X;1DCF;D;%;(:+E*H@N?9F4&71&*3YI9(8T
M!3)D!Q,R;R%47_$A6VI\(6>AO&HW" M%5-&X30KSZU)"PS[_J02+TL[-T+@N
M=A.SJ##\0Z[#(EK](%:^LJ>HLB=^J &F4)?KD9BAF! =7"+M4@*)65;S#N/[
M#[*L2=)MI8IQOR"K$FH^)]U152B41 !?Q.JQ9-MLJM\)3BM3* 7P-Y'G85NA
M%2UEPUNMA"#$P:P$H\*6[4;?L=84E3I'T%%F1%?ICL/2RHJ 0,$+S!IANBXI
M1T]3_*!WSAG]9OATMJJ+'+JCAE%YI,G]_%5Q%LW[WX8,;7&<D RNQ(H@DGY,
MHGGM:G-(J%:DW.& ;,VV$C09#  Q]"^,FA9:WNS"YW7@:$1_@\Z@U\>'R56G
M-QJ)GQ <AH+,65%92Q'BI#,:CO'W#( ;]Q"H[C<B0?!]1<D:R?-4O 339>C4
MZXZNJ&^_.YT@*M5%35KBY^/M\U]D;9"J[Q15WV"-O@1V?:BLZCLU955B<]"H
MQ]>VR,H%5>1Q>E;E#;/KU:KV65E&#H-IH+J_B+ZJT#/#?B  ;;^0>:2,F10Q
MFV30URA/>TG9;5D5^4PBZ82A$>[MG(&@5B7RKYBWS0J]"(P0\DD*1V><ZKG"
M%_.V&O(%PG=03V$KX,Q2EE%R.%-:\#N'S;=O7WMZ"77145H*U,%3(MDL570=
ML%ME2HZ&++Q/MDRURWQ-WY,A!^-M%=37% ;C)P&D4)S/[>$+N1@=MGTG=&"T
M1T;9ED=#61=H\^F>UT!M>=6*/&"(:;1MF:CVQ&5R(GB?E]Z\N173WK@C#IU'
M6-&AE1">L'3H7G&2%?.-X#42OL:RPD*H?,ZFK^9<) XD*&9A&A85;!'PPDQC
MZQGY'@JVJ'1(U>+YD3K5PL#8]CR\YO(28BIG0GFZ'2[NY0TWK THM]@$@XJ!
MDO<\&+#%^I8K"IPA)WKMBI^]5"U;:%?M(_@,5P146@VA=!,VT1NG*<ZQ,H,W
MHC.DM:<IO&)21 ZD4*T0<M/V.&$<;\X["OF\T/YXI-;$:>\:U38NG0WP""!'
M8_#;;3S*R(BKB-M4V60F_L7&U^T01=RI)DY*JM$S1<S<E![::2T+0+;8+DSA
M;1I2@$D>Z&16'F?DZ2%&]ITZC!?/N)N&EWWA3Y:;I,@Y:;&H#^$3V_\ZK'G>
M"<50IDQL74GQH:&=;Y%EBKQ(EASEV4:[06D)MJC_EE$_@40GXT=8E X#0JBP
MSX_!T#Q#<M4E.>%J3@Z#J$$V0,+0V8*OK/_U?!JD^WORZ>0/\.G@X^B4J?2L
MUT6GI/W!//%L>$XB33^.=7<8>^2GF;:FR0^5)C=?A9O'CW#SCN7_E2R](\I!
MOCZ<E7Z[/3UP^XE B^,I(TD$;HI)C=#)242LFB7#/YJ3]G?AV8(F\5![A:S
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M+6R;^U]__"C-0H.("S5'UUYW,C[QN5K\XJHU_XIA5CF8$W]<*@ET4 .\GU?
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MB5YH")64!N(13;7Q2&$[;W41P#K%.ZJ?2Z2@*6KO=&M B[<K";-+H'GF/:"
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M2')8Y5S6C1B*(%-6RU6O_OMEOC1[>\-LN$,]A<5UL2FS#15I^4AK*&VX75!
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M?&G4DEQW^0\?7K)IUV8;J7@3S^$4M04\O>/F"ZD($))',;$,T2).FDE?\="
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M0:&4TNZ.5L^Z@\\V54?G5'Y!23IU"!(K-4-=,DC.H6-US^SR>9Y=/G_(X5*
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M+HT&I_0 OI\["!'?T ;Y9W1O_@]02P,$%     @ !)\"4]+T[< F"P  41X
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M6YDN^]BDV3:(.O3;)"3OM[F1D>.KE3>,@>47=2Y=93;;]+6"I9FS* U4*[-
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MOI4M,_5B)P- ;6%D ?M(L,="S"?3Z<7"4\)<3NI/7%Z;2&J CDUP C [2-F
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ML47R7+YS^0YYM;7NDR^)@MA5VOCK7AG"YG(P\%E)E?3G=D,&)X5UE0Q8NO7
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M!W<NZJ9,IA$H;U?@N?K2\;MK2778IQQ1*1W%"P\4LA4> ;Y1HAU_4TR"(X8
MB38LJC;:OA#Y<_$4!\<^J06FA\F4U/#3E50H+XP-Z"JFN71*O^ X5SQ]GFD_
M?=J\ _N^&*&4 9=]K7/DC@7WR>-,LLIA=E=$)M:4Z\\EE7YOF4N\=\ASQR B
M0%*G$!5UJ-WW0!W-HR2.KDT0$&LSB<0SJS&IGF+7''7+X[?M\]#2&!P;):-T
MB(_Y+$DG$_$K*(ARV@H<U]9[YN$\F8RG^#]#PTU3C(/_"C$0K.&DP7,I;J57
M&932\\F,=8?GBSFXKW3-68K[TV[_>PP?'+PZ*G+K^+;R(G9@\P#I=KOGVTWS
M:ODJWKS]/DJW5B"6I@*JZ?D<S';->ZI9!+N);YB5#7@1Q<\23U!R+(#SPMJP
M7["#[E&[_!=02P,$%     @ !)\"4X^M,AL= P  9P8  !D   !X;"]W;W)K
M<VAE971S+W-H965T,3DN>&UL?57;;MLP#/T5PMA# WCU+8F3(@G0IBNV81V*
MWO8P[$&QF42H++F2G+3]^E%RZF9#FY=$%Y[#0U*D)UNE'\P:T<)3):29!FMK
MZY,H,L4:*V:.58V2;I9*5\S25J\B4VMDI0=5(DKC>!A5C,M@-O%G5WHV48T5
M7.*5!M-4%=//9RC4=AHDP>O!-5^MK3N(9I.:K? &[5U]I6D7=2PEKU :KB1H
M7$Z#T^3DK._LO<$]QZW96X.+9*'4@]M\*Z=![ 2AP,(Z!D9_&YRC$(Z(9#SN
M.(/.I0/NKU_9+WSL%,N"&9PK\8N7=CT-1@&4N&2-L-=J^Q5W\0P<7Z&$\;^P
M;6US\E@TQJIJ!Z9]Q67[SYYV>=@#C.(/ .D.D'K=K2.O\IQ9-IMHM07MK(G-
M+7RH'DWBN'1%N;&:;CGA[&RNY :UY0N!<(.2*PT_E44#1[>,SDQO$EERXXRC
M8D=YUE*F'U .X5))NS;P1998_HN/2%ZG,7W5>)8>)/S>R&/(XA#2.$T.\&5=
MS)GGRS[@.\>%A7-N"J%,HQ%^GRZ,U?0^_AP@[W?D?4_>_X#\AMJF;"B;:@ES
MIO4SERNX9Z*AG#)9PEPU-;W&:^:23(L++IDLG-&IUDRND%Z\->]E_:!?U[PG
MIF8%3@/J3H-Z@\'L=HVP5((ZSSFPKJ*[]N,OY)[+MJM]>RRH9<$2@+*<O3X"
M+NE(-8:4F]X)4"6PJP2<8X'5 C5DB3^)X4ISBJ5F EBE&FE=$OZC)"_&$IT3
M] FR_B#,TS&M^N-!F(YBN),$I0?Y@B645"-/0SH*T7A,LW_O"LF-:2B#"(4R
MM@=')*^?)+08I.%XE/?@5ED2))1<?;:H*Z@=G"(F;=)+JMFSSPS)209AEHR<
MG'X:IN/LK80;5T*'P<>&VV?R5E$=\=T8/T&:AWD^=#RC,!OG<,&X?J,XD)*C
M'[A! 6G/)R<)AZ/<L0R'83S(X+WW&>TU?X5ZY4>< 9^X=@YTI]T4/6V'QYMY
M.X(OF5YQ:4#@DJ#Q<3X(0+=CK=U85?M1LE"6!I-?KNE+@-H9T/U244"[C7/0
M?5MF?P%02P,$%     @ !)\"4U(<^>LS P  $PD  !D   !X;"]W;W)K<VAE
M971S+W-H965T,C N>&UL[5;MCMHZ$'V5472E[DHTGR2$%2!!N[T?4E6T=-L?
M5_>'209BK1-3VUFV;W_'3DBW'Z!]@/X [)DYQV><&2:SHU0/ND(T\%2+1L^]
MRIC#31#HHL*::5\>L"'/3JJ:&=JJ?: /"EGI0+4(XC#,@IKQQEO,G&VM%C/9
M&L$;7"O0;5TS]76%0A[G7N2=#'=\7QEK"!:S ]OC!LW]8:UH%PPL):^QT5PV
MH' W]Y;1S2JU\2[@$\>C?K8&F\E6R@>[^;N<>Z$5A (+8QD8_3SB&Q3"$I&,
M+SVG-QQI@<_7)_9W+G?*9<LTOI'B,R]--?=R#TK<L5:8.WG\"_M\G,!""NV^
MX=C%)E,/BE8;6?=@4E#SIOME3_T]/ /DX1E W -BI[L[R*E\RPQ;S)0\@K+1
MQ&87+E6')G&\L0]E8Q1Y.>',8F-D\5!)4:+2K^#V2\O-5[CZR+8"]?4L,'2$
M#0R*GF[5T<5GZ#)X+QM3:;AM2BR_QP<D;= 7G_2MXHN$_[2-#TDX@CB,HPM\
MR9!OXOB2,WQ]AO\NM]HH*HG_+G".!\ZQXQR?NT/JE+(5"'('[C[AP\&5W%JP
M!I:V[NC,7UWF15[;CS?ZP J<>]1P&M4C>HN/%<)."FHFWNR!:V"GAK+'RY8:
MSDF0G036E-0[E"LO#):]C_62>J]@UL6;KL4)=?-=&AKNOA%TCN61J5+#IF+$
M#9]=Z6/Y>OF(BCH9;I]0%5PCK F%9\/^5*PQ0&6+\(YQ!9^8:!%6C&Z-4$S;
MA-YB@?46%221JX$0XE&:1:,\CN$/R%,_G9(Y&Y&+]E&8^7G>$9/8),I'21Y9
M1S;VDQ"B-!^-T\P:)I$_'@\98J^X#.XV]QH>*6'"7Z5)0O'1-0'2V ]#N)JF
MHRR<6$,49_YX"O3?L$/NHG,*SJ?7O8YI#E?9:#(-3\%Q\D-N5-LXU#;E%6>)
M_3A\XD\HL<P:G?XDM_@+Q9H.Q9J^N%A_?JX7:O4B[>]:_5VK+ZC5X-F@JE'M
MW3C64,BV,=W,&JS#Q%]V@^Y;>/>Z\)ZI/:?;$+@C:.A/J#Y5-X*[C9$'-_:V
MTM 0=<N*WEI0V0#R[Z0TIXT]8'@/6OP/4$L#!!0    (  2? E/-4KM3,P8
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MNP&^-A<3RND+<R4;5Y"'WV!'@RL0Q.X]S:MDPZT2!\>R46$J=F/J/7EA29I
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MI:#E!MRSG"XIX>!7\$ .I-P3\/@$%FQ?+0EX/R,BHSG_(-]^7\S ^W<?P#M
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M+&=2U79HVQO!=DT+\I$)P8KF<DNR%:EJ@'R_9DP\W]0!^C[YY#]02P,$%
M  @ !)\"4U(9<4%0!@  ^R,  !D   !X;"]W;W)K<VAE971S+W-H965T,C,N
M>&ULO9I;;]I(&(;_R@CUHI6:XCG9N$J0$K*'5ELI*NWV8K47CAG BNVAGG'2
M[J_?L7$9\!P"BL5-@N'[QN\<WF>&#U\^\>I!K!F3X$>1E^)JM)9R\WX\%NF:
M%8EXQS>L5)\L>54D4EU6J['85"Q9M$E%/D9!$(Z+)"M'T\OVO;MJ>LEKF6<E
MNZN J(LBJ7[>L)P_78W@Z-<;G[/56C9OC*>7FV3%YDQ^W=Q5ZFJ\:V61%:P4
M&2]!Q997HVOX?D;C)J&-^#MC3V+O-6BZ<L_Y0W/Q87$U"AI%+&>I;)I(U+]'
M-F-YWK2D='SO&AWM[MDD[K_^U?KO;>=59^X3P68\_Y8MY/IJ-!F!!5LF=2X_
M\Z<_6=<AVK27\ERT?\%3%QN,0%H+R8LN62DHLG+[/_G1#<1> B2.!-0EH&,3
M<)> VXYNE;7=NDUD,KVL^!.HFFC56O.B'9LV6_4F*YMIG,M*?9JI/#F]240F
M %^"NXH)5LID.[CE LRW$]M\-L]69;;,TJ24X#I->5W*K%R!.YYG:<8$N  ?
MRD<FI)I>"6:)9"M>->^_OF4RR7+Q1D5\G=^"UZ_>@%<@*\&7-:^%NHFX'$O5
MB4;*..T$WVP%(X?@CW7Y#N#@+4 !@I;TF3_]EJ4J';;IP6'Z6 W=;OS0;OQ0
MVQYVMG<OP9RE=95)U>6WX/I1]3BYS]F%\MB%2'(&_OE+)8$/DA7B7\\M\>Z6
MN+TE<=SRNN"5S/YC"Y!R(6TCN,T/V_S&QX]3A., QY?CQ_V1,L,P(C2,=F$'
M\LA.'O'*^Z/B0H"Z5%#)6Y4K!1/K1&_;H7OWAP&B/9&6(!P@NT2ZDTA/DYBK
M:V;52(W;7V#8UV@)@CB&=I'A3F3H%?F;D)G"E%*W3+(*/"9YS6P*0^/F:K(C
MTI]L,TQ--HDF=I'13F0TB,C(%!G%<81Z(LTP'&+GBISL1$Z\(F^2\D&A?<-%
M)H7'@/&NO?A<GH>!YG3P0M=W#1R,GAJ\H#?&EK )@2BPCS'<VTC@0+[O&CKT
M=%^E&8.I0Z)F-41#^;YKZ<#3_=5JBW&8'FJX0S_=CW54UTQOMB/8UVB&J=FF
MQ"%30Q[Z*3_CU8972B>XY\8^?MBFIC*D9_.5IBST8_8(7UD(2^.POPE8PG!
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M.3T2:0/,_:T0^FEBSR?M>73Q'U!+ P04    "  $GP)3HVHKKI(#  #&#
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M]%K!F 86 E>P5" ?5B"5X=MY635O&E[E*!O*>>\>1BJ"'SM)K)00'W[2L,L
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M-Z2%L;+?'U,WI8FJQ<5&LWTV71D++=@"F0X(E5K 2ET!;"@L< SW5LEBI0@
MIFYJFE(W -/1[)]-5^#]B1G#8,S>3!0E,U08.(9P<VI8*06 J9,V$%:J!V Z
MFA&TZ<I<AL$:R71(L! #5@H/8$/E@6/X-R>+E0H!V'?3&E**"F!_/&O(U]DX
M6JFW13(M$BS0@)6"!-A0D>"8$\"</_;5^I=N>D-*U0'LC^<-^7U/1UNVP1;(
M=,!!WA4),U0J 'A_1299*2R ?3==(J4H ?;'<XE\"Y?(C&$P9F\FBH09RA<
M;!^>25:J"^# 37-(*4>  _AQQS(_$?3]''U^PA+(=$ P/Z%4,,"&$@8 W:]*
M("OU!G#@IE&DU"K P1A5/3>]@%>V&<-@S-XDU)K,1WE$?:IM$LA*!0(<N.D1
M*74,<#"*1Q3TZ^SW^35B&(Q936*B_,**D-2'[J=MVM\,$'J[^K&5[:?;W\]Y
MU_UHS$3"5S^^\SFM'K*B1@M^+YIZ;]L=8=7JYVQ6;YKRL?N]EKNR:<J\>SGG
MZ8Q7+4#\_;XLF\V;]@#;7Q6Z^#]02P,$%     @ !)\"4^.AHZ_V @  ? <
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M+'5K/RSI>43M!&A_J93=39R#[L&=_@902P,$%     @ !)\"4PL6*HG-"
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MY*Y^UIB0,)<J2^K"VH,D2JO_V7W=$:T"%CU1P*H+6%\7,$\4L.L"]M "3EW
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M[*_++%]JI=,]3I[I3,K(GHM0*X>CZ[N>>DWKPC#^B34!>&D-YF5G/-A]WW@
M+ZWQ>&D!+RV<E^.-!UZOZ?:-![#5PKG6C$?3E@^Z+9AI8)KECS<& #<+E\6M
M54OX:'W7Z)E?2,*9S 4OA+,>E[U>0@P8@JK:H,4DX\*@1O#H[SB>;("FC4/S
M$\M%CJ40&TAGFZ-UMPV@LW')^(0U]-SNZD%T"6VW-@]P0)V[B)[;747H8&MH
M&P!G]VXRG+%@G=?6VHZ<<@'@9^-;"F^R>+UB>E&U$5G2VQ/=_01LM6H#'&T<
M4I^&"X"YW=U,<!$?@&XV3K=J>M7JO!Z5WTH\EYOV9:2\3147::G:I1ZQ<$=8
MNB8+O:R(LWUWV!Y[ C"TQX.A#3"T!\-P4/ %W5F #;X#7'.&<.UTQ^O&WXAL
MG8<ZWU0+. R"#D#0&0^"#D#0Z87@.=WL=+EGN9B\=0!\#@X^W8FMW9TDTBMQ
ME>G&-BSL373SGAJL/JWAM+9?<32V@F+H(L<!Z#GC*3X'H.:,M4*>.]T5,AX$
M0#GGYZ^/YST^Z&5QW[Z4 [!T\-7P?7&VR3!30$1GO+6O"[AS>_8VOUT5+=SN
MXI>B!PL 0Q=?^YZ'J45M;8 4<8&4+D[*<Z3(HK8U5(JX0$D79]@94F3A=I6A
MA3D!]'-Q^KVKUR,1EX4?>7*B_JX@G*+AT#IHPF7AN+N]"[<K)*?8>9 +T'5Q
MZ%8XT'ECJ:.X".)20U0Z_X8)E7+Q+>+-!<"Z=#R( /5<G'KG3M?N.1.:3UQ@
MIHNKR$,WBZJ;X4CFV!&XVSTQ @>JD^DCCV!3R@/L>CAVF\!XWPB?FUKX("/B
M 4"]\=2D!XSTOJ>:7'C'U"1%EDL><-(;6TTN>FKH59,>\-3#>=H,_G UZ0$K
MO?'4I-<Z<!]+32Z\KII$3]\]@)WW\]7DHL<'T^U5DQYPU<.Y^C;4K4@Q4T!&
M;SPU20%K=#0UN:1=-6D& 78M VA(>^3DF9ML2]H5E":ZX4>!F?1[,G-)N\H2
M7X%38";%B?:4ZRI+>F0;$KU# W2D.!V_'2U+VKWK9%JH5X!5BDO0'\&698\/
M07V0ZQ_.<4VK[QR7 M'I=]OT7-(NPDVTFULWJ'!\#EMJ+&GWMA2JV"D@E^+(
M;>-1%)<AROL[\FM95KO1%;*G' !04US"GG,]9$F[VZ!3&[LRY /*?1SEC]9<
M V*B-M=V!1L1'^#MX_!^G67KNRB.\=J[P [0VW/ :Q_G=96#SQ)K/B#8'^_N
MJ ]$]4<CJG^$J&A\ 5#]_P.@]O@P8.O/!X#Z/^=(?=E3KTE[%B8^T-?'Z0NQ
M7E[G+S<GAMT'\UO74<<[3O*!HCY.T:>$_)&+I":F_0)@:H S]8?$?(\/!Q%!
M#R+"Z],0 : ZP%$]VA3HJ??T%)BU?F]2_,+I/1/;*)4DYAMMR;@H%)>H?C14
MO5'9OOP)RBI3>@:4+W><Z25-\8#^?I-EZO"F^%5+\].MZ[\!4$L#!!0    (
M  2? E,514H[\P,  ,0-   9    >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM
M;+57T6[;-A3]%<+80PO4D2A9LEPX!I(8VU)D:)"LV\.P!UJ^CHE*HDI2=O+W
MNZ0429TDIABP%UNB>.XYO.0])-=G(;^J(X FSWE6J,O94>ORH^>I] @Y4Q>B
MA *_'(3,F<97^>2I4@+;6U">>8'OQU[.>#';K&W;O=RL1:4S7L"])*K*<R9?
MKB$3Y\L9G;TV//"GHS8-WF9=LB=X!/VEO)?XYK51]CR'0G%1$ F'R]D5_;@-
M+,#V^(/#6?6>B1G*3HBOYN5V?SGSC2+((-4F!,._$]Q EIE(J.-;$W36<AI@
M__DU^L]V\#B8'5-P([(_^5X?+V?)C.SAP*I,/XCSK] ,*#+Q4I$I^TO.==]E
M-"-II;3(&S JR'E1_[/G)A$] %U, ((&$/PH(&P X8\"%@U@83-3#\7F8<LT
MVZRE.!-I>F,T\V"3:=$X?%Z8>7_4$K]RQ.G-5?JMXHJ;.5!D3JZ4 JV(;96P
M)ZS8DSO.=CS#+J#,]RK']G=;T(QGZCUBOCQNR;N?WJ\]C7I,5"]MN*]K[F""
M^U-57)#0_T "/Z C\!LW? LIPJF%^R/PK1O^.=47Q!^%>YC$-I-!F\G Q@LG
MXEU7"EM4D[PZI>2O.VPCMQIR];>#(VPY0LNQF.#X18C]F6?96*YK9&R1IMI/
M&[KR([KT?1S=J9_6D9[)*HZ#?L_OY"U:>0NGO/L#%/#L&&?4!HK^MUS&+4?L
M%'O#U'%LU<2#[$1TX2\GD[-L^99.O@=06O)48_6D$]1U@*A';>9DBCAIB1,G
M\56:BJK JC;%7!58RQEJD) "/[%=!FI,2C*00L-H-:EEU6I9N5>(Q!U+ZA>K
M!7!N2]Q#] =2@!Y3L1JH6"9!.*F"^IWK^>[),-O!7!SFE0+"C.F-&H@_X _M
M2ICB[[DN=?)_UD>0-?%H^AOX]_D/DVGFSJ5HX&2^+30KGKB9=]QT:YL?51 ,
MQYY$OF,]TL[%Z'^VL6T#[?.N:!).UQ_MW(FZ[:DMA)*]F(4_2K\8T,_C! U@
MDK[S-!J]12\KK+RLVT]'%41#!<DBBJ85=(Y'W9:WA0-(:8O_!$4UGH!X2!^N
M?,?2ZPR0NAWP#O" ]N;PAR8X=Q==YX/4;81UT;W%/W2^.0V3Z<V1=MY'W>;7
MIE^SY[Z,2?NC0_^;1V&PBB?%!)T#!FX'_%UHEI$4CWU\#Y*9'79,0C"TP$4<
M47]Z*P@Z$PS<)OAJ ZT/$7UDFG!%X+D$NU-J07: Y_A]A?<#+%F"-QV;OK*2
MI5#C4]C0]K?P?VOU>B=F<[_YC<DGCB?@# Z(\2_,A4#65X;Z18O2'J)W0N.1
MW#X>\9H%TG3 [P<A].N+.9>W%[?-/U!+ P04    "  $GP)3K:"HX\P"  "P
M!P  &0   'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6R=55UOVC 4_2M741^H
MU)*0A ]5@%1@U3JM$VK7[6':@YM<B%7'IK8#[-_/=D)&2QI5>R&V<\^YYYY+
MKL<[(9]5AJAAGS.N)EZF]>;*]U6284Y45VR0FS<K(7.BS5:N?;612%('RID?
M!L' SPGEWG3LSI9R.A:%9I3C4H(J\IS(/S-D8C?Q>M[AX)ZN,VT/_.EX0];X
M@/IQLY1FY]<L*<V1*RHX2%Q-O.O>U7QDXUW #XH[=;0&6\F3$,]V<YM.O, *
M0H:)M@S$/+8X1\8LD9'Q4G%Z=4H+/%X?V&]<[::6)Z)P+MA/FNILXHT\2'%%
M"J;OQ>XS5O7T+5\BF'*_L*MB P^20FF15V"C(*>\?))]Y<,1P/ T \(*$'X4
M$%6 R!5:*G-E+8@FT[$4.Y VVK#9A?/&H4TUE-LN/FAIWE*#T]/KY*6@BEI+
M%5S"4@IP]L -Y80GE#"XY>6?Q;K>6: FE*ES&[M"CGNS>'Q80.?L',[ !Y41
MB0HHAT=.M;HPAV;]/1.%(CQ58U\;T3:UGU0"9Z7 \!V!$=P)KC,%GWB*:0-^
MWHX?M.!]8U;M6'AP;!:V$GXI>!>BX +"( R:]/PW_)6<J&Y@Y/BB=_AFA3(G
M2L%1)^'75W,&MQIS];LE1USGB%V.^)T<][A%7F!3\TK@P 'MQ-A.XS ,>F-_
M>VS):=1P$,1Q'?5*5;]6U6]5]<W,.,H3D2-TF%#JO$E?_S1S'/7?R#L-NHR"
M?M!OUC>H]0U:.W.B#S8HP>QSTR'WG5RU]&989QFVNC CBB;0L=^@I7>\C4Z4
M-*.C(H-N/'CCQ&G09:\[&C8;,:HECEHE+B@K-*8?$3EJ$OFV7:=!32+]HZ&8
MHUR[NT(9_PNNR_E8G];7T;6;POZ_\/(NNR-R3<U\9+@RT* [-'\86=X/Y4:+
MC1NQ3T*;@>V6F;E24=H \WXEA#YL;(+ZDI[^!5!+ P04    "  $GP)3MZ;U
M^.H&  "O'@  &0   'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6RU65%/XS@0
M_BM6M2>!!#2VDS9!@+2T+-O3LH=@]_;A= ]NXK:Y3>*L[5"0]L>?G82D)8Y;
M[I872-*9\>?QS'PSR=F:\>]B1:D$CVF2B?/!2LK\=#@4X8JF1)RPG&;JEP7C
M*9'JEB^'(N>41*52F@R1XXR&*8FSP<59^>R67YRQ0B9Q1F\Y$$6:$OYT21.V
M/A_ P?.#NWBYDOK!\.(L)TMZ3^77_):KNV%C)8I3FHF898#3Q?G@/3R=85\K
ME!)_QG0M-JZ!WLJ<L>_Z9A:=#QR-B"8TE-H$4?\>Z(0FB;:D</RHC0Z:-;7B
MYO6S]0_EYM5FYD30"4N^Q9%<G0_\ 8CH@A2)O&/KC[3>D*?MA2P1Y5^PKF6=
M 0@+(5E:*RL$:9Q5_\EC[8@-!8Q[%%"M@%XJC'L4<*V 7R@@V*/@U@KNOI"\
M6L';=X51K3#:5V%<*XSW5?!K!7]?A:!6",IPJ,ZO//PID>3BC+,UX%I:6=,7
M9025VNK,XTP'^[WDZM=8Z<F+"<L>*)?Q/*'@GF8QX^ SDU2 8_"9<$YT*(*#
M*94D3L3AV5"J-;7F,*SM7U;V48]]"&Y8)E<"7&41C0SZ4[L^WJ5_;=<?6?2'
MRE>-P]"SPRZ1U> -X2< PR. ' 2_WD_!P;M#ENO$%2O"J3! G.RR^%0;A'YM
M,'H'AJ"RUVMU:K?Z>Y$IG,X63H.5JU^^VP_[6W3Z<5W_DMU]W-^*!<O,;F5*
MPQT[V@HTW&0F+LWB7K-S"6:9D+Q0Y"+!7Y^4 )A)FHJ_+>;=QKQ;FG=[S']B
M0@#%-O11QMFRB,6J7(4M%%7,I>E$*GNCTI[FT(>+,1Q[CN.<#1\V?=Z5.QYY
MP:;<%F"O >Q9 ;^/_E'E4(,40#) HBC6<4@2D),X G$&0I+'DB1'@/XH8OD$
M0I;F+*MW%6X4NIX=3KT.<NB,<6>'5UVYP/%'';D/73DT=KU>3XP:3XS^AR>.
MX^RX]@18<):"M:[C2M94O$<=A*[C] (<-P#'5H"WY*E!5V3K.(NL("ICWJ;;
M1YX%AM_ \.TP. LIC43EA@J(BO6M4)@S!6Y%HZ6QEEWZW8@8!19H00,ML$+[
M7*1SRG5<UM54P8O4@QYHX&<M9\(8=-PW<CVO$[0[Q;8V IVV@7"L6]GL(*K6
MX:>NA!CTM1:6X@4WVA;X%M41HG8!9$^RY9+3)9$4Y#S.PCA7Z4125NAJ4D@A
M21E+)K:O#6\5RBJ<7Y[)M!;=/!3L>F,4=$2O]Q>=&0"X@8?\_K"%+2E!;'7+
M+)-4\;X$7+OF@ A 0$YYJ,[ 1)V3'>:<D['WF^V\6CJ#=C[;3G9=X8] 1LO2
M'PM1D"RD*KN$L0)-H(';,(:61(<M;4$[;\TR59U5\%2I70V)I>^J#DI[#[R#
M1VHELP,KZSH)&VS.B>.X#G+='FPMD4 [DQBPJ6A7GCK0?8Q&5H(\5"G==J1&
ME-4Z_B;5N?Z)Z_<@;)D$VJFDS/.=!SB%)@X)#"EWO8_D-M:6;J"=;TJL.:=I
M7*1&D'YW:3PV@MQ#<AMD2SS0SCQW-"]XN"*"1DT]JWH^U4(]EU/CG!<8NB/7
M,Y8U@Z@;C RB5_M;O89=!NM:W9[I6A)#=A)37GGN690WLBY-U:.ATX7@!-"$
MUB3J6<\0M>2'H)V;PI 7ZOR>B[$1*NPVGT:<L,LK-I M@2([@;Y^P$!=BALC
M&Y:6M= NU@HY52$/#B):71WJ@:&,^B@6H4X#(R)LR$-;:XI:OD)VOGK[<>8:
M=5D-.E:'MJ2&[*3VK6[GR]),2[AY,4_B4&%;4*Z[[)K?-'?T\L9EO<RF@Y$7
MC%6_M!VF$X,@=J"/T?A%0=G#XO:>6[)$=K)LIIH%ZVW4C6]_ND,6=!UKDK7T
MB.ST6)^#2C+5@\6"_D?ZKE?9I&\,O1/<0]^HI41DI\1?-ZI.4'<6"UYVU=LH
M6TY$=DY\]0BC?G\Q@!R!.QK1M!S2CL"M2@$6@3\R:GL1U+(3=MYBV,$MH6 [
MH7Q9J<!8L20"DI-R1H[(D]ZEZ8WK!'<I _6< 6[I MOI0KE:T+ HWS?O!<(P
M#_6!V'CE9N>)>\G"[W4.21XOERJ%5-B&"1$B7CQUJBY0\T]8<*X/9?<LM&-Q
MB'5?;YN&<,LNV,XN;Q717];,AJ_E#^R]242WQ1K;B_4K(WK4"2:O)Y;:THSM
MI?G5 6T83/H"NJV_V%Y_;\ACG!8ID(T[GIO]9TC;P;Y'$-L7#/R^&!YN?*1*
M*5^67SA5^NC>JWIMW3QMOJ*^+[\=OGA^"4\GT/!\"D\_F)Y?P]./U;?3=MGJ
M4^X-X4LU]("$+A0$_2YB 'CU=;2ZD2PO/YW-F90L+2]7E$24:P'U^X*IW*EO
M] +--^J+?P%02P,$%     @ !)\"4USSP(<< P  E0@  !D   !X;"]W;W)K
M<VAE971S+W-H965T,S<N>&ULC59-;]LX$/TKA+"'!&BB;\D.; .MC:)=M NC
M:78/10^T/+:)4J1*4G;<7[]#2E&=E62L#Q8IOC?SW@PE:G:2ZH<^ !CR7'*A
MY][!F.K!]W5Q@)+J>UF!P)6=5"4U.%5[7U<*Z-:12NY'09#Y)67"6\S<O;5:
MS&1M.!.P5D3794G5^1UP>9I[H?=RXPO;'XR]X2]F%=W#(YBG:JUPYG=1MJP$
MH9D41,%N[KT-'U:YQ3O WPQ.^F),K).-E#_LY.-V[@56$' HC(U \7*$)7!N
M Z&,GVU,KTMIB9?CE^COG7?TLJ$:EI+_P[;F,/<F'MG"CM;<?)&G#]#Z26V\
M0G+M_LFIQ08>*6IM9-F244')1'.ESVT=+@AA,D*(6D+T?PEQ2XC_2\A&"$E+
M2%QE&BNN#BMJZ&*FY(DHB\9H=N"*Z=AHGPG;]D>C<)4ASRR64AQ!&;;A0!Y!
M,*G(7]* )G?M=4W/U"[>K,!0QO4MKER27M!1$,7D2K2GQQ6Y^>-VYAM4;7/[
M1:OP7:,P&E'X9RWN21R\L1G" ?KR.GT%!=)#1P\&Z*OK],_TW++#R6NVCY7N
MRAUUY8Y<N'@DW*N:OB'+6BD0AE"QQ4*)HIU^>[O11N$C\?U*RKA+&;N4R4C*
MM6*B8!7EA):RQNAR1\P!FH8U>O!UH UJ8&(_U)\F?N;BV]?(<1$G:1Y-@P +
M>KQL11^93--H$O20JSXR3X/FUR%?V4TZN\E5NT\";>(6_ 5;LF6Z<)9OL 2\
MMOY(?;D.&T.8UC45!9!":C.X/YN$Z876NSA(PK#O?P"91M-)/NHJ[5RE5UU]
ME08;R*78WQE0):FL!7QM8B^%:V'5;*DA^6E/5!RF<3CIR^\CDR2*IO&H_*R3
MGUV5OZ1*G6WUCY378%7#SYJ9,]:\K*2 H5TY9"7K"8SR/,_Z3OK 9!)/Q_N0
M=T;RJT;>4Z9^FQA_C,C-)S@")]'@ALH''J@P>[U-&A]]9))E03K0$?_B#+ '
M]F>J]DQHPF&'W. ^QV*HYA!L)D96[EC82(.'C!L>\+L!E 7@^DZBJ79B3YKN
M2V3Q+U!+ P04    "  $GP)3-7Z="<,"  !?"   &0   'AL+W=O<FMS:&5E
M=',O<VAE970S."YX;6RU5FUOTS 0_BM6M$F=!'GMRYC:2EM;Q!"3JHW!!\0'
M-[FTUAR[V.[:_7O.3AJZD88)Q)?$OMSS/'?GE\MP*]6#7@$8LBNXT"-O9<SZ
M(@ATNH*":E^N0>"77*J"&IRJ9:#7"FCF0 4/XC#L!P5EPAL/G6VNQD.Y,9P)
MF"NB-T5!U=,5<+D=>9&W-]RRY<I80S >KND2[L#<K^<*9T'-DK$"A&92$ 7Y
MR+N,+F8#Z^\<OC#8ZH,QL9DLI'RPD^MLY(4V(."0&LM \?4($^#<$F$8/RI.
MKY:TP,/QGOV]RQUS65 -$\F_LLRL1MZY1S+(Z8:;6[G] %4^/<N72J[=DVQ+
MWV[/(^E&&UE48(R@8*)\TUU5AP- = P05X#X):![!)!4@.2U"MT*T'VM0J\"
MN-2#,G=7N"DU=#Q4<DN4]48V.W#5=VBL%Q-VG]P9A5\9XLSX6J2R /*9[DAG
M"H8RKL_(6W)_-R6=DS-R0I@@-XQS7%0]# PJ6ER05NQ7)7M\A#TA-U*8E28S
MD4'6@)^VX_LM^  SK=.-]^E>Q:V$'S?")TGXAL1A'#7$,WD]/&Q*Y]_49W^M
M_JP82;WVB>-+_KSVLQW%S47=V?WV"?W(M8%"?V]1Z=8J7:?2/:(RRW-PMP%N
M):=G4$]1 Z1#-:%D#2H%8<Z:=E<[\\ ?A*=-B]@.BR._UXB;MN,Z<<\/P].F
M0&?MR"CTW[U4?%;+7EW+7BO1!$\#$TLL%^&,+AAGAH'&\SK/0<"N1:%?*_3_
MXYX8U"J#UCQN(=N4C0*OE_3WI)Z:-D-)&94WF>U_C^.DZ^,Y>CQ<PR:OQ#^O
MO<IX@X,;LP"U=*U*8R@;8<H#5%OK;GCIFL +^U5T,8D:[%/LGF6S^T5?MMX;
MJI9,:,(A1ZG0'^"2J[*=E1,CU^Z^7DB#M[\;KO / )1UP.^YE&8_L0+U/\7X
M)U!+ P04    "  $GP)3^(=$N28$  !N$0  &0   'AL+W=O<FMS:&5E=',O
M<VAE970S.2YX;6REF']OFS@8Q]^*A4ZZ3;H&;'Z$3$FD9NUN=]*VJ%&WOUUP
M$E3 F>TDG70O_FQP<3+ #:T4)4#PUQ\_]O-],-,C98]\2X@ 3T5>\IFS%6+W
MP75YLB4%YB.Z(Z7\9TU9@84\91N7[QC!:=6HR%WD>9%;X*QTYM/JVI+-IW0O
M\JPD2P;XOB@P^[4@.3W.'.@\7[C+-ENA+KCSZ0YOR(J(^]V2R3.W44FS@I0\
MHR5@9#USKN&'!8I5@^J.[QDY\I-CH(;R0.FC.ODGG3F>(B(Y2822P/+G0#Z2
M/%=*DN.G%G6:/E7#T^-G]4_5X.5@'C G'VG^(TO%=N;$#DC)&N]S<4>/GXD>
M4*CT$IKSZAL<];V> Y(]%[30C25!D97U+W[2@3AIX/<U0+H!JKCKCBK*&RSP
M?,KH$3!UMU13!]50J]82+BO5K*P$D_]FLIV8KP1-'K<T3PGC?X+;G_M,_ )7
MH+H,ONVJR"US+,-7IN".<,&R1)!4WW"M8JI:O+LA F<Y?S]UA:12VFZB"18U
M >HAB, 76HHM![=E2M+S]JX<33,D]#RD!;(*_KLO1\#W_@+(0_ /X *^Q8SP
M^MNB[S<A\RO]P!8R'1N;7M#H!96>WZ?W$EC8"(56L 66$Y40@ 5X()NL++-R
M ^@:[ C+: K>U1%X#_X#7;&H0UOW$%8]J(P^S%$8P1BAJ7OH0(L:M,B*]C?#
MI5HV%S%$+08?QGX,NQ'&#<+8BJ G#) GPI*,7PHS;L%<A;X?A#TT<4,36VFD
MI:Q)=G%(XC9%[ ?QI!MBTD!,+ETP1*;WP*4R:2\5%/GRTPT%/6-)GC4A?E16
M2M*KZP-ALC2 6SUE8"G=AU@R!9[8'GQ3KMRO;M1Q/7P5!V,DG197]Q:?!",.
M1V'/_$!D,-%E>3.4IY:%Z 0(1L&H;VZ,]T&[^75DT5 TO[5NPAYW@<9"87!I
M.@W%"3HBY46C2=S#9-P87FS'OV774,2PM;B@YX_&?:O+F#*TNW*[GA\Q2VVE
M"!JWA6-K$K]"VW@GM)OG5UH>I+R4?DNI@VU315XD'QIZPFI<%=IM=5"Q@VT;
MA6$<A%$W!3(NBCS[Y*[N.=!ANHA$ZYT5F4D8>>,>$N.UR.ZU VN=5COCB,83
MKP?#>"FR>^G9JGE%O=/R9^LEDB6OYTD &4]%_K!Z5RT@()_G"?B$,P:^XWQO
M*WO(^"2R^^3+F3/0FW1_\6_N&?>X)S+NB>SN^=K*IV7/_7P,1T'00V3<$KW@
MEJ<)-90JZJ!"T2CH\7!D?!;9'VM?7_FT<(L)]3PD(.//:( _OZWVZ9[.UI<?
MMQG=DRUP0=BFVNASD-!]*>K=<'.U>9EP76^AS>WUFX@OF,F\X" G:]G4&XWE
MBF+UYKX^$717;:@?J)#;\^IP2[#<0:L;Y/]K2L7SB>J@><4R_Q]02P,$%
M  @ !)\"4X"W?9V' P  LPH  !D   !X;"]W;W)K<VAE971S+W-H965T-# N
M>&ULM5;;CMLV$/V5@="@"9!8-U_DP#:P6:=(BK8Q=I'TH>@#+8TM8B51(2E[
MW:_OD)*UREI6BZ#5@\W;F3ESX7 61R$?5(JHX3'/"K5T4JW+MZZKXA1SID:B
MQ()V=D+F3--4[EU52F2)!>69&WC>U,T9+YS5PJYMY&HA*IWQ C<25)7G3)[>
M82:.2\=WS@MW?)]JL^"N%B7;XSWJS^5&TLQMI20\QT)Q48#$W=*Y\=^N_=
M[(DO'(^J,P9CRE:(!S/YF"P=SS#"#&-M1##Z.^ M9IF11#R^-D*=5J<!=L=G
MZ3]9X\F8+5-X*[+?>:+3I1,YD.".59F^$\</V!@T,?)BD2G["\?FK.= 7"DM
M\@9,#')>U/_LL7%$!^!/KP""!A \!XRO ,(&$/Y;P+@!C*UG:E.L']9,L]5"
MBB-(<YJDF8%UID63^;PP<;_7DG8YX?3J7HOX(159@E+]".^_5ER?X W\QJ1D
M)B+P<HV:\4R]HM7/]VMX^<.KA:M)L\&[<:/E7:TEN*8%RQ'X_FL(/'_> [\=
MAO_*Y A""P^\'OAZ&/YS51#<LW#_6[A+[FI]%K0^"ZR\\)HU*9/XQF1; K<B
MIRNHF$WB&W):L4>Z%AJV)^B>V["37;XY,IG '[^02/BH,5=_#A *6T*A)32^
M0NA3I95F1<*+/8C24%&@4Z:!] ,^HHRY8MN,@JD,)=47P76M8F)5F&IQ6/FA
M9[Z%>^CA-FZYC?\3;J_A:.\H^8H=4%+-.>\BE)+'1-ZD7XE4M(P1O3;45**.
M#7-_-.DW8-(:,!F,]ON\S,0)$>Q5@4TEXY1""IN,%0.QF[;BIX/^J:5*+!NY
M"225-,XB2[E(^BY++7#:L7(6!M&L&ZK:'9<'KP1SUI*=#9*]J70J)/^+6*IG
MO('EHBIT7VV87="8>,W73R=JZ42#=#;61< +H >0,D3L+FF54NPER_MX#0L/
MX81,JH$0SUN:\T%)=V@>8!-3]CW^6\\O_!>,HVC ?[[W5/V]06K?F=Q^YWGQ
M_X_;XS_58C\8OC^F&$ GW*94,&6N3VP*+N4$-30/U$$U583VV'FWMXC\@\)H
M,O*\%T/<G\JV/URW+7>B<Z 'UM9G2F/85;KJ6*0&B[9_6;7'TV@Z?987;J=!
M,.T</:A[3H4XPQWAO-&,!,BZ0ZHG6I2V9]@*31V(':;45:(T!VA_)X0^3TP;
MTO:IJ[\!4$L#!!0    (  2? E,74SVO%@,  -@)   9    >&PO=V]R:W-H
M965T<R]S:&5E=#0Q+GAM;+56;6_;-A#^*P=]VH A>K.=.+ --';7!4M;(T';
M#\,P,-)))DJ)&GFR$Z _?D=)D=W4U@)L^2+Q[7GN[CGRR-E.FZ]V@TCP4*C2
MSKT-477I^S;98"'LF:ZPY)E,FT(0=TWNV\J@2!M0H?PH""9^(63I+6;-V-HL
M9KHF)4M<&[!U40CS>(5*[^9>Z#T-W,I\0V[ 7\PJD>,=TJ=J;;CG]RRI++"T
M4I=@,)M[;\++MV'L ,V*SQ)W]J -+I1[K;^ZSG4Z]P+G$2I,R%$(_FUQB4HY
M)O;C[X[4ZVTZX&'[B?W7)G@.YEY87&KU1::TF7L7'J28B5K1K=[]AEU 8\>7
M:&6;+^S:M9.)!TEM21<=F#TH9-G^Q4,GQ $@FIX 1!T@>@X(3@#B#A _!X0G
M *,.,'H.B$X QAV@"=UO8V^$6PD2BYG1.S!N-;.Y1J-^@V:]9.DVRAT9GI6,
MH\52%X4DSCR!*%-8ZI)DF6.92+27<(.Y4+ V.D%,>=S"3RLD(97]>>83FW<D
M?M*9NFI-12=,?4SH#.+P%XB"<)K(K51_);JH%.]F.L*V? %;-&W9*D%XE&0U
M3/)>/'8>14&%)-W>/<+R=ICE39WO SM.XW-:^MQ$?6ZBAG=T@O>FKF0)ZR8V
MN"XSXS)3_!#H=]QQSQTWW/$)[G>L^O?9AC]N> U<$Q;VSP$+H][":-#[#W5Q
MCP9T!FUV+ BE,,=4/8+L@DFAKKA:?(.3"5RV1L:-$5?UMHO1S-\>\6O<^S4>
M].O3':RD)2,38@%J0\#E%FB#\$$;_IER/\_.?]Q(/:#&I+<Z>26]SWL+YR_4
MNSE;T)\M"YE4++7(N6<)6&A)CRSZOY_!J_,?U(^/JW_1>WDQZ.5U2>SD6AAB
M!6YQZZX2=KG;Y-]@G6&)#P-R3'M#TU<2/ SVM3-XZ1;O3GVG]=$:$KQ4R_"@
M>(?_2<UW=[\/!;HO1&'T6F+N"U(8_V]BKCJN0S&C9V+Z!Y>B>_.\%R;G_0\*
M,\8$9^<,-NTSHNV0KII[\EX3W[I-<\-/+S1N <]G6M-3QUV]_6-N\0]02P,$
M%     @ !)\"4WS$,2OH 0  6@0  !D   !X;"]W;W)K<VAE971S+W-H965T
M-#(N>&ULG53?3]LP$/Y7K+R#TY0RA-)(T!4Q":2*"O: T.0DE\3"/S+[LG3_
M_6PG#=W4\K"7V'>^[[O[SN>DO3;OM@% LI-"V674(+;7E-JB <GLN6Y!N9-*
M&\G0F::FMC7 R@"2@B9Q?$DEXRK*TN#;F"S5'0JN8&.([:1DYO<M"-TOHUFT
M=SSQND'OH%G:LAJV@,_MQCB+3BPEEZ LUXH8J);1S>QZE?CX$/#"H;<'>^*5
MY%J_>^-;N8QB7Q (*- S,+?\@A4(X8E<&3]'SFA*Z8&'^SW[7=#NM.3,PDJ+
M[[S$9AE=1:2$BG4"GW1_#Z.>A><KM+#A2_HA=C&/2-%9U'($NPHD5\/*=F,?
M#@ 75R< R0A(_@4L3@#F(V >A Z5!5E?&;(L-;HGQD<[-K\)O0EHIX8K?XM;
M-.Z4.QQF#RP'D5)T5-Y!BQ%V^SEL+<!=)1X!K@9@<@+XPD0'?\.H*WFJ.YGJ
M3@+/Q0F>FZ+0G4*N:K)%IDIF2DN>VY(AD-?U#OV<Y0+(6G42#/,C\W9,YN=9
M.GM6,];^^,@V)1MR?61ZX/9H._Y?1A+/+L]F<_+Z"#('\W:L:_3@YOVK>V2F
MYLH2 97+%Y]_<5-DADD>#-1MN-5<HQNML&W<XP?C ]QYI37N#3]?T^\D^P-0
M2P,$%     @ !)\"4U$MJ$PT P  ^A,   T   !X;"]S='EL97,N>&ULW5AM
M;]HP$/XKD3M-K30U@:PI60%I0ZHT:9LJM1_VK3+$ 4N.G3FF@_[Z^>(07NIC
MK!\V6%")?8_ON>?.E\9MOS)+P>YGC)E@40A9#<C,F/)#&%:3&2MH=:E*)BV2
M*UU08Z=Z&E:E9C2KP*D083>*DK"@7))A7\Z+V\)4P43-I1F0I#4%[O8Y&Y!.
M\IX$CFZD,C8@C^=O?\R5N7D3N/O9N[.SZ/'B9M=^7@,7)/227AU >AE%.#&
M&'ER&/D^;HSZ>IMZ4^?O=?40YVB7(-I#DAZ4W)[<:N*PV?MA/U=RW0(Q<08;
MF18L>*)B0$94\+'FX)73@HNE,W?!,%%"Z<#8WK-2.F"IGAW<<3-HRX:GX%+I
M.K:+X+['S?(=8#4#@5R(5F"7.,.P7U)CF):W=E(OKHTOH* 9/RQ+JW"JZ;+3
MO2)KA_IF@XR5SIANPW3(RC3L"Y:#',VG,[@;588 &J,*.\@XG2I):PTKCV9@
M:2=,B'MX9K_G6]R+?&-/(]A1V0ZMH&;H:-P$^#?9'/<F;?PJWJ#D3\I\FMMT
M9#V'7F%WFN5\4<\7>2L 8^_@[+0LQ?*CX%-9,)?\P0&'?;KR"V9*\V<;#5IE
M8@U,D^"):<,GFY:?FI8/;&%6[;3(<<W=$]3\=^L\99)I*C9%V]X_YBJ_6G%\
M_:\DU[]5=@5[-38OXF,7>74*(I-3$'D2/=D[!9'I\8N,CU-CV!PR-DXR6^>8
MUAK >7% OL')5*R#!N,Y%X;+9C;C6<;DB^.,I3=T;/^PV>*WZS.6T[DP#RTX
M(.OQ5Y;Q>9&VJ^Z@$,VJ]?@+I-=)VL.JC<5EQA8L&S53/1W7P\ .;-3F H==
MY+:^_ CFXS _ A@6!U. ^3@O+,[_E$\/S<=AF+:>%^FA/CW4QWGYD%']P>+X
M?5)[^3--TSA.$JRBHY%7P0BK6Y+ CY\-TP8>6!R(]&>UQG<;[Y#]?8#MZ;X.
MP3+%.Q'+%*\U(/ZZ@4>:^G<;BP,>V"Y@O0/Q_7&@I_P^<0R[BFG#GF <25,,
M@5[T]VB2(-5)X./?'^PIB>,T]2. ^17$,8; TX@CF +0@"%Q7+\'=]Y'X>H]
M%:[_VS?\!5!+ P04    "  $GP)3EXJ[',     3 @  "P   %]R96QS+RYR
M96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY
M/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL
M/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%
MY4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.
MW&,EC'%BM/XU@LD/['X 4$L#!!0    (  2? E.6,,J M ,  '@<   /
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MN%9E<_1GW0^;^2=02P$"% ,4    "  $GP)3!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (  2? E,/
M:-&G[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    (  2? E.97)PC$ 8  )PG   3              "  <T!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ !)\"4R:?^F;"!0
MT1@  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    (  2? E.)YLAI*0<  (D>   8              " @08.
M  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  $GP)3S*1H
M,.,"  !_"0  &               @(%E%0  >&PO=V]R:W-H965T<R]S:&5E
M=#,N>&UL4$L! A0#%     @ !)\"4R7'8"<2!P  0Q\  !@
M ("!?A@  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (  2?
M E,%_GNH6@,  ,@)   8              " @<8?  !X;"]W;W)K<VAE971S
M+W-H965T-2YX;6Q02P$"% ,4    "  $GP)3B#ZY+6X)  #V.0  &
M        @(%6(P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%
M  @ !)\"4^%</GI$"0  D28  !@              ("!^BP  'AL+W=O<FMS
M:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (  2? E.SWRWH6"0  +UN   8
M              " @70V  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"
M% ,4    "  $GP)3I5A4%JT,   ")   &               @($"6P  >&PO
M=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ !)\"4^G8PY%)#P
MXC(  !D              ("!Y6<  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX
M;6Q02P$"% ,4    "  $GP)3L,3PDI$+  #N(   &0              @(%E
M=P  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (  2? E.8
MX8S60P0  $8*   9              " @2V#  !X;"]W;W)K<VAE971S+W-H
M965T,3(N>&UL4$L! A0#%     @ !)\"4[U$UR*%!   O D  !D
M     ("!IX<  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  2? E,81/><^@0  . *   9              "
M@8?"  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ !)\"
M4X^M,AL= P  9P8  !D              ("!N,<  'AL+W=O<FMS:&5E=',O
M<VAE970Q.2YX;6Q02P$"% ,4    "  $GP)34ASYZS,#   3"0  &0
M        @($,RP  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0
M   (  2? E/-4KM3,P8  %L:   9              " @7;.  !X;"]W;W)K
M<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ !)\"4X\_7Q?:!   ,Q<
M !D              ("!X-0  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q0
M2P$"% ,4    "  $GP)34AEQ05 &  #[(P  &0              @('QV0
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    (  2? E-]ZHUU
MH (  -P&   9              " @7C@  !X;"]W;W)K<VAE971S+W-H965T
M,C0N>&UL4$L! A0#%     @ !)\"4QY=N*NT P  FPX  !D
M ("!3^,  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    "  $
MGP)3HVHKKI(#  #&#   &0              @($ZYP  >&PO=V]R:W-H965T
M<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (  2? E/XO*,K;P,  /T*   9
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M970S,2YX;6Q02P$"% ,4    "  $GP)3XZ&CK_8"  !\!P  &0
M    @(&D!0$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    (
M  2? E,+%BJ)S0@  ,8U   9              " @=$( 0!X;"]W;W)K<VAE
M971S+W-H965T,S,N>&UL4$L! A0#%     @ !)\"4Q5%2COS P  Q T  !D
M             ("!U1$! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"
M% ,4    "  $GP)3K:"HX\P"  "P!P  &0              @('_%0$ >&PO
M=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    (  2? E.WIO7XZ@8
M *\>   9              " @0(9 0!X;"]W;W)K<VAE971S+W-H965T,S8N
M>&UL4$L! A0#%     @ !)\"4USSP(<< P  E0@  !D              ("!
M(R ! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    "  $GP)3
M-7Z="<,"  !?"   &0              @(%V(P$ >&PO=V]R:W-H965T<R]S
M:&5E=#,X+GAM;%!+ 0(4 Q0    (  2? E/XAT2Y)@0  &X1   9
M      " @7 F 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%
M  @ !)\"4X"W?9V' P  LPH  !D              ("!S2H! 'AL+W=O<FMS
M:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    "  $GP)3%U,]KQ8#  #8"0
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M+G)E;'-02P$"% ,4    "  $GP)3EC#*@+0#  !X'   #P
M@ $_. $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ !)\"4[[+,T&9 0
M=1D  !H              ( !(#P! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ !)\"4R/5;@VH 0  N!D  !,              ( !
M\3T! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     #( ,@"5#0  RC\!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>299</ContextCount>
  <ElementCount>403</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>81</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2114102 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2118103 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2123104 - Disclosure - Convertible Senior Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotes</Role>
      <ShortName>Convertible Senior Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2127105 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2129106 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2133107 - Disclosure - Commitment and Contingencies: Legal Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings</Role>
      <ShortName>Commitment and Contingencies: Legal Proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2315302 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/FairValueMeasurements</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2319303 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/Acquisitions</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2324304 - Disclosure - Convertible Senior Notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesTables</Role>
      <ShortName>Convertible Senior Notes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/ConvertibleSeniorNotes</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2330305 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/StockholdersEquity</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2416411 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2417412 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2420413 - Disclosure - Acquisitions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2421414 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisitions - Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2422415 - Disclosure - Acquisitions - Pro Forma Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails</Role>
      <ShortName>Acquisitions - Pro Forma Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2425416 - Disclosure - Convertible Senior Notes - Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails</Role>
      <ShortName>Convertible Senior Notes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2426417 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails</Role>
      <ShortName>Convertible Senior Notes - Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2428418 - Disclosure - Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTaxDetails</Role>
      <ShortName>Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/IncomeTax</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2431419 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails</Role>
      <ShortName>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2432420 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2434421 - Disclosure - Commitment and Contingencies: Legal Proceedings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails</Role>
      <ShortName>Commitment and Contingencies: Legal Proceedings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="lgnd-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - lgnd-20210630.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - lgnd-20210630.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="lgnd-20210630.htm">lgnd-20210630.htm</File>
    <File>lgnd-20210630.xsd</File>
    <File>lgnd-20210630_cal.xml</File>
    <File>lgnd-20210630_def.xml</File>
    <File>lgnd-20210630_lab.xml</File>
    <File>lgnd-20210630_pre.xml</File>
    <File>lgnd_63021exhibit311.htm</File>
    <File>lgnd_63021exhibit312.htm</File>
    <File>lgnd_63021exhibit321.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>lgnd-20210630_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>60
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lgnd-20210630.htm": {
   "axisCustom": 0,
   "axisStandard": 26,
   "contextCount": 299,
   "dts": {
    "calculationLink": {
     "local": [
      "lgnd-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lgnd-20210630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lgnd-20210630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lgnd-20210630_lab.xml"
     ],
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lgnd-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "lgnd-20210630.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd"
     ]
    }
   },
   "elementCount": 539,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 2,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 7
   },
   "keyCustom": 52,
   "keyStandard": 351,
   "memberCustom": 37,
   "memberStandard": 40,
   "nsprefix": "lgnd",
   "nsuri": "http://www.ligand.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.ligand.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118103 - Disclosure - Acquisitions",
     "role": "http://www.ligand.com/role/Acquisitions",
     "shortName": "Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123104 - Disclosure - Convertible Senior Notes",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotes",
     "shortName": "Convertible Senior Notes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127105 - Disclosure - Income Tax",
     "role": "http://www.ligand.com/role/IncomeTax",
     "shortName": "Income Tax",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129106 - Disclosure - Stockholders' Equity",
     "role": "http://www.ligand.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133107 - Disclosure - Commitment and Contingencies: Legal Proceedings",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings",
     "shortName": "Commitment and Contingencies: Legal Proceedings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315302 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319303 - Disclosure - Acquisitions (Tables)",
     "role": "http://www.ligand.com/role/AcquisitionsTables",
     "shortName": "Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324304 - Disclosure - Convertible Senior Notes (Tables)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesTables",
     "shortName": "Convertible Senior Notes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ieb2751225b4e422c8601c5b45f74edf0_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ieb2751225b4e422c8601c5b45f74edf0_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330305 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.ligand.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ic303d3a8e76444c19a42764555e9621a_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "lgnd:ScheduleOfShortTermInvestmentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ieb2751225b4e422c8601c5b45f74edf0_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "lgnd:ScheduleOfShortTermInvestmentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ieb2751225b4e422c8601c5b45f74edf0_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ieb2751225b4e422c8601c5b45f74edf0_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ieb2751225b4e422c8601c5b45f74edf0_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ieb2751225b4e422c8601c5b45f74edf0_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ieb2751225b4e422c8601c5b45f74edf0_I20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ie2c3e0ab5c404e47a177e468672a1455_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ie2c3e0ab5c404e47a177e468672a1455_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ieb2751225b4e422c8601c5b45f74edf0_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ieb2751225b4e422c8601c5b45f74edf0_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ieb2751225b4e422c8601c5b45f74edf0_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ieb2751225b4e422c8601c5b45f74edf0_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesRestrictedStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "if487bbb8057a47a2bfafd87e853aa62f_D20100101-20100131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfContingentValueRightsSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contingent_value_right_series",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416411 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "if487bbb8057a47a2bfafd87e853aa62f_D20100101-20100131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfContingentValueRightsSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contingent_value_right_series",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i30b9d60f80524037808096d46cfdd9bf_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417412 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails",
     "shortName": "Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i30b9d60f80524037808096d46cfdd9bf_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ie650f5facb7d4c908578773f98df20f6_D20201001-20201001",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420413 - Disclosure - Acquisitions - Narrative (Details)",
     "role": "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
     "shortName": "Acquisitions - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ie650f5facb7d4c908578773f98df20f6_D20201001-20201001",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ieb2751225b4e422c8601c5b45f74edf0_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421414 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details)",
     "role": "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "Acquisitions - Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0b069c2c100449aeadeb5889f43faee8_I20201001",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i373622f14721402a91753acb36279106_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422415 - Disclosure - Acquisitions - Pro Forma Financial Information (Details)",
     "role": "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
     "shortName": "Acquisitions - Pro Forma Financial Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i373622f14721402a91753acb36279106_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425416 - Disclosure - Convertible Senior Notes - Narrative (Details)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
     "shortName": "Convertible Senior Notes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i11b1244fd6124eb2b9e0ee4aa2f36ac9_D20210301-20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i68aebd079e8d43ca8aaffead3aa479b9_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426417 - Disclosure - Convertible Senior Notes - Notes Payable (Details)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails",
     "shortName": "Convertible Senior Notes - Notes Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i68aebd079e8d43ca8aaffead3aa479b9_I20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428418 - Disclosure - Income Tax (Details)",
     "role": "http://www.ligand.com/role/IncomeTaxDetails",
     "shortName": "Income Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ifa6b8e5ef49e44a1a9aa9d047df544ce_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431419 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "role": "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails",
     "shortName": "Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ifa6b8e5ef49e44a1a9aa9d047df544ce_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostDirectMaterial",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ieb2751225b4e422c8601c5b45f74edf0_I20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432420 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "role": "http://www.ligand.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ieb2751225b4e422c8601c5b45f74edf0_I20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i3d23921891db45d19e297bbe9bbe585a_D20191029-20191029",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "patent",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434421 - Disclosure - Commitment and Contingencies: Legal Proceedings (Details)",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails",
     "shortName": "Commitment and Contingencies: Legal Proceedings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i3d23921891db45d19e297bbe9bbe585a_D20191029-20191029",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "patent",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i5b4bbd2625d4455fa460a3f0fb8beaf6_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "ib66c936d8d3e4e1680b40926d0d9de06_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i8f7fffe49713495aad4f0ffcb6a85aa9_D20200101-20200331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114102 - Disclosure - Fair Value Measurements",
     "role": "http://www.ligand.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210630.htm",
      "contextRef": "i0ab9ba60031443b1914427c4ad47f752_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": null,
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - lgnd-20210630.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - lgnd-20210630.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 81,
   "tag": {
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]",
        "terseLabel": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]",
        "terseLabel": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Addresses [Line Items]",
        "terseLabel": "Entity Addresses [Line Items]"
       }
      }
     },
     "localname": "EntityAddressesLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesTable": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container of address information for the entity",
        "label": "Entity Addresses [Table]",
        "terseLabel": "Entity Addresses [Table]"
       }
      }
     },
     "localname": "EntityAddressesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_FormerAddressMember": {
     "auth_ref": [
      "r639",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former address for entity",
        "label": "Former Address [Member]",
        "terseLabel": "Former Address"
       }
      }
     },
     "localname": "FormerAddressMember",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "lgnd_AccruedAssetAcquisitionsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Asset Acquisitions, Current",
        "label": "Accrued Asset Acquisitions, Current",
        "terseLabel": "Acquisition related liabilities"
       }
      }
     },
     "localname": "AccruedAssetAcquisitionsCurrent",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedInventoryPurchases": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Inventory Purchases",
        "label": "Accrued Inventory Purchases",
        "terseLabel": "Accrued inventory purchases"
       }
      }
     },
     "localname": "AccruedInventoryPurchases",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedSubcontractorExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Subcontractor Expenses, Current",
        "label": "Accrued Subcontractor Expenses, Current",
        "terseLabel": "Subcontractor"
       }
      }
     },
     "localname": "AccruedSubcontractorExpensesCurrent",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedSupplierExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Supplier Expenses, Current",
        "label": "Accrued Supplier Expenses, Current",
        "terseLabel": "Supplier"
       }
      }
     },
     "localname": "AccruedSupplierExpensesCurrent",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment",
        "label": "Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions",
        "label": "Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions",
        "negatedTerseLabel": "Tax effect for 2023 Notes transactions"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions",
        "label": "Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions",
        "terseLabel": "Warrant and bond hedge unwind transactions"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AmortizationOfOtherEconomicRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Other Economic Rights",
        "label": "Amortization of Other Economic Rights",
        "verboseLabel": "Amortization of commercial license and other economic rights"
       }
      }
     },
     "localname": "AmortizationOfOtherEconomicRights",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AziyoAndCorMatrixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aziyo and CorMatrix",
        "label": "Aziyo and CorMatrix [Member]",
        "terseLabel": "Aziyo and CorMatrix"
       }
      }
     },
     "localname": "AziyoAndCorMatrixMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_AziyoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AziyoMember",
        "terseLabel": "Aziyo"
       }
      }
     },
     "localname": "AziyoMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_BasisOfPresentationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of presentation.",
        "label": "Basis of Presentation [Line Items]",
        "terseLabel": "Basis of Presentation [Line Items]"
       }
      }
     },
     "localname": "BasisOfPresentationLineItems",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BasisOfPresentationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of Presentation.",
        "label": "Basis of Presentation [Table]",
        "terseLabel": "Basis of Presentation [Table]"
       }
      }
     },
     "localname": "BasisOfPresentationTable",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BusinessCombinationConsiderationTransferredHoldback": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Holdback",
        "label": "Business Combination, Consideration Transferred, Holdback",
        "terseLabel": "Holdback from acquisition"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredHoldback",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency",
        "label": "Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency",
        "terseLabel": "Earnout rights recognized"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure",
        "label": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure",
        "terseLabel": "Fair value of contingent earn-out payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues",
        "label": "Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues",
        "terseLabel": "Proportion of milestone payments (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "label": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "terseLabel": "Frequency of cash payments to CVR holders"
       }
      }
     },
     "localname": "BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "label": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "terseLabel": "Number of CVRs issued from each CVR series"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "label": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "terseLabel": "Number of CVRs issued per acquiree share"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current",
        "negatedTerseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets",
        "terseLabel": "Intangibles acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate",
        "terseLabel": "Discount rate used to value intangible assets acquired (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities",
        "negatedTerseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets",
        "terseLabel": "Right-of-use asset"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets",
        "terseLabel": "Tangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "label": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "terseLabel": "Additional allowance for credit losses recorded related to COVID-19"
       }
      }
     },
     "localname": "COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseAndOtherEconomicRightsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License and Other Economic Rights",
        "label": "Commercial License and Other Economic Rights [Abstract]",
        "verboseLabel": "Commercial License and Other Economic Rights"
       }
      }
     },
     "localname": "CommercialLicenseAndOtherEconomicRightsAbstract",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License and Other Economic Rights, Allowance for Credit Loss",
        "label": "Commercial License and Other Economic Rights, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit loss"
       }
      }
     },
     "localname": "CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CommercialLicenseRights",
        "terseLabel": "Commercial license and other economic rights, net"
       }
      }
     },
     "localname": "CommercialLicenseRights",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Value Right for Internal Research and Development",
        "label": "Contingent Value Right for Internal Research and Development [Member]",
        "terseLabel": "Contingent Value Right for Internal Research and Development"
       }
      }
     },
     "localname": "ContingentValueRightForInternalResearchAndDevelopmentMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContingentValueRightOnProductRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Value Right on Product Revenues",
        "label": "Contingent Value Right on Product Revenues [Member]",
        "terseLabel": "Contingent Value Right on Product Revenues"
       }
      }
     },
     "localname": "ContingentValueRightOnProductRevenuesMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Revenue",
        "label": "Contract Revenue [Member]",
        "terseLabel": "Contract revenue"
       }
      }
     },
     "localname": "ContractRevenueMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractRevenueServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Revenue, Service",
        "label": "Contract Revenue, Service [Member]",
        "terseLabel": "Service Revenue"
       }
      }
     },
     "localname": "ContractRevenueServiceMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ConvertibleSeniorNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes due 2023",
        "label": "Convertible Senior Notes due 2023 [Member]",
        "terseLabel": "2023 Convertible Senior Notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2023Member",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credits Applied on Advances on Inventory Purchases",
        "label": "Credits Applied on Advances on Inventory Purchases",
        "terseLabel": "Credits applied on advances on inventory purchases"
       }
      }
     },
     "localname": "CreditsAppliedOnAdvancesOnInventoryPurchases",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CurrentPortionOfLiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CurrentPortionOfLiabilityForContingentValueRights",
        "verboseLabel": "Current contingent liabilities"
       }
      }
     },
     "localname": "CurrentPortionOfLiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
        "terseLabel": "Maximum threshold of debt trading price trigger (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available for Sale and Equity Securities, FV-NI",
        "label": "Debt Securities, Available for Sale and Equity Securities, FV-NI",
        "totalLabel": "Estimated fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]",
        "terseLabel": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties"
       }
      }
     },
     "localname": "DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnout Rights for Partner Research and Development",
        "label": "Earnout Rights for Partner Research and Development [Member]",
        "terseLabel": "Earnout Rights for Partner Research and Development"
       }
      }
     },
     "localname": "EarnoutRightsForPartnerResearchAndDevelopmentMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EmployeeStockPurchasePlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Abstract]",
        "label": "Employee Stock Purchase Plan [Abstract]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanAbstract",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EmployeeStockPurchasePlanMember",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EvomelaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Evomela",
        "label": "Evomela [Member]",
        "terseLabel": "Evomela"
       }
      }
     },
     "localname": "EvomelaMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition",
        "terseLabel": "Contingent liabilities from xCella asset acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "negatedTerseLabel": "Adjustments"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "label": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "negatedLabel": "Credit loss adjustments of finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ForecastedCashFlowsEffectiveInterestRatePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forecasted Cash Flows, Effective Interest Rate, Percent",
        "label": "Forecasted Cash Flows, Effective Interest Rate, Percent",
        "terseLabel": "Effective interest rate for forecasted cash flows (as a percent)"
       }
      }
     },
     "localname": "ForecastedCashFlowsEffectiveInterestRatePercent",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_GainLossOnShortTermInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Short-term Investments",
        "label": "Gain (Loss) on Short-term Investments",
        "negatedLabel": "Loss (gain) from short-term investments"
       }
      }
     },
     "localname": "GainLossOnShortTermInvestments",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_GlaxoSmithKlineBiologicalsSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GlaxoSmithKline Biologicals S.A.",
        "label": "GlaxoSmithKline Biologicals S.A. [Member]",
        "terseLabel": "GSK"
       }
      }
     },
     "localname": "GlaxoSmithKlineBiologicalsSAMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_IcagenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Icagen",
        "label": "Icagen [Member]",
        "terseLabel": "Icagen"
       }
      }
     },
     "localname": "IcagenMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_IncreaseDecreaseInDebtDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Debt Discount",
        "label": "Increase (Decrease) in Debt Discount",
        "negatedLabel": "Increase (decrease) in debt discount"
       }
      }
     },
     "localname": "IncreaseDecreaseInDebtDiscount",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_InterPartesReviewOfPatentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inter Partes Review of Patent",
        "label": "Inter Partes Review of Patent [Member]",
        "terseLabel": "Inter Partes Review of Patent"
       }
      }
     },
     "localname": "InterPartesReviewOfPatentMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_KyprolisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kyprolis",
        "label": "Kyprolis [Member]",
        "terseLabel": "Kyprolis"
       }
      }
     },
     "localname": "KyprolisMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LiabilityForContingentValueRights",
        "verboseLabel": "Long-term contingent liabilities"
       }
      }
     },
     "localname": "LiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyCrystalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Crystal [Member]",
        "label": "Liability For Contingent Value Rights Company, Crystal [Member]",
        "terseLabel": "Contingent liabilities - Crystal"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyCrystalMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyCydexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Cydex",
        "label": "Liability For Contingent Value Rights Company, Cydex [Member]",
        "verboseLabel": "Contingent liabilities - CyDex"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyCydexMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyIcagenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Icagen",
        "label": "Liability For Contingent Value Rights Company, Icagen [Member]",
        "terseLabel": "Contingent liabilities - Icagen"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyIcagenMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Metabasis",
        "label": "Liability For Contingent Value Rights Company, Metabasis [Member]",
        "terseLabel": "Contingent liabilities - Metabasis"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyMetabasisMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyPfenexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Pfenex",
        "label": "Liability For Contingent Value Rights Company, Pfenex [Member]",
        "terseLabel": "Contingent liabilities - Pfenex"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyPfenexMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyXCellaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, xCella",
        "label": "Liability For Contingent Value Rights Company, xCella [Member]",
        "terseLabel": "Contingent liabilities - xCella"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyXCellaMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability for Restricted Investments Owed to Former Licensees [Member]",
        "label": "Liability for Restricted Investments Owed to Former Licensees [Member]",
        "terseLabel": "Amounts owed to former licensor"
       }
      }
     },
     "localname": "LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees",
        "label": "License Fees [Member]",
        "terseLabel": "License Fees"
       }
      }
     },
     "localname": "LicenseFeesMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees, Milestones, and Product, Other, Product, Other",
        "label": "License Fees, Milestones, and Product, Other, Product, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "LicenseFeesMilestonesAndProductOtherProductOtherMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseeAccrualCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensee Accrual, Current",
        "label": "Licensee Accrual, Current",
        "terseLabel": "Amounts owed to former licensees"
       }
      }
     },
     "localname": "LicenseeAccrualCurrent",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LupinPatentInfringementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lupin Patent Infringement",
        "label": "Lupin Patent Infringement [Member]",
        "terseLabel": "Lupin Patent Infringement"
       }
      }
     },
     "localname": "LupinPatentInfringementMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol",
        "label": "Material Sales, Captisol [Member]",
        "verboseLabel": "Captisol"
       }
      }
     },
     "localname": "MaterialSalesCaptisolMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MetabasisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Metabasis",
        "label": "Metabasis [Member]",
        "terseLabel": "Metabasis"
       }
      }
     },
     "localname": "MetabasisMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone",
        "label": "Milestone [Member]",
        "terseLabel": "Milestone"
       }
      }
     },
     "localname": "MilestoneMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MilestonePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payments",
        "label": "Milestone Payments [Member]",
        "terseLabel": "Milestone Payments"
       }
      }
     },
     "localname": "MilestonePaymentsMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
        "negatedLabel": "Change in estimated fair value of contingent liabilities"
       }
      }
     },
     "localname": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_NumberOfContingentValueRightsSeries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Contingent Value Rights Series",
        "label": "Number of Contingent Value Rights Series",
        "terseLabel": "Number of CVR Series"
       }
      }
     },
     "localname": "NumberOfContingentValueRightsSeries",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_NumberOfOptionsUnderConvertibleBondHedges": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Options under Convertible Bond Hedges",
        "label": "Number of Options under Convertible Bond Hedges",
        "terseLabel": "Number of options under convertible bond hedges"
       }
      }
     },
     "localname": "NumberOfOptionsUnderConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_NumberOfPetitionsFiled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Petitions Filed",
        "label": "Number of Petitions Filed",
        "terseLabel": "Number of petitions filed"
       }
      }
     },
     "localname": "NumberOfPetitionsFiled",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_PaymentsForConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Convertible Bond Hedges",
        "label": "Payments for Convertible Bond Hedges",
        "terseLabel": "Payments for convertible bond hedges"
       }
      }
     },
     "localname": "PaymentsForConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options",
        "label": "Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options",
        "terseLabel": "Gross payments to acquire business attributable to vested portion of stock options"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHolders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders",
        "label": "Payments to Contingent Value Right Holders",
        "negatedTerseLabel": "Payments to CVR holders and other contingent payments"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHolders",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHoldersFinancingActivity": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders, Financing Activity",
        "label": "Payments to Contingent Value Right Holders, Financing Activity",
        "negatedLabel": "Payments to CVR Holders"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHoldersFinancingActivity",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToUnwindWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Unwind Warrants",
        "label": "Payments to Unwind Warrants",
        "terseLabel": "Payments to unwind warrants"
       }
      }
     },
     "localname": "PaymentsToUnwindWarrants",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PfenexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pfenex",
        "label": "Pfenex [Member]",
        "terseLabel": "Pfenex"
       }
      }
     },
     "localname": "PfenexMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_Phase3ClinicalTrialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phase 3 Clinical Trial",
        "label": "Phase 3 Clinical Trial [Member]",
        "terseLabel": "Phase 3 Clinical Trial"
       }
      }
     },
     "localname": "Phase3ClinicalTrialMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ProceedsFromUnwindingConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Unwinding Convertible Bond Hedges",
        "label": "Proceeds from Unwinding Convertible Bond Hedges",
        "terseLabel": "Proceeds from unwinding convertible bond hedges"
       }
      }
     },
     "localname": "ProceedsFromUnwindingConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ReturnsAccrual": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Returns Accrual",
        "label": "Returns Accrual",
        "terseLabel": "Return reserve"
       }
      }
     },
     "localname": "ReturnsAccrual",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_RoyaltyOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty, Other",
        "label": "Royalty, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RoyaltyOtherMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]",
        "verboseLabel": "Schedule of Accounting for Share-Based Compensation"
       }
      }
     },
     "localname": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Commercial License Rights",
        "label": "Schedule of Commercial License Rights [Table Text Block]",
        "terseLabel": "Schedule of Commercial License and Other Economic Rights"
       }
      }
     },
     "localname": "ScheduleOfCommercialLicenseRightsTableTextBlock",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Short-Term investments",
        "label": "Schedule of Short-Term investments [Table Text Block]",
        "terseLabel": "Schedule of Short-Term Investments"
       }
      }
     },
     "localname": "ScheduleOfShortTermInvestmentsTableTextBlock",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_SelexisAndDianomiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selexis and Dianomi",
        "label": "Selexis and Dianomi [Member]",
        "terseLabel": "Selexis and Dianomi"
       }
      }
     },
     "localname": "SelexisAndDianomiMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_SelexisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selexis",
        "label": "Selexis [Member]",
        "terseLabel": "Selexis"
       }
      }
     },
     "localname": "SelexisMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent",
        "label": "Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent",
        "terseLabel": "Payout range (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_TaurusBiosciencesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Taurus Biosciences, LLC",
        "label": "Taurus Biosciences, LLC [Member]",
        "terseLabel": "Taurus"
       }
      }
     },
     "localname": "TaurusBiosciencesLLCMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US District Court for the Northern District of Ohio",
        "label": "US District Court for the Northern District of Ohio [Member]",
        "terseLabel": "US District Court for the Northern District of Ohio"
       }
      }
     },
     "localname": "USDistrictCourtForTheNorthernDistrictOfOhioMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_XCellaBiosciencesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "xCella Biosciences, Inc.",
        "label": "xCella Biosciences, Inc. [Member]",
        "terseLabel": "xCella"
       }
      }
     },
     "localname": "XCellaBiosciencesIncMember",
     "nsuri": "http://www.ligand.com/20210630",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r52",
      "r54",
      "r118",
      "r119",
      "r272",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r125",
      "r132",
      "r138",
      "r214",
      "r407",
      "r408",
      "r409",
      "r423",
      "r424",
      "r473",
      "r476",
      "r478",
      "r479",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r125",
      "r132",
      "r138",
      "r214",
      "r407",
      "r408",
      "r409",
      "r423",
      "r424",
      "r473",
      "r476",
      "r478",
      "r479",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r125",
      "r132",
      "r138",
      "r214",
      "r407",
      "r408",
      "r409",
      "r423",
      "r424",
      "r473",
      "r476",
      "r478",
      "r479",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r271",
      "r310",
      "r368",
      "r370",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r557",
      "r611",
      "r613",
      "r633",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r271",
      "r310",
      "r368",
      "r370",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r557",
      "r611",
      "r613",
      "r633",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r182",
      "r346",
      "r349",
      "r559",
      "r610",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r182",
      "r346",
      "r349",
      "r559",
      "r610",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r271",
      "r310",
      "r357",
      "r368",
      "r370",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r557",
      "r611",
      "r613",
      "r633",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r271",
      "r310",
      "r357",
      "r368",
      "r370",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r557",
      "r611",
      "r613",
      "r633",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r53",
      "r54",
      "r118",
      "r119",
      "r272",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r126",
      "r127",
      "r128",
      "r129",
      "r190",
      "r191",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r254",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r423",
      "r424",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r520",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r37",
      "r526"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r10",
      "r26",
      "r185",
      "r186"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of premium (discount) on investments, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities [Abstract]",
        "verboseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r39"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "verboseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r39"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Royalties owed to third parties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r59",
      "r60",
      "r61",
      "r599",
      "r621",
      "r625"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r58",
      "r61",
      "r67",
      "r68",
      "r69",
      "r122",
      "r123",
      "r124",
      "r461",
      "r616",
      "r617",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted-average estimated useful life of finite-lived intangible assets acquired"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r27",
      "r410",
      "r526"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r407",
      "r408",
      "r409",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "negatedLabel": "Adjustments to additional paid in capital, equity component of convertible debt",
        "verboseLabel": "Reacquisition of equity due to 2023 debt extinguishment, net of tax"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Adjustment on reacquisition of equity due to 2023 debt extinguishment, net of tax"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r371",
      "r373",
      "r412",
      "r413"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r266",
      "r324",
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "verboseLabel": "Adjustments to additional paid-in-capital from warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvancesOnInventoryPurchases": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of capitalized payments made in advance for inventory that is expected to be received within one year or the normal operating cycle, if longer.",
        "label": "Advances on Inventory Purchases",
        "terseLabel": "Advances on inventory purchases"
       }
      }
     },
     "localname": "AdvancesOnInventoryPurchases",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AgencySecuritiesMember": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities issued by government sponsored entities.",
        "label": "Agency Securities [Member]",
        "terseLabel": "Agency bonds"
       }
      }
     },
     "localname": "AgencySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r101",
      "r291",
      "r300",
      "r301",
      "r513"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and issuance fees"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r114",
      "r171",
      "r174",
      "r180",
      "r210",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r457",
      "r462",
      "r494",
      "r524",
      "r526",
      "r575",
      "r598"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r51",
      "r114",
      "r210",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r457",
      "r462",
      "r494",
      "r524",
      "r526"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "verboseLabel": "Assets, fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r197"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r194",
      "r222"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "auth_ref": [
      "r199",
      "r200",
      "r591"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r192",
      "r195",
      "r222",
      "r581"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r375",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "verboseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r367",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r367",
      "r369",
      "r435",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Post-combination expense"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "terseLabel": "Basic (USD per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "terseLabel": "Diluted (USD per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Schedule of Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill acquired that is expected to be deductible for tax purposes"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r447",
      "r448",
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred in acquisition"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r100",
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "negatedTerseLabel": "Reduction in contingent liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r446",
      "r449",
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent earn-out payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Contingent consideration liability, measurement input (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/Acquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts and unbilled receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedTerseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "negatedLabel": "Deferred revenue",
        "negatedTerseLabel": "Deferred revenue acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r438"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred tax assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedLabel": "Deferred tax liability acquired in connection with the acquired intangibles",
        "negatedTerseLabel": "Deferred tax liabilities, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r437",
      "r438"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Finite-lived intangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r438"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedLabel": "Liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r437",
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Total consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r437",
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r105",
      "r106",
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accrued fixed asset purchases"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r8",
      "r34",
      "r103"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r95",
      "r103",
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r95",
      "r503"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Warrant exercise price (USD per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "netLabel": "Outstanding warrants to purchase shares of Viking's common stock (shares)",
        "verboseLabel": "Warrants issued in public offering (shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants outstanding (shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r45",
      "r248",
      "r583",
      "r603"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r251",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitment and Contingencies: Legal Proceedings"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r122",
      "r123",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r25",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r25",
      "r526"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.001 par value; 60,000 shares authorized; 16,676 and 16,080 shares issued and outstanding at June\u00a030, 2021 and December\u00a031, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r63",
      "r65",
      "r66",
      "r72",
      "r585",
      "r607"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetGross": {
     "auth_ref": [
      "r187",
      "r219",
      "r334",
      "r336"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss",
        "terseLabel": "Gross contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r334",
      "r335",
      "r347"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized from milestone method revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Contractual relationships",
        "verboseLabel": "Contractual Relationships"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "verboseLabel": "Fair value of the 2023 Notes outstanding (Level 2)"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "2023 convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "auth_ref": [
      "r20",
      "r576",
      "r595",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r358",
      "r366",
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostDirectMaterial": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of material used for good produced and service rendered.",
        "label": "Cost, Direct Material",
        "terseLabel": "Cost of Captisol"
       }
      }
     },
     "localname": "CostDirectMaterial",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r110",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r285",
      "r292",
      "r293",
      "r295",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Convertible Senior Notes"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r20",
      "r22",
      "r23",
      "r113",
      "r120",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r281",
      "r282",
      "r283",
      "r284",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r298",
      "r299",
      "r300",
      "r301",
      "r514",
      "r576",
      "r577",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "terseLabel": "Carrying value of equity component of the 2023 Notes"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r270",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Initial conversion price (USD per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r42",
      "r270",
      "r325",
      "r328",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Initial conversion rate (shares per $1,000)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Stock price trigger to classify convertible debt as current (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r268",
      "r298",
      "r299",
      "r512",
      "r514",
      "r515"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal amount of the 2023 Notes outstanding",
        "verboseLabel": "Aggregate principal amount outstanding"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.",
        "label": "Debt Instrument, Increase, Accrued Interest",
        "terseLabel": "Accrued Interest"
       }
      }
     },
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r41",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r43",
      "r113",
      "r120",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r281",
      "r282",
      "r283",
      "r284",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r298",
      "r299",
      "r300",
      "r301",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Repurchased amount of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r43",
      "r113",
      "r120",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r281",
      "r282",
      "r283",
      "r284",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r294",
      "r298",
      "r299",
      "r300",
      "r301",
      "r325",
      "r329",
      "r330",
      "r331",
      "r511",
      "r512",
      "r514",
      "r515",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r281",
      "r511",
      "r515"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Unamortized discount (including unamortized debt issuance cost)"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r281",
      "r511",
      "r515"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt premium"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r196",
      "r222",
      "r226",
      "r227"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Allowance for Credit Loss",
        "terseLabel": "Credit losses related to available-for-sale debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized net gain (loss) on available-for-sale securities, net of deferred tax"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r204",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of positions in an unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r513"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DemandDepositsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts that may or may not bear interest and that depositor is entitled to withdraw at anytime without prior notice. Checking and negotiable order of withdrawal (NOW) accounts are the most common forms of demand deposits.",
        "label": "Demand Deposits [Member]",
        "terseLabel": "Bank deposits"
       }
      }
     },
     "localname": "DemandDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r101",
      "r169"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization of intangible assets"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]",
        "terseLabel": "Dilutive potential common shares:"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r346",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Revenue by Source"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r73",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r139",
      "r142",
      "r147",
      "r148",
      "r149",
      "r152",
      "r153",
      "r479",
      "r480",
      "r586",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Summary of computation of basic and diluted net income (loss) per share",
        "verboseLabel": "Earnings Per Share, Basic and Diluted:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r73",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r142",
      "r147",
      "r148",
      "r149",
      "r152",
      "r153",
      "r479",
      "r480",
      "r586",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r150",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "verboseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareProFormaAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Pro Forma [Abstract]",
        "terseLabel": "Net income (loss) per common share:"
       }
      }
     },
     "localname": "EarningsPerShareProFormaAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate (as a percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards": {
     "auth_ref": [
      "r399"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash paid by the entity during the period to settle equity instruments granted under equity-based payment arrangements.",
        "label": "Share-based Payment Arrangement, Cash Used to Settle Award",
        "terseLabel": "Cash to settle unvested stock options recognized as share-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.",
        "label": "Share-based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period",
        "verboseLabel": "Shares available for future purchases (shares)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r67",
      "r68",
      "r69",
      "r122",
      "r123",
      "r124",
      "r127",
      "r135",
      "r137",
      "r154",
      "r214",
      "r324",
      "r332",
      "r407",
      "r408",
      "r409",
      "r423",
      "r424",
      "r478",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r616",
      "r617",
      "r618",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvesteeMember": {
     "auth_ref": [
      "r209",
      "r563",
      "r565",
      "r567",
      "r569",
      "r571",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor.",
        "label": "Equity Method Investee [Member]",
        "terseLabel": "Viking Therapeutics, Inc."
       }
      }
     },
     "localname": "EquityMethodInvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r493"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r17",
      "r21",
      "r205",
      "r596",
      "r629",
      "r630",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Corporate equity securities",
        "verboseLabel": "Investment in Viking common stock"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r490",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "verboseLabel": "Schedule of Assets and Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Fair Value by Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r481",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r283",
      "r298",
      "r299",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r482",
      "r530",
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r489",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r481",
      "r482",
      "r485",
      "r486",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r283",
      "r358",
      "r359",
      "r364",
      "r366",
      "r482",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r283",
      "r298",
      "r299",
      "r358",
      "r359",
      "r364",
      "r366",
      "r482",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r283",
      "r298",
      "r299",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r482",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "verboseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r487",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Level 3 Financial Instruments"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair value adjustments to contingent liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value of level 3 financial instruments as of June\u00a030, 2021",
        "periodStartLabel": "Fair value of level 3 financial instruments as of December\u00a031, 2020"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r283",
      "r298",
      "r299",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r530",
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r489",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "verboseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r517"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r518",
      "r519"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Payments under financing lease obligations"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Financing lease right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r202",
      "r203",
      "r206",
      "r207",
      "r208",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r224",
      "r225",
      "r228",
      "r229",
      "r294",
      "r322",
      "r469",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r240"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less: accumulated amortization",
        "negatedTerseLabel": "Accumulated amortization on finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r235",
      "r237",
      "r240",
      "r241",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r240",
      "r561"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      },
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "netLabel": "Gross",
        "verboseLabel": "Definite lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r235",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r240",
      "r560"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Gain Contingencies [Line Items]",
        "terseLabel": "Gain Contingencies [Line Items]"
       }
      }
     },
     "localname": "GainContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainContingenciesTable": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sets forth the existing conditions, situations, or sets of circumstances involving uncertainties as of the balance sheet date (or before issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization, and previously disclosed contingent gains that were recognized as income in the period.",
        "label": "Gain Contingencies [Table]",
        "terseLabel": "Gain Contingencies [Table]"
       }
      }
     },
     "localname": "GainContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of entity's patents that another entity has allegedly infringed.",
        "label": "Gain Contingency, Patents Allegedly Infringed upon, Number",
        "terseLabel": "Number of patents allegedly infringed upon"
       }
      }
     },
     "localname": "GainContingencyPatentsAllegedlyInfringedUponNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r79",
      "r101",
      "r193"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "verboseLabel": "Gain (loss) from short-term investments"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r101",
      "r302",
      "r303"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss (gain) on debt extinguishment",
        "negatedTerseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "verboseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "verboseLabel": "SBC - General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r230",
      "r231",
      "r526",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r232"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis": {
     "auth_ref": [
      "r201",
      "r590"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r171",
      "r173",
      "r176",
      "r179",
      "r181"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r243",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r115",
      "r419",
      "r421",
      "r422",
      "r425",
      "r427",
      "r429",
      "r430",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/IncomeTax"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Examination [Line Items]",
        "terseLabel": "Income Tax Examination [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxExaminationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationTable": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.",
        "label": "Income Tax Examination [Table]",
        "terseLabel": "Income Tax Examination [Table]"
       }
      }
     },
     "localname": "IncomeTaxExaminationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r116",
      "r136",
      "r137",
      "r170",
      "r417",
      "r426",
      "r428",
      "r609"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r97",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r48",
      "r582",
      "r605"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax receivable and payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r149"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Stock options (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r234",
      "r238"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "totalLabel": "Total goodwill and other identifiable intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Including Goodwill) [Abstract]",
        "verboseLabel": "Summary of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r70",
      "r168",
      "r510",
      "r513",
      "r587"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r92",
      "r96",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r39"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r9",
      "r49",
      "r526"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r78",
      "r167"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r604"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r38",
      "r114",
      "r175",
      "r210",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r458",
      "r462",
      "r463",
      "r494",
      "r524",
      "r525"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r32",
      "r114",
      "r210",
      "r494",
      "r526",
      "r578",
      "r601"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r40",
      "r114",
      "r210",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r458",
      "r462",
      "r463",
      "r494",
      "r524",
      "r525",
      "r526"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "verboseLabel": "Liabilities, fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Commercial license rights"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "totalLabel": "Total long-term portion of notes payable"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r43",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable, Current and Noncurrent [Abstract]",
        "terseLabel": "Notes Payable, Current and Noncurrent [Abstract]"
       }
      }
     },
     "localname": "LongtermNotesPayableCurrentAndNoncurrentTotalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of civil complaints filed against entity"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Mutual fund"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r95",
      "r98",
      "r102"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r6",
      "r62",
      "r64",
      "r69",
      "r71",
      "r102",
      "r114",
      "r126",
      "r130",
      "r131",
      "r132",
      "r133",
      "r136",
      "r137",
      "r146",
      "r171",
      "r173",
      "r176",
      "r179",
      "r181",
      "r210",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r480",
      "r494",
      "r584",
      "r606"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss):"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting Standards Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental schedule of non-cash activity:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (loss), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "totalLabel": "Total operating costs and expenses"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "verboseLabel": "Operating costs and expenses:"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r171",
      "r173",
      "r176",
      "r179",
      "r181"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r517"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r517"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "netLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r7",
      "r121",
      "r164",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r39"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r50",
      "r526"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r56",
      "r57",
      "r59"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "verboseLabel": "Unrealized net gain (loss) on available-for-sale securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncome": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Operating Income",
        "negatedTerseLabel": "Other operating income"
       }
      }
     },
     "localname": "OtherOperatingIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentedTechnologyMember": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patented technology to exploit the technology for a period of time specified by law.",
        "label": "Patented Technology [Member]",
        "verboseLabel": "Complete technology"
       }
      }
     },
     "localname": "PatentedTechnologyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "terseLabel": "Payment for contingent consideration liabilities"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForHedgeFinancingActivities": {
     "auth_ref": [
      "r91",
      "r99"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Payments for Hedge, Financing Activities",
        "negatedTerseLabel": "Payments to convertible bond holders for warrant purchases"
       }
      }
     },
     "localname": "PaymentsForHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r82",
      "r85"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Share repurchase"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r83",
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash payments for acquisition"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Cash paid for acquisition, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-term Investments",
        "negatedTerseLabel": "Purchase of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r375",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r24",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r24",
      "r526"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at June\u00a030, 2021 and December\u00a031, 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromHedgeFinancingActivities": {
     "auth_ref": [
      "r88",
      "r99"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Proceeds from Hedge, Financing Activities",
        "terseLabel": "Proceeds from convertible bond hedge settlement"
       }
      }
     },
     "localname": "ProceedsFromHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": {
     "auth_ref": [
      "r82",
      "r85"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Maturities, Prepayments and Calls of Short-term Investments",
        "terseLabel": "Proceeds from maturity of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-term Investments",
        "verboseLabel": "Proceeds from sale of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r86",
      "r402"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Net proceeds from stock option exercises and ESPP"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r6",
      "r62",
      "r64",
      "r69",
      "r94",
      "r114",
      "r126",
      "r136",
      "r137",
      "r171",
      "r173",
      "r176",
      "r179",
      "r181",
      "r210",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r456",
      "r459",
      "r460",
      "r464",
      "r465",
      "r480",
      "r494",
      "r588"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r18",
      "r19",
      "r242",
      "r526",
      "r592",
      "r602"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r33",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Credit Losses"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r365",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r365",
      "r521",
      "r523",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repurchase of 2023 Notes"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "terseLabel": "Repayments of notes"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r414",
      "r558",
      "r635"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "verboseLabel": "SBC - Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r8",
      "r16",
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash in other current assets"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r332",
      "r410",
      "r526",
      "r600",
      "r620",
      "r625"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r122",
      "r123",
      "r124",
      "r127",
      "r135",
      "r137",
      "r214",
      "r407",
      "r408",
      "r409",
      "r423",
      "r424",
      "r478",
      "r616",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings (Accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r165",
      "r166",
      "r172",
      "r177",
      "r178",
      "r182",
      "r183",
      "r184",
      "r345",
      "r346",
      "r559"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Total revenue",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r109",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RoyaltyAgreementsMember": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement, generally for a defined period of time, entitling the entity to use the rights and property of another party. Examples include, but not limited to, licensing the use of copyrighted materials and leasing the extraction of natural resources.",
        "label": "Royalty Agreements [Member]",
        "terseLabel": "Royalty Agreements"
       }
      }
     },
     "localname": "RoyaltyAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalties",
        "verboseLabel": "Royalties"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r435",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "verboseLabel": "Schedule of Carrying Values and Coupon Rates on Financing Arrangements"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Schedule of Computation of Basic and Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r235",
      "r239",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "verboseLabel": "Schedule of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "verboseLabel": "Schedule of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r35",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r375",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r379",
      "r390",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Schedule of Stock Option Plan Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Schedule of Fair-Value Options Awarded to Employees and Directors"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r46",
      "r111",
      "r155",
      "r156",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r317",
      "r322",
      "r325",
      "r326",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period",
        "terseLabel": "Performance period for awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on purchase date that participants pay for shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date",
        "terseLabel": "Share purchase price as percent of market price (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period (shares)",
        "periodStartLabel": "Nonvested at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "verboseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period (USD per share)",
        "periodStartLabel": "Nonvested at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "RSUs vested (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "RSUs vested (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Outstanding options that are exercisable (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Outstanding options that are exercisable, weighted average exercise price (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r381",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "verboseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at end of period (USD per share)",
        "periodStartLabel": "Balance at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r372",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Options exercised (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r375",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r394",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r21",
      "r579",
      "r580",
      "r597"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r628",
      "r629",
      "r630",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-term Investments [Member]",
        "terseLabel": "Short-term Investments",
        "verboseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r47",
      "r67",
      "r68",
      "r69",
      "r122",
      "r123",
      "r124",
      "r127",
      "r135",
      "r137",
      "r154",
      "r214",
      "r324",
      "r332",
      "r407",
      "r408",
      "r409",
      "r423",
      "r424",
      "r478",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r616",
      "r617",
      "r618",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r154",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r24",
      "r25",
      "r324",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r24",
      "r25",
      "r324",
      "r332",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r24",
      "r25",
      "r332",
      "r374",
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Authorized stock repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Stock Repurchase Program, Period in Force",
        "terseLabel": "Period in force of stock repurchase program"
       }
      }
     },
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized stock repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r24",
      "r25",
      "r324",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock (shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r24",
      "r25",
      "r324",
      "r332"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Repurchase of common stock",
        "terseLabel": "Stock repurchased during period"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r25",
      "r30",
      "r31",
      "r114",
      "r189",
      "r210",
      "r494",
      "r526"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r112",
      "r309",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r323",
      "r332",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Core Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r346",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r346",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Transferred over Time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r202",
      "r203",
      "r206",
      "r207",
      "r208",
      "r294",
      "r322",
      "r469",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r117",
      "r358",
      "r366",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "Treasury bill"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "verboseLabel": "Unrealized loss on AFS investments"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Investment in warrants",
        "verboseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r141",
      "r149"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used in diluted per share calculations (in shares)",
        "totalLabel": "Shares used to compute diluted income per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r139",
      "r149"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used in basic per share calculations (in shares)",
        "verboseLabel": "Weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "verboseLabel": "Restricted stock (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 13
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2646-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=125513658&loc=d3e32014-111567"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466103&loc=SL6014347-161799"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(k)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL7498348-110258"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r636": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r637": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r638": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r639": {
   "Name": "Form 10-Q",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r640": {
   "Name": "Form 8-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "308"
  },
  "r641": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r642": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r643": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r644": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r645": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r646": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r647": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r648": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r649": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r650": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(ee)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3581-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>61
<FILENAME>0000886163-21-000119-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000886163-21-000119-xbrl.zip
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MG0'A\&30//^"D3 (JWS=X0(5!4V!"9IU4&?YY2*,G-VZ=*88R1@2112=?#0
M)8=2<O$XWI<,K5V$2.85#@9XL[M%3)..@7969\PE6XA91F(NEI2(*66M[2($
M_;<AD.EI2,S@7/*HBA; T0L&)TBY7+= 5NG,XS=;0YJWN7N612MABG A@I8I
M5&6Q/BMK/(1$"Z EMU=S=%J:PD&) !.UL$Y!238F89.2KB3AA)_L4#3?FO*"
MQA4JG^-@=+K#-FJ(J=86'?YQ>O'(UX++#1H=]/-Z[RT-1_2]C+'OMJ=.E+_
MWCY]VA9I ]]WCDZ.&J*?"3AXU:@">@O*JYH=B%:QBA8=1&B T;PE*,Q08">]
MSD1:XPE??K>/HC@:DUF:9&6<'SV_R_G!\^_U-E_% *1B,*7H$&MZDHS2".:6
M62.A19+SCP&VT9T1/>N\)18G]^Q^)W9I93BD$<-@ P_[@\==''Y6-O4Y@X-[
M(>]0.NCUN_W]T_F%P.5 #275U1!%U:T(D94U.'+&RVPL:*L;X5/G7E[3<[<B
M12FC+8)C-@"E(N2 42677<ZVE 75+S;&F3;QJ#D#((FB!@G2DJUVT%.T('-1
MPNFZ _B"ZM4MR6EZ^J1-<"PKXZU 4"(A<;CGO R1D*46%U2?'I\,1_TC&HQI
M364X!YWCIJB642XA9BF+21!"8FL8-&9=="V%)IHQ=]4$D4TQ88^M0D(CDH@
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M08G'NOM)*+8("<479HQU[6)0M5I0.4L;;TJ0,5?T<:X!-,4=YXSSSL>L.-@
MB<DK4"4%$R!I75RSQ@(7R4\U9F2N>#)*YI*U@&A,8+3H()W55'RPS9K_6"0
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MS#9+:TTA C_^0Y8#0(_** %?\(H[#JBOS9$RMKX_1[I@QFWVP 5I(('! JY
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M!16#H,)AAR5O;F"-6GSZ8*\B/=06KG.P%@I<'PO7D46 8^0Q$ W"F63<!^)
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MT5&>K(U<N0S+%E535RXK(D5M 3P'BZ( >(8 'MD35"MME"-@F'7 /(V@B7/
MJ7;4!N$XT0G O*58B9^8KT91!4H4,6+1EL-8,IS];L>5N^>/H!PW;C,8K(1U
M7D(,/KDPGG%0-MD,FACJI YIVY YFYZ:_ERCB!"U1>Y\TU@5Y#X>N6/& M$T
MLJI4#DG&0C[+L,I$P$&;B)C@/N:"H"TR?26O(CX\32ZKN^V)OQJ*>Y-W/"BI
M3=U&Z^'UF2?N_JJP\]PR=A4ZGHB./]TPI((7B%$&V*I\5T5;, ;'M'8X9IH;
M+7&B8]PB7+3(S/27!X-AP>),X;3":8O)3U8X;5).&YF8+E*+36(RI$($)JT"
M)8.!]$OK.#9<,I$YC0J2.(TO"Z>ME%XE[T3BJ]W-WW=?[1[M[APV-O>W&X='
M!UO_^^^#5]L[;P__UMAY\V[WZ/V].M8#AF)LCFB:!=\]STE,?IZD>_WM6?CL
M3]/*-?!/+C,V-D[:QK9/VH-VZ#]_U%IXZ(',(I^Q4EB?N'+TF;G(Q48:TWCZ
M*V9QW=7#53&JYE@ ^_5P997LKX\PLC[?2(GDI#8(,P6,! *,L0 6V0B2"$TY
MCKS*_XIEB\BIO<;Z2?"%B5:2B>98RKLPT71,-'+W$).>1^L@(%3E;\"@I90@
MB+0Q*A(=HKDZAE1UJHBW!A;[G19>[SSX<1N^!#0NU"K*T_%J-!N%CAY#1S>R
M/VED#9*!022. [.$@95( ?&46LP5)PQ5E[\Q*LF?5A>^\S$E"GQG ]^1-4&P
M9X[EVG@486 >"; L,G!1^D"(8<38G VJQ:=/#UF"&:<S)ZXDP0R\U(F?U,$2
M\+BH7%##:7G=[>66',0K@KIXT>UM74_5'^;DO.2:>0Q?W<@2I:A)U(01&!XD
M,&<0*"\"1*Z5((IC9$5S@[<$+]<Q5Q?23YXDJD#ZJ2$],D$\8X(+A !S2X&E
MQ0O66PDZ>,<]"9'IT-R@NJ6*HK%H$^2ZHE8O? V=\U#DC,7)&9F(<DO^; ^.
MM\[[:51"[YJHBFOT&%ZZD4W*2NE<3O5 /#? I/-@\N5QEYPD(JP13/CJR >S
MHFRL+I+GH&P4)#\%DL>*8$02N",&E)$,&/(\?8<-4!81-3XA5<?F!M$M1F<5
M'E=$CBE%CNY/^::*TE$+H^-FEII"4E.1U(U$4\0C(GB@:1$1"2P2!)8F7XC$
M@#F*T1FL\QW/-,4U\H**LK%TUD:!\&PA/&9G>.\P$1*4]@B84P0,IAJH9%@0
MI['@-$?BJ^FC\(N0,1LS(_Z4@ZJ$:CREF7%_?II"0U/1T(T,4X()CF.BH8CR
M&8DA'#37#$+T-EALJ F\N<'JY.H4T6+IS(B"WEFB=ZP^%V9>1.-!":.!X?1%
M815!ZRB8]I%(YJN$L[I.Z>'64JNX+V.$NWUW:QK-XMZKEJO-87-0,THLV93,
M=2-+%3-."DH5\.H@UT8$6@8!/$3+&==>6-3<X*3%]*R2W3P,&DLD;JPIUN=@
MKQ2L3X_UB[&BOS:[$0Q(U GK5*&<2$6!#8QBBH)&*B<=0*B%,5X*L*^!#)(P
M1#/NJB;E&\?]T&EW>XU.=Q"F*"BZ#@[5?.(YKB9F.]A!R;_W2)ZZD?")RJ"<
ML@2,SR7!K+6@DC&2O*F\RVBJ.2'-#8IYB^)2$VQU\3N?*(Z"W]G@=ZQXAZ71
MQ8C!1RV!J4!!D\  &RI%E$I:YIH;C)$6*7K(?-'WJMOY!(/0.RT74FIC2U31
MZR5:?;:$].5&!DDN4+ & \%: &.<@W%:@:0".1JI<#F63+?2_E*C,]X2IK$T
MYD2!\-- >.R$14DO&$8@+,; L(^Y7KG(+H+!*GU+'<T0)JR4*Y\K *]OE[0[
MKGL:&@/SO>@2"]<EKF9EMYJ4(_-]3$DMY8XG9*(?FS<B-8PE1"L*-E^\9TA(
MT$(D8DK>CE'.2158<T.@%N)U<FZ*.+$TUD0!\1.!>*S$!TU6 [4((HLY PY%
M8*70"=.)B%UPQG&>0,Q:7-=)85PKA:+<)JFE:7%/*'J13A_)2S=2EF(1*+'.
M@$7> W/.@V8L0D18,,:T-SFU#VM)692*U47QXBZ4%!0_'L5CUH5Q4;F  $6K
MDXO $&B'#?B@<,!4*,5=E?"&U2GO\!J(%<-BHR?7)D:Y.5(/DR)/R[AS4UCH
M<2QT(\NGQ<)(90,$9 PPZA28M*T IYX@Y@-3'#4WB&HA)&KDXQ2A8OF,B8+?
MF>%W+(R":>H])H"X3+Z H0(T%0(,13;R1,H4^>8&12TEZH3?-= H'GZKI-PF
MJ;GI,<9:A:LFXJH;*3Z%TLXA%<"G?088"QS2;W+>'LXL$0%'AYL;3.B6G)ZL
MRCV2E4+Y?.^1%)1/BO(QBP019C#RX)E(V-;1@-7" P_.F*B,<50T-P0G">6S
M2N5;+I!,6Y2P>WK:'IR&7+7.=/PH\-/]RBAYP!C\]<Q<D>'3[/C?^^WGG?;)
M_VL.>N?A=F#W=:\W.WYKO,\%]P_ _8VLF@$+&Z+G0&6.GTQ@!T4(!J,$H8$R
MJ23-B/H)\ NK5_D4*W.27:JLS*==F>-A@=K+M A!^9"#<=+>9!E5((F*&C-"
M#8_WKLPU\%0/!UWWY;A[DN#0_ULC_/>\/;AX7$G:&18/?K)GS'LW]^VO-=$?
M7O>NPC#[><9;C?_Y%;6]#KW#8],+,W&W=_=?3&")7S>T6IFO3>^@=S@P@^"K
M..E1PRZ-=%0H\0&4^'ZPMW5)B5L:??B_8^1._^B8/_7YP>?W;&][EQR\W.-[
MG]/_C][@@R-_O/_C]\\?_GS1WC_=^?'^:).E\?OQ?S]VT4>!N6%:.U!8JWQW
MRX*EG@#C"@LFJ0Z:_'K?O&=Q/<[+*XMKE1:7"IA)@@0DN]$!HP:!(=&"-!$+
M2H,27C8WT#.$;D>WW/I%X\ST&E_SQ/[6N'<]]O.$]Q>^%*MUU]\\'QQW>XGF
M?1$A%K($]UC.U)6W,@7.Y$JL,9&<(3)9C9@JZIRTR.I?\-N=ZVG^^V993W59
M3U$CRW"40"3%:;]T.9$LS:4GJ'(\NDA"S*$^R1Y\ *4-EU?#7$_L8J@MF:4N
M+\=OR8_NA\Y#UN+!^: _,)UL1I?%N)#%^/[;1\4$Y8A;$+E2 C,B\9KS&IC'
MFNN *<5N,>3VB!6UV^^?%V9;X&*RV-,@(PA'0KXBH4!S3L$2KH20QD<O)EU,
M"Z.GLI@6NYB<E8JJ9'$E)K)IFV0:#!(AY_7QU%K,G/5+PTQEKZO#BO),6AL\
MQ)!W."($V" L)/N>JL@3H>2<#C]"K_O7=M<#++-V12#5 5IW-/T-,VC\Y[P3
MAB(<1:U&7G+5N[:#"Z<V]"Y?PM5+Z%IZK:3#$JOX) $_>=*]Z1__&LN5)E3P
M.RE^1Z>"4A-FHT&@C4P(M-XE:S.PG#_6(9Q,48)5UJH5P>2W&@4HE@#C.L;O
M%- ^(6A'!Z928.T1XV"BR;G9HL\%]@@(%*1GR;*W3-01M/,^JZW/T5Z.%^AV
MZGZN-VQE.7>9'6S=+VSES6][I_N?/QSMI']WDKW\AKW__$=J1^KW]OOTV2].
MWQ_]\67_Z#W^OQ^[WS\BG6\C*@(X:I_5( O&BK1=6XXQ,<+(B&I[J%=65HU7
MEC:,6RF3[V5"5AP9!8-5^E$%B:57GGD_AQ.].3-<.7ZIQ?K;PQ\UQ@XQ%8"@
M?.] 4@W&10*(2D%$4 3)L!B1LBRFI5M,.;E&Y#P""IH#X]J"0MH!X4AK(KA/
M;#?,[#6?P[RYY*__:1T6;7/1"_$=_<AR6EJ-*2"1G32$$2B=/#5C+1(\)H--
MV/FHY=,MIG+JLMAU)$,B+N\]2(5B(K1\ZN*8 X29EM+YH$EL;F#1$O+VI;S;
MA)9E[7ELI671+>VB>X\_$LLCY<R DUQ#XA8)B6LLA,B4%"H*2G\505J;=51V
MPAHL)NJ1CQ@1P,&FG3!YE,FU9#&M*$:U"D13:BL&0^HA)MF533:CT[Q6(SWL
M+*2'?PTG%U.<[:U#4K-95: > VHY#7@4.$='>(J+A"!/0>I<$8X'#3H#36$A
MI:%$6XD2O&95^7%)[^6O-"P?O[466,X6EJ-#.B&L"DQ5\>D(&#,.#)4!O/66
M:TQTVA+SKE<C6*[!1?K;1W.;J>UYW,U)X\RT/;0[#6?.V@-S4K()+BZESVA6
M7J=)V>UL#:>D$-)$A'2C(J/5BCFB,#"'DYV05@%H:@(0%HP-'@<D7'.#,M'B
MLD[YTDNH3UV,A8+>>:-W9$Z0Y$5'2A$XG"P)ID*6 4,$FV@7$:JBD"K74U4M
MRNN$WC7(SW"'3>'<^>GY28YQ:'2K=,6N>WK6"\>ATV]_#8V3;G_-RA_\?2[F
M13]U,WUWBXY&TU%E.=T:GXQA8997:4;VP^ @'IGOA:8FHJD;51J#H,:EW00\
M53ES(&/)Z[$:/.;*V61C5&?Y2MR.)/E'$2)6 +N/-RX*=A>#W9&)H:6*TL@
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MA"F0GQ[R(Y,%^>@LMQHXRS&+/B=.PM@!%S&!/A A)4^01[K%"5\6R*^E8O*
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MM#G-*?^]R157FZKFZO)?35V^NI0O+5W*D?U"6H_U^S<_<A^U]9@#ULH 4UB
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MDTN8MBE,E/(VWX4F+:2F]@27++RE&&[%<%M &$^AMFFH;5SCLI$0ZS#DZQ+
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MR\0B#L0#.<XM$DF:I+73/CDPGT67J%MWQ;Y5%<COHQLW-=R>ND#? =NH OV
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M3RW58MU.O[8P]&K@1Q%0:#<V_[X:M(O5=,\]S$M546DE5'JU2"TB9PQ31Q"
M$T-<D8!,/OE*DA0<WE",^YQJH>3E ,B#6#?5%[%^OH@JS@\KSG.2P87UC:5
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M&B#>9/"_MX95TZWVJMUIK]N-5K7 *C[(P^6>5"$I%P']B<N]MJER^0RM0)0
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M54:?4<;N_+*$/6/J^R[[]?>8YG6PFS58<Z/+?J,G]'4]2[_GH^;21Z_H9=H
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ML[5-0+Q-%>]'*]XFD6 TT9)PQ:EPEDM&F592"ADB\]6-LE'BO>1&(09S&W%
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M%CCW#,"UK=<C%O&DB!6!FLA3Y*"R32*@I@4/C-/@4SV1OV$BON1F8+"PB9(
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MZD#!"!PY0RDR&'MGHF-,XXUMN;CM7?#: KS>Q1>Q:L 67\0# #L+4W'"2R_
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MBQ=DR5X0'QWCA!,99;8<='22DY H5HPGG(H7I'40GBO6(8-AR6,4B<SI[&4
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M/'-.68RT9AAQ'7+E AM0](9'PKCCS&YL\TTAEE6QH%2%+*RW\D[?@?64QE(
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M_WJZ8+J?>N&FU>*/.O%KO5H.TN^S/KP<P,H8="PLF_YX]&?NP>\-4-;>-_>
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MB? IMNA]^NC5S&5-,^(6O07CLU-&1!="1D\X)TCM>?%#X'0>H<*-LE254QJ
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M*P3AG&9@Z"0G$UHE_/0!G'-D)EME+4_@=7#"<YZ4T"I+;G-JE?#JH7AOAN*
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MFEO*YE((-"A+-6BG8XHV:Z%-"^%5@W#C<!^ 16:<)&"%)R"](\:@11T,%13
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MVOQ__/!_-L^V^\$?TZ<Z<L.#;K\:&XY\.AI2B.T79J9LU^W'U#_YA92_W#N
M>0$PV[B3-DO7N?G"I/ R!:^^A=ZX_+$S& \[W?[?:71R5/I"=?N=/[M?\(WU
MZIW1X6!X0D[2\*CQH5'Y%$[\EU0M&;*(/^FX?NRD_XR[)Z>=40KC8<4.'3=,
MG=!SHU$W=U/L./S+WZ[;*U\C2#=DA$31_'SI\10[@W+YOCM(Y6[_76YW@B]0
MPD?5;<I%W4FGE_Y.O0[O#'+GY#!U,C)1Y^]"19W#;AJZ83@\72]WQ#='J?F,
M"^.KOA,GMQX?X\W_,QZ<X.OC83?@9W"<R&-E "B_'?QEU,4E<F7:1B?#\<*,
ME/OAX,J%^P/\-Y2N5NO5N(\&,?5(?9]R4U=1^4D*A_WN?\:3.WT][(;#CNOU
M\#8'?9RVX'#(.(/CH^/)%."E!QXEX>]J]O'.Y?'KNV_4%/#A\F4;GXSQ*3+2
MP)FGQR'C57 &^ZFZ&_ZLY_(?.UM__K.L2+D)KB2R@SN=SODQBN,@;G3^PCEW
M?Y]9ZH9\-.;[:_?D$*>PBYC%4:"VF;Z!%SP8)H=#+O/7QQNFSFG"2<8%O$0(
M&PM61+562:?53-<"4RJJC7'I7;_^:YG4:N"#4;ID?/B-$2[+*)_6SXOKTHWE
MJOV48C7*<BO\^+!<?X#/7RWB:*/SIM\I,"N_K7>^3N;C++"^NN'0E9$/TVC<
M*YW8.GDX..I\2 DU9V?W$*]VG,8H9R.\7-CHH)CAU\M4'+O3^J$KX?J:AF74
M)R>]5)X5)PA7<M2)^!1XS0H,W2&NU'_&;EAF%(>-&M^>!X^X&CPS-/Z[A\JC
M\R$<#G! D\_AR- V*#CQIPVX_D!4'CV1\]4B\C<74/=,T-8G;(+B.$PA(1'5
M%#P1P+(T]3>JW#?]KQ'*&:II1.8P321NNGR3*R.E3:]50:=(5$'$\1@E!J5E
M?DDT2H^.!F6"!B@ZY7,S\<>!;B&W]HI0JO4+=$0MG&Q"WDWA[**4I\($.#6(
M_5&YT82M:T!/21OO45/OC)8+N9:KC="4;4!^H^"N@X/O'Z0+T- M: W% *J0
MMO:KPY__0+B._EF#]V)R6BL?KJAB4"2VP A?5993!9G1"?XSG=\FC;R<8WC4
M_88JHW]R..JD?KG_;^-^JOE=T/5."6RHF"9]2\/0+;>8$1P^R?@$[]&O5/R"
M5&QT'CT(Q6J!</>LS. 2O!B>CDI6U,4=-W$I+I!CA[([\%,U5@^ADCI$$B+M
M&-]UX7"CLST8S6#9N/Y,110\S9@[%B@-CFM1&Z(L'XQ[[F0P/)TKEU&G&DVN
MAC*U)M+P !6'0YU<BVFEN"=/54/F+$A&8_\YU8"K%#!>-&?\0ZT>:GA5J.SV
MC\<GE:(M]YF;095Q5!YV8I?.-<J,G*8:IT#RP WC%"CXUVK^^O',#.(4X7QU
M<0*F0 OHA!3\-B8%UZA\[\)YV>B\F(^[MB+G0SAR1>OA$B)=]DXG3[O 'D\
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MG,\T2\BKLB_0MAG,L%''#$XIXMR4ATF6[[BJ_MBK+9;#[G%S+7)502X,2L6
M1K759F!A25DI63#]00-.%\3.WBR"[F&(Y>*XL!_'>;VMBU9,:S X/RAE*.L*
MQF62%JI9K$^G+54HNZSFQ:0&<5TC$V>]S/"L&$)%#7/ZFN#J)@I@O>#VG )H
MUI2]4?;/C^,H?Q@U6<VV%8!VFP 630;%J0$1:5;9RV0%BVP?Z-H]"LK%AHS8
MZ%Q9'6<)P7T7I(C,*^ZO2+@>W7XQ]1T.C[:_'_ =_E%\^O4CWWGY#K_S_G#G
MU^VOV]]W#C_]]8YM'^U]0\_BRV*X'M[C^]N7>^+3;OSR:1?O]Q+']^LKNO=]
MZ_LV?]W[]/+C:2FNOW-4Y77 SN>M_9QEP-D,1!M?VN)Q= ; X2O@G'&O-/J$
MB^&:&EQF@G'\H, UX<9Z8T106FBGDZ&+\7UGTQ 6+.[K"_:%E/+CL9P=>X <
MHK%.2FE ">&"#-EHPSE/V5IVQ]&(US?SF2S!!+6JVKI@$WI%57,9]=M^YVTX
M&938]DDT6JU2IR'G]5--#:1)U@[JO>*2'.!;]3[MA*F+88+FRDFJ,]'G9;Y/
M*C4Y+ HB?>N.)O9D^4!W4D,D5%71\;I?&V\41>R[.!,'=4T(-SPH9(U/\:4V
M_T,I;HQOK:,]64+?T;I#+RN-FBFIU6C2MY)-.IH5HB_7/.T<H_XO^R$K;T25
ME2II&/@0O5)&H!3ZG%4_J*HJ%5UXDP3 I"3-,KO@=81@J9'::"VR-3%SU#P5
M5U<ES,CTQ6("X"WS_N:[_+M#G):<ABAO*Y.\=_\D__W=MWVE$@@;/#'5-CVU
MEM@0':$<>3Z7RDDLK&V"DC],".U.;=55%8IY#,^D4.M42M)HI0KN/( @?/R^
MG[@6@?% LA2"@&2EB*(L<H$VN=3 &-,H"-QNJ!^57BA>;FC";5)LK93A:9R8
MUB7#SB1U%:^K41__YC7 J*?*!AY04 "L2RXF+XVQ&41V*4V;ARZ?6ZY,$'ZV
MDK7S<IOOEU-@$6T@PA2*48P1;X4EGG'K(9NLN5C;U/I'&<&5QUYDJ[F),ZE<
M,\GR+87_9KF\E4M?,N!F_33J&E"]A8V2%9&ORTIR_DBXKFH4]NSD;?<-WQ?"
M9\ZU)\QH=%6,1GE+2&S>F@ \4J.*:ROTQF7=O"?R-BOT.DD1[?>J(H45EZ'(
MY3'^L5MG!,V%KFPPU\658C.9_$SZ!:NO?+9R9)TI/E&ADZ)3"P97V?Z9UOVX
M87F/>^3%ACOR8C Z>9LGVC:^*M4=3RO3JQYP>?OY:MV=SWNPCVMA2^4- B$R
ME%4CB5?.$EP:D4OP%S!?RAV=+Z)XEAKK[D5GB^34>;['.,FDN=>-CDFI*WJN
M6%E##AMIRZM7=^<6-7=F;7O<%>T(CBL"/8.>())F+"H?@P67M5<I44&EMEF;
MF.C%Z+G)T?=/\'[CD+PZ%)\!B?!GAJ2WNT'L"V,9)!-(9%(CDIPDSB.F<L@T
M"*#!@2HE$\Z[,?]GL>AQ*1Q0-=4JCGY5J'M4O(0XE\')QG&UC7#F#*MQ4+A0
MZ'BF(B9F;W]:_:_2)9?V19JT.KJ@P=%HH</1M0YSA5JYP]QJJ^&"]B,+E036
M"^V4H[QZ3[[>)?KOT;0UHOOJAK'9Q:W9IZE,^+BJW%N7JBYEJ ?G2A7X%$H'
MJZ+73SO3#U]4QWBQA\]$G8>0>E.'!S]9KE!N7BJJ5QM;XVI7:EIWX8(3NZH^
MQ>1Q3DZ&73^N4X!KACQ#XN6TL)@$D\=8,!2F=2R0'= X;E2I+L0W]<S2I,'8
MI?KAKY^HN7@?_OQ"0L[%SOQ68P)W!W]6J_E'+3YO\X=2I?]MW?7QV=H?V[MX
M[W?[7C/-LP8"@AE2"M,0JY4G%,V2%%6,3D.I.+%Q65?<1>^LZIM02S&*59&E
MZ;EII7N+@7P]X1Y-*Z9.]/FTQUZY*O+HW'0^&91RI0L8J$1WA;<HV]VH2^4R
MT)UWR]N/6N@@>IYV+Q#6<R):D>PB4TY)N#86*G*]B;1I;ZB-)AEK YALO&3<
M15".:AL2,XO2MIB@?1-I>W5TW!N<IO2A'G+5H>K?Q9IYT7CJTO'C-1KJKZJ:
MO>6WC_B)W<&'JB'J5J5AG[%8'K#2BD@HH-I'(KWQ:&9:5GPU1EQ.0(4$8,JM
M;9H-?8V]A5&:=:.H3);%R+23IE516AM/+ J4V;KYYV#2N!@)]._N8#Q"N^6@
M=**L#=#)\6":+'U-I]6-:A-GNI%16+OI&34K5(TZ]9%;'??E(KJ!W=')L"JL
M-+44SO;''912> O1-O11''?=<:#!AW"8XKB7WN;WLPE^,XL\J4,VIULE6_W8
MJ#6T57I4(Q K6^8Y1R3L'NSGI*F(@1/#42- \II4Y:*3,UY8L!$U]N*IOL@\
M)0B*EH BP:(3I547.H>N9"4E6(Q(J#9&JC(]E51/6EG7G6[K+>6)$=^H"73%
M.>E$?4RCC&J5,HL1ZE\8/3FKOU:"1QLI:*X6A?4Y0:1O:"DU?$:\VRQD\ER-
MH:NB*]KR:]<NOV8><_FU'\:X+* 'O6(TMW($@YZ $-EY%UUP8+U&(A1A.LX+
M;_9CZ"T4O30136V6,J!-I!+U.%H?G04NH\I&K;5EL5:X+-9#I.JB\7*K*D]/
M,G/M26:@_>09UBVWX<\;:X5*KF&N%<G$-U[A1]#5/-,Q[(%3T7[6>*M3T8[>
MP1[_2-%PXSM5.MD[-.!>=_<^;YUN'^T<HOM^^O;EEV]HU!TNIJ)]>GGX^=,N
MCO/S'MO[?( &7^QM__5;=_OEF],]_NK;SO<W\';W=6^'OSY;T KMNLC19"24
M94> A42LB93H&)5(BHO ]=JF9.OHF[4%K>X3O^_1)T5;<IK=\KQ*5=T+>5T=
M'?+3]#1?N$)4+37=A)J:!5Q89B8EYHC"]240H>IS'HD(DGFAK/$!J8G3RX)-
MVLI5=P+-K1#JG;7Z[ ^%O_05K?OL%H0\LU)53]C,&@]+9][ZD^_GZ]LRVDT8
MK5FYQ6?/<G"62 !7*K=D8KG31!E@,JFJQWTIQ">D;6VM>RT>.BSA'I/<T')J
M-6F;VT\GK=WU--ALNL1_]!QR6NT]5JO<TME-Z*Q9Q@2X\BK&1+*"B+ZC2<1E
MPXF17B*M"4E+@(->-_RR"(?61+L;U[&\)H-,QJ/)P4=KD]T_BRW?L2R/^#9_
M'$T^W#+7#9AKI[GKE973(7I-,K6EEGOBQ":I2<E<CD'ZI 0REUBG^M;.96N(
MW02Y=1V*^JRVM;R>AN55K>G.H!^:_F3+73?AKK/;8A17N?2<<(H1X-X3SX 2
M891QPMND/*V<2'%9UE]K==T)@M_,@DWF82:MW?4$[*[YPK;<=7/N:FZ @8[*
M1,B$)_03@3E#+ N9!,6BEB'(4O5F4QBY3F^_K?^(+:^'JI7\ZR2^[4YZW<H-
M?HU!7!#G5LJ2$KYASD<5E;2Q<H&US7^P?R[$:;56X[U;C5/Q:0GR)@39W%(3
M3%C'2]]. U4Q,$&\ $F<I> 3 \U!KVU:MF[$K<,Q6NONIXX]C]UIL1N>EV5W
MDX8\C\P]G1QS-M^8+/4?]4JW;'8#-GO;W&;CWDH9>2*<JBJ"(Y$B#.70TRF.
MQEY2=FU3K1L&;0>>^^.QX3C%6_<6>[0FTXI0V=*]U,G"-MZ8,%O+7S?AK^96
MFY$B928H 67QAW>1>.TU22I2'DNC7P-KFV8=Y/DJ,FWCQ+N![\M45Y?L#$NI
MD'%KASU=.VRZU._KE6YY[":!&KM;)[-HVJU]X063'@))M#B7PB=BG6,D\6 I
MTZ'DGY4#3TO/'QJTEMC=8/GW4MZXM<.>FAU6+6OCSRUMW8BV7C5IBQO-8DJ:
MQ(BV%W@%Q'B12&1&)\&<%39>%J?1&F!W&:+1MJ9^>A;8/$:C\5ZUW"V'W8C#
MWC0Y3$;.N*2&T%)I"7+9TL_XBBGF#+-:@C=5O(;AK>EUWT[DB?O6I+)G&/'_
MA/ELNLJ[[EMKC_TLEVTWN2Q(<")83VRBQ1YSEGC# RF-Q)"_G!(AKVU*L<[M
M^=IQC](@H^7.YRN"M#V?VY[/*QZ,L53+,+6G"#>CS7=-VC2TM$93G/B4$@'.
M++&:6F("TTY:$;T152N@=4:7E?FY.@V?SU4_NZMJA#.47MKM[?+RA.<+;/VX
M8-8_V#\[TY"GT@ZWKK4_:A:/F]:P6^CO]?>D^'6SMMWYBM6-&N?7K%ZW,1_/
M!=6 JZJ7>*$C7S+VOPZ&7Y!,ZG9CI>#DL)OZH:[,/2H5PWMX@6FIRRHO%C]3
ME2,9G?;3\ !ONW%YK?]E4=Z;G==G. \7/13>P]%'G.UKM,KX8S+W?Y2IWYJ5
M%YQ.U*O)4Z&1^+)T #FIXGRKXJ$SRJ./D_)^OB3DYX]0#@U"D(P#)QH$>JX*
MT.X3*A+'4O#HMUK!V=KFSJ"?SG'65(0/&N(XDY^Z?4:<S795V+IX8@B3X\$H
MC6[?B?5AZIQ.=6BC[N1HVGKF1@6,D<-UICE)YCU$Y8QPRHN@N0HA6R,O,0_4
M YD'C<R'YUO%^/.>V/FZ+RUJ"4<IT39J E([8ET4!%Q2*:+W1)5?VQ3J_%[/
MV9KOB)_+VEO7E5=N(DY"IV2]]TYG!CI*RRCPX%6DR60A6G%:17$*W[:_[C,#
ME=E!J*&.@-:&&,[Q5Z^LM](S9E"<+LVO/R--I4/0K%_J8I.BF:ERN=15!:YG
MC5K*9QN]AF:]B#I'Z>1P$.M^(?,&<1-KI]&,:&H:#4Z*<)2[#4Y=K]Z%F[5T
MP==5X5&T5^?-:8^'@Z(ZIA$@R/+#Y(Y*.Z5AU0<\#P='U;71_$O]T:2P=[.5
M_&P>BNTTL\;FH[VTLWQ=D/ZR#D^7SQVJ/Y\F[4+0</X^[;)7*GY7R?I%F93)
M[3;&4^N:8NV5[O4'S0&.1RF/>_B N;KY506V4TPL4V5\#@#4<!\-HS%DSQWE
M+LH+6R\L6EQQ/#Q-;KB(^BF,7U=]VG\OL[^8+/77Y"&VZF?X6 W\=QSW<P/T
M]U=RYV _2^F448ZPG T!J@4QREO"HN:<TL"<TFN;C&_8Q9K2G;( HTMQ.W,-
MSLCV,\+L#!)_I]&T"0#>]7,*9YYU,B<_;I-VIDG:M(K_WVY8-;,NH[U4 :.B
M].7,[ P,F8LJ,J5D3@E,];^DT,$TCDM.X5Q/BHO\H'O*;WPY>?+W^.#/M_?9
M]G>\]]=]7G8!.$.O1^2 9IR4Q%-P!$UR+S/PG'WIXG/>GOL_1;!N)B/ )*I[
MZ3+H#!DE)"BID!&"I!XMR1]UR6EEY"%DY.V[?9ZX4$8 B<Z7UB60R]8>)2P)
M:0 @45_JNIT/$IXTR*O;++F+O$=7^/NA+(>?:=K46@[+%[+P?7MK'VBP J@@
M3&<4LAC0LS02#0FKF S29,4R"IF8-]]=L!P>PP[*[AF5OF#F7+N%1[WE4BGQ
MYD'_]/MGOU9WC9SNT)Y'']H0?W='B%;7F[4C+,Q7+E]M7)UI-Y1=KS>J>HA,
M.@T?S9N)3MM939H(#E,N/ME7_(P[[=3-7B=7:]QS=F74)I-V;9T^3G:W7R.M
M<N]\:=5=9L0/QB<XAG!A"\W:O/O6'4T:OC4MQTFGQM()<Z-SD\VVNVWM<]%^
M[G#PNCSYF_D$/._6/5_V>5"*:DI)AD@)"*>(1^.$R&PL2]H(#6:Q%<_#8GS>
M! @A>U2U]IF>GI36F>.^0_S6/44'M4HYVZL5/SSN+39JG<(1_QNFN@'0J/NM
M<X0C.AQU4K\T\?EMC-I2T*I;."T@F/09GYYS-+!PZ%#5ABHBKM*YO[G^N(RT
M;C5.IR[!07$X.JGJ[%9 &M*PH+%S,F_'W:2,&N=5@\(F44VT^ZSST<7&0'FB
M0S=SZ<XTUIOT#*LF89@FA+#8J:QFL/FD9K0+^Z%X<DT^05.B/R@T4\ZPT./I
MG>+;I6=OL_/S9-ZK/JSU8M0M8@?C7L2Y*Q^<3EZ9R?,]85/5F;9:_[.$5)9X
M>L-"YWU\(AQ2]ZH1Y?')>'C1H,YT:EJOSN6.*R:>S.2$7DL/IW.<]V@:XBBV
MP<SE;_]T0QR] 4K_U&6O?D^8Z[79N?%@[3*Z]UP6^W/%1R\(V*G[:-U/?(I=
M(%Y]87S*;D6+9^BP4NAG./'2Z,>G/S\?%I7%#V;G40?[+T[)94U(ZNVZGXP^
M6>U M^M-P<\&NJUH*-OU'OI&AXM"<5X.%CD#RIUE6@H7//Y56S3JZUT""I-=
M@MK*OV5,6\,=&$W]@:>5)?K;E[<O>X<[1WMRA[\ZQ7NPG5W\_7.@>T>?CO:^
M'^+W7A]NOWS_93%.;>_H';S]ZQ7_]/F+V-LM,6X?6?E]Y_O[[J>C3Y_?_OJZ
MM_?7JZ\[O[YO]ELYW7ZYQ_>58UF+K FK*G;P$K,6F"%.,JUC3BEQ7GI#KW/*
MEANH=D>A:/<;]MORW=/GNR2"=I "D\J#I-EKJ65VW!C&J,UZPG>LY;N5YKNO
M^SH)RC1W)(,  I$AU^7 B4LR,9E9H*4ZD5;K%,Z7)UI%KGO4B5O7P^E..BF;
M)H.CU/E';S :W2JGY(G1\45/^%1(=U6,3)2_-Y7X_8["UU+O3:BWNV!JQB1P
M%:O:EAR*J9F)UX82@4J4:QZ]AE2ZQX X?V[Z<)4N?Y):KVU/MC2U<C1UDPS9
M)1B'(WQ>?-42UNH0UM=]SIP0D@MB8I8$@ GBHC;$2\ZHRUR)6!K&T'5)VU)P
M][5?>\X8K(YU\/<C!&EUNO/+-7:S;[P7L!+76)*M7ZL6L2KK?#$!_]N-NJ$U
M]!^O!KU*@?Z1AA\*5)=K\/,;!)*\<L,^SN-H.I)*W%H%^4,%V>BH5BSZTWV;
MLPA>2F*HC@0"Y<1&L,18+Z,"[0RE:YMT \[7AF@-^I:.5L.@OX2/;FG8\X9=
MWQ+3W1/3]SDQ?63[%!5)5H(182-:[R( \<R:TOA14)3=%+5:VV0;YGQ/C<=L
MNS\*X^YEMS<^.=\H[=:% U?M.6]\K/9X^/1QF7<3@6MY],<\^F'!P.,>%$0T
MZ[0+)3H@6F*%0WM/H1+,03(6367@W7K'=HGE#.\I J EI-5YM,=JX+74]!.^
MY]?];$(P-ED"JG25]$H2'X$2;I7(T7 5E+RU>;?L JNS\EAUM\*S&5L/EYUU
M:>FL<UNP=2Z'&P_'HTY#MA]#EMG;?N=#.CY))06W8V?I'(TD^OJYIBD>52HX
M+FF=@1'3WZDW."XY$G^7(EG]DZX?Q%E:>/?H:%QEV"*_?)VD80V^DFFB>Z_K
MAU42^2058Z$R6+Y181=G8[(Y6\ZT!BN,!0O:.:,I.CS1LPEI66K)],69XR9Y
MNPHO+P;]43=.TF]V2[Y+G6W'GFW9EIV77_CVNWT(7##-(W&Y5 &RS!!K@R'*
M4F8YN)Q#7-N4&^=C*#O3DBV3LE$W*_1SG_+PASNMLIAV!Y-<WJF I-&OP^9A
MXS.4 ;']=5]8RR7^1Q3.-&HEHXD%STFBU. ;E*;LUS9AX_QF:$,&JKH5=8:J
M6SE)N*S(P&6T\+^#7BR*]3E+AD1VL, =53:1R&,BD+4N\=6!)&5,*,5 G$O%
MC3KO1<TDXW RE27AL.3_C7*5$)>.^MW<#=.L8+0])IF1M1ZK*O'YU!FEDY-2
M M*?-O1@2<'=Z'3^0BW8&PTZW=&HM GL5R6-JA6LDN%>_/F^SK,<'Y=[WZ@*
MF4F6___LO7ESW$:2!_I5$-J=73NB0:,*A<M^3Q&T*&GH%4D=M/WD?QAU@834
MUS2Z15&?_F5F%=#H@Z<HDA)[8BR2W3CJR,H[?RDMUS:2(D'\L5RD91&I,H-S
M4F0.A6R9$I<!(&\BI+ @$%C5 ETV$!=GCY<:#Y\CK@ ORXBIU(:1S$4H&&;
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M]!L<@56 QF,T3%9P9&#?\9$6-9TI02XL(NJM0&<NNC%6 <[AXV;%_;((1
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M>]E'&%8RS.SGL=6=[^>$3F.N%^X@$WZ*)CZ5)CFS#$'.,%D;>*R;6S/DYIH
ML^+F1PN'-9"3CW9*EF2E*U ^I_7_DNKJ F\*\8O*/@RL^D1KY<S'K> MQN3P
MC0\K]+$_@@GR7H!G)Z##$^Q9B4<'V<K]QD+0:BYG$\J@Q!V9U75+D!VJ\R4?
MSA>#@%*8"HG*#.Y:NW?(#7WZI:XF>C; Q$EM,;+BS _8&MQ?RJ;MGRV 3M5>
M2H,%@VZ"8XONH\Z1:(;0VN#H(YA-2/YC4VAZ/KQO:AVO!K*8IX#ZL*R<3,Y\
M&';F9/YBE&<@SX"49WJ**;N$3DYU,,,ISA8'A]_TF]M)U\!;E&V-KCZ6Y95
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M:=EHW6&CR!VOW:7W80@^HJA@3DWU YG&9?VR367./^"@NBZ=[AMUS#W_=,/
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M6U?$(A<L%LSDI4AYE(O81&5:JL06,3/L*$F>W*&^M=X\RK:""P70C>R*Q=,
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MNC/SAXEF3PDVE:)H\7"$N:P++UG8%]226A#N]F!ZI6%B,4$-M?0):!5@)8Q
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MD[AJS-7QT,X&(SW29$:[^HNY%;S5?;#CJ"P)X:54'-"]M9&N0/-@M#39>$Y
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M3BH,8*'6'O9X>NU60]#PSG)[#[?^3D"J'M.N/]F3;=\UF&]#]OL#!5J 0 L
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ML0T\/$;@X0B<O4_D ::C+#6S6[.-0NP3A=!G5.S_O04DJA=#<#+X)HR#'YL
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M%7(['VS4-)^C#)!6"IX^R!2\?=+Q#G[6-U;/5''E)WQ+"09&H6H_BG7&]TE
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MP+(]C&'MHKS"=)$J!6FUV*OL_N]C.)+7C<Y#;%0\FY7A)$U!/,9:QX"11XO
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M4==RN.L) E^T.,2'*"H0@404B%3O(D+10BH*Q9[LG\HZA\-!*CQ42O!O+WB
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MW.;'.*I&Z[]=1HR1@]%G54HPNS :Y-@S5:*-X0_S^HF*,98B#STM)_;6=LO
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M!DXF%GD TMHQ1/\DWT8X;"R_O<?;JTW5CV/8GJ-^(R+^K%#S57U4[^LO6-@
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MDI!@BDRYSU7J=:B&Y[-LI?YF"NBQ5YV*=E(AZ9A<8$#T9!HBU#A:8$J1^U3
MH!*I]W9UNU"SW;HI6Y%@^R%O:*XN8?JA1LX?X<'EWM<T.:PI;B=+%2:%+IO
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M#8\E[2,W][Y^JD>SO^(4RW@Y$L7Z4DI@4A1D6@3.(()E!;*4PD7 W.OV^U)
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MB1=70AJ4P=Z:,6T4L0M>T/XA*Q+K5V5=#;! VP;1U$&VU@:7.U50W8P7=[F
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MK208DL7<BW#WHNV=<)5 DV*FZYC^].W]'*8+2"OU3?/JNR-E7I0E%)F=]8K
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MK!$A*5GF0$ )Z(1(?>[3-\<X*+OWP9-T6Q+T)NG)'>(I?-GF1)8-08.:1"^
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M5W?UTY\XT]4,NX+Q"MM2KX=3&/LX[7^%%W[J%SA[V:C(,;8BEEM<]V54Q);
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M\*6VN'#$"Y6(9EI+<-0#J+9RN 9S.@'JE@9NX%;.)J>WH^'H-K2%)*_T#DX
M+E> 1"E?3B1PNM*>$JU1KXQQR5(C&73"]_2549^&%BXF6J:(]MWP]? K3*9E
M_)->*L$/Q8':[$+)HL:@FAI4,.28>8Y.B8>277=P+%?!.<!JT8"[NS[ESH9O
ML)MQ#64^X-G-1OQ.CTOKL\"A16Y\61R!. :1>!HL53&+K-L$H^L0G:0FJIB_
MP8JRQ+&,=Y)WBK(0279TEFE$B06NB0#-J59!P8-7AG=1PRT@)RJ"[8W=8(%X
M>,3HZT3#9+(DQ%+Y)R>#HC3XA[+,4<:">3"7HY47<9+*J$A%@UV(]< @1>.C
MDR2(<F#(N"48)SLBHJ3<2Z%HH\7C^Y)''0(:[$Q<AT;+<]_^\ )!+F*GT7#R
M*^31&.:_]\E_@\EO_>%HO"RM@),AAM2W/^7E_US@CW^#Z=DHW72@M$U LU(D
MV'+_SW*.7Y4[)XJS%$H4[]M$-7L<Y),/C8Y5$ UFQ:LA+-[%7V&(?$U[S%B'
M[YTC09:;,U8F8DT(1.,K+@/W*6K74*?W )V(IG8S=(.Y[RU,;^P,)4,M"S(B
MA(R^7,+9."AFB9$A1(\1'FVT$WL+QI/G>GNC-MAB?>G'0YR[)N]A/+N._JN?
M]&,Y3NP/+J:0KO>7*9,>RO0C11$BH"0C>.*""QCS:QM#FY6I(\ GKXH61%2L
M#_\@S%[.,6H3%6&F=):QD$OE1ERF3/ J"FZU;1-2KX2S?RTT(:^+0#:R?(,M
MM[]#Z1:+(_R*OL_G13'6=_E>98LY6)L5%ZZ<+^O28,KJ\GYP2M"O9RQ3&T)X
MZ*[;]C+9".9IRJ<=4PVV[.X:9&&(GI4<>'2>!,=%.9K6Q NM2?!>EFHIFIHV
M'L@:0*<IE1K6;["7MT;!"W3WB^EH$16&3U NGV4B?6E5""$2J1A-*L9,:9L@
M94.@IRFBEFPUB'2OO+GY;61=>FY'=,.9+)!DYJ7 "R5*L612= ;\0PVN*EP?
MVLNM_4:^[ [&//2-_<EXVGL_'J6+.'TW7J3>SNZSR@PA<9>0L^B(%(81;QT&
M:U0G#TYYH)V."O !-]2 ?[NKA'4(]GU3OP:9HXI&K>B]WL!S,\-Z<=FU"Z@.
MM_2W8OP^G/W>W*_#U'W:*YEY;QI $-Q'S0FE6N+LYU.YEZ&(]3Z%I%'_W2[5
M'2/W:^[T[Y'Z3:S;(&C],+KT@[+;/KN/SK-4-)5:;E+A\"@K^6Z,$UVN-T>'
M+F]H='_R)HS].8$5J;E[&V%KNU:\2ELNWO>6]ZL^^@%,GOLOT_YD-%C@LCE(
MYT,@B27$!11(4,82CW"C##1Q>Z>7X?V[_(\]Y"FS6=6 %=_>&:[EM=O%3=QE
M20EF1$SHDV!X:E!J&$#8R"FABFHH_>J=,YTH7?GQ3Y[,W8VV=HMGGW4X/GYZ
M]_R__O/=FQ<O/WQ\^7]^?_WI_[:MQ_'0\]K7Y>@\VCOU.:(3QD7AM4Y)<F$=
MEP*YS=E(RR#(Q^MS//3DZG4Z3)(F*\D)HV65,*Q<.P%',,S(&/\;D(VJ%]2O
MT_%Z&,?@)_ "YO]]/:_R?#8:X!LSF9_P?Q@-!J]&XS_\./48-30G!,=M5$0&
MAT-G.'3I;0C6,I-%FZ%O"/0HCM8VT<F*P_5FQ#0H C+?&WL]F5Q ZE&AK! B
MDV0]+4VT,G'S"UK!.><=#;+-R=I-%/M70%/*[NY6;6OO!J')_5'VLBX]WQ4N
M]C0+=+=PB?:VO .11O"VI(.T.?.XC^7$=;";[1L<@\T0S87YXF+<'WZ>EZ:>
M"W:Y<P^I=)# X'Y>%8!EEH(.E@A>#H29U<31TE$ F)2::=_J8M068+\#/35D
MK\$1VQK(?_.#"UB#&&=$DS&Z+_O!KB3X<Q)F%W]TLAB3,"U8FUO\FV/]+N56
MB[L&9V[/TC\N%HFNGT;/4IJ1X0?O?3^]'C[W7_I3/Y@A#W>1?P TW00CDD6(
M/!_J!XBCSW-*9Z/N22DA^HP1\ZQ-DBZ7HB$SDET.R@(&S=#&PVX]LM-6\E'I
MHD%6[<QR'^#+Q3B>E1'<7QUZ-MK =#G^3J+\$5DY=!?$QZ"U30F$;G7^_!BV
MT]9>96X:9.P^A' N;VZYCMP#80S#9)E2)*Y,\-I1*3T-X'*CF/$Q:-^O=C9G
MID'R[@L(TT5#YSY,GGWU_4$YT\>QEWW^WX=HH4'_7Y"6M[M[2BD-U%MBF$9K
M"%&*!&E/F&$Q!NXL3J)-E+0ITM,65E/>[NMLZY8GL].&+JLW(H?^Y^&\9TN\
M_#3VP\E@MH)?_VN,A5(P/#FBP,"B(X1.0$+9HE%:&7Q?.IWJU$)TFB(['&GW
ME;=U>^%-7,>YV8K;.!KB+[[+ST?#KS">]O&5*F]:#R!SQKTFI;QB27U+)!AG
M2'(:A\ DE;%-N<L:Z$]3I ?C=\4>[VZI"5U&\'<_QI>KW!+]=31,_PGI,T[R
M?_2':?;.E5[MH^&DQV40&I@GP',IJ^$X\0[]4,%=9-H9X62L-C]V@G2:VCL@
M;2O4MUO^1)=AE%NH.4.\_>9\A&%_-'X[FL+DUG"D5\X7ES:!I$3&<CL_&DVH
MHX$:!US)7$V%&T'[SM78CL85JMSYJ*/+B&95*'I4.BT34,*-0*-Y6FZ\444"
MI<+2DN4@VFPX=X9XFL)KR]0*3>U\FG'[HK5 SU,G@QA8TCAF!:4 55GZ37"4
M4^U\F^M ![Z]OD]M;&_Q%?SO?J?GYL$^+K;)F)1)$E:6(F2>^"0544XY;:51
MVC8Z%UV;2%$G/2 C)5H&4KJ+(TD& R[E&3$ +%+A'8?#I =LL0;$.+HHU50^
M?RRWPE",D]^_)#^%ER7%;5*6KS?]R;3G=6:>9T,$+>U$F<8AAVA0IHGIQ$,0
ML4UOIXX GWS"5 LBFB3+W+J9Y!QGRD5'(.(B(XV?'9M;HB28P(5(/K4)VX_F
MSMXNG.]@S$/?V;LWA#L[ )/9-19T8*5@D(DRZ.9*BL/R1I0R9:"YT51+T6;]
M?Q#6D=SJVXCN=<K9V>P-YH@[F!:I]%U ;7+%;V--K(2UWZM^#>B[6T>@FNWW
M)@RCE+ N8]QKPJR"(7J)Z!OBA"IQ<E7<"M;FP&N/@EAS_^]0>MC$Y$U:8)V?
MC^8AT>)B3.(T2.8I"4FQTE<I$1LP4J#49NDUB[)1,:-[4 Y0&6)WBNXUL]K%
MO@W2Z]=L62S L8QA;L'E==&WC:7D!2Z$(D637 XRA] FMG@(UBD(H9[=&\P"
M&/%<G%\,<.9+L[VK,O QG)4I\^NBD.<"J!<Q2W :_2.-,4_QF6R(B3C)9<0A
M6,_;K!"=(9Z$6)KPT:0+WA3'"FE94F>!B@H!TKA F B!R. 3"<)Y8F(P+)DH
M@VLSC:S&<PJ2J&#IBAGSY:KN\[E$2RNUV4'+/-/K77Z61E]FUIU53W R6\<<
MX9%F7.U $$NM)X[G%+E2656L&],%T1...)L8O>*DT 7?LOI)!X35B\QTP[;_
MBC/U.=U ,#L04KD<34>D@0<1$J4D*BF(%%D0;W%.55PH\#E&Y3M5T3QZR3Q0
MJ.88%+,)#WM6RO49[6*5=-Y+YG!MU.443G*@Q!K\JP]">1NSB-"IB46=5>@.
MNOT6V&C![B;KTR[4K V'*];A*,4@)Z/\?@P3!#G+[\2??[PX/_?CRU'^V/\\
M[.=^+(E.5\=$[T>#?NS#Y&W)@"IC?U&<M<'D-NYN=3FJ/G_G.AWMK'&G;@=0
MS2BW2MFHI?6E%ZNRW--L0Q9)ZUY5)+L%/>_'I57+]/+]8)[N5IS]+[>/HH()
MT3&)43Q7$MURCJ]/YN5MLI:Q+%#9;4H]/XYM]QW#>3F=O_>G9\_Q7<98=/RF
M[T-_4#(IYC5V%E?._@6I!X)+[8T@(EI#)"A./$=OE^:L7=1)F]BF?]!F./<?
M(E96T?V-QV8T-=B5?#[PD\F[O$@A?3?^4*KG7A7IOKK[\=P/!I!^O5S\WF3Q
MBY,>I8JBD0)1:I:_AVN6!Y:)LMIP':@PNDW/RQV!GY[L]DADB^.05?!??L,P
MOS^!]^-^A*L?7F%F/:]<"!;%$;U%'T:S0 *N7@3];\MI<-PFLS_U/0;W^]!<
M5=(:[)RN!'VS(CAEI<QH$H0;"$1ZI8E5H D%28-BX*ALLX?Z&++O0S_;4M&@
M+$G7^X\EZ_3]:#(C8SGE+O\^Z7DJ:/(XB"# EGO;M'PEB$-O.^E@K69M\L.J
MP#\YT>V?U 8E3!X>Q+/!8/2''\;R]^=C2/WI+"]:2I$M<$.H 59NYU+B9!1E
MQ6?&!9E2L <0XFJTWYGN*E!6L6+(O'SKN[^]?L'<(JJ?8,P"_:\%\FJL\PVG
MNUG_/8Y&RLQ0U(; %R67--T(J?13=9I&GJ2X$Y"OJY%; \[)J.I ##6H*_(L
M?2U()^^&I0'I$'_Y\OVBDL6DIP.H:'-&!\ )]!53)#ZY<GC'DK.4@G5M<J(>
M0G4R(JI.0<7:(7.!S[0[>?;ERZ /Z=WP0:!@P;$8RVI<ND"'LI/BO20Z1&&E
M8K@DRVXSS09//1DMM+5W[6(?I29$]),II.=^<O8*9[O)_-ACEJ8S;W;\P4]+
M(:Y8RD,$;[4,5A$AT5.3P7CB(J!MI/,*P&A]=UMXC38V?/!IR:.EU2L6Y5@4
MGS\_+QL1?O"F'V?=XH?SE*Z7<30<G??C?#MBC=_%@ G'?"24&U%VPRQQ0$O_
M:S",LI TM=WFDEU@G)9Z]L=(S>(9MZY3WBME^:SL7'R>I1?]>GG]*^_]9?G6
MLW*Q=?;'Z@*!K"< I .-)A0X?4JI2S92E 3 4:.!\=!H;Z#)<$Y&K\=#>O5*
M'&N&%,_Z\'4VI'<9<>;1^+R\@\\Q6BT-67!LHPN<VW'8R\E=9F%$P( 4W[Y2
MIQQ=0N\C(\"Y$CX$Z:GN-$760G0RZCL<3TTJ; RG_52Z;Z*3<+W_\?);'%PD
M2*_0J&6 %_/,@G?Y;H_09^<EMNW) #Q"C.A=TC(*!?C."$U8H-'A()+UC6IC
MU8!_,M(\'*DM"G5\C&>0+@: K](Z<\V3ABF::1;T&BI"<5\1* >.0&-P65IG
M0IM<BJX(]W7YN_5ZVX*08[DF_@%F]TK>>QS6S1I(OU[>_,DL@Y3KI+@)B5A3
MFIWZ9 F&4A:G<.^RUYI1U>9<NSO&@Z7S-Y'(O3L?3:AJT5/R!IY%!FD71$TO
MF=_'=)@;YJU8?$ L.U"P'W'DC-.S5Y$XDV*Y_H+>8&2Q-#Y/@I8:3*K-2K8O
M43QRR_QPFMC$\LWJ#OP&T[-R!/05)E-87F74 6-.@5.C\"F41KN\7(DR)%M'
M18X29](VFEB/:?\.\ZZ,K:PYL+.Y&V1\ONH/,6+L^\'KX03=GMF619$[+I?4
M"0,D.LJ)U!;]-O3>2D$OIZG#99.VR9Q> ^BD'8P:)#3(C9O-B!G&UUU@,6I[
MEU>@G7S"CYRL_M'B]>DREJ9^2,W1',:#J2*3T9%QW&!QJSJFF#4/ 5]D+4H3
M P6!>&,U"2Y9$)"R]VVZ-QV_7A]QKHY>KIM0NY>:/Y%E*5E)N*>E_ A +&T+
M) $#-&0E0;A6EW0.7O/G<,P^6BIH$UH:N&B+A.@E&,NSC<AB9J6<,92^3QHP
M#M%!1A'180RBB49NP?B.];$]'0WFD%_]H!SX?#P#F+XIO[V\=1ZL]U$)C4$J
MCP67(%9A6!$<@,79UAC3ID#0.D0G[<!7H:'!E855N)8WRSL@:^J/K\=V&.^Z
M#H<=A+$# 7N:018($1B^$^B>1<-*4:,0B.5(I V*.^5R5J;-;<Y]2^,11W;?
MRMC$[BT*6I^-QM-/,#Z?[U3-ULW%:@?46B=\)L B#MCA6*UDFF3 U2[*2"&W
MV15:CVG_GD@MYNYE%U4Q>T4'M!02F26/S,2>$N6@T$D2"4HIDG(\GW4B.2$>
METP 6:_@S]5C3])MV-ZP%2^/78%8%D3M *-Z+; ; /9?\&M+"NZ2N(/]*A=D
MN@D'."JPU$1V!B<.Z4HQ2F4\@1"4I,H8&^M5_&M.XP-%N.JRN(G9*K/WF__6
M/[\X7P 1(99.-XKX+!B1-%-T*WR8Y46YE'),W8[A.O%WZ]'[+82UM?%'-2Q7
M>;7\#4UU#21P$8,4#I_L$8B5G@2!>E0A^6!<U!$ZQ>#=*+SYZ"=(X=:6:^ !
MORKF@C?]KY!>#Z<XNM)KYMED M/)KY>_^7^,QK-:!?.\@!RY9$(0I34.6'-)
M;,P!/4#K$3B3H5'GHPU GJ03U9JLBA>H.T"]!OK6G\,R<:@#W*9[-!L"/MBQ
M:!L!=!=:-?;V.YFMA)V995:P3#S#:5<F?-5=-C@*9[(607C!V]2%. JQ/7ZF
M>91:VX2T%JF%HTL_F%X^^SP&N+EQD73P-&1+1#")2,Y2N13,$5NT)EK'I6_3
M[G -H/UO%C4E\FZ:8046*CO$S\O-#AA_*7ET992S%\-2GH6'2$R20*320"P$
M183V5F0KD_:=2FIU*P.\ L%)^D-5S%VQHL<L,H OBP(!5Z*\"W&A^RX@Z^\^
M=85W@&+T.S,YVA<-M3>Q.H.-TK)LJ2#,NU*S6I0>P<$APY8YFQ7UW4KS/06M
M/%2%_C!2V<3Z%24R[SS_K_[E:)E K97BP7)"I<854P1/'%6!<$L# P4:U\W;
M*EAS\_C&A^YY_Z2-S4<5#%;1'9C?8X8!H#R779.R5$FA=V-G&[:<.^(%NBA@
MI7 T*,J5[T3=K8\].?*V-UJ+'F6EED')L)I-,SY%28U&3F)61-J@T5&)KE2'
MTLGY''5JU(?L)HR3].=V-WC%^EO7A]2/E,"8/%@#8S:,82I6NO%B=!E3TVVN
M%J,ZS%[8#F+9M-C)OIANDN'28&P4J+->E6656B(]$\0QC+(9#]DPE:F+!RK>
M<S3J?61S[<C%NPG!3:[O3J;C?IQ"NIF;[D)R8-%*^'1TYF*(Q/&4280@0[9:
M*MMHAVT5G/WOKQV>Z7MW?7>EJ<$5@AT+M/QZN?H#9N^IB-%'1X&HF$M%4,E(
MT.C@,(C*,:%L;G0AH>&@3MNA/!(Q5*P"^O#0;KS97? U=34?0W@@M_%8)-%)
MJCORV2(H?@PGHTP(JP.Q^+_2QR\C3@.EF9\Q,FL6<IM4^L/H[3%'[ZG*;1,:
M6\0MQ:.XZ>>4U6&Y+6311>:SJLNEJ;7BGGA I"P&<(F:$'2;G9@'0.W?':S+
MX-VHHI+YC[U_YJ(M7;C\.+H8QT-UT5R#XJ"]-+M8YDY'32^4<)PQED22TEB'
MSK\. MTT385T:J>.FFOP[-A-IC_QGS^/X?-B^ET\Y,U533_J;>E3R(B.I44$
M1$V<LXHPQU#F20?5:#%[#-GN(?;L\^8+T/V^C:^'98%"\Y?\#?S_],E_ZXFR
MQ"3+"*XMY0(PP\B.V4A$MA$X2\SX-NE26X#=_WQ<54OW0^VV=#4(Q-?88Q[4
M.:>8-RX2* 4S<;+0Q$>EB62:*@B99=%F"7\(U;YJB3952C6S'[IZ:#EQ?#\>
MI8LX?3=>%!)?G/<#Y\89DFGIC<>U)"%E-)$(+D1OJ?*=:H1VRH58A>!06R;U
MJ!U5-''EG)@%GNO:%S"Y2MAY'%3UO*FU</:?)[4[4_=IKV3FO6D@,>]=3HS@
M)%ANRSA&K- X1UJN++?XDZB?*O</Y#WMB?I-K-LNM7IYCL!$- )P!G.E1CI0
M11RN?D0GPQ173LA6WN9-&/O-L*E$S>IDZ2WL6CLGZK\NOZ IKO)[RH8!,R(0
MEF7IID4="1I!91V9!D0E[E*\)BGJ]N<>H(;J]A8>U3%/[;3#EU\QKACXY3U3
M0R65.,LP&R*1PHM2^,.3:**1.M+2O;H34;<^]LGRM+UQ*I8NG2%9#&C636H!
MAPGKC05'N"JC8IX2RTHK,NN"4])ZE7,GKNY_]I,E;$<S52Q7-8/SFY_UK!F4
M_K>3Y_[+M#\9#1:X>/0&WVU&5-+HQV>?4$W*$$%#AAQ\9#EUHN^!ASSE1:VJ
M 6O/FLN]F45DMLQ"9LZFS!(!#N6B$U#BO KH[>N<(\TB*M6)TI4?_^3)W-UH
MM6?5.X@6 UU>,3,"EV+E2W,7'*=F$K\RD7@M76( /LINF=P//65_I-:BX %&
MM[=?[?=ST7_Q%<"5CX58N(B)T%P.R;),Q,=@"6>*<L#HRLENS=SN??33IG W
M2]5^(7_KXSP_'0V7PRK51K.$TE6U5,YP/I(@,B<T:9:ITC18TVV1O/W!3YNS
M7:Q4V\6YJ9\EK+)H+'<RBB=V\^L%9.L<PG*.1,]*XUR&OK3*@3C 64-B/.19
MMQM.VSW_:?._!YNO+<IV).?YUP4%GZ.+^'DTQN\=Z%#_(2@'/=GO;*,[Q_LF
M29]=],D;+ATZUE(R!3(([P7-2>YTO/\0J%J]#I]]Q8\KAR6O1N,2.5QGS;RY
M.GJ3PIG$7 D&*<Z9J 1BBRN+X6"DT@AN;:/<HDU@[IS$=^<1+R!,;R27G8_&
MT_Z_2I[Y9#HCM2>2,UGBG*2$YD1&AI$WKBY$JFQ!1A.C;E,-=5.D!TC+;Z:O
M>SE[+5EKD8K_,-X8+\XO9KVG_CH>32:_#\?@!V4 ?T6S_PIY-(:2QB"M5,*4
M&AXQ _J=5!-<'C/Q-GGN+=4^-6J 6P/^=ZS'!ORVR&?><A!O\&_7@["**T%5
M)!%XPC<-!>4L#H<I'X2C%-UN?U0BO07_ATAK\MN@/=EZ(]T>3L_JD%Q)\LTJ
ME2R0DO/E(9-2!H')A/9RC6XH=43X/4FM"DL-6F7,6S1>XWGU]6V_1Q.UF7E-
MP"J#"H^*6&4I\2%$Y2+ER;;LA7D;S2FK9&?K5RR,/MLVN#,CWAG^XD+>+<1_
M>_NZ9VF(CFI<K!4O)I#%!!+G1JEE\(:&%+N=W6_U^%,4R)[(:%#L]6'0\_Q$
MPSPWC 6BLRMWW&,@MIR2)R^$!\82AS:WMSN VU?B[_XFF=J,'#H9^$:-R=6-
M%J,-.F*0FYQD1*:$8PG1$F>,B\E*&66GG."-U75D/7RK\]ZU?>\&]C_V-JA=
MQO*C?>]V[7LWD4G3]KU;<'SLN@6A!.?,$^^")++4W/ 9WVLE'8<8=12T3>QW
M_'K=MGWOL<AU$VH;R/0%G/MA>@%?1I/^=:<N)8VA/))@-"LABR2>9W1!0Q"1
MYN14HZV&56B>>)/6C?B]Y^KM2$Z#G?_GH_&7T=A/[^RV+<!1G7R($HC"<*6\
M5HX$Z=S,L56EE:!S;3+['X3U'4NH'ETM-N@_PS!>WD/E0#%?-F.M+IVJ@U:E
MR'LB$40V@283<AL1K<;S':NG D$-MLQ+;W.,FW"T[_V7JUP7Y;W3WEL"+IC2
M<BEB[.,3R5;JLI%OI&NS"[$2SG<LFMWIV</&^#*CW"@ZVU-SQ1>4I9FZA5)(
M)3NGA0E2\#9%(%;C^8Y54X&@BKOG2U2_74PO_.#5Q3!=9]1%7!0#4;I4R!$R
MEZDODJBRXD(&@S)O(IB[2+YCJ>Q$2H,]\M\_?AJ#GUR,[\M7BI*58Q5)$94K
MA<>5DH(E6G"?C?1EN$WDLA[3=RR<2D15;"^S1/9W7VJ]3I?9W8I:FW#20Q''
MXI;C:$T6Q$KKA;;49-KI*OS&JKD%XSL6RO9T-*A67_RIT?!F'5Z14L HWQ"5
M2P\&;]$3+S6F3?"!!B&5%6WT<0_*=ZR1W6A96S;V2++M_SH:I3_Z@P'^@]F%
M@M<)/P)_NQPSW6T!=Z L_&T@'C0[?V>;WLG:C])938T0UBFI4&596YYST-%0
M;R7?*6M_&[#-6GQ>GYR+:$*P/!$?O";2&$,\H+_'>##,2<E$W'NCXC>U<O?O
M?O!;F%Z5?UOR\2Q,9A>+>CKA?"5Y((*7=!!M*'&29F)%H$P9&57LU#=L8TML
M@O*H6E5NIZ*[\WXSDAILUB_Q])BQFD7T9P4M+HPSD3B%2UZ@((*'((*33<2R
M1+!_(;3C:53!R UVTQ]0_BP!NL>U94IQ0ZB1!E6OT=O1BA/0(<FL8J*LC=OX
M&+(3%D=54AKLI3^ [T8"_>("TLR#Z'D9N!8:B!<E5.8VDA#1AP::@V=61]KH
M>&9SK-^GL&H0UV +OHMI>HS*[*TK>W?X3D@!BMAD&'':F91!"-.M&VH3K^:$
MY52=G :;\=<YM@^(?YX(*;DTH>3;,PH8V&O-2& R$&V-9<E0Q>^V4ZU^U_<Q
MC/O*3&[N$#>BY8CRDM<-ZM?+W_P_1N/G S^9M^U(FDJN$B79"T&DHI8X*ABQ
M.E!AC7 RMI'=!B /WQ6JKDRZKXL[T;5?A_T:Z(VN'UW@-LU>WA#PP1*4VPB@
MN]"JL7<$HK-,0U)!$Q.UF-?<<RH+@AZ "E8PFR&=KM@>SRX^2JUM0EH#C;W'
MT /7XO0)XMEP-!A]7E;Y5%QPQY5%7+(TD-1RGC@FI792">U";G.7?AVBH]J?
MW)W*40,>&FQ+?AK[!&6,5SG-&'OB8#1)"3U/R;PE%L 3(;QS+E'INM5^W^9^
MPRTDIZV'G>S>8)Y8]KCY (/9#L7DK/]E"2U+E8)WG(#(*$S&/'%.%,6JJ((/
M@KHVE]8? '7:ZJC%1I.,WWDUO0L_^-#_?'9U%\*S$%G"\45G2J5GF4A(.A.-
M<QO8R(S6;7:+U@ Z<8%48&'MON*1Y#U<)R\O2BXNS[]?QM%P=-Z/\Y$?*.5A
M0W0'S7;8Q9)W$AT4CX;38&B40DIA [5<17"EU&GTUNR4Z+ ASCWD.%B>LHI9
M$A8-3K; +?'11,)MY,EY"2JT24IOF>.PJ(IZQ];/5MKZ:D<[:F6%M8DP$5GI
M@V.(MUR3G"$KX1+GO%LQX T??%3S^';"N%.UNYW=&\0'CQZ:LE!B:=!$9%QG
M) ,@CJE(%)/!@>84_-[?D#V?9+?G==.3[$U(J5W]??/3T.=C2/UI*07W+/WC
M8EZ?=M+S-#J7#2>!9X>!L<,WS**W)"6WI5JA\I1VFG J 3I!/1V,K_UF3[R%
M:8^+J%#TJ31 */4OO4;'.$E\-Z)'SP6QF[U/4XCK!$75@) &&1!;Y&S$$(.(
MF9?,(/Q#!D\L*$:<X<8Q&9.,S:H?'6VRS3')J@9QM<O^/0!W]32:E&:BI',$
MCJNVM$X0;Y)&QU(X[UE,FG9K8[3IDT]0,^T9:'"%<8/#^11M\%R6'L0@2@=K
MBDB5)X:A@^=+&W+3Y@SGB:;6;!.T-:;E*:;6!.^%CY&C*CQ&%ZJTE:*2D@0L
M>0;<B_ CM::R3'9(K=F$KB/(<N@"]T=J33,![)CNL U[1R ZGM%Y*H507!(E
M&@'\2JI4\G4C#<KZG-H4!S@*L55,K=FGUC8AK8'&YGYK?_CYV><QS%;CJUI>
M3,G $R>*<XQH WJMWN:  2YS)J<8%&W33&4MI*/:1=^=S%$+)BKNGI<>KL_+
MX1:,O_CQ]+*,<_9ZV)01! \D"EENN?.RZP&6F)!Q@-D(KCO=F<4'W% %_NVN
M(M8A.%&_J(K!*^Y*%CP?X,O%.)YY#&V7LKP+<9D)T 'D)BY/)W5TAK=?!Z<.
MDZ-]T5!Q7=D,K*<L*>G*Y2)\0:0&1D(,G%#/'*>E&(KHU"ON*6AEC7]R0*EL
M8OW:!VS/_M6_'#T;IN>C\6]^.NY_6ZQU1@9FDI>$@YG=*93H>AE%V"Q=3--D
M6;=>(6L>L-\6Z(VX&%4V9$6G88;I(PP )8RH7O1]V0==%K2A*G$J'2Z*PN,@
MK25>EU;#,@;G#+.4Q4[DKGG R9%;PY!KW]PCR9"[_DX>C3^>^3'@IY76E.=?
M<.J<?=:!LN,V0';0S+AM+7@G*XXS%([5&N<')94SSG(GN!',*<59<#MEQ6V
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M\*?VU&3T2+1_'"K:A)@6ZEF *W/S5Q@CYN5B#CEK+;+%49>;"0)''9C M=B
M-RYQ8[HY,)LK9AVD_6\B-*#PKDBJV+_RKL+[\2A=Q.GM5R&IK)D/ACBA9\<V
MB00N%!$YY&A!<&TZ72+JY-"N0O!].C95^*A8Q/\&GF**!:+EV5X74-4W(=;"
MV?^6Q.Y,W:>]DIDK1[OKP;&$43Q&?*AMK@F&\HP$G3 4Q"F+,R$IF'H[D7OF
M_H%]C#U1OXEU:Y\6O"@5=D9?REG[!_A\,2B_>_E\='Z.DVG?#W[K#V R'0VA
MP/[4!YP6/XPN_>#&M=B8?=GAL80G$8ADN%1:IH HJZW2.H#AW=KU[0QEO[LD
ME?@<'8R,V@G][\_\!,1S_%D_^L&G<?_JF@$8X?!%H21Y]+:EIAG71XGV$2RB
MX^,]E]!)(FL?\>2IKV.\M;/#O_]RQS!O\*^S'\R^7P;^ ?)/Y;^_?WA]9:0_
M_OCC3X/^9S],?XJC\U]F]EE73?E&EM HSPMWO>H/_; H]_5P,AU?S'[S!4Q]
M?S"YC7C2/_\R>%0"E9[\R_6X;]MC\?A;,MF7!>#;%(8)4!S]])>?^S&EZ#0+
M A1(C%8#!@PAI&"#4,($N[:F]888#M_*YLU56Y6H',@L)<Y801#I59F[<B1,
M6$N3 *?Y\;:SN1K&$5TY?>X'L2PB^.6'T6#P:C3^PX]3#UP,4GH,E'!J0@<F
M!^)=*6;!E4-;<X6335L[MQK:P<M1[/$-:'@_M8)N6E9SO3'CE<Z-]P9S9QJ<
M?+AC[47&Z>RS>H'G[#&")\Y04_9E<% Y932^5Y%SG1UO7."SYG">=&YQ#=EU
MJ&J]7\W4CM<>;I&\[)"L<N+4 B?" N(*)A$/5)>.[U8FZW3J>(&LT^-^J*XI
M07OJ ='EO5CS6OP5.7LSFDQ>#^/@(I7\_9=^/,1?F_2RML&[%(FTBN$?6I"@
M,"!*X&BD&H(UC6LWMA[B#_4_!6W5OF=9>91KNI:^0NYO9+OVHM II)C+L66I
MUV ]\B)+57VIF! YL-3M.OI!X/]X4YZ4@%H6$ZOJCQE*'0?-<0JP."BA&0DB
MET%9J8/R/$=V5&O,!C[\839EYF>;PM DL\E$ <ZJ,BL@GM-$@I8\Y9RYN;MM
M>T0;,D^XOW"5;8"]LG^$_84?:I3$N9>914VR*BE WI5*-&7JT)QGZQR3KK%3
M>N)=]#;2SG9=]#;A\."]S;J _=%%KS[O.S4YVX:T@RN-VN0,.$FT]YI(!09C
M(I5(.4S*2:./IQKWM7KJ7?3V)[!-N-ISWRL%GAEN,^$FX@2NT!Q.V( 3> !&
M+5#AVN06/^&^5QO1N4'?JTVX6'ON4C$!X$8\.7E;*I]/^U]AAV/]!S]OY\/Z
M[FCO',%[ET K:V2V44:@+@AAL@ A-951\-Z#GUS]FO]U>)"C\  Z$38[?E V
M$IM4)-IDIW6,EJJ]U1>I=NR]_.SGH_/0'\YW7&YN9-Q(JF8]+Q2^63@G6\D"
M3M$T$ N@2,Z!J^ E9XV:-VZ"\BCNQV^GFG4%#ZJ3T^"8^/K\95$;8 D>)G\=
MCR:3GJ2"&YT%"2XH7-49)6B8LFU' XO&9D]=$_$\ANR$!%.5A(9E5&X+>M4&
MZM7>7$_1G'#Z=R1I@[J."5=@U#HZATXIPW/BJHU+M 78$Y)2:ZIJ%WS= N^5
M\_>B/RF[9>AI]G"F%-(K3W LD<@0#;'!<()>$X1RX\2(^)AC51'/"0CJ4.PT
MZ".ZPC;/1Y/IN[R8;=-+'-+T<K8L^[C\\:0'+E@3O<15N62'\XRSKA>,)!<D
MX_C&*-5FZ=L2\ FH;I^4-3BPV^)]N1$KSX+97LI.I20X$<IA7 SE. -#*9(I
MOD9,4 FV39.["N!/4('[HK)VY=?'?,IGT^FX'RZFY0#BT^AO,)E">C\:EP&]
MRQ^GH_C/=U]FL7I/B:"R8IQP6VJ:1"A=+XS'*9S9F"FS]NYMMD>SXW:$= (R
M.R!'#6J[OCS_,AA= BRN]WP\\S@6/X%4ZB$#3M'SE)#)V:O!Z(^7.4.<EK_]
M/BG5:C_"=#J 9R4_I$S@TB=F!+H*PA(IHB(N>DYB!$T=6*=TF[HRU89P N(\
M+*T-"LZLF,Q+BLGG8?]?D%XG? ?[N5_>LL51[L+)N'VDBS^[."\9=5,__-S'
M7\9A^2"BHT"RDR6U.25BO>/$!9,P2*>>IS9J;32@$]+N,5!>L>C <EA+G*\*
M,_"F__4FNOE0_@XE=1J'\A4=E,^ ;V.^&+SI9^@Q+9T'FHF-'+'SY(F3DA(>
MN$LV^<@:91?O@OJ$-+DW\NX+S]7>I:GP,LU_N>P3C"Z&TP]^"CT1*'BG4$!:
MI')[-Y6V0P;UA &=!FI][E9]=U^(3T"=Q\OPBJWLW>[<;W R4ZZ>!!__V3->
MR:12(&+6+L9'7MIA2>)$9CXP$T7L5K!ABX>?L+JJVGV%4':[-[9%]/\>QA%_
MB)/VU2X5?("O,+Q K\$Z:[V7&)4QU+ITVI' O"$T1Y6LB#S<W4JLMS_]$+#3
M%MA^^%HAONIG(EO/Q9]NS<0]4,YQK3V)JEQHH(J2H)U%*X-2-DF1J=[[^GH;
MXPE+\A LKE!GM0.5&D.[\9V>9"[+4)+X9<F#9B%B6$4M<4;F'$ :T^AV>:,!
MG8"4CXGR%5)N<6*S];A>P-R%^>2_W1RB$2[@RZK0X_7E3 I*1:),"2BC)49M
MEHNV"6CMQO9#X*V$L$+KNYT'=?>0EE>(KX?_[OI7XV7/N<A NT0T*(\1'+Z\
M0:  54I1&R^#DKRR+_L(I!.0X0$Y6B&U:LW^;HSDAJD^P,!/RRE".;(7+%C-
MDB08^TM<!B0EKIA,. I""9=CX_Y_CV,\ 7TU)F:%AH[JT.;Y!<['P^F-'RSG
MZ$7(U]-H3"=X)A),Q#^"(U[E0)C6(0>=17)[2[MH-\S35O*1R&/%R[#SN4\C
M]V014-H '%<%1F*,K+2&#<128"0+DRA&FUG$-@=#38?U0^P-Z%\A[JW/EI:C
M*RT%_N@/!DO8+R[*!>GW,.Z/4L\Q"V!\J1$+)??=)A*D4B12PX5-C"O3YO;*
M0ZA.2%K5C+\B-7SGZRD?XQFDBP&\RRO&/_GU\L;?YE?IF3,YF* )-X82Z62Y
M)($Q5K B^A)R.=$F9W=3I/NJM=%,-TVI.98*&>OZX8ID3:E;2*Q.CLCD&+X7
M,1.6P0FA0%#;IOCND34M;RN"CKW)-R'C($VFNP#\T9M\2T(W[C:]#1L'D4V0
MP240B>B0!+IEZ*#96"[0@#/,2>NSW]O-Y2/N3=Y6+9N04+UZ;88A?%OVV&99
MV8!\^502#QGWZ*133JA)@@LA T+IEH9_XU./PH_=Q>*C&N:JW=KCD[\87TQ^
M[8\FL0_#"),W;YXO6[M*YYRDF2BG0ZG$J4A@+A)F;5;E_\!VVSQ?_XR3XK22
M*6N_F?_]' 8#?P/6ZV%<P&)2!66R( Q=:R(I1Y]:)D6< <U%YJ A=&)X_3-.
MBN%*IJQ],?EU])]A>%53)J-S*C5Q.*7@9%+ZR90P6/'@I%.,"M/MK;WYJ2?%
MXM;F:G#?]^X]O$_X[V:> D-<*65--#,,]>3HO.H&E<I8[[G X*2)0[4.T7<1
MME6AHT%5]U6XEGVI.B!K&K"MQW:82*T.AQV$L0,!#6*T!Q!R[C/32)[P :..
MG/!E4%$1FJU/B@4GZ/[FD@-&9?M6QB9VWX,B;MYM6*Q^64H=E0"B="E ![CZ
MA0R)9.UM%%'&:-MD,3Z.;?\N1RTF'Q'(CC2TZ+^T_H[7KY>_^7^,QL\''M?=
M\JIDF9FT@I/H2SZO9)'XH#4)U%+%K'(^M)E+-@#Y7;@JK4AKX.0^ /4:Z%M_
MOGS;NL!M6U-Y,\ 'JJK<2@#=A5:-O18U<#>$;:4"G'0M03_ $FF$(-['2*C-
MW"43I=;J=,7V6('E(]7:)J0UT%A)8QW[.+WP@UD/L&6O9N=4!L,X :HSD2EY
M$KQG:(?$<X!(<VA3:V$-H /45VY)Y*@^"PV\JD\0SX:CP>CSY:P.R3TS+/;^
M%06OF";9.G3]),?0@SM+8F ^!D3*9)O3^4[P3ELX]1EJ,<=<3*:C<QC/\IV+
M'WG6_[*$9@4$)Q,JW)24)V 69]F,,D>4BML4/)=MYIGUH$Y;,K78J+A'6-K6
M?\!1S[<R,!R5@LI9@7I3NI898CT(PJW*E!IO:>Z45(:?>D,.^+>[4KCUV)..
MN+8W<,6RC5<@EB>*'6!L$B-UY[O^:_YXS+,#!7=)W,%^%6?WNW!"\IY&5FZ4
M)H0C RNEU1WA4:24I U&=6IT=QPTKHDFZK.XB=DJL_<;6NK\XGP!)%GO3+"4
MH&N)08\5K+3%8D09K='5],+83M%C)_YN/7I_Z^U.QA_5L%Q%+WT&Q'^[ 81&
MD[31J13.0+<@H2A#UH&D4F6<*:YST/4HO/GH)TCAUI9K%(6ON'?ZZ^75^4[.
M/E'M).&II-^(I$D(1A/@'*3EF7O>IMWEH]!.VG%J0U#%ZL./ +QQ -0%8-,M
MZ4<A'F83NC*UW82S(R_[FX)N ,4YT)<F4[BX12"2&4M\R)+(H+P55@EGVUQ;
M/)!P'ME0/K1N-J&C=D+F-;I9\XG9GN6KT?CU< KCH1]\@ G@P\Z>#=.+TBQN
M]*4<'2^66N.TIC1KXI-!;PF E]8GG*CLO9<R9K1+I^R^'4#L?X>G,I^C Y!1
M.V][%>YWP_?C4;J(TV5MN 5.K87P5 0B2E\F6;;$'?."Z.!4Z:">A-Q>-&L>
M>O(BJ6'LVC/+2S\>CBZF\U,05/%[/YX.RV;E R)&F-(RQ&M<0E-$=.P<@"2T
M="0!9SG/W<2QQ<-/2B2MC5\[:_RW_@ FT]$0EJT=E@&YH4R6-3=85Q9>FXG/
M6A,58Y1&\T"=Z"2(-0\X*=)K&'%MQDVCSJZWZR[XU747JO1\W>!)5;O!;CO"
M.WUB0:;(6 )F-4/2P'J<PHW(AC,GLPF]+9_9L(.LBA1,I@*%!AEUE]$EH=*1
M2'7.(C@G>=LN#WOJ(+M]^1P_*5/Q2_R5KWY0WMB>E]HDAO$%BZ&T/N*"6"-Q
MV8Z2T\A+QX_C+WIX?UQ'<6=G.V4VK9^TFP!J^_$UAX:NQG3<C]/Y('O9::&8
MET1+7Q(7,$;Q1I>"*))JFXTP=^>"/110OHWQ!#1Z3"PVO/I?L739_#?Q4P#?
MP%FCFFRHX58 $9*5]'H?B9.*$6=] I\$<-WI]/.P,_":T9V QH]6# VNVM4<
MX_OQZ N,IY?O!QY'.E]T9N%?::6>M(B>I&35/*G,,XWKCN!2:YR A=];R^GZ
MP_LA^89RJ'A!H_[:-=L9R[]/EN7_487@J<H$&'@,I[4ASGA%-$@?%,TTW"U5
MN@\?Y [*$Y#K<3%9,>^MQ7OX;GH&X[>C8;RY!/6,H9F7'D\@RQT_1S7QSN:R
M^ AA!97>'W]5W95#.P%]'Z<,*J8B-.]LUN/!*.71KY*>S[I!.N*R*"7].=41
MPPG+S=ZGXKLH3T"JQ\7D?8GN7#!_686U)[*+ -'BA,94N6 3$ >WI:>SDAB;
M.N':;#8N$9R 6G8RZGURC[R2_;,XN_H^>>\O9UEE*0D:N./$LG)E H,[8@/*
M69B8@,8@ (X_#'ITF"<DT^.5Q_UW8>M"]M5G<!S7^.)6,ZG%V'N>&ANH-T3A
M-$[*H1+QEGD277(\"YV$ZG;8NA>X)R#D(^7VOGIWKE2_WZ83-C,5E7&$>15*
M>6Y&K(P*WU<M@N8X6$N?X$Q^W#U)CG<FWT4>*TXQCN>,[0WX"=SLE!8\>,J<
M(%F5UH#X:A,OLB<^"98C53EMWV*L&LH3T.UQ,;E"HT=UU':]K7'C9[,-CQX&
M$SX*CW;WI5^PY4"\#!(5:0%#1VF$._[.I>O'=P)2/V)!K-#]49VXK6EGB3$$
MS/*S0=!4EA]/7**.!&F%CSI1&8X_SGP2?4V/1>\5A+!"ZT?5COHM3'O@O-#:
M>&*\YF4\Z%)Y)8GVU'*A=&+T^(6- _FAXBH4KY!LM9.W&X9Z?S&.9^@]O1_W
M(SP;S#X#O[W<PWSY[0N4_"5\]UY N2(QV[L^+UL[O9)$&Y,Q! )0(D$+XH2B
M^(>(WND<F&[3(JWJ,$Y0KONG=X58=[[)N_&]YI2%"! 9<50R(CGS)'!@)#H#
M+ 8:76Y3?^M)-F';16A-J3GV)FS&!2LUO@T $(FDU!#+ B="JY2EX (=CWU-
M>T^J[L!&(NC8A&T3,@[23:L+P!]-V+8D=..V6MNP<1#96!8E\RD2K9W%V5EI
MXK1)&,V7_J>>XIS==F?G:31A:ZN634AHVH0MX+--2)9D#!1(J>5# KIAA)6*
M2Z54H39WDNJ?:!.VC2R^M@G;)N9:>PFHT8W-]^/1J]'XW+_">'(8^W[P>IC+
MW\L/*UW5[/*(JG<T-Q[3G<N9W I6\I],!B&]D,XFQ5RTI=662E3W-GU8PUN9
M8&2*CM%Y:RD92PG9%!3!B$AF*9FA=F]![Q6J!NO1E9V7QWZ4\\"8UR2#LJ4G
MMR&.1TIHI(@88PF6]C;PN^".8BK;3B,=5J6=J&A0#?LAB&]A^GJ(DP2\&4TF
M/2LRY2D#X;XD_43/B579$H83L%,Y.<_:%&OK#/$[4<[VM#3P?DMUC?[P\^0]
MC#^>^3$L03X+DUGQ]Y[GB@:32CG17$HXZ&( 5NXG "CJ(O>TS4;.8\A.2"U5
M26AX=^_F7N8"XEWHO_I)/_8<2CI%D 2="9P4'2)W/@')SN6DI?+:M+WST17I
M_D54E^L.F\[5B-I/[+T.[XO^X&(*J2=YC(YC+*)SN<;*<HE*%$:9-B<%%DH.
MX*&EM<#Z_8IK&[(:S%L;[XKF2&DNU:*L#_@Z*,:)UV@M[Q6UU%IO3)MCWR=Y
M:K'+DM>4FF,_M0@&@+'@23*1X5B\(C8Z2H#-"D]@..%^G%KL+(*.IQ:;D'&0
M[><N '^<6FQ)Z,;[T-NP<1#9Y!0RCQ)G9QU+97&*0-VLW@VW%)=?Q<S>]HB.
M^-2BK5HV(:'IJ05C25A0DO!28AX],4Z"9:6PKG1!*1VE['9+^=A/+3:R^-I3
MBTW,M8]3B^>CX5<8SS*"/L*P/QJ_'4UA\M:/2\G-K[##847'3][YC&*;$=PY
MFO#!1&#!:(PCI#4LI(C!2W088@A%1>AU?,9N,^\+"-/70XRG+LYG6=]+;SAQ
MY1DS&-RP4E!,9W1+H@4B<F0BI$"3:%/N< V@75>8VQ_[RL=E+EJR^O]O[\J:
MVSB2]/O^E]RM^WC9"%WV*M8C:B5YYA%11Q:%'0I0 *!MS:^?K 9(41 @ $17
M Z08CI ID43G\5559G;6E])IRAQ%YK6OW5/$'VRIG,Q2!L>94'N-0CM2T:\2
M#;\-]8&!]<.D%WLW>,/PK5P=@3O.NRGK[Q?T1Z:</]$WPB6.DBU9YJR@Z#K2
M$44&5\6UWO&H133&MIGUN[^,CQ$KO?FD09SZ=C9-B'G^"]FE2OT&%Q?E]7Q^
M'28)7TSG"XK C,].N @1*[-[/;9#JFT"#*T7OOC"VK 4[I;M<:"E9Q\T*-1]
MJ_6=8WSY90WPW]6F CY"+9,,9(?2;8&^-AG%&N,9ZZ0Q)>I&(Z#W%O%Q8*:-
M1WKDV#M T*[?GH^$]+HXR4!'2O>4E!ZBZ.8/2Z20/GMA3@:=I8@_#73NX9$&
MW'=;!?U [I]_G%[E#[.0QY/+E^'+?&05;8C>*G!TDH)*1M+NR!B@I4PDHBI:
MM^D"/4C,1PZAHSW38,K=;F'K> Q,US4'O2,WX=^E8B-+D!1#PK_AX)BO?[5!
M6"6\;-1;<6^1?Q9X]>&Q!A1QNP7_&OE?E/>+:?IGM]5^F(TO+W$V\HJ+%(."
M;#V)C[* IQ22_EJ4X<*A;O1^\TC!?Q;8]>>]'BGLNNKH5ME7(VLWJ# M]9=6
MR^<;1;+(C(M@(.=*M&B<@)@P0J$0( >6:MO;7L7H/J5ZV!@[K9-Z)(G[:IPE
MT<"RM7R9IOXZZSHF31&"80!FN *E6*&#G_9@[;D1C!<72IL76UM%>MC0Z=?B
M#1C7OE7V]TGX-"58_ZL2O^.G\?6G48BJ,&8(F]S*RM[*('I.0D9TP3A>K_0/
M<*Q]+]EC 4:/]N^3A6RS@._P\^JB_:J +F2,BOD"'"LYB10%@B3=/>6:Q:82
MI&Y38/RQ7(\1'$?9O@7Y%PFTFB!X4;JW@3<<J%8;)90D3:TFP1Q'B#(Z$"5P
MZRF;3*H-*+9)]#C@T(N]6[!AK;\R2;/*4[=B&;UY@S+R)DI424(NIH JW('/
M-H-!+[EFDC*^-HWK>XGW."#2OR=:,$K]2N:9UQLZ.+^8O/JK#CJ]'L\_5I$O
MNIAY9)(7+JL RH?Z!U8;^ S(ZD2#I)00;:*.G:(]#ISTZX$^*9RZ9.L&N"]Q
M^?_7DRK3R_&\X]H>6=K=!"7DD",7%#-+3>F3-<!0.9:XC4GL[,W9XSD/V]5]
M&[(%]=&S_/_7\T5WI'V8/LNY,V^X>AO&M%F]")_'BW!5)TXMOKR8?OH\G73P
MO)-[=T@56F(4'D'S6.]=B%@S* E,)*U2BLA=F\Z(/J1_V!@[F1\W@/'H O"+
MJS"GR.H?M:6-Y)MUXZ3>7%=K7I3WF*YG'<W=BW!UA?GYE]7/S5<_.*=3U;#
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M[&^.D4-AM3(1B@T"E.490K*.3BR=K6?"JG"BE[8#:/\H Y!V2^ ,E_-!^'W
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M'F36B,RW@Q^%ERJM/,"O\%U.'%OX&CS\)%MJ]XG;2\-G*1M]QJW<-  '#J[
MFV&[4H['Z(_2G: ^""5CZ&8F[V$] "M?>7<Y1F5\ON+#2%J?\3ZMEMI&U #N
MJIXR#6B3(-I0(E=IP*9I[T-H/(YP<>)>K1@X1W(./O5E_%AO<^'+18P7R0J+
MD=+S27?V/88@?JQLR,YB^7;"CU5@QV;E!WT&/H/ZD^@?+4V.<H3Q)SJB[X(]
MS=,MXMW6W@0K=GJF,.:^;U#:N?*^]W.Z5++\!F;;I8<<7D"^U9,^>;^6!MSK
MD<I<MOUF//W,ILU7SMJ/'[E<J:7+BCU-P<Y07FUZ'6ONFF;N2A(\7X7:=%M[
MKS%D*MX&76R[W[K?N*MS?YB5;MT*"I\P?K1_$S7B:E[<.^R<Y['G,F.;+;>K
MDWN_-;'AS;E"(4C^N)$?%SU,$6Q14=L3W+";><03]T7-ZP6+'8S$[:NB@HR/
MFK]2X,/LS<BGTZ=-QH&LV%<KNF0V622Q9$ZD9+0<_*1&J:O,FCJH91CY)?\J
MNUP[,Y/*^ZDA0[TY>O14ZO/:Q W93.E4'#WGE2<EJ4E:TS'.1 V[Y.XP3OJ
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MX2-S-A])F_4@='()XW.X41Q[UG"RCBL>1>'''J !$RTT8,J-<9A^3PFEBGH
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MK(UKU<8,C!)2WQS/4MO%;^FU>V[G-50?J(BI@3F_N2;SV#7/KL5S'\I/U:(
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MR()//0Q4$GN>;WH VPC=WY5W<')MTP0Q7]]RF>F>2N*><0LD[S EDV"ZC2%
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M*I[,HE=V%,E![8*5HQI1/U 62629*=/6XP([;:]'BRM[?W;9?VD!,&O2 S3
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M/=\%AQ"KJ4R5N&Y=+SV!!JI,[XB/<M?P4-,NZ,*L$M)9XK,R0*/HMVL3[RY
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M0QBNK3$R:P4A)*81Q8K0P U1[SPFAL-6]"1/7Q=XELB>*C0X25.;,%M+5VA
MY]UM1+PWQ7+:NNOUJS>]]WV?K:XX7/AX5W2_T:JL CA0EH49,A\7_DUZH)I0
MW;G7H#.(,$1]T3GLPIUVO>]^W;:?ZA2XPDA@_,GM*=$U"9JELA\SI\^:FS ,
MCCQEH[EY\QPC^(J>+5F=&)9&/HZ+FGTWJ7*E0[-KF0.Q92I+]XN0_ZK9!J.L
M3ATHF9P%R'H@JM[8 S7TRZBW0?W1-77<\:,*L^+M-7VMJ-/0Q0F5#,&BF0XE
MKE?@=%2]+G#R\]HGG\E!0]',TAT$E]DQ4SQ]#1I/?-NH?JN1:DYPHMFN9/I&
M_K2]\D^#[CMJ?D35 R1FNE%99N\VHET08(CZJ<,!:^\GCW^/<?R;.E+\;&RW
M_B1VON<R^#,G^]U2.]C_(]4"5O#G(/OB[\FZQGJH\Z5XS6#?+'A=HHEB)+O%
MUX8I"<G;OV)R3$LA (@=8RL<..<M H(X-NFV?\Q-=EZ^@^ZNZFEE\=D0:QA6
M0!15EQ^Q5QE[$KY<UU_E&86'Z_HGE!QXY>*KI=W.X2:S(^/8ME9[: A[UKGS
M=YO2!#4>BZJH0?&0!5QQW<VF6+SQ/#?I?G78\Y<67> #\7UF3ZYOV=%4GIC%
M'L];"U760$T((=N-OZS.%?7<7XB;')KE.2[&?IS>7'M>?5^\&DKCOFD;#&<@
M33S>%T,R7"@?Y<5?*T^6;F)@/9RK)+59!Y:],&A'W8"'3]N)]_7^^3Z[M698
M!%* >&1\&,WJC3%_TW7FN>%ZQUWBUP&QP]*C7N?.&=/'V*@),7U/EE&% :<5
M9_((H<*=-FX0;+K@GE/DXF?0=/GLE>X<QT(S:+)^BV'#+NB@Y:P!]QYC&R](
M7EOAXIH+KF&M0/+CKCUL59XIAR\N?54 ;[E#5X^W0;W'5Z""QF*T64FK1Q^(
M><;I'+AY4T'2X(K!/;U_]A?Y/OYW**!*-L&!4HL\A&Q+X<1V(:#W,B_8YEI1
MRFT\[$J*XV]DTZ7LYW2WCM\%05X1 ?,61@448?U%5!3BN88$S68B635^*I2\
M"R*Z[57E4\^@&A=4SZ$Z &(&(.P5]!3\:)?&8ZCYGQ]K_>E[<M]<.<W_7_TY
M@S)@XWH1MRO>:OFBF?7S[MKZ':-'V98%D!]AXG+2WT.&T$3Q5C*G@!ZEK.:T
MKY.7P\&P*2DN;MTEAA>EIYNT#97%UDO<ZZ_H7#$5F^;8\$,* UMPIO9H!ZZ"
M,(3C^GA%MC%_D2G]J\C""2OD-.U&;%=MGL068V;JOY'/'.JYO^0'-TCYLLK[
MVO5VAN/-$..#<1G,LD7*K.HB04OP6#3NBC3Q:$@VZ:S+5NU)G-^+?D"D;D^/
M=K56Z=P_>FM603'^('(Y-.M\Q;F;E <Y:Y(3/;=F*MZ&*ZS,71 LUDZ+TQ"E
M-Q-F$ UD.5-'O3N_=Q^J%I6AS'9R. +#AA"+&];&/DZZB=ML7"YYEF(P. U;
MC(''UNI[']LOL>[;:DW7I\KG7;4+4L?O?^GQ:HG?KE:O-[/!->YHG:CH6Y%
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M$A H;N 5ES;C%OTNU&&97J=5]6=(N>6ZY(=&Z-D\[E(?G!%B^I;[GN^VT;K
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M,]^6H<B.X1U53ASZH1Q<V#MP6*?KS/ *_.H[O\<6YG7=>A(^)W+$^N<ARVZ
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M,-E9^5V0?W'>I8.'_S7F!3+SIQ'; (3;>@8G3CW0AO<E!"0<.(,Y,.KD8S<
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MVRU/7(%NJSXG#;"\ORV;2']7'&14&C<ZR_M:).FBCN C(4'AU*!Z+BE.F@D
M\['CS\?H527;Q89B_.]'*.4JG%[PW9CKV'KT,*]X%^3-CX?PH>H/(/F=/ZZE
M$]$M_*=K[\3KT'_560B8R;==G*T=2W]91Q[NAXW[)[J_;]4CHEU/O'AJ^?)
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M<,RNU@$S/3$M[*KB;8R5SD) 8(WN4JUY16%<9>5^!=6\I.U"7[L+2!MZ7EB
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M'8+P6-IQLQXJBMSN/]J C2J>D>]O0"(;E<0*8"DI B(S/V5^VSONCP.V8:X
MYAFPG>Q_^CRP!>7*#3)W'BBY"NL]7VBZNQ\MTA6:E35*8J\_@-,3565 ##,
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M+(HMETLEHWZ3K6H+/*&[K5RC7 -27FX@*Q4C?NW_[W\6XHW\#5!+ P04
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M.S<EV $$-?X.L(8(<"N1F6:89I*/J]O93=W(*KR3$_0$!1M)05]4T* 'G;
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MIE$FH!!1%/LL99XG3&,']]Q_;CY7 [$K-F$>-+B/NN,+@0-"1M;4VUR WQN
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M23?M-Y<;QVW@1M'H#X3EAM&<IGG"C:-^-Y9O4NX]&T35LQVB9[M*:_DO@&(
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M8II!%D4Q1 'WI!&<$<CBD*D]6TJ05?,+)ZCFIG8_%RKN1#HPRR?0"0>:?FB
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M2@[0,(KWL3O6B[@9!P0^Y$\<^OK@*J!--;ZWW_%]ZZ;H%/P%QM@7+*4P#(6
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M+6U7I=3W:,A]!*4X<MT/"8;8\U)($\K2#'/L"[MU?_\X<WO56YA@@]-RC3]
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MU2@+8YAA1*$(<$2D&<PYPHL5OU46NIFM:S*LT>.=-8]W?_#QGNX.(RC7("_
MBEMV3C>BW,P&=4;C-!JV@PM>=8#_J(K_K6G=@'9G0MI0Y-1&-!IX4B/0AHI=
M*\_JVH$G)?@AK_'R[?<'OF)Y+0W$ZGW3,H^]?JP_%O5_\/HSSMG"BW"",Y[!
M,*8!1#B.((X\#C/*XLC#/ LCJU )TX'G9N3IX@&< 9%_5Z5Y5,%=\"!O?B?G
MQ_8LQ)1[PU.0$1@=^_RC@0SZF$$'&I#'&DC8X$E2K( [//BPI,KMD8?IX-,>
M=EA2\NR8P_9Z%T%<G8)L7\KW*ZD!>%4O(B:D THQC&*4012&*J0+(YA056LL
MBT1(C5Q0JU'GJJDZ?.<$>1TBVDPS.:=O9+7T+!VE@WP!C$D],S[L!$DCAHP=
M&OD%H\A.D'$\L.S4Q>>=9>BR_%6NO,//9?&N*._Q^Y50_U%_V@0RL(2&G*<I
M3$6$(8HY@41MCX5I)"(O00E%5J>MEN//33==TSO.'I>\V?DI@ 8.>LB''4"8
MSH;=8<,('$]UL-"#?K&?:/#[C6Y@,DJ R4 &1SDV,,7P(D<$E@0=.@ZPO<V
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M ,=[XF_4&'9VF,-Y,C.^7H;]T4-92 TVLEP )26L"]A)< '6^($2X )@(1<
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M!7Y7Y("6'8?KP\M,ZX\6U-@7X7]:9..>Z7F!\,9]*(:MH;_@?+554_K#NIE
M$D0>\@-IOZ/8ES:]:DRI0M6BB%$1"$PBCFS,^<-#S<V&5TAWRJ@/;]MPA&&S
MM<0-;R/K_:&46:O@TVPX59='AIM4M9T6>U<-&5SQ\D=E[U>U?(IR^66E;Q@-
M,Q;!C 0!1)1&,,695#HLI#SU,XP8']+^UC'.N2FK=_DJKSE<YE^E*96O<0+<
MG,F\?'W$_AQ/?ZPV<.9^S..U]EGXH)^%GN3S/'/;,S6S/7OK8_UAS^#V$#[F
M6=R^X89V#&AKWGWA#RKP8W5[7>/ZL5I0$1*:"@$]&B80^9[T*3/.H @12E&&
M4Y]8=@S8/]#<E'Z#=5WF<HT6-'!M.P8<8/>XMG;)V<CJ=BA= SH&'.?BC(X!
M!VX\<<> X^(][QAPXOMVZJ JZ\75X[VJ R17N+="<%I_ULE&G\0E*[23?,G^
M\[&J>Z5#:,C\E'H(>HDGI%DI.,0\BR#.$D&C,,0L,.HZ/F3PN:F-#3XS#3&(
M\.-:8VP:1]8D&^B@P7X!&O1J]['#?P$V$IRNE&.L9,ZA[IAA)>_;,ZKD;[L&
MU:"!)U%,YU#2*:NS[C&\?6%3PNPS?N!E^^*D69:%"#/(D6IS$F44DA0GJC!&
M)F@6()]8;;CM'65N*JE7,/%!H;3S4_<3:>9EGDW/V*IFPXP&Z%"3&%'@O$OC
M\Y$F[\9X4-A]71</?WE 9.'GLJ"<L^J=Q/7;ZEN^8M(:NE(;^M(NDB[2ZV+%
M_L+9+:\609BB*/ C*#SY#_)2 DD08(@RCF.?IDB0Q+AXH/FX<],,'7*@IA(\
M=MA5O& ''A")'MQI^!8!@Q9S<5R5C,CPR,IEF]PU;-###11P\)<1R;6HZC<.
MR1,5\7-%MEW@I3UE1T,M+6XW77"EO8Q;X90#+G=V9G+53W:Y*?&J:GHX^ N6
M8A^E 851Z*40,11#DF0^S!(O" C!GI\:Y7D/&7QNB\ 64%!OD*J(<GVV4>5.
MLH4.3\?@,PLG)+_(0<0VZSWHHQXDG.1K[-.!PP!>>LO_)#4&^_BG[S$P.)R3
M>A.T\H4S?J]]YL:'OOE6M%Y9YB4LHEX(!4\SU16/04*ECYLDA'E9%L1^8A<>
M;C;NW#2:SKK>X%:G?AWR]5Z2!&\9*FXX!V:Z; 1F1U9CAJ2.X$);<N4V:-QP
M[&G#QNT(>18X;GGY %=\CVYL(D@/),^\KZI'SB2 ]K23Z_"]!6-!D& N55F"
MY3^QET'"(@2)AV).F$A":J3/'&*:FZ[;!.9>_?5+!7(-6G?*:L-2>-,RR\*]
M=#1Y!G[]]%/R(K9>;X[VUIJOP/O-M'6B-8'6TT^;Q8[!]-,WT6["=--HM]_@
MEO"C>Q&.AIING\(M-UM[&(YO/61K^PY7/+R2'^<4+V]*U9FG,3<%YSY+ @JS
M"!&Y3JHEDG@1#' 2^$DL,.-&.QG'AYG;JJ>!@A!T4('&:K.%>I!0D^UH%S2-
MO?N\EZ$A364.4V6SN>R"LJGVDNT>+LLMXU-$'-\A/GCUA!O"IR38WO\]^>UA
M6R*?Y91]E)-X^3VO%HRS-$L3!JF*9I>^00)Q3 B,4HY5H9 P8LQFWZ-_\]FI
M/OD;4.# [PJ>9:K,%FUF6Q5#R1A;P9GR8+W?L$]@IYL*6P-,NG.P3[3=[8&]
MWQE8WE\7"N<?N-0!VC3Z)'ZKFKCF!2,DID$:0#^+ VFXQ"E,PQC#,/1#@K/8
M2YE1T*#!6'-[A1NHZGARJ=""4L&%A8"/59=48EDT_0C/9B^Y(_9&?N=;E$##
MO&B\+L6;A-ID<*S+9U+:A)M);ZPM9'B\XIU]@?+3A+DM,WYDO&F+A9\6_%G)
M;X-+!CA%UWS)I8YJC5$/27>'11AZE$I'* T#F+$H@F$@HA"GG"=>:NP(;=UZ
M;NJC!6=APF\S9>#A#)9_9 70XAKBQFQS8.&Z#.9B(G?EU.-@YY_LE?:H3[)]
MQ71^R%ZD6[['_F\,,V6:9*QU$; W>467A>I?L.">QQA#"<Q0*!5/A$-(,HIA
M++(D(F%,>>39%:TY.);-TS=-?9D&ZD6OWJ"=Y7*85C.[Q0E5(RNMCJ--^Q6P
MP>G.(CE)A5-[Y/!HDUHC)X7>M45.7S# $KG\[_RI._\7089H$C&8,!)"1#F!
MJ8@YS*0_PRCFQ!/"V [IW7AN5HB&9K'^]CDRL$ &2C[VJ[Q!Y6B]W2/GT=6V
M__WIUMH]*+=6VGV?G]D1L.D!]$&U'/.[\*8P$3RA/J19%$/D9PQF?NK#E"-$
M4U]X#(=V*^V1T>:WUFIT36^UH4W5]I!JN#_@AJBQ]P=Z#<X:H!= 0P7^"'%)
M!IR,TVELSW@OTR_LL. 'NWX=N628POC(:U6O]W-9?,T99Z^??JM4783WNHY7
MOKJ]I'7^M:F90*JZQ+1>Q%%"0R[U2("B2&T]$DC"E$ _91@E)/&\-+73(_8@
MYJ=>E ! +(MO;1)%WH$'>(W^3W9Z9\#<F*FC<?D>64M)\$"3W<%7U1I?*0DD
MYW\$:R' 1@KP>R>'0_TUG$2G:FT C$FUW7":=I7@&7<ZTYCJ58YIVRZR3ZOM
MAHK/^B]NMU]\_;3NN'BUQ%7UIKC'^6H1"4R2./(A]Q)5E1Q+:RR@$0S\D(2^
M)Z(LM#O%&1OQW-RHWJ: U *;?JH:,OB] 6UYR#O^M%L:C7.8S,E,ST'S.-SX
M')O;<4S8T5"_C"$\]B0<-*=''WC8PJ/+ZGYZT)E0_75-+7_OI(FI:A3I0KT+
M+_*B0,@G):)80"14<4KDRP4D9CP6S$N2V"H3TWCDN2T$&KB=GC=GV4Q?C\+=
MR'JWJ5N^!MVSF2\:(UL!!VOD[A2P-5E.%:GYZ),J1&M2=A6;_0W.Z/BM$C3S
MIOZBJIVV0(C2-*$4IBSR( JQ*LR=J.I \A-?\ @GD77W[YU!YJ9V-LVPUT#;
MXGT#VH+O$GI<[;BB:60-,X"A8;W##U!P7A_QW9M.WU/\@%A[^XL?^NXP*^3]
MBA;W_ 9_WYSR6>XS';G#C)[0!B60,'L'RZ-L&1GPX729.S;>I N;@>"[2YG)
M)0/.FIM>X-7EP\,R5\;^)?NJ@NNJ3WH?:27G[^FS?+!4V'VUR%@0<:I*<6*.
MI76=,4@"+X.8>H2PB$L#VZC>G?7(<UOF6NP -^"!U.&XA:]^SCL!P$,G@<71
MMM64&)Q]CT7TR&JHX_ARP_%EC^,U=O!Y;(XMHOO&XGJBX#^'G-O%+0SA[6A@
M@]4-IXM\&"+G5FC$H!L,C%&DM'SD_3+Q;6WHRQ7[*&5M?^E,H(#$#-%0E5,(
M$HB\2,!41 0&A(<9#5-$$;4,7+0",+\CT!9_O_.#93BCW0R8&:'CL3KR@K"'
MSE&LTF$$N0V'M(,P;8SD('J>!4X.N\O@Q+&\YKK)RJ;%11.Z^6'=VRL. T_5
MEH<I5M5A4,1@&J<,)ED6$98D@1]:=3,R&71N=NV!=C1=/YOA/=6,9L#P&- Q
MKV.?Y#F@=$@ZF3%'KO/*3@\\=8*9,15[,LW,KQVFFOI->%9,-]6]*Y;R^JII
M+KE(6"2BF"+(12*D6L)8%>'S81IEL4>1B ,L%G51XZ696CHUH)5*6@\[WOMS
MH\8 R]Z:KYII53W<_QMPC=Q.(YTDWDP;N:1S9$WT88?#M\=9LU8ZIE0X53@G
M!YU4V9A2L*MHC*\[X_S\H,6U$)P1CTOMDI)$6CXDB2'.? X3%D:9+P+.$F'G
MN1T?<'Z>VM#3\L.<6AR1.^%IDG/Q/1[81=>CR_%1^$E2W)]_'QYR^D/OD^+O
M/>D^?=70[C<K[8;]+:_OKA[EVGO/RTV83_O$8YZQC/L^]#'"JG08E?Z3GT$>
M^6$D B*$L*J:8S+HW/RG-[RM=5[RKWQEF[UJ1+.98G%-WMA[_2U<\$WB!1W@
MBTW@XPAJQH8BQYUU# :>N-&..17/^^Y87#M,_>AZAZ]QQ=E5<?_ 5Y4^!;DL
M2_D(Z>B=ZO73YCN?\9/ZV^4W7+)/NA)Q]?:[Z@Q4\>I]6Y7X;US5#>'L4IH7
M^)9WGW\N<\H7/ RBP/,1Q&F40,1X*CTNZ78EL8>2D M"P]C.')I6@!F:5XT4
M@+<P&7CUV_4;7=A45Q/^HYV>G/AY,-.X\YWCD76W%@H2)17HBP[ZLJLH]OX7
M6_F!)N "M!1<@#4)JEM(0\,%Z(@ +1/K;P'-A;LEX67FT.GB,K$(DRY3+S,]
MNPO>"Z$8>(;+F Z 4UWQ<O9^=84?\AHOI<N?$*8"XPE*?(C\T(-92CD402AB
M:<C'&-L>UNX?:7Z+T08H>)!(H50TM,%J>3A[@%K#4]CSZ1K[N'7#DX*H%/+5
M"9[LCUJ/L^#V3/7 6-,>GAX7^-DIZ8FO#RDNT^P1Z%.,RTT[KO7&5>3'4>2G
M4A]DPH.(2^LW8TD"8Y&$.$DR['&C8U"3P>;FOO<@2@^^J??8.WFP*4]S@N7C
M2L(U=Q,%9FBHH(_UM-MN3YU%-)Y#"B<*P#N'2LM*06;<'*\>=.(>$U84,I-F
MN\J0X37C'.RNH[8XPBD-I15&$A54'?H)Q)&TS'@4),R+_)"PQ,X4,QUZ?K;9
MA_>7K]]_>'_S_NTUN/SX!ES??+KZ][]\^O#F[9?K_PW>_K^_O;_Y#[?'O);!
M<V-0^R+'OJ-$SMFR,^E)\,M$R]E28GLR["A"[B:_SU>WGT379?*3^*4HV*?R
MFI=?I1?:UFGPPU3P&$=0VH()1$%"(>9"M8;$ 6<I0C@(;(YXC$:=FY'8@%9]
MFSK8ZF<%7#(.6N@#2VV838.9JG).[LAZRA&OUDK+BB>G&LMLY$G5E149N[K*
M[N)ABNKM_<.R>.*\O>?^S;@NO?NM$)SJ(DFJ--)-<<WK>LGU7ERUP BE2<A#
M&$>Q5&$B0A '401]E/(0$QH&J5&%=^?(YJ;P=-V#N@"5Q@@>=7TIWL;@@:(]
MVRDY+6Y7^7_+#W#5'.NT>_VT?RC OZN?+0_&W4VZF>I\D:F<\)AF??JRV;1N
MRUOHLG%RKALAFN,9=ZK6.:].U;$[=).J;.>D[JIU]P/8J?ZJK!>_YJO\_O&^
M+3++D<=2C_DP042=T"<9S#Q*(!69+_^;I2+T3%3WLSO/3?6VX,RTY7.>CFN[
MLZ0?65NUN!R6V3TH[3$=(B_JZ0_YVZ[N>'[72=[]@\)T[^[A+PPSN[:;?%\5
MT@8H:Y4-<87+\DG5UKDO'E>UM/WN>..8*N50K-2&+4IX$J;J10U%"!%),YBF
MTG7,4(R%H!EEV,K0.@/+W-[O#G'3ZT+Y.TTJ@[:9-&+UM_J. _G<A>!C4=NF
MD)XS<6;&TD33,;+"45* C1@7H">(LHW:>6ID49/2;J.M97%G)3D@U*E== Z>
M22TA!\3MVCXN;CG@D'8=0/FN*/?VA%:CX-735?E4U>L&NC1$$?%8!F/J,X@\
MD:KMN1!R'OH>812A"!L?W0Z",#O]NNFLWL\@@Z!%;7$L.6Q*#,YY1R=ZHO.%
M)R %.-C+OA7BHF-^2,^U85-@<5X\^E1,=(H\UI38G3"?Q>;1<^=A=Y[N-/HL
MR;?.J,^[TYEU[GCUA5.>ZU*_BY $#)& 0-_'ZIB:($@X]B 1?A EE%+N6:7W
M[!UE;NM'6PJO5BC5#F<+T\X$W\^GF7%]-DLC*_]-K4!)T ;A".DZ1YD8ITK@
MUD@O4Q]PG[ '*P/N_?(P'?#ZL<I7O%+JA>2K9H=OK7[D3U7.=%'=[<#GJSOU
MX_M59Q0?N&2MU/Q%D 1$VJP>I'(R(,J"&!)"0^@A3&.<"!%F;+'BMRH4[\9<
MN4P$W^A%S)H7\9D0X[V47SA[I/JT1<4V/S>!+2LE3/4LF&G$.4WM-#JVDQCT
M1+[H6W5;(FREW<BO:<'5@[#9NCAT:2_?TIW>GGB^G*X$4V&?=&V9>$)V5ZNI
MAQ]L Y>JO_P;WOSW_6J[E'P;B/^1UPL<\HBP+(91*'R(U(F47- BZ&<L"WSJ
MITF&!RQAY@AFN@HU)2-P4^9*!1Y:1](/F QCJ]HEMY.9VAHL>-7!_J-2Z\\Z
M5FP(WRK3(85Q:HQ;$NC:0C<=?FJSW9*6/;:\[1W&V%Y>> P'B"-UI(X91#'F
M$-,,04I)D-(DC+((F06EFPUH\YY-%(I>K&YAS<O[?1:T73+0:;I=;!//2%6=
MQ#K5#J.;W<0Y[1P.VR4\1UGHKE^?Q&?Y@'0[US=Z!RO&01"EF8#"IP0BKBIF
M!"*!**(D2C(_%&%H?-QT:)2Y[0AJG,J)ZB,%OVNL-F<9!UDU4 4NN!K;9QV;
M)HM3'1=T371PLY>VGQQIRU,\'%62!R^>3C>>PK^E$D]^>6#XN0YO_"3>?J?:
M(_TBO:E/.OA1_5]% 'S%2^6P?N%57>94^EKJ@\L5V_Y#[YL+QE 0!BB )&4>
M1!FGD""209Y$*!.,(.$9'=N/B'%N6K@14<=+M4(":1]ST/RL>U50*8%EE/D(
M<VOFC[[PC(V\%FPFJY,/* '5)"G0;>1Y#_L%V(C5?*B\V=V_]2YP&*$^WDRX
MC54? >>T4>OC$?TL?GW$H5Q'T^H?*]6Q3BU9_@*)C-*$JD N)/UP$0J8I0&'
MA"41C3%BQ&YM,!YY;AK__4IZW7BIG/$69Z/Q7^E,HTK7DOM'_\+S/,MB<N9S
M8:;+1V%X9 U](OAU0[E&/D6DZP&N)HIKW1U])E&L!T@QCUD]=(.!,0)XJ5I/
M7=]Q7G]0<RUOW&8H>Q%)4H(Q]((PAHA' 4Q]AJ# 4A>'+$Z\P"KD__!0<]-3
M+5*@H8(.Z\!T\",,&QZ6.^%M]+V"8939'T6?9,/MZ?'AX:8]\#TI]K,SVM-7
M#-A(_&6)OQ?7]WE]]^_R*_QU7BR+VYSB975]V<;J$A2D<80XC!#S(4I" K,@
MP]"/,(K3A&64Q<9;BJ?'FYOR^.7ZWRWVQ@SX--A,=,O2R*IB!RSHH077/UW^
M-"2JW(!&B\U&MW1.M.UXBE9'&Y#FW!S=BC2XS72;DN8R;6U/6EPVY,CF>8S-
MEW5YAO=,/E"YR/&ZEY4N?E9R)CW>?KFAJI+/WK/&5ZK]M(K!45[T(@B1CY&7
M2,\T%A!Y-(-9AF*EM)&7Q2GR XLCH(E0STWK=]@:A_:QK<#09(3FFX9Q721-
M*S9XA>4ORN^EDAE#IW?:I\/D*&N&<SZVN;LWG',C->B+W87S=(+OQO6 5O:+
MYZT%+\#ZP5(,S/$!L3G$F^&#,M6AX,P>&,M3QXDG[O@IYE1@)CP5G9C?[5/6
MJ0<_NQ;K.YR7.C!&W7Y95(\E7Y XRD0J$(PB+Y)6#%/%KQF#29!Z).2"12P=
M7(%USX S#';K1XH*B;@Q/P:76MW'LMF.E3OF1E[&W\GG?475D832L!^+E5C_
M88M-)46;=[N18Y22JT?X&JO0ZKXA7ZJ\ZA'QCQ15/7;5.>FS'XJJ>B?A-N%X
MCZHNXD.;I%"]YJ(H>2]M[]=\591Y_215()?/J.J!OGV7IK3$K[R^*^0GJOZ>
MSHI8)%CX291@R/R 0900#G&:J%X>6 @O2S*&L$USX FQ6WEA$_09;C-97\EG
MH/HC(%I,Z7YM\G^')/U.\Q28:=:9SNW(:KJ;U@]Z6I4" 1O1P4;V;L;;LCZ-
M2* GDS*8-[G.%TKCJ\!P*<-2W:FCR'7"\Z3S-4(:]33X7R Y>]*)V9_R/2V$
M8:OAYS(ORJ;-E?0,EKBJI$?0G"A=LO]\; 9YPRM:YKJ0[$(@CGPO3&#"(PZ1
MH)E<TE (PR@./.9'61 G-D?'M@#FMCNX"]IR';+FWVPQ&9/5D5>$7;P732&<
MLBN9L\$/?O]<+'/Z!&[X]QJ\ECK@[PY/HX=2Z%1)6X.85-,.I6A770Z^SU"=
MU[:!UNT:=+W<ZO)1ZM52;8LLTI1YF&0>3)(T@@C[!)(L2F&0I<3+XH#1,++3
M<,>&FYL^6Z-MZX?C-=(NEL\R@.\$VZ;ZS!6'(VNO#7T:Z4735;4"&[ N-90)
M*8[UT=$A)]8^)N(_US5&5PULY_D5YTNUG_JN**_QDJM0OVM.'\MF(Y72Q_M'
MW;;NEU):=;^M2HZ7:MA?<+YJ+$)I"RXX2E"F2GF%@L0092R#*48(!G[D"RX"
MW\^LVK@X034W/:6Q@L<U6' KT5H:7VZFRTR#33X)(RLZ'9.\$> "K 6$$BRL
ML I-[HD%F@G;" :49!>=7R^%<]BVU"77;IN<.D$V;4M4EV0^:Z#J].;V?0NN
MFOOG7WF3A=(8H9_$)6OZIEQ^SZN%%U*2(,0AC_T0(D\508MB# 7F5/J^7LQC
MHY:KI@/.3=5N,(,&]$7;^EWEC'7 P>\*NF%@GS'UQW7K&(2.K#:=<&G55,&&
MH+-[+1@--ED+!AO1^YT9K*ZS4SJ,YXN;$K-\=7O]=$^*Y8+ZE&",":21P! 1
M26@6(,EJXJ<ABN(D282)=GEVY[FID18<:-"9*8KG=!W7"&>1,/*K;RB_\<M]
M4-8];W'%Z4^WQ=>?Y37-2RQ_T.^O?G.?WVF25_2@ -V[>/@+0_,Z&]=OO>W>
M1+*HPF2"49+&?@2IGS#I<_D>3.6,0I2D&>&I[WG4RN<Z/-3<7LL.Z=9AZ@58
M':E'9DNNF8?DAK+1W9Z6K<UIXSH\SVD)M]-L.$ZV/#C<Q-F5I\1^GDYY\HJS
MH]+::MGK9M0QRA(6A2GT<::"ZY,,8I(BZ/$H9DF*29*%@R/2=@:;7S1:"[!?
M;>U/@T/1=JDUTQ5NZ!I95VS%F76DC=S7^P ;8P68[0[W4L%E!\0^$EAVZ(H7
M3N>YI+1\Y.PYT$661JE/0@03WT,0Q8)!PG $<8RY_$$0Y(46=6RG0V[T1DY?
M_[;%.[!FY#1S?EP9SFP*?^CTG.YIV*>S9_=8O%!>CI/'X\=.RAGTF+Q<0L[)
M&9LL&^<PDA\S%><DLZ/EX9P>>9B[\PM?\1(OY9B7[#Y?Y<HNTEN@34?X11J2
M."&>\GF$"OR+&<PP2F&4!CP2B">1%]CY/"=&G)_CTP+6Z@%O0;9S?TY1;>8#
M.:1OY#6[S]LV5M""=><+&;+BU"$Z->:D7I$A ;NND>EE T/N\)..5KXI6MW6
M:42N-FH^"5W0K]5ZB\C+.!$D@;$GE0S"/H)9F'B0T 2%W*=>QJ(!'3ML,,S4
M9]&%-1]PSH HRJ;40)4WILV*ZQ*>5)?C;*6P#-2SF2,S%>6<\HF"^%K8JLY#
M"P]LD.N-7MVG27%]>8IK^["^ :2Y#?*S 3!MR-\ :IX%  ZYQ_ ZHIN\116E
MKH/4%UX4!2(4$4QCU;TCRB@D84AAG*81IPDG-++</CXPTOQ,J%ZY0W#-5[E4
M8Q^+VC9[[Q"QI@=-9Y,U^BD3J7OIR.#W43(<3O#@O)CGOK$F+]UY1.!]A3J/
M?7V84M AQZ]QQ9G*:Y&VU6XSM==/FZ^TRNKR&R[9)QU[4KW]SDN:5\I;_!M7
MW4.D2RA?*7S+VT_XYS*G?.$AD3%!$/08\B$B2LD$2%I1C&64(/E9E-F<:$^$
M>V['XY\>ZZJ6CHN*W&BB?Z19<(=K($4%?"/3!?C62@5P(U;W*0</2C#PZK?K
M-[H.LDZCL,RBF.JI,=.@,WP61M;(6AQ(E#R@+W._G2<@3Z#_O59PH"6_ *WL
M%^!M_ZGIY <M =VG'&@*W&G[B>?,Z>HQ%?9)5Z.))V1W=9MZ>#<9-9O@<+4Z
M_XKK]K>/<G7^TN3ZWWSCRZ_\UV)5WVW*ARS2-(Y37RZ'?HQ45A]/(691 E.2
M!B%)$\_'5LNA*V!S6^_^EM=W^0H4*PZ>."[/2Z@9/%MFR]!+S,$4EO^IM)I6
MLB?YZ5(K_O;(ZEH**/VJ[F/P1GYR 5K)P;=F9C_)F?T/.;/]TD?CI=Z<.R6C
M9M\,!O>B"3CG4GHJ!^?L^P_3].O[O%\]2)O[ __*EV%;X!EYE-*0^Y#[<E91
M$&<P$[X/"?&9\$+JT\SR[.G(://;--'H_ND?_-C[<VBGD(^2&A(2AZ$'D?P7
M(L25;X@H3*E\?4B*@H 1FQ71$:53+'(:&W#(I=EZY8BAD9>@S;*@:BHIH!>@
M)>QT_7;K!<. $Z=KP+'Q)E7K!H+O:FJ32\XZG]OJ3RM_JG+6%BQ:M[!=M[J^
MI'7^52\,"YKA-&8,0X$\#A%#,<2"I=#/DAC'0>S[OE7RQ%EHYJ9KNET =6+7
M:U5-^_+8!R&ZF3BK4[SQIV.:8ST]$QM)P)8HZ\BNIPNPE@9LQ'%^S'<>JV.<
M^PU$]!('@>>1=^!D\,R;#FQ<JZN[;4SOUJX(<1KBR,\@9CB&2" .L<="*+6J
M'V94)$%JU,#A^#!S4YE71?E0Z&X+O"GW6*T!6[:,/<"JYR4D9AQ&G*?2G1 8
M8LP#& @1>&&LBK-B.W?B?%ZG\20VA0-!O@)_S?^NM!LM[N^EYM/UGISP:[:L
MG,_9R.M%6VMT@W $\_<X"6Y[TNX?:MJVLD?%?=89]OBW!Z3J*,6NTGV^2--Y
M]<C;YS7".,D")"#S6 "1%T604)K Q$.IET8$,X\:M\G9.\3\-&P#$I0-2HL4
MA_T4'G_EW1 S\NN^YJ0%.*19V7YR+/(USB9IHOR*7;(<)3\<%?]HLL+^*Z=+
M+CB*?"L9X/@W!QZ3-4D!G\M"\$IUD,7+=WR3,!2PT$=(FCD1]P5$:<8@P;%<
M(2AA7N8E/HM\.X/G^(#S,WSZ0('@MH;D"7X-CZN<<3:R)NRRG+9(4U =YCK9
MD>+V&.CXD-,>[AB)_^S(QNRJ@7VC'28K?:KO>*E*\;?9UOJ*14AC3#+5=%H%
MI*$DP9!$823]KR2F*"5!1(W:R$Z&>&[FFP;9=ART;%D]^N2:Z<)93=G(ZG2D
M7-3F(=C(W5[IL!_W5'/DMJWWZ*BG[0X^U20\:S(^V<##EJDKO6NEJS@W,4/2
MBT<>(]*+1SZ#2!50QJHY.8DQ3VB&XEA8MHG;'6)^9NU5;^ON ORC]Y/G^> !
MM_WA_@QB[\+SO";BN.K5<O\S\..+.(FU=I$_>NGZ2[F<LE;M%+W89UR#?WM<
M\38*P;L ZO73WWK#J79AVH]\_9'\@KS9 U?[XWSY9+=(/9M:LS7EG.D:?6]!
MSU-;$[X[7-=,N]/7A^1WJEZ?#3*I-CPDXJ[R.OB]@8E<>85O;TN5Z"G5X"?1
MNNX?I()\7_/[:L&")/-B2B#W> 91F%&(4YK V$_CC&4B"!)D53[PQ(!S,TBW
M\:KDR/4FFL(,-&C#C31CTLVT@DLJ1]829[)HGP!F2(W;3+!3@TZ;$F9(P;/<
M,-/KABD<:2L5W1ES4]BPJPU!J5SB>9A*9E5+R9 3F'DBA3AFA*0L%CST;%I*
M'AS)2L5,T #R1HT!"NWTY/UFD -JE1ZFUTRG."%M9&72Q]A5*WW5PCR<?&:M
M0TY2X51Y'!YM4JUQ4NA==7'Z@HF329NCU?>KJB[U<5&E7;2;.[QJTWL^%CI4
M@+.=Y)Y?Y*UKE5BP2=;PHQ"GG# 8Q"A4+0&E2DJY_H=ZPB.$!_'B0==0OZYQ
M69LIICF(9O,Z[PHXZIO=X%=.&>&W^6JELU,%:#"\4*:IRT<JB;#TXF,/$NZG
M$/DD@EG 4\B#2(7HL"!*<?M(O5VQ_\D/5"?>1(\37['_40^2V7H^!Z@S,AT<
M)#NWL5,]9MK]ZEIRLTF%7M.S)Q%:4Z1SV$;)5)O3G,\C6=JE8#]&)O4(4^DL
MS7H,; ,K0Q8%^Y8OE]T6_YO'4MH;35.<!2.!B$B0P22)5"QM1&'FR^<RS&CL
MA2*D8>;9['P=&VQNNUX=UH$%UX[R:K9PN6)KY 6E@WFQ.=9LD+;-KQR6?S0@
MQ&WMQV,#3EOXT4#T9U4?3:X9&$:"J[SZ)"XI+1YU-D73K+OY=U.R"R>(,9)B
MZ3RJYGK$QS!-(P(#RN,PIAF5NL7NU,YLX/F=Y6G<ROC^+._:17!:1G>8<6X8
MHN&<Q['C+#H"-Y O0-LB?M16\79,N8UV,!MZVI %*SJ>Q1W873T\>"#7>3#5
MY8JMT[VH2HH,L1>1S*,PCH- 6C1$6C0>8C!,,Q*+.!7$8S86S9&QYF;0]*#J
MHWW:!VM_AG^(8?/C? >\37"RWZ?LRHBR06?[)\AP?LQ_:+S)3_Q/"+[O\/_4
M)4/51A.Z_XB77Y3/U26\D8 +'A,5<$0"9<1(E4$%@QGR@BP4/ L\;*<R]HXS
M/W6QA@E*OM0&2W67/UBKBOVL9I%/_1!',$8L4P%=@30-10P))1&B%&44<=N
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MK9L1BX>L&]4&P6NDX]D](^/U(3^/1(P6Y"=&>XWNX^>=/M-XO.>&N*57;<W
M_U9L??_7ZO['>O7T_<>'^4]U^[ R:]#_MBK[U::6D)T5&!>IB>)@6F1FC6@8
M!I9)B2 O"ZR1++CV3/0/;^/DF%YO[*;+4H%G8SW8-+8#;3/![-_XLE.$677D
MM=>=J\B,Z%F]98M91:U39@5JOQE_%VI7OF4S9W=57:S^!7PQOX 6#&#1 !8@
M.TZ'2BT'-'ZYUX#I>I7*+Q\[)UD$-@#HH?5@0X8:<(ST:2YL]LL'I:J_SQ>J
MVAB6L_+ =^N5?!*;6M=M_]];28PLS\N<Y H2DMO>=JJ 94YS6)1,$DXX3PLG
M<8$K;)C:1Z(VS>-L8R#R#F=(\?&,3.2M \!Z8!A[Z\--S=2MZ3>-O.3-BS]?
MEC4)-A4>9T[QIV2D ZAKIB;0:=1U6/8>30U\]'CG5-?Y?G!H=>6C!GQKML.T
MF>^=[+;2K,RQ3B')2[,BX81 EBD.,4J%1(KD:>FT(ND;9&I?BZV97=&(S['X
M.2 =O@T!X(E,_L?(#*'T<Q!Y<'8 J$8B98\?DQ_57H"@ETO/W3L>65ZP_H -
M+UT[M'9R8^;)Y@#4:CQ5D[JY>+)G=-L>8UMY'$3+5*L$,BJDH<&$VIA:PUHS
M)^4Y+LO4KZ^#S_ ^/^MQFCU\>WIX8.MG>R*]ZRBX[%3%/THS2W,]KTOS=HXV
M@E6>&S)>T^2VTQ(+^LCD>P1DHWC\9FO[=BK^%D7@9@AL@:L9/0P8N6[1'YKC
M"L4!SQ@0Z7T3/Y1\6J@OVA9"JK4]CFSCS:87QGU=#+F5\=5YCG*:$JBDM-U2
MT]0V"DH@P8E,TX1G6CLI@PT9?&J186>^Y;V= Z!;>.T8\+WYX:P>YJ)M\>(1
M'/E.CT-<&1'TR)1W >^N?TYMOU.?Q.OQ]@A2(^(^4O#JA'^@>'8@6KUQKN\S
MQXM_!WI[$!</?<:P>/G]P^-B]:Q4+8?19-.VZ[:B*$F!&8$TMY7K2<X@EQQ!
M16FID% B%=SGU/+L2)/['-3*(&UFL5]8>QY-MQ@V"$:QV;M??N.F12Z"V/5%
M=(+&I>='&S4(O>CTRXCS\@T#F>)?3_Z*I8<W3>A7W!@6945UVN>PO\W#(<;]
M09YT[^A7>/JJ@=G1G5+G;\_;?_V/N5J;!_UX_J1^&G]M4F]!&19YJF&:JM)\
ML;B&)5$F@LA2Q3.>*"&]^B6[#3NUS]=.(A=LC:W7,)]O_S$LA]H-?3=""(]I
M9**X!D[_3&LO=,(F7KL-/6X>MA<<1VG9?G=?F<K1]E_FI12(8U@0H2 N%(>\
ML!3$92F*#"<Z1X.R-"89*>\?30\\_!^48C&UD'@?AVNS(:Y*=)CJ<9G3#V5X
M3L*P=(/7S"1P2Q*X)FS?*2#<2FGFLE+-QL$LU2A%3"'(&"IL(ADRB[E20)(C
M+3.1%!EUHJAS TR-I%IEC:V1[<:BX_MY%L9^R@H!3NP5D"\N S1'3CM_A>;(
MBP>.K#ERVIUCS9$SUPU;_/Q=,=O SK+TQ^7CT^;>/*85LR^)Q(0K#8E.<XC3
MDD*:8@X+A;5("RTT]=JB.S_4U%[J/4M!;2JPM@YL&M"#L-NB)@QND=_WH9!Y
M+V(NHQ%TX=(SW*B+E<MNOUR@.-PQC#*^/)I5SF:^_%ZWW[U=RDYQ<;M[5Y*,
M:,XE3$5I96FQ@"SC#%)"&"<)*DE"_#)?+HXYO727K<E-@^YZ5:]:J_^G'X5<
M1MR-28*B&)E0=O"]W<+7F1ME8]49G*#\<GG446G&&827;.-^X^#FF)W\SN?5
M1E5W[-E&/^V"MBR+7-/,+#-4:FO6RPSR5',HL@2C@A:(8M_>F.='FUJTLJ\5
M55OKW1>S!UDW8@F&5V12.8(*M)9&.$]TPB1TW\N>$<=N>WG9^1-=+QUN&L8?
M=^N54$I6'XRIMDSOB_[V8[7>W*OUPT<S:K5INF4PI;!4MK4N)6;-@W,!N18<
M2I+GADIRQ4KA%[FX#3R]\*6S&]C)!;;6UB;T5-9V:%CM <QWUOL1CN-4N#%/
M>'@C4] AKM]:7+_M</WH@*LW&?G!%)25'(<>E9[\X'C)4YYW#PUXZHXC>VWK
M4UJ*-"\)M/(\$*LR@;Q(%*09(9BBI$"%T];JV1&F%]@TO7NLA;XQS4OP7..8
M*R")'KOLT(@2KIQQ/7"(\G*4D<.2,TX>AR+G+AQ:.-3Q0B/U_G%I7B#S-S.=
MZRS#5,,",5LD9(5;2$[,O['"O/ X)=*I@\^E@:;V;G=VM9TB?.M[SJ#I]I:'
MP"CRR[XSL>WS< ,Z*T,6Y_3C$+@0Y\Q@(Q?=]+M\7&!SX?J!6ZBVX./S:KGJ
M=DV:I[=[)MM=/:FER$I60/.91^:+S\QJ)%<:4L)Q0;.B+*3O/JK3P--;C305
M,EU7F78;]6^^VZANJ#ONI09',O:&:@WAOL7;%C*MT7%* /V "KNYZC;TN#NL
M7G <;;/ZW7WE <]>KR4B,UVRK( BYQKBW*Q N$8IU'F9"<E*E*?*1\'RQ!A>
M(<H(VI7MVU&OTUN\O4LV3D'I>58SR0957XXX)' ;JA[WXYR_O%9KJ1Y'SYZQ
M7-TNJLX%ZWI2F;4.GR_K7W?7^.#M:FG',6%/G=?:5(9]K*HG)>VFQWLF?IRZ
MY)M:SU4UPSS1:6X6,511!G$I2LC3G,$$81.T<$V5=.J$%]7*J2V(=IU WO[C
M:P7FM1L-^9BX[X?]6U#5EGND?D:;XGX.F\S$16;!;9N^/1]OP-Y,;IUH<_S;
MXN./>Y/[OI[<DQ>";Y.9;X^,X2G,^TB)QZ\\_WXIS;'GI3<S.MK@XR58Q\;O
M($\[^F##5@:[ZO&[M0V)-\]WYH78V'2/?SW-'^TKU^0O2UX4><XE+(2TS7!%
M#GDB"LA+7F1EDNC2K4>=[\!3^ZKOBR%TEM^ VO8FHZFSWB]OW'L^W-8<,5".
M?YQZ!:C>RQ)?A(*N59P''W4!XPO)RU6-]_T#J<N>Y7Q5C^:']X-5RHSU?<T>
M[@PKKN3'Y8>5^3VFLX2EA)62F?4*,BL7A!2D.4<P*1A3B.=4(>%%6PZ#3HVR
M&NO ? FTM:_.^JC/'-=;/\!CXX@G6;G,@"-1!<8U,DDU9[8[>T%KL"&M+=BU
MT0&)R@.AL"3E,O"X!.4!Q1$Y^=Q[;4QU7DK^DPD&/V[4@TU02PM>R 32(M<0
M*\M0*4$VTS4G1.A49TY[*X-&GQI5.32( ']:ZT%M_N#@RF5B?".LP'!'9K!@
M2%\1<7D@%BGL<K'@E6(O#W#.!V ^#[GR:.F3,G3:]5=Z[KIY89UQ;KNCE8PG
M$-,2028*#3436*E48LF\V*U_N*G166L6V!W0+JS9P]NF74#;\R#J:@Q'.Y.J
M+;W9=E)[CM!'S0V5.$=5IX=\G5.K7O?/'F#UWS7@+.OC4JSM,]^IYO\_+NT7
MZ]V\$JLG\TNGI4X0*Q DF5G<86ES:"BR?^0T(9E2M"AG2_7==H]R.)/J'\WI
ME2B;5V)_S*@GV;6=X(UL+?Z;77)(^U&7K=4>IPP7P'8X&PH X%AY>!UR[_:1
MJ\.A=\&1\SAE"8?@2&<E5R'I=]+AADWO><6%1XQWZN#FR\'9@>,M83I8VD?O
MPL1;87Y+3PM+:;^O5U7UQ])8L+#-S6RRPF_*K!74/?LURW5"BB0SR];$%HAS
M64"*:0[3G".9YJA(2^3&QT'MFAYSU]:"IZVY8+&RRA_7]:<<-F=NT>)X\S"9
MA:_YNYU;H)FQG6/ >G8#>.T;,,[%:R=Y%=91&T@.L^Q56T9>!>:E)I'7/7S@
MTGO]G2WG_UU_YM^NEM5J,9?U'^H>8:KJ0H O>MMQ_IOYFUI I+)?#T,]3VME
MKOXV_[Z<Z[FPIS2B_JB8D/[./$\89_::0!",)$<$IH+E$)=:P5)@ I.2Z3(C
M*J>Y4Q.(UW)@:ML#=6_0YB!YYVS3ZW;766?/-;#S#73.>>X?C/V3<=R1F/ /
M(?8>QY[K-^# ^;9AX]Y/P_P<M@" '0)@!T';*;GW)P/^=&F2X;^!\DJ3&'9+
M9FPGQMWD>:4I.MHV>BT[!FQ$W<K_?&H+P.]7MU+.K6%L<<?F\N/R+7N<;]C"
M?,O?:ZW$ID[FZB0OOJGE?+6NA2_NUVQ9,5'7&\QPGM&2* X+DBK;2RF!%)78
MUGX7G.6($91U:Z5[QZ3JX%8.6#G=C_#)-#X 53MADQF >8M1J_NRV3/>8P,G
M_/0Z[):]SFR-\T';\PUL5F#G';#NV1VBUL$;NW8"C8]M;NU6RJ=QLYW9^ZG,
MK,=NWJO.\$@;@*\TTWY;A]$FHG>W,?RHXVU01D/L8$\SWBA#]1Q>[K'6F4(_
M5@OSC*II3_)UM5B8]?Y?;"UG*<V)MK+8J*0$8H(+2#.FH2P%8KC,D2Z8G\R#
MU_A36\J>.0S8]^'?0-=$Q_H!6D<\4WA\I\EM_1D1_-<YSKH&]P&J$X/0"RQ&
MX6?#R!H5@P ZEJX8]IB!68RV;]MOMFW;V]6#+49OHAY&18HQ1I#RQ,K;F!4,
M+;DT?T2)D&;Y0HO$*UWQY#!3H[?])G9BST[/_,/3D+IQU/5 1::BBXW^/INW
MA54_.M'?@!F%O="$31T\/=2X.8*][AXE _9?'5@Q?%:8F(@F/($)4AABF1FF
ML'_4)>*EXB1A"1LD*_%R)"^*&$%<XMZ.L9?I=ZP1'D@B_%II\ E11I\D^ @Z
MX'&3^HY&FX;N]\54OK,W#,PO.;VV:U4<$Z(T*7(%29D55EFB@"56*50YH8H0
M+%!.?,*)WM&F%E7L[9@\MCLFHK'7,QVD%V+'-(]0P$7?7CS898*[7:8($II.
MH(3-L^@=<=S\"1?GC_(BG&X:**!K@D?#2_;_[&+G)UO8W:/;S5NV7C\;XJI+
MXV<$)RG)"PI51A*(=4D@DR@U_RB$6;,PLVQ17J*Z+J-.C5FLM?77M ZXU<YN
M3]5=)\3=""8XCI&)9@MA_2][)M\ M@&=U8VZ1T#17A^4P@KY.HT\KKBO#QA'
M@K]>-X=1V]K)=-A3[;EL)>:V=1%WROPXEQOVW99F"6/56JFOZJ=:/IFP7I ,
M(2Q3B)G((2X(A661)U QPI2F4F8BNT9DZQKCIL9O5EA@M>YR8A[F"U5M5DME
MPJCGYCSJ#3.K"?#8N'1>Q2[^K#J<!K_B7$7FT--R2GO:2 ?>'=1W[3RT,]SY
M"#HG7W%&KU/.&FMF7U4P*^H,7RV2%6(*?+6QKAKS526Q0J!U20DKR!C#%A7W
M2OQ8KA:K[\_U'NE',\KRNSUFOJTJM>GZ:RLL$,U3!1'),H@EHK:,V:PL-#'_
M*PA/$Z]V9$ZC3NVC^[:N=]A:[K>4<,/9;2D1'+W(G\&=O; V&.PL!HW)$?8N
MO$ *NI)P&WG4E807&"]7$GXW#Z.A3ZOE=]LLRM:1[/433B@KD!04<DVL2#?+
M(:4Y@2H5J18$9R7-?7CG]#!3(QIK9=,ZR]IY<TVOYC.XNO',]6A%)I9A0'E3
M23\.0;GCS%"CDD6_NR_9X<+5H;+1WBFMUFO+/E8I_)[]LK+<(BMH021,"3+L
MP!6%I1(Y-'^%D&1,RX3[%=TZC>OT HQ:5-L9V?43V5@SKTTL.X6X&V^$0_&5
M-1%:5-N. />]J 9(&^M!*7*RV*F17SE%K >,RXEA?3</V.ILTWFJ^]4?R[_F
M2_E/9O-Z-M6L4"*E.K$[E;;L/T<E9"DOH-9FM<1$R;+4*3[I'65JX4EGITUZ
M?ZHM!7^UIGIL2YW%U&'', 12D3EE'Z3&2/#/@"!Y;,*% &NDW;0AH/EMAUT"
MHW=?Z^S-XVU07;+_8*?IXL4#J+"5MKIK3A^^Z.T>U8?5^J20^TPE*#'A6 Z1
MP,I$:9GAR#S)8)GDN"A33!#1;CW?AAG@\SL?I_=;)XLG=MO$WHIX R?#@5RC
M AS[T-K7]D"T,ABS7K[Q?^IX1#38XP.&&OZ4P>O*+AZT^3DSE"6T0"R'.LFL
MC%Z:&V[*$ICDG!"FF,PRZ5G%M/_\J45NM6%UKIWWXO  -N=EX% PXB_XM@NZ
M.HTNZ*KNE-.AUV\'8XR]4COEX(DUV<G+!J:^+5A5?=%M /-E79-!US]FISOT
MEBT62O[VW 4Z[875+$>(,IH:,(N20DRQAAQK"E5*N'GKF:*IG"W5QNTMO](:
MO_VC361.^/*TJ39L*6TR5[>,L_'W5MJ_L@44M4S//^;_9:[ZM\J6 -G.[4T7
MA3?-!8Y))J%F5%"4BEP@J'2)(289@ISS#/(DR87B:4$T\NLD/,:LCAIF=A9V
MK??F2S.I?#$79BZU6ML)?YVY<_M\C#@?L:-2ZXE]@5H;#?4U_=#V6ZOM/ *-
M2X _;U>_VSL"[C\&PC=L$N:5-HV;GAD&P*/$S4"/O6J?\U3P_1]-H>U,BH0R
ME4@H=6*"9J+-6EXE!50FAF9%H0A2PE>_QVGD 0<O8VCR[.]:V::F;4%RG3R]
MJGN4[RWTNPS-09N ?;/BM6UZ+<CC[Z&>:2C9&AT<S4'[JX%0?87-UH'H#MU[
M=0#*<2.V[TFOL2OKX-F9+5J7.X?LUYI07:VM@MRGN;#UC+=+^<62TGOCV.IA
M+IJOQNUBL?J+&4_MQLM:R?FF[NQ.M4RDU#E$26ZC;)+8KI<:,IYJEG%&D]2]
M\?55IDQM*V5K9:W#)FH[:RUKG^W;J^;&92MW+,1C!]!;/T#K2/UQK5T!G2]M
M@'P##J>F<:@6K1YM:CR^'J--T4A?E=A3Y;DO'P+=_CWZJT88<;\^!!*'>_=!
MGCA0?\..\]D,TQ7M-]N-;<G^+.,8L4(G,%.%_6R9A29/2@13A1#31)>:9'Z;
M0_T#3F_OIWG?VG2P-ZT"Q]]NP%(Y=G=Q1-IM*R<<>I$_- UL^Y9VR5]O6F//
M;Y7YZW(XH1)6G*-_R'$5.IS</Y+I<+MK&*UTT;BAJKOU2B@E*]N!OA[SX_*G
MJNR MV(S_UEOP<QH@M,,HPPJPDN();<[(>8?*$ES0JFBDO@H&0\T8Z+;(K6Y
M?F3CB[\;^\2 <^0-$!L=O>F,!_9=^EL;4FT= #L/PE'40.B"<I:O#:.2V$"
M7K+:T,=<1W/WJ[:8\&R?^EE!N9 4ES"7PD12*<XA%8;A\A1ICE+*=%Y>P7"7
M+9@HN=UUIZ,K;7O'U[8W8F>=X<.8SV%*_$@O$,+C;_BV9H/.[AM06W[3B*1=
M1'DPU;D#%H7E'(9_%8)SA^4<MWD\86"2R.DJZM^>;5G2[:]Y-4,9*7B!*20$
M&S8KBPS2,F508B50GF:%YEYJ:Q='G-JNY3EA GO6W!3/6:L]:PPOX^YXX!\2
MS>@[DM<!Z7]:[PI.V//XBZ..>^+N"L+1F;KSC7[44ZTWL[^S7_.'IX>V@E^G
M*<M+S:&J&[YSAB%+D8V:6(X94S@K2Q>*.7KRU*BD-<Z-*HYQZJ>$J[R/_.JW
M=@64+#CK;=^[;&[:>X_-GUZ^P\=/'>5=/>M,]TZ>OV"@=,"N=&*6,,EH6@BH
MDB2'6.L"VA(\*$B9Y$59%DRE/NK+>\_V>O]&TUOVKALYA9K;YWD@%I'?QD\.
M /@7_!^[&K;*?^_YXY;V'SMV5,]_XA*_%U.J^>R368HOWIN/[N:YC@!+3-.L
MS!04,I-V'X%"FE$!F<9$R33)*75JG7KBV5/[,-;F@<8^KWCZ%&[]K^:5:,1^
M-3V <'Y%>UP^\8I62OS[]]7/_V'N:MY.\R_U2UF_CJ>>-<KKV.-$]SKV73(@
M#>A_/3\:P^:=SA0JRI0FA8:9TM+60PC(<Z1AJA.E5)J7@E'GO)[#9T_M=>RL
M\TC^> %6_SMX)021W\'.L,O1ZD48/)):AL,Q4I;*Q1^%7YK):7][\T9>W#)>
M(LAI6P\R.\Y<,O"P8>\\X^]LTV:OWZU5EPE=BQ0O%M47_>W':KVQ6D+-D4?]
M7V<YHE07G$"1, UQR1)8<E["4J>DE 7/4^*E9WZE/5.CMX-#0?#0.%0W3J^L
M]8TZUGQGO^>QQ)63YWA6,=Z4Q#[ .)B-G2\W8,^;5E7=^%/7_>RFZ:/#-/F?
M:X0!-^QAQY4VC7L"$@; HV.10(\=V-U._%#R:5'KR8KUDY)[R[Y[QA=JVSM\
M1@NJB"AS2$IJ:^1Y BE-;,X+M;T_4\TT]TNF<Q_<Y]4>)[&NL[W1;*ZM!RY[
M$-?.@AN3QD$V,FE>@!3\65L.K.F@MCW@L8H_8&';Z;D//VZ+/6]8CMKN^3]A
M8'\MV^MS>])(4E%H(7-(66HE(0F&3/$44B03F6NDB\RK/>?!TZ<6^]7&#3^W
M/43.C6 &XQ&90]RA\&^"=<KEL$VO#D88M\G5*>>.FEJ=O&A@X'&R'>=>G]3J
MM^?=-6WN2&W E\>ZS_GO=;7SQ^6=6L]7\I_*%ADH>6N^_NR[>O_+5B14ZFX]
M%VI6J (7B#%8E%1"C!(.2UIJ*#(J*2^*/.6>&A$C6C^]T*>VW7R;W_SQ[9UM
M+=,H@WAJ1XPY_XXQTS3G-';0M=>M>-_O_9;%E<UF.=G6V'I_ UK_;\#OK<[(
M$C08W( .!=#" #H<0 U$[-['46=OA(;*<>R?0)?FJ!/CUOHYK@G#OHJ?U<8V
M:KM;KW[.I57U^*-NM/!AOF1+<9#Z?<NKS9J)S8SF7*<YXA APFVC:?-QDQ1#
M+BDK2D;2LO!<EOL;,;UO5-VL4"]6?[5;<+HS'K"M]?_3[XLU8&[</CQQ\8[\
M_3#&-YTA._/MM^*-]<!\!OX&MD[LE:68R+SU(V!T/AS$H#0^P(Q1V7@X3"])
M]8HG^:>1M(??4IJ?;F6>V/S+=LV:*BXH21EDC!*(A4Q@J<T_$,W+,B4L9]JI
M+=7EH::V]&^S*K;FWG3_ZK\=X(!S/Y^%12\R;UT'G%>:BALF@[)6+CQZM"06
M-Q?W<UH<[Q@61OU=L>II78=V'Y>/3YOM#Y@FBB8LY3 K,D,4!6>0IH6VG6(D
MTH6FJG3J+7MIH*G1Q)Z=H#9T^&[A66S=@IT0B$6FAF%@>4<LEY (&I><'6S4
MZ..2RR]CC(O7#]Q[M'JUK3J?+3K;/,\(PRRU_:9SRB7$C&>09<C*A:0%%PAG
M9>Z5,'X\A!<EC)8W7NW9^6]UT>K&LZ'E"3#3,F,9RW.HI,00YVD!&4\D3"5)
M$Z8*F<M\]EBOI;]MV-I1;?DZ2%\.%P_8W]BB5C)B&\#5]_ER:5<_MCRXMN!J
M<'4FS&\R1= $MJ5MA2@A+PF"E&M1YKG6B&4MN.^7CNW.0D#;#38*L,I*:@:#
MU'%_^"J08F_C'KS'C7G@=K-9S_G3ICXVWZS '5L'+94^CTC8K='C8<;=P3SK
MYM%&X_DKAY8R6X'U^K'U!F7UL9;PGA5(,ZI2#=/"YN*D!8:<8@2E3$J<Y$@I
MXKGI=V:D">[L[6O.MXKF ^7+SX#K1@<! (O,"2U2M8DWS?F-6>8V9H8L2.[%
M(7 9\NFQ1BX^[G7XN.2X__*AV=1M9\/CGR^1**_;V&2R3,T:U_9HUPF'7)0)
MECE/D5^/]O-#36V5N[4T!#OT(.Q&$&%PB\P1.\@.:"(X2UP&(W!B\=GA1LX9
MON3V<3KPQ3N&,<9Q<]1;(59/RTUUQYYMA'B[E,<I>K,4&_(HE;2MULW"."L*
M0R1UHZQ4,,Q5D9?"LS/6 #.FQC2=S5;&OXZN;2H_:W-6!]=B#YPB-SJ*#WQD
MJCK3G7D[%7=[4^&3D1V@8;,/DI$[.#N9\LHMG7W@NMSCV>MIP[CS/5O;79SJ
M3JUK1KY;KSZLU@]L>]"/$U9RFF)8$EU"S!,!2UO6SG.:,$TXY\I)[<5UP*GQ
MH<T"Z$2&K?C]W^J\P*X]F/7 ,]GB(N)NI!<2Q]@'DJVI-G6NB<)LL=@*U/9&
M29EP!2<H8UT<=%1N<H7@)0LYWS>@1+]K\72G-O,Z^^S#?&$6'3C#""<\@80H
M!+'49EG'"P2UR&2&$DI*YMYB_O08DV.5;5.TQ\Y.H*VA'L7K9]#LIX] &$5F
MC!T\6Q/!AS#P>-3X7P_32+7^_G#Y%?_W ]$K G#FUO'$ /IM/Q %N'#I ,([
MDYXK?LS5S_KLUPZVUI9?C2=OUW/#/7-FPKW5T^:K3>$U_U581=P$::6R4L!<
MV>ZN64Y@R1$S_\@2RB6A(G7JXAS4JJF1:F,AJ'.?P1M6 69C-6NIXP99V#ES
M(.+7F(G8QW5U,<5O1U47-V#/K8:JMHZ!SK,;T,YA[=P-:-U[C=GS^$Z\QBR.
M]&49=3;]/DJA4>_]C 4;;+P/7VA\#CZ5P1\^;/?B=S9?5K;9DJJ^+-__L@*X
M3_/J1V/ .\4WLU3RA..<PZQ,,XA+*^T@&8=)DG.$)=4"L4[=WVT#X^*83J_Q
MH9Y_Y ^CM1:\^<YLV<)J":0Q$J@#R_VV,"[#3A"7DA8IU$HG9DF72,AIPJ!F
M9<*R1"0TR0<T58B!_1B]%.H),,@?@FYYT\Y%:/#=-I#"8#E.4&%M!6\^U=MO
M!L;W1S"^ZX/1>_O(&9J@^T>71QUU \D9A)<[2.XW#DP0V'62^:H>VRXE7_1>
M-L(LDRD2R"8*L,PLEYC!FU.9P(Q(G1>%SCC'UW6M.C/R1/FG_ER#]=;FP3VK
MS@'NF#<0!K]7Z$RU,]>RS7[Z491.5!?0B=5\ZMRPK]5OZ@(,/2VF+MT9*KM^
M>VC#94DI)1@BF900*\9@B6S!LHDR"YMJC_+44XCC[& ^+\E(DF$G<NT]C\5Z
ML'4CES!XQ=X=<4]FCG(P=AFDR/G-KW,8=MGMR_G.5QZ =0_^M%I^MT*'GU<;
MU1WLOWU:VQF_7<K/QI_F#W41R_85D+I B&4E1#8U&FN*(,4"&]QY+ICDG @G
M<?FKK)C:?F]M?)<<<P-:^^LLF9T'+J]1P(ERXZKH\,<^GPN%O'_?BFN0"]OA
M8I EX_;"N :LHZX95SUL&%G:U>+'I7E4O=>]"^IN'VQ>U$PRGBF44RBL9C:F
M&8:4%%8<(<URBD2&-/)AQ?[AID9_._LD8+6%W882F&^=\..\"WB[D5LX%".S
MF#44["R]V5_E-<:&XRTW4((2U(4A1V4B-_=?4H[C70,%J8SEK/JQZSV\E%N%
MEX\;];#3.LH1$HB4"92JR" 6)NXJLSR!(B,4IRA!:<%]:,9YY*DQSK>GQ\=%
M?;QCZZOW-(V7JR6T+G425+Z+/_>Y<*.@* A'CZEJF_?:G=MP:J<R5=L=1V#*
M%ZVPNE+.HX\K)^4+RI&*E/<#!JI#_V3SA0W&/JS6W]A"?5.B5=JW]+G3W?^Z
M6IBG?/_?BJWO_UK=_UBOGK[_^##_J3ZP^?H?;/&D9HEA-%2('&;*-B*1,H54
M$@FSK!!*(9YFS"O7.YQI4V/"6[VQ"7=+!9Z-T6#3F RTL;G^&\_RF(!SZ$:0
MKS,S8\1S.T]NP-9+J%=K6#&[5FU]>S;_=5%3HXV>#=%^,VZ:CUGWG\$[\U],
M1-CX#U@]WU_,?+<8  L"L+B8<2P8H$8CH"9W\!D**^@=SKQQU<"#PWHD)1Y^
MA&$?AE94Y-L/I3:?[._-9NA8.:N$I1)E20DE(9;FE80TH3EDB6(IQX1+Y=5!
MX-Q 4R/M3F6E-A1TE@Z2"CN+K1O]AD L,ID. \N;YBXA$92TS@XV*@5=<ODE
MH5R\?A@]?'FL6\0OOW^RQ89=1>'S;B-O)G6)F4HSB%21&IXH2LA)FL.4<(Z2
M@FBMO0X=+HXX-<*P6YY-W[)59SI8U(6Z@PNA+Z/NQB!!L8Q,)5M;06WLS;9V
MV01A.X/#<8HS-D')Y?*HH[*,,P@OZ<;]QF&\LPUO]B00/ZS5OY[44CR_6SVP
M^7)&99IB;*6?L#WN+-("4D*8"5@REFF>9802'^9Q&'-JW+-;4Y@URYYLY]9L
M\&=CN&?DX@*_&P4%!C4R"0W$T)M\/% )2C\NXXY*0!Y O*0@GUM#'"Q^,#^9
M]HBKH(9M$,>0255 7"(">8DS:-BG$$FA69X0OSRN<T--+XOK]OOW=9V3"A[7
M\Z68/[+%]F#Q:5-MV%*:S\(U)XI[0&<D(X@0"87 $F*1:4BE3B I4,DQRTG.
MG2H:0\(\CI+72V@UV/Q0P+S6"#1Y%>'!'G)P.PS"L8]LK961#VN/@8AX3+LW
MV"L>T!Z[W'\T>^+ZH5)>YAU4U>;]+UM4IF9Y02F2)84IY@G$EIAY4I8PEZC@
MS 2'Z:Z.R(TG7HS@]-L>M5BK,Q"HQD)?H:U# -W>_"&@C"6-U:+Q_@(: [2N
M3OH<6,3J<(R1U:E..G@L.W7ZLH'IK7-AGF*/.TTLT70@^[NRL@JSHF1,J\S$
M4VE*($[,ZJY,%(<2(\5S$W2IPJM!Q=F1IO;%M_4'MH^:^>0O:IL56-LV:YX[
M1^>1=7O'@^ 5^6W?V@AV1H(_&S-#)I%>@B)LHNC9T<9-!KWD]%'"Y\4;_+M=
M[37#:?<:2I%+F9LOO.940TQL!UN4F']3!9>9+'F9.6WUG'SZU*C@L!&3U_[-
M:?3Z7_VK,8G\NOO!X=69ZJS;@YI1'3]MM/Y39QW9;SEU_B+_5_2MK759*_9V
M)=4,FR\T1U::C1*['9)GD&K-S2J=,Q."IU1(IXR@EP^>VHOYMJ[#,L8!:YW[
M&WD UN67<2@$D=]#1^^]7L!3K@YZ]PX>--IK=\K\_3?NY'\?%C)_51OSQBK9
M*2_>"O'T\+2P2\UW2L_%?#/3(BU54BB8$,8A3LO$*G\IF.N2*25MY:GPVY6\
M/.CT]B<[FX%JC?8+H!UP=HNDPV(7^=W>@K9587VS9R]H#3XOD.8=7+NC$S3*
M=AAVU'#;'8:7<;?'G5>4L>_K-MV97TR[EJ0EP:)$!412&*9)9&&81B*KXX,U
M+I,TU5ZY83UC32T&:+3.^)'6V8 Z]C/@NM%+(,@B\\H^6JWP MCK.Q]AU>Z
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M5LJZEH\M[MC<+%S>LL?YABT^K-9J_GW99*:*Y_LU6U:+9NMG>_>,I+HLDZR
M).$88F(+CD4J8<(*K72.,-78.2P(9=74@H#69B!:H\%F9S5@6[,]/A3!YL\A
M%'B-68G\X=]S"6Q68.<4L%[9_?C6KWJ?OIZ[SC6PYQNX?=6Y\_BDO\8<CO0!
M'W$N_3[6H3'O_30'&VR\#W%H? X^N\$?/FR;KBM7VU5T?%:;MM9C1DE:*O/U
MA$G.",0L32$WRVRSI.9)B:1*,^EU\-XWV-0^B=LZOEWIGD>/,R=XW7;K0H$6
M^XO5X?5U#R^FS52!V\5B]1<S[UO=3OBM"1[G&V"[]FVKX<+MZ;F@%71CKW?
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M]1M<O[LG'S;*Z]KG1O>&]EXS\'#:H7#]G\QN)VP^5M63DC,J,\V2DIN/>9E
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M=T*"4G<D4T>E^[APO_Q$1!YMP!G4QZ4ARSNVWJCJJ_HY5W]]T7<F4EQNVK.
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M4IOJ5OSK:;Y6\G8I/YF_GB\:,>6J>GHPER_-U^3[?'OQK$@1%2C7L*!EO6E
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M!P[K6//EXZ-<Z<70',Q++A=K67VT2R,+D(TP8%5)XV)\+ZK"9E;T26_HV>Z
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M]::/VE]5(]6/^F[:A^I%@'Z'$KV]W[BZ0LY2:V<7KJ)KK&+!+43#TZ>M]\C
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MJ1<@D<HA+:*<)8G^G;!JDG/JX5,S!!4HXV9&\1OV"VCAVF\PCMB[O*VXAI/
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M>(LWE(GJH2:@A3HUZBL:J!X2^NU3WXT#''2_/J_+A3155AY9N6@##)??%F:
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M4#:0KFZ]UUQ0(4 :%P@3(1 9?")!.$],#(8E$V5P=<S7X_0,7!'0.YQZD/K
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MDF\ .'>/[>.+69'K"#P$2I4E@>E2S6(2\=H&XCW"GT4,HW*=6_='R1FX@/<
M(-I?"PU Z7TWC4C]33W\-%UG<I=#U*]%1:UP$@]_(J@21(;HB0^6$B532IJ#
M<:).7>7&) Z;AJ]7,UY%10U@;]T:Z?6W<YBF\>("%8:&N>RC].O%XGVW^ ]8
M'NTCKG$O.NZ)3J5OG,EERF1*1*GLK8^XT5(=R[8IA0,7DM<!R(-XLH*V!I_P
M==6K<-7G]?+#^J)_/L(P-[+26=V6*WUI@B#!,2 )@M4F*05YLR&U3RXQ<$EX
M5=#T*-P&#-7OTQGXR?B?D&Z&2MSN6\"3 ".9(08A3Z34B3@I0IEIAZPYRHRM
M\[#E.X0-7/%]$+/4IVYZ3"?\ZR\/9/X.O['\T?(GY=]]A/Q3^>_O']_>66$R
M/O73]">,458?_ZN?C^==_G#KP_#GGR[.SOSLLLN?QJ?3<1['\BY\U188)?RA
MFXQCJ4VXP]M\?(9^\??LUE[K_7+#XWWNU\L^0%D]?N'; D\K2#_O.7MEA@2N
M!PX>=],YKI7\>MKP;2JO)U_ZR;4[> -SA2)FV:.MBP9A+JW&T,!HA*(3UG&6
ME:GS@KT7\O>>7[,/$65^Z*2;H].!O_VL_C^CRG^=E/*\F+2*%@0QG"[;(N#.
MCT4^7%#NE9*L4B/S0W,ZK/=Y^+WQ8'I.R\CJS7UIYD09ZF1IY81Y 2<-%2*Y
MQ!6Q69M2&!^)HU03X#(&F5A*ILX51!,GS5*Y)_F>YBY7?][:Q=Q#D J#D) T
MD:R\0XV<$LXE&)$A4ZB3;M^,OA_!JF^#P_M6O8(6F[@N_# ;=[-5&=1'B!,_
MGR\MS5*VUW/I7L$\SL;GJU<NGC.1M"/9,XM'(V(J>#PDC<^69Q%,8K7:<VY'
MZ; )C>$16U6S+:1!R@.8UQC+GZ'8YB/TRS0PY8GEM,Q60%?(,@O$9\,5!>]"
MK.-?WZ5CV"3'\*C;0RL-8.H]_''+PL^Z*7X95])YW-Y39V,J=73295'^",33
MTBV4@P/'J'256F=O2^FPU?+#X[*J9AM [GK$3'E<7=YJ%7F51ZO':.>[,YC=
MYTX9W'PY4I)C2$0*C&VM3YQX]% 2SRP%6Z>!\79T#ENS/CQJ*VJU"<Q>C<V<
M?Y[Y5%(>RU:-#\=J'DTFW1^EB<^;;O:JNPB+?#&YGCFW%,+()Z,28YQH4WKB
MBU([X0(0"((#993K5*N=5W]<#%NZW@+>!T)$ [OA\:X"JR89*(>WR"L>7E^A
M=-R]8C$9'Z(6G( .&&X*K4A@-))H&6->1:-SG?XZ.Q [;&'[\-BNK=\FT@FO
M_6R*#E9Y6+7D]_X)Y81428+"/8E!@50F$*>M)91R&K27SE;JQ?,=PH:M<A\>
MG'WJ[4>\M_Z\/),.?<>P7G7@&X;'>&_J?B&9E+G$XQUHS!B@94X"]0ZQ2KGW
MR=E0*0AOXG[AU7CN3T]GI1W&<JEUS+#4VLT&-KC+'$^4.!YX:2+MB%,T$RJS
MTHSCAJ9UTK8;D?<CW"YL@\+[YK=_'0Y=RO@I?H%T\=3$J'N,!6XT<U02X2S%
MDTLRXDLS?BJ .6]LI/<'%S]1W;C-JC_"_< NF*NKG@8"J=)&^A/$];RGHZ]^
M/"G\E,9M?G)_3TEON)!9DQ "2C!#J?GPFC >J ;$5ZK4(W<;*G^$2X6]S&,M
MC3: UIN=^!;E.#T=E^3&? [+\61_[;KTQW@RN<<B%3S(4.:(TP#E()#$ _4D
M,PI4*)]5K#,Y80=B?X2+AWVP6UN_@X;]]\Z2THZP-'/UDW?C"-/YJD_<_>-$
M>*IR&3S.4ID6*:,DCOE$A'*& R0CA=[RM-]HX1_A,J&' []_)35E1=?//-Z-
M?1A/EN?%/<Z4"EY$R<MLB=)+ D7HK#&$61$U4\ZF5-MX?H_&'^$:H!^;V:LV
MVS&53S817KYGFY>?'_WA9VG^N7M]=C[I+@'*<?%J/(.('W]/"/=$DIAUV7A&
ME"KO5V(VQ JF2$K16Q4LJD)M95]K4OLCW KL;92;@4,3=PBW8],KH:P[T2ZE
M<"6"9=OCJU=\Y=:DM*9=:6\^OSA;=9>_)PR+)L$ 'F:,B?*VJ[R,-WII,Z*P
M6BA9J==?1:9^A+N+?DZ+8?'2V.:Y?Z53K@#BTFI,+DH+[WLYGI!CI!39\RAV
M&6A"?\\:H@P58(U4(.ODAW<D>-CN"BV!OIZ>?\2+O/=^-O/EFOT5+/QX<O K
MO0?K#WRY][P\FKKF@Z"4BVB++:.X742TI9=-)J$88^<<5]#@"\J^KOEN-OR3
MH[>76WU$67D"Z!S!'1TP(G)  @=>QG$'EZ5U)M1Y2+0IA3_"9=\V6'S:=/>H
MR09R,.N!.1\\<O1YYC&$B4N7ZM?+VS\Y^C8NH^Z2XB8D8@T D3ZA^*RVA.'Q
ME[W6C*HZWL;F- [<K[ *1AY46U916&-0?-6=^?%TE$N7%Z\B<29%(@UZ/SXN
M!WC[)"BCAJHZ9O$A+<-"JY;6GP'7#BIH $1EIRTN?X/%ERZM+L<!?H.S +.1
M#L"XP&TF? JET!X]=V"&9.NHR%'BKJP#IJ=I:@=4NVC[?CEB/Z)O $373L3;
M*;H.%\ND1-E::+:I$P9(=)03J:T@7@9.<*,Y31V:;\JJ(.@)@@;NLGJ(XZX/
M532 J*7-QI5+!O@3S+Z.2P>K6][J#7?SS_B1\\=_M-ZD,6L> @I0E]IRC/X#
M\<M&Q2Y9$)"R]W4>$/3)Q;"FKQ=8=8WHN %\WYIIN#;YD64IF:1$4K\LAX@D
MZ"0)&* A*PG"U3EM'Y R+-*&0\7]YIM[J:@!C/VC9+VFBROB+<^V=$S*3* H
M(#+B-*";JX., J-\&NKTI[E#QK G<#/8VETU3=R__.HGY57BIR\ BW?=NMU&
M.0Z"]3XJH3&"XK%P(HA5K(QD [!X+AACZKQ\>HJB@5NB'\+CZT49#9BKQ_A8
M;S5D  6$OD4T#,430EBUVK!!<:=<SJK2A?;3- U[2/:C\PV M(,"&H#28^7^
M:UL+U%HG?"; (@K(H6RL9)ID0%L;9:20ZX2D3]/4'I1VT?J#A\"]J&! ,,UG
MB]'',AAQN;%2HAP4'N\B@2!2*+3062>2$]+OD@D@-\(-?NHMS.#?[N/ESK(#
MCW^M>7SM+MX6,'$%9<Y*\U1/G$$\2Q<3<<IX B$H294Q-FZ46=@<%4.:C#U4
M=E_I.\AO8+7_YK^-SR[.UH2+$&T(5A&?!<-X,)=)DQZQGQ2XE'),F^7&-U+\
MG:4'5OTNBNOZD.+0ZA]/;Q$>N(A!"H>4>B3<2D^"0.RKD'PP+NH(&\4YFZG_
M]M+#!-"]J7]G*3;@5;Y!XA?P;ORUS->X^\KIU\O?_']VL^/2@')UJ9@CEZ6:
M4NDRDDIS26S, 3TIZY%1)D.E,IXMB!QX5O:!;D.JJ*QM--XP]MZ?P=5-);/,
M"I9)F;^&.RX <=D@M\YD+8+P@M>9A+ EH8/?<]0!S.; W%M[#8#S8W?I)XO+
MH],9P.W0+^G@:<B6E$:[1'*6B/>>(R_1FF@=E[Y2_[K'"6H6;/N#X'ZE2@\:
M&=@%.RY5O3 [+^4712K+36@IS\)#)"9)(%)I(!:"(D)[*[*52?N-1B1NY(D]
M1L&PSQBKA^A["WWH:!W.UX]AKJ%_GZ6K^QQI6;94$.91.)(+B?LL.-2_9<YF
M1;WL#TD;DS5<N+>_YKO::ABZ_\_1/\>7W57)EE:*!\L)E=J71IP8'%$5"+<T
M,%"@T41_[\W%_0\=,-:OHZ^N!^$-K?1/, '<"FO*?98J*3R$[3(+QKDC7N!)
M"A8#6QH4Y<IOI/8['SM@E%]?\;L+L '/=OG8LA0'+,VA3U%2HU&?,:LRRUKC
MJ1H=X<;IY'R.NM*4W#MD#/N\_""!_.YB;P SCS][/RHE(*<K9_S7R\=?]=ZP
M/4U%JK>V'P7JK%?%9);^_9Z)TKN$EPY0V3"5J8M0!7HUN!DV#ML#7!NU/SZ@
MIAM ^T>8+V;CN(!TNW;.A>3 HE216CSA8XC$\91)A" Q_-1259K7^R@Y [][
M&APE#YZQ[*NR!G!W-%V,4WD./OX*-WWT7G^+DXL$:35=XNS\XNKAXX,7Y9>/
M?\#2)H@8?704B(IE3HJ6C 2-YQ>#J!P3RN9*Q9,5F1JVH\9AO(9&(-'L[KAE
M/QAE0E@=B,7_PQ L9^3' /$V&R.S9B'7J;'['F4#^P:M0&@C:.^HSP;PN3QX
M;A^'Q1Q<A8@6O3".1YOWH?3EYYYX0,Y8#. 2-2'H.E'6,T2UB,I=M7_?B>U)
M%0V@ZLFSY=UX"F\7<#8?!1.BPS,&3Q4EB0Q<$)\Y)5%9RU@6WL8Z!:'?IVW8
M]C\'.:%[5E #D'MLA-E59\?+=<O[CQ"[T^GXGY!&(+C490"IB-80"65K<2\(
MS5D[##6UB;6>?6U#Y[#FKF^4/'CI54UE+0"RW"*?Y/63HY/9LA/N^XMBSD_R
MS>%Q["<32+]>KG]OOO[%^8A215&H@2A5GKY%B9(%EHFRVG =J#"ZCF.X)^'#
M/C6K#=D#*G5[#+L5AJ>PJ(?@U]]*?^<Y?)B-(US_\)I#-O+*A6 15M%;0.^:
M!1*4Y41F:SD-CMM4I_W.3N0.^U!M"+3VJL FGD4^RN;)Q6*^\-.$42%Z2MZZ
MF 3A!M!3\DH3JT 3"I(&Q<#1S4H,^H'D+<J&?6<R!/IV54L#!_KS@T)^G\[
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M3&]A43,O8ZZEE!]S3,+EU0.C"S_YS2_*MR\'>CBS!Z4#OZOI2\9-/;NQWK
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MQZ<?1_2JS09\GF?X^?7R-_^?W>QXXN?S9=>KI*GD*E$,900>M8I:XJA@Q.I
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MX2ZG:2]B'Q@V'^'\8A:_^#E<@_\^2^L=YBE+2KJ2_4#A2 V,A!@XH9XY3LM
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M1 A>!K]=:=GVL!G3F1R@LKM*WT-^(ZO]-_Q[^O7\ZX9PM#)A'9%I"??D+9D
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MSX>WZQ#\%"=MFP0C)IU99L "A8-*2@YHF0.AK0_,"&&Q7>W]<9H$,Z="+,I
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MZN6/=U,,T[,:O==[6A=GH)%(CQ18E7JLI7*PX-UZ;FJ0TGCG; Q-X/0H69U
MZC#5SUOIH2=07;(RS<O?,E;K2^]G'^O%Y06EC2]Q.5W^.9N'95Y\KQ)\._MV
MOJ*7Y[-(?[66[%UQ; Y=?>V#KH($[0H)I#B*!-(Z]A=HT07O&MV8:\[:N. >
M$(8/ ;P+3(Q=6W'%P,65[-IJA[2SEL_%O=>Z@X*S'Q]*GN6_-\4 PK)$(K;
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M8#4;"E:MC02SQ$I")GRC4LN#R!XW_&\"V-;*.YU%]H:1?CC#&;W[CD@NI7%
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M;57PW(8(YWE=;VMX)V *O  $&FW_.CV4,>WP::[6[X+Z?\C(XTPVHQ"YA %
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MG7>A0P!]KI>[O/*&6/%I7_ TKYJ>_P]02P,$%     @ !)\"4R@P@2BL"
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M"@(!8HR!IFM;Z(C,R2Q!44'"@O81!7XL=8[]2&XH#)NUR93T(<##FNTB9@-
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M</GN@SJOI7G>ROY#YWF;L=UF;/>PL=VU[??B]W:@8%T'=CB)L?*%E2_PYM%
M%V;6' 6[</^Y7$6YX:.]XC?B\Y 4DHK+"3ZK: 5V<#S&$U%:\X>"S^-1+WAX
M>MVH]#&P?@Z;-8MO7O77M[O_ 5!+ 0(4 Q0    (  2? E.)"%YV7B$" 'G"
M&  1              "  0    !L9VYD+3(P,C$P-C,P+FAT;5!+ 0(4 Q0
M   (  2? E-#'L+.JA$  !.Y   1              "  8TA @!L9VYD+3(P
M,C$P-C,P+GAS9%!+ 0(4 Q0    (  2? E,D%2/V"B,  )5C 0 5
M      "  68S @!L9VYD+3(P,C$P-C,P7V-A;"YX;6Q02P$"% ,4    "  $
MGP)322&^E<UG  "P?00 %0              @ &C5@( ;&=N9"TR,#(Q,#8S
M,%]D968N>&UL4$L! A0#%     @ !)\"4S^.W(.#D@  *LH  !0
M     ( !H[X" &QG;F0M,C R,3 V,S!?9S$N:G!G4$L! A0#%     @ !)\"
M4Y73Q+X?  $ J; * !4              ( !6%$# &QG;F0M,C R,3 V,S!?
M;&%B+GAM;%!+ 0(4 Q0    (  2? E.>#!@E+X\  *>+!@ 5
M  "  :I1! !L9VYD+3(P,C$P-C,P7W!R92YX;6Q02P$"% ,4    "  $GP)3
M1)/%V;D(  #%.@  &               @ $,X00 ;&=N9%\V,S R,65X:&EB
M:70S,3$N:'1M4$L! A0#%     @ !)\"4R@P@2BL"   KCL  !@
M     ( !^^D$ &QG;F1?-C,P,C%E>&AI8FET,S$R+FAT;5!+ 0(4 Q0    (
M  2? E-G:D%)M@8  -@K   8              "  =WR! !L9VYD7S8S,#(Q
D97AH:6)I=#,R,2YH=&U02P4&      H "@"> @  R?D$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
